data_2ktl_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ktl _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 491' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.94 0.4 . . . . 0.0 110.687 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 492' ' ' ARG . . . . . 0.509 ' HA ' ' O ' ' A' ' 585' ' ' LEU . 0.1 OUTLIER -135.31 136.01 41.25 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.661 -179.835 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 493' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 586' ' ' VAL . 46.7 t -134.02 163.45 37.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.938 178.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 6.1 t -123.35 134.51 54.01 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 121.184 0.516 . . . . 0.0 111.377 178.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 495' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.47 163.31 51.74 Favored Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.422 179.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 496' ' ' PRO . . . . . 0.522 ' HG2' ' CD2' ' A' ' 499' ' ' LEU . 19.5 Cg_endo -58.51 119.87 7.39 Favored 'Trans proline' 0 CA--C 1.532 0.409 0 C-N-CA 122.235 1.957 . . . . 0.0 112.214 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 497' ' ' LYS . . . . . 0.465 ' CA ' ' HB ' ' A' ' 588' ' ' ILE . 2.1 ttpp -57.72 -30.04 65.22 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -179.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 498' ' ' SER . . . . . 0.401 ' O ' ' CD1' ' A' ' 501' ' ' TYR . 0.3 OUTLIER -60.86 -48.9 79.71 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -176.59 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 499' ' ' LEU . . . . . 0.522 ' CD2' ' HG2' ' A' ' 496' ' ' PRO . 3.1 pp -73.97 -8.24 55.38 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -178.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . 0.45 HG21 ' HA ' ' A' ' 497' ' ' LYS . 26.6 t -73.0 -25.8 22.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.286 0.565 . . . . 0.0 111.355 -179.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 501' ' ' TYR . . . . . 0.555 ' O ' ' CG2' ' A' ' 564' ' ' THR . 0.4 OUTLIER -53.88 -29.72 42.85 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 -178.69 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -72.04 -50.05 31.62 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 -175.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 503' ' ' LYS . . . . . 0.599 ' O ' ' CG ' ' A' ' 507' ' ' LYS . 7.4 mttt -119.38 133.94 55.47 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 118.694 0.679 . . . . 0.0 111.142 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 504' ' ' THR . . . . . 0.447 ' OG1' ' N ' ' A' ' 564' ' ' THR . 6.8 m -73.32 -76.61 0.12 Allowed 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . 0.532 ' CE2' ' CD1' ' A' ' 576' ' ' LEU . 0.3 OUTLIER -75.52 -60.08 2.46 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -179.471 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 506' ' ' SER . . . . . 0.722 ' O ' ' CD1' ' A' ' 510' ' ' TRP . 8.0 t -48.97 -72.69 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 -176.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 507' ' ' LYS . . . . . 0.702 ' HD3' ' N ' ' A' ' 508' ' ' VAL . 0.0 OUTLIER -48.82 -48.38 41.57 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -176.893 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 508' ' ' VAL . . . . . 0.702 ' N ' ' HD3' ' A' ' 507' ' ' LYS . 50.1 t -55.07 -58.71 3.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 509' ' ' LEU . . . . . 0.548 ' HG ' ' H ' ' A' ' 510' ' ' TRP . 2.0 pp -56.98 -60.1 4.08 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 -177.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 510' ' ' TRP . . . . . 0.86 ' CD1' ' HA ' ' A' ' 518' ' ' LYS . 63.2 p-90 -72.47 -51.77 18.73 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -176.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 511' ' ' SER . . . . . 0.525 ' N ' ' CE3' ' A' ' 510' ' ' TRP . 0.5 OUTLIER -66.35 -47.48 73.32 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -176.818 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 512' ' ' ALA . . . . . 0.415 ' CB ' ' O ' ' A' ' 508' ' ' VAL . . . -71.24 -72.81 0.2 Allowed 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 117.756 2.502 . . . . 0.0 117.756 -174.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 513' ' ' GLY . . . . . 0.505 ' H ' ' HE2' ' A' ' 584' ' ' LYS . . . -114.6 -35.57 1.4 Allowed Glycine 0 CA--C 1.5 -0.877 0 N-CA-C 121.39 3.316 . . . . 0.0 121.39 -172.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 514' ' ' LEU . . . . . 0.517 ' HG ' ' CG ' ' A' ' 584' ' ' LYS . 2.8 mt -108.16 -47.03 3.62 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 119.798 3.258 . . . . 0.0 119.798 -170.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 515' ' ' VAL . . . . . 0.556 ' O ' ' CA ' ' A' ' 510' ' ' TRP . 90.1 t -153.06 171.88 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.582 0 N-CA-C 117.073 2.249 . . . . 0.0 117.073 -172.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 516' ' ' ALA . . . . . 0.549 ' N ' ' CG1' ' A' ' 515' ' ' VAL . . . -69.09 3.04 2.3 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 113.012 -1.904 . . . . 0.0 109.366 175.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 517' ' ' SER . . . . . 0.881 ' O ' ' N ' ' A' ' 521' ' ' GLY . 0.4 OUTLIER -58.35 8.75 0.01 OUTLIER 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 115.43 1.641 . . . . 0.0 115.43 -172.122 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 518' ' ' LYS . . . . . 0.86 ' HA ' ' CD1' ' A' ' 510' ' ' TRP . 0.0 OUTLIER -45.8 -45.41 14.79 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 104.321 -2.474 . . . . 0.0 104.321 175.74 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 519' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.32 -56.43 4.88 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.427 -1.26 . . . . 0.0 109.706 173.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 520' ' ' GLU . . . . . 0.863 ' HB2' ' HA ' ' A' ' 517' ' ' SER . 9.3 mm-40 -63.64 -48.31 77.81 Favored 'General case' 0 C--N 1.351 0.654 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.02 -179.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 521' ' ' GLY . . . . . 0.881 ' N ' ' O ' ' A' ' 517' ' ' SER . . . -54.9 -53.55 39.14 Favored Glycine 0 CA--C 1.499 -0.929 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.443 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . 0.476 ' HA ' HG12 ' A' ' 525' ' ' ILE . 0.1 OUTLIER -47.82 -48.31 30.75 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.109 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 523' ' ' ARG . . . . . 0.442 ' HB3' ' O ' ' A' ' 520' ' ' GLU . 1.5 tpt180 -50.67 -48.71 58.32 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.095 178.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 524' ' ' ILE . . . . . 0.445 ' O ' ' ND2' ' A' ' 527' ' ' ASN . 34.0 mm -55.12 -54.07 28.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.352 0.596 . . . . 0.0 110.029 179.104 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 525' ' ' ILE . . . . . 0.487 HG12 ' O ' ' A' ' 521' ' ' GLY . 0.6 OUTLIER -50.5 -47.48 27.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 177.715 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 526' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -56.56 -48.28 77.69 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 113.996 -1.456 . . . . 0.0 108.521 177.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 527' ' ' ASN . . . . . 0.445 ' ND2' ' O ' ' A' ' 524' ' ' ILE . 0.0 OUTLIER -48.35 -39.45 22.18 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 113.784 -1.553 . . . . 0.0 108.003 176.924 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 528' ' ' ASN . . . . . 0.575 ' HA ' ' CG2' ' A' ' 556' ' ' ILE . 0.5 OUTLIER 74.51 40.19 0.42 Allowed 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.185 -178.775 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 529' ' ' GLY . . . . . . . . . . . . . . . -119.26 37.96 2.99 Favored Glycine 0 CA--C 1.521 0.466 0 CA-C-N 114.595 -1.184 . . . . 0.0 111.826 178.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 530' ' ' ALA . . . . . 0.677 ' O ' ' HB ' ' A' ' 556' ' ' ILE . . . -132.76 164.53 26.6 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.834 0.826 . . . . 0.0 112.42 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 531' ' ' TYR . . . . . 0.678 ' HE2' ' CD1' ' A' ' 553' ' ' PHE . 2.2 t80 -135.02 152.89 52.13 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 124.89 1.276 . . . . 0.0 109.061 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 532' ' ' VAL . . . . . 0.554 ' CB ' ' HB ' ' A' ' 554' ' ' THR . 0.4 OUTLIER -133.42 135.67 55.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 CA-C-O 121.807 0.813 . . . . 0.0 111.564 178.69 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 533' ' ' GLY . . . . . 0.73 ' O ' HG13 ' A' ' 575' ' ' ILE . . . -133.16 150.08 19.74 Favored Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 114.464 -1.244 . . . . 0.0 113.414 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 534' ' ' SER . . . . . 0.574 ' OG ' ' O ' ' A' ' 567' ' ' PHE . 0.5 OUTLIER -134.92 137.21 42.93 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.51 -0.345 . . . . 0.0 111.307 178.848 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 535' ' ' ARG . . . . . 0.521 ' O ' ' HB3' ' A' ' 573' ' ' LEU . 24.8 tpt85 . . . . . 0 C--N 1.33 -0.257 0 C-N-CA 120.657 -0.417 . . . . 0.0 112.077 178.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 . . . . . 0 N--CA 1.451 -0.396 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 550' ' ' ASP . . . . . 0.501 ' O ' ' HA ' ' A' ' 535' ' ' ARG . 96.2 m-20 -65.37 -46.24 80.92 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.487 179.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 551' ' ' LEU . . . . . . . . . . . . . 19.4 tp -131.57 141.96 49.81 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.426 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 552' ' ' THR . . . . . 0.564 ' O ' ' HA2' ' A' ' 533' ' ' GLY . 37.9 m -132.23 147.83 52.43 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.486 0.66 . . . . 0.0 111.441 179.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 553' ' ' PHE . . . . . 0.678 ' CD1' ' HE2' ' A' ' 531' ' ' TYR . 8.9 m-30 -132.27 139.45 48.25 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.463 -1.244 . . . . 0.0 107.927 179.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 554' ' ' THR . . . . . 0.554 ' HB ' ' CB ' ' A' ' 532' ' ' VAL . 0.4 OUTLIER -130.43 141.73 42.95 Favored Pre-proline 0 C--N 1.326 -0.434 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -178.727 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 555' ' ' PRO . . . . . 0.53 ' O ' ' CG2' ' A' ' 556' ' ' ILE . 78.8 Cg_endo -87.77 1.12 6.96 Favored 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 123.055 2.503 . . . . 0.0 110.152 177.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 556' ' ' ILE . . . . . 0.677 ' HB ' ' O ' ' A' ' 530' ' ' ALA . 7.0 tp 62.71 34.02 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.312 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 178.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . 0.643 ' O ' ' CE2' ' A' ' 559' ' ' TRP . 33.5 mttt -103.48 142.21 34.66 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 558' ' ' THR . . . . . . . . . . . . . 3.4 t -57.42 116.22 3.2 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 -171.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 559' ' ' TRP . . . . . 0.643 ' CE2' ' O ' ' A' ' 557' ' ' LYS . 0.0 OUTLIER -139.5 112.27 7.91 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 112.827 -1.988 . . . . 0.0 105.803 174.442 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 560' ' ' ASN . . . . . 0.559 ' O ' ' CG2' ' A' ' 564' ' ' THR . 77.6 m-20 -84.0 -76.64 0.29 Allowed 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 118.123 -1.431 . . . . 0.0 113.541 -176.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 561' ' ' ALA . . . . . 0.616 ' O ' HG23 ' A' ' 564' ' ' THR . . . -75.57 -50.33 15.91 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 -178.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 562' ' ' SER . . . . . . . . . . . . . 38.8 m -49.57 -54.83 16.0 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -177.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 563' ' ' LYS . . . . . 0.562 ' HG3' ' CD2' ' A' ' 559' ' ' TRP . 2.1 mmpt? -70.5 -47.79 58.79 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -178.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 564' ' ' THR . . . . . 0.616 HG23 ' O ' ' A' ' 561' ' ' ALA . 3.9 t -49.27 -71.35 0.07 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.578 0.227 . . . . 0.0 111.556 -178.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 565' ' ' GLN . . . . . 0.586 ' H ' HG22 ' A' ' 564' ' ' THR . 0.0 OUTLIER -49.37 -46.45 47.2 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.785 0.326 . . . . 0.0 111.518 179.786 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -49.15 -61.32 2.14 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 567' ' ' PHE . . . . . 0.574 ' O ' ' OG ' ' A' ' 534' ' ' SER . 0.2 OUTLIER -96.78 -40.68 8.84 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -177.529 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 568' ' ' ILE . . . . . 0.515 ' N ' ' CD1' ' A' ' 567' ' ' PHE . 0.9 OUTLIER -62.81 8.09 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -179.413 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 569' ' ' ILE . . . . . 0.468 ' H ' ' C ' ' A' ' 567' ' ' PHE . 0.8 OUTLIER -55.04 -40.39 54.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 178.482 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 570' ' ' ASP . . . . . 0.564 ' OD2' ' HB2' ' A' ' 574' ' ' LEU . 5.7 m-20 33.85 61.27 0.49 Allowed 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 114.04 -1.436 . . . . 0.0 112.576 173.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 571' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 570' ' ' ASP . . . -51.94 -45.45 56.07 Favored Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 116.856 -2.592 . . . . 0.0 108.222 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 572' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -120.8 -16.07 8.24 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 175.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 573' ' ' LEU . . . . . 0.521 ' HB3' ' O ' ' A' ' 535' ' ' ARG . 1.5 tp -139.87 136.95 34.48 Favored 'General case' 0 C--N 1.354 0.794 0 N-CA-C 116.591 2.071 . . . . 0.0 116.591 -176.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 574' ' ' LEU . . . . . 0.564 ' HB2' ' OD2' ' A' ' 570' ' ' ASP . 0.1 OUTLIER -135.11 133.24 39.03 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 173.503 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 575' ' ' ILE . . . . . 0.73 HG13 ' O ' ' A' ' 533' ' ' GLY . 0.0 OUTLIER -134.72 138.3 49.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 119.087 0.858 . . . . 0.0 111.448 177.893 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 576' ' ' LEU . . . . . 0.532 ' CD1' ' CE2' ' A' ' 505' ' ' PHE . 0.1 OUTLIER -132.52 135.61 46.1 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 177.889 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 577' ' ' LYS . . . . . . . . . . . . . 12.0 mtpt -132.6 135.8 46.12 Favored 'General case' 0 C--N 1.31 -1.125 0 C-N-CA 119.593 -0.843 . . . . 0.0 110.582 178.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.75 131.83 51.23 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 177.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 579' ' ' GLY . . . . . . . . . . . . . . . -90.49 -2.27 73.41 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 115.432 -0.804 . . . . 0.0 113.424 -178.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 580' ' ' LYS . . . . . 0.488 ' O ' ' CD1' ' A' ' 581' ' ' TRP . 0.0 OUTLIER -73.33 -48.22 36.14 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 119.043 -1.063 . . . . 0.0 109.097 179.338 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 581' ' ' TRP . . . . . 0.488 ' CD1' ' O ' ' A' ' 580' ' ' LYS . 24.1 m0 -139.07 -52.38 0.55 Allowed 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 114.606 1.335 . . . . 0.0 114.606 177.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 582' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.55 165.44 27.24 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -174.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 583' ' ' MET . . . . . . . . . . . . . 7.6 ttt -117.46 134.29 55.01 Favored 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 106.46 -1.681 . . . . 0.0 106.46 174.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 584' ' ' LYS . . . . . 0.517 ' CG ' ' HG ' ' A' ' 514' ' ' LEU . 1.4 tmmt? -128.41 133.6 48.62 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 178.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 585' ' ' LEU . . . . . 0.509 ' O ' ' HA ' ' A' ' 492' ' ' ARG . 0.0 OUTLIER -125.98 136.72 53.32 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.921 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 586' ' ' VAL . . . . . 0.462 HG21 ' HD3' ' A' ' 584' ' ' LYS . 24.8 t -131.06 144.91 36.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.554 -177.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 587' ' ' SER . . . . . 0.403 ' N ' HG12 ' A' ' 586' ' ' VAL . 49.8 m -107.21 135.63 48.4 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 177.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . 0.509 ' CG1' ' HB2' ' A' ' 570' ' ' ASP . 23.0 pt -133.58 137.63 52.46 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.508 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -178.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 7.7 m -132.63 137.1 54.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 114.31 -1.314 . . . . 0.0 110.603 178.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 590' ' ' SER . . . . . . . . . . . . . 1.7 t . . . . . 0 C--N 1.326 -0.445 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.753 -179.819 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 491' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.113 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 492' ' ' ARG . . . . . 0.501 ' CG ' ' HG ' ' A' ' 585' ' ' LEU . 0.0 OUTLIER -135.27 134.05 39.56 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.061 178.759 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 493' ' ' VAL . . . . . 0.495 ' HB ' ' CA ' ' A' ' 513' ' ' GLY . 39.4 t -136.06 163.41 34.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.373 178.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 53.5 m -125.41 133.66 52.42 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.119 0.485 . . . . 0.0 110.298 177.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 495' ' ' LEU . . . . . 0.412 HD21 HG21 ' A' ' 588' ' ' ILE . 0.0 OUTLIER -136.08 163.89 47.02 Favored Pre-proline 0 CA--C 1.53 0.196 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.578 179.686 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -54.37 119.65 6.73 Favored 'Trans proline' 0 CA--C 1.532 0.414 0 C-N-CA 121.931 1.754 . . . . 0.0 111.515 178.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 497' ' ' LYS . . . . . 0.478 ' CA ' ' HB ' ' A' ' 588' ' ' ILE . 0.8 OUTLIER -62.0 -30.28 70.83 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -179.204 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 498' ' ' SER . . . . . . . . . . . . . 2.1 m -58.15 -47.4 83.48 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -178.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 2.2 pp -72.81 -7.83 52.61 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -178.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . 0.437 ' CG1' ' CG2' ' A' ' 568' ' ' ILE . 42.9 t -74.46 -25.83 19.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.374 0.607 . . . . 0.0 111.243 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 501' ' ' TYR . . . . . 0.609 ' O ' ' CG2' ' A' ' 564' ' ' THR . 0.3 OUTLIER -53.86 -29.46 41.48 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 -178.449 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 502' ' ' ASP . . . . . 0.406 ' N ' ' CD1' ' A' ' 501' ' ' TYR . 8.6 m-20 -75.56 -50.15 16.45 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 -175.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 503' ' ' LYS . . . . . 0.588 ' O ' ' CG ' ' A' ' 507' ' ' LYS . 0.2 OUTLIER -119.23 135.11 54.84 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 118.868 0.758 . . . . 0.0 111.298 -179.656 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 504' ' ' THR . . . . . 0.426 ' OG1' ' N ' ' A' ' 564' ' ' THR . 2.2 m -73.32 -76.52 0.12 Allowed 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . 0.511 ' CZ ' ' HB2' ' A' ' 530' ' ' ALA . 0.3 OUTLIER -75.61 -60.39 2.33 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 -179.414 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 506' ' ' SER . . . . . 0.775 ' O ' ' CD1' ' A' ' 510' ' ' TRP . 8.0 t -48.97 -72.79 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -175.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 507' ' ' LYS . . . . . 0.699 ' HD3' ' N ' ' A' ' 508' ' ' VAL . 0.0 OUTLIER -49.37 -48.28 46.96 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -177.021 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 508' ' ' VAL . . . . . 0.699 ' N ' ' HD3' ' A' ' 507' ' ' LYS . 50.9 t -51.65 -60.72 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 509' ' ' LEU . . . . . 0.542 ' CD1' ' N ' ' A' ' 510' ' ' TRP . 2.6 pp -58.37 -61.06 2.86 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 115.753 1.76 . . . . 0.0 115.753 -176.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 510' ' ' TRP . . . . . 0.838 ' CD1' ' HA ' ' A' ' 518' ' ' LYS . 66.7 p-90 -72.38 -52.14 17.34 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -176.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 511' ' ' SER . . . . . 0.509 ' N ' ' CE3' ' A' ' 510' ' ' TRP . 1.4 t -64.79 -47.8 76.77 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -177.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 512' ' ' ALA . . . . . 0.435 ' CB ' ' O ' ' A' ' 508' ' ' VAL . . . -71.4 -72.84 0.2 Allowed 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 117.728 2.492 . . . . 0.0 117.728 -174.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 513' ' ' GLY . . . . . 0.574 ' H ' ' HE2' ' A' ' 584' ' ' LYS . . . -114.55 -35.06 1.47 Allowed Glycine 0 CA--C 1.503 -0.701 0 N-CA-C 121.24 3.256 . . . . 0.0 121.24 -172.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 514' ' ' LEU . . . . . 0.504 ' HG ' ' CG ' ' A' ' 584' ' ' LYS . 3.2 mt -107.5 -46.37 3.86 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 119.356 3.095 . . . . 0.0 119.356 -170.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 515' ' ' VAL . . . . . 0.551 ' CG2' ' N ' ' A' ' 516' ' ' ALA . 2.4 p -154.6 173.1 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.646 0 N-CA-C 117.619 2.451 . . . . 0.0 117.619 -172.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 516' ' ' ALA . . . . . 0.551 ' N ' ' CG2' ' A' ' 515' ' ' VAL . . . -67.94 4.05 1.32 Allowed 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 126.599 1.96 . . . . 0.0 109.864 177.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 517' ' ' SER . . . . . 0.861 ' HA ' ' HB3' ' A' ' 520' ' ' GLU . 0.6 OUTLIER -57.7 9.19 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 116.133 1.901 . . . . 0.0 116.133 -171.972 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 518' ' ' LYS . . . . . 0.838 ' HA ' ' CD1' ' A' ' 510' ' ' TRP . 0.6 OUTLIER -45.43 -47.42 13.75 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 104.268 -2.493 . . . . 0.0 104.268 175.398 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 519' ' ' SER . . . . . . . . . . . . . 68.5 p -74.98 -58.16 3.45 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 114.531 -1.213 . . . . 0.0 110.178 173.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 520' ' ' GLU . . . . . 0.861 ' HB3' ' HA ' ' A' ' 517' ' ' SER . 2.7 tp10 -59.9 -47.61 85.07 Favored 'General case' 0 C--N 1.35 0.598 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.747 -178.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 521' ' ' GLY . . . . . 0.832 ' N ' ' O ' ' A' ' 517' ' ' SER . . . -49.75 -55.4 14.37 Favored Glycine 0 CA--C 1.493 -1.3 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . 0.456 ' HA ' HG12 ' A' ' 525' ' ' ILE . 14.3 mt-30 -47.68 -47.82 29.47 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 523' ' ' ARG . . . . . 0.51 ' HB3' ' O ' ' A' ' 520' ' ' GLU . 0.1 OUTLIER -50.7 -49.01 58.56 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.536 178.475 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 524' ' ' ILE . . . . . 0.492 ' O ' ' ND2' ' A' ' 527' ' ' ASN . 36.0 mm -56.65 -54.99 22.09 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 CA-C-O 121.352 0.596 . . . . 0.0 109.883 179.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 525' ' ' ILE . . . . . 0.551 HG12 ' O ' ' A' ' 521' ' ' GLY . 0.5 OUTLIER -50.22 -47.2 25.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 177.739 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 526' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -55.03 -48.05 73.92 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 113.764 -1.562 . . . . 0.0 108.506 177.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 527' ' ' ASN . . . . . 0.492 ' ND2' ' O ' ' A' ' 524' ' ' ILE . 0.0 OUTLIER -48.17 -39.99 22.6 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 113.957 -1.474 . . . . 0.0 107.734 177.124 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 528' ' ' ASN . . . . . 0.628 ' HA ' HG21 ' A' ' 556' ' ' ILE . 0.2 OUTLIER 73.65 40.26 0.5 Allowed 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.349 -179.373 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 529' ' ' GLY . . . . . . . . . . . . . . . -119.68 32.71 4.9 Favored Glycine 0 CA--C 1.524 0.616 0 CA-C-N 115.0 -1.0 . . . . 0.0 112.597 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 530' ' ' ALA . . . . . 0.891 ' O ' ' HB ' ' A' ' 556' ' ' ILE . . . -133.48 164.57 26.85 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.246 0.546 . . . . 0.0 112.438 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 531' ' ' TYR . . . . . 0.551 ' HA ' ' O ' ' A' ' 554' ' ' THR . 0.0 OUTLIER -133.99 155.82 49.28 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 177.648 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 532' ' ' VAL . . . . . 0.545 ' CB ' ' HB ' ' A' ' 554' ' ' THR . 0.5 OUTLIER -129.17 136.34 59.79 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 CA-C-O 121.789 0.804 . . . . 0.0 111.894 179.929 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 533' ' ' GLY . . . . . 0.747 ' O ' HG13 ' A' ' 575' ' ' ILE . . . -132.33 147.13 18.69 Favored Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 114.442 -1.254 . . . . 0.0 113.504 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 534' ' ' SER . . . . . 0.427 ' C ' ' HD2' ' A' ' 535' ' ' ARG . 3.4 m -134.7 136.73 42.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.248 -0.476 . . . . 0.0 111.43 179.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 535' ' ' ARG . . . . . 0.574 ' HG2' ' CD2' ' A' ' 573' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.266 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.966 178.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 2.3 p30 . . . . . 0 N--CA 1.451 -0.424 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 550' ' ' ASP . . . . . 0.488 ' O ' ' HA ' ' A' ' 535' ' ' ARG . 0.5 OUTLIER -58.66 -47.81 83.19 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.396 179.39 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 551' ' ' LEU . . . . . . . . . . . . . 7.1 tp -131.36 142.48 50.08 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.43 -0.805 . . . . 0.0 108.969 178.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 552' ' ' THR . . . . . 0.646 ' O ' ' HA2' ' A' ' 533' ' ' GLY . 4.3 m -132.94 147.65 52.28 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.756 0.789 . . . . 0.0 112.395 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 553' ' ' PHE . . . . . 0.543 ' HA ' ' CE2' ' A' ' 531' ' ' TYR . 17.4 m-85 -133.71 136.95 44.99 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 176.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 554' ' ' THR . . . . . 0.551 ' O ' ' HA ' ' A' ' 531' ' ' TYR . 1.2 m -133.66 138.67 31.57 Favored Pre-proline 0 C--N 1.308 -1.224 0 C-N-CA 119.822 -0.751 . . . . 0.0 110.492 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 555' ' ' PRO . . . . . 0.593 ' O ' HG23 ' A' ' 556' ' ' ILE . 65.7 Cg_endo -83.49 19.24 1.37 Allowed 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 121.898 1.732 . . . . 0.0 111.764 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 556' ' ' ILE . . . . . 0.891 ' HB ' ' O ' ' A' ' 530' ' ' ALA . 4.5 tp 62.66 34.01 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.188 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 176.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . 0.599 ' O ' ' CE2' ' A' ' 559' ' ' TRP . 0.0 OUTLIER -103.82 126.03 50.66 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 179.897 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 558' ' ' THR . . . . . . . . . . . . . 3.6 t -57.81 118.22 5.09 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 115.413 1.634 . . . . 0.0 115.413 -172.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 559' ' ' TRP . . . . . 0.599 ' CE2' ' O ' ' A' ' 557' ' ' LYS . 0.0 OUTLIER -138.5 130.7 28.56 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 175.214 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 560' ' ' ASN . . . . . 0.577 ' O ' ' CG2' ' A' ' 564' ' ' THR . 11.0 m-80 -90.88 -76.32 0.44 Allowed 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 118.305 -1.358 . . . . 0.0 114.116 -177.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 561' ' ' ALA . . . . . 0.69 ' O ' HG23 ' A' ' 564' ' ' THR . . . -75.23 -57.29 3.98 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 116.368 1.988 . . . . 0.0 116.368 -177.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 562' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -49.0 -52.48 24.72 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -176.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 563' ' ' LYS . . . . . 0.564 ' HG2' ' CE2' ' A' ' 559' ' ' TRP . 0.0 OUTLIER -70.8 -48.01 56.47 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -178.412 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 564' ' ' THR . . . . . 0.69 HG23 ' O ' ' A' ' 561' ' ' ALA . 6.8 t -49.63 -69.37 0.12 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.867 0.365 . . . . 0.0 111.288 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 565' ' ' GLN . . . . . 0.563 ' H ' ' CG2' ' A' ' 564' ' ' THR . 2.0 tp60 -50.07 -46.62 53.48 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 566' ' ' GLU . . . . . 0.433 ' HG2' ' CD1' ' A' ' 567' ' ' PHE . 14.0 tt0 -49.24 -65.42 0.57 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 111.863 0.319 . . . . 0.0 111.863 -178.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 567' ' ' PHE . . . . . 0.585 ' C ' ' H ' ' A' ' 569' ' ' ILE . 0.0 OUTLIER -97.18 -51.52 4.17 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.747 0.784 . . . . 0.0 112.007 -178.973 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 568' ' ' ILE . . . . . 0.572 ' CG1' ' HA ' ' A' ' 564' ' ' THR . 12.0 mm -57.26 9.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 114.321 -1.309 . . . . 0.0 113.321 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 569' ' ' ILE . . . . . 0.585 ' H ' ' C ' ' A' ' 567' ' ' PHE . 0.9 OUTLIER -53.87 -39.03 38.23 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.845 0 N-CA-C 104.266 -2.494 . . . . 0.0 104.266 178.154 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 570' ' ' ASP . . . . . 0.471 ' OD2' ' HB2' ' A' ' 574' ' ' LEU . 32.5 m-20 35.45 50.0 0.53 Allowed 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 113.726 -1.579 . . . . 0.0 111.342 174.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -50.54 -44.13 46.03 Favored Glycine 0 N--CA 1.439 -1.101 0 C-N-CA 118.37 -1.871 . . . . 0.0 109.051 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 572' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -118.44 -18.09 9.24 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 120.252 -0.579 . . . . 0.0 112.16 175.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 573' ' ' LEU . . . . . 0.574 ' CD2' ' HG2' ' A' ' 535' ' ' ARG . 0.7 OUTLIER -141.2 137.68 32.8 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 574' ' ' LEU . . . . . 0.471 ' HB2' ' OD2' ' A' ' 570' ' ' ASP . 1.1 tp -133.98 131.94 39.54 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 174.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 575' ' ' ILE . . . . . 0.747 HG13 ' O ' ' A' ' 533' ' ' GLY . 0.0 OUTLIER -134.64 137.19 51.58 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-N 118.557 0.617 . . . . 0.0 111.612 178.802 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 576' ' ' LEU . . . . . 0.5 HD21 ' HB3' ' A' ' 584' ' ' LYS . 0.0 OUTLIER -133.08 135.67 45.44 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 177.375 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 577' ' ' LYS . . . . . 0.412 ' HG2' ' HB2' ' A' ' 583' ' ' MET . 7.5 mttt -130.62 135.59 48.02 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.254 177.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -124.88 132.01 53.36 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 579' ' ' GLY . . . . . . . . . . . . . . . -89.55 -2.19 76.6 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 115.229 -0.896 . . . . 0.0 113.251 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 580' ' ' LYS . . . . . 0.491 ' O ' ' CD1' ' A' ' 581' ' ' TRP . 0.0 OUTLIER -72.56 -48.46 39.9 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 118.957 -1.097 . . . . 0.0 108.815 179.27 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 581' ' ' TRP . . . . . 0.491 ' CD1' ' O ' ' A' ' 580' ' ' LYS . 25.5 m0 -139.29 -53.02 0.55 Allowed 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 114.452 1.278 . . . . 0.0 114.452 177.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 582' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.38 165.18 28.13 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -174.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 583' ' ' MET . . . . . 0.412 ' HB2' ' HG2' ' A' ' 577' ' ' LYS . 0.3 OUTLIER -113.97 134.78 54.62 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 174.156 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 584' ' ' LYS . . . . . 0.574 ' HE2' ' H ' ' A' ' 513' ' ' GLY . 1.4 tmmt? -120.77 133.85 55.31 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 177.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 585' ' ' LEU . . . . . 0.501 ' HG ' ' CG ' ' A' ' 492' ' ' ARG . 1.4 tp -118.8 136.32 54.06 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 586' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 493' ' ' VAL . 2.5 t -132.88 137.15 54.46 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -177.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 587' ' ' SER . . . . . . . . . . . . . 55.6 m -109.35 134.95 51.19 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 177.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . 0.478 ' HB ' ' CA ' ' A' ' 497' ' ' LYS . 0.2 OUTLIER -134.6 152.63 33.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -178.649 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 4.6 t -122.6 138.82 51.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 114.031 -1.441 . . . . 0.0 110.781 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 590' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.327 -0.381 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.163 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 491' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.284 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 492' ' ' ARG . . . . . 0.45 ' HG2' ' HB3' ' A' ' 585' ' ' LEU . 0.0 OUTLIER -134.32 133.12 40.34 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.726 177.366 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 493' ' ' VAL . . . . . 0.47 ' CG2' ' CA ' ' A' ' 513' ' ' GLY . 44.5 t -136.98 163.69 31.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 494' ' ' THR . . . . . 0.422 ' N ' ' CG1' ' A' ' 493' ' ' VAL . 32.3 p -117.69 134.25 55.09 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 121.147 0.498 . . . . 0.0 110.127 177.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 495' ' ' LEU . . . . . 0.543 ' O ' HG21 ' A' ' 588' ' ' ILE . 0.0 OUTLIER -135.22 164.4 44.08 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.377 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 496' ' ' PRO . . . . . 0.409 ' HD2' ' CD1' ' A' ' 495' ' ' LEU . 11.9 Cg_exo -69.63 119.39 6.35 Favored 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 122.065 1.844 . . . . 0.0 111.199 178.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 497' ' ' LYS . . . . . 0.495 ' N ' HG21 ' A' ' 588' ' ' ILE . 2.4 ttpt -57.43 -30.21 64.79 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -178.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 498' ' ' SER . . . . . 0.418 ' O ' ' CD1' ' A' ' 501' ' ' TYR . 0.3 OUTLIER -59.14 -48.7 80.66 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 114.414 1.264 . . . . 0.0 114.414 -176.757 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 1.5 pp -74.2 -10.24 59.41 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -178.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . 0.499 HG12 HG22 ' A' ' 508' ' ' VAL . 20.8 t -76.54 -27.21 17.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.337 0.589 . . . . 0.0 111.88 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 501' ' ' TYR . . . . . 0.53 ' O ' HG23 ' A' ' 564' ' ' THR . 0.3 OUTLIER -54.09 -30.6 49.03 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -177.704 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 502' ' ' ASP . . . . . 0.432 ' N ' ' CD1' ' A' ' 501' ' ' TYR . 4.6 t0 -75.78 -51.3 12.94 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 -175.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 503' ' ' LYS . . . . . 0.583 ' HB3' ' HG2' ' A' ' 507' ' ' LYS . 0.0 OUTLIER -120.59 140.6 51.28 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 118.76 0.709 . . . . 0.0 110.572 178.936 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 504' ' ' THR . . . . . 0.511 ' O ' HG21 ' A' ' 508' ' ' VAL . 3.3 m -72.6 -74.4 0.17 Allowed 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -178.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . 0.53 ' CD2' HD12 ' A' ' 556' ' ' ILE . 0.2 OUTLIER -73.3 -57.63 3.88 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -177.262 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 506' ' ' SER . . . . . 0.849 ' O ' ' CD1' ' A' ' 510' ' ' TRP . 10.1 t -48.8 -66.38 0.41 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -176.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 507' ' ' LYS . . . . . 0.583 ' HG2' ' HB3' ' A' ' 503' ' ' LYS . 0.0 OUTLIER -48.75 -56.13 9.51 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -176.849 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 508' ' ' VAL . . . . . 0.56 HG12 ' HG ' ' A' ' 574' ' ' LEU . 48.4 t -49.9 -61.14 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -179.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 509' ' ' LEU . . . . . 0.55 ' CD1' ' N ' ' A' ' 510' ' ' TRP . 2.5 pp -54.27 -63.07 1.27 Allowed 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 115.626 1.713 . . . . 0.0 115.626 -177.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 510' ' ' TRP . . . . . 0.853 ' CD1' ' HA ' ' A' ' 518' ' ' LYS . 66.3 p-90 -72.85 -51.39 18.95 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 -175.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 511' ' ' SER . . . . . 0.529 ' N ' ' CE3' ' A' ' 510' ' ' TRP . 0.3 OUTLIER -64.39 -47.19 80.18 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.299 -0.864 . . . . 0.0 113.305 -176.753 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 512' ' ' ALA . . . . . 0.484 ' HB2' HD21 ' A' ' 495' ' ' LEU . . . -70.92 -73.79 0.16 Allowed 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 118.158 2.651 . . . . 0.0 118.158 -173.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 513' ' ' GLY . . . . . 0.605 ' H ' ' HE2' ' A' ' 584' ' ' LYS . . . -115.48 -34.98 1.35 Allowed Glycine 0 CA--C 1.501 -0.825 0 N-CA-C 120.84 3.096 . . . . 0.0 120.84 -172.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 514' ' ' LEU . . . . . 0.603 ' HG ' ' HB2' ' A' ' 584' ' ' LYS . 0.1 OUTLIER -106.86 -46.53 3.93 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 119.473 3.138 . . . . 0.0 119.473 -169.887 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 515' ' ' VAL . . . . . 0.544 ' CG2' ' N ' ' A' ' 516' ' ' ALA . 2.5 p -154.4 172.29 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 N-CA-C 117.981 2.585 . . . . 0.0 117.981 -172.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 516' ' ' ALA . . . . . 0.544 ' N ' ' CG2' ' A' ' 515' ' ' VAL . . . -68.62 3.71 1.74 Allowed 'General case' 0 C--N 1.333 -0.109 0 C-N-CA 126.741 2.016 . . . . 0.0 110.012 177.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 517' ' ' SER . . . . . 0.855 ' HA ' ' HB3' ' A' ' 520' ' ' GLU . 0.6 OUTLIER -57.84 9.1 0.01 OUTLIER 'General case' 0 N--CA 1.428 -1.526 0 N-CA-C 116.153 1.909 . . . . 0.0 116.153 -171.797 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 518' ' ' LYS . . . . . 0.853 ' HA ' ' CD1' ' A' ' 510' ' ' TRP . 0.1 OUTLIER -45.3 -46.93 13.04 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 104.277 -2.49 . . . . 0.0 104.277 175.423 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 519' ' ' SER . . . . . . . . . . . . . 58.0 p -75.1 -60.05 2.47 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 114.658 -1.156 . . . . 0.0 110.15 173.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 520' ' ' GLU . . . . . 0.855 ' HB3' ' HA ' ' A' ' 517' ' ' SER . 5.7 tp10 -57.81 -47.47 82.52 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.497 -179.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 521' ' ' GLY . . . . . 0.834 ' N ' ' O ' ' A' ' 517' ' ' SER . . . -49.29 -54.37 16.02 Favored Glycine 0 CA--C 1.493 -1.328 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.033 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . 0.445 ' HA ' HG12 ' A' ' 525' ' ' ILE . 0.9 OUTLIER -47.42 -47.33 26.72 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.465 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 523' ' ' ARG . . . . . 0.452 ' O ' ' HB2' ' A' ' 526' ' ' ASN . 2.2 ttt180 -50.4 -48.78 55.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.844 178.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 524' ' ' ILE . . . . . 0.47 ' O ' ' ND2' ' A' ' 527' ' ' ASN . 23.1 mt -58.25 -55.2 23.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.412 0.625 . . . . 0.0 109.827 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 525' ' ' ILE . . . . . 0.578 HG12 ' O ' ' A' ' 521' ' ' GLY . 0.3 OUTLIER -50.02 -47.58 23.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 177.761 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 526' ' ' ASN . . . . . 0.452 ' HB2' ' O ' ' A' ' 523' ' ' ARG . 32.1 m-20 -56.17 -47.89 77.39 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 114.35 -1.295 . . . . 0.0 108.23 177.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 527' ' ' ASN . . . . . 0.47 ' ND2' ' O ' ' A' ' 524' ' ' ILE . 0.0 OUTLIER -47.9 -40.24 21.27 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 113.986 -1.461 . . . . 0.0 107.534 176.817 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 528' ' ' ASN . . . . . 0.579 ' HA ' ' CG2' ' A' ' 556' ' ' ILE . 1.7 t-20 73.44 40.28 0.53 Allowed 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.461 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 529' ' ' GLY . . . . . . . . . . . . . . . -116.33 31.68 5.9 Favored Glycine 0 CA--C 1.522 0.523 0 CA-C-N 114.994 -1.003 . . . . 0.0 112.436 178.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 530' ' ' ALA . . . . . 0.855 ' O ' ' HB ' ' A' ' 556' ' ' ILE . . . -133.44 164.42 27.17 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.532 0.682 . . . . 0.0 112.749 -179.015 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 531' ' ' TYR . . . . . 0.55 ' HA ' HG21 ' A' ' 554' ' ' THR . 0.0 OUTLIER -134.65 157.92 45.41 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.752 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 532' ' ' VAL . . . . . 0.655 ' HB ' HG22 ' A' ' 554' ' ' THR . 0.5 OUTLIER -132.84 136.62 55.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-O 121.921 0.867 . . . . 0.0 112.133 179.886 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 533' ' ' GLY . . . . . 0.798 ' O ' HG13 ' A' ' 575' ' ' ILE . . . -128.64 148.63 18.07 Favored Glycine 0 N--CA 1.441 -1.01 0 CA-C-N 114.155 -1.384 . . . . 0.0 112.609 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 534' ' ' SER . . . . . 0.471 ' N ' ' HB ' ' A' ' 552' ' ' THR . 0.2 OUTLIER -134.73 146.88 49.84 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.528 -0.336 . . . . 0.0 110.617 179.62 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 535' ' ' ARG . . . . . 0.516 ' HB3' ' CD2' ' A' ' 573' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.233 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 178.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 . . . . . 0 N--CA 1.452 -0.359 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 550' ' ' ASP . . . . . 0.501 ' O ' ' HG2' ' A' ' 535' ' ' ARG . 0.1 OUTLIER -56.51 -37.84 70.99 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 121.764 0.793 . . . . 0.0 108.963 178.946 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 551' ' ' LEU . . . . . . . . . . . . . 14.6 tp -132.09 140.47 48.84 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.661 -1.154 . . . . 0.0 108.891 178.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 552' ' ' THR . . . . . 0.531 ' OG1' ' HB3' ' A' ' 567' ' ' PHE . 7.7 m -132.81 150.32 52.17 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.711 0.767 . . . . 0.0 111.728 179.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 553' ' ' PHE . . . . . 0.507 ' CD1' ' CE1' ' A' ' 531' ' ' TYR . 0.2 OUTLIER -132.92 138.54 46.99 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 114.442 -1.254 . . . . 0.0 108.166 178.135 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 554' ' ' THR . . . . . 0.655 HG22 ' HB ' ' A' ' 532' ' ' VAL . 0.4 OUTLIER -131.3 140.78 39.58 Favored Pre-proline 0 C--N 1.312 -1.047 0 C-N-CA 120.304 -0.558 . . . . 0.0 111.173 -179.713 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 555' ' ' PRO . . . . . 0.527 ' O ' HG21 ' A' ' 556' ' ' ILE . 35.0 Cg_endo -91.15 7.7 3.43 Favored 'Trans proline' 0 N--CA 1.438 -1.785 0 C-N-CA 122.256 1.971 . . . . 0.0 110.338 178.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 556' ' ' ILE . . . . . 0.855 ' HB ' ' O ' ' A' ' 530' ' ' ALA . 6.3 tp 62.4 33.21 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.302 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 177.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . 0.704 ' O ' ' CE2' ' A' ' 559' ' ' TRP . 0.0 OUTLIER -104.48 141.42 36.4 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 179.386 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 558' ' ' THR . . . . . . . . . . . . . 1.6 t -57.68 115.91 3.08 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 -172.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 559' ' ' TRP . . . . . 0.704 ' CE2' ' O ' ' A' ' 557' ' ' LYS . 0.0 OUTLIER -139.21 121.61 16.07 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 112.356 -2.202 . . . . 0.0 106.602 174.871 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 560' ' ' ASN . . . . . 0.501 ' O ' ' CG2' ' A' ' 564' ' ' THR . 81.2 m-20 -91.2 -76.8 0.43 Allowed 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 118.233 -1.387 . . . . 0.0 113.917 -177.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 561' ' ' ALA . . . . . 0.577 ' O ' HG21 ' A' ' 564' ' ' THR . . . -75.53 -49.74 17.78 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 115.968 1.84 . . . . 0.0 115.968 -177.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 562' ' ' SER . . . . . . . . . . . . . 9.9 t -48.8 -55.71 10.79 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -176.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 563' ' ' LYS . . . . . 0.563 ' HG3' ' CG ' ' A' ' 559' ' ' TRP . 0.1 OUTLIER -70.82 -47.97 56.61 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -178.307 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 564' ' ' THR . . . . . 0.607 HG23 ' H ' ' A' ' 565' ' ' GLN . 9.0 t -50.07 -72.0 0.06 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.81 0.338 . . . . 0.0 111.699 -179.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 565' ' ' GLN . . . . . 0.607 ' H ' HG23 ' A' ' 564' ' ' THR . 1.1 tp60 -50.69 -46.66 58.91 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 566' ' ' GLU . . . . . 0.428 ' HG2' ' CD1' ' A' ' 567' ' ' PHE . 67.3 tt0 -49.17 -66.45 0.4 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.863 0.363 . . . . 0.0 111.696 -178.229 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 567' ' ' PHE . . . . . 0.586 ' C ' ' H ' ' A' ' 569' ' ' ILE . 0.1 OUTLIER -97.39 -53.64 3.4 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.533 0.683 . . . . 0.0 111.701 -179.278 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 568' ' ' ILE . . . . . 0.552 ' CG1' ' HA ' ' A' ' 564' ' ' THR . 14.9 mm -53.95 10.43 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.503 -0.841 0 CA-C-N 114.494 -1.23 . . . . 0.0 113.888 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 569' ' ' ILE . . . . . 0.586 ' H ' ' C ' ' A' ' 567' ' ' PHE . 0.9 OUTLIER -55.73 -33.87 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 N-CA-C 103.815 -2.661 . . . . 0.0 103.815 177.7 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 570' ' ' ASP . . . . . 0.534 ' CB ' ' HB2' ' A' ' 574' ' ' LEU . 7.8 p30 34.56 42.82 0.08 Allowed 'General case' 0 CA--C 1.492 -1.264 0 CA-C-N 113.421 -1.718 . . . . 0.0 110.591 174.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 571' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' A' ' 570' ' ' ASP . . . -49.49 -43.46 35.93 Favored Glycine 0 N--CA 1.436 -1.342 0 N-CA-C 106.981 -2.448 . . . . 0.0 106.981 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 572' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -119.03 -17.99 8.88 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-O 118.937 -0.554 . . . . 0.0 112.298 174.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 573' ' ' LEU . . . . . 0.516 ' CD2' ' HB3' ' A' ' 535' ' ' ARG . 1.5 tp -142.21 136.55 30.0 Favored 'General case' 0 C--N 1.362 1.124 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 -178.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 574' ' ' LEU . . . . . 0.56 ' HG ' HG12 ' A' ' 508' ' ' VAL . 8.9 tp -136.22 133.84 37.49 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 114.339 -1.301 . . . . 0.0 107.613 173.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 575' ' ' ILE . . . . . 0.798 HG13 ' O ' ' A' ' 533' ' ' GLY . 0.0 OUTLIER -133.86 137.16 52.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 O-C-N 122.001 -0.437 . . . . 0.0 110.766 178.253 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 576' ' ' LEU . . . . . 0.511 ' CD2' ' HA ' ' A' ' 509' ' ' LEU . 0.1 OUTLIER -133.33 135.3 44.7 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 177.523 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 577' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -132.99 135.24 45.36 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.194 -1.002 . . . . 0.0 109.979 177.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.0 132.04 53.32 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 579' ' ' GLY . . . . . . . . . . . . . . . -89.81 -2.18 75.77 Favored Glycine 0 N--CA 1.442 -0.942 0 CA-C-N 115.294 -0.867 . . . . 0.0 113.173 -178.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 580' ' ' LYS . . . . . 0.418 ' O ' ' CD1' ' A' ' 581' ' ' TRP . 0.0 OUTLIER -72.9 -48.1 40.17 Favored 'General case' 0 N--CA 1.441 -0.904 0 C-N-CA 119.17 -1.012 . . . . 0.0 108.908 179.256 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 581' ' ' TRP . . . . . 0.418 ' CD1' ' O ' ' A' ' 580' ' ' LYS . 13.6 m0 -139.64 -52.84 0.53 Allowed 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 177.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 582' ' ' LYS . . . . . . . . . . . . . 3.1 ptpt -140.15 164.94 28.7 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 -175.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 583' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -113.7 134.68 54.6 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 174.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 584' ' ' LYS . . . . . 0.605 ' HE2' ' H ' ' A' ' 513' ' ' GLY . 0.5 OUTLIER -122.89 133.6 54.41 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 178.979 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 585' ' ' LEU . . . . . 0.45 ' HB3' ' HG2' ' A' ' 492' ' ' ARG . 9.8 tt -120.62 135.56 55.07 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 586' ' ' VAL . . . . . 0.548 HG13 ' N ' ' A' ' 587' ' ' SER . 55.2 t -134.04 144.15 36.3 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 112.991 0.738 . . . . 0.0 112.991 -177.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 587' ' ' SER . . . . . 0.548 ' N ' HG13 ' A' ' 586' ' ' VAL . 3.1 m -107.29 135.88 48.06 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 176.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . 0.543 HG21 ' O ' ' A' ' 495' ' ' LEU . 0.0 OUTLIER -132.77 136.93 55.0 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.47 0 CA-C-O 121.701 0.762 . . . . 0.0 112.785 -177.309 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 589' ' ' VAL . . . . . 0.488 ' N ' ' HB2' ' A' ' 497' ' ' LYS . 7.1 p -125.26 150.34 30.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 114.376 -1.284 . . . . 0.0 110.843 179.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 590' ' ' SER . . . . . . . . . . . . . 3.3 p . . . . . 0 C--N 1.326 -0.441 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.172 -179.491 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 491' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.165 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 492' ' ' ARG . . . . . 0.533 ' HA ' ' O ' ' A' ' 585' ' ' LEU . 0.0 OUTLIER -135.81 136.97 41.1 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.085 178.944 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 493' ' ' VAL . . . . . 0.469 HG21 ' CA ' ' A' ' 513' ' ' GLY . 89.4 t -133.13 163.57 37.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.354 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 494' ' ' THR . . . . . 0.454 ' N ' ' CG1' ' A' ' 493' ' ' VAL . 91.8 m -114.68 135.9 53.64 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.441 0.638 . . . . 0.0 111.74 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 495' ' ' LEU . . . . . 0.51 ' O ' HG23 ' A' ' 588' ' ' ILE . 0.2 OUTLIER -134.27 164.66 42.37 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.086 179.869 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 496' ' ' PRO . . . . . 0.428 ' HD2' HD11 ' A' ' 495' ' ' LEU . 23.2 Cg_exo -63.68 119.56 6.66 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 121.982 1.788 . . . . 0.0 111.721 179.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 497' ' ' LYS . . . . . 0.604 ' HA ' ' CG2' ' A' ' 588' ' ' ILE . 0.2 OUTLIER -53.07 -30.0 33.51 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -178.961 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 498' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -57.56 -48.66 78.75 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -177.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 499' ' ' LEU . . . . . 0.452 ' CD1' ' CD1' ' A' ' 495' ' ' LEU . 2.3 pp -74.37 -9.07 58.23 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -178.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . 0.443 ' HA ' ' CE ' ' A' ' 507' ' ' LYS . 2.9 p -75.61 -26.43 18.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.352 0.596 . . . . 0.0 111.717 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 501' ' ' TYR . . . . . 0.584 ' O ' ' CG2' ' A' ' 564' ' ' THR . 0.3 OUTLIER -53.88 -29.69 42.7 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -178.71 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 502' ' ' ASP . . . . . 0.444 ' N ' ' CD1' ' A' ' 501' ' ' TYR . 0.4 OUTLIER -75.82 -49.92 16.63 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 -175.561 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 503' ' ' LYS . . . . . 0.631 ' O ' ' CG ' ' A' ' 507' ' ' LYS . 4.8 mttt -119.31 133.8 55.54 Favored 'General case' 0 CA--C 1.522 -0.113 0 CA-C-N 118.985 0.811 . . . . 0.0 112.094 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 504' ' ' THR . . . . . 0.418 ' OG1' ' N ' ' A' ' 564' ' ' THR . 2.0 m -73.56 -75.12 0.16 Allowed 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.635 -0.711 . . . . 0.0 112.918 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . 0.556 ' CE1' HD11 ' A' ' 556' ' ' ILE . 7.3 m-85 -74.37 -62.9 1.36 Allowed 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -178.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 506' ' ' SER . . . . . 0.772 ' O ' ' CD1' ' A' ' 510' ' ' TRP . 7.6 t -49.28 -72.59 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -175.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 507' ' ' LYS . . . . . 0.685 ' HD3' ' N ' ' A' ' 508' ' ' VAL . 0.0 OUTLIER -48.99 -48.52 43.39 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -176.37 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 508' ' ' VAL . . . . . 0.685 ' N ' ' HD3' ' A' ' 507' ' ' LYS . 89.1 t -52.89 -59.03 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -179.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 509' ' ' LEU . . . . . 0.55 ' CD1' ' N ' ' A' ' 510' ' ' TRP . 3.0 pp -60.42 -61.84 2.3 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 -176.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 510' ' ' TRP . . . . . 0.772 ' CD1' ' O ' ' A' ' 506' ' ' SER . 65.1 p-90 -72.2 -49.74 33.06 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -176.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 511' ' ' SER . . . . . 0.497 ' N ' ' CE3' ' A' ' 510' ' ' TRP . 0.5 OUTLIER -64.95 -47.39 77.81 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.164 -0.926 . . . . 0.0 112.898 -177.089 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 512' ' ' ALA . . . . . 0.501 ' HB1' HD21 ' A' ' 495' ' ' LEU . . . -71.19 -73.97 0.16 Allowed 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 117.398 2.37 . . . . 0.0 117.398 -174.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 513' ' ' GLY . . . . . 0.469 ' CA ' HG21 ' A' ' 493' ' ' VAL . . . -115.95 -36.11 1.18 Allowed Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 121.73 3.452 . . . . 0.0 121.73 -172.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 514' ' ' LEU . . . . . 0.627 HD23 ' HG2' ' A' ' 584' ' ' LYS . 0.5 OUTLIER -108.96 -39.11 5.4 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 120.431 3.493 . . . . 0.0 120.431 -169.646 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 515' ' ' VAL . . . . . 0.567 ' CG1' ' HB2' ' A' ' 517' ' ' SER . 13.7 p -153.18 172.12 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 118.053 2.612 . . . . 0.0 118.053 -171.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 516' ' ' ALA . . . . . 0.523 ' H ' ' CG2' ' A' ' 515' ' ' VAL . . . -69.07 2.64 2.59 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 112.559 -2.11 . . . . 0.0 110.753 177.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 517' ' ' SER . . . . . 0.806 ' O ' ' N ' ' A' ' 521' ' ' GLY . 0.5 OUTLIER -57.68 8.5 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 -172.221 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 518' ' ' LYS . . . . . 0.747 ' HA ' ' CD1' ' A' ' 510' ' ' TRP . 0.0 OUTLIER -46.66 -51.78 15.17 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 104.369 -2.456 . . . . 0.0 104.369 174.989 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 519' ' ' SER . . . . . . . . . . . . . 3.5 m -75.35 -57.45 3.89 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.146 173.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 520' ' ' GLU . . . . . 0.637 ' CB ' ' HA ' ' A' ' 517' ' ' SER . 0.0 OUTLIER -55.91 -47.85 76.73 Favored 'General case' 0 C--N 1.349 0.578 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.71 -179.042 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 521' ' ' GLY . . . . . 0.806 ' N ' ' O ' ' A' ' 517' ' ' SER . . . -49.55 -55.37 13.74 Favored Glycine 0 CA--C 1.491 -1.42 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.543 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -47.73 -47.45 30.19 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 523' ' ' ARG . . . . . . . . . . . . . 1.6 ttt85 -50.49 -49.03 56.55 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.0 178.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 524' ' ' ILE . . . . . 0.431 ' O ' ' ND2' ' A' ' 527' ' ' ASN . 12.7 mt -59.36 -55.26 24.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.237 0.542 . . . . 0.0 110.253 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 525' ' ' ILE . . . . . 0.555 HG12 ' O ' ' A' ' 521' ' ' GLY . 0.9 OUTLIER -50.26 -47.49 25.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 177.864 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 526' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -56.1 -48.58 75.87 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 114.112 -1.404 . . . . 0.0 108.276 177.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 527' ' ' ASN . . . . . 0.431 ' ND2' ' O ' ' A' ' 524' ' ' ILE . 0.0 OUTLIER -48.62 -39.76 25.2 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 113.754 -1.566 . . . . 0.0 107.778 176.639 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 528' ' ' ASN . . . . . 0.576 ' C ' HG22 ' A' ' 556' ' ' ILE . 12.6 t-20 74.07 40.3 0.46 Allowed 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.227 -179.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 529' ' ' GLY . . . . . . . . . . . . . . . -115.98 36.36 3.87 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 114.619 -1.173 . . . . 0.0 111.569 178.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 530' ' ' ALA . . . . . 0.751 ' O ' ' HB ' ' A' ' 556' ' ' ILE . . . -132.8 164.96 25.68 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.656 0.741 . . . . 0.0 112.363 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 531' ' ' TYR . . . . . 0.598 ' HE1' ' CD1' ' A' ' 553' ' ' PHE . 3.2 t80 -134.52 149.55 50.68 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 124.634 1.174 . . . . 0.0 108.871 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 532' ' ' VAL . . . . . 0.625 ' HB ' ' HB ' ' A' ' 554' ' ' THR . 1.1 t -129.96 136.1 59.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 CA-C-N 119.485 1.039 . . . . 0.0 112.216 179.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 533' ' ' GLY . . . . . 0.734 ' O ' HG13 ' A' ' 575' ' ' ILE . . . -133.11 147.4 18.97 Favored Glycine 0 N--CA 1.441 -1.022 0 CA-C-N 114.0 -1.454 . . . . 0.0 112.961 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 534' ' ' SER . . . . . 0.603 ' HB2' ' OG1' ' A' ' 552' ' ' THR . 38.5 m -134.79 143.53 47.13 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.584 -0.308 . . . . 0.0 111.072 178.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 535' ' ' ARG . . . . . 0.588 ' HA ' ' O ' ' A' ' 550' ' ' ASP . 3.0 tpp180 . . . . . 0 C--N 1.33 -0.251 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 178.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 . . . . . 0 N--CA 1.448 -0.53 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 550' ' ' ASP . . . . . 0.588 ' O ' ' HA ' ' A' ' 535' ' ' ARG . 1.8 m-20 -70.82 -41.09 72.02 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.953 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 551' ' ' LEU . . . . . 0.418 HD12 ' CE1' ' A' ' 553' ' ' PHE . 7.2 tp -131.26 140.28 49.79 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.416 178.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 552' ' ' THR . . . . . 0.649 ' O ' ' HA2' ' A' ' 533' ' ' GLY . 6.2 m -133.32 147.34 51.86 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.573 0.701 . . . . 0.0 111.987 179.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 553' ' ' PHE . . . . . 0.598 ' CD1' ' HE1' ' A' ' 531' ' ' TYR . 17.6 m-30 -132.86 136.22 46.09 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 177.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 554' ' ' THR . . . . . 0.625 ' HB ' ' HB ' ' A' ' 532' ' ' VAL . 19.2 m -135.04 139.68 32.71 Favored Pre-proline 0 C--N 1.314 -0.975 0 C-N-CA 118.851 -1.14 . . . . 0.0 113.245 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 555' ' ' PRO . . . . . 0.615 ' HD2' ' CZ2' ' A' ' 559' ' ' TRP . 5.8 Cg_exo -77.58 11.99 2.02 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.78 2.32 . . . . 0.0 112.789 179.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 556' ' ' ILE . . . . . 0.751 ' HB ' ' O ' ' A' ' 530' ' ' ALA . 4.9 tp 62.37 34.42 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.335 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 177.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . 0.704 ' O ' ' CE2' ' A' ' 559' ' ' TRP . 33.3 mttt -103.37 133.23 48.77 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 558' ' ' THR . . . . . . . . . . . . . 3.4 t -58.05 116.5 3.56 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -172.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 559' ' ' TRP . . . . . 0.704 ' CE2' ' O ' ' A' ' 557' ' ' LYS . 0.0 OUTLIER -139.87 112.4 7.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 113.142 -1.844 . . . . 0.0 106.28 175.1 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 560' ' ' ASN . . . . . 0.561 ' O ' ' CG2' ' A' ' 564' ' ' THR . 86.0 m-20 -77.82 -75.96 0.2 Allowed 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 118.659 -1.216 . . . . 0.0 113.351 -176.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 561' ' ' ALA . . . . . 0.638 ' O ' HG22 ' A' ' 564' ' ' THR . . . -75.14 -53.12 9.39 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 115.951 1.834 . . . . 0.0 115.951 -178.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 562' ' ' SER . . . . . . . . . . . . . 69.4 m -49.23 -54.95 14.23 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -176.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 563' ' ' LYS . . . . . 0.554 ' HG2' ' CD1' ' A' ' 559' ' ' TRP . 0.2 OUTLIER -70.65 -47.91 57.61 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -178.188 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 564' ' ' THR . . . . . 0.638 HG22 ' O ' ' A' ' 561' ' ' ALA . 7.9 t -49.79 -68.02 0.21 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.847 0.356 . . . . 0.0 111.276 -179.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 565' ' ' GLN . . . . . 0.57 ' H ' ' CG2' ' A' ' 564' ' ' THR . 2.4 tp60 -49.88 -47.0 52.16 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -49.42 -61.72 1.94 Allowed 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.861 -178.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 567' ' ' PHE . . . . . 0.56 ' C ' ' H ' ' A' ' 569' ' ' ILE . 0.0 OUTLIER -97.15 -54.32 3.21 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.68 0.752 . . . . 0.0 111.875 -178.95 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 568' ' ' ILE . . . . . 0.6 ' CG2' ' O ' ' A' ' 568' ' ' ILE . 1.7 mp -56.18 9.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 114.487 -1.233 . . . . 0.0 113.72 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 569' ' ' ILE . . . . . 0.56 ' H ' ' C ' ' A' ' 567' ' ' PHE . 0.9 OUTLIER -54.56 -36.47 35.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 104.292 -2.484 . . . . 0.0 104.292 177.354 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 570' ' ' ASP . . . . . 0.485 ' CB ' ' O ' ' A' ' 573' ' ' LEU . 7.7 p30 34.1 57.8 0.62 Allowed 'General case' 0 CA--C 1.502 -0.903 0 CA-C-N 113.716 -1.584 . . . . 0.0 112.04 174.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 571' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 570' ' ' ASP . . . -51.02 -45.22 51.11 Favored Glycine 0 N--CA 1.438 -1.172 0 C-N-CA 117.469 -2.301 . . . . 0.0 107.982 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 572' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -120.3 -16.74 8.4 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 175.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 573' ' ' LEU . . . . . 0.485 ' O ' ' CB ' ' A' ' 570' ' ' ASP . 2.2 tp -140.55 136.34 32.75 Favored 'General case' 0 C--N 1.355 0.823 0 N-CA-C 115.912 1.819 . . . . 0.0 115.912 -177.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 574' ' ' LEU . . . . . 0.444 HD21 ' CG1' ' A' ' 508' ' ' VAL . 0.5 OUTLIER -135.94 132.73 36.81 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 173.422 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 575' ' ' ILE . . . . . 0.734 HG13 ' O ' ' A' ' 533' ' ' GLY . 0.0 OUTLIER -134.3 139.98 46.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 118.858 0.754 . . . . 0.0 111.928 178.53 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 576' ' ' LEU . . . . . 0.478 ' CD2' ' HB3' ' A' ' 509' ' ' LEU . 0.0 OUTLIER -133.01 136.62 46.12 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 114.944 -1.025 . . . . 0.0 108.767 177.945 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 577' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.02 135.44 51.79 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 177.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.429 ' HB2' ' O ' ' A' ' 582' ' ' LYS . 0.5 OUTLIER -126.94 132.02 50.95 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 177.973 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 579' ' ' GLY . . . . . . . . . . . . . . . -90.45 -2.26 73.53 Favored Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 115.092 -0.958 . . . . 0.0 113.493 -178.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 580' ' ' LYS . . . . . 0.473 ' O ' ' CD1' ' A' ' 581' ' ' TRP . 0.0 OUTLIER -70.84 -48.38 54.3 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 118.738 -1.185 . . . . 0.0 108.564 179.083 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 581' ' ' TRP . . . . . 0.473 ' CD1' ' O ' ' A' ' 580' ' ' LYS . 27.1 m0 -139.81 -53.37 0.53 Allowed 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 177.09 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 582' ' ' LYS . . . . . 0.429 ' O ' ' HB2' ' A' ' 578' ' ' LEU . 0.0 OUTLIER -140.5 165.44 27.43 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 -175.19 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 583' ' ' MET . . . . . . . . . . . . . 1.7 ttt -109.04 135.0 50.93 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 173.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 584' ' ' LYS . . . . . 0.627 ' HG2' HD23 ' A' ' 514' ' ' LEU . 10.9 tppt? -120.34 133.38 55.46 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 178.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 585' ' ' LEU . . . . . 0.533 ' O ' ' HA ' ' A' ' 492' ' ' ARG . 0.9 OUTLIER -116.03 136.12 53.32 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.839 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 586' ' ' VAL . . . . . 0.435 ' O ' ' O ' ' A' ' 574' ' ' LEU . 85.8 t -132.94 137.49 53.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-O 121.053 0.454 . . . . 0.0 111.721 -178.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 587' ' ' SER . . . . . 0.416 ' N ' HG12 ' A' ' 586' ' ' VAL . 58.8 m -106.63 135.79 47.53 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 177.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . 0.604 ' CG2' ' HA ' ' A' ' 497' ' ' LYS . 0.0 OUTLIER -133.41 136.75 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -177.581 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 589' ' ' VAL . . . . . 0.472 ' N ' ' HB2' ' A' ' 497' ' ' LYS . 5.6 m -132.6 137.14 54.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.635 178.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 590' ' ' SER . . . . . . . . . . . . . 10.7 t . . . . . 0 C--N 1.327 -0.396 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.984 -179.795 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 491' ' ' ALA . . . . . 0.426 ' HB1' HD21 ' A' ' 514' ' ' LEU . . . . . . . . 0 C--O 1.232 0.149 0 N-CA-C 111.131 0.049 . . . . 0.0 111.131 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 492' ' ' ARG . . . . . 0.4 ' CD ' ' CD2' ' A' ' 585' ' ' LEU . 2.7 mmm180 -137.8 132.67 33.0 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.535 176.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 493' ' ' VAL . . . . . 0.616 ' CG2' ' HA3' ' A' ' 513' ' ' GLY . 16.9 m -138.25 163.78 28.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 178.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 79.6 p -116.94 132.56 56.67 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 176.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 495' ' ' LEU . . . . . 0.55 ' O ' ' CG2' ' A' ' 588' ' ' ILE . 0.0 OUTLIER -137.1 164.5 41.68 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.23 -179.556 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 496' ' ' PRO . . . . . 0.444 ' HD2' ' CD1' ' A' ' 495' ' ' LEU . 2.8 Cg_exo -76.94 119.95 5.28 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.045 2.497 . . . . 0.0 110.947 178.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 497' ' ' LYS . . . . . 0.687 ' N ' HG21 ' A' ' 588' ' ' ILE . 15.6 tttm -53.24 -29.78 34.5 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -177.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 498' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.9 -49.12 78.73 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -177.086 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 499' ' ' LEU . . . . . 0.427 ' CD1' HD11 ' A' ' 495' ' ' LEU . 2.0 pp -74.38 -8.82 57.55 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -178.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . 0.474 HG22 HG13 ' A' ' 568' ' ' ILE . 0.9 OUTLIER -74.98 -25.66 18.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.455 0.645 . . . . 0.0 111.678 -179.029 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 501' ' ' TYR . . . . . 0.654 ' O ' HG23 ' A' ' 564' ' ' THR . 0.3 OUTLIER -57.26 -29.48 63.86 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 114.981 1.475 . . . . 0.0 114.981 -178.288 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -75.99 -50.16 15.63 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 116.306 1.965 . . . . 0.0 116.306 -174.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 503' ' ' LYS . . . . . 0.576 ' O ' ' CG ' ' A' ' 507' ' ' LYS . 3.3 mttm -119.1 137.88 53.27 Favored 'General case' 0 N--CA 1.46 0.066 0 CA-C-N 119.27 0.941 . . . . 0.0 112.204 -178.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 504' ' ' THR . . . . . 0.499 ' OG1' ' N ' ' A' ' 564' ' ' THR . 24.8 m -73.52 -76.99 0.11 Allowed 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . 0.543 ' CZ ' HD12 ' A' ' 556' ' ' ILE . 0.2 OUTLIER -75.7 -61.12 2.03 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -179.164 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 506' ' ' SER . . . . . 0.668 ' O ' ' CD1' ' A' ' 510' ' ' TRP . 62.2 m -48.98 -72.75 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -175.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 507' ' ' LYS . . . . . 0.689 ' HD3' ' N ' ' A' ' 508' ' ' VAL . 0.0 OUTLIER -49.2 -48.22 45.51 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -176.673 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 508' ' ' VAL . . . . . 0.689 ' N ' ' HD3' ' A' ' 507' ' ' LYS . 69.8 t -52.46 -59.2 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 509' ' ' LEU . . . . . 0.59 ' HG ' ' H ' ' A' ' 510' ' ' TRP . 1.9 pp -60.18 -60.89 3.1 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 -177.052 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 510' ' ' TRP . . . . . 0.668 ' CD1' ' O ' ' A' ' 506' ' ' SER . 51.4 p-90 -72.26 -51.75 19.48 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -176.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 511' ' ' SER . . . . . 0.541 ' N ' ' CD2' ' A' ' 510' ' ' TRP . 0.4 OUTLIER -63.98 -47.99 78.18 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.884 -177.238 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 512' ' ' ALA . . . . . . . . . . . . . . . -71.46 -73.66 0.17 Allowed 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 117.073 2.249 . . . . 0.0 117.073 -174.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 513' ' ' GLY . . . . . 0.616 ' HA3' ' CG2' ' A' ' 493' ' ' VAL . . . -115.84 -35.77 1.22 Allowed Glycine 0 CA--C 1.507 -0.468 0 N-CA-C 121.558 3.383 . . . . 0.0 121.558 -173.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 514' ' ' LEU . . . . . 0.612 ' HG ' ' HE2' ' A' ' 584' ' ' LYS . 0.0 OUTLIER -107.69 -45.45 4.02 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 119.898 3.296 . . . . 0.0 119.898 -169.195 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 515' ' ' VAL . . . . . 0.578 HG21 ' H ' ' A' ' 517' ' ' SER . 9.9 p -145.1 172.3 4.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 117.927 2.566 . . . . 0.0 117.927 -171.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 516' ' ' ALA . . . . . 0.482 ' H ' ' CG2' ' A' ' 515' ' ' VAL . . . -89.87 0.53 56.99 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 113.25 -1.796 . . . . 0.0 108.663 178.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 517' ' ' SER . . . . . 0.996 ' O ' ' N ' ' A' ' 521' ' ' GLY . 4.0 p -61.44 10.26 0.02 OUTLIER 'General case' 0 N--CA 1.426 -1.64 0 C-N-CA 126.171 1.788 . . . . 0.0 115.289 -173.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 518' ' ' LYS . . . . . 0.616 ' HB2' ' CE2' ' A' ' 510' ' ' TRP . 0.8 OUTLIER -42.73 -39.75 2.55 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 105.426 -2.064 . . . . 0.0 105.426 178.221 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 519' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.68 -54.25 8.54 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 114.891 -1.049 . . . . 0.0 108.217 172.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 520' ' ' GLU . . . . . 0.664 ' HB3' ' HA ' ' A' ' 517' ' ' SER . 0.2 OUTLIER -67.67 -48.07 67.68 Favored 'General case' 0 C--N 1.35 0.626 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.373 179.845 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 521' ' ' GLY . . . . . 0.996 ' N ' ' O ' ' A' ' 517' ' ' SER . . . -49.6 -52.81 23.35 Favored Glycine 0 CA--C 1.494 -1.248 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 178.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . 0.482 ' HA ' HG12 ' A' ' 525' ' ' ILE . 3.8 mm-40 -48.19 -47.48 35.31 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 523' ' ' ARG . . . . . 0.409 ' O ' ' HB3' ' A' ' 526' ' ' ASN . 0.0 OUTLIER -49.99 -49.16 51.45 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.736 178.855 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 524' ' ' ILE . . . . . 0.457 ' HA ' ' HB3' ' A' ' 527' ' ' ASN . 4.3 mp -59.3 -51.79 68.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.466 0.651 . . . . 0.0 109.412 179.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 525' ' ' ILE . . . . . 0.604 HG12 ' O ' ' A' ' 521' ' ' GLY . 1.2 mm -50.66 -47.42 28.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 177.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 526' ' ' ASN . . . . . 0.409 ' HB3' ' O ' ' A' ' 523' ' ' ARG . 1.0 OUTLIER -58.69 -47.93 82.83 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 114.253 -1.339 . . . . 0.0 108.321 177.51 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 527' ' ' ASN . . . . . 0.457 ' HB3' ' HA ' ' A' ' 524' ' ' ILE . 0.0 OUTLIER -48.09 -39.57 20.68 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 113.994 -1.457 . . . . 0.0 107.477 176.604 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 528' ' ' ASN . . . . . 0.618 ' C ' HG21 ' A' ' 556' ' ' ILE . 13.2 t-20 74.2 40.98 0.41 Allowed 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.867 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 529' ' ' GLY . . . . . . . . . . . . . . . -113.96 29.3 7.83 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-N 115.118 -0.946 . . . . 0.0 112.516 178.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 530' ' ' ALA . . . . . 0.916 ' O ' ' HB ' ' A' ' 556' ' ' ILE . . . -133.53 164.27 27.53 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.216 0.532 . . . . 0.0 112.423 -179.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 531' ' ' TYR . . . . . 0.516 ' CE1' ' CD1' ' A' ' 553' ' ' PHE . 0.0 OUTLIER -134.59 152.53 51.84 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 177.601 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 532' ' ' VAL . . . . . 0.554 ' HB ' ' HB ' ' A' ' 554' ' ' THR . 0.5 OUTLIER -129.2 135.8 61.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 CA-C-O 122.003 0.906 . . . . 0.0 112.121 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 533' ' ' GLY . . . . . 0.627 ' O ' HG13 ' A' ' 575' ' ' ILE . . . -133.74 161.71 24.33 Favored Glycine 0 N--CA 1.441 -1.016 0 CA-C-N 114.32 -1.309 . . . . 0.0 114.48 -179.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 534' ' ' SER . . . . . 0.51 ' OG ' ' O ' ' A' ' 567' ' ' PHE . 5.3 t -134.05 141.89 47.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.834 -0.683 . . . . 0.0 110.626 178.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 535' ' ' ARG . . . . . 0.556 ' HA ' ' O ' ' A' ' 550' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.358 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 178.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 . . . . . 0 N--CA 1.451 -0.407 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 550' ' ' ASP . . . . . 0.556 ' O ' ' HA ' ' A' ' 535' ' ' ARG . 3.9 p30 -50.89 -36.47 38.22 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.722 0.773 . . . . 0.0 108.995 178.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 551' ' ' LEU . . . . . . . . . . . . . 13.6 tp -131.39 139.22 49.41 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.524 -1.216 . . . . 0.0 107.881 177.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 552' ' ' THR . . . . . 0.584 ' O ' ' HA2' ' A' ' 533' ' ' GLY . 6.9 m -133.76 148.07 51.35 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.683 0.754 . . . . 0.0 111.842 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 553' ' ' PHE . . . . . 0.516 ' CD1' ' CE1' ' A' ' 531' ' ' TYR . 9.9 m-85 -134.09 137.91 44.93 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.788 -1.097 . . . . 0.0 108.402 177.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 554' ' ' THR . . . . . 0.554 ' HB ' ' HB ' ' A' ' 532' ' ' VAL . 2.0 m -132.23 138.57 32.57 Favored Pre-proline 0 C--N 1.307 -1.278 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 178.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 555' ' ' PRO . . . . . 0.664 ' O ' HG23 ' A' ' 556' ' ' ILE . 67.6 Cg_endo -84.54 19.21 1.42 Allowed 'Trans proline' 0 N--CA 1.446 -1.311 0 C-N-CA 121.664 1.576 . . . . 0.0 111.918 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 556' ' ' ILE . . . . . 0.916 ' HB ' ' O ' ' A' ' 530' ' ' ALA . 3.8 tp 61.21 31.77 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 177.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.85 119.84 39.97 Favored 'General case' 0 CA--C 1.501 -0.925 0 N-CA-C 104.36 -2.459 . . . . 0.0 104.36 178.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 558' ' ' THR . . . . . . . . . . . . . 3.3 t -56.76 116.98 3.48 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-O 122.576 1.179 . . . . 0.0 114.084 -171.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 559' ' ' TRP . . . . . 0.442 ' CH2' ' CD ' ' A' ' 555' ' ' PRO . 5.3 m0 -137.05 111.49 8.57 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 104.521 -2.4 . . . . 0.0 104.521 175.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 560' ' ' ASN . . . . . 0.593 ' O ' ' CG2' ' A' ' 564' ' ' THR . 84.4 m-20 -77.15 -75.59 0.2 Allowed 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -174.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 561' ' ' ALA . . . . . 0.632 ' O ' HG21 ' A' ' 564' ' ' THR . . . -74.19 -57.27 4.06 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 116.055 1.872 . . . . 0.0 116.055 -177.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 562' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -49.59 -53.59 23.03 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -177.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 563' ' ' LYS . . . . . 0.447 ' HG3' HG23 ' A' ' 504' ' ' THR . 0.0 OUTLIER -69.38 -49.03 59.17 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.489 -178.439 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 564' ' ' THR . . . . . 0.654 HG23 ' O ' ' A' ' 501' ' ' TYR . 13.8 t -51.07 -65.22 0.59 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.567 0.222 . . . . 0.0 111.451 -178.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 565' ' ' GLN . . . . . 0.535 ' H ' ' CG2' ' A' ' 564' ' ' THR . 8.4 tp60 -48.95 -47.05 44.18 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.848 0.356 . . . . 0.0 111.053 179.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -49.5 -55.65 12.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 0.0 112.21 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 567' ' ' PHE . . . . . 0.51 ' O ' ' OG ' ' A' ' 534' ' ' SER . 0.6 OUTLIER -96.89 -42.63 7.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.347 0.594 . . . . 0.0 112.46 -178.296 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 568' ' ' ILE . . . . . 0.598 HG23 ' O ' ' A' ' 568' ' ' ILE . 1.2 tp -61.2 9.06 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 N-CA-C 113.939 1.088 . . . . 0.0 113.939 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 569' ' ' ILE . . . . . 0.464 ' H ' ' C ' ' A' ' 567' ' ' PHE . 0.7 OUTLIER -54.46 -40.25 48.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 N-CA-C 104.005 -2.591 . . . . 0.0 104.005 178.295 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 570' ' ' ASP . . . . . 0.483 ' HB2' ' CD1' ' A' ' 588' ' ' ILE . 17.2 p30 32.13 56.84 0.36 Allowed 'General case' 0 CA--C 1.509 -0.599 0 CA-C-N 113.738 -1.574 . . . . 0.0 113.527 172.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 571' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 570' ' ' ASP . . . -51.3 -44.79 52.64 Favored Glycine 0 N--CA 1.44 -1.035 0 C-N-CA 116.819 -2.61 . . . . 0.0 108.575 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 572' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -120.29 -15.89 8.55 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 175.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 573' ' ' LEU . . . . . 0.496 ' HB3' ' O ' ' A' ' 535' ' ' ARG . 1.1 tp -139.75 139.9 36.6 Favored 'General case' 0 C--N 1.353 0.746 0 N-CA-C 116.913 2.19 . . . . 0.0 116.913 -176.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 574' ' ' LEU . . . . . 0.549 ' HB3' ' CD1' ' A' ' 588' ' ' ILE . 0.3 OUTLIER -135.07 133.6 39.49 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 172.642 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 575' ' ' ILE . . . . . 0.627 HG13 ' O ' ' A' ' 533' ' ' GLY . 0.0 OUTLIER -134.12 137.24 52.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 118.623 0.647 . . . . 0.0 111.596 178.812 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 576' ' ' LEU . . . . . 0.495 ' CD1' ' CE1' ' A' ' 505' ' ' PHE . 0.0 OUTLIER -133.15 135.41 45.14 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 177.361 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 577' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -131.45 134.8 46.57 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 119.089 -1.045 . . . . 0.0 110.036 177.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.46 132.2 54.23 Favored 'General case' 0 C--O 1.243 0.732 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 579' ' ' GLY . . . . . . . . . . . . . . . -88.18 -2.0 80.96 Favored Glycine 0 N--CA 1.44 -1.047 0 CA-C-N 114.901 -1.045 . . . . 0.0 113.411 -178.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 580' ' ' LYS . . . . . 0.591 ' CD ' ' CE2' ' A' ' 581' ' ' TRP . 0.0 OUTLIER -71.22 -49.65 41.16 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 118.656 -1.217 . . . . 0.0 108.441 179.279 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 581' ' ' TRP . . . . . 0.591 ' CE2' ' CD ' ' A' ' 580' ' ' LYS . 0.7 OUTLIER -140.92 -51.32 0.45 Allowed 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 175.823 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 582' ' ' LYS . . . . . 0.545 ' HE2' ' CD1' ' A' ' 581' ' ' TRP . 0.0 OUTLIER -139.76 165.29 27.69 Favored 'General case' 0 CA--C 1.512 -0.511 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -175.079 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 583' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.13 135.08 51.49 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 175.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 584' ' ' LYS . . . . . 0.63 ' HD3' ' N ' ' A' ' 585' ' ' LEU . 9.1 tppt? -116.44 133.67 55.75 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 585' ' ' LEU . . . . . 0.63 ' N ' ' HD3' ' A' ' 584' ' ' LYS . 7.7 tt -120.88 137.07 54.76 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -179.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 586' ' ' VAL . . . . . 0.452 ' CG2' ' CG2' ' A' ' 493' ' ' VAL . 55.9 t -131.95 137.01 55.78 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.777 -178.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 587' ' ' SER . . . . . . . . . . . . . 1.4 m -107.31 134.63 50.1 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 177.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . 0.687 HG21 ' N ' ' A' ' 497' ' ' LYS . 0.0 OUTLIER -135.98 136.4 49.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -177.754 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 6.1 m -133.58 136.81 53.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.943 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 590' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.565 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 491' ' ' ALA . . . . . 0.422 ' CB ' ' NZ ' ' A' ' 584' ' ' LYS . . . . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.62 0.248 . . . . 0.0 110.63 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 492' ' ' ARG . . . . . 0.463 ' HD3' ' HG ' ' A' ' 585' ' ' LEU . 0.0 OUTLIER -136.39 134.93 38.32 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 179.434 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 493' ' ' VAL . . . . . 0.569 ' HB ' ' CA ' ' A' ' 513' ' ' GLY . 75.2 t -135.2 163.48 35.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.68 177.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 494' ' ' THR . . . . . 0.433 ' N ' ' CG1' ' A' ' 493' ' ' VAL . 18.5 m -123.85 135.3 53.66 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.153 0.502 . . . . 0.0 111.201 178.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 495' ' ' LEU . . . . . 0.443 ' CD2' HG22 ' A' ' 588' ' ' ILE . 0.0 OUTLIER -134.46 163.7 49.31 Favored Pre-proline 0 CA--C 1.531 0.239 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.298 179.546 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.45 120.06 7.72 Favored 'Trans proline' 0 CA--C 1.532 0.393 0 C-N-CA 122.225 1.95 . . . . 0.0 112.358 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 497' ' ' LYS . . . . . 0.519 ' CA ' ' HB ' ' A' ' 588' ' ' ILE . 0.9 OUTLIER -56.9 -30.31 63.81 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.663 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 498' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.79 -48.34 66.94 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 499' ' ' LEU . . . . . 0.582 ' O ' ' HE3' ' A' ' 507' ' ' LYS . 0.3 OUTLIER -73.45 -8.85 57.61 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.605 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . 0.572 ' HA ' ' HE3' ' A' ' 507' ' ' LYS . 0.3 OUTLIER -60.06 -24.98 31.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.362 0.601 . . . . 0.0 111.113 -179.836 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 501' ' ' TYR . . . . . 0.585 ' O ' HG23 ' A' ' 564' ' ' THR . 0.1 OUTLIER -71.24 -29.9 65.68 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 115.027 1.492 . . . . 0.0 115.027 -177.598 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 502' ' ' ASP . . . . . 0.402 ' OD1' ' CZ ' ' A' ' 501' ' ' TYR . 11.3 m-20 -75.2 -51.22 13.88 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 116.057 1.873 . . . . 0.0 116.057 -174.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 503' ' ' LYS . . . . . 0.627 ' O ' ' CG ' ' A' ' 507' ' ' LYS . 7.4 mttt -120.73 134.48 55.28 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-N 119.346 0.976 . . . . 0.0 111.576 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 504' ' ' THR . . . . . 0.441 ' N ' ' HB ' ' A' ' 564' ' ' THR . 4.2 m -72.91 -76.25 0.12 Allowed 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . 0.541 ' CD1' HG13 ' A' ' 525' ' ' ILE . 12.6 p90 -75.26 -59.12 2.88 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 506' ' ' SER . . . . . 0.783 ' O ' ' CD1' ' A' ' 510' ' ' TRP . 5.2 t -49.39 -72.28 0.05 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 -175.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 507' ' ' LYS . . . . . 0.721 ' HD3' ' N ' ' A' ' 508' ' ' VAL . 0.0 OUTLIER -48.96 -49.12 42.06 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -176.231 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 508' ' ' VAL . . . . . 0.721 ' N ' ' HD3' ' A' ' 507' ' ' LYS . 51.5 t -53.33 -60.02 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -179.085 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 509' ' ' LEU . . . . . 0.558 ' HG ' ' H ' ' A' ' 510' ' ' TRP . 2.6 pp -60.59 -62.69 1.68 Allowed 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 -177.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 510' ' ' TRP . . . . . 0.783 ' CD1' ' O ' ' A' ' 506' ' ' SER . 63.9 p-90 -72.86 -53.63 10.92 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 114.66 1.355 . . . . 0.0 114.66 -176.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 511' ' ' SER . . . . . 0.517 ' N ' ' CE3' ' A' ' 510' ' ' TRP . 1.7 t -65.48 -47.92 74.4 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.89 -177.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 512' ' ' ALA . . . . . 0.453 ' CB ' ' O ' ' A' ' 508' ' ' VAL . . . -71.64 -72.46 0.22 Allowed 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 117.184 2.291 . . . . 0.0 117.184 -174.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 513' ' ' GLY . . . . . 0.604 ' HA3' ' HE3' ' A' ' 584' ' ' LYS . . . -114.57 -34.88 1.49 Allowed Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 121.369 3.308 . . . . 0.0 121.369 -172.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 514' ' ' LEU . . . . . 0.572 ' HG ' ' HE2' ' A' ' 584' ' ' LYS . 1.7 mt -107.12 -46.49 3.89 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 119.579 3.178 . . . . 0.0 119.579 -170.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 515' ' ' VAL . . . . . 0.585 ' CG1' ' HB2' ' A' ' 517' ' ' SER . 4.7 p -154.28 173.16 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 117.617 2.451 . . . . 0.0 117.617 -171.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 516' ' ' ALA . . . . . 0.521 ' H ' ' CG2' ' A' ' 515' ' ' VAL . . . -67.84 3.83 1.36 Allowed 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 126.515 1.926 . . . . 0.0 110.078 177.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 517' ' ' SER . . . . . 0.854 ' HA ' ' HB2' ' A' ' 520' ' ' GLU . 0.4 OUTLIER -57.8 9.11 0.01 OUTLIER 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 115.979 1.844 . . . . 0.0 115.979 -172.213 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 518' ' ' LYS . . . . . 0.777 ' HA ' ' CD1' ' A' ' 510' ' ' TRP . 0.0 OUTLIER -45.56 -49.78 13.63 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 104.248 -2.501 . . . . 0.0 104.248 175.304 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 519' ' ' SER . . . . . . . . . . . . . 11.3 p -75.15 -56.93 4.23 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.2 173.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 520' ' ' GLU . . . . . 0.854 ' HB2' ' HA ' ' A' ' 517' ' ' SER . 0.8 OUTLIER -58.1 -47.41 83.31 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.023 -178.892 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 521' ' ' GLY . . . . . 0.805 ' N ' ' O ' ' A' ' 517' ' ' SER . . . -49.18 -55.99 11.3 Favored Glycine 0 CA--C 1.492 -1.39 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.273 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -47.74 -47.42 30.31 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 178.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 523' ' ' ARG . . . . . 0.437 ' O ' ' HB3' ' A' ' 526' ' ' ASN . 0.1 OUTLIER -50.36 -48.9 55.49 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.786 178.534 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 524' ' ' ILE . . . . . 0.491 HD12 HG23 ' A' ' 524' ' ' ILE . 1.7 mt -57.33 -55.77 18.95 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 CA-C-O 121.571 0.7 . . . . 0.0 109.613 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 525' ' ' ILE . . . . . 0.596 HG12 ' O ' ' A' ' 521' ' ' GLY . 0.8 OUTLIER -50.15 -47.4 24.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.163 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 526' ' ' ASN . . . . . 0.437 ' HB3' ' O ' ' A' ' 523' ' ' ARG . 1.1 t30 -56.84 -48.02 79.0 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-N 114.36 -1.291 . . . . 0.0 108.314 177.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 527' ' ' ASN . . . . . 0.453 ' ND2' ' O ' ' A' ' 524' ' ' ILE . 0.0 OUTLIER -48.04 -40.09 21.86 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.087 -1.415 . . . . 0.0 107.49 176.658 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 528' ' ' ASN . . . . . 0.744 ' HA ' ' CG2' ' A' ' 556' ' ' ILE . 1.8 t30 73.61 39.92 0.53 Allowed 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 114.638 -1.164 . . . . 0.0 111.529 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 529' ' ' GLY . . . . . . . . . . . . . . . -113.78 21.97 15.42 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 114.507 -1.224 . . . . 0.0 111.69 178.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 530' ' ' ALA . . . . . 0.772 ' O ' ' HB ' ' A' ' 556' ' ' ILE . . . -133.67 163.07 30.26 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.252 0.548 . . . . 0.0 112.231 -179.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 531' ' ' TYR . . . . . 0.515 ' HA ' ' O ' ' A' ' 554' ' ' THR . 0.0 OUTLIER -133.92 162.69 31.35 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 177.49 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 532' ' ' VAL . . . . . 0.49 HG13 ' OG1' ' A' ' 554' ' ' THR . 0.9 OUTLIER -131.37 135.48 59.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 CA-C-O 122.148 0.975 . . . . 0.0 111.862 179.772 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 533' ' ' GLY . . . . . 0.606 ' HA2' ' HB ' ' A' ' 552' ' ' THR . . . -133.66 153.88 21.05 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 114.189 -1.369 . . . . 0.0 113.966 -179.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 534' ' ' SER . . . . . 0.583 ' HB2' ' OG1' ' A' ' 552' ' ' THR . 19.1 m -134.31 136.39 43.45 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.389 -0.405 . . . . 0.0 111.437 178.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 535' ' ' ARG . . . . . 0.619 ' HA ' ' O ' ' A' ' 550' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.411 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 178.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 . . . . . 0 N--CA 1.448 -0.557 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 550' ' ' ASP . . . . . 0.619 ' O ' ' HA ' ' A' ' 535' ' ' ARG . 0.7 OUTLIER -56.04 -41.3 74.79 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.548 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 551' ' ' LEU . . . . . 0.505 ' HA ' ' HD2' ' A' ' 535' ' ' ARG . 7.6 tp -131.47 140.09 49.49 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.72 177.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 552' ' ' THR . . . . . 0.606 ' HB ' ' HA2' ' A' ' 533' ' ' GLY . 0.3 OUTLIER -133.71 149.46 51.5 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 122.118 0.961 . . . . 0.0 112.73 179.078 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 553' ' ' PHE . . . . . 0.504 ' HA ' ' CE2' ' A' ' 531' ' ' TYR . 3.4 m-85 -134.12 137.37 44.5 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 106.29 -1.745 . . . . 0.0 106.29 176.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 554' ' ' THR . . . . . 0.515 ' O ' ' HA ' ' A' ' 531' ' ' TYR . 1.8 m -132.53 138.38 31.96 Favored Pre-proline 0 C--N 1.304 -1.388 0 C-N-CA 119.197 -1.001 . . . . 0.0 110.582 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 555' ' ' PRO . . . . . 0.552 ' O ' HG21 ' A' ' 556' ' ' ILE . 65.3 Cg_endo -84.28 14.27 2.48 Favored 'Trans proline' 0 N--CA 1.439 -1.717 0 C-N-CA 121.647 1.564 . . . . 0.0 111.14 179.117 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 556' ' ' ILE . . . . . 0.772 ' HB ' ' O ' ' A' ' 530' ' ' ALA . 1.2 tp 69.73 33.63 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 N-CA-C 115.065 1.506 . . . . 0.0 115.065 176.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . 0.61 ' O ' ' CE2' ' A' ' 559' ' ' TRP . 0.0 OUTLIER -103.87 148.46 26.12 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -179.289 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 558' ' ' THR . . . . . 0.484 ' HA ' ' CZ ' ' A' ' 505' ' ' PHE . 3.7 t -69.96 115.9 9.71 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 -172.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 559' ' ' TRP . . . . . 0.61 ' CE2' ' O ' ' A' ' 557' ' ' LYS . 0.0 OUTLIER -141.24 123.07 15.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 112.642 -2.072 . . . . 0.0 105.599 174.184 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 560' ' ' ASN . . . . . 0.489 ' O ' ' CG2' ' A' ' 564' ' ' THR . 60.3 m-20 -90.54 -77.01 0.42 Allowed 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 117.627 -1.629 . . . . 0.0 113.129 -177.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 561' ' ' ALA . . . . . 0.581 ' O ' HG21 ' A' ' 564' ' ' THR . . . -76.22 -50.44 14.45 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 115.502 1.667 . . . . 0.0 115.502 -179.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 562' ' ' SER . . . . . . . . . . . . . 5.1 t -49.37 -56.68 8.78 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -176.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 563' ' ' LYS . . . . . 0.495 ' HG2' ' CD1' ' A' ' 559' ' ' TRP . 0.0 OUTLIER -69.17 -48.51 62.02 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -178.307 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 564' ' ' THR . . . . . 0.643 ' O ' ' HB ' ' A' ' 568' ' ' ILE . 10.6 t -50.22 -68.32 0.18 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.801 0.334 . . . . 0.0 111.842 -179.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 565' ' ' GLN . . . . . 0.559 ' H ' ' CG2' ' A' ' 564' ' ' THR . 3.8 tp60 -50.02 -47.17 53.27 Favored 'General case' 0 C--N 1.319 -0.721 0 O-C-N 122.173 -0.33 . . . . 0.0 111.635 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 566' ' ' GLU . . . . . 0.41 ' HG2' ' CD1' ' A' ' 567' ' ' PHE . 27.9 tt0 -49.54 -62.64 1.44 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -178.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 567' ' ' PHE . . . . . 0.577 ' C ' ' H ' ' A' ' 569' ' ' ILE . 0.0 OUTLIER -97.27 -50.64 4.48 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.449 0.642 . . . . 0.0 112.132 -178.53 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 568' ' ' ILE . . . . . 0.643 ' HB ' ' O ' ' A' ' 564' ' ' THR . 1.7 mp -58.1 10.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 114.805 -1.089 . . . . 0.0 113.266 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 569' ' ' ILE . . . . . 0.577 ' H ' ' C ' ' A' ' 567' ' ' PHE . 1.2 pt -52.8 -38.32 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 N-CA-C 104.253 -2.499 . . . . 0.0 104.253 178.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 570' ' ' ASP . . . . . 0.478 ' CB ' ' O ' ' A' ' 573' ' ' LEU . 30.2 m-20 34.55 52.62 0.56 Allowed 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 113.701 -1.59 . . . . 0.0 112.149 173.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -51.48 -44.56 53.43 Favored Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 118.226 -1.94 . . . . 0.0 109.084 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 572' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -118.97 -17.33 9.07 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 176.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 573' ' ' LEU . . . . . 0.58 ' HB3' ' O ' ' A' ' 535' ' ' ARG . 1.1 tp -140.12 137.08 34.19 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -178.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 574' ' ' LEU . . . . . 0.567 ' HB3' ' O ' ' A' ' 586' ' ' VAL . 0.3 OUTLIER -134.46 132.92 39.86 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 174.244 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 575' ' ' ILE . . . . . 0.585 HG13 ' O ' ' A' ' 533' ' ' GLY . 0.0 OUTLIER -134.05 137.17 52.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 118.914 0.779 . . . . 0.0 112.074 179.125 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 576' ' ' LEU . . . . . 0.491 HD23 ' HG3' ' A' ' 584' ' ' LYS . 0.0 OUTLIER -133.58 135.59 44.37 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 176.948 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 577' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.8 135.34 45.62 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 118.906 -1.117 . . . . 0.0 110.548 177.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.403 ' HA ' ' HB2' ' A' ' 530' ' ' ALA . 0.3 OUTLIER -123.63 131.72 53.68 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 177.834 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 579' ' ' GLY . . . . . . . . . . . . . . . -91.21 -2.38 71.07 Favored Glycine 0 CA--C 1.5 -0.857 0 CA-C-N 115.404 -0.816 . . . . 0.0 114.447 -177.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 580' ' ' LYS . . . . . 0.473 ' HE2' HG12 ' A' ' 524' ' ' ILE . 0.4 OUTLIER -75.32 -46.47 33.13 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 118.777 -1.169 . . . . 0.0 109.153 179.111 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 581' ' ' TRP . . . . . 0.448 ' CD1' ' HD2' ' A' ' 580' ' ' LYS . 0.1 OUTLIER -138.74 -51.65 0.56 Allowed 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 177.911 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 582' ' ' LYS . . . . . 0.403 ' HG2' ' CD1' ' A' ' 581' ' ' TRP . 1.1 ptpm? -139.56 165.0 28.4 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -175.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 583' ' ' MET . . . . . . . . . . . . . 2.3 ttt -118.85 134.81 54.91 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 174.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 584' ' ' LYS . . . . . 0.604 ' HE3' ' HA3' ' A' ' 513' ' ' GLY . 0.0 OUTLIER -121.71 133.05 54.94 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.023 -0.989 . . . . 0.0 108.335 179.53 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 585' ' ' LEU . . . . . 0.548 ' N ' ' HD3' ' A' ' 584' ' ' LYS . 2.9 tp -119.46 136.68 54.21 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 179.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 586' ' ' VAL . . . . . 0.567 ' O ' ' HB3' ' A' ' 574' ' ' LEU . 11.5 t -131.95 137.08 55.63 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.696 -178.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 587' ' ' SER . . . . . . . . . . . . . 7.6 m -110.24 135.79 50.44 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 177.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . 0.519 ' HB ' ' CA ' ' A' ' 497' ' ' LYS . 0.2 OUTLIER -133.81 144.64 35.15 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.607 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -178.606 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 5.3 m -132.87 137.26 54.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 114.204 -1.362 . . . . 0.0 110.742 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 590' ' ' SER . . . . . . . . . . . . . 2.5 t . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.624 -179.956 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 491' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.07 0 N-CA-C 111.606 0.224 . . . . 0.0 111.606 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 492' ' ' ARG . . . . . 0.513 ' HD3' ' CD2' ' A' ' 585' ' ' LEU . 0.0 OUTLIER -136.05 132.02 35.65 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.583 0.23 . . . . 0.0 110.807 177.49 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 493' ' ' VAL . . . . . 0.579 ' CG2' ' HA3' ' A' ' 513' ' ' GLY . 39.5 t -138.0 163.11 30.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.492 177.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 494' ' ' THR . . . . . 0.5 ' N ' ' CG1' ' A' ' 493' ' ' VAL . 41.9 p -127.19 133.87 50.22 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 120.399 -0.521 . . . . 0.0 110.344 176.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 495' ' ' LEU . . . . . 0.492 ' O ' ' CG2' ' A' ' 588' ' ' ILE . 0.3 OUTLIER -135.89 164.57 42.26 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.558 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -61.72 119.31 6.37 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 121.676 1.584 . . . . 0.0 111.185 178.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 497' ' ' LYS . . . . . 0.477 ' CA ' ' HB ' ' A' ' 588' ' ' ILE . 15.0 ttmt -52.33 -30.23 27.45 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -178.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 498' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.3 -48.11 81.55 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -177.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 499' ' ' LEU . . . . . 0.442 ' CD1' ' CD1' ' A' ' 495' ' ' LEU . 2.2 pp -73.53 -8.16 54.79 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -178.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . 0.457 HG11 ' CG1' ' A' ' 568' ' ' ILE . 36.3 t -74.57 -25.45 19.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.435 0.636 . . . . 0.0 111.498 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 501' ' ' TYR . . . . . 0.665 ' O ' ' CG2' ' A' ' 564' ' ' THR . 3.7 m-30 -53.45 -29.13 34.02 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -178.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -76.15 -50.28 15.03 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 116.45 2.019 . . . . 0.0 116.45 -175.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 503' ' ' LYS . . . . . 0.575 ' O ' ' CG ' ' A' ' 507' ' ' LYS . 0.2 OUTLIER -120.27 136.44 54.66 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 119.59 1.086 . . . . 0.0 112.676 -178.51 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 504' ' ' THR . . . . . 0.55 ' OG1' ' N ' ' A' ' 564' ' ' THR . 23.7 m -73.61 -77.2 0.11 Allowed 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 179.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . 0.521 ' CE2' ' CD1' ' A' ' 576' ' ' LEU . 0.2 OUTLIER -75.74 -60.33 2.36 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -179.18 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 506' ' ' SER . . . . . 0.703 ' O ' ' CD1' ' A' ' 510' ' ' TRP . 6.1 t -48.7 -72.04 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 -175.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 507' ' ' LYS . . . . . 0.684 ' HD3' ' N ' ' A' ' 508' ' ' VAL . 0.0 OUTLIER -48.9 -48.58 42.27 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -176.479 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 508' ' ' VAL . . . . . 0.684 ' N ' ' HD3' ' A' ' 507' ' ' LYS . 55.3 t -52.63 -58.02 3.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 C-N-CA 120.668 -0.413 . . . . 0.0 112.081 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 509' ' ' LEU . . . . . 0.592 ' HG ' ' H ' ' A' ' 510' ' ' TRP . 2.6 pp -59.66 -66.0 0.58 Allowed 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 -177.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 510' ' ' TRP . . . . . 0.703 ' CD1' ' O ' ' A' ' 506' ' ' SER . 68.3 p-90 -73.18 -50.74 20.89 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 -176.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 511' ' ' SER . . . . . 0.504 ' N ' ' CD2' ' A' ' 510' ' ' TRP . 0.3 OUTLIER -62.27 -46.23 89.72 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 114.437 -1.256 . . . . 0.0 113.022 -177.024 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 512' ' ' ALA . . . . . 0.478 ' HB2' HD23 ' A' ' 495' ' ' LEU . . . -71.13 -74.87 0.14 Allowed 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 116.305 1.965 . . . . 0.0 116.305 -174.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 513' ' ' GLY . . . . . 0.579 ' HA3' ' CG2' ' A' ' 493' ' ' VAL . . . -116.88 -39.56 0.82 Allowed Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 121.837 3.495 . . . . 0.0 121.837 -173.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 514' ' ' LEU . . . . . 0.613 ' CD2' ' HB2' ' A' ' 584' ' ' LYS . 4.1 pp -112.83 -36.65 5.09 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 121.11 3.744 . . . . 0.0 121.11 -171.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 515' ' ' VAL . . . . . 0.731 ' CG1' ' HB2' ' A' ' 517' ' ' SER . 9.9 p -125.76 165.86 22.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 117.99 2.589 . . . . 0.0 117.99 -171.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 516' ' ' ALA . . . . . 0.406 ' H ' ' CG2' ' A' ' 515' ' ' VAL . . . -90.44 1.01 57.07 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 112.46 -2.154 . . . . 0.0 109.078 178.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 517' ' ' SER . . . . . 0.925 ' O ' ' N ' ' A' ' 521' ' ' GLY . 0.1 OUTLIER -60.15 10.19 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 126.072 1.749 . . . . 0.0 115.224 -172.957 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 518' ' ' LYS . . . . . 0.692 ' HA ' ' CD1' ' A' ' 510' ' ' TRP . 0.0 OUTLIER -43.54 -46.76 7.17 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 177.232 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 519' ' ' SER . . . . . . . . . . . . . 85.2 p -74.63 -56.15 5.13 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.462 173.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 520' ' ' GLU . . . . . 0.851 ' HB2' ' HA ' ' A' ' 517' ' ' SER . 4.8 mm-40 -62.03 -47.25 85.57 Favored 'General case' 0 C--N 1.349 0.573 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.848 -179.158 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 521' ' ' GLY . . . . . 0.925 ' N ' ' O ' ' A' ' 517' ' ' SER . . . -49.16 -53.09 20.51 Favored Glycine 0 CA--C 1.493 -1.292 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . 0.418 ' HA ' HG12 ' A' ' 525' ' ' ILE . 3.7 mt-30 -48.09 -47.52 34.19 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 177.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 523' ' ' ARG . . . . . 0.448 ' HB3' ' O ' ' A' ' 520' ' ' GLU . 2.4 tpt85 -50.25 -48.92 54.45 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.848 178.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 524' ' ' ILE . . . . . 0.454 ' O ' ' ND2' ' A' ' 527' ' ' ASN . 30.1 mm -57.44 -54.06 35.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.441 0.639 . . . . 0.0 109.592 179.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 525' ' ' ILE . . . . . 0.546 HG12 ' O ' ' A' ' 521' ' ' GLY . 1.1 mm -50.27 -47.56 25.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 177.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 526' ' ' ASN . . . . . 0.443 ' HB2' ' O ' ' A' ' 523' ' ' ARG . 34.8 m-80 -57.82 -47.33 82.92 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-N 114.225 -1.352 . . . . 0.0 108.575 177.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 527' ' ' ASN . . . . . 0.454 ' ND2' ' O ' ' A' ' 524' ' ' ILE . 0.0 OUTLIER -47.3 -39.32 14.42 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 113.988 -1.46 . . . . 0.0 107.741 177.239 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 528' ' ' ASN . . . . . 0.675 ' HA ' HG21 ' A' ' 556' ' ' ILE . 7.9 t-20 74.25 40.42 0.43 Allowed 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.491 -179.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 529' ' ' GLY . . . . . . . . . . . . . . . -117.61 31.55 5.71 Favored Glycine 0 CA--C 1.523 0.593 0 CA-C-N 114.922 -1.035 . . . . 0.0 112.497 178.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 530' ' ' ALA . . . . . 0.867 ' O ' ' HB ' ' A' ' 556' ' ' ILE . . . -133.43 163.93 28.26 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 121.161 0.505 . . . . 0.0 112.263 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 531' ' ' TYR . . . . . 0.559 ' HA ' ' O ' ' A' ' 554' ' ' THR . 0.0 OUTLIER -134.61 152.93 52.13 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.667 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 532' ' ' VAL . . . . . 0.558 ' CB ' ' HB ' ' A' ' 554' ' ' THR . 0.5 OUTLIER -127.09 135.64 63.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 CA-C-O 121.981 0.896 . . . . 0.0 112.093 179.635 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 533' ' ' GLY . . . . . 0.686 ' O ' HG13 ' A' ' 575' ' ' ILE . . . -133.68 151.73 20.26 Favored Glycine 0 N--CA 1.441 -0.98 0 CA-C-N 114.251 -1.34 . . . . 0.0 113.4 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 534' ' ' SER . . . . . 0.499 ' OG ' ' O ' ' A' ' 567' ' ' PHE . 0.6 OUTLIER -134.57 137.55 43.86 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.447 -0.376 . . . . 0.0 111.016 179.109 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 535' ' ' ARG . . . . . 0.611 ' O ' ' HB3' ' A' ' 573' ' ' LEU . 12.4 tpt180 . . . . . 0 C--N 1.331 -0.202 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.449 -0.524 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 550' ' ' ASP . . . . . 0.573 ' O ' ' HA ' ' A' ' 535' ' ' ARG . 0.6 OUTLIER -72.54 -42.17 65.01 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.263 179.739 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 551' ' ' LEU . . . . . . . . . . . . . 8.8 tp -131.37 140.57 49.71 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.335 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 552' ' ' THR . . . . . 0.646 ' O ' ' HA2' ' A' ' 533' ' ' GLY . 27.1 m -133.04 147.93 52.22 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.618 0.723 . . . . 0.0 111.912 179.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 553' ' ' PHE . . . . . 0.528 ' CD1' ' CE1' ' A' ' 531' ' ' TYR . 14.3 m-85 -133.86 136.77 44.59 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 177.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 554' ' ' THR . . . . . 0.559 ' O ' ' HA ' ' A' ' 531' ' ' TYR . 0.8 OUTLIER -134.0 138.96 31.83 Favored Pre-proline 0 C--N 1.308 -1.214 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.327 179.544 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 555' ' ' PRO . . . . . 0.573 ' HD2' ' CZ2' ' A' ' 559' ' ' TRP . 79.8 Cg_endo -86.22 20.33 1.25 Allowed 'Trans proline' 0 N--CA 1.445 -1.33 0 C-N-CA 121.972 1.782 . . . . 0.0 111.043 178.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 556' ' ' ILE . . . . . 0.867 ' HB ' ' O ' ' A' ' 530' ' ' ALA . 4.2 tp 63.27 35.17 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 177.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 2.2 mtmp? -102.86 122.11 43.86 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 558' ' ' THR . . . . . . . . . . . . . 12.0 m -56.91 118.57 5.08 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 115.61 1.707 . . . . 0.0 115.61 -171.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 559' ' ' TRP . . . . . 0.573 ' CZ2' ' HD2' ' A' ' 555' ' ' PRO . 0.0 OUTLIER -138.24 111.96 8.29 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 112.441 -2.163 . . . . 0.0 105.715 175.486 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 560' ' ' ASN . . . . . 0.533 ' O ' ' HB ' ' A' ' 564' ' ' THR . 51.2 m-20 -80.44 -74.82 0.29 Allowed 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 -175.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 561' ' ' ALA . . . . . 0.431 ' O ' HG21 ' A' ' 564' ' ' THR . . . -73.94 -65.33 0.85 Allowed 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 -176.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 562' ' ' SER . . . . . . . . . . . . . 1.4 p -49.06 -52.19 26.97 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -175.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 563' ' ' LYS . . . . . 0.523 ' HG2' ' CE2' ' A' ' 559' ' ' TRP . 9.3 tppt? -70.93 -49.13 48.97 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 564' ' ' THR . . . . . 0.665 ' CG2' ' O ' ' A' ' 501' ' ' TYR . 1.7 t -50.03 -62.4 1.59 Allowed 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.563 -178.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 565' ' ' GLN . . . . . 0.482 ' N ' ' CG2' ' A' ' 564' ' ' THR . 0.0 OUTLIER -49.13 -47.6 45.4 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 122.282 -0.261 . . . . 0.0 111.355 178.495 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -49.66 -56.27 10.71 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -178.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 567' ' ' PHE . . . . . 0.516 ' CE2' HG12 ' A' ' 532' ' ' VAL . 1.4 p90 -96.83 -46.0 6.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.433 0.635 . . . . 0.0 111.944 -178.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 568' ' ' ILE . . . . . 0.509 ' N ' ' O ' ' A' ' 564' ' ' THR . 1.3 tp -58.11 9.44 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.504 -0.822 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 569' ' ' ILE . . . . . 0.537 ' O ' ' OD1' ' A' ' 570' ' ' ASP . 0.0 OUTLIER -55.0 -38.94 47.51 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 N-CA-C 104.967 -2.234 . . . . 0.0 104.967 179.184 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 570' ' ' ASP . . . . . 0.537 ' OD1' ' O ' ' A' ' 569' ' ' ILE . 13.4 p30 31.61 58.12 0.3 Allowed 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 114.289 -1.323 . . . . 0.0 112.307 173.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -51.62 -45.1 54.55 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 117.288 -2.387 . . . . 0.0 108.79 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 572' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -119.57 -16.81 8.82 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 112.411 0.522 . . . . 0.0 112.411 175.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 573' ' ' LEU . . . . . 0.611 ' HB3' ' O ' ' A' ' 535' ' ' ARG . 1.2 tp -140.14 136.9 33.98 Favored 'General case' 0 C--N 1.351 0.659 0 N-CA-C 115.756 1.761 . . . . 0.0 115.756 -177.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 574' ' ' LEU . . . . . 0.574 ' HB3' ' CD1' ' A' ' 588' ' ' ILE . 0.1 OUTLIER -134.77 133.83 40.29 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 105.847 -1.908 . . . . 0.0 105.847 173.707 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 575' ' ' ILE . . . . . 0.686 HG13 ' O ' ' A' ' 533' ' ' GLY . 0.0 OUTLIER -133.55 136.08 54.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.401 178.65 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 576' ' ' LEU . . . . . 0.551 ' CD2' ' HB3' ' A' ' 509' ' ' LEU . 0.0 OUTLIER -133.99 135.63 43.56 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 177.1 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 577' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.32 135.26 46.08 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 118.88 -1.128 . . . . 0.0 110.513 177.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.01 132.12 54.0 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 177.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 579' ' ' GLY . . . . . . . . . . . . . . . -89.8 -2.15 75.85 Favored Glycine 0 CA--C 1.499 -0.92 0 CA-C-N 115.244 -0.889 . . . . 0.0 113.431 -178.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 580' ' ' LYS . . . . . 0.48 ' O ' ' CD1' ' A' ' 581' ' ' TRP . 0.0 OUTLIER -72.67 -48.15 41.49 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 118.998 -1.081 . . . . 0.0 108.964 179.426 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 581' ' ' TRP . . . . . 0.48 ' CD1' ' O ' ' A' ' 580' ' ' LYS . 28.4 m0 -139.03 -52.82 0.56 Allowed 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 177.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 582' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.84 165.22 27.88 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 -174.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 583' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.2 135.06 53.33 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 174.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 584' ' ' LYS . . . . . 0.613 ' HB2' ' CD2' ' A' ' 514' ' ' LEU . 2.3 tppt? -117.25 134.27 54.99 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 585' ' ' LEU . . . . . 0.513 ' CD2' ' HD3' ' A' ' 492' ' ' ARG . 4.2 tt -121.68 135.9 54.95 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 178.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 586' ' ' VAL . . . . . . . . . . . . . 16.9 t -133.31 137.07 53.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.204 -178.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 587' ' ' SER . . . . . . . . . . . . . 70.8 m -109.98 135.02 51.49 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 176.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . 0.574 ' CD1' ' HB3' ' A' ' 574' ' ' LEU . 0.0 OUTLIER -134.53 141.85 42.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -177.868 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 5.2 m -133.28 137.02 54.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 114.166 -1.379 . . . . 0.0 110.422 177.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 590' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.326 -0.441 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.445 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 491' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.879 0.371 . . . . 0.0 111.934 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 492' ' ' ARG . . . . . 0.509 ' CD ' ' HG ' ' A' ' 585' ' ' LEU . 0.0 OUTLIER -134.37 134.86 42.2 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.855 179.101 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 493' ' ' VAL . . . . . 0.492 ' CG2' ' CA ' ' A' ' 513' ' ' GLY . 85.9 t -135.28 163.73 35.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.242 178.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 494' ' ' THR . . . . . 0.435 ' N ' ' CG1' ' A' ' 493' ' ' VAL . 1.3 m -125.72 135.89 52.58 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.323 0.582 . . . . 0.0 111.231 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 495' ' ' LEU . . . . . 0.534 ' HG ' ' CG2' ' A' ' 588' ' ' ILE . 2.1 pp -133.93 163.3 52.12 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 115.239 -0.892 . . . . 0.0 110.122 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 496' ' ' PRO . . . . . 0.471 ' O ' ' CD1' ' A' ' 495' ' ' LEU . 20.4 Cg_exo -63.36 118.67 5.58 Favored 'Trans proline' 0 CA--C 1.534 0.477 0 C-N-CA 121.712 1.608 . . . . 0.0 111.327 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 497' ' ' LYS . . . . . 0.442 ' HA ' ' HB ' ' A' ' 588' ' ' ILE . 8.6 tttm -50.19 -29.87 10.22 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -179.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 498' ' ' SER . . . . . 0.421 ' HA ' ' CE2' ' A' ' 501' ' ' TYR . 1.0 OUTLIER -56.3 -48.45 76.64 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 113.758 1.022 . . . . 0.0 113.758 -177.345 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 499' ' ' LEU . . . . . 0.447 HD22 ' HD2' ' A' ' 496' ' ' PRO . 0.7 OUTLIER -73.71 -8.43 55.95 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -178.542 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . 0.448 ' HA ' ' NZ ' ' A' ' 507' ' ' LYS . 1.7 p -74.73 -25.58 19.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.275 0.56 . . . . 0.0 111.613 -179.016 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 501' ' ' TYR . . . . . 0.635 ' O ' ' CG2' ' A' ' 564' ' ' THR . 6.7 m-30 -53.96 -30.61 47.61 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 114.217 1.192 . . . . 0.0 114.217 -178.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -77.38 -51.16 11.28 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.059 1.874 . . . . 0.0 116.059 -175.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 503' ' ' LYS . . . . . 0.558 ' O ' ' CG ' ' A' ' 507' ' ' LYS . 0.0 OUTLIER -121.2 136.12 55.03 Favored 'General case' 0 C--N 1.339 0.132 0 CA-C-N 118.885 0.766 . . . . 0.0 112.375 -179.109 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 504' ' ' THR . . . . . 0.421 ' O ' ' CG2' ' A' ' 508' ' ' VAL . 90.5 m -73.29 -75.68 0.14 Allowed 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 179.047 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . 0.472 ' CE1' ' HA ' ' A' ' 558' ' ' THR . 0.0 OUTLIER -74.87 -62.48 1.53 Allowed 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -178.888 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 506' ' ' SER . . . . . 0.802 ' O ' ' CD1' ' A' ' 510' ' ' TRP . 66.5 m -49.59 -73.23 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -175.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 507' ' ' LYS . . . . . 0.722 ' HD3' ' N ' ' A' ' 508' ' ' VAL . 0.0 OUTLIER -49.05 -48.89 43.59 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -176.425 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 508' ' ' VAL . . . . . 0.722 ' N ' ' HD3' ' A' ' 507' ' ' LYS . 47.7 t -55.83 -62.33 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.722 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 509' ' ' LEU . . . . . 0.554 ' CD1' ' N ' ' A' ' 510' ' ' TRP . 1.9 pp -49.9 -63.01 1.24 Allowed 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -177.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 510' ' ' TRP . . . . . 0.855 ' CD1' ' HA ' ' A' ' 518' ' ' LYS . 67.4 p-90 -72.89 -49.74 27.98 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 -176.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 511' ' ' SER . . . . . 0.507 ' N ' ' CE3' ' A' ' 510' ' ' TRP . 0.3 OUTLIER -62.87 -47.07 84.94 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.289 -0.869 . . . . 0.0 113.178 -176.81 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 512' ' ' ALA . . . . . 0.482 ' CB ' ' CD2' ' A' ' 495' ' ' LEU . . . -70.97 -73.5 0.17 Allowed 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 118.242 2.682 . . . . 0.0 118.242 -173.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 513' ' ' GLY . . . . . 0.492 ' CA ' ' CG2' ' A' ' 493' ' ' VAL . . . -114.67 -36.05 1.33 Allowed Glycine 0 CA--C 1.502 -0.743 0 N-CA-C 121.295 3.278 . . . . 0.0 121.295 -172.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 514' ' ' LEU . . . . . 0.464 ' CD1' ' HB2' ' A' ' 584' ' ' LYS . 1.6 mt -108.94 -43.21 4.26 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 120.053 3.353 . . . . 0.0 120.053 -170.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 515' ' ' VAL . . . . . 0.53 ' CG2' ' N ' ' A' ' 516' ' ' ALA . 3.8 p -154.0 172.12 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 117.721 2.489 . . . . 0.0 117.721 -171.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 516' ' ' ALA . . . . . 0.53 ' N ' ' CG2' ' A' ' 515' ' ' VAL . . . -68.42 3.97 1.54 Allowed 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 127.054 2.142 . . . . 0.0 110.238 177.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 517' ' ' SER . . . . . 0.813 ' O ' ' N ' ' A' ' 521' ' ' GLY . 0.4 OUTLIER -57.32 8.81 0.01 OUTLIER 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 115.575 1.695 . . . . 0.0 115.575 -171.853 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 518' ' ' LYS . . . . . 0.855 ' HA ' ' CD1' ' A' ' 510' ' ' TRP . 2.3 ttpt -46.37 -51.4 14.96 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 104.462 -2.422 . . . . 0.0 104.462 174.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 519' ' ' SER . . . . . . . . . . . . . 35.2 t -75.0 -57.01 4.17 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.101 173.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 520' ' ' GLU . . . . . 0.706 ' HB2' ' HA ' ' A' ' 517' ' ' SER . 0.3 OUTLIER -57.47 -48.0 80.35 Favored 'General case' 0 C--N 1.348 0.536 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.926 -178.97 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 521' ' ' GLY . . . . . 0.813 ' N ' ' O ' ' A' ' 517' ' ' SER . . . -49.46 -56.81 10.22 Favored Glycine 0 CA--C 1.493 -1.296 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.525 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -47.82 -47.32 31.24 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 523' ' ' ARG . . . . . 0.421 ' O ' ' HB3' ' A' ' 526' ' ' ASN . 0.5 OUTLIER -50.12 -48.79 53.32 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.785 178.557 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 524' ' ' ILE . . . . . 0.484 ' HA ' ' HB3' ' A' ' 527' ' ' ASN . 29.8 mm -59.36 -54.05 39.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.325 0.583 . . . . 0.0 110.043 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 525' ' ' ILE . . . . . 0.542 HG12 ' O ' ' A' ' 521' ' ' GLY . 1.3 mm -50.27 -47.3 25.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 177.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 526' ' ' ASN . . . . . 0.421 ' HB3' ' O ' ' A' ' 523' ' ' ARG . 1.0 OUTLIER -57.93 -47.85 81.63 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 114.607 -1.179 . . . . 0.0 108.325 177.142 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 527' ' ' ASN . . . . . 0.484 ' HB3' ' HA ' ' A' ' 524' ' ' ILE . 0.0 OUTLIER -47.73 -39.13 16.88 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 113.965 -1.471 . . . . 0.0 107.931 176.807 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 528' ' ' ASN . . . . . 0.769 ' HA ' ' CG2' ' A' ' 556' ' ' ILE . 14.1 t-20 75.17 40.61 0.33 Allowed 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 114.854 -1.066 . . . . 0.0 112.088 -179.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 529' ' ' GLY . . . . . . . . . . . . . . . -112.46 20.25 21.02 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 114.524 -1.217 . . . . 0.0 111.661 177.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 530' ' ' ALA . . . . . 0.777 ' O ' ' HB ' ' A' ' 556' ' ' ILE . . . -133.76 163.68 28.92 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -179.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 531' ' ' TYR . . . . . 0.505 ' CE2' ' HA ' ' A' ' 553' ' ' PHE . 0.0 OUTLIER -133.76 162.59 31.57 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 177.578 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 532' ' ' VAL . . . . . 0.587 ' HB ' ' HB ' ' A' ' 554' ' ' THR . 0.6 OUTLIER -127.47 135.06 64.32 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 CA-C-O 121.956 0.884 . . . . 0.0 111.819 179.131 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 533' ' ' GLY . . . . . 0.696 ' HA2' ' O ' ' A' ' 552' ' ' THR . . . -133.62 148.44 19.39 Favored Glycine 0 N--CA 1.445 -0.7 0 CA-C-N 114.252 -1.34 . . . . 0.0 113.496 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 534' ' ' SER . . . . . 0.41 ' CB ' ' HB3' ' A' ' 567' ' ' PHE . 0.1 OUTLIER -135.14 141.28 45.92 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 179.724 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 535' ' ' ARG . . . . . 0.645 ' O ' ' HB3' ' A' ' 573' ' ' LEU . 26.2 tpt85 . . . . . 0 N--CA 1.464 0.248 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.848 178.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 . . . . . 0 CA--C 1.512 -0.506 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 550' ' ' ASP . . . . . 0.511 ' O ' ' HA ' ' A' ' 535' ' ' ARG . 11.4 m-20 -77.78 -39.37 44.22 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.053 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 551' ' ' LEU . . . . . 0.414 HD11 ' CE1' ' A' ' 553' ' ' PHE . 3.0 tp -131.25 140.76 49.89 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.951 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 552' ' ' THR . . . . . 0.696 ' O ' ' HA2' ' A' ' 533' ' ' GLY . 1.9 m -132.87 146.09 51.5 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.491 0.663 . . . . 0.0 110.98 178.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 553' ' ' PHE . . . . . 0.505 ' HA ' ' CE2' ' A' ' 531' ' ' TYR . 9.8 m-85 -134.39 137.01 43.75 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 177.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 554' ' ' THR . . . . . 0.587 ' HB ' ' HB ' ' A' ' 532' ' ' VAL . 21.7 m -133.94 138.62 31.14 Favored Pre-proline 0 C--N 1.303 -1.423 0 C-N-CA 119.42 -0.912 . . . . 0.0 110.045 178.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 555' ' ' PRO . . . . . 0.569 ' O ' HG23 ' A' ' 556' ' ' ILE . 85.6 Cg_endo -85.48 25.29 0.7 Allowed 'Trans proline' 0 N--CA 1.438 -1.771 0 C-N-CA 121.452 1.434 . . . . 0.0 109.857 178.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 556' ' ' ILE . . . . . 0.777 ' HB ' ' O ' ' A' ' 530' ' ' ALA . 1.4 tp 64.59 32.6 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 177.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -103.96 131.19 51.45 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 558' ' ' THR . . . . . 0.472 ' HA ' ' CE1' ' A' ' 505' ' ' PHE . 3.5 t -58.17 116.38 3.52 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 116.071 1.878 . . . . 0.0 116.071 -172.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 559' ' ' TRP . . . . . 0.639 ' CE3' ' HG3' ' A' ' 563' ' ' LYS . 1.3 m0 -139.33 111.49 7.46 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 104.414 -2.439 . . . . 0.0 104.414 173.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 560' ' ' ASN . . . . . 0.485 ' O ' ' HB ' ' A' ' 564' ' ' THR . 51.1 m-80 -90.98 -75.32 0.47 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 115.116 1.524 . . . . 0.0 115.116 -175.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 561' ' ' ALA . . . . . 0.456 ' O ' HG22 ' A' ' 564' ' ' THR . . . -73.76 -63.42 1.21 Allowed 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 115.729 1.751 . . . . 0.0 115.729 -176.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 562' ' ' SER . . . . . . . . . . . . . 69.2 m -48.83 -50.84 32.65 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -176.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 563' ' ' LYS . . . . . 0.639 ' HG3' ' CE3' ' A' ' 559' ' ' TRP . 1.2 mmpt? -71.2 -49.01 48.02 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -178.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 564' ' ' THR . . . . . 0.687 ' O ' ' HB ' ' A' ' 568' ' ' ILE . 3.4 t -51.17 -62.93 1.31 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.794 0.331 . . . . 0.0 110.709 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 565' ' ' GLN . . . . . 0.535 ' NE2' ' HA ' ' A' ' 565' ' ' GLN . 3.6 tp60 -50.23 -47.34 54.99 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.858 0.361 . . . . 0.0 111.28 178.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 566' ' ' GLU . . . . . 0.425 ' HG2' ' CD1' ' A' ' 567' ' ' PHE . 23.3 tt0 -49.2 -68.54 0.17 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -178.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 567' ' ' PHE . . . . . 0.625 ' C ' ' H ' ' A' ' 569' ' ' ILE . 0.2 OUTLIER -91.01 -51.85 5.14 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.397 0.618 . . . . 0.0 111.57 -179.094 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 568' ' ' ILE . . . . . 0.687 ' HB ' ' O ' ' A' ' 564' ' ' THR . 1.9 mp -56.17 8.98 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 114.83 -1.077 . . . . 0.0 113.259 -179.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 569' ' ' ILE . . . . . 0.625 ' H ' ' C ' ' A' ' 567' ' ' PHE . 1.3 pt -54.13 -36.39 32.13 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.728 0 N-CA-C 104.146 -2.538 . . . . 0.0 104.146 177.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 570' ' ' ASP . . . . . 0.518 ' OD2' HG23 ' A' ' 568' ' ' ILE . 28.4 m-20 35.39 54.84 0.83 Allowed 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 113.453 -1.703 . . . . 0.0 111.661 174.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -51.28 -44.89 52.62 Favored Glycine 0 N--CA 1.438 -1.169 0 C-N-CA 118.045 -2.026 . . . . 0.0 108.455 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 572' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -119.89 -17.12 8.57 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 175.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 573' ' ' LEU . . . . . 0.645 ' HB3' ' O ' ' A' ' 535' ' ' ARG . 0.9 OUTLIER -140.7 136.65 32.83 Favored 'General case' 0 C--N 1.354 0.768 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 -177.937 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 574' ' ' LEU . . . . . 0.511 ' HB2' ' OD2' ' A' ' 570' ' ' ASP . 0.7 OUTLIER -135.29 133.48 38.92 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 173.865 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 575' ' ' ILE . . . . . 0.584 HG13 ' O ' ' A' ' 533' ' ' GLY . 0.0 OUTLIER -133.48 137.19 53.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 119.133 0.879 . . . . 0.0 111.745 178.736 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 576' ' ' LEU . . . . . 0.562 HD22 ' HB3' ' A' ' 584' ' ' LYS . 0.0 OUTLIER -133.31 135.32 44.75 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 177.255 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 577' ' ' LYS . . . . . 0.451 ' CD ' ' CD1' ' A' ' 531' ' ' TYR . 0.2 OUTLIER -128.22 135.48 49.74 Favored 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.104 178.044 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.81 132.7 52.2 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 579' ' ' GLY . . . . . . . . . . . . . . . -88.51 -2.14 79.86 Favored Glycine 0 N--CA 1.438 -1.169 0 CA-C-N 114.759 -1.11 . . . . 0.0 112.962 -179.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 580' ' ' LYS . . . . . 0.458 ' HD2' ' CZ2' ' A' ' 581' ' ' TRP . 18.9 pttt -66.1 -50.46 63.96 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 118.891 -1.124 . . . . 0.0 108.047 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 581' ' ' TRP . . . . . 0.458 ' CZ2' ' HD2' ' A' ' 580' ' ' LYS . 0.0 OUTLIER -142.35 -52.03 0.4 Allowed 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 175.815 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 582' ' ' LYS . . . . . 0.411 ' HE3' ' CD1' ' A' ' 581' ' ' TRP . 0.4 OUTLIER -139.56 166.06 25.58 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 114.398 1.258 . . . . 0.0 114.398 -174.508 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 583' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -109.2 135.24 50.63 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 174.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 584' ' ' LYS . . . . . 0.652 ' NZ ' ' O ' ' A' ' 508' ' ' VAL . 1.1 tmmt? -114.8 133.85 55.6 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 178.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 585' ' ' LEU . . . . . 0.509 ' HG ' ' CD ' ' A' ' 492' ' ' ARG . 5.0 tp -122.38 136.69 54.94 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 586' ' ' VAL . . . . . 0.464 ' O ' ' HB3' ' A' ' 574' ' ' LEU . 9.5 t -132.91 144.58 36.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -178.043 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 587' ' ' SER . . . . . . . . . . . . . 2.9 m -109.83 136.35 49.28 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 177.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . 0.534 ' CG2' ' HG ' ' A' ' 495' ' ' LEU . 0.0 OUTLIER -132.7 136.74 55.38 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -177.958 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 5.6 m -133.07 137.06 54.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 114.356 -1.293 . . . . 0.0 110.688 178.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 590' ' ' SER . . . . . . . . . . . . . 2.6 m . . . . . 0 C--N 1.327 -0.394 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.449 179.914 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 491' ' ' ALA . . . . . 0.417 ' CB ' ' NZ ' ' A' ' 584' ' ' LYS . . . . . . . . 0 C--O 1.23 0.048 0 CA-C-O 120.454 0.169 . . . . 0.0 110.574 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 492' ' ' ARG . . . . . 0.443 ' CD ' ' CD2' ' A' ' 585' ' ' LEU . 0.0 OUTLIER -135.85 135.23 39.61 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.981 0.419 . . . . 0.0 111.851 179.883 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 493' ' ' VAL . . . . . 0.529 ' HB ' ' HA3' ' A' ' 513' ' ' GLY . 84.8 t -134.93 163.2 37.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.135 177.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 494' ' ' THR . . . . . 0.434 ' N ' ' CG1' ' A' ' 493' ' ' VAL . 5.3 t -122.49 134.86 54.56 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.143 0.497 . . . . 0.0 111.147 178.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 495' ' ' LEU . . . . . 0.513 HD21 HG22 ' A' ' 588' ' ' ILE . 0.0 OUTLIER -135.49 164.57 42.62 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.401 179.593 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -66.69 119.42 6.45 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 121.759 1.639 . . . . 0.0 110.918 178.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 497' ' ' LYS . . . . . 0.502 ' N ' HG21 ' A' ' 588' ' ' ILE . 5.6 tmtt? -53.81 -30.02 43.2 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -178.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 498' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.92 -48.36 82.01 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -177.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 2.2 pp -73.52 -8.87 57.71 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -178.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . 0.459 HG22 ' HA ' ' A' ' 497' ' ' LYS . 39.8 t -75.41 -25.4 17.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.21 0.528 . . . . 0.0 111.922 -179.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 501' ' ' TYR . . . . . 0.617 ' O ' ' CG2' ' A' ' 564' ' ' THR . 0.7 OUTLIER -52.95 -28.7 24.84 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -178.201 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.4 -50.08 17.0 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 115.563 1.69 . . . . 0.0 115.563 -175.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 503' ' ' LYS . . . . . 0.569 ' O ' ' CG ' ' A' ' 507' ' ' LYS . 0.5 OUTLIER -119.44 135.29 54.82 Favored 'General case' 0 C--N 1.338 0.074 0 CA-C-N 119.201 0.909 . . . . 0.0 111.843 -179.41 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 504' ' ' THR . . . . . 0.487 ' OG1' ' N ' ' A' ' 564' ' ' THR . 62.5 m -73.18 -76.61 0.12 Allowed 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . 0.497 ' CZ ' ' CD1' ' A' ' 556' ' ' ILE . 0.2 OUTLIER -75.08 -60.87 2.1 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -179.25 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 506' ' ' SER . . . . . 0.455 ' O ' ' HG ' ' A' ' 509' ' ' LEU . 1.4 m -48.82 -72.72 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 -176.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 507' ' ' LYS . . . . . 0.715 ' HD3' ' N ' ' A' ' 508' ' ' VAL . 0.0 OUTLIER -50.41 -48.92 55.96 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -176.878 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 508' ' ' VAL . . . . . 0.715 ' N ' ' HD3' ' A' ' 507' ' ' LYS . 47.9 t -52.66 -58.84 2.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -178.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 509' ' ' LEU . . . . . 0.578 ' CD1' ' N ' ' A' ' 510' ' ' TRP . 1.5 pp -58.16 -62.84 1.53 Allowed 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 -177.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 510' ' ' TRP . . . . . 0.615 ' CE3' ' HG3' ' A' ' 518' ' ' LYS . 6.0 p-90 -73.06 -52.49 14.15 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 114.706 1.372 . . . . 0.0 114.706 -176.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 511' ' ' SER . . . . . 0.486 ' N ' ' CE3' ' A' ' 510' ' ' TRP . 0.2 OUTLIER -61.87 -48.41 80.62 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.684 -176.893 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 512' ' ' ALA . . . . . 0.439 ' HB2' ' CD2' ' A' ' 495' ' ' LEU . . . -72.1 -73.77 0.18 Allowed 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 117.162 2.282 . . . . 0.0 117.162 -174.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 513' ' ' GLY . . . . . 0.65 ' HA3' ' HE3' ' A' ' 584' ' ' LYS . . . -115.23 -35.13 1.36 Allowed Glycine 0 N--CA 1.449 -0.477 0 N-CA-C 121.408 3.323 . . . . 0.0 121.408 -172.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 514' ' ' LEU . . . . . 0.582 ' HG ' ' HE2' ' A' ' 584' ' ' LYS . 1.3 mt -107.58 -38.73 5.82 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 120.09 3.367 . . . . 0.0 120.09 -170.013 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 515' ' ' VAL . . . . . 0.563 HG21 ' H ' ' A' ' 517' ' ' SER . 14.3 p -152.95 172.08 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 N-CA-C 118.108 2.633 . . . . 0.0 118.108 -172.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 516' ' ' ALA . . . . . 0.501 ' H ' ' CG2' ' A' ' 515' ' ' VAL . . . -85.94 2.69 45.15 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 127.055 2.142 . . . . 0.0 108.956 178.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 517' ' ' SER . . . . . 0.882 ' O ' ' N ' ' A' ' 521' ' ' GLY . 10.4 p -59.82 13.0 0.01 OUTLIER 'General case' 0 N--CA 1.424 -1.729 0 C-N-CA 126.326 1.85 . . . . 0.0 115.49 -173.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 518' ' ' LYS . . . . . 0.631 ' C ' ' O ' ' A' ' 517' ' ' SER . 2.1 mppt? -40.61 -44.36 2.1 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 178.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 519' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.37 -52.46 12.07 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.323 173.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 520' ' ' GLU . . . . . 0.815 ' HB2' ' HA ' ' A' ' 517' ' ' SER . 9.0 mm-40 -63.1 -46.81 85.6 Favored 'General case' 0 C--N 1.35 0.591 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.277 -179.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 521' ' ' GLY . . . . . 0.882 ' N ' ' O ' ' A' ' 517' ' ' SER . . . -49.16 -58.75 7.58 Favored Glycine 0 CA--C 1.495 -1.172 0 N-CA-C 111.344 -0.702 . . . . 0.0 111.344 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . 0.4 ' HA ' HG12 ' A' ' 525' ' ' ILE . 3.8 mt-30 -47.99 -47.89 32.8 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 178.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 523' ' ' ARG . . . . . 0.467 ' HB3' ' O ' ' A' ' 520' ' ' GLU . 0.4 OUTLIER -50.26 -48.75 54.67 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.823 178.945 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 524' ' ' ILE . . . . . 0.418 ' O ' ' ND2' ' A' ' 527' ' ' ASN . 6.0 mt -58.31 -54.86 27.06 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 CA-C-O 121.341 0.591 . . . . 0.0 109.745 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 525' ' ' ILE . . . . . 0.563 HG12 ' O ' ' A' ' 521' ' ' GLY . 1.0 OUTLIER -50.37 -47.6 26.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.091 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 526' ' ' ASN . . . . . . . . . . . . . 36.7 m-20 -58.2 -47.78 82.4 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 114.373 -1.285 . . . . 0.0 108.643 177.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 527' ' ' ASN . . . . . 0.418 ' ND2' ' O ' ' A' ' 524' ' ' ILE . 0.0 OUTLIER -47.69 -39.83 18.45 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 113.971 -1.468 . . . . 0.0 108.028 177.282 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 528' ' ' ASN . . . . . 0.687 ' HA ' ' CG2' ' A' ' 556' ' ' ILE . 14.6 t-20 73.99 39.85 0.49 Allowed 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.187 -179.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 529' ' ' GLY . . . . . . . . . . . . . . . -114.83 20.52 14.77 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 114.265 -1.334 . . . . 0.0 111.54 178.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 530' ' ' ALA . . . . . 0.774 ' O ' ' HB ' ' A' ' 556' ' ' ILE . . . -133.71 156.76 47.36 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.86 0.362 . . . . 0.0 111.649 -179.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 531' ' ' TYR . . . . . 0.514 ' CE1' ' CD1' ' A' ' 553' ' ' PHE . 0.1 OUTLIER -133.28 158.8 42.03 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 178.039 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 532' ' ' VAL . . . . . 0.569 ' CB ' ' HB ' ' A' ' 554' ' ' THR . 0.5 OUTLIER -125.52 135.78 62.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-O 122.025 0.917 . . . . 0.0 112.958 -178.301 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 533' ' ' GLY . . . . . 0.603 ' HA2' ' O ' ' A' ' 552' ' ' THR . . . -134.41 161.14 24.4 Favored Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 114.381 -1.281 . . . . 0.0 114.865 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 534' ' ' SER . . . . . 0.607 ' O ' ' HA ' ' A' ' 551' ' ' LEU . 6.7 t -133.8 137.28 45.01 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 114.912 -0.644 . . . . 0.0 110.628 178.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 535' ' ' ARG . . . . . 0.729 ' O ' ' HB3' ' A' ' 573' ' ' LEU . 7.1 tpt85 . . . . . 0 C--N 1.33 -0.276 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 178.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 2.6 p30 . . . . . 0 N--CA 1.449 -0.493 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 550' ' ' ASP . . . . . 0.693 ' O ' ' HA ' ' A' ' 535' ' ' ARG . 1.3 t70 -58.75 -47.94 82.93 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 551' ' ' LEU . . . . . 0.607 ' HA ' ' O ' ' A' ' 534' ' ' SER . 7.9 tp -120.37 140.06 51.87 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 552' ' ' THR . . . . . 0.603 ' O ' ' HA2' ' A' ' 533' ' ' GLY . 3.2 m -133.39 148.0 51.79 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.861 0.839 . . . . 0.0 112.295 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 553' ' ' PHE . . . . . 0.514 ' CD1' ' CE1' ' A' ' 531' ' ' TYR . 0.3 OUTLIER -134.66 137.46 43.62 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 176.554 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 554' ' ' THR . . . . . 0.569 ' HB ' ' CB ' ' A' ' 532' ' ' VAL . 0.9 OUTLIER -132.83 138.11 31.18 Favored Pre-proline 0 C--N 1.31 -1.124 0 C-N-CA 119.474 -0.89 . . . . 0.0 110.338 179.304 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 555' ' ' PRO . . . . . 0.61 ' O ' HG23 ' A' ' 556' ' ' ILE . 61.0 Cg_endo -86.33 25.07 0.7 Allowed 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 122.208 1.938 . . . . 0.0 112.064 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 556' ' ' ILE . . . . . 0.774 ' HB ' ' O ' ' A' ' 530' ' ' ALA . 1.5 tp 64.4 33.11 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 115.714 1.746 . . . . 0.0 115.714 176.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . 0.59 ' O ' ' CE2' ' A' ' 559' ' ' TRP . 3.7 mttt -104.24 125.86 50.87 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 -179.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 558' ' ' THR . . . . . . . . . . . . . 2.8 t -58.13 117.64 4.6 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -173.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 559' ' ' TRP . . . . . 0.59 ' CE2' ' O ' ' A' ' 557' ' ' LYS . 0.0 OUTLIER -138.72 112.16 8.17 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 175.479 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 560' ' ' ASN . . . . . 0.609 ' O ' ' CG2' ' A' ' 564' ' ' THR . 26.2 m-80 -76.26 -76.27 0.17 Allowed 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 118.829 -1.149 . . . . 0.0 113.934 -175.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 561' ' ' ALA . . . . . 0.675 ' O ' HG22 ' A' ' 564' ' ' THR . . . -75.16 -55.04 6.13 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 116.241 1.941 . . . . 0.0 116.241 -177.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 562' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -49.31 -53.77 20.39 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -176.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 563' ' ' LYS . . . . . 0.578 ' HG3' ' CE2' ' A' ' 559' ' ' TRP . 2.4 mmtt -70.86 -47.55 58.7 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -178.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 564' ' ' THR . . . . . 0.675 HG22 ' O ' ' A' ' 561' ' ' ALA . 3.3 t -48.53 -67.45 0.27 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.7 0.286 . . . . 0.0 110.879 -178.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 565' ' ' GLN . . . . . 0.522 ' H ' HG21 ' A' ' 564' ' ' THR . 0.0 OUTLIER -48.86 -46.77 42.84 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.757 0.313 . . . . 0.0 111.055 179.16 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -49.66 -67.18 0.28 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -178.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 567' ' ' PHE . . . . . 0.511 ' O ' ' OG ' ' A' ' 534' ' ' SER . 0.3 OUTLIER -89.13 -41.02 12.52 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -177.932 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 568' ' ' ILE . . . . . 0.569 ' O ' ' CG ' ' A' ' 570' ' ' ASP . 0.6 OUTLIER -61.59 9.84 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 179.63 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 569' ' ' ILE . . . . . 0.496 ' H ' ' C ' ' A' ' 567' ' ' PHE . 2.7 pp -55.56 -45.02 78.57 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.317 0 N-CA-C 104.112 -2.551 . . . . 0.0 104.112 177.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 570' ' ' ASP . . . . . 0.601 ' CB ' ' O ' ' A' ' 573' ' ' LEU . 1.3 p30 31.29 60.17 0.27 Allowed 'General case' 0 CA--C 1.511 -0.554 0 CA-C-N 114.236 -1.347 . . . . 0.0 112.16 173.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -51.49 -45.22 53.77 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 117.423 -2.323 . . . . 0.0 109.08 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 572' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -119.35 -16.94 8.93 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 175.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 573' ' ' LEU . . . . . 0.729 ' HB3' ' O ' ' A' ' 535' ' ' ARG . 0.7 OUTLIER -140.29 137.94 34.57 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 -178.116 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 574' ' ' LEU . . . . . 0.459 ' HB2' HD11 ' A' ' 568' ' ' ILE . 0.1 OUTLIER -133.55 134.84 43.86 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 174.223 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 575' ' ' ILE . . . . . 0.558 HG13 ' O ' ' A' ' 533' ' ' GLY . 0.0 OUTLIER -133.04 136.98 54.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 C-N-CA 119.799 -0.76 . . . . 0.0 112.469 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 576' ' ' LEU . . . . . 0.494 ' CD1' ' CE1' ' A' ' 505' ' ' PHE . 0.0 OUTLIER -133.16 135.03 44.9 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 176.73 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 577' ' ' LYS . . . . . . . . . . . . . 2.9 mtpm? -133.4 135.4 44.61 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 118.762 -1.175 . . . . 0.0 111.232 178.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.413 ' HA ' ' HB2' ' A' ' 530' ' ' ALA . 0.3 OUTLIER -125.62 131.66 52.63 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.068 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 579' ' ' GLY . . . . . . . . . . . . . . . -91.3 -2.19 71.09 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.396 -0.82 . . . . 0.0 113.582 -178.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 580' ' ' LYS . . . . . 0.542 ' HD2' ' CG ' ' A' ' 581' ' ' TRP . 0.0 OUTLIER -72.8 -47.36 47.12 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 119.123 -1.031 . . . . 0.0 108.945 179.387 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 581' ' ' TRP . . . . . 0.542 ' CG ' ' HD2' ' A' ' 580' ' ' LYS . 32.5 m0 -138.49 -52.93 0.6 Allowed 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 177.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 582' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.68 165.29 27.65 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 -174.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 583' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -117.15 134.29 54.96 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 174.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 584' ' ' LYS . . . . . 0.65 ' HE3' ' HA3' ' A' ' 513' ' ' GLY . 0.1 OUTLIER -121.22 133.66 55.17 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.988 -1.005 . . . . 0.0 108.762 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 585' ' ' LEU . . . . . 0.574 ' N ' ' HD3' ' A' ' 584' ' ' LYS . 6.2 tt -118.23 135.55 54.2 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 178.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 586' ' ' VAL . . . . . 0.429 ' CG1' HD22 ' A' ' 495' ' ' LEU . 77.4 t -133.26 138.57 51.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 C-N-CA 120.506 -0.477 . . . . 0.0 111.538 -178.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 587' ' ' SER . . . . . 0.404 ' N ' HG12 ' A' ' 586' ' ' VAL . 0.9 OUTLIER -106.73 135.53 48.11 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 177.733 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . 0.513 HG22 HD21 ' A' ' 495' ' ' LEU . 0.1 OUTLIER -133.67 137.12 53.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -177.992 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 589' ' ' VAL . . . . . 0.437 ' N ' ' HB2' ' A' ' 497' ' ' LYS . 5.4 m -127.52 137.37 57.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 114.334 -1.303 . . . . 0.0 110.804 178.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 590' ' ' SER . . . . . . . . . . . . . 28.0 t . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.279 -179.59 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 491' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.099 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 492' ' ' ARG . . . . . 0.415 ' HD2' HD22 ' A' ' 585' ' ' LEU . 0.0 OUTLIER -136.12 134.37 38.24 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.957 178.438 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 493' ' ' VAL . . . . . 0.632 ' CG2' ' HA3' ' A' ' 513' ' ' GLY . 11.2 m -136.2 163.81 33.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.816 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 9.0 t -120.2 133.36 55.51 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 121.043 0.449 . . . . 0.0 110.305 177.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 495' ' ' LEU . . . . . 0.487 ' CD1' ' CG2' ' A' ' 500' ' ' VAL . 1.6 pp -136.2 163.16 52.07 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.928 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 496' ' ' PRO . . . . . 0.446 ' O ' ' CD1' ' A' ' 495' ' ' LEU . 14.7 Cg_exo -67.35 119.3 6.31 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 122.313 2.008 . . . . 0.0 112.152 178.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 497' ' ' LYS . . . . . 0.528 ' HA ' ' HB ' ' A' ' 588' ' ' ILE . 20.1 tttt -51.85 -30.37 23.37 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -179.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 498' ' ' SER . . . . . . . . . . . . . 11.9 t -60.29 -48.35 82.11 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -177.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 499' ' ' LEU . . . . . 0.416 HD21 ' HB2' ' A' ' 496' ' ' PRO . 2.0 pp -74.18 -8.67 57.0 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -178.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . 0.487 ' CG2' ' CD1' ' A' ' 495' ' ' LEU . 13.8 t -75.45 -26.01 18.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.099 0.476 . . . . 0.0 112.239 -178.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 501' ' ' TYR . . . . . 0.491 ' O ' ' CG2' ' A' ' 564' ' ' THR . 6.3 m-85 -53.94 -30.61 47.27 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -178.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -75.82 -50.21 15.82 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 115.456 1.651 . . . . 0.0 115.456 -175.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 503' ' ' LYS . . . . . 0.61 ' O ' ' CG ' ' A' ' 507' ' ' LYS . 0.2 OUTLIER -119.2 132.57 55.96 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 118.79 0.723 . . . . 0.0 111.776 -179.323 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 504' ' ' THR . . . . . 0.508 ' OG1' ' N ' ' A' ' 564' ' ' THR . 4.6 m -72.96 -75.62 0.14 Allowed 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . 0.631 ' CE1' ' HA ' ' A' ' 558' ' ' THR . 0.0 OUTLIER -74.71 -62.69 1.45 Allowed 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 -179.107 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 506' ' ' SER . . . . . 0.758 ' O ' ' CD1' ' A' ' 510' ' ' TRP . 66.6 m -49.15 -72.81 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -175.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 507' ' ' LYS . . . . . 0.717 ' HD3' ' N ' ' A' ' 508' ' ' VAL . 0.0 OUTLIER -48.7 -48.49 40.24 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -176.153 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 508' ' ' VAL . . . . . 0.717 ' N ' ' HD3' ' A' ' 507' ' ' LYS . 61.3 t -54.76 -57.76 5.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -179.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 509' ' ' LEU . . . . . 0.612 ' HG ' ' H ' ' A' ' 510' ' ' TRP . 2.0 pp -59.64 -63.45 1.3 Allowed 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 -177.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 510' ' ' TRP . . . . . 0.758 ' CD1' ' O ' ' A' ' 506' ' ' SER . 63.7 p-90 -72.75 -49.69 29.34 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -176.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 511' ' ' SER . . . . . 0.523 ' N ' ' CD2' ' A' ' 510' ' ' TRP . 0.3 OUTLIER -62.75 -48.24 80.06 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.658 -177.014 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 512' ' ' ALA . . . . . 0.43 ' CB ' ' CD2' ' A' ' 495' ' ' LEU . . . -71.79 -75.18 0.14 Allowed 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 117.011 2.226 . . . . 0.0 117.011 -174.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 513' ' ' GLY . . . . . 0.632 ' HA3' ' CG2' ' A' ' 493' ' ' VAL . . . -117.63 -35.23 1.09 Allowed Glycine 0 CA--C 1.501 -0.787 0 N-CA-C 120.778 3.071 . . . . 0.0 120.778 -173.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 514' ' ' LEU . . . . . 0.7 ' HB3' HG22 ' A' ' 515' ' ' VAL . 0.0 OUTLIER -96.67 -46.95 6.09 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 119.542 3.164 . . . . 0.0 119.542 -168.746 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 515' ' ' VAL . . . . . 0.7 HG22 ' HB3' ' A' ' 514' ' ' LEU . 22.0 t -151.2 171.25 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 117.196 2.295 . . . . 0.0 117.196 -172.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 516' ' ' ALA . . . . . 0.499 ' H ' ' CG1' ' A' ' 515' ' ' VAL . . . -73.59 2.88 7.07 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 112.558 -2.11 . . . . 0.0 108.67 175.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 517' ' ' SER . . . . . 0.852 ' HA ' ' HB2' ' A' ' 520' ' ' GLU . 0.6 OUTLIER -58.33 9.6 0.01 OUTLIER 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 116.004 1.853 . . . . 0.0 116.004 -172.024 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 518' ' ' LYS . . . . . 0.755 ' HA ' ' CD1' ' A' ' 510' ' ' TRP . 0.0 OUTLIER -45.1 -48.26 12.04 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 175.841 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 519' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -75.21 -56.31 4.85 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.172 173.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 520' ' ' GLU . . . . . 0.852 ' HB2' ' HA ' ' A' ' 517' ' ' SER . 2.0 mm-40 -59.64 -47.58 85.05 Favored 'General case' 0 C--N 1.35 0.588 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.228 -178.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 521' ' ' GLY . . . . . 0.785 ' N ' ' O ' ' A' ' 517' ' ' SER . . . -49.01 -54.2 15.52 Favored Glycine 0 CA--C 1.496 -1.108 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -48.62 -47.3 40.2 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 523' ' ' ARG . . . . . 0.404 ' O ' ' N ' ' A' ' 527' ' ' ASN . 0.0 OUTLIER -49.9 -48.92 51.27 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.725 178.667 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 524' ' ' ILE . . . . . 0.434 ' CG2' ' HG2' ' A' ' 580' ' ' LYS . 28.1 mm -57.33 -55.92 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 CA-C-O 121.403 0.62 . . . . 0.0 109.725 179.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 525' ' ' ILE . . . . . 0.48 HG12 ' O ' ' A' ' 521' ' ' GLY . 1.5 mm -50.28 -47.4 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 177.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 526' ' ' ASN . . . . . . . . . . . . . 36.6 m-20 -57.63 -47.76 81.32 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 114.633 -1.167 . . . . 0.0 108.5 177.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 527' ' ' ASN . . . . . 0.427 ' ND2' ' O ' ' A' ' 524' ' ' ILE . 0.0 OUTLIER -47.94 -39.54 19.52 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 113.971 -1.468 . . . . 0.0 107.715 176.891 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 528' ' ' ASN . . . . . 0.747 ' HA ' ' CG2' ' A' ' 556' ' ' ILE . 2.5 t30 74.31 39.99 0.45 Allowed 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 114.631 -1.168 . . . . 0.0 111.633 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 529' ' ' GLY . . . . . . . . . . . . . . . -114.22 25.6 10.46 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 114.324 -1.307 . . . . 0.0 111.192 177.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 530' ' ' ALA . . . . . 0.807 ' O ' ' HB ' ' A' ' 556' ' ' ILE . . . -133.49 159.48 40.27 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.095 0.474 . . . . 0.0 112.046 -179.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 531' ' ' TYR . . . . . 0.52 ' CE2' ' CD2' ' A' ' 553' ' ' PHE . 0.0 OUTLIER -134.04 158.52 43.34 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 177.508 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 532' ' ' VAL . . . . . 0.482 HG12 ' OG1' ' A' ' 554' ' ' THR . 0.4 OUTLIER -126.69 135.59 63.26 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 C-N-CA 119.401 -0.919 . . . . 0.0 112.356 -179.758 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 533' ' ' GLY . . . . . 0.641 ' HA2' ' O ' ' A' ' 552' ' ' THR . . . -133.83 154.07 21.16 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 114.43 -1.259 . . . . 0.0 114.078 -179.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 534' ' ' SER . . . . . 0.49 ' N ' ' HB ' ' A' ' 552' ' ' THR . 44.7 t -134.16 137.08 44.23 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.303 -0.449 . . . . 0.0 111.37 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 535' ' ' ARG . . . . . 0.676 ' O ' ' HB3' ' A' ' 573' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.326 0 C-N-CA 120.305 -0.558 . . . . 0.0 112.452 178.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 . . . . . 0 N--CA 1.45 -0.45 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 550' ' ' ASP . . . . . 0.532 ' O ' ' HA ' ' A' ' 535' ' ' ARG . 4.4 m-20 -59.34 -46.95 87.2 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.23 179.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 551' ' ' LEU . . . . . . . . . . . . . 15.9 tp -131.48 139.87 49.43 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.184 -0.917 . . . . 0.0 108.968 178.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 552' ' ' THR . . . . . 0.641 ' O ' ' HA2' ' A' ' 533' ' ' GLY . 23.6 m -133.43 148.15 51.76 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.667 0.746 . . . . 0.0 111.933 179.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 553' ' ' PHE . . . . . 0.52 ' CD2' ' CE2' ' A' ' 531' ' ' TYR . 9.6 m-85 -134.59 137.07 43.42 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 176.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 554' ' ' THR . . . . . 0.489 HG23 ' HD2' ' A' ' 555' ' ' PRO . 2.8 m -133.21 139.03 32.95 Favored Pre-proline 0 C--N 1.306 -1.309 0 C-N-CA 119.745 -0.782 . . . . 0.0 109.554 178.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 555' ' ' PRO . . . . . 0.642 ' O ' HG22 ' A' ' 556' ' ' ILE . 81.2 Cg_endo -83.37 21.76 1.0 Allowed 'Trans proline' 0 N--CA 1.445 -1.324 0 C-N-CA 121.493 1.462 . . . . 0.0 111.878 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 556' ' ' ILE . . . . . 0.807 ' HB ' ' O ' ' A' ' 530' ' ' ALA . 2.0 tp 63.74 32.65 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 177.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 4.0 tttm -104.07 120.06 40.28 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 558' ' ' THR . . . . . 0.631 ' HA ' ' CE1' ' A' ' 505' ' ' PHE . 8.4 t -57.85 116.66 3.6 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 115.988 1.847 . . . . 0.0 115.988 -172.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 559' ' ' TRP . . . . . 0.495 ' HB2' ' HB2' ' A' ' 563' ' ' LYS . 1.0 OUTLIER -138.4 111.19 7.68 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 103.638 -2.727 . . . . 0.0 103.638 173.796 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 560' ' ' ASN . . . . . 0.474 ' O ' ' CG2' ' A' ' 564' ' ' THR . 30.2 m120 -68.91 -75.87 0.1 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 -174.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 561' ' ' ALA . . . . . 0.624 ' HA ' ' CG2' ' A' ' 564' ' ' THR . . . -74.24 -48.77 26.59 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 -177.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 562' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.41 -54.72 16.03 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -177.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 563' ' ' LYS . . . . . 0.495 ' HB2' ' HB2' ' A' ' 559' ' ' TRP . 0.0 OUTLIER -69.32 -48.63 60.91 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.087 0.402 . . . . 0.0 112.087 -178.653 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 564' ' ' THR . . . . . 0.624 ' CG2' ' HA ' ' A' ' 561' ' ' ALA . 5.5 t -49.77 -71.32 0.07 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.661 0.267 . . . . 0.0 111.698 -178.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 565' ' ' GLN . . . . . 0.551 ' H ' ' CG2' ' A' ' 564' ' ' THR . 0.0 OUTLIER -48.73 -46.91 41.59 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.658 0.266 . . . . 0.0 111.66 179.966 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -49.98 -61.75 1.96 Allowed 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -178.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 567' ' ' PHE . . . . . 0.548 ' CE1' HD11 ' A' ' 568' ' ' ILE . 0.1 OUTLIER -96.66 -31.23 12.81 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -177.145 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 568' ' ' ILE . . . . . 0.548 HD11 ' CE1' ' A' ' 567' ' ' PHE . 1.0 OUTLIER -73.12 8.73 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.06 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -179.24 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 569' ' ' ILE . . . . . 0.428 ' CD1' ' N ' ' A' ' 570' ' ' ASP . 2.7 pp -53.57 -38.52 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 N-CA-C 104.709 -2.33 . . . . 0.0 104.709 178.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 570' ' ' ASP . . . . . 0.637 ' OD2' ' HB3' ' A' ' 574' ' ' LEU . 9.7 t0 33.14 60.29 0.44 Allowed 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 114.179 -1.373 . . . . 0.0 111.936 172.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -55.06 -46.27 78.56 Favored Glycine 0 N--CA 1.439 -1.152 0 C-N-CA 116.861 -2.59 . . . . 0.0 107.784 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 572' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -120.85 -17.42 7.91 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 174.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 573' ' ' LEU . . . . . 0.676 ' HB3' ' O ' ' A' ' 535' ' ' ARG . 0.7 OUTLIER -140.57 137.49 33.76 Favored 'General case' 0 C--N 1.355 0.83 0 N-CA-C 116.175 1.917 . . . . 0.0 116.175 -177.848 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 574' ' ' LEU . . . . . 0.637 ' HB3' ' OD2' ' A' ' 570' ' ' ASP . 0.0 OUTLIER -134.92 134.1 40.28 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 173.612 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 575' ' ' ILE . . . . . 0.624 HG13 ' O ' ' A' ' 533' ' ' GLY . 0.0 OUTLIER -133.13 137.07 54.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-O 121.564 0.697 . . . . 0.0 111.818 179.393 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 576' ' ' LEU . . . . . 0.511 ' CD2' ' HB3' ' A' ' 584' ' ' LYS . 0.0 OUTLIER -133.19 135.8 45.3 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 177.25 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 577' ' ' LYS . . . . . . . . . . . . . 3.9 mtpt -129.98 135.38 48.24 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.656 178.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.453 ' HA ' ' HB1' ' A' ' 530' ' ' ALA . 0.2 OUTLIER -124.99 131.79 53.36 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 177.739 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 579' ' ' GLY . . . . . . . . . . . . . . . -90.78 -1.94 72.93 Favored Glycine 0 N--CA 1.442 -0.965 0 CA-C-N 115.169 -0.923 . . . . 0.0 113.494 -178.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 580' ' ' LYS . . . . . 0.545 ' HD2' ' CG ' ' A' ' 581' ' ' TRP . 3.0 pptp? -72.53 -47.73 46.0 Favored 'General case' 0 N--CA 1.438 -1.046 0 C-N-CA 118.851 -1.14 . . . . 0.0 108.726 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 581' ' ' TRP . . . . . 0.545 ' CG ' ' HD2' ' A' ' 580' ' ' LYS . 33.3 m0 -138.84 -53.21 0.58 Allowed 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 177.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 582' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.44 165.53 27.17 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 -174.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 583' ' ' MET . . . . . . . . . . . . . 1.1 ttt -109.32 134.89 51.24 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 173.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 584' ' ' LYS . . . . . 0.555 ' HB2' ' HG ' ' A' ' 514' ' ' LEU . 5.5 tppt? -120.08 133.77 55.43 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 178.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 585' ' ' LEU . . . . . 0.489 ' N ' ' HD3' ' A' ' 584' ' ' LYS . 5.8 tt -120.0 136.38 54.57 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 -179.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 586' ' ' VAL . . . . . 0.47 ' O ' ' HB3' ' A' ' 574' ' ' LEU . 72.0 t -133.31 137.65 52.82 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.813 -178.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 587' ' ' SER . . . . . 0.432 ' N ' HG12 ' A' ' 586' ' ' VAL . 1.9 m -109.83 136.5 49.04 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 177.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . 0.528 ' HB ' ' HA ' ' A' ' 497' ' ' LYS . 3.3 pt -133.35 136.35 54.95 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 -178.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 3.8 t -133.74 138.15 51.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 114.022 -1.445 . . . . 0.0 110.287 178.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 590' ' ' SER . . . . . . . . . . . . . 6.9 m . . . . . 0 C--N 1.325 -0.472 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.254 179.805 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 491' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.12 0 CA-C-O 120.57 0.224 . . . . 0.0 110.967 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 492' ' ' ARG . . . . . 0.423 ' NE ' ' CD2' ' A' ' 585' ' ' LEU . 10.6 tpt180 -136.25 134.38 38.01 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 178.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 493' ' ' VAL . . . . . 0.489 ' CG2' ' CG2' ' A' ' 586' ' ' VAL . 25.3 m -136.98 163.87 31.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 116.212 -0.449 . . . . 0.0 112.026 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 70.0 p -115.89 132.82 56.53 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 176.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 495' ' ' LEU . . . . . 0.521 ' HG ' ' N ' ' A' ' 496' ' ' PRO . 0.0 OUTLIER -136.62 162.84 53.76 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.637 -179.667 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 496' ' ' PRO . . . . . 0.521 ' N ' ' HG ' ' A' ' 495' ' ' LEU . 9.8 Cg_exo -71.84 120.0 6.58 Favored 'Trans proline' 0 CA--C 1.534 0.481 0 C-N-CA 122.376 2.051 . . . . 0.0 111.328 178.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 497' ' ' LYS . . . . . 0.565 ' CA ' ' HB ' ' A' ' 588' ' ' ILE . 0.1 OUTLIER -56.6 -30.25 63.0 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -178.739 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 498' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.56 -48.47 79.35 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -177.14 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 499' ' ' LEU . . . . . 0.457 ' CD1' HD11 ' A' ' 495' ' ' LEU . 2.6 pp -73.85 -9.08 58.29 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -178.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . 0.431 HG23 HG13 ' A' ' 568' ' ' ILE . 3.5 p -75.34 -25.38 17.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.507 0.67 . . . . 0.0 111.595 -179.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 501' ' ' TYR . . . . . 0.676 ' O ' ' CG2' ' A' ' 564' ' ' THR . 2.6 m-30 -53.72 -29.27 38.54 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -178.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -76.67 -50.2 14.29 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 116.176 1.917 . . . . 0.0 116.176 -175.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 503' ' ' LYS . . . . . 0.579 ' O ' ' CG ' ' A' ' 507' ' ' LYS . 8.9 mttt -119.81 136.41 54.48 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 119.178 0.899 . . . . 0.0 112.561 -178.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 504' ' ' THR . . . . . 0.627 ' OG1' ' N ' ' A' ' 564' ' ' THR . 51.0 m -74.07 -76.61 0.13 Allowed 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 179.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . 0.633 ' CZ ' HD11 ' A' ' 556' ' ' ILE . 0.2 OUTLIER -75.31 -60.98 2.06 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -178.965 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 506' ' ' SER . . . . . 0.783 ' O ' ' CD1' ' A' ' 510' ' ' TRP . 0.7 OUTLIER -49.6 -73.07 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 114.833 1.419 . . . . 0.0 114.833 -176.264 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 507' ' ' LYS . . . . . 0.706 ' HD3' ' N ' ' A' ' 508' ' ' VAL . 0.0 OUTLIER -49.18 -48.61 45.0 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -176.756 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 508' ' ' VAL . . . . . 0.706 ' N ' ' HD3' ' A' ' 507' ' ' LYS . 98.0 t -53.91 -59.48 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 509' ' ' LEU . . . . . 0.545 ' CD1' ' N ' ' A' ' 510' ' ' TRP . 2.2 pp -56.52 -61.8 2.17 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 115.477 1.658 . . . . 0.0 115.477 -177.115 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 510' ' ' TRP . . . . . 0.839 ' CD1' ' HA ' ' A' ' 518' ' ' LYS . 67.1 p-90 -72.79 -51.46 18.9 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -176.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 511' ' ' SER . . . . . 0.497 ' N ' ' CE3' ' A' ' 510' ' ' TRP . 0.6 OUTLIER -64.18 -47.45 79.78 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.363 -0.835 . . . . 0.0 113.174 -176.854 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 512' ' ' ALA . . . . . 0.411 ' CB ' ' O ' ' A' ' 508' ' ' VAL . . . -70.95 -73.04 0.18 Allowed 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 117.796 2.517 . . . . 0.0 117.796 -174.085 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 513' ' ' GLY . . . . . 0.704 ' H ' ' HE2' ' A' ' 584' ' ' LYS . . . -114.76 -35.2 1.42 Allowed Glycine 0 CA--C 1.5 -0.897 0 N-CA-C 120.853 3.101 . . . . 0.0 120.853 -172.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 514' ' ' LEU . . . . . 0.536 ' HG ' ' HB2' ' A' ' 584' ' ' LYS . 0.1 OUTLIER -107.14 -46.84 3.81 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 119.506 3.151 . . . . 0.0 119.506 -170.056 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 515' ' ' VAL . . . . . 0.547 ' CG2' ' N ' ' A' ' 516' ' ' ALA . 2.5 p -154.71 172.72 0.61 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.589 0 N-CA-C 117.887 2.551 . . . . 0.0 117.887 -172.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 516' ' ' ALA . . . . . 0.547 ' N ' ' CG2' ' A' ' 515' ' ' VAL . . . -67.89 4.18 1.26 Allowed 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 126.761 2.025 . . . . 0.0 109.696 177.099 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 517' ' ' SER . . . . . 0.841 ' O ' ' N ' ' A' ' 521' ' ' GLY . 0.5 OUTLIER -57.55 9.28 0.01 OUTLIER 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 115.775 1.769 . . . . 0.0 115.775 -172.043 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 518' ' ' LYS . . . . . 0.839 ' HA ' ' CD1' ' A' ' 510' ' ' TRP . 0.0 OUTLIER -45.06 -46.82 11.73 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 104.351 -2.463 . . . . 0.0 104.351 175.413 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 519' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.16 -58.29 3.37 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.962 173.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 520' ' ' GLU . . . . . 0.831 ' HB2' ' HA ' ' A' ' 517' ' ' SER . 2.6 mm-40 -59.05 -47.44 85.21 Favored 'General case' 0 C--N 1.351 0.659 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.941 -178.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 521' ' ' GLY . . . . . 0.841 ' N ' ' O ' ' A' ' 517' ' ' SER . . . -49.12 -55.16 12.57 Favored Glycine 0 CA--C 1.493 -1.333 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.25 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -48.02 -47.42 33.45 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 523' ' ' ARG . . . . . 0.459 ' O ' ' HB3' ' A' ' 526' ' ' ASN . 0.1 OUTLIER -50.2 -48.94 54.02 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.988 178.463 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 524' ' ' ILE . . . . . 0.483 ' O ' ' ND2' ' A' ' 527' ' ' ASN . 12.8 mm -58.24 -54.82 27.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.424 0.63 . . . . 0.0 109.717 179.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 525' ' ' ILE . . . . . 0.558 HG12 ' O ' ' A' ' 521' ' ' GLY . 0.7 OUTLIER -50.4 -47.42 26.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 177.683 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 526' ' ' ASN . . . . . 0.459 ' HB3' ' O ' ' A' ' 523' ' ' ARG . 0.9 OUTLIER -55.8 -47.99 76.16 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 114.122 -1.399 . . . . 0.0 108.228 177.393 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 527' ' ' ASN . . . . . 0.483 ' ND2' ' O ' ' A' ' 524' ' ' ILE . 0.0 OUTLIER -48.13 -40.13 22.75 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.076 -1.42 . . . . 0.0 107.189 176.517 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 528' ' ' ASN . . . . . 0.671 ' HA ' HG23 ' A' ' 556' ' ' ILE . 13.5 t-20 73.67 40.47 0.49 Allowed 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 114.631 -1.168 . . . . 0.0 111.736 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 529' ' ' GLY . . . . . . . . . . . . . . . -115.69 27.64 8.23 Favored Glycine 0 CA--C 1.523 0.583 0 C-N-CA 120.337 -0.935 . . . . 0.0 112.779 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 530' ' ' ALA . . . . . 0.95 ' O ' ' HB ' ' A' ' 556' ' ' ILE . . . -133.96 164.03 28.21 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 112.524 0.565 . . . . 0.0 112.524 -179.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 531' ' ' TYR . . . . . 0.538 ' CE2' ' CD2' ' A' ' 553' ' ' PHE . 0.0 OUTLIER -133.99 156.02 48.93 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 177.875 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 532' ' ' VAL . . . . . 0.564 ' HB ' ' HB ' ' A' ' 554' ' ' THR . 0.5 OUTLIER -127.33 135.5 63.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 C-N-CA 119.537 -0.865 . . . . 0.0 112.123 -179.647 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 533' ' ' GLY . . . . . 0.664 ' O ' HG13 ' A' ' 575' ' ' ILE . . . -133.88 155.64 21.91 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 114.367 -1.288 . . . . 0.0 113.841 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 534' ' ' SER . . . . . 0.532 ' HB2' ' OG1' ' A' ' 552' ' ' THR . 0.6 OUTLIER -134.54 141.24 46.63 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.176 -0.512 . . . . 0.0 110.936 178.605 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 535' ' ' ARG . . . . . 0.544 ' O ' ' HB3' ' A' ' 573' ' ' LEU . 9.2 tpp85 . . . . . 0 CA--C 1.531 0.232 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 179.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 . . . . . 0 N--CA 1.451 -0.423 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 550' ' ' ASP . . . . . 0.527 ' O ' ' HA ' ' A' ' 535' ' ' ARG . 1.2 p30 -51.85 -41.89 62.19 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.106 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 551' ' ' LEU . . . . . . . . . . . . . 10.7 tp -131.62 139.47 49.14 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.661 -1.154 . . . . 0.0 108.53 177.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 552' ' ' THR . . . . . 0.638 ' O ' ' HA2' ' A' ' 533' ' ' GLY . 5.6 m -133.83 148.31 51.29 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.598 0.713 . . . . 0.0 111.756 179.345 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 553' ' ' PHE . . . . . 0.538 ' CD2' ' CE2' ' A' ' 531' ' ' TYR . 21.8 m-85 -134.25 137.65 44.48 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.07 -0.968 . . . . 0.0 108.613 177.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 554' ' ' THR . . . . . 0.564 ' HB ' ' HB ' ' A' ' 532' ' ' VAL . 2.8 m -132.5 139.04 33.49 Favored Pre-proline 0 C--N 1.307 -1.253 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 555' ' ' PRO . . . . . 0.74 ' O ' HG22 ' A' ' 556' ' ' ILE . 77.5 Cg_endo -83.78 24.0 0.79 Allowed 'Trans proline' 0 N--CA 1.444 -1.411 0 C-N-CA 121.573 1.516 . . . . 0.0 112.142 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 556' ' ' ILE . . . . . 0.95 ' HB ' ' O ' ' A' ' 530' ' ' ALA . 7.3 tp 61.38 30.9 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 177.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . 0.49 ' HB3' ' CE2' ' A' ' 559' ' ' TRP . 0.3 OUTLIER -105.79 117.85 35.08 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 105.096 -2.187 . . . . 0.0 105.096 179.257 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 558' ' ' THR . . . . . . . . . . . . . 2.3 t -56.89 117.82 4.33 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -172.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 559' ' ' TRP . . . . . 0.49 ' CE2' ' HB3' ' A' ' 557' ' ' LYS . 5.4 m0 -136.58 111.8 9.08 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 104.981 -2.229 . . . . 0.0 104.981 175.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 560' ' ' ASN . . . . . 0.487 ' O ' ' HB ' ' A' ' 564' ' ' THR . 75.9 m-20 -78.25 -74.4 0.27 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -175.018 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 561' ' ' ALA . . . . . 0.41 ' O ' HG23 ' A' ' 564' ' ' THR . . . -73.16 -64.01 1.06 Allowed 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 115.752 1.76 . . . . 0.0 115.752 -176.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 562' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.01 -50.65 35.05 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -176.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 563' ' ' LYS . . . . . 0.488 ' CB ' ' HB2' ' A' ' 559' ' ' TRP . 0.0 OUTLIER -70.67 -49.07 51.18 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.392 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 564' ' ' THR . . . . . 0.676 ' CG2' ' O ' ' A' ' 501' ' ' TYR . 2.0 t -53.7 -64.33 0.86 Allowed 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 121.114 -0.235 . . . . 0.0 110.922 -178.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 565' ' ' GLN . . . . . 0.496 ' N ' ' CG2' ' A' ' 564' ' ' THR . 0.0 OUTLIER -48.51 -47.46 38.89 Favored 'General case' 0 C--N 1.321 -0.643 0 O-C-N 122.135 -0.353 . . . . 0.0 111.195 179.012 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 566' ' ' GLU . . . . . 0.419 ' O ' ' CD1' ' A' ' 569' ' ' ILE . 1.8 tt0 -49.61 -56.13 11.12 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -178.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 567' ' ' PHE . . . . . 0.53 ' O ' ' OG ' ' A' ' 534' ' ' SER . 0.4 OUTLIER -97.22 -45.09 6.65 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.417 0.627 . . . . 0.0 112.156 -178.387 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 568' ' ' ILE . . . . . 0.556 ' N ' ' O ' ' A' ' 564' ' ' THR . 1.5 tp -58.0 9.29 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 569' ' ' ILE . . . . . 0.466 ' O ' ' OD1' ' A' ' 570' ' ' ASP . 0.0 OUTLIER -55.09 -39.22 49.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 104.525 -2.398 . . . . 0.0 104.525 179.009 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 570' ' ' ASP . . . . . 0.508 ' CB ' ' O ' ' A' ' 573' ' ' LEU . 15.1 p30 31.77 55.75 0.3 Allowed 'General case' 0 CA--C 1.51 -0.587 0 CA-C-N 114.04 -1.436 . . . . 0.0 112.643 173.295 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -51.39 -44.88 53.22 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 117.316 -2.373 . . . . 0.0 108.505 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 572' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -119.6 -16.44 8.85 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 175.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 573' ' ' LEU . . . . . 0.544 ' HB3' ' O ' ' A' ' 535' ' ' ARG . 1.3 tp -139.86 137.29 34.78 Favored 'General case' 0 C--N 1.353 0.746 0 N-CA-C 116.39 1.996 . . . . 0.0 116.39 -177.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 574' ' ' LEU . . . . . 0.506 ' HB3' ' CD1' ' A' ' 588' ' ' ILE . 0.2 OUTLIER -134.81 133.39 39.74 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 173.048 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 575' ' ' ILE . . . . . 0.664 HG13 ' O ' ' A' ' 533' ' ' GLY . 0.0 OUTLIER -134.09 138.24 50.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 118.86 0.754 . . . . 0.0 112.007 179.297 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 576' ' ' LEU . . . . . 0.499 HD23 ' HB3' ' A' ' 584' ' ' LYS . 0.1 OUTLIER -132.99 135.53 45.52 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 177.181 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 577' ' ' LYS . . . . . . . . . . . . . 25.2 mttt -132.2 135.45 46.34 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 119.009 -1.076 . . . . 0.0 110.359 177.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.4 ' HA ' ' HB3' ' A' ' 530' ' ' ALA . 0.3 OUTLIER -124.45 131.91 53.5 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 177.84 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 579' ' ' GLY . . . . . . . . . . . . . . . -89.1 -2.2 78.04 Favored Glycine 0 CA--C 1.498 -0.976 0 CA-C-N 115.236 -0.893 . . . . 0.0 113.335 -178.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 580' ' ' LYS . . . . . 0.449 ' O ' ' CD1' ' A' ' 581' ' ' TRP . 0.0 OUTLIER -72.41 -48.16 43.52 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 119.087 -1.045 . . . . 0.0 108.889 179.233 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 581' ' ' TRP . . . . . 0.449 ' CD1' ' O ' ' A' ' 580' ' ' LYS . 23.6 m0 -139.7 -53.12 0.53 Allowed 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 177.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 582' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.26 165.37 27.58 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -174.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 583' ' ' MET . . . . . . . . . . . . . 1.9 ttt -110.76 134.52 52.41 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.468 -1.679 . . . . 0.0 106.468 173.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 584' ' ' LYS . . . . . 0.704 ' HE2' ' H ' ' A' ' 513' ' ' GLY . 0.5 OUTLIER -119.66 134.73 55.11 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 178.787 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 585' ' ' LEU . . . . . 0.466 ' HG ' ' CG2' ' A' ' 575' ' ' ILE . 5.7 tt -121.4 136.96 54.9 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 586' ' ' VAL . . . . . 0.501 HG23 ' NZ ' ' A' ' 584' ' ' LYS . 30.7 t -132.19 137.07 55.4 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.734 -178.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 587' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -112.87 134.32 54.44 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 177.168 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . 0.565 ' HB ' ' CA ' ' A' ' 497' ' ' LYS . 0.1 OUTLIER -135.17 140.58 44.81 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.568 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -178.257 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 6.2 p -133.14 145.73 33.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 114.369 -1.287 . . . . 0.0 110.473 178.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 590' ' ' SER . . . . . . . . . . . . . 6.0 t . . . . . 0 C--N 1.326 -0.417 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.672 179.983 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 491' ' ' ALA . . . . . 0.491 ' CB ' HD21 ' A' ' 514' ' ' LEU . . . . . . . . 0 N--CA 1.463 0.216 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 492' ' ' ARG . . . . . 0.426 ' CD ' ' HG ' ' A' ' 585' ' ' LEU . 1.0 OUTLIER -136.49 131.69 34.32 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 175.561 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 493' ' ' VAL . . . . . 0.523 HG23 ' HA3' ' A' ' 513' ' ' GLY . 2.5 m -139.33 164.02 25.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.688 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 79.7 p -130.63 132.9 45.72 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.604 176.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 495' ' ' LEU . . . . . 0.431 ' CD1' ' O ' ' A' ' 496' ' ' PRO . 2.2 pp -137.04 163.23 50.84 Favored Pre-proline 0 CA--C 1.53 0.18 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.588 178.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 496' ' ' PRO . . . . . 0.444 ' HD2' HD21 ' A' ' 499' ' ' LEU . 19.8 Cg_exo -63.29 119.21 6.19 Favored 'Trans proline' 0 CA--C 1.533 0.428 0 C-N-CA 121.921 1.747 . . . . 0.0 111.658 179.014 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 497' ' ' LYS . . . . . 0.441 ' CA ' ' HB ' ' A' ' 588' ' ' ILE . 23.7 ttpt -56.62 -30.39 63.23 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -178.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 498' ' ' SER . . . . . . . . . . . . . 12.2 t -55.94 -48.0 76.55 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -177.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 499' ' ' LEU . . . . . 0.444 HD21 ' HD2' ' A' ' 496' ' ' PRO . 1.1 pp -73.45 -8.36 55.58 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -178.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 500' ' ' VAL . . . . . 0.49 ' HA ' ' NZ ' ' A' ' 507' ' ' LYS . 12.0 t -74.59 -25.28 19.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.31 0.576 . . . . 0.0 111.793 -179.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 501' ' ' TYR . . . . . 0.627 ' O ' ' CG2' ' A' ' 564' ' ' THR . 3.1 m-85 -53.55 -29.69 38.18 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -178.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 502' ' ' ASP . . . . . 0.402 ' O ' ' HB2' ' A' ' 560' ' ' ASN . 2.1 m-20 -76.36 -50.09 15.12 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 115.807 1.78 . . . . 0.0 115.807 -175.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 503' ' ' LYS . . . . . 0.553 ' O ' ' CG ' ' A' ' 507' ' ' LYS . 0.1 OUTLIER -119.65 135.39 54.83 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-N 119.153 0.888 . . . . 0.0 111.939 -178.896 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 504' ' ' THR . . . . . 0.611 ' OG1' ' N ' ' A' ' 564' ' ' THR . 69.7 m -73.21 -76.63 0.12 Allowed 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . 0.523 ' CE2' ' CD1' ' A' ' 576' ' ' LEU . 0.3 OUTLIER -75.78 -59.12 2.89 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -179.416 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 506' ' ' SER . . . . . 0.817 ' O ' ' CD1' ' A' ' 510' ' ' TRP . 8.0 t -49.0 -71.48 0.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 -175.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 507' ' ' LYS . . . . . 0.565 ' HD3' ' N ' ' A' ' 508' ' ' VAL . 0.0 OUTLIER -48.01 -49.07 32.22 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -174.782 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 508' ' ' VAL . . . . . 0.565 ' N ' ' HD3' ' A' ' 507' ' ' LYS . 0.2 OUTLIER -64.23 -49.57 80.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 C-N-CA 120.299 -0.561 . . . . 0.0 111.964 -178.467 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 509' ' ' LEU . . . . . 0.584 ' HG ' ' H ' ' A' ' 510' ' ' TRP . 1.1 pp -55.99 -62.07 1.95 Allowed 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 -178.04 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 510' ' ' TRP . . . . . 0.86 ' CD1' ' HA ' ' A' ' 518' ' ' LYS . 67.4 p-90 -73.08 -49.67 27.26 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 114.722 1.378 . . . . 0.0 114.722 -176.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 511' ' ' SER . . . . . 0.506 ' N ' ' CE3' ' A' ' 510' ' ' TRP . 0.3 OUTLIER -63.5 -47.61 81.0 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -176.606 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 512' ' ' ALA . . . . . 0.43 ' CB ' ' CD2' ' A' ' 495' ' ' LEU . . . -70.89 -73.62 0.17 Allowed 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 117.841 2.534 . . . . 0.0 117.841 -174.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 513' ' ' GLY . . . . . 0.621 ' H ' ' HE2' ' A' ' 584' ' ' LYS . . . -115.05 -35.06 1.39 Allowed Glycine 0 CA--C 1.499 -0.945 0 N-CA-C 120.696 3.038 . . . . 0.0 120.696 -173.039 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 514' ' ' LEU . . . . . 0.492 ' HG ' ' HB2' ' A' ' 584' ' ' LYS . 0.1 OUTLIER -103.08 -47.97 4.18 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 119.105 3.002 . . . . 0.0 119.105 -170.171 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 515' ' ' VAL . . . . . 0.566 ' CG1' ' HB2' ' A' ' 517' ' ' SER . 2.4 p -155.99 172.26 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 117.606 2.447 . . . . 0.0 117.606 -173.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 516' ' ' ALA . . . . . 0.544 ' N ' ' CG2' ' A' ' 515' ' ' VAL . . . -68.06 4.08 1.36 Allowed 'General case' 0 C--O 1.231 0.104 0 C-N-CA 126.57 1.948 . . . . 0.0 109.636 176.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 517' ' ' SER . . . . . 0.839 ' O ' ' N ' ' A' ' 521' ' ' GLY . 0.6 OUTLIER -57.63 8.89 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 116.065 1.876 . . . . 0.0 116.065 -171.984 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 518' ' ' LYS . . . . . 0.86 ' HA ' ' CD1' ' A' ' 510' ' ' TRP . 0.0 OUTLIER -45.4 -46.7 13.47 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 104.432 -2.433 . . . . 0.0 104.432 175.41 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 519' ' ' SER . . . . . . . . . . . . . 1.4 p -75.08 -59.11 2.89 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.607 -1.178 . . . . 0.0 109.966 173.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 520' ' ' GLU . . . . . 0.837 ' HB2' ' HA ' ' A' ' 517' ' ' SER . 2.7 mm-40 -58.28 -47.43 83.65 Favored 'General case' 0 C--N 1.35 0.629 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.75 -179.152 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 521' ' ' GLY . . . . . 0.839 ' N ' ' O ' ' A' ' 517' ' ' SER . . . -49.01 -53.98 16.37 Favored Glycine 0 CA--C 1.493 -1.317 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.072 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 522' ' ' GLN . . . . . 0.439 ' HA ' HG12 ' A' ' 525' ' ' ILE . 2.0 mm100 -47.91 -47.28 32.31 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 523' ' ' ARG . . . . . 0.462 ' O ' ' HB3' ' A' ' 526' ' ' ASN . 0.4 OUTLIER -50.33 -48.82 55.21 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.818 178.266 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 524' ' ' ILE . . . . . 0.493 ' O ' ' ND2' ' A' ' 527' ' ' ASN . 18.2 mt -57.56 -54.86 25.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.518 0.675 . . . . 0.0 109.585 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 525' ' ' ILE . . . . . 0.566 HG12 ' O ' ' A' ' 521' ' ' GLY . 0.6 OUTLIER -50.39 -47.47 26.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.834 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 526' ' ' ASN . . . . . 0.462 ' HB3' ' O ' ' A' ' 523' ' ' ARG . 0.9 OUTLIER -56.28 -47.44 78.63 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 113.987 -1.461 . . . . 0.0 108.434 177.651 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 527' ' ' ASN . . . . . 0.493 ' ND2' ' O ' ' A' ' 524' ' ' ILE . 0.0 OUTLIER -47.52 -39.85 17.28 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.115 -1.402 . . . . 0.0 107.523 177.056 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 528' ' ' ASN . . . . . 0.633 ' HA ' HG23 ' A' ' 556' ' ' ILE . 1.9 t30 73.79 40.21 0.49 Allowed 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.384 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 529' ' ' GLY . . . . . . . . . . . . . . . -118.05 31.22 5.75 Favored Glycine 0 CA--C 1.523 0.585 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.657 178.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 530' ' ' ALA . . . . . 0.903 ' O ' ' HB ' ' A' ' 556' ' ' ILE . . . -133.54 164.38 27.3 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.333 0.587 . . . . 0.0 112.541 -179.027 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 531' ' ' TYR . . . . . 0.547 ' CE1' ' HA ' ' A' ' 553' ' ' PHE . 0.0 OUTLIER -134.36 152.88 52.06 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 177.752 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 532' ' ' VAL . . . . . 0.52 ' HB ' ' HB ' ' A' ' 554' ' ' THR . 0.4 OUTLIER -126.04 135.82 62.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 CA-C-O 121.871 0.844 . . . . 0.0 111.745 179.75 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 533' ' ' GLY . . . . . 0.709 ' O ' HG13 ' A' ' 575' ' ' ILE . . . -133.31 152.86 20.54 Favored Glycine 0 N--CA 1.443 -0.844 0 CA-C-N 114.472 -1.24 . . . . 0.0 113.783 -179.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 534' ' ' SER . . . . . 0.561 ' OG ' ' O ' ' A' ' 567' ' ' PHE . 0.5 OUTLIER -134.26 141.83 47.12 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.147 -0.527 . . . . 0.0 110.903 179.079 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 535' ' ' ARG . . . . . 0.592 ' HA ' ' O ' ' A' ' 550' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.27 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 179.225 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 . . . . . 0 N--CA 1.449 -0.524 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 550' ' ' ASP . . . . . 0.592 ' O ' ' HA ' ' A' ' 535' ' ' ARG . 40.6 m-20 -54.55 -38.62 66.83 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 551' ' ' LEU . . . . . . . . . . . . . 14.7 tp -131.47 139.61 49.39 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.35 177.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 552' ' ' THR . . . . . 0.666 ' O ' ' HA2' ' A' ' 533' ' ' GLY . 28.9 m -133.54 146.67 51.26 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.714 0.769 . . . . 0.0 112.166 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 553' ' ' PHE . . . . . 0.547 ' HA ' ' CE1' ' A' ' 531' ' ' TYR . 24.8 m-85 -133.99 136.88 44.41 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 176.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 554' ' ' THR . . . . . 0.52 ' HB ' ' HB ' ' A' ' 532' ' ' VAL . 1.9 m -133.55 138.98 32.41 Favored Pre-proline 0 C--N 1.304 -1.377 0 C-N-CA 120.042 -0.663 . . . . 0.0 109.515 178.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 555' ' ' PRO . . . . . 0.61 ' O ' HG22 ' A' ' 556' ' ' ILE . 81.3 Cg_endo -82.47 19.43 1.28 Allowed 'Trans proline' 0 N--CA 1.447 -1.216 0 C-N-CA 121.486 1.457 . . . . 0.0 111.561 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 556' ' ' ILE . . . . . 0.903 ' HB ' ' O ' ' A' ' 530' ' ' ALA . 4.1 tp 61.92 32.36 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 177.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 4.3 tttt -104.09 122.0 44.38 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 105.183 -2.155 . . . . 0.0 105.183 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 558' ' ' THR . . . . . . . . . . . . . 6.5 t -56.88 117.55 4.07 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 -171.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 559' ' ' TRP . . . . . 0.463 ' CH2' ' HD2' ' A' ' 555' ' ' PRO . 5.3 m0 -136.89 112.05 9.06 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 104.408 -2.442 . . . . 0.0 104.408 175.618 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 560' ' ' ASN . . . . . 0.489 ' O ' ' HB ' ' A' ' 564' ' ' THR . 2.5 p30 -80.93 -74.8 0.3 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 115.372 1.619 . . . . 0.0 115.372 -174.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 561' ' ' ALA . . . . . . . . . . . . . . . -72.9 -61.97 1.62 Allowed 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 115.181 1.548 . . . . 0.0 115.181 -176.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 562' ' ' SER . . . . . . . . . . . . . 85.5 p -49.27 -50.37 39.23 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -177.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 563' ' ' LYS . . . . . 0.449 ' CB ' ' HB2' ' A' ' 559' ' ' TRP . 0.0 OUTLIER -70.98 -48.95 50.41 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -178.449 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 564' ' ' THR . . . . . 0.627 ' CG2' ' O ' ' A' ' 501' ' ' TYR . 2.0 t -54.09 -65.03 0.64 Allowed 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 121.218 -0.193 . . . . 0.0 111.35 -178.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 565' ' ' GLN . . . . . 0.488 ' N ' ' CG2' ' A' ' 564' ' ' THR . 0.0 OUTLIER -49.0 -47.41 44.36 Favored 'General case' 0 C--N 1.321 -0.649 0 O-C-N 122.067 -0.395 . . . . 0.0 111.367 179.028 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -49.71 -67.0 0.3 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -178.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 567' ' ' PHE . . . . . 0.561 ' O ' ' OG ' ' A' ' 534' ' ' SER . 0.2 OUTLIER -86.99 -43.25 12.49 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -178.056 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 568' ' ' ILE . . . . . 0.515 HD12 ' CZ ' ' A' ' 567' ' ' PHE . 1.0 OUTLIER -62.05 8.69 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 -179.64 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 569' ' ' ILE . . . . . 0.472 ' H ' ' C ' ' A' ' 567' ' ' PHE . 0.9 OUTLIER -54.72 -40.8 53.06 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 N-CA-C 105.048 -2.204 . . . . 0.0 105.048 178.905 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 570' ' ' ASP . . . . . 0.569 ' OD2' ' HB2' ' A' ' 574' ' ' LEU . 5.6 m-20 33.8 59.93 0.53 Allowed 'General case' 0 CA--C 1.507 -0.68 0 CA-C-N 113.833 -1.53 . . . . 0.0 112.994 173.113 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 571' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 570' ' ' ASP . . . -51.84 -45.06 55.84 Favored Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 116.865 -2.588 . . . . 0.0 108.088 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 572' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -120.41 -16.15 8.44 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 175.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 573' ' ' LEU . . . . . 0.484 ' HB3' ' O ' ' A' ' 535' ' ' ARG . 2.0 tp -139.85 137.05 34.61 Favored 'General case' 0 C--N 1.354 0.772 0 N-CA-C 116.627 2.084 . . . . 0.0 116.627 -176.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 574' ' ' LEU . . . . . 0.569 ' HB2' ' OD2' ' A' ' 570' ' ' ASP . 0.1 OUTLIER -135.18 132.97 38.62 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 173.605 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 575' ' ' ILE . . . . . 0.709 HG13 ' O ' ' A' ' 533' ' ' GLY . 0.0 OUTLIER -134.58 138.12 50.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 119.222 0.919 . . . . 0.0 111.763 178.786 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 576' ' ' LEU . . . . . 0.523 ' CD1' ' CE2' ' A' ' 505' ' ' PHE . 0.0 OUTLIER -132.93 135.35 45.49 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 176.875 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 577' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -132.8 135.59 45.77 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 119.057 -1.057 . . . . 0.0 110.533 177.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.86 131.87 53.66 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 177.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 579' ' ' GLY . . . . . . . . . . . . . . . -89.1 -2.06 78.29 Favored Glycine 0 N--CA 1.441 -1.007 0 CA-C-N 115.192 -0.913 . . . . 0.0 113.495 -178.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 580' ' ' LYS . . . . . 0.462 ' O ' ' CD1' ' A' ' 581' ' ' TRP . 0.1 OUTLIER -74.33 -47.55 33.74 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 118.968 -1.093 . . . . 0.0 109.151 179.373 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 581' ' ' TRP . . . . . 0.462 ' CD1' ' O ' ' A' ' 580' ' ' LYS . 26.6 m0 -139.34 -52.63 0.55 Allowed 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 178.156 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 582' ' ' LYS . . . . . 0.406 ' CD ' ' CD1' ' A' ' 514' ' ' LEU . 0.0 OUTLIER -139.81 165.25 27.79 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 -174.327 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 583' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.75 134.53 54.7 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 174.099 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 584' ' ' LYS . . . . . 0.621 ' HE2' ' H ' ' A' ' 513' ' ' GLY . 0.3 OUTLIER -123.69 134.43 53.72 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.302 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 585' ' ' LEU . . . . . 0.426 ' CD1' ' O ' ' A' ' 574' ' ' LEU . 6.1 tp -121.05 137.05 54.84 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -179.131 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 586' ' ' VAL . . . . . 0.515 ' CG2' HG22 ' A' ' 493' ' ' VAL . 6.0 t -131.56 136.75 56.72 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.67 -179.064 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 587' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.92 134.21 53.62 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 176.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . 0.508 HD11 HG21 ' A' ' 588' ' ' ILE . 0.2 OUTLIER -134.96 147.74 29.33 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 -178.503 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 8.0 m -132.46 148.05 31.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 113.916 -1.493 . . . . 0.0 110.334 178.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 590' ' ' SER . . . . . . . . . . . . . 4.2 t . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.978 -179.706 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 1.5 mtt . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 120.62 0.248 . . . . 0.0 111.48 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 455' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -73.52 -43.89 0.6 Allowed 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.407 2.071 . . . . 0.0 112.351 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 456' ' ' ARG . . . . . . . . . . . . . 4.7 ptm180 -75.74 -26.49 57.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.014 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 4.9 t -105.89 32.4 4.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.941 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -62.51 170.27 2.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.091 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 7.5 t -110.17 97.01 28.41 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.899 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.25 117.1 3.28 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.527 2.151 . . . . 0.0 112.278 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . 86.84 56.58 2.19 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.522 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -100.43 149.22 35.9 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.718 0.294 . . . . 0.0 110.874 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.78 -174.08 1.02 Allowed 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.555 2.17 . . . . 0.0 112.308 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 15.7 mttt -101.48 -176.51 3.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.899 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 38.2 t -103.34 -73.31 0.67 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.959 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 77.8 p -59.67 -36.02 75.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.913 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 8.6 mp -114.63 71.04 0.75 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.811 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 77.8 p -99.37 43.36 1.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.838 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 129.04 -36.88 2.31 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.246 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -110.54 117.51 33.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.866 0.365 . . . . 0.0 110.618 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 471' ' ' VAL . . . . . . . . . . . . . 11.1 p -113.24 108.34 25.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.136 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 6.9 p-10 -162.6 99.23 1.09 Allowed Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.943 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -68.71 -167.87 0.21 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.406 2.071 . . . . 0.0 112.28 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -135.91 36.77 2.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.87 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 43.6 t -100.54 -30.96 11.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.985 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 476' ' ' GLY . . . . . . . . . . . . . . . 120.48 -11.27 10.47 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.803 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 477' ' ' ASN . . . . . 0.467 ' N ' ' HD2' ' A' ' 478' ' ' PRO . 0.1 OUTLIER -50.11 -51.58 60.97 Favored Pre-proline 0 CA--C 1.53 0.193 0 CA-C-O 120.496 0.188 . . . . 0.0 111.48 -179.967 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 478' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 477' ' ' ASN . 71.3 Cg_endo -75.45 -24.83 11.76 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.353 2.035 . . . . 0.0 112.524 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -62.86 84.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.921 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -77.13 113.69 33.11 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.996 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -49.76 -77.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.42 2.08 . . . . 0.0 112.461 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 482' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.56 -72.31 0.46 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.995 0.426 . . . . 0.0 110.719 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 483' ' ' THR . . . . . . . . . . . . . 1.7 t -136.79 139.43 41.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.712 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 484' ' ' ASN . . . . . 0.647 ' O ' ' CD ' ' A' ' 489' ' ' PRO . 1.9 m-80 -51.03 -55.66 16.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.096 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 485' ' ' PHE . . . . . 0.649 ' HA ' ' HG2' ' A' ' 489' ' ' PRO . 90.7 m-85 -49.01 -45.57 42.65 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.158 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 486' ' ' ALA . . . . . 0.53 ' O ' ' HB2' ' A' ' 490' ' ' SER . . . -50.35 -70.0 0.1 Allowed 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -176.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -72.79 -76.51 0.12 Allowed 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 116.249 1.944 . . . . 0.0 116.249 -175.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 488' ' ' MET . . . . . 0.51 ' CB ' ' HD3' ' A' ' 489' ' ' PRO . 0.1 OUTLIER -54.95 -53.58 59.64 Favored Pre-proline 0 N--CA 1.474 0.755 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -177.346 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 489' ' ' PRO . . . . . 0.649 ' HG2' ' HA ' ' A' ' 485' ' ' PHE . 4.9 Cg_exo -88.31 41.85 0.66 Allowed 'Trans proline' 0 CA--C 1.528 0.178 0 C-N-CA 124.538 3.492 . . . . 0.0 114.306 -176.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 490' ' ' SER . . . . . 0.53 ' HB2' ' O ' ' A' ' 486' ' ' ALA . 11.5 t -120.84 39.05 3.88 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 491' ' ' ALA . . . . . . . . . . . . . . . -106.04 135.1 48.09 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.687 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 492' ' ' ARG . . . . . 0.509 ' HA ' ' O ' ' A' ' 585' ' ' LEU . 0.1 OUTLIER -135.31 136.01 41.25 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.661 -179.835 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 493' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 586' ' ' VAL . 46.7 t -134.02 163.45 37.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.938 178.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 6.1 t -123.35 134.51 54.01 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 121.184 0.516 . . . . 0.0 111.377 178.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 495' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.47 163.31 51.74 Favored Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.422 179.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 496' ' ' PRO . . . . . 0.522 ' HG2' ' CD2' ' A' ' 499' ' ' LEU . 19.5 Cg_endo -58.51 119.87 7.39 Favored 'Trans proline' 0 CA--C 1.532 0.409 0 C-N-CA 122.235 1.957 . . . . 0.0 112.214 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 497' ' ' LYS . . . . . 0.465 ' CA ' ' HB ' ' A' ' 588' ' ' ILE . 2.1 ttpp -57.72 -30.04 65.22 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -179.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 498' ' ' SER . . . . . 0.401 ' O ' ' CD1' ' A' ' 501' ' ' TYR . 0.3 OUTLIER -60.86 -48.9 79.71 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -176.59 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 499' ' ' LEU . . . . . 0.522 ' CD2' ' HG2' ' A' ' 496' ' ' PRO . 3.1 pp -73.97 -8.24 55.38 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -178.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . 0.45 HG21 ' HA ' ' A' ' 497' ' ' LYS . 26.6 t -73.0 -25.8 22.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.286 0.565 . . . . 0.0 111.355 -179.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 501' ' ' TYR . . . . . 0.555 ' O ' ' CG2' ' A' ' 564' ' ' THR . 0.4 OUTLIER -53.88 -29.72 42.85 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 -178.69 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -72.04 -50.05 31.62 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 -175.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 503' ' ' LYS . . . . . 0.599 ' O ' ' CG ' ' A' ' 507' ' ' LYS . 7.4 mttt -119.38 133.94 55.47 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 118.694 0.679 . . . . 0.0 111.142 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 504' ' ' THR . . . . . 0.447 ' OG1' ' N ' ' A' ' 564' ' ' THR . 6.8 m -73.32 -76.61 0.12 Allowed 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . 0.532 ' CE2' ' CD1' ' A' ' 576' ' ' LEU . 0.3 OUTLIER -75.52 -60.08 2.46 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -179.471 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 506' ' ' SER . . . . . 0.722 ' O ' ' CD1' ' A' ' 510' ' ' TRP . 8.0 t -48.97 -72.69 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 -176.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 507' ' ' LYS . . . . . 0.702 ' HD3' ' N ' ' A' ' 508' ' ' VAL . 0.0 OUTLIER -48.82 -48.38 41.57 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -176.893 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 508' ' ' VAL . . . . . 0.702 ' N ' ' HD3' ' A' ' 507' ' ' LYS . 50.1 t -55.07 -58.71 3.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 509' ' ' LEU . . . . . 0.548 ' HG ' ' H ' ' A' ' 510' ' ' TRP . 2.0 pp -56.98 -60.1 4.08 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 -177.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 510' ' ' TRP . . . . . 0.86 ' CD1' ' HA ' ' A' ' 518' ' ' LYS . 63.2 p-90 -72.47 -51.77 18.73 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -176.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 511' ' ' SER . . . . . 0.525 ' N ' ' CE3' ' A' ' 510' ' ' TRP . 0.5 OUTLIER -66.35 -47.48 73.32 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -176.818 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 512' ' ' ALA . . . . . 0.415 ' CB ' ' O ' ' A' ' 508' ' ' VAL . . . -71.24 -72.81 0.2 Allowed 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 117.756 2.502 . . . . 0.0 117.756 -174.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 513' ' ' GLY . . . . . 0.505 ' H ' ' HE2' ' A' ' 584' ' ' LYS . . . -114.6 -35.57 1.4 Allowed Glycine 0 CA--C 1.5 -0.877 0 N-CA-C 121.39 3.316 . . . . 0.0 121.39 -172.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 514' ' ' LEU . . . . . 0.517 ' HG ' ' CG ' ' A' ' 584' ' ' LYS . 2.8 mt -108.16 -47.03 3.62 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 119.798 3.258 . . . . 0.0 119.798 -170.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 515' ' ' VAL . . . . . 0.556 ' O ' ' CA ' ' A' ' 510' ' ' TRP . 90.1 t -153.06 171.88 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.582 0 N-CA-C 117.073 2.249 . . . . 0.0 117.073 -172.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 516' ' ' ALA . . . . . 0.549 ' N ' ' CG1' ' A' ' 515' ' ' VAL . . . -69.09 3.04 2.3 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 113.012 -1.904 . . . . 0.0 109.366 175.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 517' ' ' SER . . . . . 0.881 ' O ' ' N ' ' A' ' 521' ' ' GLY . 0.4 OUTLIER -58.35 8.75 0.01 OUTLIER 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 115.43 1.641 . . . . 0.0 115.43 -172.122 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 518' ' ' LYS . . . . . 0.86 ' HA ' ' CD1' ' A' ' 510' ' ' TRP . 0.0 OUTLIER -45.8 -45.41 14.79 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 104.321 -2.474 . . . . 0.0 104.321 175.74 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 519' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.32 -56.43 4.88 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.427 -1.26 . . . . 0.0 109.706 173.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 520' ' ' GLU . . . . . 0.863 ' HB2' ' HA ' ' A' ' 517' ' ' SER . 9.3 mm-40 -63.64 -48.31 77.81 Favored 'General case' 0 C--N 1.351 0.654 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.02 -179.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 521' ' ' GLY . . . . . 0.881 ' N ' ' O ' ' A' ' 517' ' ' SER . . . -54.9 -53.55 39.14 Favored Glycine 0 CA--C 1.499 -0.929 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.443 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . 0.476 ' HA ' HG12 ' A' ' 525' ' ' ILE . 0.1 OUTLIER -47.82 -48.31 30.75 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.109 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 523' ' ' ARG . . . . . 0.442 ' HB3' ' O ' ' A' ' 520' ' ' GLU . 1.5 tpt180 -50.67 -48.71 58.32 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.095 178.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 524' ' ' ILE . . . . . 0.445 ' O ' ' ND2' ' A' ' 527' ' ' ASN . 34.0 mm -55.12 -54.07 28.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.352 0.596 . . . . 0.0 110.029 179.104 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 525' ' ' ILE . . . . . 0.487 HG12 ' O ' ' A' ' 521' ' ' GLY . 0.6 OUTLIER -50.5 -47.48 27.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 177.715 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 526' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -56.56 -48.28 77.69 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 113.996 -1.456 . . . . 0.0 108.521 177.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 527' ' ' ASN . . . . . 0.445 ' ND2' ' O ' ' A' ' 524' ' ' ILE . 0.0 OUTLIER -48.35 -39.45 22.18 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 113.784 -1.553 . . . . 0.0 108.003 176.924 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 528' ' ' ASN . . . . . 0.575 ' HA ' ' CG2' ' A' ' 556' ' ' ILE . 0.5 OUTLIER 74.51 40.19 0.42 Allowed 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.185 -178.775 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 529' ' ' GLY . . . . . . . . . . . . . . . -119.26 37.96 2.99 Favored Glycine 0 CA--C 1.521 0.466 0 CA-C-N 114.595 -1.184 . . . . 0.0 111.826 178.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 530' ' ' ALA . . . . . 0.677 ' O ' ' HB ' ' A' ' 556' ' ' ILE . . . -132.76 164.53 26.6 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.834 0.826 . . . . 0.0 112.42 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 531' ' ' TYR . . . . . 0.678 ' HE2' ' CD1' ' A' ' 553' ' ' PHE . 2.2 t80 -135.02 152.89 52.13 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 124.89 1.276 . . . . 0.0 109.061 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 532' ' ' VAL . . . . . 0.554 ' CB ' ' HB ' ' A' ' 554' ' ' THR . 0.4 OUTLIER -133.42 135.67 55.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 CA-C-O 121.807 0.813 . . . . 0.0 111.564 178.69 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 533' ' ' GLY . . . . . 0.73 ' O ' HG13 ' A' ' 575' ' ' ILE . . . -133.16 150.08 19.74 Favored Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 114.464 -1.244 . . . . 0.0 113.414 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 534' ' ' SER . . . . . 0.574 ' OG ' ' O ' ' A' ' 567' ' ' PHE . 0.5 OUTLIER -134.92 137.21 42.93 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.51 -0.345 . . . . 0.0 111.307 178.848 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 535' ' ' ARG . . . . . 0.521 ' O ' ' HB3' ' A' ' 573' ' ' LEU . 24.8 tpt85 -159.55 90.49 1.91 Allowed Pre-proline 0 C--N 1.33 -0.257 0 C-N-CA 120.657 -0.417 . . . . 0.0 112.077 178.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 536' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -78.31 -43.65 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.686 2.257 . . . . 0.0 112.446 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 92.17 50.49 2.61 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.447 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 538' ' ' VAL . . . . . . . . . . . . . 11.8 p -116.19 -45.98 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 CA-C-O 121.033 0.444 . . . . 0.0 111.357 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 539' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.99 162.04 14.4 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.253 -178.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.35 30.79 5.67 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.741 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 541' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -94.04 99.86 12.09 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.178 0.514 . . . . 0.0 110.657 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 542' ' ' GLU . . . . . 0.4 ' CB ' ' CD ' ' A' ' 543' ' ' PRO . 0.0 OUTLIER -49.12 176.85 0.04 OUTLIER Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.119 179.884 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 543' ' ' PRO . . . . . 0.424 ' HA ' ' CB ' ' A' ' 548' ' ' PRO . 91.8 Cg_exo -44.22 -51.87 6.32 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.556 2.171 . . . . 0.0 112.59 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . 0.651 ' O ' ' N ' ' A' ' 546' ' ' GLY . . . 47.43 23.95 2.28 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 121.01 -0.614 . . . . 0.0 113.542 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 545' ' ' GLY . . . . . 0.643 ' O ' ' N ' ' A' ' 547' ' ' MET . . . 52.81 -48.69 0.01 OUTLIER Glycine 0 CA--C 1.53 1.031 0 N-CA-C 115.472 0.949 . . . . 0.0 115.472 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . 0.651 ' N ' ' O ' ' A' ' 544' ' ' GLY . . . -50.25 55.21 0.01 OUTLIER Glycine 0 CA--C 1.528 0.866 0 N-CA-C 115.599 1.0 . . . . 0.0 115.599 -178.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 547' ' ' MET . . . . . 0.643 ' N ' ' O ' ' A' ' 545' ' ' GLY . 0.3 OUTLIER 51.6 53.9 13.88 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 117.822 0.811 . . . . 0.0 111.637 179.2 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 548' ' ' PRO . . . . . 0.424 ' CB ' ' HA ' ' A' ' 543' ' ' PRO . 6.5 Cg_endo -47.63 166.84 0.1 OUTLIER 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 123.114 2.543 . . . . 0.0 112.584 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -123.85 -24.69 4.4 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.486 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 550' ' ' ASP . . . . . 0.501 ' O ' ' HA ' ' A' ' 535' ' ' ARG . 96.2 m-20 -65.37 -46.24 80.92 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.487 179.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 551' ' ' LEU . . . . . . . . . . . . . 19.4 tp -131.57 141.96 49.81 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.426 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 552' ' ' THR . . . . . 0.564 ' O ' ' HA2' ' A' ' 533' ' ' GLY . 37.9 m -132.23 147.83 52.43 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.486 0.66 . . . . 0.0 111.441 179.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 553' ' ' PHE . . . . . 0.678 ' CD1' ' HE2' ' A' ' 531' ' ' TYR . 8.9 m-30 -132.27 139.45 48.25 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.463 -1.244 . . . . 0.0 107.927 179.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 554' ' ' THR . . . . . 0.554 ' HB ' ' CB ' ' A' ' 532' ' ' VAL . 0.4 OUTLIER -130.43 141.73 42.95 Favored Pre-proline 0 C--N 1.326 -0.434 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -178.727 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 555' ' ' PRO . . . . . 0.53 ' O ' ' CG2' ' A' ' 556' ' ' ILE . 78.8 Cg_endo -87.77 1.12 6.96 Favored 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 123.055 2.503 . . . . 0.0 110.152 177.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 556' ' ' ILE . . . . . 0.677 ' HB ' ' O ' ' A' ' 530' ' ' ALA . 7.0 tp 62.71 34.02 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.312 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 178.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . 0.643 ' O ' ' CE2' ' A' ' 559' ' ' TRP . 33.5 mttt -103.48 142.21 34.66 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 558' ' ' THR . . . . . . . . . . . . . 3.4 t -57.42 116.22 3.2 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 -171.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 559' ' ' TRP . . . . . 0.643 ' CE2' ' O ' ' A' ' 557' ' ' LYS . 0.0 OUTLIER -139.5 112.27 7.91 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 112.827 -1.988 . . . . 0.0 105.803 174.442 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 560' ' ' ASN . . . . . 0.559 ' O ' ' CG2' ' A' ' 564' ' ' THR . 77.6 m-20 -84.0 -76.64 0.29 Allowed 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 118.123 -1.431 . . . . 0.0 113.541 -176.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 561' ' ' ALA . . . . . 0.616 ' O ' HG23 ' A' ' 564' ' ' THR . . . -75.57 -50.33 15.91 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 -178.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 562' ' ' SER . . . . . . . . . . . . . 38.8 m -49.57 -54.83 16.0 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -177.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 563' ' ' LYS . . . . . 0.562 ' HG3' ' CD2' ' A' ' 559' ' ' TRP . 2.1 mmpt? -70.5 -47.79 58.79 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -178.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 564' ' ' THR . . . . . 0.616 HG23 ' O ' ' A' ' 561' ' ' ALA . 3.9 t -49.27 -71.35 0.07 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.578 0.227 . . . . 0.0 111.556 -178.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 565' ' ' GLN . . . . . 0.586 ' H ' HG22 ' A' ' 564' ' ' THR . 0.0 OUTLIER -49.37 -46.45 47.2 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.785 0.326 . . . . 0.0 111.518 179.786 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -49.15 -61.32 2.14 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 567' ' ' PHE . . . . . 0.574 ' O ' ' OG ' ' A' ' 534' ' ' SER . 0.2 OUTLIER -96.78 -40.68 8.84 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -177.529 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 568' ' ' ILE . . . . . 0.515 ' N ' ' CD1' ' A' ' 567' ' ' PHE . 0.9 OUTLIER -62.81 8.09 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -179.413 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 569' ' ' ILE . . . . . 0.468 ' H ' ' C ' ' A' ' 567' ' ' PHE . 0.8 OUTLIER -55.04 -40.39 54.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 178.482 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 570' ' ' ASP . . . . . 0.564 ' OD2' ' HB2' ' A' ' 574' ' ' LEU . 5.7 m-20 33.85 61.27 0.49 Allowed 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 114.04 -1.436 . . . . 0.0 112.576 173.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 571' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 570' ' ' ASP . . . -51.94 -45.45 56.07 Favored Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 116.856 -2.592 . . . . 0.0 108.222 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 572' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -120.8 -16.07 8.24 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 175.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 573' ' ' LEU . . . . . 0.521 ' HB3' ' O ' ' A' ' 535' ' ' ARG . 1.5 tp -139.87 136.95 34.48 Favored 'General case' 0 C--N 1.354 0.794 0 N-CA-C 116.591 2.071 . . . . 0.0 116.591 -176.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 574' ' ' LEU . . . . . 0.564 ' HB2' ' OD2' ' A' ' 570' ' ' ASP . 0.1 OUTLIER -135.11 133.24 39.03 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 173.503 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 575' ' ' ILE . . . . . 0.73 HG13 ' O ' ' A' ' 533' ' ' GLY . 0.0 OUTLIER -134.72 138.3 49.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 119.087 0.858 . . . . 0.0 111.448 177.893 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 576' ' ' LEU . . . . . 0.532 ' CD1' ' CE2' ' A' ' 505' ' ' PHE . 0.1 OUTLIER -132.52 135.61 46.1 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 177.889 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 577' ' ' LYS . . . . . . . . . . . . . 12.0 mtpt -132.6 135.8 46.12 Favored 'General case' 0 C--N 1.31 -1.125 0 C-N-CA 119.593 -0.843 . . . . 0.0 110.582 178.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.75 131.83 51.23 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 177.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 579' ' ' GLY . . . . . . . . . . . . . . . -90.49 -2.27 73.41 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 115.432 -0.804 . . . . 0.0 113.424 -178.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 580' ' ' LYS . . . . . 0.488 ' O ' ' CD1' ' A' ' 581' ' ' TRP . 0.0 OUTLIER -73.33 -48.22 36.14 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 119.043 -1.063 . . . . 0.0 109.097 179.338 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 581' ' ' TRP . . . . . 0.488 ' CD1' ' O ' ' A' ' 580' ' ' LYS . 24.1 m0 -139.07 -52.38 0.55 Allowed 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 114.606 1.335 . . . . 0.0 114.606 177.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 582' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.55 165.44 27.24 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -174.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 583' ' ' MET . . . . . . . . . . . . . 7.6 ttt -117.46 134.29 55.01 Favored 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 106.46 -1.681 . . . . 0.0 106.46 174.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 584' ' ' LYS . . . . . 0.517 ' CG ' ' HG ' ' A' ' 514' ' ' LEU . 1.4 tmmt? -128.41 133.6 48.62 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 178.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 585' ' ' LEU . . . . . 0.509 ' O ' ' HA ' ' A' ' 492' ' ' ARG . 0.0 OUTLIER -125.98 136.72 53.32 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.921 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 586' ' ' VAL . . . . . 0.462 HG21 ' HD3' ' A' ' 584' ' ' LYS . 24.8 t -131.06 144.91 36.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.554 -177.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 587' ' ' SER . . . . . 0.403 ' N ' HG12 ' A' ' 586' ' ' VAL . 49.8 m -107.21 135.63 48.4 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 177.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . 0.509 ' CG1' ' HB2' ' A' ' 570' ' ' ASP . 23.0 pt -133.58 137.63 52.46 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.508 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -178.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 7.7 m -132.63 137.1 54.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 114.31 -1.314 . . . . 0.0 110.603 178.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 590' ' ' SER . . . . . . . . . . . . . 1.7 t -73.51 131.03 41.31 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.753 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 591' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -50.35 -49.0 55.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.413 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -51.54 -49.62 61.62 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.045 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 8.8 mmtp -51.57 -48.75 63.03 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.705 0.764 . . . . 0.0 109.363 179.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 594' ' ' PHE . . . . . 0.566 ' O ' ' HG ' ' A' ' 597' ' ' LEU . 1.0 OUTLIER -50.19 -48.45 54.18 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.85 178.5 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 595' ' ' LYS . . . . . 0.561 ' HA ' ' CE2' ' A' ' 604' ' ' TRP . 4.4 mmpt? -49.6 -47.61 49.42 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 596' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.44 -59.03 5.1 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 597' ' ' LEU . . . . . 0.566 ' HG ' ' O ' ' A' ' 594' ' ' PHE . 1.9 pp -60.41 -58.0 10.36 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 121.239 0.543 . . . . 0.0 112.259 -178.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 598' ' ' GLY . . . . . 0.479 ' O ' ' CD1' ' A' ' 604' ' ' TRP . . . -82.0 13.28 38.72 Favored Glycine 0 C--N 1.32 -0.325 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.909 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 599' ' ' LEU . . . . . 0.462 ' HA ' ' CD1' ' A' ' 604' ' ' TRP . 3.7 pp -48.21 -11.42 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -175.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 600' ' ' THR . . . . . . . . . . . . . 29.1 m -140.32 65.99 1.4 Allowed 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.999 0.904 . . . . 0.0 110.897 177.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 601' ' ' ALA . . . . . 0.447 ' CB ' ' HD2' ' A' ' 602' ' ' PRO . . . -132.36 179.79 1.27 Allowed Pre-proline 0 N--CA 1.446 -0.664 0 CA-C-N 113.904 -1.498 . . . . 0.0 109.343 178.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 602' ' ' PRO . . . . . 0.447 ' HD2' ' CB ' ' A' ' 601' ' ' ALA . 87.6 Cg_endo -78.97 -7.31 15.36 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 121.891 1.727 . . . . 0.0 111.274 178.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 603' ' ' GLY . . . . . . . . . . . . . . . -71.28 -50.13 23.17 Favored Glycine 0 C--N 1.335 0.491 0 CA-C-N 115.773 -0.649 . . . . 0.0 113.84 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 604' ' ' TRP . . . . . 0.561 ' CE2' ' HA ' ' A' ' 595' ' ' LYS . 4.2 m95 -71.33 -46.22 61.1 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 117.339 0.57 . . . . 0.0 111.613 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 605' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -50.78 -54.95 19.28 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.901 0.382 . . . . 0.0 110.243 -179.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -60.86 -63.62 1.24 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.663 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 607' ' ' VAL . . . . . . . . . . . . . 52.2 t -50.82 -71.37 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -178.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 608' ' ' VAL . . . . . . . . . . . . . 98.6 t -69.38 -59.35 3.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -177.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 609' ' ' GLY . . . . . . . . . . . . . . . -57.94 -63.48 5.23 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 121.044 -0.598 . . . . 0.0 113.137 -178.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 610' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.02 -58.59 3.89 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.864 0.364 . . . . 0.0 110.857 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 57.63 29.04 60.65 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.553 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 11.2 pttt -126.63 38.99 4.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.841 0.353 . . . . 0.0 110.912 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 613' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -98.53 157.28 16.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.854 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -59.74 -60.78 9.48 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.884 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 615' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.24 96.17 0.79 Allowed 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.483 2.122 . . . . 0.0 112.291 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 616' ' ' SER . . . . . . . . . . . . . 6.9 m -67.61 149.35 98.35 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.865 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo . . . . . 0 C--O 1.248 1.015 0 C-N-CA 122.535 2.156 . . . . 0.0 112.342 179.992 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 2.3 mtm . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 120.609 0.242 . . . . 0.0 111.465 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 455' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -50.43 164.94 0.43 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.414 2.076 . . . . 0.0 112.307 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 456' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -82.47 -26.49 32.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.995 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 5.0 t -119.23 36.0 4.63 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.891 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -84.07 130.71 34.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.111 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.46 174.79 5.13 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.877 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.4 139.17 55.86 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.599 2.2 . . . . 0.0 112.291 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . 130.49 43.11 0.2 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.539 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -109.69 155.2 41.84 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 120.715 0.293 . . . . 0.0 110.896 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.38 154.4 65.33 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.619 2.213 . . . . 0.0 112.322 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 4.5 pttt -59.8 152.4 23.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.892 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 1.9 m -96.81 22.17 8.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.174 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 6.8 t -69.88 -20.93 63.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.029 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 1.1 pp -71.44 74.53 0.75 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.874 0.369 . . . . 0.0 110.91 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 74.9 m -125.02 43.27 3.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.894 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 129.02 -36.95 2.3 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.276 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -116.76 117.71 30.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.865 0.364 . . . . 0.0 110.695 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 471' ' ' VAL . . . . . . . . . . . . . 9.6 p -112.94 108.05 24.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.182 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -111.22 92.0 14.74 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.844 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -68.16 178.46 3.58 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.505 2.137 . . . . 0.0 112.289 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -97.93 36.7 1.51 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.921 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 1.2 p -60.15 -30.87 69.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.868 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 476' ' ' GLY . . . . . . . . . . . . . . . 119.84 -29.83 5.91 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.52 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 477' ' ' ASN . . . . . 0.445 ' N ' ' HD3' ' A' ' 478' ' ' PRO . 49.1 t30 50.97 53.31 13.67 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-O 120.653 0.263 . . . . 0.0 111.277 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 478' ' ' PRO . . . . . 0.445 ' HD3' ' N ' ' A' ' 477' ' ' ASN . 85.7 Cg_endo -84.36 34.23 0.51 Allowed 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.774 2.316 . . . . 0.0 112.918 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 -104.14 85.45 2.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.791 0.329 . . . . 0.0 111.008 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -117.27 149.99 45.53 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.038 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -85.15 39.81 0.76 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.799 2.333 . . . . 0.0 112.882 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 482' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.32 -39.84 61.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.094 0.473 . . . . 0.0 110.68 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 483' ' ' THR . . . . . . . . . . . . . 9.0 t -135.67 171.83 13.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.534 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 484' ' ' ASN . . . . . 0.55 ' O ' ' CD ' ' A' ' 489' ' ' PRO . 35.0 m-20 -104.7 -20.38 13.65 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.1 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 485' ' ' PHE . . . . . 0.616 ' HA ' ' HG2' ' A' ' 489' ' ' PRO . 2.6 m-85 -49.32 -47.2 47.31 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.575 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -71.78 -47.6 52.39 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -178.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -70.94 -74.24 0.15 Allowed 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 -176.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 488' ' ' MET . . . . . 0.559 ' HB2' ' HD3' ' A' ' 489' ' ' PRO . 2.1 mtt -52.52 -52.44 63.59 Favored Pre-proline 0 N--CA 1.472 0.672 0 O-C-N 122.09 -0.381 . . . . 0.0 112.001 -178.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 489' ' ' PRO . . . . . 0.616 ' HG2' ' HA ' ' A' ' 485' ' ' PHE . 15.3 Cg_exo -74.5 42.39 0.78 Allowed 'Trans proline' 0 N--CA 1.472 0.252 0 C-N-CA 124.114 3.209 . . . . 0.0 112.789 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 84.5 p -38.29 -36.23 0.21 Allowed 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -179.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 491' ' ' ALA . . . . . . . . . . . . . . . -132.87 135.97 45.92 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.631 -0.427 . . . . 0.0 112.081 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 492' ' ' ARG . . . . . 0.501 ' CG ' ' HG ' ' A' ' 585' ' ' LEU . 0.0 OUTLIER -135.27 134.05 39.56 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.061 178.759 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 493' ' ' VAL . . . . . 0.495 ' HB ' ' CA ' ' A' ' 513' ' ' GLY . 39.4 t -136.06 163.41 34.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.373 178.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 53.5 m -125.41 133.66 52.42 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.119 0.485 . . . . 0.0 110.298 177.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 495' ' ' LEU . . . . . 0.412 HD21 HG21 ' A' ' 588' ' ' ILE . 0.0 OUTLIER -136.08 163.89 47.02 Favored Pre-proline 0 CA--C 1.53 0.196 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.578 179.686 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -54.37 119.65 6.73 Favored 'Trans proline' 0 CA--C 1.532 0.414 0 C-N-CA 121.931 1.754 . . . . 0.0 111.515 178.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 497' ' ' LYS . . . . . 0.478 ' CA ' ' HB ' ' A' ' 588' ' ' ILE . 0.8 OUTLIER -62.0 -30.28 70.83 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -179.204 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 498' ' ' SER . . . . . . . . . . . . . 2.1 m -58.15 -47.4 83.48 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -178.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 2.2 pp -72.81 -7.83 52.61 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -178.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . 0.437 ' CG1' ' CG2' ' A' ' 568' ' ' ILE . 42.9 t -74.46 -25.83 19.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.374 0.607 . . . . 0.0 111.243 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 501' ' ' TYR . . . . . 0.609 ' O ' ' CG2' ' A' ' 564' ' ' THR . 0.3 OUTLIER -53.86 -29.46 41.48 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 -178.449 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 502' ' ' ASP . . . . . 0.406 ' N ' ' CD1' ' A' ' 501' ' ' TYR . 8.6 m-20 -75.56 -50.15 16.45 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 -175.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 503' ' ' LYS . . . . . 0.588 ' O ' ' CG ' ' A' ' 507' ' ' LYS . 0.2 OUTLIER -119.23 135.11 54.84 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 118.868 0.758 . . . . 0.0 111.298 -179.656 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 504' ' ' THR . . . . . 0.426 ' OG1' ' N ' ' A' ' 564' ' ' THR . 2.2 m -73.32 -76.52 0.12 Allowed 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . 0.511 ' CZ ' ' HB2' ' A' ' 530' ' ' ALA . 0.3 OUTLIER -75.61 -60.39 2.33 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 -179.414 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 506' ' ' SER . . . . . 0.775 ' O ' ' CD1' ' A' ' 510' ' ' TRP . 8.0 t -48.97 -72.79 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -175.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 507' ' ' LYS . . . . . 0.699 ' HD3' ' N ' ' A' ' 508' ' ' VAL . 0.0 OUTLIER -49.37 -48.28 46.96 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -177.021 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 508' ' ' VAL . . . . . 0.699 ' N ' ' HD3' ' A' ' 507' ' ' LYS . 50.9 t -51.65 -60.72 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 509' ' ' LEU . . . . . 0.542 ' CD1' ' N ' ' A' ' 510' ' ' TRP . 2.6 pp -58.37 -61.06 2.86 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 115.753 1.76 . . . . 0.0 115.753 -176.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 510' ' ' TRP . . . . . 0.838 ' CD1' ' HA ' ' A' ' 518' ' ' LYS . 66.7 p-90 -72.38 -52.14 17.34 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -176.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 511' ' ' SER . . . . . 0.509 ' N ' ' CE3' ' A' ' 510' ' ' TRP . 1.4 t -64.79 -47.8 76.77 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -177.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 512' ' ' ALA . . . . . 0.435 ' CB ' ' O ' ' A' ' 508' ' ' VAL . . . -71.4 -72.84 0.2 Allowed 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 117.728 2.492 . . . . 0.0 117.728 -174.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 513' ' ' GLY . . . . . 0.574 ' H ' ' HE2' ' A' ' 584' ' ' LYS . . . -114.55 -35.06 1.47 Allowed Glycine 0 CA--C 1.503 -0.701 0 N-CA-C 121.24 3.256 . . . . 0.0 121.24 -172.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 514' ' ' LEU . . . . . 0.504 ' HG ' ' CG ' ' A' ' 584' ' ' LYS . 3.2 mt -107.5 -46.37 3.86 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 119.356 3.095 . . . . 0.0 119.356 -170.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 515' ' ' VAL . . . . . 0.551 ' CG2' ' N ' ' A' ' 516' ' ' ALA . 2.4 p -154.6 173.1 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.646 0 N-CA-C 117.619 2.451 . . . . 0.0 117.619 -172.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 516' ' ' ALA . . . . . 0.551 ' N ' ' CG2' ' A' ' 515' ' ' VAL . . . -67.94 4.05 1.32 Allowed 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 126.599 1.96 . . . . 0.0 109.864 177.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 517' ' ' SER . . . . . 0.861 ' HA ' ' HB3' ' A' ' 520' ' ' GLU . 0.6 OUTLIER -57.7 9.19 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 116.133 1.901 . . . . 0.0 116.133 -171.972 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 518' ' ' LYS . . . . . 0.838 ' HA ' ' CD1' ' A' ' 510' ' ' TRP . 0.6 OUTLIER -45.43 -47.42 13.75 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 104.268 -2.493 . . . . 0.0 104.268 175.398 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 519' ' ' SER . . . . . . . . . . . . . 68.5 p -74.98 -58.16 3.45 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 114.531 -1.213 . . . . 0.0 110.178 173.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 520' ' ' GLU . . . . . 0.861 ' HB3' ' HA ' ' A' ' 517' ' ' SER . 2.7 tp10 -59.9 -47.61 85.07 Favored 'General case' 0 C--N 1.35 0.598 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.747 -178.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 521' ' ' GLY . . . . . 0.832 ' N ' ' O ' ' A' ' 517' ' ' SER . . . -49.75 -55.4 14.37 Favored Glycine 0 CA--C 1.493 -1.3 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . 0.456 ' HA ' HG12 ' A' ' 525' ' ' ILE . 14.3 mt-30 -47.68 -47.82 29.47 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 523' ' ' ARG . . . . . 0.51 ' HB3' ' O ' ' A' ' 520' ' ' GLU . 0.1 OUTLIER -50.7 -49.01 58.56 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.536 178.475 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 524' ' ' ILE . . . . . 0.492 ' O ' ' ND2' ' A' ' 527' ' ' ASN . 36.0 mm -56.65 -54.99 22.09 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 CA-C-O 121.352 0.596 . . . . 0.0 109.883 179.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 525' ' ' ILE . . . . . 0.551 HG12 ' O ' ' A' ' 521' ' ' GLY . 0.5 OUTLIER -50.22 -47.2 25.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 177.739 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 526' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -55.03 -48.05 73.92 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 113.764 -1.562 . . . . 0.0 108.506 177.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 527' ' ' ASN . . . . . 0.492 ' ND2' ' O ' ' A' ' 524' ' ' ILE . 0.0 OUTLIER -48.17 -39.99 22.6 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 113.957 -1.474 . . . . 0.0 107.734 177.124 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 528' ' ' ASN . . . . . 0.628 ' HA ' HG21 ' A' ' 556' ' ' ILE . 0.2 OUTLIER 73.65 40.26 0.5 Allowed 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.349 -179.373 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 529' ' ' GLY . . . . . . . . . . . . . . . -119.68 32.71 4.9 Favored Glycine 0 CA--C 1.524 0.616 0 CA-C-N 115.0 -1.0 . . . . 0.0 112.597 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 530' ' ' ALA . . . . . 0.891 ' O ' ' HB ' ' A' ' 556' ' ' ILE . . . -133.48 164.57 26.85 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.246 0.546 . . . . 0.0 112.438 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 531' ' ' TYR . . . . . 0.551 ' HA ' ' O ' ' A' ' 554' ' ' THR . 0.0 OUTLIER -133.99 155.82 49.28 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 177.648 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 532' ' ' VAL . . . . . 0.545 ' CB ' ' HB ' ' A' ' 554' ' ' THR . 0.5 OUTLIER -129.17 136.34 59.79 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 CA-C-O 121.789 0.804 . . . . 0.0 111.894 179.929 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 533' ' ' GLY . . . . . 0.747 ' O ' HG13 ' A' ' 575' ' ' ILE . . . -132.33 147.13 18.69 Favored Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 114.442 -1.254 . . . . 0.0 113.504 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 534' ' ' SER . . . . . 0.427 ' C ' ' HD2' ' A' ' 535' ' ' ARG . 3.4 m -134.7 136.73 42.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.248 -0.476 . . . . 0.0 111.43 179.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 535' ' ' ARG . . . . . 0.574 ' HG2' ' CD2' ' A' ' 573' ' ' LEU . 0.0 OUTLIER -160.17 91.41 1.73 Allowed Pre-proline 0 C--N 1.33 -0.266 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.966 178.349 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 536' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -77.72 -32.53 2.7 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.559 2.173 . . . . 0.0 112.16 179.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 72.22 54.62 7.73 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.575 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 538' ' ' VAL . . . . . 0.4 HG11 ' N ' ' A' ' 539' ' ' LYS . 12.3 p -116.2 -45.95 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 CA-C-O 121.005 0.431 . . . . 0.0 111.686 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 539' ' ' LYS . . . . . 0.4 ' N ' HG11 ' A' ' 538' ' ' VAL . 9.9 mtmm -107.7 152.21 24.63 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.948 -178.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 6.0 mtmt -98.03 30.65 2.98 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.739 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 541' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -88.71 100.12 12.88 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.53 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -48.46 153.81 1.26 Allowed Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.004 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 543' ' ' PRO . . . . . 0.406 ' CA ' ' HG3' ' A' ' 548' ' ' PRO . 75.1 Cg_exo -50.27 -52.25 9.33 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.575 2.183 . . . . 0.0 113.021 -179.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . 0.554 ' O ' ' N ' ' A' ' 546' ' ' GLY . . . 39.88 41.0 1.78 Allowed Glycine 0 CA--C 1.521 0.439 0 C-N-CA 121.047 -0.597 . . . . 0.0 113.121 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 545' ' ' GLY . . . . . 0.611 ' O ' ' N ' ' A' ' 547' ' ' MET . . . 53.86 -29.98 0.01 OUTLIER Glycine 0 CA--C 1.533 1.197 0 N-CA-C 115.355 0.902 . . . . 0.0 115.355 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 544' ' ' GLY . . . -51.91 55.37 0.01 OUTLIER Glycine 0 CA--C 1.528 0.904 0 N-CA-C 115.212 0.845 . . . . 0.0 115.212 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 547' ' ' MET . . . . . 0.611 ' N ' ' O ' ' A' ' 545' ' ' GLY . 0.0 OUTLIER 52.27 55.02 14.59 Favored Pre-proline 0 N--CA 1.464 0.233 0 CA-C-N 118.541 1.171 . . . . 0.0 110.959 -179.912 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 548' ' ' PRO . . . . . 0.444 ' HD3' ' N ' ' A' ' 547' ' ' MET . 84.9 Cg_exo -45.75 152.68 0.96 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 123.096 2.53 . . . . 0.0 113.433 -178.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -124.66 -27.2 3.71 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.167 178.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 550' ' ' ASP . . . . . 0.488 ' O ' ' HA ' ' A' ' 535' ' ' ARG . 0.5 OUTLIER -58.66 -47.81 83.19 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.396 179.39 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 551' ' ' LEU . . . . . . . . . . . . . 7.1 tp -131.36 142.48 50.08 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.43 -0.805 . . . . 0.0 108.969 178.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 552' ' ' THR . . . . . 0.646 ' O ' ' HA2' ' A' ' 533' ' ' GLY . 4.3 m -132.94 147.65 52.28 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.756 0.789 . . . . 0.0 112.395 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 553' ' ' PHE . . . . . 0.543 ' HA ' ' CE2' ' A' ' 531' ' ' TYR . 17.4 m-85 -133.71 136.95 44.99 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 176.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 554' ' ' THR . . . . . 0.551 ' O ' ' HA ' ' A' ' 531' ' ' TYR . 1.2 m -133.66 138.67 31.57 Favored Pre-proline 0 C--N 1.308 -1.224 0 C-N-CA 119.822 -0.751 . . . . 0.0 110.492 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 555' ' ' PRO . . . . . 0.593 ' O ' HG23 ' A' ' 556' ' ' ILE . 65.7 Cg_endo -83.49 19.24 1.37 Allowed 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 121.898 1.732 . . . . 0.0 111.764 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 556' ' ' ILE . . . . . 0.891 ' HB ' ' O ' ' A' ' 530' ' ' ALA . 4.5 tp 62.66 34.01 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.188 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 176.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . 0.599 ' O ' ' CE2' ' A' ' 559' ' ' TRP . 0.0 OUTLIER -103.82 126.03 50.66 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 179.897 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 558' ' ' THR . . . . . . . . . . . . . 3.6 t -57.81 118.22 5.09 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 115.413 1.634 . . . . 0.0 115.413 -172.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 559' ' ' TRP . . . . . 0.599 ' CE2' ' O ' ' A' ' 557' ' ' LYS . 0.0 OUTLIER -138.5 130.7 28.56 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 175.214 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 560' ' ' ASN . . . . . 0.577 ' O ' ' CG2' ' A' ' 564' ' ' THR . 11.0 m-80 -90.88 -76.32 0.44 Allowed 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 118.305 -1.358 . . . . 0.0 114.116 -177.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 561' ' ' ALA . . . . . 0.69 ' O ' HG23 ' A' ' 564' ' ' THR . . . -75.23 -57.29 3.98 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 116.368 1.988 . . . . 0.0 116.368 -177.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 562' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -49.0 -52.48 24.72 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -176.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 563' ' ' LYS . . . . . 0.564 ' HG2' ' CE2' ' A' ' 559' ' ' TRP . 0.0 OUTLIER -70.8 -48.01 56.47 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -178.412 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 564' ' ' THR . . . . . 0.69 HG23 ' O ' ' A' ' 561' ' ' ALA . 6.8 t -49.63 -69.37 0.12 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.867 0.365 . . . . 0.0 111.288 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 565' ' ' GLN . . . . . 0.563 ' H ' ' CG2' ' A' ' 564' ' ' THR . 2.0 tp60 -50.07 -46.62 53.48 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . 0.433 ' HG2' ' CD1' ' A' ' 567' ' ' PHE . 14.0 tt0 -49.24 -65.42 0.57 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 111.863 0.319 . . . . 0.0 111.863 -178.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 567' ' ' PHE . . . . . 0.585 ' C ' ' H ' ' A' ' 569' ' ' ILE . 0.0 OUTLIER -97.18 -51.52 4.17 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.747 0.784 . . . . 0.0 112.007 -178.973 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 568' ' ' ILE . . . . . 0.572 ' CG1' ' HA ' ' A' ' 564' ' ' THR . 12.0 mm -57.26 9.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 114.321 -1.309 . . . . 0.0 113.321 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 569' ' ' ILE . . . . . 0.585 ' H ' ' C ' ' A' ' 567' ' ' PHE . 0.9 OUTLIER -53.87 -39.03 38.23 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.845 0 N-CA-C 104.266 -2.494 . . . . 0.0 104.266 178.154 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 570' ' ' ASP . . . . . 0.471 ' OD2' ' HB2' ' A' ' 574' ' ' LEU . 32.5 m-20 35.45 50.0 0.53 Allowed 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 113.726 -1.579 . . . . 0.0 111.342 174.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -50.54 -44.13 46.03 Favored Glycine 0 N--CA 1.439 -1.101 0 C-N-CA 118.37 -1.871 . . . . 0.0 109.051 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 572' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -118.44 -18.09 9.24 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 120.252 -0.579 . . . . 0.0 112.16 175.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 573' ' ' LEU . . . . . 0.574 ' CD2' ' HG2' ' A' ' 535' ' ' ARG . 0.7 OUTLIER -141.2 137.68 32.8 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 574' ' ' LEU . . . . . 0.471 ' HB2' ' OD2' ' A' ' 570' ' ' ASP . 1.1 tp -133.98 131.94 39.54 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 174.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 575' ' ' ILE . . . . . 0.747 HG13 ' O ' ' A' ' 533' ' ' GLY . 0.0 OUTLIER -134.64 137.19 51.58 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-N 118.557 0.617 . . . . 0.0 111.612 178.802 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 576' ' ' LEU . . . . . 0.5 HD21 ' HB3' ' A' ' 584' ' ' LYS . 0.0 OUTLIER -133.08 135.67 45.44 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 177.375 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 577' ' ' LYS . . . . . 0.412 ' HG2' ' HB2' ' A' ' 583' ' ' MET . 7.5 mttt -130.62 135.59 48.02 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.254 177.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -124.88 132.01 53.36 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 579' ' ' GLY . . . . . . . . . . . . . . . -89.55 -2.19 76.6 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 115.229 -0.896 . . . . 0.0 113.251 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 580' ' ' LYS . . . . . 0.491 ' O ' ' CD1' ' A' ' 581' ' ' TRP . 0.0 OUTLIER -72.56 -48.46 39.9 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 118.957 -1.097 . . . . 0.0 108.815 179.27 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 581' ' ' TRP . . . . . 0.491 ' CD1' ' O ' ' A' ' 580' ' ' LYS . 25.5 m0 -139.29 -53.02 0.55 Allowed 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 114.452 1.278 . . . . 0.0 114.452 177.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 582' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.38 165.18 28.13 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -174.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 583' ' ' MET . . . . . 0.412 ' HB2' ' HG2' ' A' ' 577' ' ' LYS . 0.3 OUTLIER -113.97 134.78 54.62 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 174.156 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 584' ' ' LYS . . . . . 0.574 ' HE2' ' H ' ' A' ' 513' ' ' GLY . 1.4 tmmt? -120.77 133.85 55.31 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 177.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 585' ' ' LEU . . . . . 0.501 ' HG ' ' CG ' ' A' ' 492' ' ' ARG . 1.4 tp -118.8 136.32 54.06 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 586' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 493' ' ' VAL . 2.5 t -132.88 137.15 54.46 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -177.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 587' ' ' SER . . . . . . . . . . . . . 55.6 m -109.35 134.95 51.19 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 177.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . 0.478 ' HB ' ' CA ' ' A' ' 497' ' ' LYS . 0.2 OUTLIER -134.6 152.63 33.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -178.649 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 4.6 t -122.6 138.82 51.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 114.031 -1.441 . . . . 0.0 110.781 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 590' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.62 143.96 55.78 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.163 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 591' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -52.81 -51.57 60.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.949 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 592' ' ' GLU . . . . . 0.402 ' HA ' ' HG3' ' A' ' 595' ' ' LYS . 0.9 OUTLIER -51.08 -50.52 58.57 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.18 -179.703 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 1.9 mmtp -50.3 -48.47 55.11 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.833 0.825 . . . . 0.0 109.102 178.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 594' ' ' PHE . . . . . 0.523 ' O ' ' HG ' ' A' ' 597' ' ' LEU . 0.9 OUTLIER -50.06 -48.41 52.96 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.645 178.372 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 595' ' ' LYS . . . . . 0.489 ' HA ' ' CE2' ' A' ' 604' ' ' TRP . 6.3 mmpt? -49.43 -47.64 47.92 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 596' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -50.93 -60.54 2.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.245 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 597' ' ' LEU . . . . . 0.523 ' HG ' ' O ' ' A' ' 594' ' ' PHE . 0.6 OUTLIER -62.85 -63.31 1.25 Allowed 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 121.309 0.576 . . . . 0.0 112.105 -178.77 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 598' ' ' GLY . . . . . 0.426 ' O ' ' CD1' ' A' ' 604' ' ' TRP . . . -75.24 13.8 5.62 Favored Glycine 0 C--N 1.32 -0.349 0 CA-C-N 115.132 -0.94 . . . . 0.0 113.657 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 599' ' ' LEU . . . . . 0.478 ' HA ' ' CD1' ' A' ' 604' ' ' TRP . 2.6 pp -47.86 -14.89 0.05 Allowed 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -175.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 600' ' ' THR . . . . . . . . . . . . . 11.1 t -131.69 66.75 1.54 Allowed 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.074 -0.65 . . . . 0.0 110.642 177.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 601' ' ' ALA . . . . . . . . . . . . . . . -131.33 166.57 26.88 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.441 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 602' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -68.5 -13.4 37.32 Favored 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 122.154 1.903 . . . . 0.0 111.437 178.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 603' ' ' GLY . . . . . . . . . . . . . . . -69.1 -48.95 43.73 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.549 -0.75 . . . . 0.0 113.184 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 604' ' ' TRP . . . . . 0.489 ' CE2' ' HA ' ' A' ' 595' ' ' LYS . 0.9 OUTLIER -64.12 -46.57 83.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.799 0.333 . . . . 0.0 111.223 -179.557 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 605' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -50.3 -60.0 3.42 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.386 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 606' ' ' GLU . . . . . 0.414 ' O ' ' HB2' ' A' ' 610' ' ' LYS . 0.3 OUTLIER -61.28 -59.06 5.88 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -179.614 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 607' ' ' VAL . . . . . . . . . . . . . 90.3 t -50.66 -71.95 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 113.801 1.038 . . . . 0.0 113.801 -178.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 608' ' ' VAL . . . . . . . . . . . . . 76.2 t -70.56 -60.17 2.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -177.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 609' ' ' GLY . . . . . . . . . . . . . . . -55.42 -64.7 4.14 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 121.326 -0.464 . . . . 0.0 113.529 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 610' ' ' LYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 606' ' ' GLU . 19.8 mttt -70.42 -63.05 1.16 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.771 0.32 . . . . 0.0 110.951 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 79.71 56.51 3.32 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.693 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.25 37.37 1.25 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.844 0.354 . . . . 0.0 110.95 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 613' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -120.01 -173.69 2.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.777 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . 0.411 ' CB ' ' CD ' ' A' ' 615' ' ' PRO . 13.0 mt-10 -68.72 -60.71 4.3 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.948 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 615' ' ' PRO . . . . . 0.411 ' CD ' ' CB ' ' A' ' 614' ' ' GLU . 59.9 Cg_endo -72.41 111.09 3.13 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.529 2.153 . . . . 0.0 112.271 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 616' ' ' SER . . . . . . . . . . . . . 4.1 m -130.12 149.47 73.32 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.867 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo . . . . . 0 C--O 1.249 1.059 0 C-N-CA 122.569 2.179 . . . . 0.0 112.285 179.998 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 4.8 mtp . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.759 0.314 . . . . 0.0 111.215 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 455' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -69.61 -26.45 28.28 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.578 2.185 . . . . 0.0 112.396 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 456' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.31 -26.53 61.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.033 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 10.4 t -97.03 39.48 1.18 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.916 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -91.13 119.59 31.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.153 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 7.5 t -61.84 111.39 4.39 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.897 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -50.84 160.27 1.94 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.462 2.108 . . . . 0.0 112.368 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . 107.34 50.6 0.81 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.447 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -103.57 91.38 3.33 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 120.636 0.255 . . . . 0.0 110.978 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.08 142.04 54.84 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.39 2.06 . . . . 0.0 112.321 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.83 123.52 17.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.0 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 1.4 m -113.39 -45.6 3.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.846 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 13.0 t -123.5 31.31 5.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.83 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.23 86.01 2.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.875 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -120.08 43.46 2.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.758 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 129.05 -36.96 2.3 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.089 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -106.41 117.52 34.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.848 0.356 . . . . 0.0 110.424 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 471' ' ' VAL . . . . . . . . . . . . . 10.4 p -113.17 108.18 24.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.23 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 31.8 m-20 -155.68 87.86 3.07 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.808 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -60.54 77.43 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.784 2.323 . . . . 0.0 112.402 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -136.19 30.01 3.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.893 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 44.1 m -89.0 -52.35 5.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.979 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 476' ' ' GLY . . . . . . . . . . . . . . . 106.89 44.03 1.34 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.412 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 477' ' ' ASN . . . . . 0.468 ' N ' ' CD ' ' A' ' 478' ' ' PRO . 0.7 OUTLIER -50.45 -47.99 82.41 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 478' ' ' PRO . . . . . 0.468 ' CD ' ' N ' ' A' ' 477' ' ' ASN . 81.5 Cg_exo -45.05 -67.51 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.784 2.323 . . . . 0.0 113.366 -179.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -124.41 175.53 7.05 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.816 0.341 . . . . 0.0 111.255 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -56.83 108.28 1.17 Allowed Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.04 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -52.25 -79.02 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.496 2.131 . . . . 0.0 112.576 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 482' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -136.07 -50.4 0.7 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.35 0.595 . . . . 0.0 109.569 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 483' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.04 172.0 9.32 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.157 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 484' ' ' ASN . . . . . . . . . . . . . 19.4 m-20 -85.44 18.99 2.48 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.76 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 485' ' ' PHE . . . . . 0.431 ' CG ' ' N ' ' A' ' 486' ' ' ALA . 45.0 p90 -58.46 -52.02 67.38 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.745 0.307 . . . . 0.0 110.433 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 486' ' ' ALA . . . . . 0.431 ' N ' ' CG ' ' A' ' 485' ' ' PHE . . . -72.41 -47.3 50.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.357 0.598 . . . . 0.0 110.05 178.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -50.05 -48.34 52.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.622 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 488' ' ' MET . . . . . 0.479 ' N ' ' CD ' ' A' ' 489' ' ' PRO . 2.5 mtt 52.57 51.35 9.3 Favored Pre-proline 0 CA--C 1.529 0.149 0 CA-C-O 121.102 0.477 . . . . 0.0 110.381 -178.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 489' ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' A' ' 488' ' ' MET . 40.3 Cg_exo -33.16 -57.07 0.34 Allowed 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.901 3.067 . . . . 0.0 114.41 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 3.5 m -120.07 -66.92 1.02 Allowed 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -178.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 491' ' ' ALA . . . . . . . . . . . . . . . -134.0 139.75 46.26 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -178.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 492' ' ' ARG . . . . . 0.45 ' HG2' ' HB3' ' A' ' 585' ' ' LEU . 0.0 OUTLIER -134.32 133.12 40.34 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.726 177.366 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 493' ' ' VAL . . . . . 0.47 ' CG2' ' CA ' ' A' ' 513' ' ' GLY . 44.5 t -136.98 163.69 31.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 494' ' ' THR . . . . . 0.422 ' N ' ' CG1' ' A' ' 493' ' ' VAL . 32.3 p -117.69 134.25 55.09 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 121.147 0.498 . . . . 0.0 110.127 177.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 495' ' ' LEU . . . . . 0.543 ' O ' HG21 ' A' ' 588' ' ' ILE . 0.0 OUTLIER -135.22 164.4 44.08 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.377 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 496' ' ' PRO . . . . . 0.409 ' HD2' ' CD1' ' A' ' 495' ' ' LEU . 11.9 Cg_exo -69.63 119.39 6.35 Favored 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 122.065 1.844 . . . . 0.0 111.199 178.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 497' ' ' LYS . . . . . 0.495 ' N ' HG21 ' A' ' 588' ' ' ILE . 2.4 ttpt -57.43 -30.21 64.79 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -178.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 498' ' ' SER . . . . . 0.418 ' O ' ' CD1' ' A' ' 501' ' ' TYR . 0.3 OUTLIER -59.14 -48.7 80.66 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 114.414 1.264 . . . . 0.0 114.414 -176.757 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 1.5 pp -74.2 -10.24 59.41 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -178.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . 0.499 HG12 HG22 ' A' ' 508' ' ' VAL . 20.8 t -76.54 -27.21 17.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.337 0.589 . . . . 0.0 111.88 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 501' ' ' TYR . . . . . 0.53 ' O ' HG23 ' A' ' 564' ' ' THR . 0.3 OUTLIER -54.09 -30.6 49.03 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -177.704 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 502' ' ' ASP . . . . . 0.432 ' N ' ' CD1' ' A' ' 501' ' ' TYR . 4.6 t0 -75.78 -51.3 12.94 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 -175.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 503' ' ' LYS . . . . . 0.583 ' HB3' ' HG2' ' A' ' 507' ' ' LYS . 0.0 OUTLIER -120.59 140.6 51.28 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 118.76 0.709 . . . . 0.0 110.572 178.936 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 504' ' ' THR . . . . . 0.511 ' O ' HG21 ' A' ' 508' ' ' VAL . 3.3 m -72.6 -74.4 0.17 Allowed 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -178.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . 0.53 ' CD2' HD12 ' A' ' 556' ' ' ILE . 0.2 OUTLIER -73.3 -57.63 3.88 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -177.262 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 506' ' ' SER . . . . . 0.849 ' O ' ' CD1' ' A' ' 510' ' ' TRP . 10.1 t -48.8 -66.38 0.41 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -176.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 507' ' ' LYS . . . . . 0.583 ' HG2' ' HB3' ' A' ' 503' ' ' LYS . 0.0 OUTLIER -48.75 -56.13 9.51 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -176.849 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 508' ' ' VAL . . . . . 0.56 HG12 ' HG ' ' A' ' 574' ' ' LEU . 48.4 t -49.9 -61.14 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -179.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 509' ' ' LEU . . . . . 0.55 ' CD1' ' N ' ' A' ' 510' ' ' TRP . 2.5 pp -54.27 -63.07 1.27 Allowed 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 115.626 1.713 . . . . 0.0 115.626 -177.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 510' ' ' TRP . . . . . 0.853 ' CD1' ' HA ' ' A' ' 518' ' ' LYS . 66.3 p-90 -72.85 -51.39 18.95 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 -175.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 511' ' ' SER . . . . . 0.529 ' N ' ' CE3' ' A' ' 510' ' ' TRP . 0.3 OUTLIER -64.39 -47.19 80.18 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.299 -0.864 . . . . 0.0 113.305 -176.753 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 512' ' ' ALA . . . . . 0.484 ' HB2' HD21 ' A' ' 495' ' ' LEU . . . -70.92 -73.79 0.16 Allowed 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 118.158 2.651 . . . . 0.0 118.158 -173.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 513' ' ' GLY . . . . . 0.605 ' H ' ' HE2' ' A' ' 584' ' ' LYS . . . -115.48 -34.98 1.35 Allowed Glycine 0 CA--C 1.501 -0.825 0 N-CA-C 120.84 3.096 . . . . 0.0 120.84 -172.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 514' ' ' LEU . . . . . 0.603 ' HG ' ' HB2' ' A' ' 584' ' ' LYS . 0.1 OUTLIER -106.86 -46.53 3.93 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 119.473 3.138 . . . . 0.0 119.473 -169.887 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 515' ' ' VAL . . . . . 0.544 ' CG2' ' N ' ' A' ' 516' ' ' ALA . 2.5 p -154.4 172.29 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 N-CA-C 117.981 2.585 . . . . 0.0 117.981 -172.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 516' ' ' ALA . . . . . 0.544 ' N ' ' CG2' ' A' ' 515' ' ' VAL . . . -68.62 3.71 1.74 Allowed 'General case' 0 C--N 1.333 -0.109 0 C-N-CA 126.741 2.016 . . . . 0.0 110.012 177.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 517' ' ' SER . . . . . 0.855 ' HA ' ' HB3' ' A' ' 520' ' ' GLU . 0.6 OUTLIER -57.84 9.1 0.01 OUTLIER 'General case' 0 N--CA 1.428 -1.526 0 N-CA-C 116.153 1.909 . . . . 0.0 116.153 -171.797 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 518' ' ' LYS . . . . . 0.853 ' HA ' ' CD1' ' A' ' 510' ' ' TRP . 0.1 OUTLIER -45.3 -46.93 13.04 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 104.277 -2.49 . . . . 0.0 104.277 175.423 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 519' ' ' SER . . . . . . . . . . . . . 58.0 p -75.1 -60.05 2.47 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 114.658 -1.156 . . . . 0.0 110.15 173.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 520' ' ' GLU . . . . . 0.855 ' HB3' ' HA ' ' A' ' 517' ' ' SER . 5.7 tp10 -57.81 -47.47 82.52 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.497 -179.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 521' ' ' GLY . . . . . 0.834 ' N ' ' O ' ' A' ' 517' ' ' SER . . . -49.29 -54.37 16.02 Favored Glycine 0 CA--C 1.493 -1.328 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.033 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . 0.445 ' HA ' HG12 ' A' ' 525' ' ' ILE . 0.9 OUTLIER -47.42 -47.33 26.72 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.465 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 523' ' ' ARG . . . . . 0.452 ' O ' ' HB2' ' A' ' 526' ' ' ASN . 2.2 ttt180 -50.4 -48.78 55.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.844 178.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 524' ' ' ILE . . . . . 0.47 ' O ' ' ND2' ' A' ' 527' ' ' ASN . 23.1 mt -58.25 -55.2 23.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.412 0.625 . . . . 0.0 109.827 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 525' ' ' ILE . . . . . 0.578 HG12 ' O ' ' A' ' 521' ' ' GLY . 0.3 OUTLIER -50.02 -47.58 23.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 177.761 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 526' ' ' ASN . . . . . 0.452 ' HB2' ' O ' ' A' ' 523' ' ' ARG . 32.1 m-20 -56.17 -47.89 77.39 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 114.35 -1.295 . . . . 0.0 108.23 177.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 527' ' ' ASN . . . . . 0.47 ' ND2' ' O ' ' A' ' 524' ' ' ILE . 0.0 OUTLIER -47.9 -40.24 21.27 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 113.986 -1.461 . . . . 0.0 107.534 176.817 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 528' ' ' ASN . . . . . 0.579 ' HA ' ' CG2' ' A' ' 556' ' ' ILE . 1.7 t-20 73.44 40.28 0.53 Allowed 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.461 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 529' ' ' GLY . . . . . . . . . . . . . . . -116.33 31.68 5.9 Favored Glycine 0 CA--C 1.522 0.523 0 CA-C-N 114.994 -1.003 . . . . 0.0 112.436 178.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 530' ' ' ALA . . . . . 0.855 ' O ' ' HB ' ' A' ' 556' ' ' ILE . . . -133.44 164.42 27.17 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.532 0.682 . . . . 0.0 112.749 -179.015 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 531' ' ' TYR . . . . . 0.55 ' HA ' HG21 ' A' ' 554' ' ' THR . 0.0 OUTLIER -134.65 157.92 45.41 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.752 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 532' ' ' VAL . . . . . 0.655 ' HB ' HG22 ' A' ' 554' ' ' THR . 0.5 OUTLIER -132.84 136.62 55.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-O 121.921 0.867 . . . . 0.0 112.133 179.886 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 533' ' ' GLY . . . . . 0.798 ' O ' HG13 ' A' ' 575' ' ' ILE . . . -128.64 148.63 18.07 Favored Glycine 0 N--CA 1.441 -1.01 0 CA-C-N 114.155 -1.384 . . . . 0.0 112.609 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 534' ' ' SER . . . . . 0.471 ' N ' ' HB ' ' A' ' 552' ' ' THR . 0.2 OUTLIER -134.73 146.88 49.84 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.528 -0.336 . . . . 0.0 110.617 179.62 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 535' ' ' ARG . . . . . 0.516 ' HB3' ' CD2' ' A' ' 573' ' ' LEU . 0.0 OUTLIER -159.52 89.71 1.95 Allowed Pre-proline 0 N--CA 1.464 0.233 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 178.961 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 536' ' ' PRO . . . . . 0.571 ' HD2' ' HA ' ' A' ' 550' ' ' ASP . 35.0 Cg_endo -63.8 -35.61 55.81 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.383 2.055 . . . . 0.0 112.002 178.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 91.7 57.05 1.56 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.727 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 538' ' ' VAL . . . . . . . . . . . . . 11.8 p -116.28 -46.28 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 CA-C-O 121.084 0.469 . . . . 0.0 111.704 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 539' ' ' LYS . . . . . . . . . . . . . 14.8 mtmm -108.37 119.01 38.28 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.935 -178.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -62.34 -55.84 24.17 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.848 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 541' ' ' ASN . . . . . . . . . . . . . 57.9 t-20 -96.15 98.86 10.67 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.098 0.475 . . . . 0.0 109.849 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -123.22 110.62 30.75 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.496 -179.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 543' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -50.82 -11.91 0.5 Allowed 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.903 2.402 . . . . 0.0 113.128 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . 0.686 ' O ' ' N ' ' A' ' 546' ' ' GLY . . . 52.52 17.32 4.31 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 121.318 -0.468 . . . . 0.0 113.631 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 545' ' ' GLY . . . . . 0.622 ' O ' ' N ' ' A' ' 547' ' ' MET . . . -52.45 55.03 0.01 OUTLIER Glycine 0 CA--C 1.526 0.745 0 CA-C-O 119.633 -0.537 . . . . 0.0 113.795 178.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . 0.686 ' N ' ' O ' ' A' ' 544' ' ' GLY . . . 53.73 -53.05 0.01 OUTLIER Glycine 0 CA--C 1.528 0.849 0 CA-C-N 117.423 0.612 . . . . 0.0 114.14 -178.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 547' ' ' MET . . . . . 0.622 ' N ' ' O ' ' A' ' 545' ' ' GLY . 0.6 OUTLIER -51.07 -51.35 68.67 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 118.13 0.965 . . . . 0.0 111.038 178.968 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 548' ' ' PRO . . . . . 0.446 ' CD ' ' N ' ' A' ' 547' ' ' MET . 79.8 Cg_exo -46.71 167.35 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.314 2.676 . . . . 0.0 112.924 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -119.99 -15.22 8.81 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.67 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 550' ' ' ASP . . . . . 0.571 ' HA ' ' HD2' ' A' ' 536' ' ' PRO . 0.1 OUTLIER -56.51 -37.84 70.99 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 121.764 0.793 . . . . 0.0 108.963 178.946 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 551' ' ' LEU . . . . . . . . . . . . . 14.6 tp -132.09 140.47 48.84 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.661 -1.154 . . . . 0.0 108.891 178.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 552' ' ' THR . . . . . 0.531 ' OG1' ' HB3' ' A' ' 567' ' ' PHE . 7.7 m -132.81 150.32 52.17 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.711 0.767 . . . . 0.0 111.728 179.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 553' ' ' PHE . . . . . 0.507 ' CD1' ' CE1' ' A' ' 531' ' ' TYR . 0.2 OUTLIER -132.92 138.54 46.99 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 114.442 -1.254 . . . . 0.0 108.166 178.135 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 554' ' ' THR . . . . . 0.655 HG22 ' HB ' ' A' ' 532' ' ' VAL . 0.4 OUTLIER -131.3 140.78 39.58 Favored Pre-proline 0 C--N 1.312 -1.047 0 C-N-CA 120.304 -0.558 . . . . 0.0 111.173 -179.713 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 555' ' ' PRO . . . . . 0.527 ' O ' HG21 ' A' ' 556' ' ' ILE . 35.0 Cg_endo -91.15 7.7 3.43 Favored 'Trans proline' 0 N--CA 1.438 -1.785 0 C-N-CA 122.256 1.971 . . . . 0.0 110.338 178.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 556' ' ' ILE . . . . . 0.855 ' HB ' ' O ' ' A' ' 530' ' ' ALA . 6.3 tp 62.4 33.21 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.302 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 177.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . 0.704 ' O ' ' CE2' ' A' ' 559' ' ' TRP . 0.0 OUTLIER -104.48 141.42 36.4 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 179.386 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 558' ' ' THR . . . . . . . . . . . . . 1.6 t -57.68 115.91 3.08 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 -172.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 559' ' ' TRP . . . . . 0.704 ' CE2' ' O ' ' A' ' 557' ' ' LYS . 0.0 OUTLIER -139.21 121.61 16.07 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 112.356 -2.202 . . . . 0.0 106.602 174.871 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 560' ' ' ASN . . . . . 0.501 ' O ' ' CG2' ' A' ' 564' ' ' THR . 81.2 m-20 -91.2 -76.8 0.43 Allowed 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 118.233 -1.387 . . . . 0.0 113.917 -177.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 561' ' ' ALA . . . . . 0.577 ' O ' HG21 ' A' ' 564' ' ' THR . . . -75.53 -49.74 17.78 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 115.968 1.84 . . . . 0.0 115.968 -177.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 562' ' ' SER . . . . . . . . . . . . . 9.9 t -48.8 -55.71 10.79 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -176.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 563' ' ' LYS . . . . . 0.563 ' HG3' ' CG ' ' A' ' 559' ' ' TRP . 0.1 OUTLIER -70.82 -47.97 56.61 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -178.307 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 564' ' ' THR . . . . . 0.607 HG23 ' H ' ' A' ' 565' ' ' GLN . 9.0 t -50.07 -72.0 0.06 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.81 0.338 . . . . 0.0 111.699 -179.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 565' ' ' GLN . . . . . 0.607 ' H ' HG23 ' A' ' 564' ' ' THR . 1.1 tp60 -50.69 -46.66 58.91 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . 0.428 ' HG2' ' CD1' ' A' ' 567' ' ' PHE . 67.3 tt0 -49.17 -66.45 0.4 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.863 0.363 . . . . 0.0 111.696 -178.229 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 567' ' ' PHE . . . . . 0.586 ' C ' ' H ' ' A' ' 569' ' ' ILE . 0.1 OUTLIER -97.39 -53.64 3.4 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.533 0.683 . . . . 0.0 111.701 -179.278 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 568' ' ' ILE . . . . . 0.552 ' CG1' ' HA ' ' A' ' 564' ' ' THR . 14.9 mm -53.95 10.43 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.503 -0.841 0 CA-C-N 114.494 -1.23 . . . . 0.0 113.888 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 569' ' ' ILE . . . . . 0.586 ' H ' ' C ' ' A' ' 567' ' ' PHE . 0.9 OUTLIER -55.73 -33.87 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 N-CA-C 103.815 -2.661 . . . . 0.0 103.815 177.7 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 570' ' ' ASP . . . . . 0.534 ' CB ' ' HB2' ' A' ' 574' ' ' LEU . 7.8 p30 34.56 42.82 0.08 Allowed 'General case' 0 CA--C 1.492 -1.264 0 CA-C-N 113.421 -1.718 . . . . 0.0 110.591 174.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 571' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' A' ' 570' ' ' ASP . . . -49.49 -43.46 35.93 Favored Glycine 0 N--CA 1.436 -1.342 0 N-CA-C 106.981 -2.448 . . . . 0.0 106.981 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 572' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -119.03 -17.99 8.88 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-O 118.937 -0.554 . . . . 0.0 112.298 174.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 573' ' ' LEU . . . . . 0.516 ' CD2' ' HB3' ' A' ' 535' ' ' ARG . 1.5 tp -142.21 136.55 30.0 Favored 'General case' 0 C--N 1.362 1.124 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 -178.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 574' ' ' LEU . . . . . 0.56 ' HG ' HG12 ' A' ' 508' ' ' VAL . 8.9 tp -136.22 133.84 37.49 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 114.339 -1.301 . . . . 0.0 107.613 173.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 575' ' ' ILE . . . . . 0.798 HG13 ' O ' ' A' ' 533' ' ' GLY . 0.0 OUTLIER -133.86 137.16 52.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 O-C-N 122.001 -0.437 . . . . 0.0 110.766 178.253 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 576' ' ' LEU . . . . . 0.511 ' CD2' ' HA ' ' A' ' 509' ' ' LEU . 0.1 OUTLIER -133.33 135.3 44.7 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 177.523 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 577' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -132.99 135.24 45.36 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.194 -1.002 . . . . 0.0 109.979 177.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.0 132.04 53.32 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 579' ' ' GLY . . . . . . . . . . . . . . . -89.81 -2.18 75.77 Favored Glycine 0 N--CA 1.442 -0.942 0 CA-C-N 115.294 -0.867 . . . . 0.0 113.173 -178.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 580' ' ' LYS . . . . . 0.418 ' O ' ' CD1' ' A' ' 581' ' ' TRP . 0.0 OUTLIER -72.9 -48.1 40.17 Favored 'General case' 0 N--CA 1.441 -0.904 0 C-N-CA 119.17 -1.012 . . . . 0.0 108.908 179.256 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 581' ' ' TRP . . . . . 0.418 ' CD1' ' O ' ' A' ' 580' ' ' LYS . 13.6 m0 -139.64 -52.84 0.53 Allowed 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 177.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 582' ' ' LYS . . . . . . . . . . . . . 3.1 ptpt -140.15 164.94 28.7 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 -175.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 583' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -113.7 134.68 54.6 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 174.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 584' ' ' LYS . . . . . 0.605 ' HE2' ' H ' ' A' ' 513' ' ' GLY . 0.5 OUTLIER -122.89 133.6 54.41 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 178.979 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 585' ' ' LEU . . . . . 0.45 ' HB3' ' HG2' ' A' ' 492' ' ' ARG . 9.8 tt -120.62 135.56 55.07 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 586' ' ' VAL . . . . . 0.548 HG13 ' N ' ' A' ' 587' ' ' SER . 55.2 t -134.04 144.15 36.3 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 112.991 0.738 . . . . 0.0 112.991 -177.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 587' ' ' SER . . . . . 0.548 ' N ' HG13 ' A' ' 586' ' ' VAL . 3.1 m -107.29 135.88 48.06 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 176.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . 0.543 HG21 ' O ' ' A' ' 495' ' ' LEU . 0.0 OUTLIER -132.77 136.93 55.0 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.47 0 CA-C-O 121.701 0.762 . . . . 0.0 112.785 -177.309 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 589' ' ' VAL . . . . . 0.488 ' N ' ' HB2' ' A' ' 497' ' ' LYS . 7.1 p -125.26 150.34 30.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 114.376 -1.284 . . . . 0.0 110.843 179.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 590' ' ' SER . . . . . . . . . . . . . 3.3 p -73.32 156.37 38.49 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.172 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 591' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -50.74 -48.56 59.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.145 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 592' ' ' GLU . . . . . 0.416 ' O ' ' HG3' ' A' ' 595' ' ' LYS . 13.8 pt-20 -54.26 -49.2 70.1 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.031 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 593' ' ' LYS . . . . . 0.436 ' CB ' ' CG2' ' A' ' 589' ' ' VAL . 1.7 mmtp -62.17 -59.05 5.61 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -178.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 594' ' ' PHE . . . . . 0.441 ' O ' ' HG ' ' A' ' 597' ' ' LEU . 3.1 t80 -50.24 -48.98 54.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.251 -179.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 595' ' ' LYS . . . . . 0.541 ' O ' ' N ' ' A' ' 599' ' ' LEU . 0.0 OUTLIER -52.78 -47.35 67.58 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.122 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 596' ' ' GLU . . . . . 0.466 ' N ' ' HG3' ' A' ' 595' ' ' LYS . 0.5 OUTLIER -50.1 -65.45 0.56 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.978 -179.738 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 597' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 594' ' ' PHE . 0.5 OUTLIER -55.7 -59.54 4.7 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.146 0.498 . . . . 0.0 111.405 -179.2 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 598' ' ' GLY . . . . . 0.495 ' C ' ' H ' ' A' ' 600' ' ' THR . . . -77.95 11.77 20.22 Favored Glycine 0 CA--C 1.521 0.437 0 CA-C-N 115.43 -0.804 . . . . 0.0 113.143 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 599' ' ' LEU . . . . . 0.541 ' N ' ' O ' ' A' ' 595' ' ' LYS . 3.4 pp -51.14 2.39 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -177.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 600' ' ' THR . . . . . 0.495 ' H ' ' C ' ' A' ' 598' ' ' GLY . 7.4 t -102.79 66.64 0.94 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 118.745 0.702 . . . . 0.0 109.855 178.077 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 601' ' ' ALA . . . . . 0.41 ' CB ' ' CD ' ' A' ' 602' ' ' PRO . . . -131.24 177.15 2.38 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.587 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 602' ' ' PRO . . . . . 0.41 ' CD ' ' CB ' ' A' ' 601' ' ' ALA . 32.1 Cg_exo -57.5 -44.98 37.22 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.299 1.999 . . . . 0.0 111.666 179.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 603' ' ' GLY . . . . . . . . . . . . . . . -71.14 -48.94 29.36 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.61 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 604' ' ' TRP . . . . . 0.459 ' CH2' ' HB2' ' A' ' 595' ' ' LYS . 10.4 m95 -65.31 -47.2 77.38 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 120.969 0.414 . . . . 0.0 111.153 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 605' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -50.57 -57.74 7.44 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.169 -178.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 606' ' ' GLU . . . . . 0.418 ' O ' ' CB ' ' A' ' 610' ' ' LYS . 6.5 pt-20 -59.71 -57.37 13.19 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 607' ' ' VAL . . . . . . . . . . . . . 59.9 t -58.48 -72.02 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -178.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 608' ' ' VAL . . . . . . . . . . . . . 97.3 t -65.37 -58.28 7.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -177.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 609' ' ' GLY . . . . . . . . . . . . . . . -59.78 -61.59 7.04 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 116.156 -0.474 . . . . 0.0 113.646 -178.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 610' ' ' LYS . . . . . 0.418 ' CB ' ' O ' ' A' ' 606' ' ' GLU . 0.2 OUTLIER -58.81 -49.88 76.06 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.756 0.312 . . . . 0.0 110.808 -179.665 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 107.83 56.73 0.59 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.645 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 8.1 mtpt -93.34 39.09 1.05 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.781 0.324 . . . . 0.0 110.918 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 613' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -105.19 -166.71 1.25 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.793 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . 0.431 ' CB ' ' CD ' ' A' ' 615' ' ' PRO . 2.0 mp0 -54.99 -62.95 3.41 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.18 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 615' ' ' PRO . . . . . 0.431 ' CD ' ' CB ' ' A' ' 614' ' ' GLU . 42.3 Cg_endo -67.64 138.27 44.9 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.529 2.153 . . . . 0.0 112.266 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 616' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.96 154.27 40.39 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.924 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo . . . . . 0 C--O 1.249 1.063 0 C-N-CA 122.564 2.176 . . . . 0.0 112.328 -179.991 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.424 0 CA-C-O 120.719 0.295 . . . . 0.0 111.153 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 455' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.78 -175.49 1.18 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.541 2.161 . . . . 0.0 112.371 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 456' ' ' ARG . . . . . . . . . . . . . 3.8 mmt85 -59.94 -26.51 66.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.968 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 72.5 p -101.75 35.57 2.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.867 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -83.29 135.69 34.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.132 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -75.71 164.04 63.17 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.879 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -52.3 164.25 1.36 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.507 2.138 . . . . 0.0 112.296 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . 117.65 56.57 0.29 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.455 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 21.2 m-20 -88.16 163.18 38.11 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.753 0.311 . . . . 0.0 110.902 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -69.8 -175.84 1.3 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.546 2.164 . . . . 0.0 112.281 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -85.67 163.91 17.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.933 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 4.0 m -115.91 22.27 13.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.163 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -57.35 -29.59 64.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.031 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.67 175.42 5.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.898 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 3.1 p -81.56 43.85 0.77 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.896 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 129.1 -37.1 2.27 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.809 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 470' ' ' PHE . . . . . 0.433 ' N ' ' CD1' ' A' ' 470' ' ' PHE . 2.6 p90 -138.27 117.68 12.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.806 0.336 . . . . 0.0 110.856 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 471' ' ' VAL . . . . . . . . . . . . . 11.9 p -113.14 107.55 23.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.155 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 176.27 108.92 0.11 Allowed Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.921 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -68.0 166.97 22.96 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.339 2.026 . . . . 0.0 112.216 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -81.48 -67.55 0.77 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.92 0.391 . . . . 0.0 110.9 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -138.28 -48.29 0.53 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.634 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 476' ' ' GLY . . . . . . . . . . . . . . . 87.91 -41.85 3.09 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.797 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 477' ' ' ASN . . . . . 0.417 ' N ' ' CD ' ' A' ' 478' ' ' PRO . 2.9 t30 -50.32 -51.51 62.87 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-O 120.621 0.248 . . . . 0.0 111.391 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 478' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' A' ' 477' ' ' ASN . 96.8 Cg_endo -85.26 34.37 0.49 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.836 2.357 . . . . 0.0 113.116 -179.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -85.04 84.28 7.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.804 0.335 . . . . 0.0 110.905 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -140.66 137.91 17.93 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.806 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 481' ' ' PRO . . . . . 0.445 ' HB2' ' H ' ' A' ' 482' ' ' GLN . 82.6 Cg_exo -47.83 -79.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.432 2.088 . . . . 0.0 112.422 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 482' ' ' GLN . . . . . 0.445 ' H ' ' HB2' ' A' ' 481' ' ' PRO . 2.0 tt0 -136.48 -68.91 0.48 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.349 0.595 . . . . 0.0 109.629 179.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 483' ' ' THR . . . . . . . . . . . . . 47.5 p -136.9 171.67 14.16 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.058 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 484' ' ' ASN . . . . . 0.514 ' O ' ' CD ' ' A' ' 489' ' ' PRO . 14.9 m120 -94.33 1.56 55.89 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.455 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 485' ' ' PHE . . . . . 0.68 ' HA ' ' HG2' ' A' ' 489' ' ' PRO . 3.3 m-85 -49.71 -47.01 50.76 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.549 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -70.47 -47.43 60.64 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -177.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -70.81 -74.53 0.14 Allowed 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 -176.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 488' ' ' MET . . . . . 0.521 ' CB ' ' HD3' ' A' ' 489' ' ' PRO . 0.0 OUTLIER -52.84 -52.95 59.97 Favored Pre-proline 0 N--CA 1.469 0.519 0 CA-C-O 121.12 0.486 . . . . 0.0 111.431 -178.653 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 489' ' ' PRO . . . . . 0.68 ' HG2' ' HA ' ' A' ' 485' ' ' PHE . 3.1 Cg_exo -79.9 43.33 1.49 Allowed 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 124.54 3.493 . . . . 0.0 112.132 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -37.2 -66.18 0.25 Allowed 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -178.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 491' ' ' ALA . . . . . . . . . . . . . . . -117.72 135.37 54.08 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 119.968 -0.693 . . . . 0.0 112.34 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 492' ' ' ARG . . . . . 0.533 ' HA ' ' O ' ' A' ' 585' ' ' LEU . 0.0 OUTLIER -135.81 136.97 41.1 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.085 178.944 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 493' ' ' VAL . . . . . 0.469 HG21 ' CA ' ' A' ' 513' ' ' GLY . 89.4 t -133.13 163.57 37.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.354 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 494' ' ' THR . . . . . 0.454 ' N ' ' CG1' ' A' ' 493' ' ' VAL . 91.8 m -114.68 135.9 53.64 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.441 0.638 . . . . 0.0 111.74 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 495' ' ' LEU . . . . . 0.51 ' O ' HG23 ' A' ' 588' ' ' ILE . 0.2 OUTLIER -134.27 164.66 42.37 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.086 179.869 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 496' ' ' PRO . . . . . 0.428 ' HD2' HD11 ' A' ' 495' ' ' LEU . 23.2 Cg_exo -63.68 119.56 6.66 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 121.982 1.788 . . . . 0.0 111.721 179.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 497' ' ' LYS . . . . . 0.604 ' HA ' ' CG2' ' A' ' 588' ' ' ILE . 0.2 OUTLIER -53.07 -30.0 33.51 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -178.961 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 498' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -57.56 -48.66 78.75 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -177.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 499' ' ' LEU . . . . . 0.452 ' CD1' ' CD1' ' A' ' 495' ' ' LEU . 2.3 pp -74.37 -9.07 58.23 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -178.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . 0.443 ' HA ' ' CE ' ' A' ' 507' ' ' LYS . 2.9 p -75.61 -26.43 18.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.352 0.596 . . . . 0.0 111.717 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 501' ' ' TYR . . . . . 0.584 ' O ' ' CG2' ' A' ' 564' ' ' THR . 0.3 OUTLIER -53.88 -29.69 42.7 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -178.71 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 502' ' ' ASP . . . . . 0.444 ' N ' ' CD1' ' A' ' 501' ' ' TYR . 0.4 OUTLIER -75.82 -49.92 16.63 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 -175.561 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 503' ' ' LYS . . . . . 0.631 ' O ' ' CG ' ' A' ' 507' ' ' LYS . 4.8 mttt -119.31 133.8 55.54 Favored 'General case' 0 CA--C 1.522 -0.113 0 CA-C-N 118.985 0.811 . . . . 0.0 112.094 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 504' ' ' THR . . . . . 0.418 ' OG1' ' N ' ' A' ' 564' ' ' THR . 2.0 m -73.56 -75.12 0.16 Allowed 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.635 -0.711 . . . . 0.0 112.918 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . 0.556 ' CE1' HD11 ' A' ' 556' ' ' ILE . 7.3 m-85 -74.37 -62.9 1.36 Allowed 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -178.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 506' ' ' SER . . . . . 0.772 ' O ' ' CD1' ' A' ' 510' ' ' TRP . 7.6 t -49.28 -72.59 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -175.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 507' ' ' LYS . . . . . 0.685 ' HD3' ' N ' ' A' ' 508' ' ' VAL . 0.0 OUTLIER -48.99 -48.52 43.39 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -176.37 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 508' ' ' VAL . . . . . 0.685 ' N ' ' HD3' ' A' ' 507' ' ' LYS . 89.1 t -52.89 -59.03 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -179.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 509' ' ' LEU . . . . . 0.55 ' CD1' ' N ' ' A' ' 510' ' ' TRP . 3.0 pp -60.42 -61.84 2.3 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 -176.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 510' ' ' TRP . . . . . 0.772 ' CD1' ' O ' ' A' ' 506' ' ' SER . 65.1 p-90 -72.2 -49.74 33.06 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -176.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 511' ' ' SER . . . . . 0.497 ' N ' ' CE3' ' A' ' 510' ' ' TRP . 0.5 OUTLIER -64.95 -47.39 77.81 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.164 -0.926 . . . . 0.0 112.898 -177.089 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 512' ' ' ALA . . . . . 0.501 ' HB1' HD21 ' A' ' 495' ' ' LEU . . . -71.19 -73.97 0.16 Allowed 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 117.398 2.37 . . . . 0.0 117.398 -174.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 513' ' ' GLY . . . . . 0.469 ' CA ' HG21 ' A' ' 493' ' ' VAL . . . -115.95 -36.11 1.18 Allowed Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 121.73 3.452 . . . . 0.0 121.73 -172.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 514' ' ' LEU . . . . . 0.627 HD23 ' HG2' ' A' ' 584' ' ' LYS . 0.5 OUTLIER -108.96 -39.11 5.4 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 120.431 3.493 . . . . 0.0 120.431 -169.646 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 515' ' ' VAL . . . . . 0.567 ' CG1' ' HB2' ' A' ' 517' ' ' SER . 13.7 p -153.18 172.12 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 118.053 2.612 . . . . 0.0 118.053 -171.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 516' ' ' ALA . . . . . 0.523 ' H ' ' CG2' ' A' ' 515' ' ' VAL . . . -69.07 2.64 2.59 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 112.559 -2.11 . . . . 0.0 110.753 177.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 517' ' ' SER . . . . . 0.806 ' O ' ' N ' ' A' ' 521' ' ' GLY . 0.5 OUTLIER -57.68 8.5 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 -172.221 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 518' ' ' LYS . . . . . 0.747 ' HA ' ' CD1' ' A' ' 510' ' ' TRP . 0.0 OUTLIER -46.66 -51.78 15.17 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 104.369 -2.456 . . . . 0.0 104.369 174.989 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 519' ' ' SER . . . . . . . . . . . . . 3.5 m -75.35 -57.45 3.89 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.146 173.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 520' ' ' GLU . . . . . 0.637 ' CB ' ' HA ' ' A' ' 517' ' ' SER . 0.0 OUTLIER -55.91 -47.85 76.73 Favored 'General case' 0 C--N 1.349 0.578 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.71 -179.042 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 521' ' ' GLY . . . . . 0.806 ' N ' ' O ' ' A' ' 517' ' ' SER . . . -49.55 -55.37 13.74 Favored Glycine 0 CA--C 1.491 -1.42 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.543 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -47.73 -47.45 30.19 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 523' ' ' ARG . . . . . . . . . . . . . 1.6 ttt85 -50.49 -49.03 56.55 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.0 178.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 524' ' ' ILE . . . . . 0.431 ' O ' ' ND2' ' A' ' 527' ' ' ASN . 12.7 mt -59.36 -55.26 24.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.237 0.542 . . . . 0.0 110.253 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 525' ' ' ILE . . . . . 0.555 HG12 ' O ' ' A' ' 521' ' ' GLY . 0.9 OUTLIER -50.26 -47.49 25.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 177.864 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 526' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -56.1 -48.58 75.87 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 114.112 -1.404 . . . . 0.0 108.276 177.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 527' ' ' ASN . . . . . 0.431 ' ND2' ' O ' ' A' ' 524' ' ' ILE . 0.0 OUTLIER -48.62 -39.76 25.2 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 113.754 -1.566 . . . . 0.0 107.778 176.639 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 528' ' ' ASN . . . . . 0.576 ' C ' HG22 ' A' ' 556' ' ' ILE . 12.6 t-20 74.07 40.3 0.46 Allowed 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.227 -179.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 529' ' ' GLY . . . . . . . . . . . . . . . -115.98 36.36 3.87 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 114.619 -1.173 . . . . 0.0 111.569 178.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 530' ' ' ALA . . . . . 0.751 ' O ' ' HB ' ' A' ' 556' ' ' ILE . . . -132.8 164.96 25.68 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.656 0.741 . . . . 0.0 112.363 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 531' ' ' TYR . . . . . 0.598 ' HE1' ' CD1' ' A' ' 553' ' ' PHE . 3.2 t80 -134.52 149.55 50.68 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 124.634 1.174 . . . . 0.0 108.871 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 532' ' ' VAL . . . . . 0.625 ' HB ' ' HB ' ' A' ' 554' ' ' THR . 1.1 t -129.96 136.1 59.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 CA-C-N 119.485 1.039 . . . . 0.0 112.216 179.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 533' ' ' GLY . . . . . 0.734 ' O ' HG13 ' A' ' 575' ' ' ILE . . . -133.11 147.4 18.97 Favored Glycine 0 N--CA 1.441 -1.022 0 CA-C-N 114.0 -1.454 . . . . 0.0 112.961 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 534' ' ' SER . . . . . 0.603 ' HB2' ' OG1' ' A' ' 552' ' ' THR . 38.5 m -134.79 143.53 47.13 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.584 -0.308 . . . . 0.0 111.072 178.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 535' ' ' ARG . . . . . 0.588 ' HA ' ' O ' ' A' ' 550' ' ' ASP . 3.0 tpp180 -159.03 89.08 2.1 Favored Pre-proline 0 C--N 1.33 -0.251 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 178.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 536' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -102.53 77.1 0.03 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 124.118 3.212 . . . . 0.0 112.164 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 115.79 111.59 2.77 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.124 -1.036 . . . . 0.0 112.698 -179.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 538' ' ' VAL . . . . . . . . . . . . . 6.4 p -43.4 -24.65 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 539' ' ' LYS . . . . . . . . . . . . . 3.9 pttt -46.39 147.35 1.17 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.301 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -127.68 30.7 5.27 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.589 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 541' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -71.91 99.18 2.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.199 0.523 . . . . 0.0 110.171 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 542' ' ' GLU . . . . . 0.606 ' O ' ' N ' ' A' ' 544' ' ' GLY . 34.5 mm-40 -110.74 96.9 30.76 Favored Pre-proline 0 C--N 1.321 -0.674 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.571 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 543' ' ' PRO . . . . . 0.652 ' O ' ' N ' ' A' ' 545' ' ' GLY . 68.0 Cg_exo -51.57 55.22 0.02 OUTLIER 'Trans proline' 0 N--CA 1.481 0.79 0 C-N-CA 124.12 3.213 . . . . 0.0 114.225 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . 0.649 ' C ' ' H ' ' A' ' 546' ' ' GLY . . . 53.58 -53.13 0.01 OUTLIER Glycine 0 CA--C 1.527 0.794 0 CA-C-O 119.504 -0.609 . . . . 0.0 114.414 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 545' ' ' GLY . . . . . 0.652 ' N ' ' O ' ' A' ' 543' ' ' PRO . . . -53.41 21.33 0.01 OUTLIER Glycine 0 CA--C 1.533 1.211 0 CA-C-N 117.959 0.88 . . . . 0.0 114.725 178.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . 0.649 ' H ' ' C ' ' A' ' 544' ' ' GLY . . . 53.11 -54.61 0.01 OUTLIER Glycine 0 CA--C 1.525 0.676 0 CA-C-O 119.089 -0.84 . . . . 0.0 114.253 -178.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 547' ' ' MET . . . . . 0.612 ' N ' ' O ' ' A' ' 545' ' ' GLY . 33.3 mmt 14.52 56.43 0.08 OUTLIER Pre-proline 0 N--CA 1.473 0.712 0 CA-C-N 118.019 0.91 . . . . 0.0 112.606 178.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 548' ' ' PRO . . . . . 0.577 ' HD3' ' C ' ' A' ' 546' ' ' GLY . 81.8 Cg_exo -46.28 119.5 3.1 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 121.66 1.573 . . . . 0.0 113.178 -177.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -126.08 -37.1 2.28 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.282 178.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 550' ' ' ASP . . . . . 0.588 ' O ' ' HA ' ' A' ' 535' ' ' ARG . 1.8 m-20 -70.82 -41.09 72.02 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.953 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 551' ' ' LEU . . . . . 0.418 HD12 ' CE1' ' A' ' 553' ' ' PHE . 7.2 tp -131.26 140.28 49.79 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.416 178.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 552' ' ' THR . . . . . 0.649 ' O ' ' HA2' ' A' ' 533' ' ' GLY . 6.2 m -133.32 147.34 51.86 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.573 0.701 . . . . 0.0 111.987 179.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 553' ' ' PHE . . . . . 0.598 ' CD1' ' HE1' ' A' ' 531' ' ' TYR . 17.6 m-30 -132.86 136.22 46.09 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 177.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 554' ' ' THR . . . . . 0.625 ' HB ' ' HB ' ' A' ' 532' ' ' VAL . 19.2 m -135.04 139.68 32.71 Favored Pre-proline 0 C--N 1.314 -0.975 0 C-N-CA 118.851 -1.14 . . . . 0.0 113.245 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 555' ' ' PRO . . . . . 0.615 ' HD2' ' CZ2' ' A' ' 559' ' ' TRP . 5.8 Cg_exo -77.58 11.99 2.02 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.78 2.32 . . . . 0.0 112.789 179.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 556' ' ' ILE . . . . . 0.751 ' HB ' ' O ' ' A' ' 530' ' ' ALA . 4.9 tp 62.37 34.42 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.335 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 177.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . 0.704 ' O ' ' CE2' ' A' ' 559' ' ' TRP . 33.3 mttt -103.37 133.23 48.77 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 558' ' ' THR . . . . . . . . . . . . . 3.4 t -58.05 116.5 3.56 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -172.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 559' ' ' TRP . . . . . 0.704 ' CE2' ' O ' ' A' ' 557' ' ' LYS . 0.0 OUTLIER -139.87 112.4 7.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 113.142 -1.844 . . . . 0.0 106.28 175.1 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 560' ' ' ASN . . . . . 0.561 ' O ' ' CG2' ' A' ' 564' ' ' THR . 86.0 m-20 -77.82 -75.96 0.2 Allowed 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 118.659 -1.216 . . . . 0.0 113.351 -176.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 561' ' ' ALA . . . . . 0.638 ' O ' HG22 ' A' ' 564' ' ' THR . . . -75.14 -53.12 9.39 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 115.951 1.834 . . . . 0.0 115.951 -178.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 562' ' ' SER . . . . . . . . . . . . . 69.4 m -49.23 -54.95 14.23 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -176.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 563' ' ' LYS . . . . . 0.554 ' HG2' ' CD1' ' A' ' 559' ' ' TRP . 0.2 OUTLIER -70.65 -47.91 57.61 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -178.188 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 564' ' ' THR . . . . . 0.638 HG22 ' O ' ' A' ' 561' ' ' ALA . 7.9 t -49.79 -68.02 0.21 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.847 0.356 . . . . 0.0 111.276 -179.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 565' ' ' GLN . . . . . 0.57 ' H ' ' CG2' ' A' ' 564' ' ' THR . 2.4 tp60 -49.88 -47.0 52.16 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -49.42 -61.72 1.94 Allowed 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.861 -178.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 567' ' ' PHE . . . . . 0.56 ' C ' ' H ' ' A' ' 569' ' ' ILE . 0.0 OUTLIER -97.15 -54.32 3.21 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.68 0.752 . . . . 0.0 111.875 -178.95 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 568' ' ' ILE . . . . . 0.6 ' CG2' ' O ' ' A' ' 568' ' ' ILE . 1.7 mp -56.18 9.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 114.487 -1.233 . . . . 0.0 113.72 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 569' ' ' ILE . . . . . 0.56 ' H ' ' C ' ' A' ' 567' ' ' PHE . 0.9 OUTLIER -54.56 -36.47 35.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 104.292 -2.484 . . . . 0.0 104.292 177.354 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 570' ' ' ASP . . . . . 0.485 ' CB ' ' O ' ' A' ' 573' ' ' LEU . 7.7 p30 34.1 57.8 0.62 Allowed 'General case' 0 CA--C 1.502 -0.903 0 CA-C-N 113.716 -1.584 . . . . 0.0 112.04 174.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 571' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 570' ' ' ASP . . . -51.02 -45.22 51.11 Favored Glycine 0 N--CA 1.438 -1.172 0 C-N-CA 117.469 -2.301 . . . . 0.0 107.982 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 572' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -120.3 -16.74 8.4 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 175.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 573' ' ' LEU . . . . . 0.485 ' O ' ' CB ' ' A' ' 570' ' ' ASP . 2.2 tp -140.55 136.34 32.75 Favored 'General case' 0 C--N 1.355 0.823 0 N-CA-C 115.912 1.819 . . . . 0.0 115.912 -177.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 574' ' ' LEU . . . . . 0.444 HD21 ' CG1' ' A' ' 508' ' ' VAL . 0.5 OUTLIER -135.94 132.73 36.81 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 173.422 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 575' ' ' ILE . . . . . 0.734 HG13 ' O ' ' A' ' 533' ' ' GLY . 0.0 OUTLIER -134.3 139.98 46.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 118.858 0.754 . . . . 0.0 111.928 178.53 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 576' ' ' LEU . . . . . 0.478 ' CD2' ' HB3' ' A' ' 509' ' ' LEU . 0.0 OUTLIER -133.01 136.62 46.12 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 114.944 -1.025 . . . . 0.0 108.767 177.945 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 577' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.02 135.44 51.79 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 177.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.429 ' HB2' ' O ' ' A' ' 582' ' ' LYS . 0.5 OUTLIER -126.94 132.02 50.95 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 177.973 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 579' ' ' GLY . . . . . . . . . . . . . . . -90.45 -2.26 73.53 Favored Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 115.092 -0.958 . . . . 0.0 113.493 -178.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 580' ' ' LYS . . . . . 0.473 ' O ' ' CD1' ' A' ' 581' ' ' TRP . 0.0 OUTLIER -70.84 -48.38 54.3 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 118.738 -1.185 . . . . 0.0 108.564 179.083 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 581' ' ' TRP . . . . . 0.473 ' CD1' ' O ' ' A' ' 580' ' ' LYS . 27.1 m0 -139.81 -53.37 0.53 Allowed 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 177.09 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 582' ' ' LYS . . . . . 0.429 ' O ' ' HB2' ' A' ' 578' ' ' LEU . 0.0 OUTLIER -140.5 165.44 27.43 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 -175.19 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 583' ' ' MET . . . . . 0.414 ' HB3' ' O ' ' A' ' 488' ' ' MET . 1.7 ttt -109.04 135.0 50.93 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 173.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 584' ' ' LYS . . . . . 0.627 ' HG2' HD23 ' A' ' 514' ' ' LEU . 10.9 tppt? -120.34 133.38 55.46 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 178.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 585' ' ' LEU . . . . . 0.533 ' O ' ' HA ' ' A' ' 492' ' ' ARG . 0.9 OUTLIER -116.03 136.12 53.32 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.839 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 586' ' ' VAL . . . . . 0.435 ' O ' ' O ' ' A' ' 574' ' ' LEU . 85.8 t -132.94 137.49 53.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-O 121.053 0.454 . . . . 0.0 111.721 -178.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 587' ' ' SER . . . . . 0.416 ' N ' HG12 ' A' ' 586' ' ' VAL . 58.8 m -106.63 135.79 47.53 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 177.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . 0.604 ' CG2' ' HA ' ' A' ' 497' ' ' LYS . 0.0 OUTLIER -133.41 136.75 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -177.581 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 589' ' ' VAL . . . . . 0.472 ' N ' ' HB2' ' A' ' 497' ' ' LYS . 5.6 m -132.6 137.14 54.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.635 178.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 590' ' ' SER . . . . . . . . . . . . . 10.7 t -68.02 162.19 25.03 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.984 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 591' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -50.76 -48.87 59.12 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.879 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.1 -55.19 35.42 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -178.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 9.9 mttt -51.56 -55.16 20.72 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.45 0.643 . . . . 0.0 110.807 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 594' ' ' PHE . . . . . 0.517 ' O ' ' HG ' ' A' ' 597' ' ' LEU . 13.2 t80 -50.31 -47.39 55.67 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.583 179.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 595' ' ' LYS . . . . . 0.48 ' HG2' ' CE3' ' A' ' 604' ' ' TRP . 0.6 OUTLIER -49.47 -48.15 47.93 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.315 179.422 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 596' ' ' GLU . . . . . 0.404 ' O ' ' CD2' ' A' ' 599' ' ' LEU . 3.8 tt0 -58.82 -62.92 1.51 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.572 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 597' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 594' ' ' PHE . 2.8 pp -48.77 -50.97 31.6 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.183 0.516 . . . . 0.0 112.12 -178.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 598' ' ' GLY . . . . . 0.855 ' O ' ' CD1' ' A' ' 604' ' ' TRP . . . -93.79 11.16 71.55 Favored Glycine 0 N--CA 1.446 -0.7 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.699 -179.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 599' ' ' LEU . . . . . 0.444 ' N ' ' O ' ' A' ' 595' ' ' LYS . 4.0 pp -50.02 -5.32 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -177.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 600' ' ' THR . . . . . 0.446 ' H ' ' C ' ' A' ' 598' ' ' GLY . 31.5 m -129.8 67.38 1.46 Allowed 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 121.699 0.761 . . . . 0.0 110.964 178.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 601' ' ' ALA . . . . . 0.582 ' CB ' ' HD2' ' A' ' 602' ' ' PRO . . . -131.53 -173.51 0.34 Allowed Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 114.463 -1.244 . . . . 0.0 109.494 179.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 602' ' ' PRO . . . . . 0.582 ' HD2' ' CB ' ' A' ' 601' ' ' ALA . 49.2 Cg_endo -70.29 -33.82 13.91 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 121.609 1.539 . . . . 0.0 112.64 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 603' ' ' GLY . . . . . . . . . . . . . . . -71.47 -49.13 26.56 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.911 -0.662 . . . . 0.0 113.295 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 604' ' ' TRP . . . . . 0.855 ' CD1' ' O ' ' A' ' 598' ' ' GLY . 1.5 m95 -71.36 -46.57 60.13 Favored 'General case' 0 CA--C 1.512 -0.503 0 C-N-CA 122.833 0.453 . . . . 0.0 111.47 -178.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 605' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -50.02 -57.31 7.84 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.315 -179.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 606' ' ' GLU . . . . . 0.424 ' O ' ' HB2' ' A' ' 610' ' ' LYS . 1.2 tt0 -61.1 -62.58 1.75 Allowed 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 607' ' ' VAL . . . . . . . . . . . . . 54.6 t -56.65 -72.55 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 114.53 1.307 . . . . 0.0 114.53 -178.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 608' ' ' VAL . . . . . . . . . . . . . 53.0 t -64.91 -54.13 33.39 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -177.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 609' ' ' GLY . . . . . . . . . . . . . . . -61.94 -63.95 4.35 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 121.196 -0.526 . . . . 0.0 113.656 -178.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 610' ' ' LYS . . . . . 0.424 ' HB2' ' O ' ' A' ' 606' ' ' GLU . 1.7 mtpm? -67.57 -50.75 56.94 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.695 0.283 . . . . 0.0 111.151 -179.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 81.32 56.52 2.99 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.508 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 36.2 tttt -56.53 -28.58 60.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.737 0.303 . . . . 0.0 111.008 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 613' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -59.92 -174.79 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.879 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -72.75 -60.87 1.8 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.964 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 615' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.98 95.5 0.74 Allowed 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.541 2.161 . . . . 0.0 112.266 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 616' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -79.98 113.59 39.49 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.913 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo . . . . . 0 C--O 1.249 1.055 0 C-N-CA 122.39 2.06 . . . . 0.0 112.311 -179.984 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 81.6 mmm . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.756 0.313 . . . . 0.0 111.236 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 455' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.75 157.4 60.52 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.556 2.171 . . . . 0.0 112.308 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 456' ' ' ARG . . . . . . . . . . . . . 7.7 ptt85 -72.18 -25.69 61.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.047 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 40.8 p -95.84 39.54 1.13 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.964 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -103.31 150.32 23.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.087 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.03 148.51 34.58 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.911 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -52.66 -178.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.558 2.172 . . . . 0.0 112.32 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . 94.07 56.62 1.37 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.492 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -82.64 143.26 46.89 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.613 0.244 . . . . 0.0 110.812 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.93 176.66 8.04 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.466 2.111 . . . . 0.0 112.303 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.43 168.01 11.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.893 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 2.7 m -99.76 -56.54 2.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.897 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.01 -40.16 92.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.919 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -118.22 175.21 5.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.889 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 83.9 p -88.88 43.55 1.15 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.798 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 128.91 -37.1 2.28 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.885 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -131.74 117.74 19.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.784 0.326 . . . . 0.0 110.784 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 471' ' ' VAL . . . . . . . . . . . . . 10.7 p -113.03 108.27 25.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.21 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 34.1 p-10 -177.49 146.13 0.61 Allowed Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.906 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -73.48 95.77 0.88 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.611 2.207 . . . . 0.0 112.333 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -136.04 34.13 2.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.914 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 1.9 t -137.99 35.75 2.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.868 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 476' ' ' GLY . . . . . . . . . . . . . . . 132.87 60.35 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.488 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 477' ' ' ASN . . . . . 0.414 ' N ' ' CD ' ' A' ' 478' ' ' PRO . 4.6 t30 -50.27 -51.58 61.93 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 120.577 0.227 . . . . 0.0 111.246 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 478' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 477' ' ' ASN . 90.2 Cg_endo -81.67 -39.78 0.17 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.519 2.146 . . . . 0.0 112.543 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 25.7 m-70 -90.66 119.51 30.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.112 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 480' ' ' ALA . . . . . 0.419 ' CB ' ' CG2' ' A' ' 483' ' ' THR . . . -75.73 120.28 80.92 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.003 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -60.54 -78.39 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.328 2.018 . . . . 0.0 112.464 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 482' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.7 26.18 3.38 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.601 0.238 . . . . 0.0 111.065 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 483' ' ' THR . . . . . 0.419 ' CG2' ' CB ' ' A' ' 480' ' ' ALA . 1.9 t -70.85 66.63 0.37 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.952 0.405 . . . . 0.0 110.971 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 484' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -130.31 -69.48 0.66 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.619 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 485' ' ' PHE . . . . . 0.406 ' O ' ' CG ' ' A' ' 488' ' ' MET . 26.7 m-85 -70.84 -49.37 46.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.861 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -69.03 -47.79 64.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.919 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 487' ' ' ASN . . . . . 0.601 ' HB3' ' HD3' ' A' ' 489' ' ' PRO . 0.3 OUTLIER -66.78 -48.67 68.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.481 -179.829 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 488' ' ' MET . . . . . 0.52 ' N ' ' HD3' ' A' ' 489' ' ' PRO . 0.0 OUTLIER 52.12 51.63 10.04 Favored Pre-proline 0 N--CA 1.466 0.328 0 CA-C-O 120.669 0.271 . . . . 0.0 110.797 -179.669 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 489' ' ' PRO . . . . . 0.601 ' HD3' ' HB3' ' A' ' 487' ' ' ASN . 61.7 Cg_endo -88.59 22.76 0.82 Allowed 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.644 2.23 . . . . 0.0 114.226 -178.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.56 -69.62 0.76 Allowed 'General case' 0 N--CA 1.461 0.121 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.94 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 491' ' ' ALA . . . . . 0.426 ' HB1' HD21 ' A' ' 514' ' ' LEU . . . -135.92 135.04 39.32 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.131 177.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 492' ' ' ARG . . . . . 0.4 ' CD ' ' CD2' ' A' ' 585' ' ' LEU . 2.7 mmm180 -137.8 132.67 33.0 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.535 176.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 493' ' ' VAL . . . . . 0.616 ' CG2' ' HA3' ' A' ' 513' ' ' GLY . 16.9 m -138.25 163.78 28.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 178.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 79.6 p -116.94 132.56 56.67 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 176.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 495' ' ' LEU . . . . . 0.55 ' O ' ' CG2' ' A' ' 588' ' ' ILE . 0.0 OUTLIER -137.1 164.5 41.68 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.23 -179.556 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 496' ' ' PRO . . . . . 0.444 ' HD2' ' CD1' ' A' ' 495' ' ' LEU . 2.8 Cg_exo -76.94 119.95 5.28 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.045 2.497 . . . . 0.0 110.947 178.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 497' ' ' LYS . . . . . 0.687 ' N ' HG21 ' A' ' 588' ' ' ILE . 15.6 tttm -53.24 -29.78 34.5 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -177.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 498' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.9 -49.12 78.73 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -177.086 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 499' ' ' LEU . . . . . 0.427 ' CD1' HD11 ' A' ' 495' ' ' LEU . 2.0 pp -74.38 -8.82 57.55 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -178.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . 0.474 HG22 HG13 ' A' ' 568' ' ' ILE . 0.9 OUTLIER -74.98 -25.66 18.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.455 0.645 . . . . 0.0 111.678 -179.029 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 501' ' ' TYR . . . . . 0.654 ' O ' HG23 ' A' ' 564' ' ' THR . 0.3 OUTLIER -57.26 -29.48 63.86 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 114.981 1.475 . . . . 0.0 114.981 -178.288 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -75.99 -50.16 15.63 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 116.306 1.965 . . . . 0.0 116.306 -174.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 503' ' ' LYS . . . . . 0.576 ' O ' ' CG ' ' A' ' 507' ' ' LYS . 3.3 mttm -119.1 137.88 53.27 Favored 'General case' 0 N--CA 1.46 0.066 0 CA-C-N 119.27 0.941 . . . . 0.0 112.204 -178.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 504' ' ' THR . . . . . 0.499 ' OG1' ' N ' ' A' ' 564' ' ' THR . 24.8 m -73.52 -76.99 0.11 Allowed 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . 0.543 ' CZ ' HD12 ' A' ' 556' ' ' ILE . 0.2 OUTLIER -75.7 -61.12 2.03 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -179.164 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 506' ' ' SER . . . . . 0.668 ' O ' ' CD1' ' A' ' 510' ' ' TRP . 62.2 m -48.98 -72.75 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -175.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 507' ' ' LYS . . . . . 0.689 ' HD3' ' N ' ' A' ' 508' ' ' VAL . 0.0 OUTLIER -49.2 -48.22 45.51 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -176.673 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 508' ' ' VAL . . . . . 0.689 ' N ' ' HD3' ' A' ' 507' ' ' LYS . 69.8 t -52.46 -59.2 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 509' ' ' LEU . . . . . 0.59 ' HG ' ' H ' ' A' ' 510' ' ' TRP . 1.9 pp -60.18 -60.89 3.1 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 -177.052 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 510' ' ' TRP . . . . . 0.668 ' CD1' ' O ' ' A' ' 506' ' ' SER . 51.4 p-90 -72.26 -51.75 19.48 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -176.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 511' ' ' SER . . . . . 0.541 ' N ' ' CD2' ' A' ' 510' ' ' TRP . 0.4 OUTLIER -63.98 -47.99 78.18 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.884 -177.238 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 512' ' ' ALA . . . . . . . . . . . . . . . -71.46 -73.66 0.17 Allowed 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 117.073 2.249 . . . . 0.0 117.073 -174.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 513' ' ' GLY . . . . . 0.616 ' HA3' ' CG2' ' A' ' 493' ' ' VAL . . . -115.84 -35.77 1.22 Allowed Glycine 0 CA--C 1.507 -0.468 0 N-CA-C 121.558 3.383 . . . . 0.0 121.558 -173.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 514' ' ' LEU . . . . . 0.612 ' HG ' ' HE2' ' A' ' 584' ' ' LYS . 0.0 OUTLIER -107.69 -45.45 4.02 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 119.898 3.296 . . . . 0.0 119.898 -169.195 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 515' ' ' VAL . . . . . 0.578 HG21 ' H ' ' A' ' 517' ' ' SER . 9.9 p -145.1 172.3 4.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 117.927 2.566 . . . . 0.0 117.927 -171.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 516' ' ' ALA . . . . . 0.482 ' H ' ' CG2' ' A' ' 515' ' ' VAL . . . -89.87 0.53 56.99 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 113.25 -1.796 . . . . 0.0 108.663 178.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 517' ' ' SER . . . . . 0.996 ' O ' ' N ' ' A' ' 521' ' ' GLY . 4.0 p -61.44 10.26 0.02 OUTLIER 'General case' 0 N--CA 1.426 -1.64 0 C-N-CA 126.171 1.788 . . . . 0.0 115.289 -173.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 518' ' ' LYS . . . . . 0.616 ' HB2' ' CE2' ' A' ' 510' ' ' TRP . 0.8 OUTLIER -42.73 -39.75 2.55 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 105.426 -2.064 . . . . 0.0 105.426 178.221 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 519' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.68 -54.25 8.54 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 114.891 -1.049 . . . . 0.0 108.217 172.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 520' ' ' GLU . . . . . 0.664 ' HB3' ' HA ' ' A' ' 517' ' ' SER . 0.2 OUTLIER -67.67 -48.07 67.68 Favored 'General case' 0 C--N 1.35 0.626 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.373 179.845 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 521' ' ' GLY . . . . . 0.996 ' N ' ' O ' ' A' ' 517' ' ' SER . . . -49.6 -52.81 23.35 Favored Glycine 0 CA--C 1.494 -1.248 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 178.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . 0.482 ' HA ' HG12 ' A' ' 525' ' ' ILE . 3.8 mm-40 -48.19 -47.48 35.31 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 523' ' ' ARG . . . . . 0.409 ' O ' ' HB3' ' A' ' 526' ' ' ASN . 0.0 OUTLIER -49.99 -49.16 51.45 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.736 178.855 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 524' ' ' ILE . . . . . 0.457 ' HA ' ' HB3' ' A' ' 527' ' ' ASN . 4.3 mp -59.3 -51.79 68.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.466 0.651 . . . . 0.0 109.412 179.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 525' ' ' ILE . . . . . 0.604 HG12 ' O ' ' A' ' 521' ' ' GLY . 1.2 mm -50.66 -47.42 28.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 177.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 526' ' ' ASN . . . . . 0.409 ' HB3' ' O ' ' A' ' 523' ' ' ARG . 1.0 OUTLIER -58.69 -47.93 82.83 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 114.253 -1.339 . . . . 0.0 108.321 177.51 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 527' ' ' ASN . . . . . 0.457 ' HB3' ' HA ' ' A' ' 524' ' ' ILE . 0.0 OUTLIER -48.09 -39.57 20.68 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 113.994 -1.457 . . . . 0.0 107.477 176.604 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 528' ' ' ASN . . . . . 0.618 ' C ' HG21 ' A' ' 556' ' ' ILE . 13.2 t-20 74.2 40.98 0.41 Allowed 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.867 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 529' ' ' GLY . . . . . . . . . . . . . . . -113.96 29.3 7.83 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-N 115.118 -0.946 . . . . 0.0 112.516 178.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 530' ' ' ALA . . . . . 0.916 ' O ' ' HB ' ' A' ' 556' ' ' ILE . . . -133.53 164.27 27.53 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.216 0.532 . . . . 0.0 112.423 -179.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 531' ' ' TYR . . . . . 0.516 ' CE1' ' CD1' ' A' ' 553' ' ' PHE . 0.0 OUTLIER -134.59 152.53 51.84 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 177.601 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 532' ' ' VAL . . . . . 0.554 ' HB ' ' HB ' ' A' ' 554' ' ' THR . 0.5 OUTLIER -129.2 135.8 61.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 CA-C-O 122.003 0.906 . . . . 0.0 112.121 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 533' ' ' GLY . . . . . 0.627 ' O ' HG13 ' A' ' 575' ' ' ILE . . . -133.74 161.71 24.33 Favored Glycine 0 N--CA 1.441 -1.016 0 CA-C-N 114.32 -1.309 . . . . 0.0 114.48 -179.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 534' ' ' SER . . . . . 0.51 ' OG ' ' O ' ' A' ' 567' ' ' PHE . 5.3 t -134.05 141.89 47.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.834 -0.683 . . . . 0.0 110.626 178.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 535' ' ' ARG . . . . . 0.556 ' HA ' ' O ' ' A' ' 550' ' ' ASP . 0.0 OUTLIER -159.55 90.74 1.89 Allowed Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 178.829 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 536' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.71 -35.48 2.64 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.655 2.236 . . . . 0.0 112.413 178.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 115.47 22.19 4.87 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.666 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 538' ' ' VAL . . . . . . . . . . . . . 16.0 t -116.28 18.55 7.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.719 0.295 . . . . 0.0 111.237 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 539' ' ' LYS . . . . . 0.539 ' CG ' ' O ' ' A' ' 539' ' ' LYS . 1.0 OUTLIER -46.81 97.9 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.677 0.751 . . . . 0.0 111.896 -179.114 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.29 17.04 6.59 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.566 179.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 541' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 -96.51 99.92 11.54 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 121.092 0.472 . . . . 0.0 111.062 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 542' ' ' GLU . . . . . 0.42 ' CB ' ' HD2' ' A' ' 543' ' ' PRO . 0.7 OUTLIER -49.11 177.22 0.04 OUTLIER Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.863 179.509 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 543' ' ' PRO . . . . . 0.42 ' HD2' ' CB ' ' A' ' 542' ' ' GLU . 59.8 Cg_exo -39.31 -41.1 2.07 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.744 2.296 . . . . 0.0 112.972 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . 0.606 ' O ' ' N ' ' A' ' 546' ' ' GLY . . . -50.58 -22.3 5.43 Favored Glycine 0 CA--C 1.521 0.424 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.747 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 545' ' ' GLY . . . . . 0.542 ' C ' ' HD3' ' A' ' 548' ' ' PRO . . . 52.93 -53.21 0.01 OUTLIER Glycine 0 CA--C 1.525 0.71 0 N-CA-C 114.878 0.711 . . . . 0.0 114.878 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . 0.606 ' N ' ' O ' ' A' ' 544' ' ' GLY . . . 51.62 55.07 21.87 Favored Glycine 0 CA--C 1.523 0.572 0 CA-C-N 118.225 1.012 . . . . 0.0 113.538 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 547' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER 53.09 55.73 13.94 Favored Pre-proline 0 N--CA 1.466 0.347 0 CA-C-N 117.264 0.532 . . . . 0.0 110.916 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 548' ' ' PRO . . . . . 0.542 ' HD3' ' C ' ' A' ' 545' ' ' GLY . 53.8 Cg_endo -70.5 166.77 27.42 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.05 2.5 . . . . 0.0 113.089 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -123.98 -15.39 6.88 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.786 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 550' ' ' ASP . . . . . 0.556 ' O ' ' HA ' ' A' ' 535' ' ' ARG . 3.9 p30 -50.89 -36.47 38.22 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.722 0.773 . . . . 0.0 108.995 178.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 551' ' ' LEU . . . . . . . . . . . . . 13.6 tp -131.39 139.22 49.41 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.524 -1.216 . . . . 0.0 107.881 177.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 552' ' ' THR . . . . . 0.584 ' O ' ' HA2' ' A' ' 533' ' ' GLY . 6.9 m -133.76 148.07 51.35 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.683 0.754 . . . . 0.0 111.842 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 553' ' ' PHE . . . . . 0.516 ' CD1' ' CE1' ' A' ' 531' ' ' TYR . 9.9 m-85 -134.09 137.91 44.93 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.788 -1.097 . . . . 0.0 108.402 177.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 554' ' ' THR . . . . . 0.554 ' HB ' ' HB ' ' A' ' 532' ' ' VAL . 2.0 m -132.23 138.57 32.57 Favored Pre-proline 0 C--N 1.307 -1.278 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 178.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 555' ' ' PRO . . . . . 0.664 ' O ' HG23 ' A' ' 556' ' ' ILE . 67.6 Cg_endo -84.54 19.21 1.42 Allowed 'Trans proline' 0 N--CA 1.446 -1.311 0 C-N-CA 121.664 1.576 . . . . 0.0 111.918 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 556' ' ' ILE . . . . . 0.916 ' HB ' ' O ' ' A' ' 530' ' ' ALA . 3.8 tp 61.21 31.77 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 177.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.85 119.84 39.97 Favored 'General case' 0 CA--C 1.501 -0.925 0 N-CA-C 104.36 -2.459 . . . . 0.0 104.36 178.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 558' ' ' THR . . . . . . . . . . . . . 3.3 t -56.76 116.98 3.48 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-O 122.576 1.179 . . . . 0.0 114.084 -171.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 559' ' ' TRP . . . . . 0.442 ' CH2' ' CD ' ' A' ' 555' ' ' PRO . 5.3 m0 -137.05 111.49 8.57 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 104.521 -2.4 . . . . 0.0 104.521 175.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 560' ' ' ASN . . . . . 0.593 ' O ' ' CG2' ' A' ' 564' ' ' THR . 84.4 m-20 -77.15 -75.59 0.2 Allowed 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -174.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 561' ' ' ALA . . . . . 0.632 ' O ' HG21 ' A' ' 564' ' ' THR . . . -74.19 -57.27 4.06 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 116.055 1.872 . . . . 0.0 116.055 -177.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 562' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -49.59 -53.59 23.03 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -177.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 563' ' ' LYS . . . . . 0.447 ' HG3' HG23 ' A' ' 504' ' ' THR . 0.0 OUTLIER -69.38 -49.03 59.17 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.489 -178.439 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 564' ' ' THR . . . . . 0.654 HG23 ' O ' ' A' ' 501' ' ' TYR . 13.8 t -51.07 -65.22 0.59 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.567 0.222 . . . . 0.0 111.451 -178.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 565' ' ' GLN . . . . . 0.535 ' H ' ' CG2' ' A' ' 564' ' ' THR . 8.4 tp60 -48.95 -47.05 44.18 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.848 0.356 . . . . 0.0 111.053 179.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -49.5 -55.65 12.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 0.0 112.21 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 567' ' ' PHE . . . . . 0.51 ' O ' ' OG ' ' A' ' 534' ' ' SER . 0.6 OUTLIER -96.89 -42.63 7.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.347 0.594 . . . . 0.0 112.46 -178.296 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 568' ' ' ILE . . . . . 0.598 HG23 ' O ' ' A' ' 568' ' ' ILE . 1.2 tp -61.2 9.06 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 N-CA-C 113.939 1.088 . . . . 0.0 113.939 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 569' ' ' ILE . . . . . 0.464 ' H ' ' C ' ' A' ' 567' ' ' PHE . 0.7 OUTLIER -54.46 -40.25 48.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 N-CA-C 104.005 -2.591 . . . . 0.0 104.005 178.295 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 570' ' ' ASP . . . . . 0.483 ' HB2' ' CD1' ' A' ' 588' ' ' ILE . 17.2 p30 32.13 56.84 0.36 Allowed 'General case' 0 CA--C 1.509 -0.599 0 CA-C-N 113.738 -1.574 . . . . 0.0 113.527 172.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 571' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 570' ' ' ASP . . . -51.3 -44.79 52.64 Favored Glycine 0 N--CA 1.44 -1.035 0 C-N-CA 116.819 -2.61 . . . . 0.0 108.575 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 572' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -120.29 -15.89 8.55 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 175.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 573' ' ' LEU . . . . . 0.496 ' HB3' ' O ' ' A' ' 535' ' ' ARG . 1.1 tp -139.75 139.9 36.6 Favored 'General case' 0 C--N 1.353 0.746 0 N-CA-C 116.913 2.19 . . . . 0.0 116.913 -176.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 574' ' ' LEU . . . . . 0.549 ' HB3' ' CD1' ' A' ' 588' ' ' ILE . 0.3 OUTLIER -135.07 133.6 39.49 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 172.642 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 575' ' ' ILE . . . . . 0.627 HG13 ' O ' ' A' ' 533' ' ' GLY . 0.0 OUTLIER -134.12 137.24 52.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 118.623 0.647 . . . . 0.0 111.596 178.812 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 576' ' ' LEU . . . . . 0.495 ' CD1' ' CE1' ' A' ' 505' ' ' PHE . 0.0 OUTLIER -133.15 135.41 45.14 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 177.361 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 577' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -131.45 134.8 46.57 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 119.089 -1.045 . . . . 0.0 110.036 177.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.46 132.2 54.23 Favored 'General case' 0 C--O 1.243 0.732 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 579' ' ' GLY . . . . . . . . . . . . . . . -88.18 -2.0 80.96 Favored Glycine 0 N--CA 1.44 -1.047 0 CA-C-N 114.901 -1.045 . . . . 0.0 113.411 -178.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 580' ' ' LYS . . . . . 0.591 ' CD ' ' CE2' ' A' ' 581' ' ' TRP . 0.0 OUTLIER -71.22 -49.65 41.16 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 118.656 -1.217 . . . . 0.0 108.441 179.279 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 581' ' ' TRP . . . . . 0.591 ' CE2' ' CD ' ' A' ' 580' ' ' LYS . 0.7 OUTLIER -140.92 -51.32 0.45 Allowed 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 175.823 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 582' ' ' LYS . . . . . 0.545 ' HE2' ' CD1' ' A' ' 581' ' ' TRP . 0.0 OUTLIER -139.76 165.29 27.69 Favored 'General case' 0 CA--C 1.512 -0.511 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -175.079 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 583' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.13 135.08 51.49 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 175.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 584' ' ' LYS . . . . . 0.63 ' HD3' ' N ' ' A' ' 585' ' ' LEU . 9.1 tppt? -116.44 133.67 55.75 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 585' ' ' LEU . . . . . 0.63 ' N ' ' HD3' ' A' ' 584' ' ' LYS . 7.7 tt -120.88 137.07 54.76 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -179.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 586' ' ' VAL . . . . . 0.452 ' CG2' ' CG2' ' A' ' 493' ' ' VAL . 55.9 t -131.95 137.01 55.78 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.777 -178.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 587' ' ' SER . . . . . . . . . . . . . 1.4 m -107.31 134.63 50.1 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 177.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . 0.687 HG21 ' N ' ' A' ' 497' ' ' LYS . 0.0 OUTLIER -135.98 136.4 49.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -177.754 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 6.1 m -133.58 136.81 53.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.943 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 590' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -82.62 162.52 21.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.565 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 591' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -50.58 -49.36 56.56 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.233 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -51.95 -49.57 62.9 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 120.987 0.423 . . . . 0.0 111.343 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 10.2 mmtm -56.65 -49.39 75.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.541 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 594' ' ' PHE . . . . . 0.687 ' O ' ' HG ' ' A' ' 597' ' ' LEU . 1.2 t80 -50.51 -48.55 56.94 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.518 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 595' ' ' LYS . . . . . 0.529 ' O ' ' HB3' ' A' ' 599' ' ' LEU . 6.3 mtpt -51.18 -50.5 58.87 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.328 0.585 . . . . 0.0 110.027 179.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 596' ' ' GLU . . . . . 0.41 ' O ' ' HG ' ' A' ' 599' ' ' LEU . 0.7 OUTLIER -50.43 -48.44 56.3 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.103 -0.953 . . . . 0.0 112.965 -179.647 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 597' ' ' LEU . . . . . 0.687 ' HG ' ' O ' ' A' ' 594' ' ' PHE . 3.2 pp -72.09 -57.67 4.07 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -177.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 598' ' ' GLY . . . . . 0.786 ' O ' ' CD1' ' A' ' 604' ' ' TRP . . . -86.34 11.68 62.69 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.761 -0.654 . . . . 0.0 113.33 -178.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 599' ' ' LEU . . . . . 0.529 ' HB3' ' O ' ' A' ' 595' ' ' LYS . 2.2 pp -48.82 -12.59 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -176.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 600' ' ' THR . . . . . . . . . . . . . 47.8 p -106.55 64.39 0.66 Allowed 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.027 177.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 601' ' ' ALA . . . . . 0.552 ' CB ' ' CD ' ' A' ' 602' ' ' PRO . . . -133.41 -173.54 0.35 Allowed Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.297 178.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 602' ' ' PRO . . . . . 0.552 ' CD ' ' CB ' ' A' ' 601' ' ' ALA . 3.5 Cg_exo -76.28 -33.07 3.6 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.579 2.186 . . . . 0.0 111.624 178.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 603' ' ' GLY . . . . . . . . . . . . . . . -71.44 -49.33 25.84 Favored Glycine 0 C--N 1.334 0.425 0 C-N-CA 121.079 -0.581 . . . . 0.0 113.072 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 604' ' ' TRP . . . . . 0.786 ' CD1' ' O ' ' A' ' 598' ' ' GLY . 1.3 m95 -70.94 -47.18 60.43 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 120.846 0.355 . . . . 0.0 111.176 -179.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 605' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -50.79 -56.74 10.67 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.24 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 606' ' ' GLU . . . . . 0.411 ' O ' ' CB ' ' A' ' 610' ' ' LYS . 1.3 tt0 -57.23 -62.15 1.97 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.754 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 607' ' ' VAL . . . . . . . . . . . . . 40.1 t -64.31 -71.68 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 114.379 1.252 . . . . 0.0 114.379 -177.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 608' ' ' VAL . . . . . . . . . . . . . 62.1 t -56.17 -56.94 10.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.796 -178.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 609' ' ' GLY . . . . . . . . . . . . . . . -64.98 -63.51 4.14 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 121.151 -0.547 . . . . 0.0 113.402 -178.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 610' ' ' LYS . . . . . 0.411 ' CB ' ' O ' ' A' ' 606' ' ' GLU . 3.2 tttm -61.56 -49.94 74.64 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.81 0.338 . . . . 0.0 110.921 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 75.24 56.53 4.69 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.592 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.0 -29.68 68.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.748 0.309 . . . . 0.0 110.865 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 613' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -67.91 176.95 2.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.908 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . 0.404 ' CB ' ' CD ' ' A' ' 615' ' ' PRO . 13.4 mt-10 -73.01 -60.94 1.66 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.018 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 615' ' ' PRO . . . . . 0.404 ' CD ' ' CB ' ' A' ' 614' ' ' GLU . 59.1 Cg_endo -72.08 94.95 0.73 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.519 2.146 . . . . 0.0 112.323 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 616' ' ' SER . . . . . . . . . . . . . 3.2 m -75.37 156.89 85.22 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.856 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo . . . . . 0 C--O 1.248 0.992 0 C-N-CA 122.584 2.189 . . . . 0.0 112.293 -179.989 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.718 0.294 . . . . 0.0 111.208 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 455' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.23 118.41 4.56 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.542 2.162 . . . . 0.0 112.337 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 456' ' ' ARG . . . . . . . . . . . . . 1.4 ttm180 -66.66 -26.5 67.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.03 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 20.0 p -70.52 -51.05 31.53 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.858 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -59.95 115.92 3.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.117 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 1.4 m -90.26 149.67 41.68 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.925 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.01 -169.59 0.35 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.606 2.204 . . . . 0.0 112.313 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . 90.33 56.55 1.78 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.557 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -152.17 156.63 33.94 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 120.743 0.306 . . . . 0.0 110.887 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -68.47 119.05 6.07 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.673 2.249 . . . . 0.0 112.273 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 27.9 mttt -99.67 126.24 45.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.9 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.03 -73.99 0.58 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.82 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 27.8 m -111.72 33.75 4.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.846 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -136.5 81.8 1.9 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.903 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.78 43.49 1.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.753 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 129.07 -34.76 2.75 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.053 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -112.82 117.8 33.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.822 0.344 . . . . 0.0 110.393 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 471' ' ' VAL . . . . . . . . . . . . . 9.9 p -113.08 107.97 24.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.034 0.445 . . . . 0.0 111.255 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 23.3 t30 -177.89 85.63 0.24 Allowed Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.841 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -63.75 157.24 53.03 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.627 2.218 . . . . 0.0 112.213 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -85.23 -50.99 6.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.79 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 1.5 m -138.05 -46.35 0.52 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.835 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 476' ' ' GLY . . . . . . . . . . . . . . . 127.36 -41.71 1.56 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.527 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 477' ' ' ASN . . . . . 0.536 ' N ' ' HD3' ' A' ' 478' ' ' PRO . 27.9 t-20 47.78 53.37 13.99 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 120.511 0.196 . . . . 0.0 111.473 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 478' ' ' PRO . . . . . 0.536 ' HD3' ' N ' ' A' ' 477' ' ' ASN . 37.6 Cg_exo -55.77 -69.25 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.241 1.961 . . . . 0.0 112.314 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -124.68 85.06 2.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.05 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -140.48 131.64 13.98 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.213 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -59.08 -69.5 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.211 1.941 . . . . 0.0 111.931 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 482' ' ' GLN . . . . . . . . . . . . . 17.5 mp0 -135.33 -73.46 0.46 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.661 179.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 483' ' ' THR . . . . . . . . . . . . . 1.9 t -137.61 65.26 1.49 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.072 0.463 . . . . 0.0 110.858 178.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 484' ' ' ASN . . . . . 0.42 ' O ' ' HD3' ' A' ' 489' ' ' PRO . 34.1 t30 -130.94 -69.22 0.65 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.481 0.658 . . . . 0.0 109.653 178.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 485' ' ' PHE . . . . . 0.541 ' O ' ' HD2' ' A' ' 489' ' ' PRO . 3.6 m-85 -70.71 -46.73 62.56 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.871 179.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 486' ' ' ALA . . . . . 0.4 ' CB ' ' ND2' ' A' ' 477' ' ' ASN . . . -72.39 -47.42 49.44 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -177.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -68.06 -74.6 0.12 Allowed 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 -176.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 488' ' ' MET . . . . . 0.536 ' CB ' ' HD3' ' A' ' 489' ' ' PRO . 0.4 OUTLIER -52.86 -52.63 63.11 Favored Pre-proline 0 N--CA 1.469 0.522 0 CA-C-O 121.176 0.513 . . . . 0.0 111.335 -178.961 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 489' ' ' PRO . . . . . 0.541 ' HD2' ' O ' ' A' ' 485' ' ' PHE . 2.5 Cg_endo -86.19 43.88 1.18 Allowed 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 124.646 3.564 . . . . 0.0 112.257 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 14.3 p -36.43 -37.16 0.12 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.631 -178.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 491' ' ' ALA . . . . . 0.422 ' CB ' ' NZ ' ' A' ' 584' ' ' LYS . . . -133.41 135.0 44.36 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.63 177.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 492' ' ' ARG . . . . . 0.463 ' HD3' ' HG ' ' A' ' 585' ' ' LEU . 0.0 OUTLIER -136.39 134.93 38.32 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 179.434 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 493' ' ' VAL . . . . . 0.569 ' HB ' ' CA ' ' A' ' 513' ' ' GLY . 75.2 t -135.2 163.48 35.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.68 177.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 494' ' ' THR . . . . . 0.433 ' N ' ' CG1' ' A' ' 493' ' ' VAL . 18.5 m -123.85 135.3 53.66 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.153 0.502 . . . . 0.0 111.201 178.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 495' ' ' LEU . . . . . 0.443 ' CD2' HG22 ' A' ' 588' ' ' ILE . 0.0 OUTLIER -134.46 163.7 49.31 Favored Pre-proline 0 CA--C 1.531 0.239 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.298 179.546 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.45 120.06 7.72 Favored 'Trans proline' 0 CA--C 1.532 0.393 0 C-N-CA 122.225 1.95 . . . . 0.0 112.358 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 497' ' ' LYS . . . . . 0.519 ' CA ' ' HB ' ' A' ' 588' ' ' ILE . 0.9 OUTLIER -56.9 -30.31 63.81 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.663 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 498' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.79 -48.34 66.94 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 499' ' ' LEU . . . . . 0.582 ' O ' ' HE3' ' A' ' 507' ' ' LYS . 0.3 OUTLIER -73.45 -8.85 57.61 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.605 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . 0.572 ' HA ' ' HE3' ' A' ' 507' ' ' LYS . 0.3 OUTLIER -60.06 -24.98 31.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.362 0.601 . . . . 0.0 111.113 -179.836 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 501' ' ' TYR . . . . . 0.585 ' O ' HG23 ' A' ' 564' ' ' THR . 0.1 OUTLIER -71.24 -29.9 65.68 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 115.027 1.492 . . . . 0.0 115.027 -177.598 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 502' ' ' ASP . . . . . 0.402 ' OD1' ' CZ ' ' A' ' 501' ' ' TYR . 11.3 m-20 -75.2 -51.22 13.88 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 116.057 1.873 . . . . 0.0 116.057 -174.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 503' ' ' LYS . . . . . 0.627 ' O ' ' CG ' ' A' ' 507' ' ' LYS . 7.4 mttt -120.73 134.48 55.28 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-N 119.346 0.976 . . . . 0.0 111.576 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 504' ' ' THR . . . . . 0.441 ' N ' ' HB ' ' A' ' 564' ' ' THR . 4.2 m -72.91 -76.25 0.12 Allowed 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . 0.541 ' CD1' HG13 ' A' ' 525' ' ' ILE . 12.6 p90 -75.26 -59.12 2.88 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 506' ' ' SER . . . . . 0.783 ' O ' ' CD1' ' A' ' 510' ' ' TRP . 5.2 t -49.39 -72.28 0.05 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 -175.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 507' ' ' LYS . . . . . 0.721 ' HD3' ' N ' ' A' ' 508' ' ' VAL . 0.0 OUTLIER -48.96 -49.12 42.06 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -176.231 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 508' ' ' VAL . . . . . 0.721 ' N ' ' HD3' ' A' ' 507' ' ' LYS . 51.5 t -53.33 -60.02 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -179.085 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 509' ' ' LEU . . . . . 0.558 ' HG ' ' H ' ' A' ' 510' ' ' TRP . 2.6 pp -60.59 -62.69 1.68 Allowed 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 -177.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 510' ' ' TRP . . . . . 0.783 ' CD1' ' O ' ' A' ' 506' ' ' SER . 63.9 p-90 -72.86 -53.63 10.92 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 114.66 1.355 . . . . 0.0 114.66 -176.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 511' ' ' SER . . . . . 0.517 ' N ' ' CE3' ' A' ' 510' ' ' TRP . 1.7 t -65.48 -47.92 74.4 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.89 -177.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 512' ' ' ALA . . . . . 0.453 ' CB ' ' O ' ' A' ' 508' ' ' VAL . . . -71.64 -72.46 0.22 Allowed 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 117.184 2.291 . . . . 0.0 117.184 -174.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 513' ' ' GLY . . . . . 0.604 ' HA3' ' HE3' ' A' ' 584' ' ' LYS . . . -114.57 -34.88 1.49 Allowed Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 121.369 3.308 . . . . 0.0 121.369 -172.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 514' ' ' LEU . . . . . 0.572 ' HG ' ' HE2' ' A' ' 584' ' ' LYS . 1.7 mt -107.12 -46.49 3.89 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 119.579 3.178 . . . . 0.0 119.579 -170.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 515' ' ' VAL . . . . . 0.585 ' CG1' ' HB2' ' A' ' 517' ' ' SER . 4.7 p -154.28 173.16 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 117.617 2.451 . . . . 0.0 117.617 -171.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 516' ' ' ALA . . . . . 0.521 ' H ' ' CG2' ' A' ' 515' ' ' VAL . . . -67.84 3.83 1.36 Allowed 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 126.515 1.926 . . . . 0.0 110.078 177.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 517' ' ' SER . . . . . 0.854 ' HA ' ' HB2' ' A' ' 520' ' ' GLU . 0.4 OUTLIER -57.8 9.11 0.01 OUTLIER 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 115.979 1.844 . . . . 0.0 115.979 -172.213 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 518' ' ' LYS . . . . . 0.777 ' HA ' ' CD1' ' A' ' 510' ' ' TRP . 0.0 OUTLIER -45.56 -49.78 13.63 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 104.248 -2.501 . . . . 0.0 104.248 175.304 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 519' ' ' SER . . . . . . . . . . . . . 11.3 p -75.15 -56.93 4.23 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.2 173.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 520' ' ' GLU . . . . . 0.854 ' HB2' ' HA ' ' A' ' 517' ' ' SER . 0.8 OUTLIER -58.1 -47.41 83.31 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.023 -178.892 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 521' ' ' GLY . . . . . 0.805 ' N ' ' O ' ' A' ' 517' ' ' SER . . . -49.18 -55.99 11.3 Favored Glycine 0 CA--C 1.492 -1.39 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.273 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -47.74 -47.42 30.31 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 178.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 523' ' ' ARG . . . . . 0.437 ' O ' ' HB3' ' A' ' 526' ' ' ASN . 0.1 OUTLIER -50.36 -48.9 55.49 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.786 178.534 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 524' ' ' ILE . . . . . 0.491 HD12 HG23 ' A' ' 524' ' ' ILE . 1.7 mt -57.33 -55.77 18.95 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 CA-C-O 121.571 0.7 . . . . 0.0 109.613 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 525' ' ' ILE . . . . . 0.596 HG12 ' O ' ' A' ' 521' ' ' GLY . 0.8 OUTLIER -50.15 -47.4 24.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.163 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 526' ' ' ASN . . . . . 0.437 ' HB3' ' O ' ' A' ' 523' ' ' ARG . 1.1 t30 -56.84 -48.02 79.0 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-N 114.36 -1.291 . . . . 0.0 108.314 177.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 527' ' ' ASN . . . . . 0.453 ' ND2' ' O ' ' A' ' 524' ' ' ILE . 0.0 OUTLIER -48.04 -40.09 21.86 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.087 -1.415 . . . . 0.0 107.49 176.658 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 528' ' ' ASN . . . . . 0.744 ' HA ' ' CG2' ' A' ' 556' ' ' ILE . 1.8 t30 73.61 39.92 0.53 Allowed 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 114.638 -1.164 . . . . 0.0 111.529 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 529' ' ' GLY . . . . . . . . . . . . . . . -113.78 21.97 15.42 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 114.507 -1.224 . . . . 0.0 111.69 178.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 530' ' ' ALA . . . . . 0.772 ' O ' ' HB ' ' A' ' 556' ' ' ILE . . . -133.67 163.07 30.26 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.252 0.548 . . . . 0.0 112.231 -179.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 531' ' ' TYR . . . . . 0.515 ' HA ' ' O ' ' A' ' 554' ' ' THR . 0.0 OUTLIER -133.92 162.69 31.35 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 177.49 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 532' ' ' VAL . . . . . 0.49 HG13 ' OG1' ' A' ' 554' ' ' THR . 0.9 OUTLIER -131.37 135.48 59.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 CA-C-O 122.148 0.975 . . . . 0.0 111.862 179.772 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 533' ' ' GLY . . . . . 0.606 ' HA2' ' HB ' ' A' ' 552' ' ' THR . . . -133.66 153.88 21.05 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 114.189 -1.369 . . . . 0.0 113.966 -179.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 534' ' ' SER . . . . . 0.583 ' HB2' ' OG1' ' A' ' 552' ' ' THR . 19.1 m -134.31 136.39 43.45 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.389 -0.405 . . . . 0.0 111.437 178.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 535' ' ' ARG . . . . . 0.619 ' HA ' ' O ' ' A' ' 550' ' ' ASP . 0.0 OUTLIER -160.63 90.92 1.65 Allowed Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 178.306 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 536' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -78.22 52.03 3.93 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.903 2.402 . . . . 0.0 112.131 178.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 66.61 11.49 57.15 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.667 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 538' ' ' VAL . . . . . 0.435 ' O ' ' HB2' ' A' ' 550' ' ' ASP . 16.3 t -116.48 18.83 7.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.656 0.265 . . . . 0.0 111.357 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 539' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -45.92 119.74 2.38 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.276 0.56 . . . . 0.0 111.609 -178.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.18 31.25 5.09 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.91 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 541' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -35.9 98.1 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.173 0 CA-C-O 121.684 0.754 . . . . 0.0 111.131 -179.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 542' ' ' GLU . . . . . 0.822 ' O ' ' N ' ' A' ' 544' ' ' GLY . 5.7 pt-20 -132.56 161.5 62.93 Favored Pre-proline 0 C--N 1.318 -0.761 0 CA-C-N 114.561 -1.2 . . . . 0.0 111.043 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 543' ' ' PRO . . . . . 0.515 ' HD2' ' HB2' ' A' ' 542' ' ' GLU . 30.6 Cg_exo -25.26 56.03 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.779 1 C-N-CA 125.345 4.03 . . . . 0.0 115.463 179.363 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . 0.822 ' N ' ' O ' ' A' ' 542' ' ' GLU . . . 52.26 53.69 30.09 Favored Glycine 0 C--O 1.229 -0.185 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.749 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 545' ' ' GLY . . . . . 0.478 ' C ' ' HD3' ' A' ' 548' ' ' PRO . . . -51.0 55.55 0.01 OUTLIER Glycine 0 CA--C 1.526 0.733 0 N-CA-C 114.931 0.732 . . . . 0.0 114.931 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . 0.634 ' N ' ' O ' ' A' ' 544' ' ' GLY . . . 53.68 55.83 23.31 Favored Glycine 0 CA--C 1.522 0.528 0 C-N-CA 120.444 -0.884 . . . . 0.0 113.806 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 547' ' ' MET . . . . . . . . . . . . . 1.2 mtt 53.44 55.77 13.41 Favored Pre-proline 0 N--CA 1.466 0.338 0 CA-C-O 121.026 0.441 . . . . 0.0 112.018 179.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 548' ' ' PRO . . . . . 0.478 ' HD3' ' C ' ' A' ' 545' ' ' GLY . 9.5 Cg_endo -50.4 167.67 0.23 Allowed 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 123.31 2.673 . . . . 0.0 112.419 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -110.51 -22.42 11.67 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 550' ' ' ASP . . . . . 0.619 ' O ' ' HA ' ' A' ' 535' ' ' ARG . 0.7 OUTLIER -56.04 -41.3 74.79 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.548 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 551' ' ' LEU . . . . . 0.505 ' HA ' ' HD2' ' A' ' 535' ' ' ARG . 7.6 tp -131.47 140.09 49.49 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.72 177.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 552' ' ' THR . . . . . 0.606 ' HB ' ' HA2' ' A' ' 533' ' ' GLY . 0.3 OUTLIER -133.71 149.46 51.5 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 122.118 0.961 . . . . 0.0 112.73 179.078 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 553' ' ' PHE . . . . . 0.504 ' HA ' ' CE2' ' A' ' 531' ' ' TYR . 3.4 m-85 -134.12 137.37 44.5 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 106.29 -1.745 . . . . 0.0 106.29 176.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 554' ' ' THR . . . . . 0.515 ' O ' ' HA ' ' A' ' 531' ' ' TYR . 1.8 m -132.53 138.38 31.96 Favored Pre-proline 0 C--N 1.304 -1.388 0 C-N-CA 119.197 -1.001 . . . . 0.0 110.582 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 555' ' ' PRO . . . . . 0.552 ' O ' HG21 ' A' ' 556' ' ' ILE . 65.3 Cg_endo -84.28 14.27 2.48 Favored 'Trans proline' 0 N--CA 1.439 -1.717 0 C-N-CA 121.647 1.564 . . . . 0.0 111.14 179.117 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 556' ' ' ILE . . . . . 0.772 ' HB ' ' O ' ' A' ' 530' ' ' ALA . 1.2 tp 69.73 33.63 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 N-CA-C 115.065 1.506 . . . . 0.0 115.065 176.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . 0.61 ' O ' ' CE2' ' A' ' 559' ' ' TRP . 0.0 OUTLIER -103.87 148.46 26.12 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -179.289 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 558' ' ' THR . . . . . 0.484 ' HA ' ' CZ ' ' A' ' 505' ' ' PHE . 3.7 t -69.96 115.9 9.71 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 -172.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 559' ' ' TRP . . . . . 0.61 ' CE2' ' O ' ' A' ' 557' ' ' LYS . 0.0 OUTLIER -141.24 123.07 15.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 112.642 -2.072 . . . . 0.0 105.599 174.184 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 560' ' ' ASN . . . . . 0.489 ' O ' ' CG2' ' A' ' 564' ' ' THR . 60.3 m-20 -90.54 -77.01 0.42 Allowed 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 117.627 -1.629 . . . . 0.0 113.129 -177.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 561' ' ' ALA . . . . . 0.581 ' O ' HG21 ' A' ' 564' ' ' THR . . . -76.22 -50.44 14.45 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 115.502 1.667 . . . . 0.0 115.502 -179.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 562' ' ' SER . . . . . . . . . . . . . 5.1 t -49.37 -56.68 8.78 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -176.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 563' ' ' LYS . . . . . 0.495 ' HG2' ' CD1' ' A' ' 559' ' ' TRP . 0.0 OUTLIER -69.17 -48.51 62.02 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -178.307 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 564' ' ' THR . . . . . 0.643 ' O ' ' HB ' ' A' ' 568' ' ' ILE . 10.6 t -50.22 -68.32 0.18 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.801 0.334 . . . . 0.0 111.842 -179.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 565' ' ' GLN . . . . . 0.559 ' H ' ' CG2' ' A' ' 564' ' ' THR . 3.8 tp60 -50.02 -47.17 53.27 Favored 'General case' 0 C--N 1.319 -0.721 0 O-C-N 122.173 -0.33 . . . . 0.0 111.635 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . 0.41 ' HG2' ' CD1' ' A' ' 567' ' ' PHE . 27.9 tt0 -49.54 -62.64 1.44 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -178.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 567' ' ' PHE . . . . . 0.577 ' C ' ' H ' ' A' ' 569' ' ' ILE . 0.0 OUTLIER -97.27 -50.64 4.48 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.449 0.642 . . . . 0.0 112.132 -178.53 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 568' ' ' ILE . . . . . 0.643 ' HB ' ' O ' ' A' ' 564' ' ' THR . 1.7 mp -58.1 10.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 114.805 -1.089 . . . . 0.0 113.266 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 569' ' ' ILE . . . . . 0.577 ' H ' ' C ' ' A' ' 567' ' ' PHE . 1.2 pt -52.8 -38.32 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 N-CA-C 104.253 -2.499 . . . . 0.0 104.253 178.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 570' ' ' ASP . . . . . 0.478 ' CB ' ' O ' ' A' ' 573' ' ' LEU . 30.2 m-20 34.55 52.62 0.56 Allowed 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 113.701 -1.59 . . . . 0.0 112.149 173.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -51.48 -44.56 53.43 Favored Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 118.226 -1.94 . . . . 0.0 109.084 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 572' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -118.97 -17.33 9.07 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 176.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 573' ' ' LEU . . . . . 0.58 ' HB3' ' O ' ' A' ' 535' ' ' ARG . 1.1 tp -140.12 137.08 34.19 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -178.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 574' ' ' LEU . . . . . 0.567 ' HB3' ' O ' ' A' ' 586' ' ' VAL . 0.3 OUTLIER -134.46 132.92 39.86 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 174.244 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 575' ' ' ILE . . . . . 0.585 HG13 ' O ' ' A' ' 533' ' ' GLY . 0.0 OUTLIER -134.05 137.17 52.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 118.914 0.779 . . . . 0.0 112.074 179.125 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 576' ' ' LEU . . . . . 0.491 HD23 ' HG3' ' A' ' 584' ' ' LYS . 0.0 OUTLIER -133.58 135.59 44.37 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 176.948 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 577' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.8 135.34 45.62 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 118.906 -1.117 . . . . 0.0 110.548 177.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.403 ' HA ' ' HB2' ' A' ' 530' ' ' ALA . 0.3 OUTLIER -123.63 131.72 53.68 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 177.834 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 579' ' ' GLY . . . . . . . . . . . . . . . -91.21 -2.38 71.07 Favored Glycine 0 CA--C 1.5 -0.857 0 CA-C-N 115.404 -0.816 . . . . 0.0 114.447 -177.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 580' ' ' LYS . . . . . 0.473 ' HE2' HG12 ' A' ' 524' ' ' ILE . 0.4 OUTLIER -75.32 -46.47 33.13 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 118.777 -1.169 . . . . 0.0 109.153 179.111 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 581' ' ' TRP . . . . . 0.448 ' CD1' ' HD2' ' A' ' 580' ' ' LYS . 0.1 OUTLIER -138.74 -51.65 0.56 Allowed 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 177.911 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 582' ' ' LYS . . . . . 0.403 ' HG2' ' CD1' ' A' ' 581' ' ' TRP . 1.1 ptpm? -139.56 165.0 28.4 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -175.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 583' ' ' MET . . . . . . . . . . . . . 2.3 ttt -118.85 134.81 54.91 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 174.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 584' ' ' LYS . . . . . 0.604 ' HE3' ' HA3' ' A' ' 513' ' ' GLY . 0.0 OUTLIER -121.71 133.05 54.94 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.023 -0.989 . . . . 0.0 108.335 179.53 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 585' ' ' LEU . . . . . 0.548 ' N ' ' HD3' ' A' ' 584' ' ' LYS . 2.9 tp -119.46 136.68 54.21 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 179.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 586' ' ' VAL . . . . . 0.567 ' O ' ' HB3' ' A' ' 574' ' ' LEU . 11.5 t -131.95 137.08 55.63 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.696 -178.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 587' ' ' SER . . . . . . . . . . . . . 7.6 m -110.24 135.79 50.44 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 177.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . 0.519 ' HB ' ' CA ' ' A' ' 497' ' ' LYS . 0.2 OUTLIER -133.81 144.64 35.15 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.607 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -178.606 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 5.3 m -132.87 137.26 54.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 114.204 -1.362 . . . . 0.0 110.742 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 590' ' ' SER . . . . . . . . . . . . . 2.5 t -70.65 135.52 48.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.624 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 591' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -50.6 -50.5 53.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.044 0.45 . . . . 0.0 110.737 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -51.55 -50.46 60.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.037 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -50.44 -48.65 56.34 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.708 0.766 . . . . 0.0 109.237 179.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 594' ' ' PHE . . . . . 0.534 ' O ' ' HG ' ' A' ' 597' ' ' LEU . 0.9 OUTLIER -50.23 -48.53 54.42 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.687 178.47 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 595' ' ' LYS . . . . . 0.51 ' HA ' ' CE2' ' A' ' 604' ' ' TRP . 5.7 mmpt? -49.37 -47.65 47.45 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 596' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -51.98 -60.28 3.37 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.434 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 597' ' ' LEU . . . . . 0.534 ' HG ' ' O ' ' A' ' 594' ' ' PHE . 0.7 OUTLIER -61.66 -62.17 2.0 Allowed 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.417 0.627 . . . . 0.0 112.117 -178.699 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 598' ' ' GLY . . . . . 0.46 ' O ' ' CD1' ' A' ' 604' ' ' TRP . . . -77.13 14.03 8.72 Favored Glycine 0 C--N 1.32 -0.352 0 CA-C-N 115.043 -0.98 . . . . 0.0 113.401 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 599' ' ' LEU . . . . . 0.459 ' HA ' ' CD1' ' A' ' 604' ' ' TRP . 2.8 pp -47.45 -15.95 0.05 Allowed 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -175.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 600' ' ' THR . . . . . . . . . . . . . 11.6 t -129.83 65.91 1.48 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 119.939 -0.704 . . . . 0.0 110.413 176.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 601' ' ' ALA . . . . . . . . . . . . . . . -131.99 155.64 81.1 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.442 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 602' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.3 -19.86 44.84 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 121.942 1.761 . . . . 0.0 111.129 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 603' ' ' GLY . . . . . . . . . . . . . . . -61.33 -49.1 81.14 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.628 -0.714 . . . . 0.0 113.071 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 604' ' ' TRP . . . . . 0.51 ' CE2' ' HA ' ' A' ' 595' ' ' LYS . 1.2 m95 -66.91 -46.72 73.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.775 0.321 . . . . 0.0 111.427 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 605' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -52.17 -55.45 20.92 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.626 -179.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -59.85 -63.34 1.34 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.739 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 607' ' ' VAL . . . . . . . . . . . . . 46.3 t -50.79 -69.85 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 -178.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 608' ' ' VAL . . . . . . . . . . . . . 97.4 t -70.59 -60.72 2.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -177.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 609' ' ' GLY . . . . . . . . . . . . . . . -57.65 -62.43 6.34 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.085 -0.579 . . . . 0.0 113.222 -178.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 610' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.93 -70.17 0.29 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.824 0.345 . . . . 0.0 110.877 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 93.49 54.0 1.75 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.499 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 31.5 mtpt -60.0 -31.62 70.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.928 0.394 . . . . 0.0 111.0 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 613' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -92.11 171.15 9.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.924 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . 0.402 ' CB ' ' CD ' ' A' ' 615' ' ' PRO . 21.6 mm-40 -61.29 -61.09 8.61 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.956 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 615' ' ' PRO . . . . . 0.402 ' CD ' ' CB ' ' A' ' 614' ' ' GLU . 57.4 Cg_endo -71.23 117.49 5.18 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.541 2.16 . . . . 0.0 112.312 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 616' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -106.27 87.44 2.58 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.932 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo . . . . . 0 C--O 1.25 1.091 0 C-N-CA 122.585 2.19 . . . . 0.0 112.242 -179.953 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.625 0.25 . . . . 0.0 111.156 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 455' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.23 -28.06 23.46 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.505 2.137 . . . . 0.0 112.381 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 456' ' ' ARG . . . . . . . . . . . . . 5.6 ttt180 -83.69 -26.45 29.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.071 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 55.4 m -84.39 -31.31 24.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.939 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -67.99 121.85 16.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.141 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -114.94 96.91 46.32 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.871 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -56.02 174.34 0.33 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.57 2.18 . . . . 0.0 112.27 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . 115.22 56.55 0.36 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.595 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -158.68 143.2 11.54 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.713 0.292 . . . . 0.0 110.916 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.0 119.93 6.33 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.536 2.157 . . . . 0.0 112.274 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 4.7 mmtp -120.22 -173.55 2.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.126 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 14.5 m -94.96 22.8 6.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.068 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 5.0 m -75.77 43.86 0.27 Allowed 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . 0.405 ' CD2' ' HB ' ' A' ' 471' ' ' VAL . 0.5 OUTLIER -36.64 152.04 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.723 0.296 . . . . 0.0 111.613 179.774 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 58.3 p -97.16 27.07 4.31 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.693 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 128.93 -25.85 4.58 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.259 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -116.56 116.8 28.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.863 0.363 . . . . 0.0 110.947 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 471' ' ' VAL . . . . . 0.405 ' HB ' ' CD2' ' A' ' 467' ' ' LEU . 12.0 p -114.23 108.36 25.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.069 179.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -177.25 144.97 0.58 Allowed Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.139 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -57.4 174.64 0.48 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.408 2.072 . . . . 0.0 112.267 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 4.4 pm0 -111.5 36.89 3.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.986 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 12.8 p -49.9 -58.05 6.2 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.298 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 476' ' ' GLY . . . . . . . . . . . . . . . 96.33 -20.81 48.67 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.909 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 477' ' ' ASN . . . . . 0.423 ' N ' ' HD3' ' A' ' 478' ' ' PRO . 6.5 m-20 51.23 53.38 13.53 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-O 120.775 0.321 . . . . 0.0 111.196 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 478' ' ' PRO . . . . . 0.423 ' HD3' ' N ' ' A' ' 477' ' ' ASN . 93.3 Cg_endo -82.53 34.36 0.55 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.803 2.335 . . . . 0.0 113.31 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -53.13 137.92 32.62 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.75 0.31 . . . . 0.0 110.806 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 480' ' ' ALA . . . . . 0.424 ' CB ' ' CD ' ' A' ' 481' ' ' PRO . . . -140.39 176.22 2.65 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.552 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 481' ' ' PRO . . . . . 0.424 ' CD ' ' CB ' ' A' ' 480' ' ' ALA . 3.0 Cg_endo -81.35 40.71 1.02 Allowed 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.627 2.884 . . . . 0.0 112.675 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 482' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -34.9 -31.2 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 483' ' ' THR . . . . . 0.424 ' N ' ' O ' ' A' ' 481' ' ' PRO . 0.2 OUTLIER -46.27 171.71 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.713 0.292 . . . . 0.0 111.444 179.912 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 484' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -33.94 -35.24 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -57.07 -60.63 3.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.884 0.373 . . . . 0.0 110.208 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 486' ' ' ALA . . . . . 0.418 ' CB ' ' O ' ' A' ' 481' ' ' PRO . . . -71.59 -47.37 55.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.912 178.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 487' ' ' ASN . . . . . 0.432 ' HB3' ' HD3' ' A' ' 489' ' ' PRO . 9.2 t-20 -50.04 -48.52 52.81 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.779 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 488' ' ' MET . . . . . 0.42 ' N ' ' CD ' ' A' ' 489' ' ' PRO . 3.4 mtt 52.27 52.04 10.55 Favored Pre-proline 0 C--N 1.332 -0.155 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.014 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 489' ' ' PRO . . . . . 0.432 ' HD3' ' HB3' ' A' ' 487' ' ' ASN . 67.8 Cg_exo -23.51 -58.9 0.05 OUTLIER 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 124.223 3.282 . . . . 0.0 113.437 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 58.7 m -138.9 -68.16 0.45 Allowed 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.214 178.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 491' ' ' ALA . . . . . . . . . . . . . . . -135.45 135.6 40.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.673 -0.24 . . . . 0.0 111.606 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 492' ' ' ARG . . . . . 0.513 ' HD3' ' CD2' ' A' ' 585' ' ' LEU . 0.0 OUTLIER -136.05 132.02 35.65 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.583 0.23 . . . . 0.0 110.807 177.49 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 493' ' ' VAL . . . . . 0.579 ' CG2' ' HA3' ' A' ' 513' ' ' GLY . 39.5 t -138.0 163.11 30.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.492 177.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 494' ' ' THR . . . . . 0.5 ' N ' ' CG1' ' A' ' 493' ' ' VAL . 41.9 p -127.19 133.87 50.22 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 120.399 -0.521 . . . . 0.0 110.344 176.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 495' ' ' LEU . . . . . 0.492 ' O ' ' CG2' ' A' ' 588' ' ' ILE . 0.3 OUTLIER -135.89 164.57 42.26 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.558 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -61.72 119.31 6.37 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 121.676 1.584 . . . . 0.0 111.185 178.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 497' ' ' LYS . . . . . 0.477 ' CA ' ' HB ' ' A' ' 588' ' ' ILE . 15.0 ttmt -52.33 -30.23 27.45 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -178.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 498' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.3 -48.11 81.55 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -177.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 499' ' ' LEU . . . . . 0.442 ' CD1' ' CD1' ' A' ' 495' ' ' LEU . 2.2 pp -73.53 -8.16 54.79 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -178.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . 0.457 HG11 ' CG1' ' A' ' 568' ' ' ILE . 36.3 t -74.57 -25.45 19.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.435 0.636 . . . . 0.0 111.498 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 501' ' ' TYR . . . . . 0.665 ' O ' ' CG2' ' A' ' 564' ' ' THR . 3.7 m-30 -53.45 -29.13 34.02 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -178.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -76.15 -50.28 15.03 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 116.45 2.019 . . . . 0.0 116.45 -175.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 503' ' ' LYS . . . . . 0.575 ' O ' ' CG ' ' A' ' 507' ' ' LYS . 0.2 OUTLIER -120.27 136.44 54.66 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 119.59 1.086 . . . . 0.0 112.676 -178.51 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 504' ' ' THR . . . . . 0.55 ' OG1' ' N ' ' A' ' 564' ' ' THR . 23.7 m -73.61 -77.2 0.11 Allowed 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 179.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . 0.521 ' CE2' ' CD1' ' A' ' 576' ' ' LEU . 0.2 OUTLIER -75.74 -60.33 2.36 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -179.18 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 506' ' ' SER . . . . . 0.703 ' O ' ' CD1' ' A' ' 510' ' ' TRP . 6.1 t -48.7 -72.04 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 -175.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 507' ' ' LYS . . . . . 0.684 ' HD3' ' N ' ' A' ' 508' ' ' VAL . 0.0 OUTLIER -48.9 -48.58 42.27 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -176.479 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 508' ' ' VAL . . . . . 0.684 ' N ' ' HD3' ' A' ' 507' ' ' LYS . 55.3 t -52.63 -58.02 3.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 C-N-CA 120.668 -0.413 . . . . 0.0 112.081 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 509' ' ' LEU . . . . . 0.592 ' HG ' ' H ' ' A' ' 510' ' ' TRP . 2.6 pp -59.66 -66.0 0.58 Allowed 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 -177.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 510' ' ' TRP . . . . . 0.703 ' CD1' ' O ' ' A' ' 506' ' ' SER . 68.3 p-90 -73.18 -50.74 20.89 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 -176.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 511' ' ' SER . . . . . 0.504 ' N ' ' CD2' ' A' ' 510' ' ' TRP . 0.3 OUTLIER -62.27 -46.23 89.72 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 114.437 -1.256 . . . . 0.0 113.022 -177.024 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 512' ' ' ALA . . . . . 0.478 ' HB2' HD23 ' A' ' 495' ' ' LEU . . . -71.13 -74.87 0.14 Allowed 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 116.305 1.965 . . . . 0.0 116.305 -174.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 513' ' ' GLY . . . . . 0.579 ' HA3' ' CG2' ' A' ' 493' ' ' VAL . . . -116.88 -39.56 0.82 Allowed Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 121.837 3.495 . . . . 0.0 121.837 -173.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 514' ' ' LEU . . . . . 0.613 ' CD2' ' HB2' ' A' ' 584' ' ' LYS . 4.1 pp -112.83 -36.65 5.09 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 121.11 3.744 . . . . 0.0 121.11 -171.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 515' ' ' VAL . . . . . 0.731 ' CG1' ' HB2' ' A' ' 517' ' ' SER . 9.9 p -125.76 165.86 22.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 117.99 2.589 . . . . 0.0 117.99 -171.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 516' ' ' ALA . . . . . 0.406 ' H ' ' CG2' ' A' ' 515' ' ' VAL . . . -90.44 1.01 57.07 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 112.46 -2.154 . . . . 0.0 109.078 178.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 517' ' ' SER . . . . . 0.925 ' O ' ' N ' ' A' ' 521' ' ' GLY . 0.1 OUTLIER -60.15 10.19 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 126.072 1.749 . . . . 0.0 115.224 -172.957 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 518' ' ' LYS . . . . . 0.692 ' HA ' ' CD1' ' A' ' 510' ' ' TRP . 0.0 OUTLIER -43.54 -46.76 7.17 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 177.232 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 519' ' ' SER . . . . . . . . . . . . . 85.2 p -74.63 -56.15 5.13 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.462 173.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 520' ' ' GLU . . . . . 0.851 ' HB2' ' HA ' ' A' ' 517' ' ' SER . 4.8 mm-40 -62.03 -47.25 85.57 Favored 'General case' 0 C--N 1.349 0.573 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.848 -179.158 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 521' ' ' GLY . . . . . 0.925 ' N ' ' O ' ' A' ' 517' ' ' SER . . . -49.16 -53.09 20.51 Favored Glycine 0 CA--C 1.493 -1.292 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . 0.418 ' HA ' HG12 ' A' ' 525' ' ' ILE . 3.7 mt-30 -48.09 -47.52 34.19 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 177.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 523' ' ' ARG . . . . . 0.448 ' HB3' ' O ' ' A' ' 520' ' ' GLU . 2.4 tpt85 -50.25 -48.92 54.45 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.848 178.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 524' ' ' ILE . . . . . 0.454 ' O ' ' ND2' ' A' ' 527' ' ' ASN . 30.1 mm -57.44 -54.06 35.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.441 0.639 . . . . 0.0 109.592 179.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 525' ' ' ILE . . . . . 0.546 HG12 ' O ' ' A' ' 521' ' ' GLY . 1.1 mm -50.27 -47.56 25.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 177.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 526' ' ' ASN . . . . . 0.443 ' HB2' ' O ' ' A' ' 523' ' ' ARG . 34.8 m-80 -57.82 -47.33 82.92 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-N 114.225 -1.352 . . . . 0.0 108.575 177.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 527' ' ' ASN . . . . . 0.454 ' ND2' ' O ' ' A' ' 524' ' ' ILE . 0.0 OUTLIER -47.3 -39.32 14.42 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 113.988 -1.46 . . . . 0.0 107.741 177.239 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 528' ' ' ASN . . . . . 0.675 ' HA ' HG21 ' A' ' 556' ' ' ILE . 7.9 t-20 74.25 40.42 0.43 Allowed 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.491 -179.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 529' ' ' GLY . . . . . . . . . . . . . . . -117.61 31.55 5.71 Favored Glycine 0 CA--C 1.523 0.593 0 CA-C-N 114.922 -1.035 . . . . 0.0 112.497 178.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 530' ' ' ALA . . . . . 0.867 ' O ' ' HB ' ' A' ' 556' ' ' ILE . . . -133.43 163.93 28.26 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 121.161 0.505 . . . . 0.0 112.263 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 531' ' ' TYR . . . . . 0.559 ' HA ' ' O ' ' A' ' 554' ' ' THR . 0.0 OUTLIER -134.61 152.93 52.13 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.667 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 532' ' ' VAL . . . . . 0.558 ' CB ' ' HB ' ' A' ' 554' ' ' THR . 0.5 OUTLIER -127.09 135.64 63.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 CA-C-O 121.981 0.896 . . . . 0.0 112.093 179.635 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 533' ' ' GLY . . . . . 0.686 ' O ' HG13 ' A' ' 575' ' ' ILE . . . -133.68 151.73 20.26 Favored Glycine 0 N--CA 1.441 -0.98 0 CA-C-N 114.251 -1.34 . . . . 0.0 113.4 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 534' ' ' SER . . . . . 0.499 ' OG ' ' O ' ' A' ' 567' ' ' PHE . 0.6 OUTLIER -134.57 137.55 43.86 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.447 -0.376 . . . . 0.0 111.016 179.109 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 535' ' ' ARG . . . . . 0.611 ' O ' ' HB3' ' A' ' 573' ' ' LEU . 12.4 tpt180 -159.26 90.98 1.94 Allowed Pre-proline 0 C--N 1.331 -0.202 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 536' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.86 -51.46 1.26 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.464 2.109 . . . . 0.0 112.009 178.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 112.54 -18.52 22.63 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 120.71 -0.757 . . . . 0.0 113.273 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 538' ' ' VAL . . . . . . . . . . . . . 17.6 t -116.29 18.52 7.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.951 0.376 . . . . 0.0 111.98 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 539' ' ' LYS . . . . . . . . . . . . . 46.7 mttp -107.38 111.02 23.15 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.463 0.649 . . . . 0.0 112.129 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 4.4 mtpt -99.96 30.75 3.57 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.619 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 541' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -48.34 99.0 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.495 0.664 . . . . 0.0 111.06 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 542' ' ' GLU . . . . . 0.44 ' CB ' ' HD2' ' A' ' 543' ' ' PRO . 0.7 OUTLIER -49.04 177.26 0.04 OUTLIER Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.722 179.469 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 543' ' ' PRO . . . . . 0.448 ' O ' ' C ' ' A' ' 544' ' ' GLY . 49.6 Cg_exo -37.19 -52.27 1.43 Allowed 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.578 2.185 . . . . 0.0 112.741 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . 0.448 ' C ' ' O ' ' A' ' 543' ' ' PRO . . . 27.47 55.02 0.1 Allowed Glycine 0 C--N 1.335 0.485 0 C-N-CA 121.468 -0.396 . . . . 0.0 114.015 178.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 545' ' ' GLY . . . . . 0.568 ' O ' ' N ' ' A' ' 547' ' ' MET . . . 52.95 54.64 27.68 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.055 -1.069 . . . . 0.0 111.617 -178.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . 0.545 ' O ' ' C ' ' A' ' 547' ' ' MET . . . 53.62 -54.12 0.01 OUTLIER Glycine 0 CA--C 1.522 0.515 0 CA-C-O 119.107 -0.829 . . . . 0.0 114.585 -178.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 547' ' ' MET . . . . . 0.568 ' N ' ' O ' ' A' ' 545' ' ' GLY . 0.0 OUTLIER 19.22 55.74 0.17 Allowed Pre-proline 0 N--CA 1.473 0.71 0 CA-C-N 118.333 1.066 . . . . 0.0 111.796 178.704 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 548' ' ' PRO . . . . . 0.54 ' HD3' ' C ' ' A' ' 546' ' ' GLY . 83.4 Cg_exo -46.2 119.93 3.35 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.012 1.808 . . . . 0.0 113.479 -177.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.8 -36.48 2.4 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.124 -0.943 . . . . 0.0 108.645 178.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 550' ' ' ASP . . . . . 0.573 ' O ' ' HA ' ' A' ' 535' ' ' ARG . 0.6 OUTLIER -72.54 -42.17 65.01 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.263 179.739 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 551' ' ' LEU . . . . . . . . . . . . . 8.8 tp -131.37 140.57 49.71 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.335 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 552' ' ' THR . . . . . 0.646 ' O ' ' HA2' ' A' ' 533' ' ' GLY . 27.1 m -133.04 147.93 52.22 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.618 0.723 . . . . 0.0 111.912 179.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 553' ' ' PHE . . . . . 0.528 ' CD1' ' CE1' ' A' ' 531' ' ' TYR . 14.3 m-85 -133.86 136.77 44.59 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 177.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 554' ' ' THR . . . . . 0.559 ' O ' ' HA ' ' A' ' 531' ' ' TYR . 0.8 OUTLIER -134.0 138.96 31.83 Favored Pre-proline 0 C--N 1.308 -1.214 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.327 179.544 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 555' ' ' PRO . . . . . 0.573 ' HD2' ' CZ2' ' A' ' 559' ' ' TRP . 79.8 Cg_endo -86.22 20.33 1.25 Allowed 'Trans proline' 0 N--CA 1.445 -1.33 0 C-N-CA 121.972 1.782 . . . . 0.0 111.043 178.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 556' ' ' ILE . . . . . 0.867 ' HB ' ' O ' ' A' ' 530' ' ' ALA . 4.2 tp 63.27 35.17 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 177.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 2.2 mtmp? -102.86 122.11 43.86 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 558' ' ' THR . . . . . . . . . . . . . 12.0 m -56.91 118.57 5.08 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 115.61 1.707 . . . . 0.0 115.61 -171.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 559' ' ' TRP . . . . . 0.573 ' CZ2' ' HD2' ' A' ' 555' ' ' PRO . 0.0 OUTLIER -138.24 111.96 8.29 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 112.441 -2.163 . . . . 0.0 105.715 175.486 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 560' ' ' ASN . . . . . 0.533 ' O ' ' HB ' ' A' ' 564' ' ' THR . 51.2 m-20 -80.44 -74.82 0.29 Allowed 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 -175.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 561' ' ' ALA . . . . . 0.431 ' O ' HG21 ' A' ' 564' ' ' THR . . . -73.94 -65.33 0.85 Allowed 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 -176.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 562' ' ' SER . . . . . . . . . . . . . 1.4 p -49.06 -52.19 26.97 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -175.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 563' ' ' LYS . . . . . 0.523 ' HG2' ' CE2' ' A' ' 559' ' ' TRP . 9.3 tppt? -70.93 -49.13 48.97 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 564' ' ' THR . . . . . 0.665 ' CG2' ' O ' ' A' ' 501' ' ' TYR . 1.7 t -50.03 -62.4 1.59 Allowed 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.563 -178.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 565' ' ' GLN . . . . . 0.482 ' N ' ' CG2' ' A' ' 564' ' ' THR . 0.0 OUTLIER -49.13 -47.6 45.4 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 122.282 -0.261 . . . . 0.0 111.355 178.495 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -49.66 -56.27 10.71 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -178.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 567' ' ' PHE . . . . . 0.516 ' CE2' HG12 ' A' ' 532' ' ' VAL . 1.4 p90 -96.83 -46.0 6.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.433 0.635 . . . . 0.0 111.944 -178.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 568' ' ' ILE . . . . . 0.509 ' N ' ' O ' ' A' ' 564' ' ' THR . 1.3 tp -58.11 9.44 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.504 -0.822 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 569' ' ' ILE . . . . . 0.537 ' O ' ' OD1' ' A' ' 570' ' ' ASP . 0.0 OUTLIER -55.0 -38.94 47.51 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 N-CA-C 104.967 -2.234 . . . . 0.0 104.967 179.184 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 570' ' ' ASP . . . . . 0.537 ' OD1' ' O ' ' A' ' 569' ' ' ILE . 13.4 p30 31.61 58.12 0.3 Allowed 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 114.289 -1.323 . . . . 0.0 112.307 173.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -51.62 -45.1 54.55 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 117.288 -2.387 . . . . 0.0 108.79 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 572' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -119.57 -16.81 8.82 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 112.411 0.522 . . . . 0.0 112.411 175.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 573' ' ' LEU . . . . . 0.611 ' HB3' ' O ' ' A' ' 535' ' ' ARG . 1.2 tp -140.14 136.9 33.98 Favored 'General case' 0 C--N 1.351 0.659 0 N-CA-C 115.756 1.761 . . . . 0.0 115.756 -177.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 574' ' ' LEU . . . . . 0.574 ' HB3' ' CD1' ' A' ' 588' ' ' ILE . 0.1 OUTLIER -134.77 133.83 40.29 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 105.847 -1.908 . . . . 0.0 105.847 173.707 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 575' ' ' ILE . . . . . 0.686 HG13 ' O ' ' A' ' 533' ' ' GLY . 0.0 OUTLIER -133.55 136.08 54.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.401 178.65 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 576' ' ' LEU . . . . . 0.551 ' CD2' ' HB3' ' A' ' 509' ' ' LEU . 0.0 OUTLIER -133.99 135.63 43.56 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 177.1 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 577' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.32 135.26 46.08 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 118.88 -1.128 . . . . 0.0 110.513 177.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.01 132.12 54.0 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 177.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 579' ' ' GLY . . . . . . . . . . . . . . . -89.8 -2.15 75.85 Favored Glycine 0 CA--C 1.499 -0.92 0 CA-C-N 115.244 -0.889 . . . . 0.0 113.431 -178.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 580' ' ' LYS . . . . . 0.48 ' O ' ' CD1' ' A' ' 581' ' ' TRP . 0.0 OUTLIER -72.67 -48.15 41.49 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 118.998 -1.081 . . . . 0.0 108.964 179.426 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 581' ' ' TRP . . . . . 0.48 ' CD1' ' O ' ' A' ' 580' ' ' LYS . 28.4 m0 -139.03 -52.82 0.56 Allowed 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 177.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 582' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.84 165.22 27.88 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 -174.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 583' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.2 135.06 53.33 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 174.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 584' ' ' LYS . . . . . 0.613 ' HB2' ' CD2' ' A' ' 514' ' ' LEU . 2.3 tppt? -117.25 134.27 54.99 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 585' ' ' LEU . . . . . 0.513 ' CD2' ' HD3' ' A' ' 492' ' ' ARG . 4.2 tt -121.68 135.9 54.95 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 178.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 586' ' ' VAL . . . . . . . . . . . . . 16.9 t -133.31 137.07 53.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.204 -178.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 587' ' ' SER . . . . . . . . . . . . . 70.8 m -109.98 135.02 51.49 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 176.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . 0.574 ' CD1' ' HB3' ' A' ' 574' ' ' LEU . 0.0 OUTLIER -134.53 141.85 42.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -177.868 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 5.2 m -133.28 137.02 54.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 114.166 -1.379 . . . . 0.0 110.422 177.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 590' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.12 125.2 30.58 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.445 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 591' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -50.32 -49.34 54.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.16 0.505 . . . . 0.0 110.237 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -51.91 -49.58 62.78 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.176 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.01 -48.57 61.38 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.756 0.789 . . . . 0.0 109.156 179.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 594' ' ' PHE . . . . . 0.575 ' O ' ' HG ' ' A' ' 597' ' ' LEU . 0.9 OUTLIER -50.2 -48.39 54.23 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.572 178.281 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 595' ' ' LYS . . . . . 0.506 ' O ' ' HB3' ' A' ' 599' ' ' LEU . 0.0 OUTLIER -49.42 -48.18 47.5 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.911 0.386 . . . . 0.0 110.067 179.215 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 596' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -53.07 -55.06 26.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.618 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 597' ' ' LEU . . . . . 0.575 ' HG ' ' O ' ' A' ' 594' ' ' PHE . 0.8 OUTLIER -65.9 -60.92 2.37 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.283 0.563 . . . . 0.0 112.051 -178.64 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 598' ' ' GLY . . . . . 0.48 ' O ' ' CD1' ' A' ' 604' ' ' TRP . . . -78.88 13.08 20.43 Favored Glycine 0 C--N 1.32 -0.315 0 CA-C-N 115.279 -0.873 . . . . 0.0 113.459 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 599' ' ' LEU . . . . . 0.506 ' HB3' ' O ' ' A' ' 595' ' ' LYS . 2.8 pp -48.03 -11.49 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -175.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 600' ' ' THR . . . . . . . . . . . . . 30.0 m -141.38 66.27 1.36 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.854 0.835 . . . . 0.0 110.962 177.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 601' ' ' ALA . . . . . 0.45 ' CB ' ' HD2' ' A' ' 602' ' ' PRO . . . -132.15 177.91 2.01 Favored Pre-proline 0 N--CA 1.447 -0.592 0 CA-C-N 114.094 -1.412 . . . . 0.0 109.593 178.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 602' ' ' PRO . . . . . 0.45 ' HD2' ' CB ' ' A' ' 601' ' ' ALA . 97.6 Cg_endo -76.63 -8.29 18.1 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 121.908 1.739 . . . . 0.0 111.215 178.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 603' ' ' GLY . . . . . . . . . . . . . . . -71.19 -49.7 25.59 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 115.697 -0.683 . . . . 0.0 113.593 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 604' ' ' TRP . . . . . 0.499 ' CD1' ' HA ' ' A' ' 599' ' ' LEU . 2.1 m95 -69.51 -46.08 67.38 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 117.16 0.48 . . . . 0.0 111.67 -179.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 605' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -49.51 -53.69 22.0 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.68 -0.236 . . . . 0.0 110.836 -178.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -64.79 -56.37 13.96 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 607' ' ' VAL . . . . . . . . . . . . . 51.9 t -54.67 -72.15 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -178.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 608' ' ' VAL . . . . . . . . . . . . . 70.7 t -68.62 -55.16 16.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -177.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 609' ' ' GLY . . . . . . . . . . . . . . . -63.72 -62.97 4.79 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.975 -0.631 . . . . 0.0 113.385 -178.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 610' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.77 -68.07 0.41 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.807 0.337 . . . . 0.0 110.964 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 104.59 56.39 0.72 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.483 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.74 38.24 1.23 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.795 0.331 . . . . 0.0 110.954 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 613' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -119.95 -177.48 3.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.899 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -58.81 -60.78 9.33 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.948 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 615' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.35 -168.32 0.38 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.562 2.175 . . . . 0.0 112.313 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 616' ' ' SER . . . . . . . . . . . . . 1.3 m -156.62 86.19 2.95 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.92 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo . . . . . 0 C--O 1.25 1.084 0 C-N-CA 122.571 2.181 . . . . 0.0 112.221 -179.923 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 120.509 0.195 . . . . 0.0 111.424 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 455' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.13 -173.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.445 2.097 . . . . 0.0 112.314 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 456' ' ' ARG . . . . . . . . . . . . . 5.0 mtp180 -58.09 -26.46 62.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.08 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.65 -31.16 66.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.98 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -81.43 108.58 15.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.008 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 10.6 t -88.99 149.32 43.1 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.943 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -52.91 -174.59 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.562 2.175 . . . . 0.0 112.295 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . 129.74 -28.56 3.93 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.521 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -132.16 88.05 41.77 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.761 0.315 . . . . 0.0 110.932 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -69.29 90.58 0.47 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.523 2.149 . . . . 0.0 112.271 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 6.2 mtmp? -117.92 119.36 34.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.877 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -105.05 -75.1 0.63 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.896 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 1.4 m -120.5 30.53 6.89 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.965 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 4.7 tp -136.49 71.23 1.41 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.868 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 73.8 m -138.19 35.85 2.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.95 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 128.83 -36.87 2.33 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.357 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -120.83 117.86 28.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.841 0.353 . . . . 0.0 110.727 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 471' ' ' VAL . . . . . . . . . . . . . 9.4 p -112.98 108.11 24.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.097 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 22.0 m-80 -162.6 161.88 19.42 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.866 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -64.56 76.42 0.19 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.535 2.157 . . . . 0.0 112.139 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -97.56 36.72 1.46 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.951 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 15.9 m -54.25 -58.05 8.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.902 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 476' ' ' GLY . . . . . . . . . . . . . . . 57.41 70.07 1.09 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.678 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 477' ' ' ASN . . . . . 0.431 ' N ' ' CD ' ' A' ' 478' ' ' PRO . 0.2 OUTLIER -48.47 -51.41 51.75 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-O 120.698 0.285 . . . . 0.0 111.066 179.923 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 478' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 477' ' ' ASN . 85.4 Cg_endo -86.91 34.41 0.44 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.905 2.403 . . . . 0.0 112.638 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 12.7 p80 -47.26 170.54 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.853 0.358 . . . . 0.0 111.424 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 480' ' ' ALA . . . . . 0.414 ' CB ' ' CD ' ' A' ' 481' ' ' PRO . . . -90.5 176.46 2.94 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.192 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 481' ' ' PRO . . . . . 0.414 ' CD ' ' CB ' ' A' ' 480' ' ' ALA . 65.7 Cg_exo -42.0 -70.45 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.919 2.412 . . . . 0.0 112.884 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 482' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -135.12 -49.59 0.74 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.236 0.541 . . . . 0.0 109.844 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 483' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.66 141.6 43.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.088 179.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 484' ' ' ASN . . . . . 0.587 ' O ' ' CD ' ' A' ' 489' ' ' PRO . 1.3 m120 -86.7 -11.47 51.1 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.081 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 485' ' ' PHE . . . . . 0.644 ' HA ' ' HG2' ' A' ' 489' ' ' PRO . 55.2 m-85 -49.35 -47.33 47.52 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.576 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -72.2 -47.69 48.66 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -178.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -70.91 -74.33 0.15 Allowed 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 -176.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 488' ' ' MET . . . . . 0.532 ' HB2' ' HD3' ' A' ' 489' ' ' PRO . 0.0 OUTLIER -52.88 -52.24 66.81 Favored Pre-proline 0 N--CA 1.473 0.682 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.688 -178.454 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 489' ' ' PRO . . . . . 0.644 ' HG2' ' HA ' ' A' ' 485' ' ' PHE . 6.5 Cg_exo -79.6 41.64 1.15 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 124.18 3.253 . . . . 0.0 112.532 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -42.72 -36.77 1.53 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.904 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 491' ' ' ALA . . . . . . . . . . . . . . . -132.92 136.8 46.35 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.879 0.371 . . . . 0.0 111.934 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 492' ' ' ARG . . . . . 0.509 ' CD ' ' HG ' ' A' ' 585' ' ' LEU . 0.0 OUTLIER -134.37 134.86 42.2 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.855 179.101 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 493' ' ' VAL . . . . . 0.492 ' CG2' ' CA ' ' A' ' 513' ' ' GLY . 85.9 t -135.28 163.73 35.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.242 178.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 494' ' ' THR . . . . . 0.435 ' N ' ' CG1' ' A' ' 493' ' ' VAL . 1.3 m -125.72 135.89 52.58 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.323 0.582 . . . . 0.0 111.231 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 495' ' ' LEU . . . . . 0.534 ' HG ' ' CG2' ' A' ' 588' ' ' ILE . 2.1 pp -133.93 163.3 52.12 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 115.239 -0.892 . . . . 0.0 110.122 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 496' ' ' PRO . . . . . 0.471 ' O ' ' CD1' ' A' ' 495' ' ' LEU . 20.4 Cg_exo -63.36 118.67 5.58 Favored 'Trans proline' 0 CA--C 1.534 0.477 0 C-N-CA 121.712 1.608 . . . . 0.0 111.327 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 497' ' ' LYS . . . . . 0.442 ' HA ' ' HB ' ' A' ' 588' ' ' ILE . 8.6 tttm -50.19 -29.87 10.22 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -179.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 498' ' ' SER . . . . . 0.421 ' HA ' ' CE2' ' A' ' 501' ' ' TYR . 1.0 OUTLIER -56.3 -48.45 76.64 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 113.758 1.022 . . . . 0.0 113.758 -177.345 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 499' ' ' LEU . . . . . 0.447 HD22 ' HD2' ' A' ' 496' ' ' PRO . 0.7 OUTLIER -73.71 -8.43 55.95 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -178.542 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . 0.448 ' HA ' ' NZ ' ' A' ' 507' ' ' LYS . 1.7 p -74.73 -25.58 19.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.275 0.56 . . . . 0.0 111.613 -179.016 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 501' ' ' TYR . . . . . 0.635 ' O ' ' CG2' ' A' ' 564' ' ' THR . 6.7 m-30 -53.96 -30.61 47.61 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 114.217 1.192 . . . . 0.0 114.217 -178.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -77.38 -51.16 11.28 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.059 1.874 . . . . 0.0 116.059 -175.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 503' ' ' LYS . . . . . 0.558 ' O ' ' CG ' ' A' ' 507' ' ' LYS . 0.0 OUTLIER -121.2 136.12 55.03 Favored 'General case' 0 C--N 1.339 0.132 0 CA-C-N 118.885 0.766 . . . . 0.0 112.375 -179.109 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 504' ' ' THR . . . . . 0.421 ' O ' ' CG2' ' A' ' 508' ' ' VAL . 90.5 m -73.29 -75.68 0.14 Allowed 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 179.047 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . 0.472 ' CE1' ' HA ' ' A' ' 558' ' ' THR . 0.0 OUTLIER -74.87 -62.48 1.53 Allowed 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -178.888 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 506' ' ' SER . . . . . 0.802 ' O ' ' CD1' ' A' ' 510' ' ' TRP . 66.5 m -49.59 -73.23 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -175.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 507' ' ' LYS . . . . . 0.722 ' HD3' ' N ' ' A' ' 508' ' ' VAL . 0.0 OUTLIER -49.05 -48.89 43.59 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -176.425 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 508' ' ' VAL . . . . . 0.722 ' N ' ' HD3' ' A' ' 507' ' ' LYS . 47.7 t -55.83 -62.33 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.722 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 509' ' ' LEU . . . . . 0.554 ' CD1' ' N ' ' A' ' 510' ' ' TRP . 1.9 pp -49.9 -63.01 1.24 Allowed 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -177.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 510' ' ' TRP . . . . . 0.855 ' CD1' ' HA ' ' A' ' 518' ' ' LYS . 67.4 p-90 -72.89 -49.74 27.98 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 -176.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 511' ' ' SER . . . . . 0.507 ' N ' ' CE3' ' A' ' 510' ' ' TRP . 0.3 OUTLIER -62.87 -47.07 84.94 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.289 -0.869 . . . . 0.0 113.178 -176.81 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 512' ' ' ALA . . . . . 0.482 ' CB ' ' CD2' ' A' ' 495' ' ' LEU . . . -70.97 -73.5 0.17 Allowed 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 118.242 2.682 . . . . 0.0 118.242 -173.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 513' ' ' GLY . . . . . 0.492 ' CA ' ' CG2' ' A' ' 493' ' ' VAL . . . -114.67 -36.05 1.33 Allowed Glycine 0 CA--C 1.502 -0.743 0 N-CA-C 121.295 3.278 . . . . 0.0 121.295 -172.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 514' ' ' LEU . . . . . 0.464 ' CD1' ' HB2' ' A' ' 584' ' ' LYS . 1.6 mt -108.94 -43.21 4.26 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 120.053 3.353 . . . . 0.0 120.053 -170.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 515' ' ' VAL . . . . . 0.53 ' CG2' ' N ' ' A' ' 516' ' ' ALA . 3.8 p -154.0 172.12 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 117.721 2.489 . . . . 0.0 117.721 -171.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 516' ' ' ALA . . . . . 0.53 ' N ' ' CG2' ' A' ' 515' ' ' VAL . . . -68.42 3.97 1.54 Allowed 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 127.054 2.142 . . . . 0.0 110.238 177.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 517' ' ' SER . . . . . 0.813 ' O ' ' N ' ' A' ' 521' ' ' GLY . 0.4 OUTLIER -57.32 8.81 0.01 OUTLIER 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 115.575 1.695 . . . . 0.0 115.575 -171.853 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 518' ' ' LYS . . . . . 0.855 ' HA ' ' CD1' ' A' ' 510' ' ' TRP . 2.3 ttpt -46.37 -51.4 14.96 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 104.462 -2.422 . . . . 0.0 104.462 174.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 519' ' ' SER . . . . . . . . . . . . . 35.2 t -75.0 -57.01 4.17 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.101 173.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 520' ' ' GLU . . . . . 0.706 ' HB2' ' HA ' ' A' ' 517' ' ' SER . 0.3 OUTLIER -57.47 -48.0 80.35 Favored 'General case' 0 C--N 1.348 0.536 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.926 -178.97 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 521' ' ' GLY . . . . . 0.813 ' N ' ' O ' ' A' ' 517' ' ' SER . . . -49.46 -56.81 10.22 Favored Glycine 0 CA--C 1.493 -1.296 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.525 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -47.82 -47.32 31.24 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 523' ' ' ARG . . . . . 0.421 ' O ' ' HB3' ' A' ' 526' ' ' ASN . 0.5 OUTLIER -50.12 -48.79 53.32 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.785 178.557 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 524' ' ' ILE . . . . . 0.484 ' HA ' ' HB3' ' A' ' 527' ' ' ASN . 29.8 mm -59.36 -54.05 39.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.325 0.583 . . . . 0.0 110.043 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 525' ' ' ILE . . . . . 0.542 HG12 ' O ' ' A' ' 521' ' ' GLY . 1.3 mm -50.27 -47.3 25.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 177.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 526' ' ' ASN . . . . . 0.421 ' HB3' ' O ' ' A' ' 523' ' ' ARG . 1.0 OUTLIER -57.93 -47.85 81.63 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 114.607 -1.179 . . . . 0.0 108.325 177.142 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 527' ' ' ASN . . . . . 0.484 ' HB3' ' HA ' ' A' ' 524' ' ' ILE . 0.0 OUTLIER -47.73 -39.13 16.88 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 113.965 -1.471 . . . . 0.0 107.931 176.807 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 528' ' ' ASN . . . . . 0.769 ' HA ' ' CG2' ' A' ' 556' ' ' ILE . 14.1 t-20 75.17 40.61 0.33 Allowed 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 114.854 -1.066 . . . . 0.0 112.088 -179.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 529' ' ' GLY . . . . . . . . . . . . . . . -112.46 20.25 21.02 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 114.524 -1.217 . . . . 0.0 111.661 177.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 530' ' ' ALA . . . . . 0.777 ' O ' ' HB ' ' A' ' 556' ' ' ILE . . . -133.76 163.68 28.92 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -179.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 531' ' ' TYR . . . . . 0.505 ' CE2' ' HA ' ' A' ' 553' ' ' PHE . 0.0 OUTLIER -133.76 162.59 31.57 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 177.578 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 532' ' ' VAL . . . . . 0.587 ' HB ' ' HB ' ' A' ' 554' ' ' THR . 0.6 OUTLIER -127.47 135.06 64.32 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 CA-C-O 121.956 0.884 . . . . 0.0 111.819 179.131 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 533' ' ' GLY . . . . . 0.696 ' HA2' ' O ' ' A' ' 552' ' ' THR . . . -133.62 148.44 19.39 Favored Glycine 0 N--CA 1.445 -0.7 0 CA-C-N 114.252 -1.34 . . . . 0.0 113.496 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 534' ' ' SER . . . . . 0.41 ' CB ' ' HB3' ' A' ' 567' ' ' PHE . 0.1 OUTLIER -135.14 141.28 45.92 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 179.724 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 535' ' ' ARG . . . . . 0.645 ' O ' ' HB3' ' A' ' 573' ' ' LEU . 26.2 tpt85 -159.51 89.46 1.97 Allowed Pre-proline 0 N--CA 1.464 0.248 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.848 178.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 536' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -92.21 -84.94 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.364 2.71 . . . . 0.0 112.816 179.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 114.12 -10.04 22.71 Favored Glycine 0 C--N 1.334 0.418 0 C-N-CA 120.558 -0.83 . . . . 0.0 113.102 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 538' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -116.07 5.3 7.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-O 121.043 0.449 . . . . 0.0 111.569 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 539' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.81 146.54 1.58 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.708 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -127.78 -73.39 0.6 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.406 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 541' ' ' ASN . . . . . 0.511 ' O ' ' HD3' ' A' ' 543' ' ' PRO . 0.2 OUTLIER -59.62 102.27 0.14 Allowed 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.582 179.032 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 542' ' ' GLU . . . . . 0.54 ' O ' ' N ' ' A' ' 544' ' ' GLY . 1.1 mp0 -47.21 97.86 0.16 Allowed Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.768 -178.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 543' ' ' PRO . . . . . 0.511 ' HD3' ' O ' ' A' ' 541' ' ' ASN . 14.3 Cg_endo -52.66 55.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 124.407 3.404 . . . . 0.0 114.398 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . 0.571 ' O ' ' N ' ' A' ' 546' ' ' GLY . . . 52.91 56.07 20.44 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 119.366 -1.397 . . . . 0.0 111.394 -179.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 545' ' ' GLY . . . . . 0.487 ' O ' ' C ' ' A' ' 546' ' ' GLY . . . 55.65 -53.01 0.01 OUTLIER Glycine 0 CA--C 1.523 0.562 0 CA-C-O 119.015 -0.88 . . . . 0.0 113.86 -177.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . 0.583 ' O ' ' N ' ' A' ' 548' ' ' PRO . . . 31.02 55.87 0.27 Allowed Glycine 0 C--N 1.336 0.555 0 CA-C-N 118.742 1.271 . . . . 0.0 113.164 177.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 547' ' ' MET . . . . . 0.489 ' C ' ' O ' ' A' ' 546' ' ' GLY . 0.1 OUTLIER -6.88 -55.35 0.0 OUTLIER Pre-proline 0 N--CA 1.477 0.925 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 -177.437 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 548' ' ' PRO . . . . . 0.583 ' N ' ' O ' ' A' ' 546' ' ' GLY . 5.9 Cg_endo -88.14 119.56 1.23 Allowed 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 121.756 1.637 . . . . 0.0 110.992 178.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -126.14 -41.02 1.95 Allowed 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 550' ' ' ASP . . . . . 0.511 ' O ' ' HA ' ' A' ' 535' ' ' ARG . 11.4 m-20 -77.78 -39.37 44.22 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.053 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 551' ' ' LEU . . . . . 0.414 HD11 ' CE1' ' A' ' 553' ' ' PHE . 3.0 tp -131.25 140.76 49.89 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.951 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 552' ' ' THR . . . . . 0.696 ' O ' ' HA2' ' A' ' 533' ' ' GLY . 1.9 m -132.87 146.09 51.5 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.491 0.663 . . . . 0.0 110.98 178.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 553' ' ' PHE . . . . . 0.505 ' HA ' ' CE2' ' A' ' 531' ' ' TYR . 9.8 m-85 -134.39 137.01 43.75 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 177.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 554' ' ' THR . . . . . 0.587 ' HB ' ' HB ' ' A' ' 532' ' ' VAL . 21.7 m -133.94 138.62 31.14 Favored Pre-proline 0 C--N 1.303 -1.423 0 C-N-CA 119.42 -0.912 . . . . 0.0 110.045 178.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 555' ' ' PRO . . . . . 0.569 ' O ' HG23 ' A' ' 556' ' ' ILE . 85.6 Cg_endo -85.48 25.29 0.7 Allowed 'Trans proline' 0 N--CA 1.438 -1.771 0 C-N-CA 121.452 1.434 . . . . 0.0 109.857 178.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 556' ' ' ILE . . . . . 0.777 ' HB ' ' O ' ' A' ' 530' ' ' ALA . 1.4 tp 64.59 32.6 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 177.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -103.96 131.19 51.45 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 558' ' ' THR . . . . . 0.472 ' HA ' ' CE1' ' A' ' 505' ' ' PHE . 3.5 t -58.17 116.38 3.52 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 116.071 1.878 . . . . 0.0 116.071 -172.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 559' ' ' TRP . . . . . 0.639 ' CE3' ' HG3' ' A' ' 563' ' ' LYS . 1.3 m0 -139.33 111.49 7.46 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 104.414 -2.439 . . . . 0.0 104.414 173.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 560' ' ' ASN . . . . . 0.485 ' O ' ' HB ' ' A' ' 564' ' ' THR . 51.1 m-80 -90.98 -75.32 0.47 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 115.116 1.524 . . . . 0.0 115.116 -175.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 561' ' ' ALA . . . . . 0.456 ' O ' HG22 ' A' ' 564' ' ' THR . . . -73.76 -63.42 1.21 Allowed 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 115.729 1.751 . . . . 0.0 115.729 -176.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 562' ' ' SER . . . . . . . . . . . . . 69.2 m -48.83 -50.84 32.65 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -176.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 563' ' ' LYS . . . . . 0.639 ' HG3' ' CE3' ' A' ' 559' ' ' TRP . 1.2 mmpt? -71.2 -49.01 48.02 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -178.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 564' ' ' THR . . . . . 0.687 ' O ' ' HB ' ' A' ' 568' ' ' ILE . 3.4 t -51.17 -62.93 1.31 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.794 0.331 . . . . 0.0 110.709 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 565' ' ' GLN . . . . . 0.535 ' HA ' ' NE2' ' A' ' 565' ' ' GLN . 3.6 tp60 -50.23 -47.34 54.99 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.858 0.361 . . . . 0.0 111.28 178.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . 0.425 ' HG2' ' CD1' ' A' ' 567' ' ' PHE . 23.3 tt0 -49.2 -68.54 0.17 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -178.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 567' ' ' PHE . . . . . 0.625 ' C ' ' H ' ' A' ' 569' ' ' ILE . 0.2 OUTLIER -91.01 -51.85 5.14 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.397 0.618 . . . . 0.0 111.57 -179.094 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 568' ' ' ILE . . . . . 0.687 ' HB ' ' O ' ' A' ' 564' ' ' THR . 1.9 mp -56.17 8.98 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 114.83 -1.077 . . . . 0.0 113.259 -179.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 569' ' ' ILE . . . . . 0.625 ' H ' ' C ' ' A' ' 567' ' ' PHE . 1.3 pt -54.13 -36.39 32.13 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.728 0 N-CA-C 104.146 -2.538 . . . . 0.0 104.146 177.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 570' ' ' ASP . . . . . 0.518 ' OD2' HG23 ' A' ' 568' ' ' ILE . 28.4 m-20 35.39 54.84 0.83 Allowed 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 113.453 -1.703 . . . . 0.0 111.661 174.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -51.28 -44.89 52.62 Favored Glycine 0 N--CA 1.438 -1.169 0 C-N-CA 118.045 -2.026 . . . . 0.0 108.455 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 572' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -119.89 -17.12 8.57 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 175.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 573' ' ' LEU . . . . . 0.645 ' HB3' ' O ' ' A' ' 535' ' ' ARG . 0.9 OUTLIER -140.7 136.65 32.83 Favored 'General case' 0 C--N 1.354 0.768 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 -177.937 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 574' ' ' LEU . . . . . 0.511 ' HB2' ' OD2' ' A' ' 570' ' ' ASP . 0.7 OUTLIER -135.29 133.48 38.92 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 173.865 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 575' ' ' ILE . . . . . 0.584 HG13 ' O ' ' A' ' 533' ' ' GLY . 0.0 OUTLIER -133.48 137.19 53.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 119.133 0.879 . . . . 0.0 111.745 178.736 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 576' ' ' LEU . . . . . 0.562 HD22 ' HB3' ' A' ' 584' ' ' LYS . 0.0 OUTLIER -133.31 135.32 44.75 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 177.255 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 577' ' ' LYS . . . . . 0.451 ' CD ' ' CD1' ' A' ' 531' ' ' TYR . 0.2 OUTLIER -128.22 135.48 49.74 Favored 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.104 178.044 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.81 132.7 52.2 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 579' ' ' GLY . . . . . . . . . . . . . . . -88.51 -2.14 79.86 Favored Glycine 0 N--CA 1.438 -1.169 0 CA-C-N 114.759 -1.11 . . . . 0.0 112.962 -179.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 580' ' ' LYS . . . . . 0.458 ' HD2' ' CZ2' ' A' ' 581' ' ' TRP . 18.9 pttt -66.1 -50.46 63.96 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 118.891 -1.124 . . . . 0.0 108.047 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 581' ' ' TRP . . . . . 0.458 ' CZ2' ' HD2' ' A' ' 580' ' ' LYS . 0.0 OUTLIER -142.35 -52.03 0.4 Allowed 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 175.815 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 582' ' ' LYS . . . . . 0.411 ' HE3' ' CD1' ' A' ' 581' ' ' TRP . 0.4 OUTLIER -139.56 166.06 25.58 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 114.398 1.258 . . . . 0.0 114.398 -174.508 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 583' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -109.2 135.24 50.63 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 174.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 584' ' ' LYS . . . . . 0.652 ' NZ ' ' O ' ' A' ' 508' ' ' VAL . 1.1 tmmt? -114.8 133.85 55.6 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 178.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 585' ' ' LEU . . . . . 0.509 ' HG ' ' CD ' ' A' ' 492' ' ' ARG . 5.0 tp -122.38 136.69 54.94 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 586' ' ' VAL . . . . . 0.464 ' O ' ' HB3' ' A' ' 574' ' ' LEU . 9.5 t -132.91 144.58 36.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -178.043 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 587' ' ' SER . . . . . . . . . . . . . 2.9 m -109.83 136.35 49.28 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 177.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . 0.534 ' CG2' ' HG ' ' A' ' 495' ' ' LEU . 0.0 OUTLIER -132.7 136.74 55.38 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -177.958 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 5.6 m -133.07 137.06 54.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 114.356 -1.293 . . . . 0.0 110.688 178.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 590' ' ' SER . . . . . . . . . . . . . 2.6 m -82.27 147.58 28.84 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.449 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 591' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -50.67 -50.87 53.76 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.034 0.445 . . . . 0.0 110.776 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -52.2 -50.64 61.49 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.311 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 12.2 mmmt -50.13 -48.49 53.59 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.766 0.794 . . . . 0.0 108.927 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 594' ' ' PHE . . . . . 0.486 ' O ' ' HG ' ' A' ' 597' ' ' LEU . 0.9 OUTLIER -50.33 -47.83 55.66 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.465 -1.243 . . . . 0.0 109.694 178.125 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 595' ' ' LYS . . . . . 0.475 ' HE3' ' CE2' ' A' ' 604' ' ' TRP . 0.0 OUTLIER -48.7 -47.72 40.84 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.428 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 596' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -55.67 -62.5 1.65 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.744 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 597' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 594' ' ' PHE . 0.8 OUTLIER -56.87 -60.94 2.83 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 121.445 0.641 . . . . 0.0 112.108 -178.619 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 598' ' ' GLY . . . . . 0.468 ' O ' ' CD1' ' A' ' 604' ' ' TRP . . . -78.95 14.01 16.11 Favored Glycine 0 C--N 1.32 -0.34 0 CA-C-N 114.956 -1.02 . . . . 0.0 113.162 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 599' ' ' LEU . . . . . 0.449 ' HA ' ' CD1' ' A' ' 604' ' ' TRP . 4.5 pp -47.48 -15.73 0.05 Allowed 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -175.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 600' ' ' THR . . . . . . . . . . . . . 9.9 t -129.4 66.11 1.46 Allowed 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.247 176.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 601' ' ' ALA . . . . . . . . . . . . . . . -131.9 154.3 81.69 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.489 179.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 602' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.63 -21.19 45.7 Favored 'Trans proline' 0 N--CA 1.464 -0.207 0 C-N-CA 121.976 1.784 . . . . 0.0 111.097 178.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 603' ' ' GLY . . . . . . . . . . . . . . . -61.01 -49.14 81.88 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.669 -0.696 . . . . 0.0 113.079 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 604' ' ' TRP . . . . . 0.475 ' CE2' ' HE3' ' A' ' 595' ' ' LYS . 1.1 m95 -65.58 -46.74 78.26 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 120.856 0.36 . . . . 0.0 111.206 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 605' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -50.38 -59.8 3.63 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.271 -178.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.85 -58.69 7.39 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 607' ' ' VAL . . . . . . . . . . . . . 60.6 t -50.85 -71.86 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -178.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 608' ' ' VAL . . . . . . . . . . . . . 74.8 t -70.44 -60.34 2.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -177.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 609' ' ' GLY . . . . . . . . . . . . . . . -57.17 -62.87 5.87 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 121.146 -0.55 . . . . 0.0 113.291 -178.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 610' ' ' LYS . . . . . . . . . . . . . 17.6 tttt -62.72 -49.82 73.56 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.785 0.326 . . . . 0.0 110.98 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 74.32 54.45 6.18 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.552 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 29.2 mttt -59.0 -25.66 63.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.768 0.318 . . . . 0.0 111.036 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 613' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -77.0 172.94 12.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.824 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . 0.434 ' CB ' ' HD3' ' A' ' 615' ' ' PRO . 0.5 OUTLIER -58.44 -53.26 67.98 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.942 -179.95 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 615' ' ' PRO . . . . . 0.434 ' HD3' ' CB ' ' A' ' 614' ' ' GLU . 36.7 Cg_exo -59.92 85.54 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.402 2.068 . . . . 0.0 112.093 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 616' ' ' SER . . . . . . . . . . . . . 1.2 m -73.71 150.53 88.71 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.844 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo . . . . . 0 C--O 1.248 1.019 0 C-N-CA 122.651 2.234 . . . . 0.0 112.267 179.957 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 120.686 0.279 . . . . 0.0 111.523 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 455' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -81.56 153.52 17.9 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.527 2.152 . . . . 0.0 112.349 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 456' ' ' ARG . . . . . . . . . . . . . 29.4 mtm180 -71.18 -26.57 63.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.993 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 6.0 t -62.04 -31.31 71.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.96 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -59.7 126.74 28.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.111 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 25.1 p -89.27 155.46 49.07 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.866 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -52.13 151.65 16.34 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.649 2.233 . . . . 0.0 112.351 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . 102.67 56.6 0.81 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.499 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 41.5 p30 -86.74 148.56 46.31 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 120.657 0.265 . . . . 0.0 110.896 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -52.82 155.7 10.41 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.591 2.194 . . . . 0.0 112.279 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 5.8 tttt -75.75 160.15 30.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.863 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.74 22.15 8.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.104 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 7.0 p -63.43 -24.82 68.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.999 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.43 71.06 0.73 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.885 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -119.84 43.32 2.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.728 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 128.96 -35.83 2.54 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.261 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -119.03 117.78 29.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.88 0.372 . . . . 0.0 110.686 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 471' ' ' VAL . . . . . . . . . . . . . 10.7 p -113.11 108.41 25.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.138 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -151.09 85.79 4.99 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.946 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.79 159.77 47.67 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.545 2.164 . . . . 0.0 112.302 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -59.61 -42.92 93.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.873 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.02 -48.14 0.55 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.678 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 476' ' ' GLY . . . . . . . . . . . . . . . 92.21 -41.7 2.77 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.731 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 477' ' ' ASN . . . . . 0.419 ' N ' ' CD ' ' A' ' 478' ' ' PRO . 3.7 m-20 51.0 52.43 12.22 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-O 120.736 0.303 . . . . 0.0 111.151 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 478' ' ' PRO . . . . . 0.419 ' CD ' ' N ' ' A' ' 477' ' ' ASN . 73.6 Cg_endo -76.29 -44.16 0.26 Allowed 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.516 2.144 . . . . 0.0 112.469 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 33.5 t-80 -99.15 119.78 38.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.064 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -65.79 109.24 2.9 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.974 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -79.0 39.88 0.87 Allowed 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.956 2.437 . . . . 0.0 112.89 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 482' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.28 -40.03 64.38 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.127 0.489 . . . . 0.0 110.644 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 483' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -136.29 171.89 13.82 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.442 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 484' ' ' ASN . . . . . 0.543 ' O ' ' CD ' ' A' ' 489' ' ' PRO . 28.0 m-20 -105.0 -17.91 14.34 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.014 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 485' ' ' PHE . . . . . 0.631 ' HA ' ' HG2' ' A' ' 489' ' ' PRO . 18.4 m-85 -49.36 -47.44 47.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.514 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -70.81 -47.99 56.49 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -178.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.66 -73.83 0.17 Allowed 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -176.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 488' ' ' MET . . . . . 0.491 ' CB ' ' HD3' ' A' ' 489' ' ' PRO . 0.0 OUTLIER -52.42 -53.5 52.44 Favored Pre-proline 0 N--CA 1.47 0.567 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -177.354 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 489' ' ' PRO . . . . . 0.631 ' HG2' ' HA ' ' A' ' 485' ' ' PHE . 32.3 Cg_exo -65.09 43.28 0.14 Allowed 'Trans proline' 0 N--CA 1.476 0.485 0 C-N-CA 123.964 3.109 . . . . 0.0 113.979 -179.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 3.8 t -37.96 -42.44 0.63 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.672 0.272 . . . . 0.0 111.211 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 491' ' ' ALA . . . . . 0.417 ' CB ' ' NZ ' ' A' ' 584' ' ' LYS . . . -132.8 135.64 45.8 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.574 178.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 492' ' ' ARG . . . . . 0.443 ' CD ' ' CD2' ' A' ' 585' ' ' LEU . 0.0 OUTLIER -135.85 135.23 39.61 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.981 0.419 . . . . 0.0 111.851 179.883 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 493' ' ' VAL . . . . . 0.529 ' HB ' ' HA3' ' A' ' 513' ' ' GLY . 84.8 t -134.93 163.2 37.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.135 177.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 494' ' ' THR . . . . . 0.434 ' N ' ' CG1' ' A' ' 493' ' ' VAL . 5.3 t -122.49 134.86 54.56 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.143 0.497 . . . . 0.0 111.147 178.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 495' ' ' LEU . . . . . 0.513 HD21 HG22 ' A' ' 588' ' ' ILE . 0.0 OUTLIER -135.49 164.57 42.62 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.401 179.593 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 496' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -66.69 119.42 6.45 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 121.759 1.639 . . . . 0.0 110.918 178.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 497' ' ' LYS . . . . . 0.502 ' N ' HG21 ' A' ' 588' ' ' ILE . 5.6 tmtt? -53.81 -30.02 43.2 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -178.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 498' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.92 -48.36 82.01 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -177.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 2.2 pp -73.52 -8.87 57.71 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -178.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . 0.459 HG22 ' HA ' ' A' ' 497' ' ' LYS . 39.8 t -75.41 -25.4 17.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.21 0.528 . . . . 0.0 111.922 -179.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 501' ' ' TYR . . . . . 0.617 ' O ' ' CG2' ' A' ' 564' ' ' THR . 0.7 OUTLIER -52.95 -28.7 24.84 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -178.201 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.4 -50.08 17.0 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 115.563 1.69 . . . . 0.0 115.563 -175.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 503' ' ' LYS . . . . . 0.569 ' O ' ' CG ' ' A' ' 507' ' ' LYS . 0.5 OUTLIER -119.44 135.29 54.82 Favored 'General case' 0 C--N 1.338 0.074 0 CA-C-N 119.201 0.909 . . . . 0.0 111.843 -179.41 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 504' ' ' THR . . . . . 0.487 ' OG1' ' N ' ' A' ' 564' ' ' THR . 62.5 m -73.18 -76.61 0.12 Allowed 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . 0.497 ' CZ ' ' CD1' ' A' ' 556' ' ' ILE . 0.2 OUTLIER -75.08 -60.87 2.1 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -179.25 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 506' ' ' SER . . . . . 0.455 ' O ' ' HG ' ' A' ' 509' ' ' LEU . 1.4 m -48.82 -72.72 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 -176.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 507' ' ' LYS . . . . . 0.715 ' HD3' ' N ' ' A' ' 508' ' ' VAL . 0.0 OUTLIER -50.41 -48.92 55.96 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -176.878 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 508' ' ' VAL . . . . . 0.715 ' N ' ' HD3' ' A' ' 507' ' ' LYS . 47.9 t -52.66 -58.84 2.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -178.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 509' ' ' LEU . . . . . 0.578 ' CD1' ' N ' ' A' ' 510' ' ' TRP . 1.5 pp -58.16 -62.84 1.53 Allowed 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 -177.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 510' ' ' TRP . . . . . 0.615 ' CE3' ' HG3' ' A' ' 518' ' ' LYS . 6.0 p-90 -73.06 -52.49 14.15 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 114.706 1.372 . . . . 0.0 114.706 -176.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 511' ' ' SER . . . . . 0.486 ' N ' ' CE3' ' A' ' 510' ' ' TRP . 0.2 OUTLIER -61.87 -48.41 80.62 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.684 -176.893 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 512' ' ' ALA . . . . . 0.439 ' HB2' ' CD2' ' A' ' 495' ' ' LEU . . . -72.1 -73.77 0.18 Allowed 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 117.162 2.282 . . . . 0.0 117.162 -174.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 513' ' ' GLY . . . . . 0.65 ' HA3' ' HE3' ' A' ' 584' ' ' LYS . . . -115.23 -35.13 1.36 Allowed Glycine 0 N--CA 1.449 -0.477 0 N-CA-C 121.408 3.323 . . . . 0.0 121.408 -172.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 514' ' ' LEU . . . . . 0.582 ' HG ' ' HE2' ' A' ' 584' ' ' LYS . 1.3 mt -107.58 -38.73 5.82 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 120.09 3.367 . . . . 0.0 120.09 -170.013 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 515' ' ' VAL . . . . . 0.563 HG21 ' H ' ' A' ' 517' ' ' SER . 14.3 p -152.95 172.08 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 N-CA-C 118.108 2.633 . . . . 0.0 118.108 -172.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 516' ' ' ALA . . . . . 0.501 ' H ' ' CG2' ' A' ' 515' ' ' VAL . . . -85.94 2.69 45.15 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 127.055 2.142 . . . . 0.0 108.956 178.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 517' ' ' SER . . . . . 0.882 ' O ' ' N ' ' A' ' 521' ' ' GLY . 10.4 p -59.82 13.0 0.01 OUTLIER 'General case' 0 N--CA 1.424 -1.729 0 C-N-CA 126.326 1.85 . . . . 0.0 115.49 -173.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 518' ' ' LYS . . . . . 0.631 ' C ' ' O ' ' A' ' 517' ' ' SER . 2.1 mppt? -40.61 -44.36 2.1 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 178.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 519' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.37 -52.46 12.07 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.323 173.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 520' ' ' GLU . . . . . 0.815 ' HB2' ' HA ' ' A' ' 517' ' ' SER . 9.0 mm-40 -63.1 -46.81 85.6 Favored 'General case' 0 C--N 1.35 0.591 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.277 -179.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 521' ' ' GLY . . . . . 0.882 ' N ' ' O ' ' A' ' 517' ' ' SER . . . -49.16 -58.75 7.58 Favored Glycine 0 CA--C 1.495 -1.172 0 N-CA-C 111.344 -0.702 . . . . 0.0 111.344 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . 0.4 ' HA ' HG12 ' A' ' 525' ' ' ILE . 3.8 mt-30 -47.99 -47.89 32.8 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 178.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 523' ' ' ARG . . . . . 0.467 ' HB3' ' O ' ' A' ' 520' ' ' GLU . 0.4 OUTLIER -50.26 -48.75 54.67 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.823 178.945 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 524' ' ' ILE . . . . . 0.418 ' O ' ' ND2' ' A' ' 527' ' ' ASN . 6.0 mt -58.31 -54.86 27.06 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 CA-C-O 121.341 0.591 . . . . 0.0 109.745 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 525' ' ' ILE . . . . . 0.563 HG12 ' O ' ' A' ' 521' ' ' GLY . 1.0 OUTLIER -50.37 -47.6 26.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.091 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 526' ' ' ASN . . . . . . . . . . . . . 36.7 m-20 -58.2 -47.78 82.4 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 114.373 -1.285 . . . . 0.0 108.643 177.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 527' ' ' ASN . . . . . 0.418 ' ND2' ' O ' ' A' ' 524' ' ' ILE . 0.0 OUTLIER -47.69 -39.83 18.45 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 113.971 -1.468 . . . . 0.0 108.028 177.282 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 528' ' ' ASN . . . . . 0.687 ' HA ' ' CG2' ' A' ' 556' ' ' ILE . 14.6 t-20 73.99 39.85 0.49 Allowed 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.187 -179.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 529' ' ' GLY . . . . . . . . . . . . . . . -114.83 20.52 14.77 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 114.265 -1.334 . . . . 0.0 111.54 178.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 530' ' ' ALA . . . . . 0.774 ' O ' ' HB ' ' A' ' 556' ' ' ILE . . . -133.71 156.76 47.36 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.86 0.362 . . . . 0.0 111.649 -179.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 531' ' ' TYR . . . . . 0.514 ' CE1' ' CD1' ' A' ' 553' ' ' PHE . 0.1 OUTLIER -133.28 158.8 42.03 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 178.039 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 532' ' ' VAL . . . . . 0.569 ' CB ' ' HB ' ' A' ' 554' ' ' THR . 0.5 OUTLIER -125.52 135.78 62.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-O 122.025 0.917 . . . . 0.0 112.958 -178.301 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 533' ' ' GLY . . . . . 0.603 ' HA2' ' O ' ' A' ' 552' ' ' THR . . . -134.41 161.14 24.4 Favored Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 114.381 -1.281 . . . . 0.0 114.865 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 534' ' ' SER . . . . . 0.607 ' O ' ' HA ' ' A' ' 551' ' ' LEU . 6.7 t -133.8 137.28 45.01 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 114.912 -0.644 . . . . 0.0 110.628 178.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 535' ' ' ARG . . . . . 0.729 ' O ' ' HB3' ' A' ' 573' ' ' LEU . 7.1 tpt85 -159.83 90.46 1.85 Allowed Pre-proline 0 C--N 1.33 -0.276 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 178.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 536' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -71.25 -31.77 13.85 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.526 2.15 . . . . 0.0 112.21 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 69.08 55.99 9.7 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.528 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 538' ' ' VAL . . . . . 0.411 HG12 ' N ' ' A' ' 539' ' ' LYS . 12.9 p -116.22 -45.93 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 CA-C-O 121.021 0.438 . . . . 0.0 111.458 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 539' ' ' LYS . . . . . 0.411 ' N ' HG12 ' A' ' 538' ' ' VAL . 16.3 mttt -107.93 161.76 14.63 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.636 -178.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.81 30.56 4.3 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.93 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 541' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -96.24 99.52 11.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.106 0.479 . . . . 0.0 110.446 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -49.77 152.21 2.71 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.294 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 543' ' ' PRO . . . . . 0.403 ' HA ' ' CB ' ' A' ' 548' ' ' PRO . 9.2 Cg_endo -50.29 -44.0 40.86 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.953 2.435 . . . . 0.0 112.555 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . 0.556 ' O ' ' N ' ' A' ' 546' ' ' GLY . . . 51.2 27.26 14.93 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.879 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 545' ' ' GLY . . . . . 0.66 ' O ' ' N ' ' A' ' 547' ' ' MET . . . 53.7 -30.67 0.01 OUTLIER Glycine 0 CA--C 1.532 1.135 0 N-CA-C 115.749 1.06 . . . . 0.0 115.749 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 544' ' ' GLY . . . -51.75 54.48 0.01 OUTLIER Glycine 0 CA--C 1.528 0.888 0 CA-C-N 118.136 0.968 . . . . 0.0 115.051 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 547' ' ' MET . . . . . 0.66 ' N ' ' O ' ' A' ' 545' ' ' GLY . 35.5 mmt 51.14 53.3 13.51 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 117.963 0.882 . . . . 0.0 111.04 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 548' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 547' ' ' MET . 59.4 Cg_endo -71.55 166.5 29.2 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.853 2.368 . . . . 0.0 112.912 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -124.31 -21.71 4.89 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.187 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 550' ' ' ASP . . . . . 0.693 ' O ' ' HA ' ' A' ' 535' ' ' ARG . 1.3 t70 -58.75 -47.94 82.93 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 551' ' ' LEU . . . . . 0.607 ' HA ' ' O ' ' A' ' 534' ' ' SER . 7.9 tp -120.37 140.06 51.87 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 552' ' ' THR . . . . . 0.603 ' O ' ' HA2' ' A' ' 533' ' ' GLY . 3.2 m -133.39 148.0 51.79 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.861 0.839 . . . . 0.0 112.295 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 553' ' ' PHE . . . . . 0.514 ' CD1' ' CE1' ' A' ' 531' ' ' TYR . 0.3 OUTLIER -134.66 137.46 43.62 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 176.554 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 554' ' ' THR . . . . . 0.569 ' HB ' ' CB ' ' A' ' 532' ' ' VAL . 0.9 OUTLIER -132.83 138.11 31.18 Favored Pre-proline 0 C--N 1.31 -1.124 0 C-N-CA 119.474 -0.89 . . . . 0.0 110.338 179.304 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 555' ' ' PRO . . . . . 0.61 ' O ' HG23 ' A' ' 556' ' ' ILE . 61.0 Cg_endo -86.33 25.07 0.7 Allowed 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 122.208 1.938 . . . . 0.0 112.064 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 556' ' ' ILE . . . . . 0.774 ' HB ' ' O ' ' A' ' 530' ' ' ALA . 1.5 tp 64.4 33.11 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 115.714 1.746 . . . . 0.0 115.714 176.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . 0.59 ' O ' ' CE2' ' A' ' 559' ' ' TRP . 3.7 mttt -104.24 125.86 50.87 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 -179.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 558' ' ' THR . . . . . . . . . . . . . 2.8 t -58.13 117.64 4.6 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -173.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 559' ' ' TRP . . . . . 0.59 ' CE2' ' O ' ' A' ' 557' ' ' LYS . 0.0 OUTLIER -138.72 112.16 8.17 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 175.479 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 560' ' ' ASN . . . . . 0.609 ' O ' ' CG2' ' A' ' 564' ' ' THR . 26.2 m-80 -76.26 -76.27 0.17 Allowed 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 118.829 -1.149 . . . . 0.0 113.934 -175.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 561' ' ' ALA . . . . . 0.675 ' O ' HG22 ' A' ' 564' ' ' THR . . . -75.16 -55.04 6.13 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 116.241 1.941 . . . . 0.0 116.241 -177.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 562' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -49.31 -53.77 20.39 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -176.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 563' ' ' LYS . . . . . 0.578 ' HG3' ' CE2' ' A' ' 559' ' ' TRP . 2.4 mmtt -70.86 -47.55 58.7 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -178.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 564' ' ' THR . . . . . 0.675 HG22 ' O ' ' A' ' 561' ' ' ALA . 3.3 t -48.53 -67.45 0.27 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.7 0.286 . . . . 0.0 110.879 -178.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 565' ' ' GLN . . . . . 0.522 ' H ' HG21 ' A' ' 564' ' ' THR . 0.0 OUTLIER -48.86 -46.77 42.84 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.757 0.313 . . . . 0.0 111.055 179.16 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -49.66 -67.18 0.28 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -178.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 567' ' ' PHE . . . . . 0.511 ' O ' ' OG ' ' A' ' 534' ' ' SER . 0.3 OUTLIER -89.13 -41.02 12.52 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -177.932 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 568' ' ' ILE . . . . . 0.569 ' O ' ' CG ' ' A' ' 570' ' ' ASP . 0.6 OUTLIER -61.59 9.84 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 179.63 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 569' ' ' ILE . . . . . 0.496 ' H ' ' C ' ' A' ' 567' ' ' PHE . 2.7 pp -55.56 -45.02 78.57 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.317 0 N-CA-C 104.112 -2.551 . . . . 0.0 104.112 177.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 570' ' ' ASP . . . . . 0.601 ' CB ' ' O ' ' A' ' 573' ' ' LEU . 1.3 p30 31.29 60.17 0.27 Allowed 'General case' 0 CA--C 1.511 -0.554 0 CA-C-N 114.236 -1.347 . . . . 0.0 112.16 173.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -51.49 -45.22 53.77 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 117.423 -2.323 . . . . 0.0 109.08 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 572' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -119.35 -16.94 8.93 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 175.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 573' ' ' LEU . . . . . 0.729 ' HB3' ' O ' ' A' ' 535' ' ' ARG . 0.7 OUTLIER -140.29 137.94 34.57 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 -178.116 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 574' ' ' LEU . . . . . 0.459 ' HB2' HD11 ' A' ' 568' ' ' ILE . 0.1 OUTLIER -133.55 134.84 43.86 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 174.223 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 575' ' ' ILE . . . . . 0.558 HG13 ' O ' ' A' ' 533' ' ' GLY . 0.0 OUTLIER -133.04 136.98 54.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 C-N-CA 119.799 -0.76 . . . . 0.0 112.469 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 576' ' ' LEU . . . . . 0.494 ' CD1' ' CE1' ' A' ' 505' ' ' PHE . 0.0 OUTLIER -133.16 135.03 44.9 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 176.73 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 577' ' ' LYS . . . . . . . . . . . . . 2.9 mtpm? -133.4 135.4 44.61 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 118.762 -1.175 . . . . 0.0 111.232 178.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.413 ' HA ' ' HB2' ' A' ' 530' ' ' ALA . 0.3 OUTLIER -125.62 131.66 52.63 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.068 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 579' ' ' GLY . . . . . . . . . . . . . . . -91.3 -2.19 71.09 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.396 -0.82 . . . . 0.0 113.582 -178.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 580' ' ' LYS . . . . . 0.542 ' HD2' ' CG ' ' A' ' 581' ' ' TRP . 0.0 OUTLIER -72.8 -47.36 47.12 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 119.123 -1.031 . . . . 0.0 108.945 179.387 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 581' ' ' TRP . . . . . 0.542 ' CG ' ' HD2' ' A' ' 580' ' ' LYS . 32.5 m0 -138.49 -52.93 0.6 Allowed 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 177.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 582' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.68 165.29 27.65 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 -174.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 583' ' ' MET . . . . . 0.415 ' HE3' ' CG ' ' A' ' 488' ' ' MET . 0.3 OUTLIER -117.15 134.29 54.96 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 174.236 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 584' ' ' LYS . . . . . 0.65 ' HE3' ' HA3' ' A' ' 513' ' ' GLY . 0.1 OUTLIER -121.22 133.66 55.17 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.988 -1.005 . . . . 0.0 108.762 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 585' ' ' LEU . . . . . 0.574 ' N ' ' HD3' ' A' ' 584' ' ' LYS . 6.2 tt -118.23 135.55 54.2 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 178.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 586' ' ' VAL . . . . . 0.429 ' CG1' HD22 ' A' ' 495' ' ' LEU . 77.4 t -133.26 138.57 51.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 C-N-CA 120.506 -0.477 . . . . 0.0 111.538 -178.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 587' ' ' SER . . . . . 0.404 ' N ' HG12 ' A' ' 586' ' ' VAL . 0.9 OUTLIER -106.73 135.53 48.11 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 177.733 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . 0.513 HG22 HD21 ' A' ' 495' ' ' LEU . 0.1 OUTLIER -133.67 137.12 53.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -177.992 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 589' ' ' VAL . . . . . 0.437 ' N ' ' HB2' ' A' ' 497' ' ' LYS . 5.4 m -127.52 137.37 57.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 114.334 -1.303 . . . . 0.0 110.804 178.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 590' ' ' SER . . . . . . . . . . . . . 28.0 t -56.38 152.79 10.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.279 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 591' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -50.68 -48.98 58.37 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.859 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -60.74 -51.76 67.96 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -178.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 2.4 mttt -54.31 -56.54 17.48 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.466 0.65 . . . . 0.0 110.941 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 594' ' ' PHE . . . . . 0.534 ' O ' ' HG ' ' A' ' 597' ' ' LEU . 13.0 t80 -50.2 -47.11 54.83 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.569 179.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 595' ' ' LYS . . . . . 0.492 ' HG2' ' CE3' ' A' ' 604' ' ' TRP . 0.6 OUTLIER -49.41 -48.32 47.3 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.345 179.405 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 596' ' ' GLU . . . . . . . . . . . . . 54.1 tt0 -58.97 -59.66 5.1 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 597' ' ' LEU . . . . . 0.534 ' HG ' ' O ' ' A' ' 594' ' ' PHE . 2.9 pp -52.23 -50.38 62.12 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.182 0.515 . . . . 0.0 112.131 -178.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 598' ' ' GLY . . . . . 0.827 ' O ' ' CD1' ' A' ' 604' ' ' TRP . . . -94.49 11.38 70.24 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.769 -179.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 599' ' ' LEU . . . . . 0.441 ' HB3' ' O ' ' A' ' 595' ' ' LYS . 4.4 pp -50.04 -2.25 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -177.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 600' ' ' THR . . . . . 0.483 ' H ' ' C ' ' A' ' 598' ' ' GLY . 23.2 m -131.75 67.23 1.53 Allowed 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.883 0.849 . . . . 0.0 110.948 178.007 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 601' ' ' ALA . . . . . 0.567 ' CB ' ' HD2' ' A' ' 602' ' ' PRO . . . -131.63 -173.45 0.34 Allowed Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 114.231 -1.35 . . . . 0.0 109.563 179.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 602' ' ' PRO . . . . . 0.567 ' HD2' ' CB ' ' A' ' 601' ' ' ALA . 57.1 Cg_endo -72.23 -31.81 11.34 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 121.609 1.54 . . . . 0.0 112.529 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 603' ' ' GLY . . . . . . . . . . . . . . . -71.57 -48.78 27.64 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.983 -0.627 . . . . 0.0 113.201 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 604' ' ' TRP . . . . . 0.827 ' CD1' ' O ' ' A' ' 598' ' ' GLY . 2.1 m95 -70.99 -46.43 62.32 Favored 'General case' 0 CA--C 1.511 -0.547 0 C-N-CA 122.916 0.487 . . . . 0.0 111.554 -178.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 605' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -49.87 -60.6 2.76 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.665 -179.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.55 -60.68 3.33 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 607' ' ' VAL . . . . . . . . . . . . . 54.2 t -54.4 -72.27 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -178.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 608' ' ' VAL . . . . . . . . . . . . . 61.9 t -65.58 -58.84 5.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.384 -0.826 . . . . 0.0 113.202 -177.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 609' ' ' GLY . . . . . . . . . . . . . . . -59.14 -63.8 4.85 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 121.084 -0.579 . . . . 0.0 113.175 -178.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 610' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.67 -49.91 75.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.823 0.345 . . . . 0.0 110.837 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 85.8 56.42 2.35 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.569 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 8.4 pttt -97.81 37.01 1.44 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.825 0.345 . . . . 0.0 110.951 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 613' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -119.93 133.41 55.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.897 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . 0.409 ' CB ' ' CD ' ' A' ' 615' ' ' PRO . 2.8 mt-10 -59.62 -60.72 9.66 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.931 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 615' ' ' PRO . . . . . 0.409 ' CD ' ' CB ' ' A' ' 614' ' ' GLU . 62.9 Cg_endo -73.39 85.56 1.25 Allowed 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.484 2.123 . . . . 0.0 112.303 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 616' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.52 112.57 10.61 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.792 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo . . . . . 0 C--O 1.251 1.128 0 C-N-CA 122.421 2.081 . . . . 0.0 112.369 179.906 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 120.737 0.304 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 455' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.04 -30.05 21.58 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.541 2.161 . . . . 0.0 112.27 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 456' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -66.29 -26.58 67.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.004 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 73.4 p -100.03 31.6 3.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.975 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -107.08 130.37 54.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.101 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 59.6 p -104.43 154.05 38.65 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.814 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.1 117.37 5.07 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.495 2.13 . . . . 0.0 112.298 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . 99.8 56.59 0.95 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.544 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -97.61 148.51 34.55 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 120.74 0.305 . . . . 0.0 110.874 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -52.53 144.41 41.55 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.564 2.176 . . . . 0.0 112.293 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 6.7 tttt -107.77 128.71 54.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.928 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.63 22.31 15.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.123 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 38.3 p -54.05 -24.91 18.94 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.111 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 8.1 mp -102.88 83.69 2.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.878 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.17 43.46 2.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.954 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 129.1 -36.97 2.29 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.314 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -107.1 117.53 34.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.948 0.404 . . . . 0.0 110.526 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 471' ' ' VAL . . . . . . . . . . . . . 12.3 p -113.32 109.94 30.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.136 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -89.32 154.35 48.93 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.952 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -51.37 136.13 47.22 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.633 2.222 . . . . 0.0 112.429 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -136.08 -45.75 0.64 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.967 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.9 -27.24 51.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.08 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 476' ' ' GLY . . . . . . . . . . . . . . . 104.57 -24.98 27.18 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.62 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 7.3 p-10 43.97 53.16 10.09 Favored Pre-proline 0 CA--C 1.53 0.202 0 CA-C-O 120.796 0.331 . . . . 0.0 111.445 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -68.43 -18.82 43.78 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.584 2.189 . . . . 0.0 112.585 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -56.47 127.1 29.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.974 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 480' ' ' ALA . . . . . 0.426 ' CB ' ' CD ' ' A' ' 481' ' ' PRO . . . -140.35 177.91 1.8 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.087 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 481' ' ' PRO . . . . . 0.426 ' CD ' ' CB ' ' A' ' 480' ' ' ALA . 5.8 Cg_exo -78.64 40.01 0.86 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 123.167 2.578 . . . . 0.0 112.76 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 482' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -71.36 -61.12 1.89 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.716 0.293 . . . . 0.0 110.69 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 483' ' ' THR . . . . . . . . . . . . . 16.2 p -116.01 65.79 0.7 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.174 0.511 . . . . 0.0 111.137 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 484' ' ' ASN . . . . . 0.545 ' O ' ' HD3' ' A' ' 489' ' ' PRO . 2.2 m120 -130.73 -69.5 0.64 Allowed 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 485' ' ' PHE . . . . . 0.538 ' O ' ' HG2' ' A' ' 489' ' ' PRO . 67.6 m-85 -71.67 -46.73 57.99 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.731 177.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -72.13 -47.47 50.86 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.073 -0.967 . . . . 0.0 113.287 -178.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -70.76 -72.65 0.2 Allowed 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -176.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 488' ' ' MET . . . . . 0.481 ' CB ' ' HD3' ' A' ' 489' ' ' PRO . 2.5 ttt -51.29 -52.77 56.1 Favored Pre-proline 0 N--CA 1.47 0.531 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -177.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 489' ' ' PRO . . . . . 0.545 ' HD3' ' O ' ' A' ' 484' ' ' ASN . 11.1 Cg_exo -76.45 42.34 1.02 Allowed 'Trans proline' 0 CA--C 1.528 0.219 0 C-N-CA 123.82 3.013 . . . . 0.0 112.38 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -38.39 -30.66 0.04 OUTLIER 'General case' 0 C--O 1.232 0.134 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -179.036 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 491' ' ' ALA . . . . . . . . . . . . . . . -132.77 136.51 46.37 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.44 -0.504 . . . . 0.0 112.1 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 492' ' ' ARG . . . . . 0.415 ' HD2' HD22 ' A' ' 585' ' ' LEU . 0.0 OUTLIER -136.12 134.37 38.24 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.957 178.438 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 493' ' ' VAL . . . . . 0.632 ' CG2' ' HA3' ' A' ' 513' ' ' GLY . 11.2 m -136.2 163.81 33.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.816 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 9.0 t -120.2 133.36 55.51 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 121.043 0.449 . . . . 0.0 110.305 177.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 495' ' ' LEU . . . . . 0.487 ' CD1' ' CG2' ' A' ' 500' ' ' VAL . 1.6 pp -136.2 163.16 52.07 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.928 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 496' ' ' PRO . . . . . 0.446 ' O ' ' CD1' ' A' ' 495' ' ' LEU . 14.7 Cg_exo -67.35 119.3 6.31 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 122.313 2.008 . . . . 0.0 112.152 178.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 497' ' ' LYS . . . . . 0.528 ' HA ' ' HB ' ' A' ' 588' ' ' ILE . 20.1 tttt -51.85 -30.37 23.37 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -179.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 498' ' ' SER . . . . . . . . . . . . . 11.9 t -60.29 -48.35 82.11 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -177.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 499' ' ' LEU . . . . . 0.416 HD21 ' HB2' ' A' ' 496' ' ' PRO . 2.0 pp -74.18 -8.67 57.0 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -178.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . 0.487 ' CG2' ' CD1' ' A' ' 495' ' ' LEU . 13.8 t -75.45 -26.01 18.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.099 0.476 . . . . 0.0 112.239 -178.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 501' ' ' TYR . . . . . 0.491 ' O ' ' CG2' ' A' ' 564' ' ' THR . 6.3 m-85 -53.94 -30.61 47.27 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -178.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -75.82 -50.21 15.82 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 115.456 1.651 . . . . 0.0 115.456 -175.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 503' ' ' LYS . . . . . 0.61 ' O ' ' CG ' ' A' ' 507' ' ' LYS . 0.2 OUTLIER -119.2 132.57 55.96 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 118.79 0.723 . . . . 0.0 111.776 -179.323 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 504' ' ' THR . . . . . 0.508 ' OG1' ' N ' ' A' ' 564' ' ' THR . 4.6 m -72.96 -75.62 0.14 Allowed 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . 0.631 ' CE1' ' HA ' ' A' ' 558' ' ' THR . 0.0 OUTLIER -74.71 -62.69 1.45 Allowed 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 -179.107 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 506' ' ' SER . . . . . 0.758 ' O ' ' CD1' ' A' ' 510' ' ' TRP . 66.6 m -49.15 -72.81 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -175.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 507' ' ' LYS . . . . . 0.717 ' HD3' ' N ' ' A' ' 508' ' ' VAL . 0.0 OUTLIER -48.7 -48.49 40.24 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -176.153 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 508' ' ' VAL . . . . . 0.717 ' N ' ' HD3' ' A' ' 507' ' ' LYS . 61.3 t -54.76 -57.76 5.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -179.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 509' ' ' LEU . . . . . 0.612 ' HG ' ' H ' ' A' ' 510' ' ' TRP . 2.0 pp -59.64 -63.45 1.3 Allowed 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 -177.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 510' ' ' TRP . . . . . 0.758 ' CD1' ' O ' ' A' ' 506' ' ' SER . 63.7 p-90 -72.75 -49.69 29.34 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -176.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 511' ' ' SER . . . . . 0.523 ' N ' ' CD2' ' A' ' 510' ' ' TRP . 0.3 OUTLIER -62.75 -48.24 80.06 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.658 -177.014 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 512' ' ' ALA . . . . . 0.43 ' CB ' ' CD2' ' A' ' 495' ' ' LEU . . . -71.79 -75.18 0.14 Allowed 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 117.011 2.226 . . . . 0.0 117.011 -174.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 513' ' ' GLY . . . . . 0.632 ' HA3' ' CG2' ' A' ' 493' ' ' VAL . . . -117.63 -35.23 1.09 Allowed Glycine 0 CA--C 1.501 -0.787 0 N-CA-C 120.778 3.071 . . . . 0.0 120.778 -173.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 514' ' ' LEU . . . . . 0.7 ' HB3' HG22 ' A' ' 515' ' ' VAL . 0.0 OUTLIER -96.67 -46.95 6.09 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 119.542 3.164 . . . . 0.0 119.542 -168.746 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 515' ' ' VAL . . . . . 0.7 HG22 ' HB3' ' A' ' 514' ' ' LEU . 22.0 t -151.2 171.25 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 117.196 2.295 . . . . 0.0 117.196 -172.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 516' ' ' ALA . . . . . 0.499 ' H ' ' CG1' ' A' ' 515' ' ' VAL . . . -73.59 2.88 7.07 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 112.558 -2.11 . . . . 0.0 108.67 175.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 517' ' ' SER . . . . . 0.852 ' HA ' ' HB2' ' A' ' 520' ' ' GLU . 0.6 OUTLIER -58.33 9.6 0.01 OUTLIER 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 116.004 1.853 . . . . 0.0 116.004 -172.024 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 518' ' ' LYS . . . . . 0.755 ' HA ' ' CD1' ' A' ' 510' ' ' TRP . 0.0 OUTLIER -45.1 -48.26 12.04 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 175.841 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 519' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -75.21 -56.31 4.85 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.172 173.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 520' ' ' GLU . . . . . 0.852 ' HB2' ' HA ' ' A' ' 517' ' ' SER . 2.0 mm-40 -59.64 -47.58 85.05 Favored 'General case' 0 C--N 1.35 0.588 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.228 -178.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 521' ' ' GLY . . . . . 0.785 ' N ' ' O ' ' A' ' 517' ' ' SER . . . -49.01 -54.2 15.52 Favored Glycine 0 CA--C 1.496 -1.108 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -48.62 -47.3 40.2 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 523' ' ' ARG . . . . . 0.404 ' O ' ' N ' ' A' ' 527' ' ' ASN . 0.0 OUTLIER -49.9 -48.92 51.27 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.725 178.667 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 524' ' ' ILE . . . . . 0.434 ' CG2' ' HG2' ' A' ' 580' ' ' LYS . 28.1 mm -57.33 -55.92 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 CA-C-O 121.403 0.62 . . . . 0.0 109.725 179.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 525' ' ' ILE . . . . . 0.48 HG12 ' O ' ' A' ' 521' ' ' GLY . 1.5 mm -50.28 -47.4 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 177.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 526' ' ' ASN . . . . . . . . . . . . . 36.6 m-20 -57.63 -47.76 81.32 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 114.633 -1.167 . . . . 0.0 108.5 177.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 527' ' ' ASN . . . . . 0.427 ' ND2' ' O ' ' A' ' 524' ' ' ILE . 0.0 OUTLIER -47.94 -39.54 19.52 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 113.971 -1.468 . . . . 0.0 107.715 176.891 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 528' ' ' ASN . . . . . 0.747 ' HA ' ' CG2' ' A' ' 556' ' ' ILE . 2.5 t30 74.31 39.99 0.45 Allowed 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 114.631 -1.168 . . . . 0.0 111.633 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 529' ' ' GLY . . . . . . . . . . . . . . . -114.22 25.6 10.46 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 114.324 -1.307 . . . . 0.0 111.192 177.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 530' ' ' ALA . . . . . 0.807 ' O ' ' HB ' ' A' ' 556' ' ' ILE . . . -133.49 159.48 40.27 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.095 0.474 . . . . 0.0 112.046 -179.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 531' ' ' TYR . . . . . 0.52 ' CE2' ' CD2' ' A' ' 553' ' ' PHE . 0.0 OUTLIER -134.04 158.52 43.34 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 177.508 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 532' ' ' VAL . . . . . 0.482 HG12 ' OG1' ' A' ' 554' ' ' THR . 0.4 OUTLIER -126.69 135.59 63.26 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 C-N-CA 119.401 -0.919 . . . . 0.0 112.356 -179.758 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 533' ' ' GLY . . . . . 0.641 ' HA2' ' O ' ' A' ' 552' ' ' THR . . . -133.83 154.07 21.16 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 114.43 -1.259 . . . . 0.0 114.078 -179.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 534' ' ' SER . . . . . 0.49 ' N ' ' HB ' ' A' ' 552' ' ' THR . 44.7 t -134.16 137.08 44.23 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.303 -0.449 . . . . 0.0 111.37 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 535' ' ' ARG . . . . . 0.676 ' O ' ' HB3' ' A' ' 573' ' ' LEU . 0.0 OUTLIER -160.38 90.56 1.72 Allowed Pre-proline 0 C--N 1.329 -0.326 0 C-N-CA 120.305 -0.558 . . . . 0.0 112.452 178.118 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 536' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -72.63 -38.0 3.6 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.521 2.147 . . . . 0.0 112.18 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 84.23 52.62 3.54 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.476 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 538' ' ' VAL . . . . . 0.407 HG12 ' N ' ' A' ' 539' ' ' LYS . 11.9 p -116.23 -45.98 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 CA-C-O 121.06 0.457 . . . . 0.0 111.413 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 539' ' ' LYS . . . . . 0.407 ' N ' HG12 ' A' ' 538' ' ' VAL . 0.3 OUTLIER -107.97 162.06 14.37 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.359 -178.66 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.52 30.77 5.12 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.876 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 541' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -95.12 99.72 11.66 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.174 0.512 . . . . 0.0 110.668 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 542' ' ' GLU . . . . . 0.401 ' CB ' ' CD ' ' A' ' 543' ' ' PRO . 0.1 OUTLIER -49.06 176.05 0.04 OUTLIER Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.269 -179.84 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 543' ' ' PRO . . . . . 0.437 ' HA ' ' CB ' ' A' ' 548' ' ' PRO . 86.3 Cg_exo -45.0 -51.59 7.38 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.636 2.224 . . . . 0.0 112.781 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . 0.61 ' O ' ' N ' ' A' ' 546' ' ' GLY . . . 50.97 23.32 7.1 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.782 -0.723 . . . . 0.0 113.212 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 545' ' ' GLY . . . . . 0.634 ' O ' ' N ' ' A' ' 547' ' ' MET . . . 53.15 -46.13 0.01 OUTLIER Glycine 0 CA--C 1.531 1.046 0 N-CA-C 115.594 0.998 . . . . 0.0 115.594 179.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . 0.61 ' N ' ' O ' ' A' ' 544' ' ' GLY . . . -50.51 54.95 0.01 OUTLIER Glycine 0 CA--C 1.529 0.913 0 N-CA-C 115.522 0.969 . . . . 0.0 115.522 -178.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 547' ' ' MET . . . . . 0.634 ' N ' ' O ' ' A' ' 545' ' ' GLY . 11.6 mmt 51.24 53.67 13.94 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 117.804 0.802 . . . . 0.0 111.51 179.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 548' ' ' PRO . . . . . 0.437 ' CB ' ' HA ' ' A' ' 543' ' ' PRO . 9.5 Cg_endo -52.67 166.56 0.79 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.944 2.429 . . . . 0.0 112.754 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -124.21 -25.57 4.12 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.216 179.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 550' ' ' ASP . . . . . 0.532 ' O ' ' HA ' ' A' ' 535' ' ' ARG . 4.4 m-20 -59.34 -46.95 87.2 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.23 179.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 551' ' ' LEU . . . . . . . . . . . . . 15.9 tp -131.48 139.87 49.43 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.184 -0.917 . . . . 0.0 108.968 178.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 552' ' ' THR . . . . . 0.641 ' O ' ' HA2' ' A' ' 533' ' ' GLY . 23.6 m -133.43 148.15 51.76 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.667 0.746 . . . . 0.0 111.933 179.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 553' ' ' PHE . . . . . 0.52 ' CD2' ' CE2' ' A' ' 531' ' ' TYR . 9.6 m-85 -134.59 137.07 43.42 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 176.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 554' ' ' THR . . . . . 0.489 HG23 ' HD2' ' A' ' 555' ' ' PRO . 2.8 m -133.21 139.03 32.95 Favored Pre-proline 0 C--N 1.306 -1.309 0 C-N-CA 119.745 -0.782 . . . . 0.0 109.554 178.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 555' ' ' PRO . . . . . 0.642 ' O ' HG22 ' A' ' 556' ' ' ILE . 81.2 Cg_endo -83.37 21.76 1.0 Allowed 'Trans proline' 0 N--CA 1.445 -1.324 0 C-N-CA 121.493 1.462 . . . . 0.0 111.878 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 556' ' ' ILE . . . . . 0.807 ' HB ' ' O ' ' A' ' 530' ' ' ALA . 2.0 tp 63.74 32.65 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 177.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 4.0 tttm -104.07 120.06 40.28 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 558' ' ' THR . . . . . 0.631 ' HA ' ' CE1' ' A' ' 505' ' ' PHE . 8.4 t -57.85 116.66 3.6 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 115.988 1.847 . . . . 0.0 115.988 -172.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 559' ' ' TRP . . . . . 0.495 ' HB2' ' HB2' ' A' ' 563' ' ' LYS . 1.0 OUTLIER -138.4 111.19 7.68 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 103.638 -2.727 . . . . 0.0 103.638 173.796 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 560' ' ' ASN . . . . . 0.474 ' O ' ' CG2' ' A' ' 564' ' ' THR . 30.2 m120 -68.91 -75.87 0.1 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 -174.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 561' ' ' ALA . . . . . 0.624 ' HA ' ' CG2' ' A' ' 564' ' ' THR . . . -74.24 -48.77 26.59 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 -177.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 562' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.41 -54.72 16.03 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -177.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 563' ' ' LYS . . . . . 0.495 ' HB2' ' HB2' ' A' ' 559' ' ' TRP . 0.0 OUTLIER -69.32 -48.63 60.91 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.087 0.402 . . . . 0.0 112.087 -178.653 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 564' ' ' THR . . . . . 0.624 ' CG2' ' HA ' ' A' ' 561' ' ' ALA . 5.5 t -49.77 -71.32 0.07 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.661 0.267 . . . . 0.0 111.698 -178.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 565' ' ' GLN . . . . . 0.551 ' H ' ' CG2' ' A' ' 564' ' ' THR . 0.0 OUTLIER -48.73 -46.91 41.59 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.658 0.266 . . . . 0.0 111.66 179.966 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -49.98 -61.75 1.96 Allowed 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -178.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 567' ' ' PHE . . . . . 0.548 ' CE1' HD11 ' A' ' 568' ' ' ILE . 0.1 OUTLIER -96.66 -31.23 12.81 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -177.145 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 568' ' ' ILE . . . . . 0.548 HD11 ' CE1' ' A' ' 567' ' ' PHE . 1.0 OUTLIER -73.12 8.73 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.06 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -179.24 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 569' ' ' ILE . . . . . 0.428 ' CD1' ' N ' ' A' ' 570' ' ' ASP . 2.7 pp -53.57 -38.52 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 N-CA-C 104.709 -2.33 . . . . 0.0 104.709 178.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 570' ' ' ASP . . . . . 0.637 ' OD2' ' HB3' ' A' ' 574' ' ' LEU . 9.7 t0 33.14 60.29 0.44 Allowed 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 114.179 -1.373 . . . . 0.0 111.936 172.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -55.06 -46.27 78.56 Favored Glycine 0 N--CA 1.439 -1.152 0 C-N-CA 116.861 -2.59 . . . . 0.0 107.784 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 572' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -120.85 -17.42 7.91 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 174.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 573' ' ' LEU . . . . . 0.676 ' HB3' ' O ' ' A' ' 535' ' ' ARG . 0.7 OUTLIER -140.57 137.49 33.76 Favored 'General case' 0 C--N 1.355 0.83 0 N-CA-C 116.175 1.917 . . . . 0.0 116.175 -177.848 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 574' ' ' LEU . . . . . 0.637 ' HB3' ' OD2' ' A' ' 570' ' ' ASP . 0.0 OUTLIER -134.92 134.1 40.28 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 173.612 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 575' ' ' ILE . . . . . 0.624 HG13 ' O ' ' A' ' 533' ' ' GLY . 0.0 OUTLIER -133.13 137.07 54.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-O 121.564 0.697 . . . . 0.0 111.818 179.393 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 576' ' ' LEU . . . . . 0.511 ' CD2' ' HB3' ' A' ' 584' ' ' LYS . 0.0 OUTLIER -133.19 135.8 45.3 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 177.25 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 577' ' ' LYS . . . . . . . . . . . . . 3.9 mtpt -129.98 135.38 48.24 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.656 178.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.453 ' HA ' ' HB1' ' A' ' 530' ' ' ALA . 0.2 OUTLIER -124.99 131.79 53.36 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 177.739 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 579' ' ' GLY . . . . . . . . . . . . . . . -90.78 -1.94 72.93 Favored Glycine 0 N--CA 1.442 -0.965 0 CA-C-N 115.169 -0.923 . . . . 0.0 113.494 -178.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 580' ' ' LYS . . . . . 0.545 ' HD2' ' CG ' ' A' ' 581' ' ' TRP . 3.0 pptp? -72.53 -47.73 46.0 Favored 'General case' 0 N--CA 1.438 -1.046 0 C-N-CA 118.851 -1.14 . . . . 0.0 108.726 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 581' ' ' TRP . . . . . 0.545 ' CG ' ' HD2' ' A' ' 580' ' ' LYS . 33.3 m0 -138.84 -53.21 0.58 Allowed 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 177.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 582' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.44 165.53 27.17 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 -174.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 583' ' ' MET . . . . . . . . . . . . . 1.1 ttt -109.32 134.89 51.24 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 173.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 584' ' ' LYS . . . . . 0.555 ' HB2' ' HG ' ' A' ' 514' ' ' LEU . 5.5 tppt? -120.08 133.77 55.43 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 178.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 585' ' ' LEU . . . . . 0.489 ' N ' ' HD3' ' A' ' 584' ' ' LYS . 5.8 tt -120.0 136.38 54.57 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 -179.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 586' ' ' VAL . . . . . 0.47 ' O ' ' HB3' ' A' ' 574' ' ' LEU . 72.0 t -133.31 137.65 52.82 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.813 -178.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 587' ' ' SER . . . . . 0.432 ' N ' HG12 ' A' ' 586' ' ' VAL . 1.9 m -109.83 136.5 49.04 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 177.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . 0.528 ' HB ' ' HA ' ' A' ' 497' ' ' LYS . 3.3 pt -133.35 136.35 54.95 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 -178.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 3.8 t -133.74 138.15 51.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 114.022 -1.445 . . . . 0.0 110.287 178.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 590' ' ' SER . . . . . . . . . . . . . 6.9 m -68.12 126.77 30.57 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.254 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 591' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -50.24 -50.05 51.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.136 0.493 . . . . 0.0 110.063 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -51.64 -49.52 62.12 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.176 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 25.4 mtpt -51.08 -48.77 61.55 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.781 0.8 . . . . 0.0 109.257 179.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 594' ' ' PHE . . . . . 0.546 ' O ' ' HG ' ' A' ' 597' ' ' LEU . 0.8 OUTLIER -50.24 -48.41 54.65 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 114.543 -1.208 . . . . 0.0 109.648 178.153 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 595' ' ' LYS . . . . . 0.517 ' O ' ' HB3' ' A' ' 599' ' ' LEU . 0.0 OUTLIER -49.42 -48.2 47.45 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.263 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 596' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -52.56 -56.88 12.2 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.43 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 597' ' ' LEU . . . . . 0.546 ' HG ' ' O ' ' A' ' 594' ' ' PHE . 0.6 OUTLIER -64.82 -62.46 1.55 Allowed 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.376 0.608 . . . . 0.0 112.015 -178.767 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 598' ' ' GLY . . . . . 0.487 ' O ' ' CD1' ' A' ' 604' ' ' TRP . . . -77.8 13.45 13.08 Favored Glycine 0 C--N 1.32 -0.324 0 CA-C-N 115.119 -0.946 . . . . 0.0 113.573 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 599' ' ' LEU . . . . . 0.517 ' HB3' ' O ' ' A' ' 595' ' ' LYS . 2.6 pp -47.47 -15.18 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -175.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 600' ' ' THR . . . . . . . . . . . . . 11.0 t -131.98 66.79 1.54 Allowed 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.827 176.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 601' ' ' ALA . . . . . . . . . . . . . . . -131.47 167.56 21.33 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.477 179.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 602' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.01 -12.15 31.88 Favored 'Trans proline' 0 N--CA 1.465 -0.2 0 C-N-CA 122.225 1.95 . . . . 0.0 111.262 178.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 603' ' ' GLY . . . . . . . . . . . . . . . -70.81 -48.95 31.53 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.675 -0.693 . . . . 0.0 113.037 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 604' ' ' TRP . . . . . 0.511 ' HA ' ' HE3' ' A' ' 604' ' ' TRP . 1.0 OUTLIER -64.03 -46.41 84.58 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 120.734 0.302 . . . . 0.0 111.58 -179.344 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 605' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -50.75 -52.29 42.01 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.863 0.364 . . . . 0.0 110.363 -178.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -61.18 -63.06 1.42 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.482 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 607' ' ' VAL . . . . . . . . . . . . . 41.9 t -50.75 -71.31 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -178.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 608' ' ' VAL . . . . . . . . . . . . . 96.1 t -69.59 -58.66 4.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -177.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 609' ' ' GLY . . . . . . . . . . . . . . . -59.83 -63.58 4.96 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.007 -0.616 . . . . 0.0 113.381 -178.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 610' ' ' LYS . . . . . . . . . . . . . 11.4 mttt -70.5 -71.77 0.23 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.785 0.326 . . . . 0.0 111.036 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 101.99 46.85 1.54 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.456 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 20.5 tttt -99.34 38.93 1.34 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.839 0.352 . . . . 0.0 110.999 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 613' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -74.88 172.37 12.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.858 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . 0.404 ' CB ' ' CD ' ' A' ' 615' ' ' PRO . 7.3 mt-10 -62.74 -60.81 8.85 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.904 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 615' ' ' PRO . . . . . 0.404 ' CD ' ' CB ' ' A' ' 614' ' ' GLU . 59.1 Cg_endo -72.0 108.4 2.45 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.625 2.217 . . . . 0.0 112.267 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 616' ' ' SER . . . . . . . . . . . . . 43.2 t -67.52 111.1 6.5 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.902 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo . . . . . 0 C--O 1.249 1.046 0 C-N-CA 122.435 2.09 . . . . 0.0 112.306 -179.996 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 4.0 ptt? . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.741 0.305 . . . . 0.0 111.211 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 455' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.89 161.67 45.06 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.629 2.219 . . . . 0.0 112.288 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 456' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -85.1 -26.54 26.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.065 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 20.6 p -97.38 38.69 1.24 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.916 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -75.43 93.07 2.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.084 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 1.2 m -90.62 163.62 29.71 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.966 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -69.49 -174.7 0.9 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.604 2.202 . . . . 0.0 112.25 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . 107.04 40.77 1.77 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.507 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -94.71 162.83 24.26 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.775 0.321 . . . . 0.0 110.897 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -51.74 112.46 0.84 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.63 2.22 . . . . 0.0 112.308 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.21 119.81 39.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.852 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 1.3 m -115.83 -76.42 0.57 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.952 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -75.43 -25.97 57.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.981 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -106.31 71.13 0.86 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.889 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -114.93 42.89 2.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.785 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 128.96 -36.93 2.31 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.251 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -114.63 117.75 31.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.823 0.344 . . . . 0.0 110.603 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 471' ' ' VAL . . . . . . . . . . . . . 10.9 p -113.19 108.34 25.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.092 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 22.7 p30 -136.0 148.43 64.83 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.868 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.16 108.69 0.28 Allowed 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.561 2.174 . . . . 0.0 112.283 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -107.16 -34.03 7.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.833 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 11.1 p -103.27 -30.14 10.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.96 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 476' ' ' GLY . . . . . . . . . . . . . . . 130.96 -23.51 4.39 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.649 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 477' ' ' ASN . . . . . 0.422 ' N ' ' CD ' ' A' ' 478' ' ' PRO . 7.2 p-10 43.93 51.87 8.37 Favored Pre-proline 0 N--CA 1.463 0.202 0 CA-C-O 120.776 0.322 . . . . 0.0 111.442 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 478' ' ' PRO . . . . . 0.422 ' CD ' ' N ' ' A' ' 477' ' ' ASN . 72.0 Cg_endo -76.76 -22.67 11.66 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.614 2.209 . . . . 0.0 112.498 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -61.72 84.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.005 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -140.47 131.54 13.95 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.801 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -47.03 -79.12 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.315 2.01 . . . . 0.0 112.359 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 482' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.09 -72.01 0.46 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.294 0.569 . . . . 0.0 109.724 179.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 483' ' ' THR . . . . . . . . . . . . . 88.3 m -137.12 157.49 46.57 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.294 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 484' ' ' ASN . . . . . 0.484 ' O ' ' CD ' ' A' ' 489' ' ' PRO . 7.4 t-20 -94.59 -34.7 12.53 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 485' ' ' PHE . . . . . 0.711 ' HA ' ' HG2' ' A' ' 489' ' ' PRO . 19.5 m-85 -49.87 -46.8 51.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.02 178.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -68.96 -47.7 65.0 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -178.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -71.15 -74.81 0.14 Allowed 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 114.962 1.467 . . . . 0.0 114.962 -176.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 488' ' ' MET . . . . . 0.535 ' CB ' ' HD3' ' A' ' 489' ' ' PRO . 3.3 tpp -52.95 -53.13 58.49 Favored Pre-proline 0 N--CA 1.47 0.556 0 CA-C-O 121.204 0.526 . . . . 0.0 111.576 -178.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 489' ' ' PRO . . . . . 0.711 ' HG2' ' HA ' ' A' ' 485' ' ' PHE . 12.3 Cg_exo -75.13 44.18 1.14 Allowed 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 124.566 3.511 . . . . 0.0 112.661 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -36.78 -31.15 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -178.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 491' ' ' ALA . . . . . . . . . . . . . . . -132.02 135.7 46.72 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.499 -0.481 . . . . 0.0 110.967 178.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 492' ' ' ARG . . . . . 0.423 ' NE ' ' CD2' ' A' ' 585' ' ' LEU . 10.6 tpt180 -136.25 134.38 38.01 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 178.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 493' ' ' VAL . . . . . 0.489 ' CG2' ' CG2' ' A' ' 586' ' ' VAL . 25.3 m -136.98 163.87 31.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 116.212 -0.449 . . . . 0.0 112.026 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 70.0 p -115.89 132.82 56.53 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 176.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 495' ' ' LEU . . . . . 0.521 ' HG ' ' N ' ' A' ' 496' ' ' PRO . 0.0 OUTLIER -136.62 162.84 53.76 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.637 -179.667 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 496' ' ' PRO . . . . . 0.521 ' N ' ' HG ' ' A' ' 495' ' ' LEU . 9.8 Cg_exo -71.84 120.0 6.58 Favored 'Trans proline' 0 CA--C 1.534 0.481 0 C-N-CA 122.376 2.051 . . . . 0.0 111.328 178.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 497' ' ' LYS . . . . . 0.565 ' CA ' ' HB ' ' A' ' 588' ' ' ILE . 0.1 OUTLIER -56.6 -30.25 63.0 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -178.739 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 498' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.56 -48.47 79.35 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -177.14 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 499' ' ' LEU . . . . . 0.457 ' CD1' HD11 ' A' ' 495' ' ' LEU . 2.6 pp -73.85 -9.08 58.29 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -178.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . 0.431 HG23 HG13 ' A' ' 568' ' ' ILE . 3.5 p -75.34 -25.38 17.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.507 0.67 . . . . 0.0 111.595 -179.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 501' ' ' TYR . . . . . 0.676 ' O ' ' CG2' ' A' ' 564' ' ' THR . 2.6 m-30 -53.72 -29.27 38.54 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -178.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -76.67 -50.2 14.29 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 116.176 1.917 . . . . 0.0 116.176 -175.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 503' ' ' LYS . . . . . 0.579 ' O ' ' CG ' ' A' ' 507' ' ' LYS . 8.9 mttt -119.81 136.41 54.48 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 119.178 0.899 . . . . 0.0 112.561 -178.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 504' ' ' THR . . . . . 0.627 ' OG1' ' N ' ' A' ' 564' ' ' THR . 51.0 m -74.07 -76.61 0.13 Allowed 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 179.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . 0.633 ' CZ ' HD11 ' A' ' 556' ' ' ILE . 0.2 OUTLIER -75.31 -60.98 2.06 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -178.965 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 506' ' ' SER . . . . . 0.783 ' O ' ' CD1' ' A' ' 510' ' ' TRP . 0.7 OUTLIER -49.6 -73.07 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 114.833 1.419 . . . . 0.0 114.833 -176.264 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 507' ' ' LYS . . . . . 0.706 ' HD3' ' N ' ' A' ' 508' ' ' VAL . 0.0 OUTLIER -49.18 -48.61 45.0 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -176.756 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 508' ' ' VAL . . . . . 0.706 ' N ' ' HD3' ' A' ' 507' ' ' LYS . 98.0 t -53.91 -59.48 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 509' ' ' LEU . . . . . 0.545 ' CD1' ' N ' ' A' ' 510' ' ' TRP . 2.2 pp -56.52 -61.8 2.17 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 115.477 1.658 . . . . 0.0 115.477 -177.115 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 510' ' ' TRP . . . . . 0.839 ' CD1' ' HA ' ' A' ' 518' ' ' LYS . 67.1 p-90 -72.79 -51.46 18.9 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -176.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 511' ' ' SER . . . . . 0.497 ' N ' ' CE3' ' A' ' 510' ' ' TRP . 0.6 OUTLIER -64.18 -47.45 79.78 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.363 -0.835 . . . . 0.0 113.174 -176.854 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 512' ' ' ALA . . . . . 0.411 ' CB ' ' O ' ' A' ' 508' ' ' VAL . . . -70.95 -73.04 0.18 Allowed 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 117.796 2.517 . . . . 0.0 117.796 -174.085 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 513' ' ' GLY . . . . . 0.704 ' H ' ' HE2' ' A' ' 584' ' ' LYS . . . -114.76 -35.2 1.42 Allowed Glycine 0 CA--C 1.5 -0.897 0 N-CA-C 120.853 3.101 . . . . 0.0 120.853 -172.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 514' ' ' LEU . . . . . 0.536 ' HG ' ' HB2' ' A' ' 584' ' ' LYS . 0.1 OUTLIER -107.14 -46.84 3.81 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 119.506 3.151 . . . . 0.0 119.506 -170.056 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 515' ' ' VAL . . . . . 0.547 ' CG2' ' N ' ' A' ' 516' ' ' ALA . 2.5 p -154.71 172.72 0.61 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.589 0 N-CA-C 117.887 2.551 . . . . 0.0 117.887 -172.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 516' ' ' ALA . . . . . 0.547 ' N ' ' CG2' ' A' ' 515' ' ' VAL . . . -67.89 4.18 1.26 Allowed 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 126.761 2.025 . . . . 0.0 109.696 177.099 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 517' ' ' SER . . . . . 0.841 ' O ' ' N ' ' A' ' 521' ' ' GLY . 0.5 OUTLIER -57.55 9.28 0.01 OUTLIER 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 115.775 1.769 . . . . 0.0 115.775 -172.043 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 518' ' ' LYS . . . . . 0.839 ' HA ' ' CD1' ' A' ' 510' ' ' TRP . 0.0 OUTLIER -45.06 -46.82 11.73 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 104.351 -2.463 . . . . 0.0 104.351 175.413 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 519' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.16 -58.29 3.37 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.962 173.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 520' ' ' GLU . . . . . 0.831 ' HB2' ' HA ' ' A' ' 517' ' ' SER . 2.6 mm-40 -59.05 -47.44 85.21 Favored 'General case' 0 C--N 1.351 0.659 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.941 -178.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 521' ' ' GLY . . . . . 0.841 ' N ' ' O ' ' A' ' 517' ' ' SER . . . -49.12 -55.16 12.57 Favored Glycine 0 CA--C 1.493 -1.333 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.25 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -48.02 -47.42 33.45 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 523' ' ' ARG . . . . . 0.459 ' O ' ' HB3' ' A' ' 526' ' ' ASN . 0.1 OUTLIER -50.2 -48.94 54.02 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.988 178.463 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 524' ' ' ILE . . . . . 0.483 ' O ' ' ND2' ' A' ' 527' ' ' ASN . 12.8 mm -58.24 -54.82 27.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.424 0.63 . . . . 0.0 109.717 179.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 525' ' ' ILE . . . . . 0.558 HG12 ' O ' ' A' ' 521' ' ' GLY . 0.7 OUTLIER -50.4 -47.42 26.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 177.683 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 526' ' ' ASN . . . . . 0.459 ' HB3' ' O ' ' A' ' 523' ' ' ARG . 0.9 OUTLIER -55.8 -47.99 76.16 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 114.122 -1.399 . . . . 0.0 108.228 177.393 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 527' ' ' ASN . . . . . 0.483 ' ND2' ' O ' ' A' ' 524' ' ' ILE . 0.0 OUTLIER -48.13 -40.13 22.75 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.076 -1.42 . . . . 0.0 107.189 176.517 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 528' ' ' ASN . . . . . 0.671 ' HA ' HG23 ' A' ' 556' ' ' ILE . 13.5 t-20 73.67 40.47 0.49 Allowed 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 114.631 -1.168 . . . . 0.0 111.736 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 529' ' ' GLY . . . . . . . . . . . . . . . -115.69 27.64 8.23 Favored Glycine 0 CA--C 1.523 0.583 0 C-N-CA 120.337 -0.935 . . . . 0.0 112.779 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 530' ' ' ALA . . . . . 0.95 ' O ' ' HB ' ' A' ' 556' ' ' ILE . . . -133.96 164.03 28.21 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 112.524 0.565 . . . . 0.0 112.524 -179.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 531' ' ' TYR . . . . . 0.538 ' CE2' ' CD2' ' A' ' 553' ' ' PHE . 0.0 OUTLIER -133.99 156.02 48.93 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 177.875 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 532' ' ' VAL . . . . . 0.564 ' HB ' ' HB ' ' A' ' 554' ' ' THR . 0.5 OUTLIER -127.33 135.5 63.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 C-N-CA 119.537 -0.865 . . . . 0.0 112.123 -179.647 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 533' ' ' GLY . . . . . 0.664 ' O ' HG13 ' A' ' 575' ' ' ILE . . . -133.88 155.64 21.91 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 114.367 -1.288 . . . . 0.0 113.841 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 534' ' ' SER . . . . . 0.532 ' HB2' ' OG1' ' A' ' 552' ' ' THR . 0.6 OUTLIER -134.54 141.24 46.63 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.176 -0.512 . . . . 0.0 110.936 178.605 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 535' ' ' ARG . . . . . 0.544 ' O ' ' HB3' ' A' ' 573' ' ' LEU . 9.2 tpp85 -159.47 90.92 1.9 Allowed Pre-proline 0 CA--C 1.531 0.232 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 179.011 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 536' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.17 -46.23 1.56 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.511 2.141 . . . . 0.0 111.961 178.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 94.86 13.81 51.81 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.865 -0.683 . . . . 0.0 113.03 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 538' ' ' VAL . . . . . 0.416 ' CG1' ' O ' ' A' ' 538' ' ' VAL . 21.8 t -116.35 18.39 7.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.878 0.37 . . . . 0.0 111.679 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 539' ' ' LYS . . . . . . . . . . . . . 28.6 mttm -107.34 111.36 23.67 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.313 0.578 . . . . 0.0 112.181 -179.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 17.9 mmtt -110.38 -3.2 16.26 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.904 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 541' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -96.43 104.33 16.29 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.001 0.429 . . . . 0.0 109.922 179.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -47.62 101.6 0.27 Allowed Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.974 -179.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 543' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -51.28 -10.51 0.42 Allowed 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.353 2.702 . . . . 0.0 114.263 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . 0.555 ' C ' ' H ' ' A' ' 546' ' ' GLY . . . 52.04 54.64 25.01 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 119.806 -1.188 . . . . 0.0 111.639 -179.159 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 545' ' ' GLY . . . . . 0.621 ' O ' ' N ' ' A' ' 547' ' ' MET . . . 54.58 -7.07 0.01 OUTLIER Glycine 0 CA--C 1.528 0.881 0 CA-C-O 119.614 -0.548 . . . . 0.0 114.364 -178.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . 0.555 ' H ' ' C ' ' A' ' 544' ' ' GLY . . . -53.42 54.79 0.01 OUTLIER Glycine 0 CA--C 1.528 0.847 0 CA-C-N 117.474 0.637 . . . . 0.0 114.231 177.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 547' ' ' MET . . . . . 0.621 ' N ' ' O ' ' A' ' 545' ' ' GLY . 1.3 mpt? 52.06 54.3 13.92 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 118.568 1.184 . . . . 0.0 110.677 -179.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 548' ' ' PRO . . . . . 0.477 ' HD3' ' N ' ' A' ' 547' ' ' MET . 81.7 Cg_exo -46.44 166.46 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 123.171 2.58 . . . . 0.0 113.559 -179.201 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -124.36 -20.28 5.25 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.404 178.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 550' ' ' ASP . . . . . 0.527 ' O ' ' HA ' ' A' ' 535' ' ' ARG . 1.2 p30 -51.85 -41.89 62.19 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.106 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 551' ' ' LEU . . . . . . . . . . . . . 10.7 tp -131.62 139.47 49.14 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.661 -1.154 . . . . 0.0 108.53 177.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 552' ' ' THR . . . . . 0.638 ' O ' ' HA2' ' A' ' 533' ' ' GLY . 5.6 m -133.83 148.31 51.29 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.598 0.713 . . . . 0.0 111.756 179.345 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 553' ' ' PHE . . . . . 0.538 ' CD2' ' CE2' ' A' ' 531' ' ' TYR . 21.8 m-85 -134.25 137.65 44.48 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.07 -0.968 . . . . 0.0 108.613 177.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 554' ' ' THR . . . . . 0.564 ' HB ' ' HB ' ' A' ' 532' ' ' VAL . 2.8 m -132.5 139.04 33.49 Favored Pre-proline 0 C--N 1.307 -1.253 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 555' ' ' PRO . . . . . 0.74 ' O ' HG22 ' A' ' 556' ' ' ILE . 77.5 Cg_endo -83.78 24.0 0.79 Allowed 'Trans proline' 0 N--CA 1.444 -1.411 0 C-N-CA 121.573 1.516 . . . . 0.0 112.142 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 556' ' ' ILE . . . . . 0.95 ' HB ' ' O ' ' A' ' 530' ' ' ALA . 7.3 tp 61.38 30.9 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 177.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . 0.49 ' HB3' ' CE2' ' A' ' 559' ' ' TRP . 0.3 OUTLIER -105.79 117.85 35.08 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 105.096 -2.187 . . . . 0.0 105.096 179.257 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 558' ' ' THR . . . . . . . . . . . . . 2.3 t -56.89 117.82 4.33 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -172.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 559' ' ' TRP . . . . . 0.49 ' CE2' ' HB3' ' A' ' 557' ' ' LYS . 5.4 m0 -136.58 111.8 9.08 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 104.981 -2.229 . . . . 0.0 104.981 175.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 560' ' ' ASN . . . . . 0.487 ' O ' ' HB ' ' A' ' 564' ' ' THR . 75.9 m-20 -78.25 -74.4 0.27 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -175.018 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 561' ' ' ALA . . . . . 0.41 ' O ' HG23 ' A' ' 564' ' ' THR . . . -73.16 -64.01 1.06 Allowed 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 115.752 1.76 . . . . 0.0 115.752 -176.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 562' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.01 -50.65 35.05 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -176.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 563' ' ' LYS . . . . . 0.488 ' CB ' ' HB2' ' A' ' 559' ' ' TRP . 0.0 OUTLIER -70.67 -49.07 51.18 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.392 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 564' ' ' THR . . . . . 0.676 ' CG2' ' O ' ' A' ' 501' ' ' TYR . 2.0 t -53.7 -64.33 0.86 Allowed 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 121.114 -0.235 . . . . 0.0 110.922 -178.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 565' ' ' GLN . . . . . 0.496 ' N ' ' CG2' ' A' ' 564' ' ' THR . 0.0 OUTLIER -48.51 -47.46 38.89 Favored 'General case' 0 C--N 1.321 -0.643 0 O-C-N 122.135 -0.353 . . . . 0.0 111.195 179.012 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . 0.419 ' O ' ' CD1' ' A' ' 569' ' ' ILE . 1.8 tt0 -49.61 -56.13 11.12 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -178.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 567' ' ' PHE . . . . . 0.53 ' O ' ' OG ' ' A' ' 534' ' ' SER . 0.4 OUTLIER -97.22 -45.09 6.65 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.417 0.627 . . . . 0.0 112.156 -178.387 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 568' ' ' ILE . . . . . 0.556 ' N ' ' O ' ' A' ' 564' ' ' THR . 1.5 tp -58.0 9.29 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 569' ' ' ILE . . . . . 0.466 ' O ' ' OD1' ' A' ' 570' ' ' ASP . 0.0 OUTLIER -55.09 -39.22 49.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 104.525 -2.398 . . . . 0.0 104.525 179.009 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 570' ' ' ASP . . . . . 0.508 ' CB ' ' O ' ' A' ' 573' ' ' LEU . 15.1 p30 31.77 55.75 0.3 Allowed 'General case' 0 CA--C 1.51 -0.587 0 CA-C-N 114.04 -1.436 . . . . 0.0 112.643 173.295 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -51.39 -44.88 53.22 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 117.316 -2.373 . . . . 0.0 108.505 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 572' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -119.6 -16.44 8.85 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 175.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 573' ' ' LEU . . . . . 0.544 ' HB3' ' O ' ' A' ' 535' ' ' ARG . 1.3 tp -139.86 137.29 34.78 Favored 'General case' 0 C--N 1.353 0.746 0 N-CA-C 116.39 1.996 . . . . 0.0 116.39 -177.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 574' ' ' LEU . . . . . 0.506 ' HB3' ' CD1' ' A' ' 588' ' ' ILE . 0.2 OUTLIER -134.81 133.39 39.74 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 173.048 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 575' ' ' ILE . . . . . 0.664 HG13 ' O ' ' A' ' 533' ' ' GLY . 0.0 OUTLIER -134.09 138.24 50.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 118.86 0.754 . . . . 0.0 112.007 179.297 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 576' ' ' LEU . . . . . 0.499 HD23 ' HB3' ' A' ' 584' ' ' LYS . 0.1 OUTLIER -132.99 135.53 45.52 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 177.181 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 577' ' ' LYS . . . . . . . . . . . . . 25.2 mttt -132.2 135.45 46.34 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 119.009 -1.076 . . . . 0.0 110.359 177.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.4 ' HA ' ' HB3' ' A' ' 530' ' ' ALA . 0.3 OUTLIER -124.45 131.91 53.5 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 177.84 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 579' ' ' GLY . . . . . . . . . . . . . . . -89.1 -2.2 78.04 Favored Glycine 0 CA--C 1.498 -0.976 0 CA-C-N 115.236 -0.893 . . . . 0.0 113.335 -178.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 580' ' ' LYS . . . . . 0.449 ' O ' ' CD1' ' A' ' 581' ' ' TRP . 0.0 OUTLIER -72.41 -48.16 43.52 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 119.087 -1.045 . . . . 0.0 108.889 179.233 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 581' ' ' TRP . . . . . 0.449 ' CD1' ' O ' ' A' ' 580' ' ' LYS . 23.6 m0 -139.7 -53.12 0.53 Allowed 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 177.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 582' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.26 165.37 27.58 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -174.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 583' ' ' MET . . . . . . . . . . . . . 1.9 ttt -110.76 134.52 52.41 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.468 -1.679 . . . . 0.0 106.468 173.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 584' ' ' LYS . . . . . 0.704 ' HE2' ' H ' ' A' ' 513' ' ' GLY . 0.5 OUTLIER -119.66 134.73 55.11 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 178.787 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 585' ' ' LEU . . . . . 0.466 ' HG ' ' CG2' ' A' ' 575' ' ' ILE . 5.7 tt -121.4 136.96 54.9 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 586' ' ' VAL . . . . . 0.501 HG23 ' NZ ' ' A' ' 584' ' ' LYS . 30.7 t -132.19 137.07 55.4 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.734 -178.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 587' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -112.87 134.32 54.44 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 177.168 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . 0.565 ' HB ' ' CA ' ' A' ' 497' ' ' LYS . 0.1 OUTLIER -135.17 140.58 44.81 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.568 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -178.257 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 6.2 p -133.14 145.73 33.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 114.369 -1.287 . . . . 0.0 110.473 178.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 590' ' ' SER . . . . . . . . . . . . . 6.0 t -52.95 142.81 18.56 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.672 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 591' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -50.38 -49.16 55.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.094 0.473 . . . . 0.0 110.541 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -52.85 -50.95 62.73 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.194 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.36 -48.3 55.75 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.733 0.778 . . . . 0.0 109.132 179.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 594' ' ' PHE . . . . . 0.505 ' O ' ' HG ' ' A' ' 597' ' ' LEU . 0.9 OUTLIER -49.98 -48.07 52.51 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.495 178.326 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 595' ' ' LYS . . . . . 0.496 ' HA ' ' CE2' ' A' ' 604' ' ' TRP . 0.0 OUTLIER -49.09 -47.7 44.96 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.945 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 596' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -53.14 -63.45 1.14 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.497 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 597' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' A' ' 594' ' ' PHE . 0.7 OUTLIER -57.31 -60.6 3.39 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 121.364 0.602 . . . . 0.0 112.12 -178.682 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 598' ' ' GLY . . . . . 0.479 ' O ' ' CD1' ' A' ' 604' ' ' TRP . . . -79.78 13.56 23.48 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.056 -0.974 . . . . 0.0 113.365 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 599' ' ' LEU . . . . . 0.468 ' CA ' ' O ' ' A' ' 595' ' ' LYS . 3.6 pp -47.46 -14.05 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -175.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 600' ' ' THR . . . . . . . . . . . . . 11.8 t -131.73 66.75 1.54 Allowed 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.775 176.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 601' ' ' ALA . . . . . . . . . . . . . . . -131.37 166.79 25.3 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.447 179.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 602' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.39 -12.61 33.99 Favored 'Trans proline' 0 N--CA 1.465 -0.204 0 C-N-CA 122.215 1.943 . . . . 0.0 111.273 178.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 603' ' ' GLY . . . . . . . . . . . . . . . -70.83 -49.14 30.38 Favored Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 115.715 -0.675 . . . . 0.0 113.099 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 604' ' ' TRP . . . . . 0.496 ' CE2' ' HA ' ' A' ' 595' ' ' LYS . 1.3 m95 -65.09 -46.78 79.68 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 120.889 0.375 . . . . 0.0 111.186 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 605' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -50.24 -57.82 6.97 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.329 -178.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -61.78 -56.75 16.19 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 607' ' ' VAL . . . . . . . . . . . . . 40.0 t -54.97 -71.86 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -178.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 608' ' ' VAL . . . . . . . . . . . . . 78.4 t -68.2 -58.69 5.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -177.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 609' ' ' GLY . . . . . . . . . . . . . . . -59.1 -62.51 6.12 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 121.043 -0.599 . . . . 0.0 113.165 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 610' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.29 -49.88 70.05 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.783 0.325 . . . . 0.0 110.807 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 111.05 55.55 0.51 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.456 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -87.52 -31.12 20.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.795 0.331 . . . . 0.0 110.889 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 613' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -72.96 154.41 40.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.905 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . 0.409 ' CB ' ' CD ' ' A' ' 615' ' ' PRO . 0.0 OUTLIER -60.2 -60.7 9.77 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.885 -179.988 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 615' ' ' PRO . . . . . 0.409 ' CD ' ' CB ' ' A' ' 614' ' ' GLU . 60.3 Cg_endo -72.68 85.57 1.12 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.503 2.136 . . . . 0.0 112.372 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 616' ' ' SER . . . . . . . . . . . . . 1.3 m -87.3 149.65 47.49 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.874 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo . . . . . 0 C--O 1.249 1.054 0 C-N-CA 122.592 2.194 . . . . 0.0 112.292 179.963 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 1.3 tmm? . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.692 0.282 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 455' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.03 121.93 8.55 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.561 2.174 . . . . 0.0 112.303 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 456' ' ' ARG . . . . . . . . . . . . . 32.9 mtt180 -85.24 -26.53 26.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.977 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -82.42 -38.1 24.54 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.882 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -59.92 110.44 1.18 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.063 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 79.0 p -109.79 147.7 36.68 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.844 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.36 -170.41 0.57 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.532 2.155 . . . . 0.0 112.307 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . 83.27 27.62 39.45 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.574 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -164.93 145.42 6.09 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.633 0.254 . . . . 0.0 110.92 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -73.96 -174.11 1.62 Allowed 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.528 2.152 . . . . 0.0 112.324 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.77 179.35 5.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.885 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -98.29 22.14 10.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.117 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 2.4 m -61.45 -26.74 68.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.978 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 3.1 mt -102.33 81.26 2.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.936 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 2.5 m -137.95 43.29 2.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.808 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 129.0 -36.85 2.32 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.217 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -115.92 117.72 30.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.766 0.317 . . . . 0.0 110.674 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 471' ' ' VAL . . . . . . . . . . . . . 9.7 p -112.93 108.12 24.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.158 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -113.75 90.18 17.89 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.86 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -68.72 145.67 64.06 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.499 2.133 . . . . 0.0 112.227 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -97.82 36.78 1.48 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.989 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 3.5 m -90.03 -29.87 18.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.882 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 476' ' ' GLY . . . . . . . . . . . . . . . 124.09 44.51 0.3 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.487 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 477' ' ' ASN . . . . . 0.416 ' N ' ' HD2' ' A' ' 478' ' ' PRO . 0.7 OUTLIER -50.18 -51.69 60.39 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 120.635 0.255 . . . . 0.0 111.393 179.937 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 478' ' ' PRO . . . . . 0.416 ' HD2' ' N ' ' A' ' 477' ' ' ASN . 91.2 Cg_endo -79.64 -27.73 3.89 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.453 2.102 . . . . 0.0 112.431 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 5.2 m170 -62.81 115.95 4.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.932 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -73.46 155.63 89.41 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.066 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.49 -71.32 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.478 2.119 . . . . 0.0 112.252 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 482' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -135.33 28.99 3.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.859 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 483' ' ' THR . . . . . . . . . . . . . 55.5 m -70.39 66.77 0.32 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.073 0.463 . . . . 0.0 110.613 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 484' ' ' ASN . . . . . 0.411 ' CB ' ' CE ' ' A' ' 577' ' ' LYS . 51.1 m-20 -130.22 -68.97 0.68 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.91 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 485' ' ' PHE . . . . . 0.452 ' CD2' ' N ' ' A' ' 486' ' ' ALA . 51.1 p90 -70.34 -51.37 30.54 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.814 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 486' ' ' ALA . . . . . 0.452 ' N ' ' CD2' ' A' ' 485' ' ' PHE . . . -59.31 -47.61 84.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.179 0.514 . . . . 0.0 110.071 179.358 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 487' ' ' ASN . . . . . 0.484 ' O ' ' CG ' ' A' ' 488' ' ' MET . 53.6 t30 -69.12 -48.44 62.49 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.03 179.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 488' ' ' MET . . . . . 0.484 ' CG ' ' O ' ' A' ' 487' ' ' ASN . 2.0 ptt? 51.26 51.28 10.05 Favored Pre-proline 0 N--CA 1.465 0.285 0 CA-C-O 121.229 0.538 . . . . 0.0 110.576 -179.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 489' ' ' PRO . . . . . 0.463 ' CD ' ' N ' ' A' ' 488' ' ' MET . 71.7 Cg_endo -80.0 13.86 2.06 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.087 2.525 . . . . 0.0 114.414 -178.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.71 -69.48 0.83 Allowed 'General case' 0 C--O 1.232 0.136 0 C-N-CA 119.647 -0.821 . . . . 0.0 112.494 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 491' ' ' ALA . . . . . 0.491 ' CB ' HD21 ' A' ' 514' ' ' LEU . . . -136.12 136.49 40.14 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 179.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 492' ' ' ARG . . . . . 0.426 ' CD ' ' HG ' ' A' ' 585' ' ' LEU . 1.0 OUTLIER -136.49 131.69 34.32 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 175.561 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 493' ' ' VAL . . . . . 0.523 HG23 ' HA3' ' A' ' 513' ' ' GLY . 2.5 m -139.33 164.02 25.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.688 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 79.7 p -130.63 132.9 45.72 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.604 176.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 495' ' ' LEU . . . . . 0.431 ' CD1' ' O ' ' A' ' 496' ' ' PRO . 2.2 pp -137.04 163.23 50.84 Favored Pre-proline 0 CA--C 1.53 0.18 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.588 178.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 496' ' ' PRO . . . . . 0.444 ' HD2' HD21 ' A' ' 499' ' ' LEU . 19.8 Cg_exo -63.29 119.21 6.19 Favored 'Trans proline' 0 CA--C 1.533 0.428 0 C-N-CA 121.921 1.747 . . . . 0.0 111.658 179.014 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 497' ' ' LYS . . . . . 0.441 ' CA ' ' HB ' ' A' ' 588' ' ' ILE . 23.7 ttpt -56.62 -30.39 63.23 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -178.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 498' ' ' SER . . . . . . . . . . . . . 12.2 t -55.94 -48.0 76.55 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -177.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 499' ' ' LEU . . . . . 0.444 HD21 ' HD2' ' A' ' 496' ' ' PRO . 1.1 pp -73.45 -8.36 55.58 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -178.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 500' ' ' VAL . . . . . 0.49 ' HA ' ' NZ ' ' A' ' 507' ' ' LYS . 12.0 t -74.59 -25.28 19.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.31 0.576 . . . . 0.0 111.793 -179.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 501' ' ' TYR . . . . . 0.627 ' O ' ' CG2' ' A' ' 564' ' ' THR . 3.1 m-85 -53.55 -29.69 38.18 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -178.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 502' ' ' ASP . . . . . 0.402 ' O ' ' HB2' ' A' ' 560' ' ' ASN . 2.1 m-20 -76.36 -50.09 15.12 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 115.807 1.78 . . . . 0.0 115.807 -175.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 503' ' ' LYS . . . . . 0.553 ' O ' ' CG ' ' A' ' 507' ' ' LYS . 0.1 OUTLIER -119.65 135.39 54.83 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-N 119.153 0.888 . . . . 0.0 111.939 -178.896 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 504' ' ' THR . . . . . 0.611 ' OG1' ' N ' ' A' ' 564' ' ' THR . 69.7 m -73.21 -76.63 0.12 Allowed 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . 0.523 ' CE2' ' CD1' ' A' ' 576' ' ' LEU . 0.3 OUTLIER -75.78 -59.12 2.89 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -179.416 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 506' ' ' SER . . . . . 0.817 ' O ' ' CD1' ' A' ' 510' ' ' TRP . 8.0 t -49.0 -71.48 0.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 -175.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 507' ' ' LYS . . . . . 0.565 ' HD3' ' N ' ' A' ' 508' ' ' VAL . 0.0 OUTLIER -48.01 -49.07 32.22 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -174.782 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 508' ' ' VAL . . . . . 0.565 ' N ' ' HD3' ' A' ' 507' ' ' LYS . 0.2 OUTLIER -64.23 -49.57 80.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 C-N-CA 120.299 -0.561 . . . . 0.0 111.964 -178.467 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 509' ' ' LEU . . . . . 0.584 ' HG ' ' H ' ' A' ' 510' ' ' TRP . 1.1 pp -55.99 -62.07 1.95 Allowed 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 -178.04 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 510' ' ' TRP . . . . . 0.86 ' CD1' ' HA ' ' A' ' 518' ' ' LYS . 67.4 p-90 -73.08 -49.67 27.26 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 114.722 1.378 . . . . 0.0 114.722 -176.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 511' ' ' SER . . . . . 0.506 ' N ' ' CE3' ' A' ' 510' ' ' TRP . 0.3 OUTLIER -63.5 -47.61 81.0 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -176.606 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 512' ' ' ALA . . . . . 0.43 ' CB ' ' CD2' ' A' ' 495' ' ' LEU . . . -70.89 -73.62 0.17 Allowed 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 117.841 2.534 . . . . 0.0 117.841 -174.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 513' ' ' GLY . . . . . 0.621 ' H ' ' HE2' ' A' ' 584' ' ' LYS . . . -115.05 -35.06 1.39 Allowed Glycine 0 CA--C 1.499 -0.945 0 N-CA-C 120.696 3.038 . . . . 0.0 120.696 -173.039 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 514' ' ' LEU . . . . . 0.492 ' HG ' ' HB2' ' A' ' 584' ' ' LYS . 0.1 OUTLIER -103.08 -47.97 4.18 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 119.105 3.002 . . . . 0.0 119.105 -170.171 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 515' ' ' VAL . . . . . 0.566 ' CG1' ' HB2' ' A' ' 517' ' ' SER . 2.4 p -155.99 172.26 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 117.606 2.447 . . . . 0.0 117.606 -173.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 516' ' ' ALA . . . . . 0.544 ' N ' ' CG2' ' A' ' 515' ' ' VAL . . . -68.06 4.08 1.36 Allowed 'General case' 0 C--O 1.231 0.104 0 C-N-CA 126.57 1.948 . . . . 0.0 109.636 176.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 517' ' ' SER . . . . . 0.839 ' O ' ' N ' ' A' ' 521' ' ' GLY . 0.6 OUTLIER -57.63 8.89 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 116.065 1.876 . . . . 0.0 116.065 -171.984 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 518' ' ' LYS . . . . . 0.86 ' HA ' ' CD1' ' A' ' 510' ' ' TRP . 0.0 OUTLIER -45.4 -46.7 13.47 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 104.432 -2.433 . . . . 0.0 104.432 175.41 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 519' ' ' SER . . . . . . . . . . . . . 1.4 p -75.08 -59.11 2.89 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.607 -1.178 . . . . 0.0 109.966 173.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 520' ' ' GLU . . . . . 0.837 ' HB2' ' HA ' ' A' ' 517' ' ' SER . 2.7 mm-40 -58.28 -47.43 83.65 Favored 'General case' 0 C--N 1.35 0.629 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.75 -179.152 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 521' ' ' GLY . . . . . 0.839 ' N ' ' O ' ' A' ' 517' ' ' SER . . . -49.01 -53.98 16.37 Favored Glycine 0 CA--C 1.493 -1.317 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.072 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 522' ' ' GLN . . . . . 0.439 ' HA ' HG12 ' A' ' 525' ' ' ILE . 2.0 mm100 -47.91 -47.28 32.31 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 523' ' ' ARG . . . . . 0.462 ' O ' ' HB3' ' A' ' 526' ' ' ASN . 0.4 OUTLIER -50.33 -48.82 55.21 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.818 178.266 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 524' ' ' ILE . . . . . 0.493 ' O ' ' ND2' ' A' ' 527' ' ' ASN . 18.2 mt -57.56 -54.86 25.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.518 0.675 . . . . 0.0 109.585 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 525' ' ' ILE . . . . . 0.566 HG12 ' O ' ' A' ' 521' ' ' GLY . 0.6 OUTLIER -50.39 -47.47 26.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.834 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 526' ' ' ASN . . . . . 0.462 ' HB3' ' O ' ' A' ' 523' ' ' ARG . 0.9 OUTLIER -56.28 -47.44 78.63 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 113.987 -1.461 . . . . 0.0 108.434 177.651 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 527' ' ' ASN . . . . . 0.493 ' ND2' ' O ' ' A' ' 524' ' ' ILE . 0.0 OUTLIER -47.52 -39.85 17.28 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.115 -1.402 . . . . 0.0 107.523 177.056 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 528' ' ' ASN . . . . . 0.633 ' HA ' HG23 ' A' ' 556' ' ' ILE . 1.9 t30 73.79 40.21 0.49 Allowed 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.384 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 529' ' ' GLY . . . . . . . . . . . . . . . -118.05 31.22 5.75 Favored Glycine 0 CA--C 1.523 0.585 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.657 178.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 530' ' ' ALA . . . . . 0.903 ' O ' ' HB ' ' A' ' 556' ' ' ILE . . . -133.54 164.38 27.3 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.333 0.587 . . . . 0.0 112.541 -179.027 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 531' ' ' TYR . . . . . 0.547 ' CE1' ' HA ' ' A' ' 553' ' ' PHE . 0.0 OUTLIER -134.36 152.88 52.06 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 177.752 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 532' ' ' VAL . . . . . 0.52 ' HB ' ' HB ' ' A' ' 554' ' ' THR . 0.4 OUTLIER -126.04 135.82 62.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 CA-C-O 121.871 0.844 . . . . 0.0 111.745 179.75 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 533' ' ' GLY . . . . . 0.709 ' O ' HG13 ' A' ' 575' ' ' ILE . . . -133.31 152.86 20.54 Favored Glycine 0 N--CA 1.443 -0.844 0 CA-C-N 114.472 -1.24 . . . . 0.0 113.783 -179.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 534' ' ' SER . . . . . 0.561 ' OG ' ' O ' ' A' ' 567' ' ' PHE . 0.5 OUTLIER -134.26 141.83 47.12 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.147 -0.527 . . . . 0.0 110.903 179.079 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 535' ' ' ARG . . . . . 0.592 ' HA ' ' O ' ' A' ' 550' ' ' ASP . 0.0 OUTLIER -159.26 90.71 1.96 Allowed Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 179.225 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 536' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -59.04 -58.77 0.57 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.608 2.205 . . . . 0.0 111.86 178.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 114.64 8.36 16.29 Favored Glycine 0 CA--C 1.519 0.344 0 C-N-CA 120.829 -0.701 . . . . 0.0 113.119 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 538' ' ' VAL . . . . . . . . . . . . . 14.2 t -116.26 18.03 7.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.862 0.331 . . . . 0.0 111.653 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 539' ' ' LYS . . . . . . . . . . . . . 4.2 ptpp? -57.39 118.28 4.98 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.039 0.447 . . . . 0.0 111.194 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -128.27 -40.0 1.67 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.975 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 541' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -96.16 100.44 12.09 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.15 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -47.71 103.78 0.38 Allowed Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.884 -179.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 543' ' ' PRO . . . . . 0.434 ' HB2' ' HG3' ' A' ' 548' ' ' PRO . 77.1 Cg_exo -51.1 -7.43 0.14 Allowed 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.336 2.691 . . . . 0.0 114.522 -179.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . 0.552 ' C ' ' H ' ' A' ' 546' ' ' GLY . . . 52.09 54.74 24.69 Favored Glycine 0 C--N 1.335 0.513 0 C-N-CA 119.786 -1.197 . . . . 0.0 111.714 -179.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 545' ' ' GLY . . . . . 0.605 ' O ' ' N ' ' A' ' 547' ' ' MET . . . 54.48 -5.43 0.01 OUTLIER Glycine 0 CA--C 1.528 0.863 0 N-CA-C 114.395 0.518 . . . . 0.0 114.395 -178.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . 0.552 ' H ' ' C ' ' A' ' 544' ' ' GLY . . . -53.47 54.95 0.01 OUTLIER Glycine 0 CA--C 1.528 0.849 0 CA-C-N 117.355 0.578 . . . . 0.0 114.229 177.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 547' ' ' MET . . . . . 0.605 ' N ' ' O ' ' A' ' 545' ' ' GLY . 21.2 ttm 52.33 54.19 13.49 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 118.565 1.183 . . . . 0.0 110.502 -178.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 548' ' ' PRO . . . . . 0.482 ' HD3' ' N ' ' A' ' 547' ' ' MET . 74.4 Cg_exo -46.59 166.46 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.317 2.678 . . . . 0.0 113.639 -179.197 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -124.21 -18.11 5.95 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.229 178.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 550' ' ' ASP . . . . . 0.592 ' O ' ' HA ' ' A' ' 535' ' ' ARG . 40.6 m-20 -54.55 -38.62 66.83 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 551' ' ' LEU . . . . . . . . . . . . . 14.7 tp -131.47 139.61 49.39 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.35 177.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 552' ' ' THR . . . . . 0.666 ' O ' ' HA2' ' A' ' 533' ' ' GLY . 28.9 m -133.54 146.67 51.26 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.714 0.769 . . . . 0.0 112.166 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 553' ' ' PHE . . . . . 0.547 ' HA ' ' CE1' ' A' ' 531' ' ' TYR . 24.8 m-85 -133.99 136.88 44.41 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 176.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 554' ' ' THR . . . . . 0.52 ' HB ' ' HB ' ' A' ' 532' ' ' VAL . 1.9 m -133.55 138.98 32.41 Favored Pre-proline 0 C--N 1.304 -1.377 0 C-N-CA 120.042 -0.663 . . . . 0.0 109.515 178.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 555' ' ' PRO . . . . . 0.61 ' O ' HG22 ' A' ' 556' ' ' ILE . 81.3 Cg_endo -82.47 19.43 1.28 Allowed 'Trans proline' 0 N--CA 1.447 -1.216 0 C-N-CA 121.486 1.457 . . . . 0.0 111.561 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 556' ' ' ILE . . . . . 0.903 ' HB ' ' O ' ' A' ' 530' ' ' ALA . 4.1 tp 61.92 32.36 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 177.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 4.3 tttt -104.09 122.0 44.38 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 105.183 -2.155 . . . . 0.0 105.183 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 558' ' ' THR . . . . . . . . . . . . . 6.5 t -56.88 117.55 4.07 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 -171.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 559' ' ' TRP . . . . . 0.463 ' CH2' ' HD2' ' A' ' 555' ' ' PRO . 5.3 m0 -136.89 112.05 9.06 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 104.408 -2.442 . . . . 0.0 104.408 175.618 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 560' ' ' ASN . . . . . 0.489 ' O ' ' HB ' ' A' ' 564' ' ' THR . 2.5 p30 -80.93 -74.8 0.3 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 115.372 1.619 . . . . 0.0 115.372 -174.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 561' ' ' ALA . . . . . . . . . . . . . . . -72.9 -61.97 1.62 Allowed 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 115.181 1.548 . . . . 0.0 115.181 -176.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 562' ' ' SER . . . . . . . . . . . . . 85.5 p -49.27 -50.37 39.23 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -177.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 563' ' ' LYS . . . . . 0.449 ' CB ' ' HB2' ' A' ' 559' ' ' TRP . 0.0 OUTLIER -70.98 -48.95 50.41 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -178.449 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 564' ' ' THR . . . . . 0.627 ' CG2' ' O ' ' A' ' 501' ' ' TYR . 2.0 t -54.09 -65.03 0.64 Allowed 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 121.218 -0.193 . . . . 0.0 111.35 -178.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 565' ' ' GLN . . . . . 0.488 ' N ' ' CG2' ' A' ' 564' ' ' THR . 0.0 OUTLIER -49.0 -47.41 44.36 Favored 'General case' 0 C--N 1.321 -0.649 0 O-C-N 122.067 -0.395 . . . . 0.0 111.367 179.028 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -49.71 -67.0 0.3 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -178.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 567' ' ' PHE . . . . . 0.561 ' O ' ' OG ' ' A' ' 534' ' ' SER . 0.2 OUTLIER -86.99 -43.25 12.49 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -178.056 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 568' ' ' ILE . . . . . 0.515 HD12 ' CZ ' ' A' ' 567' ' ' PHE . 1.0 OUTLIER -62.05 8.69 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 -179.64 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 569' ' ' ILE . . . . . 0.472 ' H ' ' C ' ' A' ' 567' ' ' PHE . 0.9 OUTLIER -54.72 -40.8 53.06 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 N-CA-C 105.048 -2.204 . . . . 0.0 105.048 178.905 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 570' ' ' ASP . . . . . 0.569 ' OD2' ' HB2' ' A' ' 574' ' ' LEU . 5.6 m-20 33.8 59.93 0.53 Allowed 'General case' 0 CA--C 1.507 -0.68 0 CA-C-N 113.833 -1.53 . . . . 0.0 112.994 173.113 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 571' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 570' ' ' ASP . . . -51.84 -45.06 55.84 Favored Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 116.865 -2.588 . . . . 0.0 108.088 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 572' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -120.41 -16.15 8.44 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 175.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 573' ' ' LEU . . . . . 0.484 ' HB3' ' O ' ' A' ' 535' ' ' ARG . 2.0 tp -139.85 137.05 34.61 Favored 'General case' 0 C--N 1.354 0.772 0 N-CA-C 116.627 2.084 . . . . 0.0 116.627 -176.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 574' ' ' LEU . . . . . 0.569 ' HB2' ' OD2' ' A' ' 570' ' ' ASP . 0.1 OUTLIER -135.18 132.97 38.62 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 173.605 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 575' ' ' ILE . . . . . 0.709 HG13 ' O ' ' A' ' 533' ' ' GLY . 0.0 OUTLIER -134.58 138.12 50.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 119.222 0.919 . . . . 0.0 111.763 178.786 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 576' ' ' LEU . . . . . 0.523 ' CD1' ' CE2' ' A' ' 505' ' ' PHE . 0.0 OUTLIER -132.93 135.35 45.49 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 176.875 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 577' ' ' LYS . . . . . 0.411 ' CE ' ' CB ' ' A' ' 484' ' ' ASN . 0.9 OUTLIER -132.8 135.59 45.77 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 119.057 -1.057 . . . . 0.0 110.533 177.808 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.86 131.87 53.66 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 177.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 579' ' ' GLY . . . . . . . . . . . . . . . -89.1 -2.06 78.29 Favored Glycine 0 N--CA 1.441 -1.007 0 CA-C-N 115.192 -0.913 . . . . 0.0 113.495 -178.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 580' ' ' LYS . . . . . 0.462 ' O ' ' CD1' ' A' ' 581' ' ' TRP . 0.1 OUTLIER -74.33 -47.55 33.74 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 118.968 -1.093 . . . . 0.0 109.151 179.373 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 581' ' ' TRP . . . . . 0.462 ' CD1' ' O ' ' A' ' 580' ' ' LYS . 26.6 m0 -139.34 -52.63 0.55 Allowed 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 178.156 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 582' ' ' LYS . . . . . 0.406 ' CD ' ' CD1' ' A' ' 514' ' ' LEU . 0.0 OUTLIER -139.81 165.25 27.79 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 -174.327 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 583' ' ' MET . . . . . 0.42 ' CE ' ' HA ' ' A' ' 485' ' ' PHE . 0.0 OUTLIER -113.75 134.53 54.7 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 174.099 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 584' ' ' LYS . . . . . 0.621 ' HE2' ' H ' ' A' ' 513' ' ' GLY . 0.3 OUTLIER -123.69 134.43 53.72 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.302 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 585' ' ' LEU . . . . . 0.426 ' CD1' ' O ' ' A' ' 574' ' ' LEU . 6.1 tp -121.05 137.05 54.84 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -179.131 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 586' ' ' VAL . . . . . 0.515 ' CG2' HG22 ' A' ' 493' ' ' VAL . 6.0 t -131.56 136.75 56.72 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.67 -179.064 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 587' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.92 134.21 53.62 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 176.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . 0.508 HG21 HD11 ' A' ' 588' ' ' ILE . 0.2 OUTLIER -134.96 147.74 29.33 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 -178.503 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 8.0 m -132.46 148.05 31.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 113.916 -1.493 . . . . 0.0 110.334 178.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 590' ' ' SER . . . . . . . . . . . . . 4.2 t -45.99 145.99 1.37 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.978 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 591' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -50.49 -50.05 53.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.044 0.45 . . . . 0.0 110.494 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -51.51 -49.65 61.48 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.876 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.19 -48.55 54.12 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 594' ' ' PHE . . . . . 0.492 ' O ' ' HG ' ' A' ' 597' ' ' LEU . 0.9 OUTLIER -50.04 -48.23 52.95 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 114.583 -1.19 . . . . 0.0 109.541 178.251 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 595' ' ' LYS . . . . . 0.475 ' O ' ' CA ' ' A' ' 599' ' ' LEU . 0.0 OUTLIER -49.07 -47.71 44.8 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 179.029 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 596' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -52.73 -63.48 1.13 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.395 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 597' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 594' ' ' PHE . 0.5 OUTLIER -58.06 -62.09 2.07 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 121.535 0.683 . . . . 0.0 112.103 -178.798 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 598' ' ' GLY . . . . . 0.459 ' O ' ' CD1' ' A' ' 604' ' ' TRP . . . -77.96 13.74 12.98 Favored Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 114.966 -1.015 . . . . 0.0 113.623 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 599' ' ' LEU . . . . . 0.475 ' CA ' ' O ' ' A' ' 595' ' ' LYS . 3.3 pp -47.26 -15.82 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -175.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 600' ' ' THR . . . . . . . . . . . . . 10.1 t -128.37 66.15 1.39 Allowed 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 119.994 -0.683 . . . . 0.0 110.324 176.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 601' ' ' ALA . . . . . . . . . . . . . . . -131.83 153.19 81.36 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.548 179.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 602' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -57.05 -21.37 41.71 Favored 'Trans proline' 0 N--CA 1.465 -0.199 0 C-N-CA 122.023 1.816 . . . . 0.0 111.199 178.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 603' ' ' GLY . . . . . . . . . . . . . . . -61.3 -49.2 80.13 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.641 -0.708 . . . . 0.0 113.007 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 604' ' ' TRP . . . . . 0.475 ' CE2' ' HA ' ' A' ' 595' ' ' LYS . 1.1 m95 -64.91 -46.91 79.68 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 120.904 0.383 . . . . 0.0 111.123 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 605' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -50.32 -58.32 5.92 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.264 -178.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -60.77 -57.19 13.73 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -179.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 607' ' ' VAL . . . . . . . . . . . . . 39.0 t -55.43 -71.93 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -178.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 608' ' ' VAL . . . . . . . . . . . . . 78.8 t -67.69 -58.63 5.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -177.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 609' ' ' GLY . . . . . . . . . . . . . . . -59.51 -62.16 6.46 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 121.132 -0.556 . . . . 0.0 113.197 -178.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 610' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.56 -58.32 6.05 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.848 0.356 . . . . 0.0 110.89 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 121.63 56.41 0.22 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.576 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -97.41 32.0 2.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.793 0.33 . . . . 0.0 110.976 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 613' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -103.22 179.93 4.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.925 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . 0.407 ' CB ' ' CD ' ' A' ' 615' ' ' PRO . 7.4 mt-10 -62.18 -60.6 9.65 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.886 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 615' ' ' PRO . . . . . 0.407 ' CD ' ' CB ' ' A' ' 614' ' ' GLU . 60.9 Cg_endo -72.81 85.54 1.15 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.558 2.172 . . . . 0.0 112.298 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 616' ' ' SER . . . . . . . . . . . . . 49.0 m -75.49 149.4 83.92 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.915 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo . . . . . 0 C--O 1.249 1.041 0 C-N-CA 122.515 2.143 . . . . 0.0 112.307 -179.964 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 491' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.94 0.4 . . . . 0.0 110.687 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 492' ' ' ARG . . . . . 0.666 ' NE ' HD12 ' A' ' 585' ' ' LEU . 0.1 OUTLIER -135.31 136.01 41.25 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.661 -179.835 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 493' ' ' VAL . . . . . 0.577 ' O ' HG13 ' A' ' 586' ' ' VAL . 46.7 t -134.02 163.45 37.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.938 178.504 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 494' ' ' THR . . . . . 0.57 ' N ' HG12 ' A' ' 493' ' ' VAL . 6.1 t -123.35 134.51 54.01 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 121.184 0.516 . . . . 0.0 111.377 178.693 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 495' ' ' LEU . . . . . 0.723 ' O ' HG22 ' A' ' 588' ' ' ILE . 0.2 OUTLIER -135.47 163.31 51.74 Favored Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.422 179.235 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 496' ' ' PRO . . . . . 0.548 ' HG2' ' CD2' ' A' ' 499' ' ' LEU . 19.5 Cg_endo -58.51 119.87 7.39 Favored 'Trans proline' 0 CA--C 1.532 0.409 0 C-N-CA 122.235 1.957 . . . . 0.0 112.214 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 497' ' ' LYS . . . . . 0.484 ' CA ' ' HB ' ' A' ' 588' ' ' ILE . 2.1 ttpp -57.72 -30.04 65.22 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -179.133 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 498' ' ' SER . . . . . 0.401 ' O ' ' CD1' ' A' ' 501' ' ' TYR . 0.3 OUTLIER -60.86 -48.9 79.71 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -176.59 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 499' ' ' LEU . . . . . 0.576 HD12 ' C ' ' A' ' 499' ' ' LEU . 3.1 pp -73.97 -8.24 55.38 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -178.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 500' ' ' VAL . . . . . 0.626 HG22 ' HZ1' ' A' ' 507' ' ' LYS . 26.6 t -73.0 -25.8 22.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.286 0.565 . . . . 0.0 111.355 -179.157 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 501' ' ' TYR . . . . . 0.704 ' O ' HG21 ' A' ' 564' ' ' THR . 0.4 OUTLIER -53.88 -29.72 42.85 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 -178.69 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -72.04 -50.05 31.62 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 -175.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 503' ' ' LYS . . . . . 0.599 ' O ' ' CG ' ' A' ' 507' ' ' LYS . 7.4 mttt -119.38 133.94 55.47 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 118.694 0.679 . . . . 0.0 111.142 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 504' ' ' THR . . . . . 0.755 HG21 ' HB3' ' A' ' 563' ' ' LYS . 6.8 m -73.32 -76.61 0.12 Allowed 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 505' ' ' PHE . . . . . 0.821 ' CZ ' ' HB1' ' A' ' 530' ' ' ALA . 0.3 OUTLIER -75.52 -60.08 2.46 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -179.471 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 506' ' ' SER . . . . . 0.722 ' O ' ' CD1' ' A' ' 510' ' ' TRP . 8.0 t -48.97 -72.69 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 -176.114 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 507' ' ' LYS . . . . . 0.698 ' HD3' ' N ' ' A' ' 508' ' ' VAL . 0.0 OUTLIER -48.82 -48.38 41.57 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -176.893 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 508' ' ' VAL . . . . . 0.829 HG13 HD21 ' A' ' 574' ' ' LEU . 50.1 t -55.07 -58.71 3.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 509' ' ' LEU . . . . . 0.748 HD12 ' N ' ' A' ' 510' ' ' TRP . 2.0 pp -56.98 -60.1 4.08 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 -177.026 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 510' ' ' TRP . . . . . 0.913 ' CD1' ' HA ' ' A' ' 518' ' ' LYS . 63.2 p-90 -72.47 -51.77 18.73 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -176.01 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 511' ' ' SER . . . . . 0.525 ' N ' ' CE3' ' A' ' 510' ' ' TRP . 0.5 OUTLIER -66.35 -47.48 73.32 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -176.818 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 512' ' ' ALA . . . . . 0.785 ' HB3' ' O ' ' A' ' 508' ' ' VAL . . . -71.24 -72.81 0.2 Allowed 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 117.756 2.502 . . . . 0.0 117.756 -174.353 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 513' ' ' GLY . . . . . 0.59 ' H ' ' HE2' ' A' ' 584' ' ' LYS . . . -114.6 -35.57 1.4 Allowed Glycine 0 CA--C 1.5 -0.877 0 N-CA-C 121.39 3.316 . . . . 0.0 121.39 -172.412 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 514' ' ' LEU . . . . . 0.613 HD13 ' HG3' ' A' ' 582' ' ' LYS . 2.8 mt -108.16 -47.03 3.62 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 119.798 3.258 . . . . 0.0 119.798 -170.67 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 515' ' ' VAL . . . . . 0.613 HG12 ' N ' ' A' ' 516' ' ' ALA . 90.1 t -153.06 171.88 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.582 0 N-CA-C 117.073 2.249 . . . . 0.0 117.073 -172.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 516' ' ' ALA . . . . . 0.613 ' N ' HG12 ' A' ' 515' ' ' VAL . . . -69.09 3.04 2.3 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 113.012 -1.904 . . . . 0.0 109.366 175.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 517' ' ' SER . . . . . 0.881 ' O ' ' N ' ' A' ' 521' ' ' GLY . 0.4 OUTLIER -58.35 8.75 0.01 OUTLIER 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 115.43 1.641 . . . . 0.0 115.43 -172.122 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 518' ' ' LYS . . . . . 0.913 ' HA ' ' CD1' ' A' ' 510' ' ' TRP . 0.0 OUTLIER -45.8 -45.41 14.79 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 104.321 -2.474 . . . . 0.0 104.321 175.74 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 519' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.32 -56.43 4.88 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.427 -1.26 . . . . 0.0 109.706 173.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 520' ' ' GLU . . . . . 0.809 ' HB2' ' HA ' ' A' ' 517' ' ' SER . 9.3 mm-40 -63.64 -48.31 77.81 Favored 'General case' 0 C--N 1.351 0.654 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.02 -179.042 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 521' ' ' GLY . . . . . 0.881 ' N ' ' O ' ' A' ' 517' ' ' SER . . . -54.9 -53.55 39.14 Favored Glycine 0 CA--C 1.499 -0.929 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.443 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 522' ' ' GLN . . . . . 0.494 ' HA ' HG12 ' A' ' 525' ' ' ILE . 0.1 OUTLIER -47.82 -48.31 30.75 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.109 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 523' ' ' ARG . . . . . 0.452 ' HB3' ' O ' ' A' ' 520' ' ' GLU . 1.5 tpt180 -50.67 -48.71 58.32 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.095 178.228 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 524' ' ' ILE . . . . . 0.536 HG23 ' HG2' ' A' ' 580' ' ' LYS . 34.0 mm -55.12 -54.07 28.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.352 0.596 . . . . 0.0 110.029 179.104 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 525' ' ' ILE . . . . . 1.007 HG23 HD11 ' A' ' 556' ' ' ILE . 0.6 OUTLIER -50.5 -47.48 27.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 177.715 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 526' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -56.56 -48.28 77.69 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 113.996 -1.456 . . . . 0.0 108.521 177.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 527' ' ' ASN . . . . . 0.422 ' N ' ' O ' ' A' ' 523' ' ' ARG . 0.0 OUTLIER -48.35 -39.45 22.18 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 113.784 -1.553 . . . . 0.0 108.003 176.924 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 528' ' ' ASN . . . . . 0.71 ' HA ' HG23 ' A' ' 556' ' ' ILE . 1.4 t30 74.51 40.19 0.42 Allowed 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.185 -178.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 529' ' ' GLY . . . . . . . . . . . . . . . -119.26 37.96 2.99 Favored Glycine 0 CA--C 1.521 0.466 0 CA-C-N 114.595 -1.184 . . . . 0.0 111.826 178.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 530' ' ' ALA . . . . . 0.826 ' HB3' HG12 ' A' ' 556' ' ' ILE . . . -132.76 164.53 26.6 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.834 0.826 . . . . 0.0 112.42 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 531' ' ' TYR . . . . . 0.716 ' HA ' HG22 ' A' ' 554' ' ' THR . 2.2 t80 -135.02 152.89 52.13 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 124.89 1.276 . . . . 0.0 109.061 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 532' ' ' VAL . . . . . 0.535 ' HB ' HG21 ' A' ' 554' ' ' THR . 0.4 OUTLIER -133.42 135.67 55.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 CA-C-O 121.807 0.813 . . . . 0.0 111.564 178.69 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 533' ' ' GLY . . . . . 0.767 ' O ' HG13 ' A' ' 575' ' ' ILE . . . -133.16 150.08 19.74 Favored Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 114.464 -1.244 . . . . 0.0 113.414 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 534' ' ' SER . . . . . 0.551 ' OG ' ' O ' ' A' ' 567' ' ' PHE . 0.5 OUTLIER -134.92 137.21 42.93 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.51 -0.345 . . . . 0.0 111.307 178.848 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 535' ' ' ARG . . . . . 0.547 ' O ' ' HB3' ' A' ' 573' ' ' LEU . 24.8 tpt85 . . . . . 0 C--N 1.33 -0.257 0 C-N-CA 120.657 -0.417 . . . . 0.0 112.077 178.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 . . . . . 0 N--CA 1.451 -0.396 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 550' ' ' ASP . . . . . 0.492 ' O ' ' HA ' ' A' ' 535' ' ' ARG . 96.2 m-20 -65.37 -46.24 80.92 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.487 179.126 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 551' ' ' LEU . . . . . . . . . . . . . 19.4 tp -131.57 141.96 49.81 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.426 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 552' ' ' THR . . . . . 0.591 ' O ' ' HA2' ' A' ' 533' ' ' GLY . 37.9 m -132.23 147.83 52.43 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.486 0.66 . . . . 0.0 111.441 179.203 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 553' ' ' PHE . . . . . 0.69 ' CD1' ' HE2' ' A' ' 531' ' ' TYR . 8.9 m-30 -132.27 139.45 48.25 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.463 -1.244 . . . . 0.0 107.927 179.117 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 554' ' ' THR . . . . . 0.922 HG23 ' H ' ' A' ' 556' ' ' ILE . 0.4 OUTLIER -130.43 141.73 42.95 Favored Pre-proline 0 C--N 1.326 -0.434 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -178.727 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 555' ' ' PRO . . . . . 0.842 ' O ' HG22 ' A' ' 556' ' ' ILE . 78.8 Cg_endo -87.77 1.12 6.96 Favored 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 123.055 2.503 . . . . 0.0 110.152 177.378 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 556' ' ' ILE . . . . . 1.007 HD11 HG23 ' A' ' 525' ' ' ILE . 7.0 tp 62.71 34.02 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.312 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 178.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 557' ' ' LYS . . . . . 0.643 ' O ' ' CE2' ' A' ' 559' ' ' TRP . 33.5 mttt -103.48 142.21 34.66 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 558' ' ' THR . . . . . . . . . . . . . 3.4 t -57.42 116.22 3.2 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 -171.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 559' ' ' TRP . . . . . 0.643 ' CE2' ' O ' ' A' ' 557' ' ' LYS . 0.0 OUTLIER -139.5 112.27 7.91 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 112.827 -1.988 . . . . 0.0 105.803 174.442 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 560' ' ' ASN . . . . . 0.71 ' O ' HG22 ' A' ' 564' ' ' THR . 77.6 m-20 -84.0 -76.64 0.29 Allowed 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 118.123 -1.431 . . . . 0.0 113.541 -176.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 561' ' ' ALA . . . . . 0.649 ' HA ' ' CG2' ' A' ' 564' ' ' THR . . . -75.57 -50.33 15.91 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 -178.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 562' ' ' SER . . . . . . . . . . . . . 38.8 m -49.57 -54.83 16.0 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -177.063 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 563' ' ' LYS . . . . . 0.755 ' HB3' HG21 ' A' ' 504' ' ' THR . 2.1 mmpt? -70.5 -47.79 58.79 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -178.445 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 564' ' ' THR . . . . . 0.881 HG23 ' H ' ' A' ' 565' ' ' GLN . 3.9 t -49.27 -71.35 0.07 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.578 0.227 . . . . 0.0 111.556 -178.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 565' ' ' GLN . . . . . 0.881 ' H ' HG23 ' A' ' 564' ' ' THR . 0.0 OUTLIER -49.37 -46.45 47.2 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.785 0.326 . . . . 0.0 111.518 179.786 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -49.15 -61.32 2.14 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 567' ' ' PHE . . . . . 0.882 ' CZ ' HD13 ' A' ' 568' ' ' ILE . 0.2 OUTLIER -96.78 -40.68 8.84 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -177.529 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 568' ' ' ILE . . . . . 1.108 HD11 HD13 ' A' ' 574' ' ' LEU . 0.9 OUTLIER -62.81 8.09 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -179.413 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 569' ' ' ILE . . . . . 0.771 HG23 ' O ' ' A' ' 565' ' ' GLN . 0.8 OUTLIER -55.04 -40.39 54.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 178.482 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 570' ' ' ASP . . . . . 0.586 ' OD2' ' HB2' ' A' ' 574' ' ' LEU . 5.7 m-20 33.85 61.27 0.49 Allowed 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 114.04 -1.436 . . . . 0.0 112.576 173.352 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 571' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 570' ' ' ASP . . . -51.94 -45.45 56.07 Favored Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 116.856 -2.592 . . . . 0.0 108.222 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 572' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -120.8 -16.07 8.24 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 175.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 573' ' ' LEU . . . . . 0.547 ' HB3' ' O ' ' A' ' 535' ' ' ARG . 1.5 tp -139.87 136.95 34.48 Favored 'General case' 0 C--N 1.354 0.794 0 N-CA-C 116.591 2.071 . . . . 0.0 116.591 -176.445 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 574' ' ' LEU . . . . . 1.108 HD13 HD11 ' A' ' 568' ' ' ILE . 0.1 OUTLIER -135.11 133.24 39.03 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 173.503 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 575' ' ' ILE . . . . . 0.909 HG22 ' HB3' ' A' ' 585' ' ' LEU . 0.0 OUTLIER -134.72 138.3 49.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 119.087 0.858 . . . . 0.0 111.448 177.893 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 576' ' ' LEU . . . . . 0.532 ' CD1' ' CE2' ' A' ' 505' ' ' PHE . 0.1 OUTLIER -132.52 135.61 46.1 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 177.889 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 577' ' ' LYS . . . . . . . . . . . . . 12.0 mtpt -132.6 135.8 46.12 Favored 'General case' 0 C--N 1.31 -1.125 0 C-N-CA 119.593 -0.843 . . . . 0.0 110.582 178.244 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.543 HD12 ' O ' ' A' ' 582' ' ' LYS . 0.5 OUTLIER -126.75 131.83 51.23 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 177.579 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 579' ' ' GLY . . . . . . . . . . . . . . . -90.49 -2.27 73.41 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 115.432 -0.804 . . . . 0.0 113.424 -178.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 580' ' ' LYS . . . . . 0.536 ' HG2' HG23 ' A' ' 524' ' ' ILE . 0.0 OUTLIER -73.33 -48.22 36.14 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 119.043 -1.063 . . . . 0.0 109.097 179.338 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 581' ' ' TRP . . . . . 0.488 ' CD1' ' O ' ' A' ' 580' ' ' LYS . 24.1 m0 -139.07 -52.38 0.55 Allowed 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 114.606 1.335 . . . . 0.0 114.606 177.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 582' ' ' LYS . . . . . 0.613 ' HG3' HD13 ' A' ' 514' ' ' LEU . 0.0 OUTLIER -139.55 165.44 27.24 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -174.263 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 583' ' ' MET . . . . . 0.692 ' CE ' HD22 ' A' ' 585' ' ' LEU . 7.6 ttt -117.46 134.29 55.01 Favored 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 106.46 -1.681 . . . . 0.0 106.46 174.239 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 584' ' ' LYS . . . . . 0.662 ' HZ1' HG12 ' A' ' 508' ' ' VAL . 1.4 tmmt? -128.41 133.6 48.62 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 178.314 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 585' ' ' LEU . . . . . 0.909 ' HB3' HG22 ' A' ' 575' ' ' ILE . 0.0 OUTLIER -125.98 136.72 53.32 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.921 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 586' ' ' VAL . . . . . 0.641 HG23 ' HD3' ' A' ' 584' ' ' LYS . 24.8 t -131.06 144.91 36.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.554 -177.088 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 587' ' ' SER . . . . . . . . . . . . . 49.8 m -107.21 135.63 48.4 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 177.08 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.723 HG22 ' O ' ' A' ' 495' ' ' LEU . 23.0 pt -133.58 137.63 52.46 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.508 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -178.406 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 7.7 m -132.63 137.1 54.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 114.31 -1.314 . . . . 0.0 110.603 178.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 590' ' ' SER . . . . . . . . . . . . . 1.7 t . . . . . 0 C--N 1.326 -0.445 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.753 -179.819 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 491' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.113 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 492' ' ' ARG . . . . . 0.514 ' CG ' ' HG ' ' A' ' 585' ' ' LEU . 0.0 OUTLIER -135.27 134.05 39.56 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.061 178.759 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 493' ' ' VAL . . . . . 0.563 HG12 ' N ' ' A' ' 494' ' ' THR . 39.4 t -136.06 163.41 34.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.373 178.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 494' ' ' THR . . . . . 0.805 HG23 ' O ' ' A' ' 587' ' ' SER . 53.5 m -125.41 133.66 52.42 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.119 0.485 . . . . 0.0 110.298 177.372 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 495' ' ' LEU . . . . . 0.913 HD11 HD11 ' A' ' 499' ' ' LEU . 0.0 OUTLIER -136.08 163.89 47.02 Favored Pre-proline 0 CA--C 1.53 0.196 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.578 179.686 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 496' ' ' PRO . . . . . 0.798 ' HB2' HD23 ' A' ' 499' ' ' LEU . 46.1 Cg_exo -54.37 119.65 6.73 Favored 'Trans proline' 0 CA--C 1.532 0.414 0 C-N-CA 121.931 1.754 . . . . 0.0 111.515 178.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 497' ' ' LYS . . . . . 0.502 ' CA ' ' HB ' ' A' ' 588' ' ' ILE . 0.8 OUTLIER -62.0 -30.28 70.83 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -179.204 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 498' ' ' SER . . . . . . . . . . . . . 2.1 m -58.15 -47.4 83.48 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -178.089 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 499' ' ' LEU . . . . . 0.913 HD11 HD11 ' A' ' 495' ' ' LEU . 2.2 pp -72.81 -7.83 52.61 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -178.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 500' ' ' VAL . . . . . 0.621 HG22 ' NZ ' ' A' ' 507' ' ' LYS . 42.9 t -74.46 -25.83 19.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.374 0.607 . . . . 0.0 111.243 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 501' ' ' TYR . . . . . 0.698 ' O ' HG21 ' A' ' 564' ' ' THR . 0.3 OUTLIER -53.86 -29.46 41.48 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 -178.449 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 502' ' ' ASP . . . . . 0.406 ' N ' ' CD1' ' A' ' 501' ' ' TYR . 8.6 m-20 -75.56 -50.15 16.45 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 -175.227 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 503' ' ' LYS . . . . . 0.588 ' O ' ' CG ' ' A' ' 507' ' ' LYS . 0.2 OUTLIER -119.23 135.11 54.84 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 118.868 0.758 . . . . 0.0 111.298 -179.656 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 504' ' ' THR . . . . . 0.667 HG21 ' HB3' ' A' ' 563' ' ' LYS . 2.2 m -73.32 -76.52 0.12 Allowed 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 505' ' ' PHE . . . . . 0.644 ' CE1' HG23 ' A' ' 532' ' ' VAL . 0.3 OUTLIER -75.61 -60.39 2.33 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 -179.414 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 506' ' ' SER . . . . . 0.775 ' O ' ' CD1' ' A' ' 510' ' ' TRP . 8.0 t -48.97 -72.79 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -175.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 507' ' ' LYS . . . . . 0.694 ' HD3' ' N ' ' A' ' 508' ' ' VAL . 0.0 OUTLIER -49.37 -48.28 46.96 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -177.021 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 508' ' ' VAL . . . . . 0.88 ' CG2' HD21 ' A' ' 574' ' ' LEU . 50.9 t -51.65 -60.72 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 509' ' ' LEU . . . . . 0.806 HD12 ' N ' ' A' ' 510' ' ' TRP . 2.6 pp -58.37 -61.06 2.86 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 115.753 1.76 . . . . 0.0 115.753 -176.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 510' ' ' TRP . . . . . 0.856 ' CD1' ' HA ' ' A' ' 518' ' ' LYS . 66.7 p-90 -72.38 -52.14 17.34 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -176.019 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 511' ' ' SER . . . . . 0.509 ' N ' ' CE3' ' A' ' 510' ' ' TRP . 1.4 t -64.79 -47.8 76.77 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -177.156 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 512' ' ' ALA . . . . . 0.815 ' HB3' ' O ' ' A' ' 508' ' ' VAL . . . -71.4 -72.84 0.2 Allowed 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 117.728 2.492 . . . . 0.0 117.728 -174.554 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 513' ' ' GLY . . . . . 0.649 ' H ' ' HE2' ' A' ' 584' ' ' LYS . . . -114.55 -35.06 1.47 Allowed Glycine 0 CA--C 1.503 -0.701 0 N-CA-C 121.24 3.256 . . . . 0.0 121.24 -172.482 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 514' ' ' LEU . . . . . 0.522 ' HG ' ' CG ' ' A' ' 584' ' ' LYS . 3.2 mt -107.5 -46.37 3.86 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 119.356 3.095 . . . . 0.0 119.356 -170.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 515' ' ' VAL . . . . . 1.049 HG13 ' HB2' ' A' ' 517' ' ' SER . 2.4 p -154.6 173.1 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.646 0 N-CA-C 117.619 2.451 . . . . 0.0 117.619 -172.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 516' ' ' ALA . . . . . 0.551 ' N ' ' CG2' ' A' ' 515' ' ' VAL . . . -67.94 4.05 1.32 Allowed 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 126.599 1.96 . . . . 0.0 109.864 177.272 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 517' ' ' SER . . . . . 1.049 ' HB2' HG13 ' A' ' 515' ' ' VAL . 0.6 OUTLIER -57.7 9.19 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 116.133 1.901 . . . . 0.0 116.133 -171.972 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 518' ' ' LYS . . . . . 0.856 ' HA ' ' CD1' ' A' ' 510' ' ' TRP . 0.6 OUTLIER -45.43 -47.42 13.75 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 104.268 -2.493 . . . . 0.0 104.268 175.398 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 519' ' ' SER . . . . . . . . . . . . . 68.5 p -74.98 -58.16 3.45 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 114.531 -1.213 . . . . 0.0 110.178 173.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 520' ' ' GLU . . . . . 0.822 ' HB3' ' HA ' ' A' ' 517' ' ' SER . 2.7 tp10 -59.9 -47.61 85.07 Favored 'General case' 0 C--N 1.35 0.598 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.747 -178.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 521' ' ' GLY . . . . . 0.832 ' N ' ' O ' ' A' ' 517' ' ' SER . . . -49.75 -55.4 14.37 Favored Glycine 0 CA--C 1.493 -1.3 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 522' ' ' GLN . . . . . 0.466 ' HA ' HG12 ' A' ' 525' ' ' ILE . 14.3 mt-30 -47.68 -47.82 29.47 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 523' ' ' ARG . . . . . 0.522 ' HB3' ' O ' ' A' ' 520' ' ' GLU . 0.1 OUTLIER -50.7 -49.01 58.56 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.536 178.475 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 524' ' ' ILE . . . . . 0.637 HG21 HD22 ' A' ' 578' ' ' LEU . 36.0 mm -56.65 -54.99 22.09 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 CA-C-O 121.352 0.596 . . . . 0.0 109.883 179.182 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 525' ' ' ILE . . . . . 0.819 HG23 ' CD1' ' A' ' 556' ' ' ILE . 0.5 OUTLIER -50.22 -47.2 25.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 177.739 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 526' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -55.03 -48.05 73.92 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 113.764 -1.562 . . . . 0.0 108.506 177.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 527' ' ' ASN . . . . . 0.492 ' ND2' ' O ' ' A' ' 524' ' ' ILE . 0.0 OUTLIER -48.17 -39.99 22.6 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 113.957 -1.474 . . . . 0.0 107.734 177.124 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 528' ' ' ASN . . . . . 0.645 ' HA ' ' CG2' ' A' ' 556' ' ' ILE . 0.2 OUTLIER 73.65 40.26 0.5 Allowed 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.349 -179.373 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 529' ' ' GLY . . . . . . . . . . . . . . . -119.68 32.71 4.9 Favored Glycine 0 CA--C 1.524 0.616 0 CA-C-N 115.0 -1.0 . . . . 0.0 112.597 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 530' ' ' ALA . . . . . 0.909 ' O ' ' HB ' ' A' ' 556' ' ' ILE . . . -133.48 164.57 26.85 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.246 0.546 . . . . 0.0 112.438 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 531' ' ' TYR . . . . . 0.582 ' HA ' ' O ' ' A' ' 554' ' ' THR . 0.0 OUTLIER -133.99 155.82 49.28 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 177.648 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 532' ' ' VAL . . . . . 0.644 HG23 ' CE1' ' A' ' 505' ' ' PHE . 0.5 OUTLIER -129.17 136.34 59.79 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 CA-C-O 121.789 0.804 . . . . 0.0 111.894 179.929 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 533' ' ' GLY . . . . . 0.752 ' O ' HG13 ' A' ' 575' ' ' ILE . . . -132.33 147.13 18.69 Favored Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 114.442 -1.254 . . . . 0.0 113.504 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 534' ' ' SER . . . . . 0.425 ' C ' ' HD2' ' A' ' 535' ' ' ARG . 3.4 m -134.7 136.73 42.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.248 -0.476 . . . . 0.0 111.43 179.54 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 535' ' ' ARG . . . . . 0.853 ' HG2' HD22 ' A' ' 573' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.266 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.966 178.349 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 549' ' ' ASP . . . . . 0.476 ' HB2' HD11 ' A' ' 569' ' ' ILE . 2.3 p30 . . . . . 0 N--CA 1.451 -0.424 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 550' ' ' ASP . . . . . 0.507 ' O ' ' HB3' ' A' ' 535' ' ' ARG . 0.5 OUTLIER -58.66 -47.81 83.19 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.396 179.39 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 551' ' ' LEU . . . . . 0.634 HD21 ' HE1' ' A' ' 553' ' ' PHE . 7.1 tp -131.36 142.48 50.08 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.43 -0.805 . . . . 0.0 108.969 178.332 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 552' ' ' THR . . . . . 0.838 HG21 ' CG ' ' A' ' 567' ' ' PHE . 4.3 m -132.94 147.65 52.28 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.756 0.789 . . . . 0.0 112.395 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 553' ' ' PHE . . . . . 0.634 ' HE1' HD21 ' A' ' 551' ' ' LEU . 17.4 m-85 -133.71 136.95 44.99 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 176.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 554' ' ' THR . . . . . 0.863 HG22 ' H ' ' A' ' 556' ' ' ILE . 1.2 m -133.66 138.67 31.57 Favored Pre-proline 0 C--N 1.308 -1.224 0 C-N-CA 119.822 -0.751 . . . . 0.0 110.492 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 555' ' ' PRO . . . . . 0.827 ' O ' HG22 ' A' ' 556' ' ' ILE . 65.7 Cg_endo -83.49 19.24 1.37 Allowed 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 121.898 1.732 . . . . 0.0 111.764 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 556' ' ' ILE . . . . . 0.909 ' HB ' ' O ' ' A' ' 530' ' ' ALA . 4.5 tp 62.66 34.01 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.188 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 176.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 557' ' ' LYS . . . . . 0.599 ' O ' ' CE2' ' A' ' 559' ' ' TRP . 0.0 OUTLIER -103.82 126.03 50.66 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 179.897 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 558' ' ' THR . . . . . . . . . . . . . 3.6 t -57.81 118.22 5.09 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 115.413 1.634 . . . . 0.0 115.413 -172.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 559' ' ' TRP . . . . . 0.751 ' HZ2' HG23 ' A' ' 554' ' ' THR . 0.0 OUTLIER -138.5 130.7 28.56 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 175.214 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 560' ' ' ASN . . . . . 0.665 ' O ' HG22 ' A' ' 564' ' ' THR . 11.0 m-80 -90.88 -76.32 0.44 Allowed 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 118.305 -1.358 . . . . 0.0 114.116 -177.137 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 561' ' ' ALA . . . . . 0.526 ' HA ' ' CG2' ' A' ' 564' ' ' THR . . . -75.23 -57.29 3.98 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 116.368 1.988 . . . . 0.0 116.368 -177.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 562' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -49.0 -52.48 24.72 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -176.256 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 563' ' ' LYS . . . . . 0.667 ' HB3' HG21 ' A' ' 504' ' ' THR . 0.0 OUTLIER -70.8 -48.01 56.47 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -178.412 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 564' ' ' THR . . . . . 0.811 HG23 ' H ' ' A' ' 565' ' ' GLN . 6.8 t -49.63 -69.37 0.12 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.867 0.365 . . . . 0.0 111.288 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 565' ' ' GLN . . . . . 1.06 ' O ' HG23 ' A' ' 569' ' ' ILE . 2.0 tp60 -50.07 -46.62 53.48 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 566' ' ' GLU . . . . . 0.426 ' HG2' ' CD1' ' A' ' 567' ' ' PHE . 14.0 tt0 -49.24 -65.42 0.57 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 111.863 0.319 . . . . 0.0 111.863 -178.4 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 567' ' ' PHE . . . . . 0.838 ' CG ' HG21 ' A' ' 552' ' ' THR . 0.0 OUTLIER -97.18 -51.52 4.17 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.747 0.784 . . . . 0.0 112.007 -178.973 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 568' ' ' ILE . . . . . 0.643 ' CG1' HG23 ' A' ' 504' ' ' THR . 12.0 mm -57.26 9.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 114.321 -1.309 . . . . 0.0 113.321 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 569' ' ' ILE . . . . . 1.06 HG23 ' O ' ' A' ' 565' ' ' GLN . 0.9 OUTLIER -53.87 -39.03 38.23 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.845 0 N-CA-C 104.266 -2.494 . . . . 0.0 104.266 178.154 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 570' ' ' ASP . . . . . 0.916 ' CB ' HD11 ' A' ' 588' ' ' ILE . 32.5 m-20 35.45 50.0 0.53 Allowed 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 113.726 -1.579 . . . . 0.0 111.342 174.01 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -50.54 -44.13 46.03 Favored Glycine 0 N--CA 1.439 -1.101 0 C-N-CA 118.37 -1.871 . . . . 0.0 109.051 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 572' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -118.44 -18.09 9.24 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 120.252 -0.579 . . . . 0.0 112.16 175.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 573' ' ' LEU . . . . . 0.853 HD22 ' HG2' ' A' ' 535' ' ' ARG . 0.7 OUTLIER -141.2 137.68 32.8 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 574' ' ' LEU . . . . . 0.88 HD21 ' CG2' ' A' ' 508' ' ' VAL . 1.1 tp -133.98 131.94 39.54 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 174.447 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 575' ' ' ILE . . . . . 1.077 HG23 HD13 ' A' ' 585' ' ' LEU . 0.0 OUTLIER -134.64 137.19 51.58 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-N 118.557 0.617 . . . . 0.0 111.612 178.802 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 576' ' ' LEU . . . . . 0.547 HD22 ' CB ' ' A' ' 509' ' ' LEU . 0.0 OUTLIER -133.08 135.67 45.44 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 177.375 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 577' ' ' LYS . . . . . 0.44 ' HG2' ' HB2' ' A' ' 583' ' ' MET . 7.5 mttt -130.62 135.59 48.02 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.254 177.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.637 HD22 HG21 ' A' ' 524' ' ' ILE . 0.3 OUTLIER -124.88 132.01 53.36 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.871 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 579' ' ' GLY . . . . . . . . . . . . . . . -89.55 -2.19 76.6 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 115.229 -0.896 . . . . 0.0 113.251 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 580' ' ' LYS . . . . . 0.621 ' HG2' HG23 ' A' ' 524' ' ' ILE . 0.0 OUTLIER -72.56 -48.46 39.9 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 118.957 -1.097 . . . . 0.0 108.815 179.27 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 581' ' ' TRP . . . . . 0.491 ' CD1' ' O ' ' A' ' 580' ' ' LYS . 25.5 m0 -139.29 -53.02 0.55 Allowed 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 114.452 1.278 . . . . 0.0 114.452 177.452 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 582' ' ' LYS . . . . . 0.589 ' O ' HD12 ' A' ' 578' ' ' LEU . 0.1 OUTLIER -140.38 165.18 28.13 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -174.636 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 583' ' ' MET . . . . . 0.44 ' HB2' ' HG2' ' A' ' 577' ' ' LYS . 0.3 OUTLIER -113.97 134.78 54.62 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 174.156 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 584' ' ' LYS . . . . . 0.842 ' HD3' HG23 ' A' ' 586' ' ' VAL . 1.4 tmmt? -120.77 133.85 55.31 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 177.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 585' ' ' LEU . . . . . 1.077 HD13 HG23 ' A' ' 575' ' ' ILE . 1.4 tp -118.8 136.32 54.06 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 586' ' ' VAL . . . . . 0.848 ' N ' HD12 ' A' ' 585' ' ' LEU . 2.5 t -132.88 137.15 54.46 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -177.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 587' ' ' SER . . . . . 0.805 ' O ' HG23 ' A' ' 494' ' ' THR . 55.6 m -109.35 134.95 51.19 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 177.108 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.916 HD11 ' CB ' ' A' ' 570' ' ' ASP . 0.2 OUTLIER -134.6 152.63 33.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -178.649 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 4.6 t -122.6 138.82 51.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 114.031 -1.441 . . . . 0.0 110.781 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 590' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.327 -0.381 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.163 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 491' ' ' ALA . . . . . 0.402 ' CB ' HD21 ' A' ' 514' ' ' LEU . . . . . . . . 0 N--CA 1.465 0.284 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 492' ' ' ARG . . . . . 0.477 ' HD3' HD23 ' A' ' 585' ' ' LEU . 0.0 OUTLIER -134.32 133.12 40.34 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.726 177.366 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 493' ' ' VAL . . . . . 0.637 HG21 ' CA ' ' A' ' 513' ' ' GLY . 44.5 t -136.98 163.69 31.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 494' ' ' THR . . . . . 0.587 ' N ' HG12 ' A' ' 493' ' ' VAL . 32.3 p -117.69 134.25 55.09 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 121.147 0.498 . . . . 0.0 110.127 177.187 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 495' ' ' LEU . . . . . 1.056 HD22 ' HB2' ' A' ' 512' ' ' ALA . 0.0 OUTLIER -135.22 164.4 44.08 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.377 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 496' ' ' PRO . . . . . 0.898 ' HD2' HD12 ' A' ' 495' ' ' LEU . 11.9 Cg_exo -69.63 119.39 6.35 Favored 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 122.065 1.844 . . . . 0.0 111.199 178.501 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 497' ' ' LYS . . . . . 0.503 ' HB2' ' N ' ' A' ' 589' ' ' VAL . 2.4 ttpt -57.43 -30.21 64.79 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -178.535 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 498' ' ' SER . . . . . 0.418 ' O ' ' CD1' ' A' ' 501' ' ' TYR . 0.3 OUTLIER -59.14 -48.7 80.66 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 114.414 1.264 . . . . 0.0 114.414 -176.757 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 499' ' ' LEU . . . . . 0.548 HD21 ' HD2' ' A' ' 496' ' ' PRO . 1.5 pp -74.2 -10.24 59.41 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -178.277 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 500' ' ' VAL . . . . . 0.715 HG21 HG21 ' A' ' 588' ' ' ILE . 20.8 t -76.54 -27.21 17.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.337 0.589 . . . . 0.0 111.88 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 501' ' ' TYR . . . . . 0.596 ' O ' HG21 ' A' ' 564' ' ' THR . 0.3 OUTLIER -54.09 -30.6 49.03 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -177.704 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 502' ' ' ASP . . . . . 0.432 ' N ' ' CD1' ' A' ' 501' ' ' TYR . 4.6 t0 -75.78 -51.3 12.94 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 -175.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 503' ' ' LYS . . . . . 0.62 ' HB3' ' HG2' ' A' ' 507' ' ' LYS . 0.0 OUTLIER -120.59 140.6 51.28 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 118.76 0.709 . . . . 0.0 110.572 178.936 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 504' ' ' THR . . . . . 0.749 HG23 ' CG1' ' A' ' 568' ' ' ILE . 3.3 m -72.6 -74.4 0.17 Allowed 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -178.235 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 505' ' ' PHE . . . . . 0.743 ' CZ ' ' HB1' ' A' ' 530' ' ' ALA . 0.2 OUTLIER -73.3 -57.63 3.88 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -177.262 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 506' ' ' SER . . . . . 0.849 ' O ' ' CD1' ' A' ' 510' ' ' TRP . 10.1 t -48.8 -66.38 0.41 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -176.408 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 507' ' ' LYS . . . . . 0.62 ' HG2' ' HB3' ' A' ' 503' ' ' LYS . 0.0 OUTLIER -48.75 -56.13 9.51 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -176.849 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 508' ' ' VAL . . . . . 0.975 ' CG2' HD21 ' A' ' 574' ' ' LEU . 48.4 t -49.9 -61.14 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -179.175 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 509' ' ' LEU . . . . . 0.816 HD12 ' N ' ' A' ' 510' ' ' TRP . 2.5 pp -54.27 -63.07 1.27 Allowed 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 115.626 1.713 . . . . 0.0 115.626 -177.063 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 510' ' ' TRP . . . . . 0.873 ' CD1' ' HA ' ' A' ' 518' ' ' LYS . 66.3 p-90 -72.85 -51.39 18.95 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 -175.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 511' ' ' SER . . . . . 0.529 ' N ' ' CE3' ' A' ' 510' ' ' TRP . 0.3 OUTLIER -64.39 -47.19 80.18 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.299 -0.864 . . . . 0.0 113.305 -176.753 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 512' ' ' ALA . . . . . 1.056 ' HB2' HD22 ' A' ' 495' ' ' LEU . . . -70.92 -73.79 0.16 Allowed 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 118.158 2.651 . . . . 0.0 118.158 -173.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 513' ' ' GLY . . . . . 0.675 ' H ' ' HE2' ' A' ' 584' ' ' LYS . . . -115.48 -34.98 1.35 Allowed Glycine 0 CA--C 1.501 -0.825 0 N-CA-C 120.84 3.096 . . . . 0.0 120.84 -172.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 514' ' ' LEU . . . . . 0.619 ' HG ' ' HB2' ' A' ' 584' ' ' LYS . 0.1 OUTLIER -106.86 -46.53 3.93 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 119.473 3.138 . . . . 0.0 119.473 -169.887 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 515' ' ' VAL . . . . . 1.038 HG13 ' HB2' ' A' ' 517' ' ' SER . 2.5 p -154.4 172.29 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 N-CA-C 117.981 2.585 . . . . 0.0 117.981 -172.495 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 516' ' ' ALA . . . . . 0.546 ' N ' HG22 ' A' ' 515' ' ' VAL . . . -68.62 3.71 1.74 Allowed 'General case' 0 C--N 1.333 -0.109 0 C-N-CA 126.741 2.016 . . . . 0.0 110.012 177.376 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 517' ' ' SER . . . . . 1.038 ' HB2' HG13 ' A' ' 515' ' ' VAL . 0.6 OUTLIER -57.84 9.1 0.01 OUTLIER 'General case' 0 N--CA 1.428 -1.526 0 N-CA-C 116.153 1.909 . . . . 0.0 116.153 -171.797 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 518' ' ' LYS . . . . . 0.873 ' HA ' ' CD1' ' A' ' 510' ' ' TRP . 0.1 OUTLIER -45.3 -46.93 13.04 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 104.277 -2.49 . . . . 0.0 104.277 175.423 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 519' ' ' SER . . . . . . . . . . . . . 58.0 p -75.1 -60.05 2.47 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 114.658 -1.156 . . . . 0.0 110.15 173.299 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 520' ' ' GLU . . . . . 0.806 ' HB3' ' HA ' ' A' ' 517' ' ' SER . 5.7 tp10 -57.81 -47.47 82.52 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.497 -179.086 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 521' ' ' GLY . . . . . 0.834 ' N ' ' O ' ' A' ' 517' ' ' SER . . . -49.29 -54.37 16.02 Favored Glycine 0 CA--C 1.493 -1.328 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.033 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 522' ' ' GLN . . . . . 0.444 ' HA ' HG12 ' A' ' 525' ' ' ILE . 0.9 OUTLIER -47.42 -47.33 26.72 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.465 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 523' ' ' ARG . . . . . 0.463 ' O ' ' HB2' ' A' ' 526' ' ' ASN . 2.2 ttt180 -50.4 -48.78 55.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.844 178.327 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 524' ' ' ILE . . . . . 0.576 HD13 ' CE ' ' A' ' 580' ' ' LYS . 23.1 mt -58.25 -55.2 23.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.412 0.625 . . . . 0.0 109.827 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 525' ' ' ILE . . . . . 0.882 HG23 HD11 ' A' ' 556' ' ' ILE . 0.3 OUTLIER -50.02 -47.58 23.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 177.761 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 526' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 523' ' ' ARG . 8.2 m120 -56.17 -47.89 77.39 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 114.35 -1.295 . . . . 0.0 108.23 177.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -47.9 -40.24 21.27 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 113.986 -1.461 . . . . 0.0 107.534 176.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 528' ' ' ASN . . . . . 0.663 ' HA ' HG23 ' A' ' 556' ' ' ILE . 2.7 t30 73.44 40.28 0.53 Allowed 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.461 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 529' ' ' GLY . . . . . . . . . . . . . . . -116.33 31.68 5.9 Favored Glycine 0 CA--C 1.522 0.523 0 CA-C-N 114.994 -1.003 . . . . 0.0 112.436 178.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 530' ' ' ALA . . . . . 0.87 ' O ' ' HB ' ' A' ' 556' ' ' ILE . . . -133.44 164.42 27.17 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.532 0.682 . . . . 0.0 112.749 -179.015 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 531' ' ' TYR . . . . . 0.728 ' HA ' HG22 ' A' ' 554' ' ' THR . 0.0 OUTLIER -134.65 157.92 45.41 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.752 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 532' ' ' VAL . . . . . 0.674 HG23 ' CE1' ' A' ' 505' ' ' PHE . 0.5 OUTLIER -132.84 136.62 55.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-O 121.921 0.867 . . . . 0.0 112.133 179.886 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 533' ' ' GLY . . . . . 0.803 ' O ' HG13 ' A' ' 575' ' ' ILE . . . -128.64 148.63 18.07 Favored Glycine 0 N--CA 1.441 -1.01 0 CA-C-N 114.155 -1.384 . . . . 0.0 112.609 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 534' ' ' SER . . . . . 0.455 ' N ' ' HB ' ' A' ' 552' ' ' THR . 0.2 OUTLIER -134.73 146.88 49.84 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.528 -0.336 . . . . 0.0 110.617 179.62 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 535' ' ' ARG . . . . . 0.856 ' HB3' HD22 ' A' ' 573' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.233 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 178.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 . . . . . 0 N--CA 1.452 -0.359 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 550' ' ' ASP . . . . . 0.491 ' O ' ' HG2' ' A' ' 535' ' ' ARG . 0.1 OUTLIER -56.51 -37.84 70.99 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 121.764 0.793 . . . . 0.0 108.963 178.946 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 551' ' ' LEU . . . . . . . . . . . . . 14.6 tp -132.09 140.47 48.84 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.661 -1.154 . . . . 0.0 108.891 178.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 552' ' ' THR . . . . . 0.677 HG21 ' CG ' ' A' ' 567' ' ' PHE . 7.7 m -132.81 150.32 52.17 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.711 0.767 . . . . 0.0 111.728 179.233 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 553' ' ' PHE . . . . . 0.507 ' CD1' ' CE1' ' A' ' 531' ' ' TYR . 0.2 OUTLIER -132.92 138.54 46.99 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 114.442 -1.254 . . . . 0.0 108.166 178.135 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 554' ' ' THR . . . . . 0.929 HG23 ' H ' ' A' ' 556' ' ' ILE . 0.4 OUTLIER -131.3 140.78 39.58 Favored Pre-proline 0 C--N 1.312 -1.047 0 C-N-CA 120.304 -0.558 . . . . 0.0 111.173 -179.713 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 555' ' ' PRO . . . . . 0.843 ' O ' HG22 ' A' ' 556' ' ' ILE . 35.0 Cg_endo -91.15 7.7 3.43 Favored 'Trans proline' 0 N--CA 1.438 -1.785 0 C-N-CA 122.256 1.971 . . . . 0.0 110.338 178.065 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 556' ' ' ILE . . . . . 0.929 ' H ' HG23 ' A' ' 554' ' ' THR . 6.3 tp 62.4 33.21 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.302 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 177.484 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 557' ' ' LYS . . . . . 0.704 ' O ' ' CE2' ' A' ' 559' ' ' TRP . 0.0 OUTLIER -104.48 141.42 36.4 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 179.386 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 558' ' ' THR . . . . . . . . . . . . . 1.6 t -57.68 115.91 3.08 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 -172.049 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 559' ' ' TRP . . . . . 0.704 ' CE2' ' O ' ' A' ' 557' ' ' LYS . 0.0 OUTLIER -139.21 121.61 16.07 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 112.356 -2.202 . . . . 0.0 106.602 174.871 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 560' ' ' ASN . . . . . 0.619 ' O ' HG22 ' A' ' 564' ' ' THR . 81.2 m-20 -91.2 -76.8 0.43 Allowed 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 118.233 -1.387 . . . . 0.0 113.917 -177.583 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 561' ' ' ALA . . . . . 0.616 ' HA ' ' CG2' ' A' ' 564' ' ' THR . . . -75.53 -49.74 17.78 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 115.968 1.84 . . . . 0.0 115.968 -177.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 562' ' ' SER . . . . . 0.403 ' O ' ' HB2' ' A' ' 566' ' ' GLU . 9.9 t -48.8 -55.71 10.79 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -176.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 563' ' ' LYS . . . . . 0.569 ' HG3' ' CG ' ' A' ' 559' ' ' TRP . 0.1 OUTLIER -70.82 -47.97 56.61 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -178.307 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 564' ' ' THR . . . . . 0.834 HG23 ' H ' ' A' ' 565' ' ' GLN . 9.0 t -50.07 -72.0 0.06 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.81 0.338 . . . . 0.0 111.699 -179.226 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 565' ' ' GLN . . . . . 0.991 ' O ' HG23 ' A' ' 569' ' ' ILE . 1.1 tp60 -50.69 -46.66 58.91 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 566' ' ' GLU . . . . . 0.418 ' HG2' ' CD1' ' A' ' 567' ' ' PHE . 67.3 tt0 -49.17 -66.45 0.4 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.863 0.363 . . . . 0.0 111.696 -178.229 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 567' ' ' PHE . . . . . 0.677 ' CG ' HG21 ' A' ' 552' ' ' THR . 0.1 OUTLIER -97.39 -53.64 3.4 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.533 0.683 . . . . 0.0 111.701 -179.278 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 568' ' ' ILE . . . . . 0.848 HD12 ' CD1' ' A' ' 574' ' ' LEU . 14.9 mm -53.95 10.43 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.503 -0.841 0 CA-C-N 114.494 -1.23 . . . . 0.0 113.888 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 569' ' ' ILE . . . . . 0.991 HG23 ' O ' ' A' ' 565' ' ' GLN . 0.9 OUTLIER -55.73 -33.87 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 N-CA-C 103.815 -2.661 . . . . 0.0 103.815 177.7 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 570' ' ' ASP . . . . . 0.656 ' OD2' HD22 ' A' ' 574' ' ' LEU . 7.8 p30 34.56 42.82 0.08 Allowed 'General case' 0 CA--C 1.492 -1.264 0 CA-C-N 113.421 -1.718 . . . . 0.0 110.591 174.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 571' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' A' ' 570' ' ' ASP . . . -49.49 -43.46 35.93 Favored Glycine 0 N--CA 1.436 -1.342 0 N-CA-C 106.981 -2.448 . . . . 0.0 106.981 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 572' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -119.03 -17.99 8.88 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-O 118.937 -0.554 . . . . 0.0 112.298 174.648 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 573' ' ' LEU . . . . . 0.856 HD22 ' HB3' ' A' ' 535' ' ' ARG . 1.5 tp -142.21 136.55 30.0 Favored 'General case' 0 C--N 1.362 1.124 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 -178.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 574' ' ' LEU . . . . . 0.996 ' HB3' HD11 ' A' ' 588' ' ' ILE . 8.9 tp -136.22 133.84 37.49 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 114.339 -1.301 . . . . 0.0 107.613 173.344 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 575' ' ' ILE . . . . . 0.803 HG13 ' O ' ' A' ' 533' ' ' GLY . 0.0 OUTLIER -133.86 137.16 52.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 O-C-N 122.001 -0.437 . . . . 0.0 110.766 178.253 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 576' ' ' LEU . . . . . 0.614 HD22 ' HB3' ' A' ' 509' ' ' LEU . 0.1 OUTLIER -133.33 135.3 44.7 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 177.523 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 577' ' ' LYS . . . . . 0.403 ' N ' HD12 ' A' ' 576' ' ' LEU . 0.2 OUTLIER -132.99 135.24 45.36 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.194 -1.002 . . . . 0.0 109.979 177.026 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.574 ' HG ' HD11 ' A' ' 576' ' ' LEU . 0.4 OUTLIER -125.0 132.04 53.32 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.139 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 579' ' ' GLY . . . . . . . . . . . . . . . -89.81 -2.18 75.77 Favored Glycine 0 N--CA 1.442 -0.942 0 CA-C-N 115.294 -0.867 . . . . 0.0 113.173 -178.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 580' ' ' LYS . . . . . 0.576 ' CE ' HD13 ' A' ' 524' ' ' ILE . 0.0 OUTLIER -72.9 -48.1 40.17 Favored 'General case' 0 N--CA 1.441 -0.904 0 C-N-CA 119.17 -1.012 . . . . 0.0 108.908 179.256 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 581' ' ' TRP . . . . . 0.418 ' CD1' ' O ' ' A' ' 580' ' ' LYS . 13.6 m0 -139.64 -52.84 0.53 Allowed 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 177.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 582' ' ' LYS . . . . . 0.536 ' O ' HD12 ' A' ' 578' ' ' LEU . 3.1 ptpt -140.15 164.94 28.7 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 -175.063 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 583' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -113.7 134.68 54.6 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 174.198 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 584' ' ' LYS . . . . . 0.865 ' NZ ' HG12 ' A' ' 508' ' ' VAL . 0.5 OUTLIER -122.89 133.6 54.41 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 178.979 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 585' ' ' LEU . . . . . 0.727 ' HG ' HG23 ' A' ' 575' ' ' ILE . 9.8 tt -120.62 135.56 55.07 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 586' ' ' VAL . . . . . 0.747 HG12 ' CD1' ' A' ' 588' ' ' ILE . 55.2 t -134.04 144.15 36.3 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 112.991 0.738 . . . . 0.0 112.991 -177.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 587' ' ' SER . . . . . 0.873 ' C ' HD13 ' A' ' 588' ' ' ILE . 3.1 m -107.29 135.88 48.06 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 176.23 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.996 HD11 ' HB3' ' A' ' 574' ' ' LEU . 0.0 OUTLIER -132.77 136.93 55.0 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.47 0 CA-C-O 121.701 0.762 . . . . 0.0 112.785 -177.309 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 589' ' ' VAL . . . . . 0.503 ' N ' ' HB2' ' A' ' 497' ' ' LYS . 7.1 p -125.26 150.34 30.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 114.376 -1.284 . . . . 0.0 110.843 179.155 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 590' ' ' SER . . . . . . . . . . . . . 3.3 p . . . . . 0 C--N 1.326 -0.441 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.172 -179.491 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 491' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.165 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 492' ' ' ARG . . . . . 0.565 ' HA ' ' O ' ' A' ' 585' ' ' LEU . 0.0 OUTLIER -135.81 136.97 41.1 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.085 178.944 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 493' ' ' VAL . . . . . 0.836 HG23 ' NZ ' ' A' ' 584' ' ' LYS . 89.4 t -133.13 163.57 37.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.354 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 494' ' ' THR . . . . . 0.581 ' N ' HG12 ' A' ' 493' ' ' VAL . 91.8 m -114.68 135.9 53.64 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.441 0.638 . . . . 0.0 111.74 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 495' ' ' LEU . . . . . 0.89 HD22 ' HB2' ' A' ' 512' ' ' ALA . 0.2 OUTLIER -134.27 164.66 42.37 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.086 179.869 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 496' ' ' PRO . . . . . 0.635 ' HD2' HD21 ' A' ' 499' ' ' LEU . 23.2 Cg_exo -63.68 119.56 6.66 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 121.982 1.788 . . . . 0.0 111.721 179.044 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 497' ' ' LYS . . . . . 0.896 ' O ' HG12 ' A' ' 500' ' ' VAL . 0.2 OUTLIER -53.07 -30.0 33.51 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -178.961 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 498' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -57.56 -48.66 78.75 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -177.418 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 499' ' ' LEU . . . . . 0.81 HD11 HD13 ' A' ' 495' ' ' LEU . 2.3 pp -74.37 -9.07 58.23 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -178.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 500' ' ' VAL . . . . . 0.896 HG12 ' O ' ' A' ' 497' ' ' LYS . 2.9 p -75.61 -26.43 18.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.352 0.596 . . . . 0.0 111.717 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 501' ' ' TYR . . . . . 0.665 ' O ' HG21 ' A' ' 564' ' ' THR . 0.3 OUTLIER -53.88 -29.69 42.7 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -178.71 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 502' ' ' ASP . . . . . 0.444 ' N ' ' CD1' ' A' ' 501' ' ' TYR . 0.4 OUTLIER -75.82 -49.92 16.63 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 -175.561 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 503' ' ' LYS . . . . . 0.631 ' O ' ' CG ' ' A' ' 507' ' ' LYS . 4.8 mttt -119.31 133.8 55.54 Favored 'General case' 0 CA--C 1.522 -0.113 0 CA-C-N 118.985 0.811 . . . . 0.0 112.094 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 504' ' ' THR . . . . . 0.629 HG23 HD13 ' A' ' 568' ' ' ILE . 2.0 m -73.56 -75.12 0.16 Allowed 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.635 -0.711 . . . . 0.0 112.918 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 505' ' ' PHE . . . . . 0.986 ' CE1' HG23 ' A' ' 532' ' ' VAL . 7.3 m-85 -74.37 -62.9 1.36 Allowed 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -178.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 506' ' ' SER . . . . . 0.772 ' O ' ' CD1' ' A' ' 510' ' ' TRP . 7.6 t -49.28 -72.59 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -175.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 507' ' ' LYS . . . . . 0.679 ' HD3' ' N ' ' A' ' 508' ' ' VAL . 0.0 OUTLIER -48.99 -48.52 43.39 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -176.37 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 508' ' ' VAL . . . . . 0.881 ' CG2' HD21 ' A' ' 574' ' ' LEU . 89.1 t -52.89 -59.03 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -179.316 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 509' ' ' LEU . . . . . 0.856 ' O ' HD23 ' A' ' 514' ' ' LEU . 3.0 pp -60.42 -61.84 2.3 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 -176.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 510' ' ' TRP . . . . . 0.847 ' N ' HD12 ' A' ' 509' ' ' LEU . 65.1 p-90 -72.2 -49.74 33.06 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -176.146 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 511' ' ' SER . . . . . 0.497 ' N ' ' CE3' ' A' ' 510' ' ' TRP . 0.5 OUTLIER -64.95 -47.39 77.81 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.164 -0.926 . . . . 0.0 112.898 -177.089 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 512' ' ' ALA . . . . . 0.89 ' HB2' HD22 ' A' ' 495' ' ' LEU . . . -71.19 -73.97 0.16 Allowed 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 117.398 2.37 . . . . 0.0 117.398 -174.307 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 513' ' ' GLY . . . . . 0.46 ' CA ' ' HB ' ' A' ' 493' ' ' VAL . . . -115.95 -36.11 1.18 Allowed Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 121.73 3.452 . . . . 0.0 121.73 -172.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 514' ' ' LEU . . . . . 0.856 HD23 ' O ' ' A' ' 509' ' ' LEU . 0.5 OUTLIER -108.96 -39.11 5.4 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 120.431 3.493 . . . . 0.0 120.431 -169.646 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 515' ' ' VAL . . . . . 0.957 HG13 ' HB2' ' A' ' 517' ' ' SER . 13.7 p -153.18 172.12 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 118.053 2.612 . . . . 0.0 118.053 -171.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 516' ' ' ALA . . . . . 0.629 ' N ' HG22 ' A' ' 515' ' ' VAL . . . -69.07 2.64 2.59 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 112.559 -2.11 . . . . 0.0 110.753 177.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 517' ' ' SER . . . . . 0.957 ' HB2' HG13 ' A' ' 515' ' ' VAL . 0.5 OUTLIER -57.68 8.5 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 -172.221 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 518' ' ' LYS . . . . . 0.738 ' HA ' ' CD1' ' A' ' 510' ' ' TRP . 0.0 OUTLIER -46.66 -51.78 15.17 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 104.369 -2.456 . . . . 0.0 104.369 174.989 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 519' ' ' SER . . . . . . . . . . . . . 3.5 m -75.35 -57.45 3.89 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.146 173.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 520' ' ' GLU . . . . . 0.626 ' CB ' ' HA ' ' A' ' 517' ' ' SER . 0.0 OUTLIER -55.91 -47.85 76.73 Favored 'General case' 0 C--N 1.349 0.578 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.71 -179.042 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 521' ' ' GLY . . . . . 0.809 ' HA2' HD12 ' A' ' 524' ' ' ILE . . . -49.55 -55.37 13.74 Favored Glycine 0 CA--C 1.491 -1.42 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.543 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -47.73 -47.45 30.19 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 523' ' ' ARG . . . . . . . . . . . . . 1.6 ttt85 -50.49 -49.03 56.55 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.0 178.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 524' ' ' ILE . . . . . 0.809 HD12 ' HA2' ' A' ' 521' ' ' GLY . 12.7 mt -59.36 -55.26 24.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.237 0.542 . . . . 0.0 110.253 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 525' ' ' ILE . . . . . 0.896 HG23 ' CD1' ' A' ' 556' ' ' ILE . 0.9 OUTLIER -50.26 -47.49 25.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 177.864 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 526' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -56.1 -48.58 75.87 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 114.112 -1.404 . . . . 0.0 108.276 177.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 527' ' ' ASN . . . . . 0.414 ' HB3' ' HA ' ' A' ' 524' ' ' ILE . 0.0 OUTLIER -48.62 -39.76 25.2 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 113.754 -1.566 . . . . 0.0 107.778 176.639 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 528' ' ' ASN . . . . . 0.526 ' C ' HG21 ' A' ' 556' ' ' ILE . 1.3 t30 74.07 40.3 0.46 Allowed 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.227 -179.043 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 529' ' ' GLY . . . . . . . . . . . . . . . -115.98 36.36 3.87 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 114.619 -1.173 . . . . 0.0 111.569 178.037 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 530' ' ' ALA . . . . . 0.764 ' O ' ' HB ' ' A' ' 556' ' ' ILE . . . -132.8 164.96 25.68 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.656 0.741 . . . . 0.0 112.363 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 531' ' ' TYR . . . . . 0.609 ' HE1' ' CD1' ' A' ' 553' ' ' PHE . 3.2 t80 -134.52 149.55 50.68 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 124.634 1.174 . . . . 0.0 108.871 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 532' ' ' VAL . . . . . 0.986 HG23 ' CE1' ' A' ' 505' ' ' PHE . 1.1 t -129.96 136.1 59.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 CA-C-N 119.485 1.039 . . . . 0.0 112.216 179.362 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 533' ' ' GLY . . . . . 0.768 ' O ' HG13 ' A' ' 575' ' ' ILE . . . -133.11 147.4 18.97 Favored Glycine 0 N--CA 1.441 -1.022 0 CA-C-N 114.0 -1.454 . . . . 0.0 112.961 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 534' ' ' SER . . . . . 0.609 ' HB2' ' OG1' ' A' ' 552' ' ' THR . 38.5 m -134.79 143.53 47.13 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.584 -0.308 . . . . 0.0 111.072 178.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 535' ' ' ARG . . . . . 0.57 ' HA ' ' O ' ' A' ' 550' ' ' ASP . 3.0 tpp180 . . . . . 0 C--N 1.33 -0.251 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 178.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 . . . . . 0 N--CA 1.448 -0.53 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 550' ' ' ASP . . . . . 0.57 ' O ' ' HA ' ' A' ' 535' ' ' ARG . 1.8 m-20 -70.82 -41.09 72.02 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.953 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 551' ' ' LEU . . . . . 0.769 HD11 ' CE1' ' A' ' 553' ' ' PHE . 7.2 tp -131.26 140.28 49.79 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.416 178.628 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 552' ' ' THR . . . . . 0.884 HG21 ' CG ' ' A' ' 567' ' ' PHE . 6.2 m -133.32 147.34 51.86 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.573 0.701 . . . . 0.0 111.987 179.256 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 553' ' ' PHE . . . . . 0.769 ' CE1' HD11 ' A' ' 551' ' ' LEU . 17.6 m-30 -132.86 136.22 46.09 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 177.023 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 554' ' ' THR . . . . . 0.647 ' OG1' HG12 ' A' ' 532' ' ' VAL . 19.2 m -135.04 139.68 32.71 Favored Pre-proline 0 C--N 1.314 -0.975 0 C-N-CA 118.851 -1.14 . . . . 0.0 113.245 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 555' ' ' PRO . . . . . 0.851 ' O ' HG22 ' A' ' 556' ' ' ILE . 5.8 Cg_exo -77.58 11.99 2.02 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.78 2.32 . . . . 0.0 112.789 179.155 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 556' ' ' ILE . . . . . 0.896 ' CD1' HG23 ' A' ' 525' ' ' ILE . 4.9 tp 62.37 34.42 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.335 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 177.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 557' ' ' LYS . . . . . 0.704 ' O ' ' CE2' ' A' ' 559' ' ' TRP . 33.3 mttt -103.37 133.23 48.77 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 558' ' ' THR . . . . . . . . . . . . . 3.4 t -58.05 116.5 3.56 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -172.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 559' ' ' TRP . . . . . 0.704 ' CE2' ' O ' ' A' ' 557' ' ' LYS . 0.0 OUTLIER -139.87 112.4 7.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 113.142 -1.844 . . . . 0.0 106.28 175.1 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 560' ' ' ASN . . . . . 0.649 ' O ' HG22 ' A' ' 564' ' ' THR . 86.0 m-20 -77.82 -75.96 0.2 Allowed 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 118.659 -1.216 . . . . 0.0 113.351 -176.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 561' ' ' ALA . . . . . 0.544 ' HA ' ' CG2' ' A' ' 564' ' ' THR . . . -75.14 -53.12 9.39 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 115.951 1.834 . . . . 0.0 115.951 -178.092 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 562' ' ' SER . . . . . . . . . . . . . 69.4 m -49.23 -54.95 14.23 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -176.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 563' ' ' LYS . . . . . 0.609 ' HB3' HG21 ' A' ' 504' ' ' THR . 0.2 OUTLIER -70.65 -47.91 57.61 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -178.188 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 564' ' ' THR . . . . . 0.788 HG23 ' H ' ' A' ' 565' ' ' GLN . 7.9 t -49.79 -68.02 0.21 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.847 0.356 . . . . 0.0 111.276 -179.223 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 565' ' ' GLN . . . . . 1.033 ' O ' HG23 ' A' ' 569' ' ' ILE . 2.4 tp60 -49.88 -47.0 52.16 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -49.42 -61.72 1.94 Allowed 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.861 -178.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 567' ' ' PHE . . . . . 0.884 ' CG ' HG21 ' A' ' 552' ' ' THR . 0.0 OUTLIER -97.15 -54.32 3.21 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.68 0.752 . . . . 0.0 111.875 -178.95 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 568' ' ' ILE . . . . . 0.853 HG13 HD13 ' A' ' 574' ' ' LEU . 1.7 mp -56.18 9.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 114.487 -1.233 . . . . 0.0 113.72 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 569' ' ' ILE . . . . . 1.033 HG23 ' O ' ' A' ' 565' ' ' GLN . 0.9 OUTLIER -54.56 -36.47 35.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 104.292 -2.484 . . . . 0.0 104.292 177.354 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 570' ' ' ASP . . . . . 0.487 ' OD2' HG13 ' A' ' 588' ' ' ILE . 7.7 p30 34.1 57.8 0.62 Allowed 'General case' 0 CA--C 1.502 -0.903 0 CA-C-N 113.716 -1.584 . . . . 0.0 112.04 174.522 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 571' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 570' ' ' ASP . . . -51.02 -45.22 51.11 Favored Glycine 0 N--CA 1.438 -1.172 0 C-N-CA 117.469 -2.301 . . . . 0.0 107.982 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 572' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -120.3 -16.74 8.4 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 175.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 573' ' ' LEU . . . . . 0.485 ' O ' ' CB ' ' A' ' 570' ' ' ASP . 2.2 tp -140.55 136.34 32.75 Favored 'General case' 0 C--N 1.355 0.823 0 N-CA-C 115.912 1.819 . . . . 0.0 115.912 -177.388 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 574' ' ' LEU . . . . . 0.901 HD12 ' N ' ' A' ' 575' ' ' ILE . 0.5 OUTLIER -135.94 132.73 36.81 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 173.422 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 575' ' ' ILE . . . . . 1.031 HG23 HD13 ' A' ' 585' ' ' LEU . 0.0 OUTLIER -134.3 139.98 46.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 118.858 0.754 . . . . 0.0 111.928 178.53 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 576' ' ' LEU . . . . . 0.683 HD11 HD21 ' A' ' 578' ' ' LEU . 0.0 OUTLIER -133.01 136.62 46.12 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 114.944 -1.025 . . . . 0.0 108.767 177.945 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 577' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.02 135.44 51.79 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 177.284 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.683 HD21 HD11 ' A' ' 576' ' ' LEU . 0.5 OUTLIER -126.94 132.02 50.95 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 177.973 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 579' ' ' GLY . . . . . . . . . . . . . . . -90.45 -2.26 73.53 Favored Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 115.092 -0.958 . . . . 0.0 113.493 -178.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 580' ' ' LYS . . . . . 0.473 ' O ' ' CD1' ' A' ' 581' ' ' TRP . 0.0 OUTLIER -70.84 -48.38 54.3 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 118.738 -1.185 . . . . 0.0 108.564 179.083 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 581' ' ' TRP . . . . . 0.473 ' CD1' ' O ' ' A' ' 580' ' ' LYS . 27.1 m0 -139.81 -53.37 0.53 Allowed 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 177.09 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 582' ' ' LYS . . . . . 0.424 ' O ' ' HB2' ' A' ' 578' ' ' LEU . 0.0 OUTLIER -140.5 165.44 27.43 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 -175.19 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 583' ' ' MET . . . . . . . . . . . . . 1.7 ttt -109.04 135.0 50.93 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 173.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 584' ' ' LYS . . . . . 0.836 ' NZ ' HG23 ' A' ' 493' ' ' VAL . 10.9 tppt? -120.34 133.38 55.46 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 178.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 585' ' ' LEU . . . . . 1.031 HD13 HG23 ' A' ' 575' ' ' ILE . 0.9 OUTLIER -116.03 136.12 53.32 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.839 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 586' ' ' VAL . . . . . 0.859 ' N ' HD12 ' A' ' 585' ' ' LEU . 85.8 t -132.94 137.49 53.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-O 121.053 0.454 . . . . 0.0 111.721 -178.227 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 587' ' ' SER . . . . . 0.879 ' C ' HD13 ' A' ' 588' ' ' ILE . 58.8 m -106.63 135.79 47.53 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 177.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.879 HD13 ' C ' ' A' ' 587' ' ' SER . 0.0 OUTLIER -133.41 136.75 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -177.581 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 589' ' ' VAL . . . . . 0.488 ' N ' ' HB2' ' A' ' 497' ' ' LYS . 5.6 m -132.6 137.14 54.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.635 178.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 590' ' ' SER . . . . . . . . . . . . . 10.7 t . . . . . 0 C--N 1.327 -0.396 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.984 -179.795 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 491' ' ' ALA . . . . . 0.506 ' HB1' ' HZ3' ' A' ' 584' ' ' LYS . . . . . . . . 0 C--O 1.232 0.149 0 N-CA-C 111.131 0.049 . . . . 0.0 111.131 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 492' ' ' ARG . . . . . 0.882 ' CD ' HD22 ' A' ' 585' ' ' LEU . 2.7 mmm180 -137.8 132.67 33.0 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.535 176.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 493' ' ' VAL . . . . . 0.985 ' CG2' HG22 ' A' ' 586' ' ' VAL . 16.9 m -138.25 163.78 28.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 178.324 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 79.6 p -116.94 132.56 56.67 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 176.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 495' ' ' LEU . . . . . 0.832 HD12 ' HD2' ' A' ' 496' ' ' PRO . 0.0 OUTLIER -137.1 164.5 41.68 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.23 -179.556 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 496' ' ' PRO . . . . . 0.832 ' HD2' HD12 ' A' ' 495' ' ' LEU . 2.8 Cg_exo -76.94 119.95 5.28 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.045 2.497 . . . . 0.0 110.947 178.258 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 497' ' ' LYS . . . . . 0.82 ' N ' HG22 ' A' ' 588' ' ' ILE . 15.6 tttm -53.24 -29.78 34.5 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -177.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 498' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.9 -49.12 78.73 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -177.086 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 499' ' ' LEU . . . . . 0.774 HD21 ' HD2' ' A' ' 496' ' ' PRO . 2.0 pp -74.38 -8.82 57.55 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -178.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 500' ' ' VAL . . . . . 0.75 HG22 HG12 ' A' ' 568' ' ' ILE . 0.9 OUTLIER -74.98 -25.66 18.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.455 0.645 . . . . 0.0 111.678 -179.029 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 501' ' ' TYR . . . . . 0.631 ' O ' ' CG2' ' A' ' 564' ' ' THR . 0.3 OUTLIER -57.26 -29.48 63.86 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 114.981 1.475 . . . . 0.0 114.981 -178.288 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -75.99 -50.16 15.63 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 116.306 1.965 . . . . 0.0 116.306 -174.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 503' ' ' LYS . . . . . 0.576 ' O ' ' CG ' ' A' ' 507' ' ' LYS . 3.3 mttm -119.1 137.88 53.27 Favored 'General case' 0 N--CA 1.46 0.066 0 CA-C-N 119.27 0.941 . . . . 0.0 112.204 -178.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 504' ' ' THR . . . . . 0.819 HG23 ' CE1' ' A' ' 567' ' ' PHE . 24.8 m -73.52 -76.99 0.11 Allowed 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 505' ' ' PHE . . . . . 0.653 ' CZ ' ' HB1' ' A' ' 530' ' ' ALA . 0.2 OUTLIER -75.7 -61.12 2.03 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -179.164 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 506' ' ' SER . . . . . 0.668 ' O ' ' CD1' ' A' ' 510' ' ' TRP . 62.2 m -48.98 -72.75 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -175.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 507' ' ' LYS . . . . . 0.68 ' HD3' ' N ' ' A' ' 508' ' ' VAL . 0.0 OUTLIER -49.2 -48.22 45.51 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -176.673 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 508' ' ' VAL . . . . . 0.88 HG13 HD21 ' A' ' 574' ' ' LEU . 69.8 t -52.46 -59.2 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 509' ' ' LEU . . . . . 0.73 HD12 ' N ' ' A' ' 510' ' ' TRP . 1.9 pp -60.18 -60.89 3.1 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 -177.052 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 510' ' ' TRP . . . . . 0.73 ' N ' HD12 ' A' ' 509' ' ' LEU . 51.4 p-90 -72.26 -51.75 19.48 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -176.15 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 511' ' ' SER . . . . . 0.541 ' N ' ' CD2' ' A' ' 510' ' ' TRP . 0.4 OUTLIER -63.98 -47.99 78.18 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.884 -177.238 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 512' ' ' ALA . . . . . 0.759 ' HB3' ' O ' ' A' ' 508' ' ' VAL . . . -71.46 -73.66 0.17 Allowed 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 117.073 2.249 . . . . 0.0 117.073 -174.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 513' ' ' GLY . . . . . 0.816 ' CA ' HG21 ' A' ' 493' ' ' VAL . . . -115.84 -35.77 1.22 Allowed Glycine 0 CA--C 1.507 -0.468 0 N-CA-C 121.558 3.383 . . . . 0.0 121.558 -173.025 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 514' ' ' LEU . . . . . 0.661 ' HG ' ' HE2' ' A' ' 584' ' ' LYS . 0.0 OUTLIER -107.69 -45.45 4.02 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 119.898 3.296 . . . . 0.0 119.898 -169.195 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 515' ' ' VAL . . . . . 0.596 HG22 ' N ' ' A' ' 516' ' ' ALA . 9.9 p -145.1 172.3 4.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 117.927 2.566 . . . . 0.0 117.927 -171.223 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 516' ' ' ALA . . . . . 0.596 ' N ' HG22 ' A' ' 515' ' ' VAL . . . -89.87 0.53 56.99 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 113.25 -1.796 . . . . 0.0 108.663 178.431 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 517' ' ' SER . . . . . 0.996 ' O ' ' N ' ' A' ' 521' ' ' GLY . 4.0 p -61.44 10.26 0.02 OUTLIER 'General case' 0 N--CA 1.426 -1.64 0 C-N-CA 126.171 1.788 . . . . 0.0 115.289 -173.523 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 518' ' ' LYS . . . . . 0.626 ' HB2' ' CE2' ' A' ' 510' ' ' TRP . 0.8 OUTLIER -42.73 -39.75 2.55 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 105.426 -2.064 . . . . 0.0 105.426 178.221 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 519' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.68 -54.25 8.54 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 114.891 -1.049 . . . . 0.0 108.217 172.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 520' ' ' GLU . . . . . 0.708 ' O ' HD12 ' A' ' 524' ' ' ILE . 0.2 OUTLIER -67.67 -48.07 67.68 Favored 'General case' 0 C--N 1.35 0.626 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.373 179.845 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 521' ' ' GLY . . . . . 0.996 ' N ' ' O ' ' A' ' 517' ' ' SER . . . -49.6 -52.81 23.35 Favored Glycine 0 CA--C 1.494 -1.248 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 178.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 522' ' ' GLN . . . . . 0.497 ' HA ' HG12 ' A' ' 525' ' ' ILE . 3.8 mm-40 -48.19 -47.48 35.31 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.066 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 523' ' ' ARG . . . . . 0.418 ' O ' ' HB3' ' A' ' 526' ' ' ASN . 0.0 OUTLIER -49.99 -49.16 51.45 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.736 178.855 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 524' ' ' ILE . . . . . 0.708 HD12 ' O ' ' A' ' 520' ' ' GLU . 4.3 mp -59.3 -51.79 68.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.466 0.651 . . . . 0.0 109.412 179.045 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 525' ' ' ILE . . . . . 0.937 HG23 ' CD1' ' A' ' 556' ' ' ILE . 1.2 mm -50.66 -47.42 28.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 177.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 526' ' ' ASN . . . . . 0.418 ' HB3' ' O ' ' A' ' 523' ' ' ARG . 18.3 t-20 -58.69 -47.93 82.83 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 114.253 -1.339 . . . . 0.0 108.321 177.51 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 527' ' ' ASN . . . . . 0.454 ' HB3' ' HA ' ' A' ' 524' ' ' ILE . 0.0 OUTLIER -48.09 -39.57 20.68 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 113.994 -1.457 . . . . 0.0 107.477 176.604 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 528' ' ' ASN . . . . . 0.629 ' HA ' ' CG2' ' A' ' 556' ' ' ILE . 1.8 t30 74.2 40.98 0.41 Allowed 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.867 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 529' ' ' GLY . . . . . . . . . . . . . . . -113.96 29.3 7.83 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-N 115.118 -0.946 . . . . 0.0 112.516 178.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 530' ' ' ALA . . . . . 0.927 ' O ' ' HB ' ' A' ' 556' ' ' ILE . . . -133.53 164.27 27.53 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.216 0.532 . . . . 0.0 112.423 -179.11 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 531' ' ' TYR . . . . . 0.516 ' CE1' ' CD1' ' A' ' 553' ' ' PHE . 0.0 OUTLIER -134.59 152.53 51.84 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 177.601 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 532' ' ' VAL . . . . . 0.663 HG12 ' OG1' ' A' ' 554' ' ' THR . 0.5 OUTLIER -129.2 135.8 61.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 CA-C-O 122.003 0.906 . . . . 0.0 112.121 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 533' ' ' GLY . . . . . 0.65 ' O ' HG13 ' A' ' 575' ' ' ILE . . . -133.74 161.71 24.33 Favored Glycine 0 N--CA 1.441 -1.016 0 CA-C-N 114.32 -1.309 . . . . 0.0 114.48 -179.376 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 534' ' ' SER . . . . . 0.47 ' N ' ' HB ' ' A' ' 552' ' ' THR . 5.3 t -134.05 141.89 47.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.834 -0.683 . . . . 0.0 110.626 178.469 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 535' ' ' ARG . . . . . 0.734 ' HB3' HD22 ' A' ' 573' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.358 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 178.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 549' ' ' ASP . . . . . 0.534 ' HB3' HD11 ' A' ' 569' ' ' ILE . 16.7 m-20 . . . . . 0 N--CA 1.451 -0.407 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 550' ' ' ASP . . . . . 0.545 ' O ' ' HA ' ' A' ' 535' ' ' ARG . 3.9 p30 -50.89 -36.47 38.22 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.722 0.773 . . . . 0.0 108.995 178.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 551' ' ' LEU . . . . . . . . . . . . . 13.6 tp -131.39 139.22 49.41 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.524 -1.216 . . . . 0.0 107.881 177.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 552' ' ' THR . . . . . 0.883 HG21 ' CB ' ' A' ' 567' ' ' PHE . 6.9 m -133.76 148.07 51.35 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.683 0.754 . . . . 0.0 111.842 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 553' ' ' PHE . . . . . 0.516 ' CD1' ' CE1' ' A' ' 531' ' ' TYR . 9.9 m-85 -134.09 137.91 44.93 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.788 -1.097 . . . . 0.0 108.402 177.353 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 554' ' ' THR . . . . . 0.901 HG22 ' H ' ' A' ' 556' ' ' ILE . 2.0 m -132.23 138.57 32.57 Favored Pre-proline 0 C--N 1.307 -1.278 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 178.348 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 555' ' ' PRO . . . . . 0.837 ' O ' HG22 ' A' ' 556' ' ' ILE . 67.6 Cg_endo -84.54 19.21 1.42 Allowed 'Trans proline' 0 N--CA 1.446 -1.311 0 C-N-CA 121.664 1.576 . . . . 0.0 111.918 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 556' ' ' ILE . . . . . 0.937 ' CD1' HG23 ' A' ' 525' ' ' ILE . 3.8 tp 61.21 31.77 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 177.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.85 119.84 39.97 Favored 'General case' 0 CA--C 1.501 -0.925 0 N-CA-C 104.36 -2.459 . . . . 0.0 104.36 178.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 558' ' ' THR . . . . . . . . . . . . . 3.3 t -56.76 116.98 3.48 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-O 122.576 1.179 . . . . 0.0 114.084 -171.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 559' ' ' TRP . . . . . 0.447 ' HB2' ' CB ' ' A' ' 563' ' ' LYS . 5.3 m0 -137.05 111.49 8.57 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 104.521 -2.4 . . . . 0.0 104.521 175.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 560' ' ' ASN . . . . . 0.603 ' O ' HG22 ' A' ' 564' ' ' THR . 84.4 m-20 -77.15 -75.59 0.2 Allowed 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -174.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 561' ' ' ALA . . . . . 0.551 ' HA ' HG22 ' A' ' 564' ' ' THR . . . -74.19 -57.27 4.06 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 116.055 1.872 . . . . 0.0 116.055 -177.211 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 562' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -49.59 -53.59 23.03 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -177.154 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 563' ' ' LYS . . . . . 0.648 ' CG ' HG21 ' A' ' 504' ' ' THR . 0.0 OUTLIER -69.38 -49.03 59.17 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.489 -178.439 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 564' ' ' THR . . . . . 0.649 HG23 ' H ' ' A' ' 565' ' ' GLN . 13.8 t -51.07 -65.22 0.59 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.567 0.222 . . . . 0.0 111.451 -178.684 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 565' ' ' GLN . . . . . 0.649 ' H ' HG23 ' A' ' 564' ' ' THR . 8.4 tp60 -48.95 -47.05 44.18 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.848 0.356 . . . . 0.0 111.053 179.208 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -49.5 -55.65 12.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 0.0 112.21 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 567' ' ' PHE . . . . . 0.914 ' CZ ' HD13 ' A' ' 568' ' ' ILE . 0.6 OUTLIER -96.89 -42.63 7.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.347 0.594 . . . . 0.0 112.46 -178.296 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 568' ' ' ILE . . . . . 0.923 HD11 HD22 ' A' ' 574' ' ' LEU . 1.2 tp -61.2 9.06 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 N-CA-C 113.939 1.088 . . . . 0.0 113.939 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 569' ' ' ILE . . . . . 0.6 HG23 ' O ' ' A' ' 565' ' ' GLN . 0.7 OUTLIER -54.46 -40.25 48.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 N-CA-C 104.005 -2.591 . . . . 0.0 104.005 178.295 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 570' ' ' ASP . . . . . 0.954 ' CG ' HD13 ' A' ' 588' ' ' ILE . 17.2 p30 32.13 56.84 0.36 Allowed 'General case' 0 CA--C 1.509 -0.599 0 CA-C-N 113.738 -1.574 . . . . 0.0 113.527 172.064 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 571' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 570' ' ' ASP . . . -51.3 -44.79 52.64 Favored Glycine 0 N--CA 1.44 -1.035 0 C-N-CA 116.819 -2.61 . . . . 0.0 108.575 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 572' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -120.29 -15.89 8.55 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 175.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 573' ' ' LEU . . . . . 0.734 HD22 ' HB3' ' A' ' 535' ' ' ARG . 1.1 tp -139.75 139.9 36.6 Favored 'General case' 0 C--N 1.353 0.746 0 N-CA-C 116.913 2.19 . . . . 0.0 116.913 -176.449 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 574' ' ' LEU . . . . . 0.977 ' HB3' HD11 ' A' ' 588' ' ' ILE . 0.3 OUTLIER -135.07 133.6 39.49 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 172.642 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 575' ' ' ILE . . . . . 0.895 ' N ' HD12 ' A' ' 574' ' ' LEU . 0.0 OUTLIER -134.12 137.24 52.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 118.623 0.647 . . . . 0.0 111.596 178.812 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 576' ' ' LEU . . . . . 0.594 HD22 ' HB3' ' A' ' 509' ' ' LEU . 0.0 OUTLIER -133.15 135.41 45.14 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 177.361 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 577' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -131.45 134.8 46.57 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 119.089 -1.045 . . . . 0.0 110.036 177.383 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.45 ' CG ' HD11 ' A' ' 576' ' ' LEU . 0.3 OUTLIER -122.46 132.2 54.23 Favored 'General case' 0 C--O 1.243 0.732 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.076 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 579' ' ' GLY . . . . . . . . . . . . . . . -88.18 -2.0 80.96 Favored Glycine 0 N--CA 1.44 -1.047 0 CA-C-N 114.901 -1.045 . . . . 0.0 113.411 -178.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 580' ' ' LYS . . . . . 0.591 ' CD ' ' CE2' ' A' ' 581' ' ' TRP . 0.0 OUTLIER -71.22 -49.65 41.16 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 118.656 -1.217 . . . . 0.0 108.441 179.279 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 581' ' ' TRP . . . . . 0.591 ' CE2' ' CD ' ' A' ' 580' ' ' LYS . 0.7 OUTLIER -140.92 -51.32 0.45 Allowed 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 175.823 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 582' ' ' LYS . . . . . 0.567 ' HE2' ' CD1' ' A' ' 581' ' ' TRP . 0.0 OUTLIER -139.76 165.29 27.69 Favored 'General case' 0 CA--C 1.512 -0.511 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -175.079 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 583' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.13 135.08 51.49 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 175.167 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 584' ' ' LYS . . . . . 0.661 ' HE2' ' HG ' ' A' ' 514' ' ' LEU . 9.1 tppt? -116.44 133.67 55.75 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 585' ' ' LEU . . . . . 0.882 HD22 ' CD ' ' A' ' 492' ' ' ARG . 7.7 tt -120.88 137.07 54.76 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -179.611 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 586' ' ' VAL . . . . . 0.985 HG22 ' CG2' ' A' ' 493' ' ' VAL . 55.9 t -131.95 137.01 55.78 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.777 -178.336 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 587' ' ' SER . . . . . . . . . . . . . 1.4 m -107.31 134.63 50.1 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 177.139 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.977 HD11 ' HB3' ' A' ' 574' ' ' LEU . 0.0 OUTLIER -135.98 136.4 49.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -177.754 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 6.1 m -133.58 136.81 53.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.943 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 590' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.565 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 491' ' ' ALA . . . . . 0.422 ' CB ' ' NZ ' ' A' ' 584' ' ' LYS . . . . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.62 0.248 . . . . 0.0 110.63 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 492' ' ' ARG . . . . . 0.46 ' HD3' ' HG ' ' A' ' 585' ' ' LEU . 0.0 OUTLIER -136.39 134.93 38.32 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 179.434 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 493' ' ' VAL . . . . . 0.585 ' HB ' ' CA ' ' A' ' 513' ' ' GLY . 75.2 t -135.2 163.48 35.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.68 177.496 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 494' ' ' THR . . . . . 0.579 ' N ' HG12 ' A' ' 493' ' ' VAL . 18.5 m -123.85 135.3 53.66 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.153 0.502 . . . . 0.0 111.201 178.524 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 495' ' ' LEU . . . . . 0.804 ' O ' HG22 ' A' ' 588' ' ' ILE . 0.0 OUTLIER -134.46 163.7 49.31 Favored Pre-proline 0 CA--C 1.531 0.239 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.298 179.546 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 496' ' ' PRO . . . . . 0.569 ' HB2' HD12 ' A' ' 499' ' ' LEU . 32.5 Cg_exo -57.45 120.06 7.72 Favored 'Trans proline' 0 CA--C 1.532 0.393 0 C-N-CA 122.225 1.95 . . . . 0.0 112.358 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 497' ' ' LYS . . . . . 0.54 ' CA ' ' HB ' ' A' ' 588' ' ' ILE . 0.9 OUTLIER -56.9 -30.31 63.81 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.663 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 498' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.79 -48.34 66.94 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.267 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 499' ' ' LEU . . . . . 0.612 ' O ' ' HE3' ' A' ' 507' ' ' LYS . 0.3 OUTLIER -73.45 -8.85 57.61 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.605 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 500' ' ' VAL . . . . . 0.833 HG22 ' CG2' ' A' ' 568' ' ' ILE . 0.3 OUTLIER -60.06 -24.98 31.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.362 0.601 . . . . 0.0 111.113 -179.836 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 501' ' ' TYR . . . . . 0.56 ' O ' ' CG2' ' A' ' 564' ' ' THR . 0.1 OUTLIER -71.24 -29.9 65.68 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 115.027 1.492 . . . . 0.0 115.027 -177.598 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 502' ' ' ASP . . . . . 0.402 ' OD1' ' CZ ' ' A' ' 501' ' ' TYR . 11.3 m-20 -75.2 -51.22 13.88 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 116.057 1.873 . . . . 0.0 116.057 -174.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 503' ' ' LYS . . . . . 0.627 ' O ' ' CG ' ' A' ' 507' ' ' LYS . 7.4 mttt -120.73 134.48 55.28 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-N 119.346 0.976 . . . . 0.0 111.576 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 504' ' ' THR . . . . . 0.689 HG23 HD13 ' A' ' 568' ' ' ILE . 4.2 m -72.91 -76.25 0.12 Allowed 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 505' ' ' PHE . . . . . 0.54 ' CD1' HG13 ' A' ' 525' ' ' ILE . 12.6 p90 -75.26 -59.12 2.88 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 506' ' ' SER . . . . . 0.783 ' O ' ' CD1' ' A' ' 510' ' ' TRP . 5.2 t -49.39 -72.28 0.05 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 -175.563 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 507' ' ' LYS . . . . . 0.732 ' HD3' ' N ' ' A' ' 508' ' ' VAL . 0.0 OUTLIER -48.96 -49.12 42.06 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -176.231 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 508' ' ' VAL . . . . . 0.931 ' CG2' HD21 ' A' ' 574' ' ' LEU . 51.5 t -53.33 -60.02 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -179.085 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 509' ' ' LEU . . . . . 0.776 HD12 ' N ' ' A' ' 510' ' ' TRP . 2.6 pp -60.59 -62.69 1.68 Allowed 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 -177.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 510' ' ' TRP . . . . . 0.783 ' CD1' ' O ' ' A' ' 506' ' ' SER . 63.9 p-90 -72.86 -53.63 10.92 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 114.66 1.355 . . . . 0.0 114.66 -176.198 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 511' ' ' SER . . . . . 0.517 ' N ' ' CE3' ' A' ' 510' ' ' TRP . 1.7 t -65.48 -47.92 74.4 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.89 -177.194 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 512' ' ' ALA . . . . . 0.916 ' HB3' ' O ' ' A' ' 508' ' ' VAL . . . -71.64 -72.46 0.22 Allowed 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 117.184 2.291 . . . . 0.0 117.184 -174.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 513' ' ' GLY . . . . . 0.631 ' HA3' ' HE3' ' A' ' 584' ' ' LYS . . . -114.57 -34.88 1.49 Allowed Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 121.369 3.308 . . . . 0.0 121.369 -172.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 514' ' ' LEU . . . . . 0.585 ' HG ' ' HE2' ' A' ' 584' ' ' LYS . 1.7 mt -107.12 -46.49 3.89 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 119.579 3.178 . . . . 0.0 119.579 -170.207 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 515' ' ' VAL . . . . . 1.089 HG13 ' HB2' ' A' ' 517' ' ' SER . 4.7 p -154.28 173.16 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 117.617 2.451 . . . . 0.0 117.617 -171.715 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 516' ' ' ALA . . . . . 0.59 ' N ' HG22 ' A' ' 515' ' ' VAL . . . -67.84 3.83 1.36 Allowed 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 126.515 1.926 . . . . 0.0 110.078 177.429 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 517' ' ' SER . . . . . 1.089 ' HB2' HG13 ' A' ' 515' ' ' VAL . 0.4 OUTLIER -57.8 9.11 0.01 OUTLIER 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 115.979 1.844 . . . . 0.0 115.979 -172.213 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 518' ' ' LYS . . . . . 0.781 ' HA ' ' CD1' ' A' ' 510' ' ' TRP . 0.0 OUTLIER -45.56 -49.78 13.63 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 104.248 -2.501 . . . . 0.0 104.248 175.304 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 519' ' ' SER . . . . . . . . . . . . . 11.3 p -75.15 -56.93 4.23 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.2 173.459 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 520' ' ' GLU . . . . . 0.851 ' HB2' ' HA ' ' A' ' 517' ' ' SER . 0.8 OUTLIER -58.1 -47.41 83.31 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.023 -178.892 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 521' ' ' GLY . . . . . 0.805 ' N ' ' O ' ' A' ' 517' ' ' SER . . . -49.18 -55.99 11.3 Favored Glycine 0 CA--C 1.492 -1.39 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.273 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -47.74 -47.42 30.31 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 178.39 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 523' ' ' ARG . . . . . 0.449 ' O ' ' HB3' ' A' ' 526' ' ' ASN . 0.1 OUTLIER -50.36 -48.9 55.49 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.786 178.534 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 524' ' ' ILE . . . . . 0.722 HD13 ' HE3' ' A' ' 580' ' ' LYS . 1.7 mt -57.33 -55.77 18.95 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 CA-C-O 121.571 0.7 . . . . 0.0 109.613 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 525' ' ' ILE . . . . . 0.595 HG12 ' O ' ' A' ' 521' ' ' GLY . 0.8 OUTLIER -50.15 -47.4 24.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.163 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 526' ' ' ASN . . . . . 0.449 ' HB3' ' O ' ' A' ' 523' ' ' ARG . 19.1 t-20 -56.84 -48.02 79.0 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-N 114.36 -1.291 . . . . 0.0 108.314 177.473 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -48.04 -40.09 21.86 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.087 -1.415 . . . . 0.0 107.49 176.658 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 528' ' ' ASN . . . . . 1.036 ' HA ' HG21 ' A' ' 556' ' ' ILE . 1.8 t30 73.61 39.92 0.53 Allowed 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 114.638 -1.164 . . . . 0.0 111.529 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 529' ' ' GLY . . . . . . . . . . . . . . . -113.78 21.97 15.42 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 114.507 -1.224 . . . . 0.0 111.69 178.11 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 530' ' ' ALA . . . . . 0.795 ' O ' ' HB ' ' A' ' 556' ' ' ILE . . . -133.67 163.07 30.26 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.252 0.548 . . . . 0.0 112.231 -179.271 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 531' ' ' TYR . . . . . 0.558 ' HA ' ' O ' ' A' ' 554' ' ' THR . 0.0 OUTLIER -133.92 162.69 31.35 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 177.49 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 532' ' ' VAL . . . . . 0.553 HG12 ' OG1' ' A' ' 554' ' ' THR . 0.9 OUTLIER -131.37 135.48 59.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 CA-C-O 122.148 0.975 . . . . 0.0 111.862 179.772 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 533' ' ' GLY . . . . . 0.654 ' HA2' ' HB ' ' A' ' 552' ' ' THR . . . -133.66 153.88 21.05 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 114.189 -1.369 . . . . 0.0 113.966 -179.232 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 534' ' ' SER . . . . . 0.573 ' HB2' ' OG1' ' A' ' 552' ' ' THR . 19.1 m -134.31 136.39 43.45 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.389 -0.405 . . . . 0.0 111.437 178.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 535' ' ' ARG . . . . . 0.705 ' CG ' HD11 ' A' ' 575' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.411 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 178.306 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 . . . . . 0 N--CA 1.448 -0.557 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 550' ' ' ASP . . . . . 0.614 ' O ' ' HA ' ' A' ' 535' ' ' ARG . 0.7 OUTLIER -56.04 -41.3 74.79 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.548 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 551' ' ' LEU . . . . . 0.536 ' HA ' ' HD2' ' A' ' 535' ' ' ARG . 7.6 tp -131.47 140.09 49.49 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.72 177.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 552' ' ' THR . . . . . 0.962 HG21 ' CG ' ' A' ' 567' ' ' PHE . 0.3 OUTLIER -133.71 149.46 51.5 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 122.118 0.961 . . . . 0.0 112.73 179.078 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 553' ' ' PHE . . . . . 0.532 ' HA ' ' CE2' ' A' ' 531' ' ' TYR . 3.4 m-85 -134.12 137.37 44.5 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 106.29 -1.745 . . . . 0.0 106.29 176.323 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 554' ' ' THR . . . . . 0.558 ' O ' ' HA ' ' A' ' 531' ' ' TYR . 1.8 m -132.53 138.38 31.96 Favored Pre-proline 0 C--N 1.304 -1.388 0 C-N-CA 119.197 -1.001 . . . . 0.0 110.582 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 555' ' ' PRO . . . . . 0.817 ' O ' HG22 ' A' ' 556' ' ' ILE . 65.3 Cg_endo -84.28 14.27 2.48 Favored 'Trans proline' 0 N--CA 1.439 -1.717 0 C-N-CA 121.647 1.564 . . . . 0.0 111.14 179.117 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 556' ' ' ILE . . . . . 1.036 HG21 ' HA ' ' A' ' 528' ' ' ASN . 1.2 tp 69.73 33.63 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 N-CA-C 115.065 1.506 . . . . 0.0 115.065 176.443 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 557' ' ' LYS . . . . . 0.61 ' O ' ' CE2' ' A' ' 559' ' ' TRP . 0.0 OUTLIER -103.87 148.46 26.12 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -179.289 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 558' ' ' THR . . . . . 0.492 ' HA ' ' CE2' ' A' ' 505' ' ' PHE . 3.7 t -69.96 115.9 9.71 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 -172.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 559' ' ' TRP . . . . . 0.61 ' CE2' ' O ' ' A' ' 557' ' ' LYS . 0.0 OUTLIER -141.24 123.07 15.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 112.642 -2.072 . . . . 0.0 105.599 174.184 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 560' ' ' ASN . . . . . 0.565 ' O ' HG22 ' A' ' 564' ' ' THR . 60.3 m-20 -90.54 -77.01 0.42 Allowed 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 117.627 -1.629 . . . . 0.0 113.129 -177.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 561' ' ' ALA . . . . . 0.524 ' HA ' HG22 ' A' ' 564' ' ' THR . . . -76.22 -50.44 14.45 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 115.502 1.667 . . . . 0.0 115.502 -179.017 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 562' ' ' SER . . . . . . . . . . . . . 5.1 t -49.37 -56.68 8.78 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -176.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 563' ' ' LYS . . . . . 0.5 ' HG3' ' CZ ' ' A' ' 567' ' ' PHE . 0.0 OUTLIER -69.17 -48.51 62.02 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -178.307 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 564' ' ' THR . . . . . 0.719 HG23 ' H ' ' A' ' 565' ' ' GLN . 10.6 t -50.22 -68.32 0.18 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.801 0.334 . . . . 0.0 111.842 -179.1 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 565' ' ' GLN . . . . . 0.984 ' O ' HG23 ' A' ' 569' ' ' ILE . 3.6 tp-100 -50.02 -47.17 53.27 Favored 'General case' 0 C--N 1.319 -0.721 0 O-C-N 122.173 -0.33 . . . . 0.0 111.635 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 566' ' ' GLU . . . . . 0.405 ' HG2' ' CD1' ' A' ' 567' ' ' PHE . 27.9 tt0 -49.54 -62.64 1.44 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -178.391 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 567' ' ' PHE . . . . . 0.962 ' CG ' HG21 ' A' ' 552' ' ' THR . 0.0 OUTLIER -97.27 -50.64 4.48 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.449 0.642 . . . . 0.0 112.132 -178.53 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 568' ' ' ILE . . . . . 0.833 ' CG2' HG22 ' A' ' 500' ' ' VAL . 1.7 mp -58.1 10.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 114.805 -1.089 . . . . 0.0 113.266 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 569' ' ' ILE . . . . . 0.984 HG23 ' O ' ' A' ' 565' ' ' GLN . 1.2 pt -52.8 -38.32 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 N-CA-C 104.253 -2.499 . . . . 0.0 104.253 178.221 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 570' ' ' ASP . . . . . 0.951 ' CB ' HD11 ' A' ' 588' ' ' ILE . 30.2 m-20 34.55 52.62 0.56 Allowed 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 113.701 -1.59 . . . . 0.0 112.149 173.047 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -51.48 -44.56 53.43 Favored Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 118.226 -1.94 . . . . 0.0 109.084 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 572' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -118.97 -17.33 9.07 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 176.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 573' ' ' LEU . . . . . 0.608 ' HB3' ' O ' ' A' ' 535' ' ' ARG . 1.1 tp -140.12 137.08 34.19 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -178.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 574' ' ' LEU . . . . . 0.931 HD21 ' CG2' ' A' ' 508' ' ' VAL . 0.3 OUTLIER -134.46 132.92 39.86 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 174.244 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 575' ' ' ILE . . . . . 1.094 HG23 HD13 ' A' ' 585' ' ' LEU . 0.0 OUTLIER -134.05 137.17 52.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 118.914 0.779 . . . . 0.0 112.074 179.125 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 576' ' ' LEU . . . . . 0.585 HD22 ' HB3' ' A' ' 509' ' ' LEU . 0.0 OUTLIER -133.58 135.59 44.37 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 176.948 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 577' ' ' LYS . . . . . 0.42 ' HD2' ' CE1' ' A' ' 531' ' ' TYR . 0.0 OUTLIER -132.8 135.34 45.62 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 118.906 -1.117 . . . . 0.0 110.548 177.99 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.604 HD12 ' O ' ' A' ' 582' ' ' LYS . 0.3 OUTLIER -123.63 131.72 53.68 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 177.834 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 579' ' ' GLY . . . . . . . . . . . . . . . -91.21 -2.38 71.07 Favored Glycine 0 CA--C 1.5 -0.857 0 CA-C-N 115.404 -0.816 . . . . 0.0 114.447 -177.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 580' ' ' LYS . . . . . 0.722 ' HE3' HD13 ' A' ' 524' ' ' ILE . 0.4 OUTLIER -75.32 -46.47 33.13 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 118.777 -1.169 . . . . 0.0 109.153 179.111 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 581' ' ' TRP . . . . . 0.444 ' H ' ' HG3' ' A' ' 580' ' ' LYS . 0.1 OUTLIER -138.74 -51.65 0.56 Allowed 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 177.911 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 582' ' ' LYS . . . . . 0.604 ' O ' HD12 ' A' ' 578' ' ' LEU . 1.1 ptpm? -139.56 165.0 28.4 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -175.324 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 583' ' ' MET . . . . . . . . . . . . . 2.3 ttt -118.85 134.81 54.91 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 174.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 584' ' ' LYS . . . . . 0.631 ' HE3' ' HA3' ' A' ' 513' ' ' GLY . 0.0 OUTLIER -121.71 133.05 54.94 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.023 -0.989 . . . . 0.0 108.335 179.53 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 585' ' ' LEU . . . . . 1.094 HD13 HG23 ' A' ' 575' ' ' ILE . 2.9 tp -119.46 136.68 54.21 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 179.251 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 586' ' ' VAL . . . . . 0.589 HG23 ' HD2' ' A' ' 584' ' ' LYS . 11.5 t -131.95 137.08 55.63 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.696 -178.249 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 587' ' ' SER . . . . . 0.564 ' O ' HG23 ' A' ' 494' ' ' THR . 7.6 m -110.24 135.79 50.44 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 177.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.951 HD11 ' CB ' ' A' ' 570' ' ' ASP . 0.2 OUTLIER -133.81 144.64 35.15 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.607 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -178.606 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 5.3 m -132.87 137.26 54.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 114.204 -1.362 . . . . 0.0 110.742 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 590' ' ' SER . . . . . . . . . . . . . 2.5 t . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.624 -179.956 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 491' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.07 0 N-CA-C 111.606 0.224 . . . . 0.0 111.606 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 492' ' ' ARG . . . . . 0.655 ' HD3' HD22 ' A' ' 585' ' ' LEU . 0.0 OUTLIER -136.05 132.02 35.65 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.583 0.23 . . . . 0.0 110.807 177.49 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 493' ' ' VAL . . . . . 0.764 HG21 ' CA ' ' A' ' 513' ' ' GLY . 39.5 t -138.0 163.11 30.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.492 177.556 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 494' ' ' THR . . . . . 0.5 ' N ' ' CG1' ' A' ' 493' ' ' VAL . 41.9 p -127.19 133.87 50.22 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 120.399 -0.521 . . . . 0.0 110.344 176.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 495' ' ' LEU . . . . . 1.045 ' O ' HG22 ' A' ' 588' ' ' ILE . 0.3 OUTLIER -135.89 164.57 42.26 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.558 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 496' ' ' PRO . . . . . 0.684 ' HD2' HD21 ' A' ' 499' ' ' LEU . 24.3 Cg_exo -61.72 119.31 6.37 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 121.676 1.584 . . . . 0.0 111.185 178.574 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 497' ' ' LYS . . . . . 0.494 ' CA ' ' HB ' ' A' ' 588' ' ' ILE . 15.0 ttmt -52.33 -30.23 27.45 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -178.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 498' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.3 -48.11 81.55 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -177.487 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 499' ' ' LEU . . . . . 0.872 HD11 HD13 ' A' ' 495' ' ' LEU . 2.2 pp -73.53 -8.16 54.79 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -178.677 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 500' ' ' VAL . . . . . 0.654 HG21 HG21 ' A' ' 588' ' ' ILE . 36.3 t -74.57 -25.45 19.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.435 0.636 . . . . 0.0 111.498 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 501' ' ' TYR . . . . . 0.665 ' O ' ' CG2' ' A' ' 564' ' ' THR . 3.7 m-30 -53.45 -29.13 34.02 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -178.597 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -76.15 -50.28 15.03 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 116.45 2.019 . . . . 0.0 116.45 -175.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 503' ' ' LYS . . . . . 0.575 ' O ' ' CG ' ' A' ' 507' ' ' LYS . 0.2 OUTLIER -120.27 136.44 54.66 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 119.59 1.086 . . . . 0.0 112.676 -178.51 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 504' ' ' THR . . . . . 0.921 HG23 ' CE1' ' A' ' 567' ' ' PHE . 23.7 m -73.61 -77.2 0.11 Allowed 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 179.265 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 505' ' ' PHE . . . . . 0.765 ' CZ ' ' HB1' ' A' ' 530' ' ' ALA . 0.2 OUTLIER -75.74 -60.33 2.36 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -179.18 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 506' ' ' SER . . . . . 0.703 ' O ' ' CD1' ' A' ' 510' ' ' TRP . 6.1 t -48.7 -72.04 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 -175.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 507' ' ' LYS . . . . . 0.679 ' HD3' ' N ' ' A' ' 508' ' ' VAL . 0.0 OUTLIER -48.9 -48.58 42.27 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -176.479 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 508' ' ' VAL . . . . . 0.824 HG13 HD21 ' A' ' 574' ' ' LEU . 55.3 t -52.63 -58.02 3.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 C-N-CA 120.668 -0.413 . . . . 0.0 112.081 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 509' ' ' LEU . . . . . 0.679 HD12 ' N ' ' A' ' 510' ' ' TRP . 2.6 pp -59.66 -66.0 0.58 Allowed 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 -177.469 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 510' ' ' TRP . . . . . 0.71 ' CD1' ' HA ' ' A' ' 518' ' ' LYS . 68.3 p-90 -73.18 -50.74 20.89 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 -176.649 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 511' ' ' SER . . . . . 0.504 ' N ' ' CD2' ' A' ' 510' ' ' TRP . 0.3 OUTLIER -62.27 -46.23 89.72 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 114.437 -1.256 . . . . 0.0 113.022 -177.024 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 512' ' ' ALA . . . . . 0.755 ' HB3' ' O ' ' A' ' 508' ' ' VAL . . . -71.13 -74.87 0.14 Allowed 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 116.305 1.965 . . . . 0.0 116.305 -174.167 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 513' ' ' GLY . . . . . 0.764 ' CA ' HG21 ' A' ' 493' ' ' VAL . . . -116.88 -39.56 0.82 Allowed Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 121.837 3.495 . . . . 0.0 121.837 -173.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 514' ' ' LEU . . . . . 0.761 HD21 ' HB2' ' A' ' 584' ' ' LYS . 4.1 pp -112.83 -36.65 5.09 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 121.11 3.744 . . . . 0.0 121.11 -171.13 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 515' ' ' VAL . . . . . 0.771 ' CG1' ' HB2' ' A' ' 517' ' ' SER . 9.9 p -125.76 165.86 22.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 117.99 2.589 . . . . 0.0 117.99 -171.41 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 516' ' ' ALA . . . . . 0.533 ' N ' HG22 ' A' ' 515' ' ' VAL . . . -90.44 1.01 57.07 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 112.46 -2.154 . . . . 0.0 109.078 178.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 517' ' ' SER . . . . . 0.925 ' O ' ' N ' ' A' ' 521' ' ' GLY . 0.1 OUTLIER -60.15 10.19 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 126.072 1.749 . . . . 0.0 115.224 -172.957 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 518' ' ' LYS . . . . . 0.71 ' HA ' ' CD1' ' A' ' 510' ' ' TRP . 0.0 OUTLIER -43.54 -46.76 7.17 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 177.232 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 519' ' ' SER . . . . . . . . . . . . . 85.2 p -74.63 -56.15 5.13 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.462 173.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 520' ' ' GLU . . . . . 0.821 ' HB2' ' HA ' ' A' ' 517' ' ' SER . 4.8 mm-40 -62.03 -47.25 85.57 Favored 'General case' 0 C--N 1.349 0.573 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.848 -179.158 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 521' ' ' GLY . . . . . 0.925 ' N ' ' O ' ' A' ' 517' ' ' SER . . . -49.16 -53.09 20.51 Favored Glycine 0 CA--C 1.493 -1.292 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 522' ' ' GLN . . . . . 0.413 ' HA ' HG12 ' A' ' 525' ' ' ILE . 3.7 mt-30 -48.09 -47.52 34.19 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 177.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 523' ' ' ARG . . . . . 0.467 ' HB3' ' O ' ' A' ' 520' ' ' GLU . 2.4 tpt85 -50.25 -48.92 54.45 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.848 178.505 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 524' ' ' ILE . . . . . 0.507 HG13 ' HZ2' ' A' ' 580' ' ' LYS . 30.1 mm -57.44 -54.06 35.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.441 0.639 . . . . 0.0 109.592 179.256 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 525' ' ' ILE . . . . . 0.893 HG23 ' CD1' ' A' ' 556' ' ' ILE . 1.1 mm -50.27 -47.56 25.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 177.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 526' ' ' ASN . . . . . 0.456 ' HB2' ' O ' ' A' ' 523' ' ' ARG . 9.2 m120 -57.82 -47.33 82.92 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-N 114.225 -1.352 . . . . 0.0 108.575 177.74 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -47.3 -39.32 14.42 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 113.988 -1.46 . . . . 0.0 107.741 177.239 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 528' ' ' ASN . . . . . 0.696 ' HA ' ' CG2' ' A' ' 556' ' ' ILE . 0.5 OUTLIER 74.25 40.42 0.43 Allowed 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.491 -179.369 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 529' ' ' GLY . . . . . . . . . . . . . . . -117.61 31.55 5.71 Favored Glycine 0 CA--C 1.523 0.593 0 CA-C-N 114.922 -1.035 . . . . 0.0 112.497 178.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 530' ' ' ALA . . . . . 0.886 ' O ' ' HB ' ' A' ' 556' ' ' ILE . . . -133.43 163.93 28.26 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 121.161 0.505 . . . . 0.0 112.263 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 531' ' ' TYR . . . . . 0.592 ' HA ' ' O ' ' A' ' 554' ' ' THR . 0.0 OUTLIER -134.61 152.93 52.13 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.667 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 532' ' ' VAL . . . . . 0.72 HG23 ' CE1' ' A' ' 505' ' ' PHE . 0.5 OUTLIER -127.09 135.64 63.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 CA-C-O 121.981 0.896 . . . . 0.0 112.093 179.635 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 533' ' ' GLY . . . . . 0.702 ' O ' HG13 ' A' ' 575' ' ' ILE . . . -133.68 151.73 20.26 Favored Glycine 0 N--CA 1.441 -0.98 0 CA-C-N 114.251 -1.34 . . . . 0.0 113.4 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 534' ' ' SER . . . . . 0.484 ' N ' ' HB ' ' A' ' 552' ' ' THR . 0.6 OUTLIER -134.57 137.55 43.86 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.447 -0.376 . . . . 0.0 111.016 179.109 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 535' ' ' ARG . . . . . 0.639 ' O ' ' HB3' ' A' ' 573' ' ' LEU . 12.4 tpt180 . . . . . 0 C--N 1.331 -0.202 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.449 -0.524 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 550' ' ' ASP . . . . . 0.557 ' O ' ' HA ' ' A' ' 535' ' ' ARG . 0.6 OUTLIER -72.54 -42.17 65.01 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.263 179.739 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 551' ' ' LEU . . . . . 0.479 HD21 ' HE2' ' A' ' 553' ' ' PHE . 8.8 tp -131.37 140.57 49.71 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.335 178.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 552' ' ' THR . . . . . 0.674 ' O ' ' HA2' ' A' ' 533' ' ' GLY . 27.1 m -133.04 147.93 52.22 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.618 0.723 . . . . 0.0 111.912 179.322 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 553' ' ' PHE . . . . . 0.528 ' CD1' ' CE1' ' A' ' 531' ' ' TYR . 14.3 m-85 -133.86 136.77 44.59 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 177.122 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 554' ' ' THR . . . . . 0.633 ' CG2' ' H ' ' A' ' 556' ' ' ILE . 0.8 OUTLIER -134.0 138.96 31.83 Favored Pre-proline 0 C--N 1.308 -1.214 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.327 179.544 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 555' ' ' PRO . . . . . 0.805 ' O ' HG22 ' A' ' 556' ' ' ILE . 79.8 Cg_endo -86.22 20.33 1.25 Allowed 'Trans proline' 0 N--CA 1.445 -1.33 0 C-N-CA 121.972 1.782 . . . . 0.0 111.043 178.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 556' ' ' ILE . . . . . 0.893 ' CD1' HG23 ' A' ' 525' ' ' ILE . 4.2 tp 63.27 35.17 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 177.451 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 2.2 mtmp? -102.86 122.11 43.86 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 558' ' ' THR . . . . . . . . . . . . . 12.0 m -56.91 118.57 5.08 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 115.61 1.707 . . . . 0.0 115.61 -171.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 559' ' ' TRP . . . . . 0.601 ' CZ2' ' HD2' ' A' ' 555' ' ' PRO . 0.0 OUTLIER -138.24 111.96 8.29 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 112.441 -2.163 . . . . 0.0 105.715 175.486 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 560' ' ' ASN . . . . . 0.559 ' O ' ' HB ' ' A' ' 564' ' ' THR . 51.2 m-20 -80.44 -74.82 0.29 Allowed 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 -175.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 561' ' ' ALA . . . . . 0.431 ' O ' HG22 ' A' ' 564' ' ' THR . . . -73.94 -65.33 0.85 Allowed 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 -176.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 562' ' ' SER . . . . . . . . . . . . . 1.4 p -49.06 -52.19 26.97 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -175.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 563' ' ' LYS . . . . . 0.538 ' HG2' ' CE2' ' A' ' 559' ' ' TRP . 9.3 tppt? -70.93 -49.13 48.97 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.173 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 564' ' ' THR . . . . . 0.665 ' CG2' ' O ' ' A' ' 501' ' ' TYR . 1.7 t -50.03 -62.4 1.59 Allowed 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.563 -178.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 565' ' ' GLN . . . . . 0.59 ' O ' HG23 ' A' ' 569' ' ' ILE . 0.0 OUTLIER -49.13 -47.6 45.4 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 122.282 -0.261 . . . . 0.0 111.355 178.495 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 566' ' ' GLU . . . . . 0.433 ' O ' HD13 ' A' ' 569' ' ' ILE . 1.8 tt0 -49.66 -56.27 10.71 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -178.623 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 567' ' ' PHE . . . . . 0.921 ' CE1' HG23 ' A' ' 504' ' ' THR . 1.4 p90 -96.83 -46.0 6.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.433 0.635 . . . . 0.0 111.944 -178.225 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 568' ' ' ILE . . . . . 0.966 HD11 HD13 ' A' ' 574' ' ' LEU . 1.3 tp -58.11 9.44 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.504 -0.822 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 569' ' ' ILE . . . . . 0.59 HG23 ' O ' ' A' ' 565' ' ' GLN . 0.0 OUTLIER -55.0 -38.94 47.51 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 N-CA-C 104.967 -2.234 . . . . 0.0 104.967 179.184 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 570' ' ' ASP . . . . . 0.609 ' CG ' HD11 ' A' ' 588' ' ' ILE . 13.4 p30 31.61 58.12 0.3 Allowed 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 114.289 -1.323 . . . . 0.0 112.307 173.559 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -51.62 -45.1 54.55 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 117.288 -2.387 . . . . 0.0 108.79 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 572' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -119.57 -16.81 8.82 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 112.411 0.522 . . . . 0.0 112.411 175.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 573' ' ' LEU . . . . . 0.639 ' HB3' ' O ' ' A' ' 535' ' ' ARG . 1.2 tp -140.14 136.9 33.98 Favored 'General case' 0 C--N 1.351 0.659 0 N-CA-C 115.756 1.761 . . . . 0.0 115.756 -177.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 574' ' ' LEU . . . . . 0.966 HD13 HD11 ' A' ' 568' ' ' ILE . 0.1 OUTLIER -134.77 133.83 40.29 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 105.847 -1.908 . . . . 0.0 105.847 173.707 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 575' ' ' ILE . . . . . 0.931 ' N ' HD12 ' A' ' 574' ' ' LEU . 0.0 OUTLIER -133.55 136.08 54.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.401 178.65 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 576' ' ' LEU . . . . . 0.566 ' CD2' ' HB3' ' A' ' 509' ' ' LEU . 0.0 OUTLIER -133.99 135.63 43.56 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 177.1 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 577' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.32 135.26 46.08 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 118.88 -1.128 . . . . 0.0 110.513 177.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.613 HD12 ' O ' ' A' ' 582' ' ' LYS . 0.3 OUTLIER -123.01 132.12 54.0 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 177.892 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 579' ' ' GLY . . . . . . . . . . . . . . . -89.8 -2.15 75.85 Favored Glycine 0 CA--C 1.499 -0.92 0 CA-C-N 115.244 -0.889 . . . . 0.0 113.431 -178.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 580' ' ' LYS . . . . . 0.507 ' HZ2' HG13 ' A' ' 524' ' ' ILE . 0.0 OUTLIER -72.67 -48.15 41.49 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 118.998 -1.081 . . . . 0.0 108.964 179.426 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 581' ' ' TRP . . . . . 0.48 ' CD1' ' O ' ' A' ' 580' ' ' LYS . 28.4 m0 -139.03 -52.82 0.56 Allowed 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 177.516 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 582' ' ' LYS . . . . . 0.613 ' O ' HD12 ' A' ' 578' ' ' LEU . 0.3 OUTLIER -139.84 165.22 27.88 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 -174.878 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 583' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.2 135.06 53.33 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 174.211 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 584' ' ' LYS . . . . . 0.761 ' HB2' HD21 ' A' ' 514' ' ' LEU . 2.3 tppt? -117.25 134.27 54.99 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.457 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 585' ' ' LEU . . . . . 0.757 ' HG ' HG23 ' A' ' 575' ' ' ILE . 4.2 tt -121.68 135.9 54.95 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 178.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 586' ' ' VAL . . . . . 0.668 HG23 ' HD2' ' A' ' 584' ' ' LYS . 16.9 t -133.31 137.07 53.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.204 -178.063 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 587' ' ' SER . . . . . . . . . . . . . 70.8 m -109.98 135.02 51.49 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 176.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 1.045 HG22 ' O ' ' A' ' 495' ' ' LEU . 0.0 OUTLIER -134.53 141.85 42.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -177.868 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 5.2 m -133.28 137.02 54.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 114.166 -1.379 . . . . 0.0 110.422 177.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 590' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.326 -0.441 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.445 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 491' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.879 0.371 . . . . 0.0 111.934 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 492' ' ' ARG . . . . . 0.522 ' CD ' ' HG ' ' A' ' 585' ' ' LEU . 0.0 OUTLIER -134.37 134.86 42.2 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.855 179.101 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 493' ' ' VAL . . . . . 0.673 HG21 ' CA ' ' A' ' 513' ' ' GLY . 85.9 t -135.28 163.73 35.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.242 178.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 494' ' ' THR . . . . . 0.553 ' N ' HG12 ' A' ' 493' ' ' VAL . 1.3 m -125.72 135.89 52.58 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.323 0.582 . . . . 0.0 111.231 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 495' ' ' LEU . . . . . 0.955 ' O ' HG22 ' A' ' 588' ' ' ILE . 2.1 pp -133.93 163.3 52.12 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 115.239 -0.892 . . . . 0.0 110.122 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 496' ' ' PRO . . . . . 0.819 ' HD2' HD21 ' A' ' 499' ' ' LEU . 20.4 Cg_exo -63.36 118.67 5.58 Favored 'Trans proline' 0 CA--C 1.534 0.477 0 C-N-CA 121.712 1.608 . . . . 0.0 111.327 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 497' ' ' LYS . . . . . 0.815 ' O ' HG12 ' A' ' 500' ' ' VAL . 8.6 tttm -50.19 -29.87 10.22 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -179.118 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 498' ' ' SER . . . . . 0.44 ' HA ' ' CE2' ' A' ' 501' ' ' TYR . 1.0 OUTLIER -56.3 -48.45 76.64 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 113.758 1.022 . . . . 0.0 113.758 -177.345 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 499' ' ' LEU . . . . . 0.819 HD21 ' HD2' ' A' ' 496' ' ' PRO . 0.7 OUTLIER -73.71 -8.43 55.95 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -178.542 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 500' ' ' VAL . . . . . 0.815 HG12 ' O ' ' A' ' 497' ' ' LYS . 1.7 p -74.73 -25.58 19.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.275 0.56 . . . . 0.0 111.613 -179.016 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 501' ' ' TYR . . . . . 0.635 ' O ' ' CG2' ' A' ' 564' ' ' THR . 6.7 m-30 -53.96 -30.61 47.61 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 114.217 1.192 . . . . 0.0 114.217 -178.519 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -77.38 -51.16 11.28 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.059 1.874 . . . . 0.0 116.059 -175.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 503' ' ' LYS . . . . . 0.558 ' O ' ' CG ' ' A' ' 507' ' ' LYS . 0.0 OUTLIER -121.2 136.12 55.03 Favored 'General case' 0 C--N 1.339 0.132 0 CA-C-N 118.885 0.766 . . . . 0.0 112.375 -179.109 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 504' ' ' THR . . . . . 0.769 HG23 ' CD1' ' A' ' 568' ' ' ILE . 90.5 m -73.29 -75.68 0.14 Allowed 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 179.047 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 505' ' ' PHE . . . . . 0.74 ' HE2' HG21 ' A' ' 554' ' ' THR . 0.0 OUTLIER -74.87 -62.48 1.53 Allowed 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -178.888 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 506' ' ' SER . . . . . 0.802 ' O ' ' CD1' ' A' ' 510' ' ' TRP . 66.5 m -49.59 -73.23 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -175.684 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 507' ' ' LYS . . . . . 0.723 ' HD3' ' N ' ' A' ' 508' ' ' VAL . 0.0 OUTLIER -49.05 -48.89 43.59 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -176.425 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 508' ' ' VAL . . . . . 0.755 HG21 HD21 ' A' ' 574' ' ' LEU . 47.7 t -55.83 -62.33 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.722 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 509' ' ' LEU . . . . . 0.791 HD12 ' N ' ' A' ' 510' ' ' TRP . 1.9 pp -49.9 -63.01 1.24 Allowed 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -177.323 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 510' ' ' TRP . . . . . 0.867 ' CD1' ' HA ' ' A' ' 518' ' ' LYS . 67.4 p-90 -72.89 -49.74 27.98 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 -176.044 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 511' ' ' SER . . . . . 0.507 ' N ' ' CE3' ' A' ' 510' ' ' TRP . 0.3 OUTLIER -62.87 -47.07 84.94 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.289 -0.869 . . . . 0.0 113.178 -176.81 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 512' ' ' ALA . . . . . 0.881 ' HB2' HD23 ' A' ' 495' ' ' LEU . . . -70.97 -73.5 0.17 Allowed 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 118.242 2.682 . . . . 0.0 118.242 -173.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 513' ' ' GLY . . . . . 0.673 ' CA ' HG21 ' A' ' 493' ' ' VAL . . . -114.67 -36.05 1.33 Allowed Glycine 0 CA--C 1.502 -0.743 0 N-CA-C 121.295 3.278 . . . . 0.0 121.295 -172.082 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 514' ' ' LEU . . . . . 0.809 HD12 ' HB2' ' A' ' 584' ' ' LYS . 1.6 mt -108.94 -43.21 4.26 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 120.053 3.353 . . . . 0.0 120.053 -170.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 515' ' ' VAL . . . . . 0.97 HG13 ' HB2' ' A' ' 517' ' ' SER . 3.8 p -154.0 172.12 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 117.721 2.489 . . . . 0.0 117.721 -171.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 516' ' ' ALA . . . . . 0.581 ' N ' HG22 ' A' ' 515' ' ' VAL . . . -68.42 3.97 1.54 Allowed 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 127.054 2.142 . . . . 0.0 110.238 177.318 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 517' ' ' SER . . . . . 0.97 ' HB2' HG13 ' A' ' 515' ' ' VAL . 0.4 OUTLIER -57.32 8.81 0.01 OUTLIER 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 115.575 1.695 . . . . 0.0 115.575 -171.853 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 518' ' ' LYS . . . . . 0.867 ' HA ' ' CD1' ' A' ' 510' ' ' TRP . 2.3 ttpt -46.37 -51.4 14.96 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 104.462 -2.422 . . . . 0.0 104.462 174.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 519' ' ' SER . . . . . . . . . . . . . 35.2 t -75.0 -57.01 4.17 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.101 173.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 520' ' ' GLU . . . . . 0.735 ' HB2' ' HA ' ' A' ' 517' ' ' SER . 0.3 OUTLIER -57.47 -48.0 80.35 Favored 'General case' 0 C--N 1.348 0.536 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.926 -178.97 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 521' ' ' GLY . . . . . 0.813 ' N ' ' O ' ' A' ' 517' ' ' SER . . . -49.46 -56.81 10.22 Favored Glycine 0 CA--C 1.493 -1.296 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.525 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -47.82 -47.32 31.24 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 523' ' ' ARG . . . . . 0.432 ' O ' ' HB3' ' A' ' 526' ' ' ASN . 0.5 OUTLIER -50.12 -48.79 53.32 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.785 178.557 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 524' ' ' ILE . . . . . 0.526 HD12 ' HD3' ' A' ' 580' ' ' LYS . 29.8 mm -59.36 -54.05 39.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.325 0.583 . . . . 0.0 110.043 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 525' ' ' ILE . . . . . 0.596 HD13 ' N ' ' A' ' 525' ' ' ILE . 1.3 mm -50.27 -47.3 25.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 177.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 526' ' ' ASN . . . . . 0.432 ' HB3' ' O ' ' A' ' 523' ' ' ARG . 18.9 t-20 -57.93 -47.85 81.63 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 114.607 -1.179 . . . . 0.0 108.325 177.142 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 527' ' ' ASN . . . . . 0.493 ' HB3' ' HA ' ' A' ' 524' ' ' ILE . 0.0 OUTLIER -47.73 -39.13 16.88 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 113.965 -1.471 . . . . 0.0 107.931 176.807 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 528' ' ' ASN . . . . . 1.03 ' HA ' HG21 ' A' ' 556' ' ' ILE . 1.6 t30 75.17 40.61 0.33 Allowed 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 114.854 -1.066 . . . . 0.0 112.088 -179.116 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 529' ' ' GLY . . . . . . . . . . . . . . . -112.46 20.25 21.02 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 114.524 -1.217 . . . . 0.0 111.661 177.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 530' ' ' ALA . . . . . 0.804 ' O ' ' HB ' ' A' ' 556' ' ' ILE . . . -133.76 163.68 28.92 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -179.099 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 531' ' ' TYR . . . . . 0.533 ' CE2' ' HA ' ' A' ' 553' ' ' PHE . 0.0 OUTLIER -133.76 162.59 31.57 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 177.578 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 532' ' ' VAL . . . . . 0.662 HG12 ' OG1' ' A' ' 554' ' ' THR . 0.6 OUTLIER -127.47 135.06 64.32 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 CA-C-O 121.956 0.884 . . . . 0.0 111.819 179.131 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 533' ' ' GLY . . . . . 0.729 ' HA2' ' O ' ' A' ' 552' ' ' THR . . . -133.62 148.44 19.39 Favored Glycine 0 N--CA 1.445 -0.7 0 CA-C-N 114.252 -1.34 . . . . 0.0 113.496 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 534' ' ' SER . . . . . 0.434 ' HB2' ' OG1' ' A' ' 552' ' ' THR . 0.1 OUTLIER -135.14 141.28 45.92 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 179.724 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 535' ' ' ARG . . . . . 0.674 ' O ' ' HB3' ' A' ' 573' ' ' LEU . 26.2 tpt85 . . . . . 0 N--CA 1.464 0.248 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.848 178.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 . . . . . 0 CA--C 1.512 -0.506 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 550' ' ' ASP . . . . . 0.501 ' O ' ' HA ' ' A' ' 535' ' ' ARG . 11.4 m-20 -77.78 -39.37 44.22 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.053 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 551' ' ' LEU . . . . . 0.78 HD11 ' CE1' ' A' ' 553' ' ' PHE . 3.0 tp -131.25 140.76 49.89 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.951 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 552' ' ' THR . . . . . 0.729 ' O ' ' HA2' ' A' ' 533' ' ' GLY . 1.9 m -132.87 146.09 51.5 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.491 0.663 . . . . 0.0 110.98 178.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 553' ' ' PHE . . . . . 0.78 ' CE1' HD11 ' A' ' 551' ' ' LEU . 9.8 m-85 -134.39 137.01 43.75 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 177.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 554' ' ' THR . . . . . 0.896 HG22 ' H ' ' A' ' 556' ' ' ILE . 21.7 m -133.94 138.62 31.14 Favored Pre-proline 0 C--N 1.303 -1.423 0 C-N-CA 119.42 -0.912 . . . . 0.0 110.045 178.14 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 555' ' ' PRO . . . . . 0.811 ' O ' HG22 ' A' ' 556' ' ' ILE . 85.6 Cg_endo -85.48 25.29 0.7 Allowed 'Trans proline' 0 N--CA 1.438 -1.771 0 C-N-CA 121.452 1.434 . . . . 0.0 109.857 178.021 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 556' ' ' ILE . . . . . 1.03 HG21 ' HA ' ' A' ' 528' ' ' ASN . 1.4 tp 64.59 32.6 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 177.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -103.96 131.19 51.45 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 558' ' ' THR . . . . . 0.514 ' HA ' ' CE1' ' A' ' 505' ' ' PHE . 3.5 t -58.17 116.38 3.52 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 116.071 1.878 . . . . 0.0 116.071 -172.157 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 559' ' ' TRP . . . . . 0.645 ' CE3' ' HG3' ' A' ' 563' ' ' LYS . 1.3 m0 -139.33 111.49 7.46 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 104.414 -2.439 . . . . 0.0 104.414 173.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 560' ' ' ASN . . . . . 0.51 ' O ' ' HB ' ' A' ' 564' ' ' THR . 51.1 m-80 -90.98 -75.32 0.47 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 115.116 1.524 . . . . 0.0 115.116 -175.541 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 561' ' ' ALA . . . . . 0.451 ' O ' HG22 ' A' ' 564' ' ' THR . . . -73.76 -63.42 1.21 Allowed 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 115.729 1.751 . . . . 0.0 115.729 -176.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 562' ' ' SER . . . . . . . . . . . . . 69.2 m -48.83 -50.84 32.65 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -176.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 563' ' ' LYS . . . . . 0.645 ' HG3' ' CE3' ' A' ' 559' ' ' TRP . 1.2 mmpt? -71.2 -49.01 48.02 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -178.499 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 564' ' ' THR . . . . . 0.706 ' O ' ' HB ' ' A' ' 568' ' ' ILE . 3.4 t -51.17 -62.93 1.31 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.794 0.331 . . . . 0.0 110.709 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 565' ' ' GLN . . . . . 1.014 ' O ' HG23 ' A' ' 569' ' ' ILE . 3.7 tp-100 -50.23 -47.34 54.99 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.858 0.361 . . . . 0.0 111.28 178.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 566' ' ' GLU . . . . . 0.423 ' HG2' ' CD1' ' A' ' 567' ' ' PHE . 23.3 tt0 -49.2 -68.54 0.17 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -178.48 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 567' ' ' PHE . . . . . 0.714 ' CD2' HG21 ' A' ' 552' ' ' THR . 0.2 OUTLIER -91.01 -51.85 5.14 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.397 0.618 . . . . 0.0 111.57 -179.094 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 568' ' ' ILE . . . . . 0.769 ' CD1' HG23 ' A' ' 504' ' ' THR . 1.9 mp -56.17 8.98 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 114.83 -1.077 . . . . 0.0 113.259 -179.315 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 569' ' ' ILE . . . . . 1.014 HG23 ' O ' ' A' ' 565' ' ' GLN . 1.3 pt -54.13 -36.39 32.13 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.728 0 N-CA-C 104.146 -2.538 . . . . 0.0 104.146 177.415 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 570' ' ' ASP . . . . . 0.662 ' OD2' HD22 ' A' ' 574' ' ' LEU . 28.4 m-20 35.39 54.84 0.83 Allowed 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 113.453 -1.703 . . . . 0.0 111.661 174.13 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -51.28 -44.89 52.62 Favored Glycine 0 N--CA 1.438 -1.169 0 C-N-CA 118.045 -2.026 . . . . 0.0 108.455 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 572' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -119.89 -17.12 8.57 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 175.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 573' ' ' LEU . . . . . 0.674 ' HB3' ' O ' ' A' ' 535' ' ' ARG . 0.9 OUTLIER -140.7 136.65 32.83 Favored 'General case' 0 C--N 1.354 0.768 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 -177.937 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 574' ' ' LEU . . . . . 0.977 ' HB2' HD11 ' A' ' 588' ' ' ILE . 0.7 OUTLIER -135.29 133.48 38.92 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 173.865 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 575' ' ' ILE . . . . . 1.012 HG23 HD13 ' A' ' 585' ' ' LEU . 0.0 OUTLIER -133.48 137.19 53.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 119.133 0.879 . . . . 0.0 111.745 178.736 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 576' ' ' LEU . . . . . 0.64 HD11 HD21 ' A' ' 578' ' ' LEU . 0.0 OUTLIER -133.31 135.32 44.75 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 177.255 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 577' ' ' LYS . . . . . 0.451 ' CD ' ' CD1' ' A' ' 531' ' ' TYR . 0.2 OUTLIER -128.22 135.48 49.74 Favored 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.104 178.044 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.64 HD21 HD11 ' A' ' 576' ' ' LEU . 0.4 OUTLIER -125.81 132.7 52.2 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.537 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 579' ' ' GLY . . . . . . . . . . . . . . . -88.51 -2.14 79.86 Favored Glycine 0 N--CA 1.438 -1.169 0 CA-C-N 114.759 -1.11 . . . . 0.0 112.962 -179.09 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 580' ' ' LYS . . . . . 0.526 ' HD3' HD12 ' A' ' 524' ' ' ILE . 18.9 pttt -66.1 -50.46 63.96 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 118.891 -1.124 . . . . 0.0 108.047 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 581' ' ' TRP . . . . . 0.458 ' CZ2' ' HD2' ' A' ' 580' ' ' LYS . 0.0 OUTLIER -142.35 -52.03 0.4 Allowed 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 175.815 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 582' ' ' LYS . . . . . 0.433 ' HE3' ' CD1' ' A' ' 581' ' ' TRP . 0.4 OUTLIER -139.56 166.06 25.58 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 114.398 1.258 . . . . 0.0 114.398 -174.508 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 583' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -109.2 135.24 50.63 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 174.64 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 584' ' ' LYS . . . . . 0.809 ' HB2' HD12 ' A' ' 514' ' ' LEU . 1.1 tmmt? -114.8 133.85 55.6 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 178.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 585' ' ' LEU . . . . . 1.012 HD13 HG23 ' A' ' 575' ' ' ILE . 5.0 tp -122.38 136.69 54.94 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 586' ' ' VAL . . . . . 0.54 HG21 ' HZ3' ' A' ' 584' ' ' LYS . 9.5 t -132.91 144.58 36.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -178.043 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 587' ' ' SER . . . . . 0.484 ' C ' HD13 ' A' ' 588' ' ' ILE . 2.9 m -109.83 136.35 49.28 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 177.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.977 HD11 ' HB2' ' A' ' 574' ' ' LEU . 0.0 OUTLIER -132.7 136.74 55.38 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -177.958 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 5.6 m -133.07 137.06 54.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 114.356 -1.293 . . . . 0.0 110.688 178.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 590' ' ' SER . . . . . . . . . . . . . 2.6 m . . . . . 0 C--N 1.327 -0.394 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.449 179.914 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 491' ' ' ALA . . . . . 0.417 ' CB ' ' NZ ' ' A' ' 584' ' ' LYS . . . . . . . . 0 C--O 1.23 0.048 0 CA-C-O 120.454 0.169 . . . . 0.0 110.574 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 492' ' ' ARG . . . . . 0.66 ' CD ' HD22 ' A' ' 585' ' ' LEU . 0.0 OUTLIER -135.85 135.23 39.61 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.981 0.419 . . . . 0.0 111.851 179.883 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 493' ' ' VAL . . . . . 0.569 HG12 ' N ' ' A' ' 494' ' ' THR . 84.8 t -134.93 163.2 37.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.135 177.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 494' ' ' THR . . . . . 0.569 ' N ' HG12 ' A' ' 493' ' ' VAL . 5.3 t -122.49 134.86 54.56 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.143 0.497 . . . . 0.0 111.147 178.387 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 495' ' ' LEU . . . . . 0.919 HD22 ' HB2' ' A' ' 512' ' ' ALA . 0.0 OUTLIER -135.49 164.57 42.62 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.401 179.593 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 496' ' ' PRO . . . . . 0.737 ' HD2' HD21 ' A' ' 499' ' ' LEU . 15.4 Cg_exo -66.69 119.42 6.45 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 121.759 1.639 . . . . 0.0 110.918 178.479 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 497' ' ' LYS . . . . . 0.455 ' HB2' ' N ' ' A' ' 589' ' ' VAL . 5.6 tmtt? -53.81 -30.02 43.2 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -178.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 498' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.92 -48.36 82.01 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -177.155 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 499' ' ' LEU . . . . . 0.757 HD11 ' CD1' ' A' ' 495' ' ' LEU . 2.2 pp -73.52 -8.87 57.71 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -178.491 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 500' ' ' VAL . . . . . 0.857 HG21 HG21 ' A' ' 588' ' ' ILE . 39.8 t -75.41 -25.4 17.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.21 0.528 . . . . 0.0 111.922 -179.337 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 501' ' ' TYR . . . . . 0.83 ' O ' HG21 ' A' ' 564' ' ' THR . 0.7 OUTLIER -52.95 -28.7 24.84 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -178.201 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.4 -50.08 17.0 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 115.563 1.69 . . . . 0.0 115.563 -175.556 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 503' ' ' LYS . . . . . 0.569 ' O ' ' CG ' ' A' ' 507' ' ' LYS . 0.5 OUTLIER -119.44 135.29 54.82 Favored 'General case' 0 C--N 1.338 0.074 0 CA-C-N 119.201 0.909 . . . . 0.0 111.843 -179.41 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 504' ' ' THR . . . . . 0.764 HG23 ' CE1' ' A' ' 567' ' ' PHE . 62.5 m -73.18 -76.61 0.12 Allowed 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 505' ' ' PHE . . . . . 0.653 ' CE2' HG23 ' A' ' 532' ' ' VAL . 0.2 OUTLIER -75.08 -60.87 2.1 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -179.25 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 506' ' ' SER . . . . . 0.466 ' O ' ' HG ' ' A' ' 509' ' ' LEU . 1.4 m -48.82 -72.72 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 -176.039 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 507' ' ' LYS . . . . . 0.804 ' HZ1' HG22 ' A' ' 500' ' ' VAL . 0.0 OUTLIER -50.41 -48.92 55.96 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -176.878 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 508' ' ' VAL . . . . . 0.831 HG13 HD21 ' A' ' 574' ' ' LEU . 47.9 t -52.66 -58.84 2.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -178.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 509' ' ' LEU . . . . . 0.812 HD12 ' N ' ' A' ' 510' ' ' TRP . 1.5 pp -58.16 -62.84 1.53 Allowed 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 -177.1 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 510' ' ' TRP . . . . . 0.812 ' N ' HD12 ' A' ' 509' ' ' LEU . 6.0 p-90 -73.06 -52.49 14.15 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 114.706 1.372 . . . . 0.0 114.706 -176.227 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 511' ' ' SER . . . . . 0.486 ' N ' ' CE3' ' A' ' 510' ' ' TRP . 0.2 OUTLIER -61.87 -48.41 80.62 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.684 -176.893 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 512' ' ' ALA . . . . . 0.919 ' HB2' HD22 ' A' ' 495' ' ' LEU . . . -72.1 -73.77 0.18 Allowed 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 117.162 2.282 . . . . 0.0 117.162 -174.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 513' ' ' GLY . . . . . 0.681 ' HA3' ' HE3' ' A' ' 584' ' ' LYS . . . -115.23 -35.13 1.36 Allowed Glycine 0 N--CA 1.449 -0.477 0 N-CA-C 121.408 3.323 . . . . 0.0 121.408 -172.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 514' ' ' LEU . . . . . 0.606 ' HG ' ' HE2' ' A' ' 584' ' ' LYS . 1.3 mt -107.58 -38.73 5.82 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 120.09 3.367 . . . . 0.0 120.09 -170.013 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 515' ' ' VAL . . . . . 0.592 HG22 ' N ' ' A' ' 516' ' ' ALA . 14.3 p -152.95 172.08 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 N-CA-C 118.108 2.633 . . . . 0.0 118.108 -172.062 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 516' ' ' ALA . . . . . 0.592 ' N ' HG22 ' A' ' 515' ' ' VAL . . . -85.94 2.69 45.15 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 127.055 2.142 . . . . 0.0 108.956 178.407 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 517' ' ' SER . . . . . 0.882 ' O ' ' N ' ' A' ' 521' ' ' GLY . 10.4 p -59.82 13.0 0.01 OUTLIER 'General case' 0 N--CA 1.424 -1.729 0 C-N-CA 126.326 1.85 . . . . 0.0 115.49 -173.07 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 518' ' ' LYS . . . . . 0.631 ' C ' ' O ' ' A' ' 517' ' ' SER . 2.1 mppt? -40.61 -44.36 2.1 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 178.2 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 519' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.37 -52.46 12.07 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.323 173.362 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 520' ' ' GLU . . . . . 0.809 ' HB2' ' HA ' ' A' ' 517' ' ' SER . 9.0 mm-40 -63.1 -46.81 85.6 Favored 'General case' 0 C--N 1.35 0.591 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.277 -179.16 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 521' ' ' GLY . . . . . 0.891 ' HA2' HD12 ' A' ' 524' ' ' ILE . . . -49.16 -58.75 7.58 Favored Glycine 0 CA--C 1.495 -1.172 0 N-CA-C 111.344 -0.702 . . . . 0.0 111.344 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 522' ' ' GLN . . . . . 0.412 ' HA ' HG12 ' A' ' 525' ' ' ILE . 3.8 mt-30 -47.99 -47.89 32.8 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 178.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 523' ' ' ARG . . . . . 0.477 ' HB3' ' O ' ' A' ' 520' ' ' GLU . 0.4 OUTLIER -50.26 -48.75 54.67 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.823 178.945 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 524' ' ' ILE . . . . . 0.891 HD12 ' HA2' ' A' ' 521' ' ' GLY . 6.0 mt -58.31 -54.86 27.06 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 CA-C-O 121.341 0.591 . . . . 0.0 109.745 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 525' ' ' ILE . . . . . 0.565 ' HA ' HG13 ' A' ' 556' ' ' ILE . 1.0 OUTLIER -50.37 -47.6 26.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.091 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 526' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -58.2 -47.78 82.4 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 114.373 -1.285 . . . . 0.0 108.643 177.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -47.69 -39.83 18.45 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 113.971 -1.468 . . . . 0.0 108.028 177.282 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 528' ' ' ASN . . . . . 1.028 ' HA ' HG21 ' A' ' 556' ' ' ILE . 1.6 t30 73.99 39.85 0.49 Allowed 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.187 -179.187 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 529' ' ' GLY . . . . . . . . . . . . . . . -114.83 20.52 14.77 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 114.265 -1.334 . . . . 0.0 111.54 178.158 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 530' ' ' ALA . . . . . 0.799 ' O ' ' HB ' ' A' ' 556' ' ' ILE . . . -133.71 156.76 47.36 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.86 0.362 . . . . 0.0 111.649 -179.294 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 531' ' ' TYR . . . . . 0.532 ' HA ' ' O ' ' A' ' 554' ' ' THR . 0.1 OUTLIER -133.28 158.8 42.03 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 178.039 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 532' ' ' VAL . . . . . 0.653 HG23 ' CE2' ' A' ' 505' ' ' PHE . 0.5 OUTLIER -125.52 135.78 62.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-O 122.025 0.917 . . . . 0.0 112.958 -178.301 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 533' ' ' GLY . . . . . 0.635 ' HA2' ' O ' ' A' ' 552' ' ' THR . . . -134.41 161.14 24.4 Favored Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 114.381 -1.281 . . . . 0.0 114.865 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 534' ' ' SER . . . . . 0.601 ' O ' ' HA ' ' A' ' 551' ' ' LEU . 6.7 t -133.8 137.28 45.01 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 114.912 -0.644 . . . . 0.0 110.628 178.435 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 535' ' ' ARG . . . . . 0.758 ' O ' ' HB3' ' A' ' 573' ' ' LEU . 7.1 tpt85 . . . . . 0 C--N 1.33 -0.276 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 178.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 2.6 p30 . . . . . 0 N--CA 1.449 -0.493 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 550' ' ' ASP . . . . . 0.692 ' O ' ' HA ' ' A' ' 535' ' ' ARG . 1.3 t70 -58.75 -47.94 82.93 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 551' ' ' LEU . . . . . 0.601 ' HA ' ' O ' ' A' ' 534' ' ' SER . 7.9 tp -120.37 140.06 51.87 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.149 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 552' ' ' THR . . . . . 0.635 ' O ' ' HA2' ' A' ' 533' ' ' GLY . 3.2 m -133.39 148.0 51.79 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.861 0.839 . . . . 0.0 112.295 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 553' ' ' PHE . . . . . 0.514 ' CD1' ' CE1' ' A' ' 531' ' ' TYR . 0.3 OUTLIER -134.66 137.46 43.62 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 176.554 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 554' ' ' THR . . . . . 0.619 HG23 ' HZ2' ' A' ' 559' ' ' TRP . 0.9 OUTLIER -132.83 138.11 31.18 Favored Pre-proline 0 C--N 1.31 -1.124 0 C-N-CA 119.474 -0.89 . . . . 0.0 110.338 179.304 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 555' ' ' PRO . . . . . 0.825 ' O ' HG22 ' A' ' 556' ' ' ILE . 61.0 Cg_endo -86.33 25.07 0.7 Allowed 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 122.208 1.938 . . . . 0.0 112.064 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 556' ' ' ILE . . . . . 1.028 HG21 ' HA ' ' A' ' 528' ' ' ASN . 1.5 tp 64.4 33.11 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 115.714 1.746 . . . . 0.0 115.714 176.433 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 557' ' ' LYS . . . . . 0.59 ' O ' ' CE2' ' A' ' 559' ' ' TRP . 3.7 mttt -104.24 125.86 50.87 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 -179.576 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 558' ' ' THR . . . . . . . . . . . . . 2.8 t -58.13 117.64 4.6 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -173.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 559' ' ' TRP . . . . . 0.619 ' HZ2' HG23 ' A' ' 554' ' ' THR . 0.0 OUTLIER -138.72 112.16 8.17 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 175.479 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 560' ' ' ASN . . . . . 0.716 ' O ' HG22 ' A' ' 564' ' ' THR . 26.2 m-80 -76.26 -76.27 0.17 Allowed 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 118.829 -1.149 . . . . 0.0 113.934 -175.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 561' ' ' ALA . . . . . 0.587 ' HA ' ' CG2' ' A' ' 564' ' ' THR . . . -75.16 -55.04 6.13 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 116.241 1.941 . . . . 0.0 116.241 -177.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 562' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -49.31 -53.77 20.39 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -176.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 563' ' ' LYS . . . . . 0.597 ' HG3' ' CE2' ' A' ' 559' ' ' TRP . 2.4 mmtt -70.86 -47.55 58.7 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -178.4 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 564' ' ' THR . . . . . 0.83 HG21 ' O ' ' A' ' 501' ' ' TYR . 3.3 t -48.53 -67.45 0.27 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.7 0.286 . . . . 0.0 110.879 -178.659 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 565' ' ' GLN . . . . . 0.823 ' H ' HG23 ' A' ' 564' ' ' THR . 0.0 OUTLIER -48.86 -46.77 42.84 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.757 0.313 . . . . 0.0 111.055 179.16 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -49.66 -67.18 0.28 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -178.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 567' ' ' PHE . . . . . 0.959 ' CZ ' HD13 ' A' ' 568' ' ' ILE . 0.3 OUTLIER -89.13 -41.02 12.52 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -177.932 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 568' ' ' ILE . . . . . 0.969 HD11 HD13 ' A' ' 574' ' ' LEU . 0.6 OUTLIER -61.59 9.84 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 179.63 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 569' ' ' ILE . . . . . 0.717 HD12 ' N ' ' A' ' 570' ' ' ASP . 2.7 pp -55.56 -45.02 78.57 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.317 0 N-CA-C 104.112 -2.551 . . . . 0.0 104.112 177.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 570' ' ' ASP . . . . . 0.717 ' N ' HD12 ' A' ' 569' ' ' ILE . 1.3 p30 31.29 60.17 0.27 Allowed 'General case' 0 CA--C 1.511 -0.554 0 CA-C-N 114.236 -1.347 . . . . 0.0 112.16 173.476 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -51.49 -45.22 53.77 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 117.423 -2.323 . . . . 0.0 109.08 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 572' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -119.35 -16.94 8.93 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 175.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 573' ' ' LEU . . . . . 0.758 ' HB3' ' O ' ' A' ' 535' ' ' ARG . 0.7 OUTLIER -140.29 137.94 34.57 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 -178.116 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 574' ' ' LEU . . . . . 0.969 HD13 HD11 ' A' ' 568' ' ' ILE . 0.1 OUTLIER -133.55 134.84 43.86 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 174.223 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 575' ' ' ILE . . . . . 0.862 ' N ' HD12 ' A' ' 574' ' ' LEU . 0.0 OUTLIER -133.04 136.98 54.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 C-N-CA 119.799 -0.76 . . . . 0.0 112.469 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 576' ' ' LEU . . . . . 0.494 ' CD1' ' CE1' ' A' ' 505' ' ' PHE . 0.0 OUTLIER -133.16 135.03 44.9 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 176.73 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 577' ' ' LYS . . . . . 0.542 ' HE2' ' HE2' ' A' ' 583' ' ' MET . 2.9 mtpm? -133.4 135.4 44.61 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 118.762 -1.175 . . . . 0.0 111.232 178.258 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.615 HD12 ' O ' ' A' ' 582' ' ' LYS . 0.3 OUTLIER -125.62 131.66 52.63 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.068 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 579' ' ' GLY . . . . . . . . . . . . . . . -91.3 -2.19 71.09 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.396 -0.82 . . . . 0.0 113.582 -178.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 580' ' ' LYS . . . . . 0.655 ' HG2' HG23 ' A' ' 524' ' ' ILE . 0.0 OUTLIER -72.8 -47.36 47.12 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 119.123 -1.031 . . . . 0.0 108.945 179.387 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 581' ' ' TRP . . . . . 0.561 ' CG ' ' HD2' ' A' ' 580' ' ' LYS . 32.5 m0 -138.49 -52.93 0.6 Allowed 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 177.658 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 582' ' ' LYS . . . . . 0.615 ' O ' HD12 ' A' ' 578' ' ' LEU . 0.0 OUTLIER -139.68 165.29 27.65 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 -174.894 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 583' ' ' MET . . . . . 0.542 ' HE2' ' HE2' ' A' ' 577' ' ' LYS . 0.3 OUTLIER -117.15 134.29 54.96 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 174.236 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 584' ' ' LYS . . . . . 0.681 ' HE3' ' HA3' ' A' ' 513' ' ' GLY . 0.1 OUTLIER -121.22 133.66 55.17 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.988 -1.005 . . . . 0.0 108.762 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 585' ' ' LEU . . . . . 0.701 ' HG ' HG23 ' A' ' 575' ' ' ILE . 6.2 tt -118.23 135.55 54.2 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 178.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 586' ' ' VAL . . . . . 0.587 HG11 HD23 ' A' ' 495' ' ' LEU . 77.4 t -133.26 138.57 51.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 C-N-CA 120.506 -0.477 . . . . 0.0 111.538 -178.199 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 587' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.73 135.53 48.11 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 177.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.857 HG21 HG21 ' A' ' 500' ' ' VAL . 0.1 OUTLIER -133.67 137.12 53.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -177.992 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 589' ' ' VAL . . . . . 0.455 ' N ' ' HB2' ' A' ' 497' ' ' LYS . 5.4 m -127.52 137.37 57.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 114.334 -1.303 . . . . 0.0 110.804 178.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 590' ' ' SER . . . . . . . . . . . . . 28.0 t . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.279 -179.59 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 491' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.099 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 492' ' ' ARG . . . . . 0.862 ' CD ' HD22 ' A' ' 585' ' ' LEU . 0.0 OUTLIER -136.12 134.37 38.24 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.957 178.438 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 493' ' ' VAL . . . . . 0.838 HG21 ' HA3' ' A' ' 513' ' ' GLY . 11.2 m -136.2 163.81 33.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.816 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 9.0 t -120.2 133.36 55.51 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 121.043 0.449 . . . . 0.0 110.305 177.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 495' ' ' LEU . . . . . 1.033 HD11 ' CG2' ' A' ' 500' ' ' VAL . 1.6 pp -136.2 163.16 52.07 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.928 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 496' ' ' PRO . . . . . 0.791 ' HD2' HD21 ' A' ' 499' ' ' LEU . 14.7 Cg_exo -67.35 119.3 6.31 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 122.313 2.008 . . . . 0.0 112.152 178.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 497' ' ' LYS . . . . . 0.526 ' HA ' ' HB ' ' A' ' 588' ' ' ILE . 20.1 tttt -51.85 -30.37 23.37 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -179.142 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 498' ' ' SER . . . . . . . . . . . . . 11.9 t -60.29 -48.35 82.11 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -177.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 499' ' ' LEU . . . . . 0.791 HD21 ' HD2' ' A' ' 496' ' ' PRO . 2.0 pp -74.18 -8.67 57.0 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -178.506 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 500' ' ' VAL . . . . . 1.033 ' CG2' HD11 ' A' ' 495' ' ' LEU . 13.8 t -75.45 -26.01 18.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.099 0.476 . . . . 0.0 112.239 -178.764 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 501' ' ' TYR . . . . . 0.669 ' O ' HG21 ' A' ' 564' ' ' THR . 6.3 m-85 -53.94 -30.61 47.27 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -178.142 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -75.82 -50.21 15.82 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 115.456 1.651 . . . . 0.0 115.456 -175.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 503' ' ' LYS . . . . . 0.61 ' O ' ' CG ' ' A' ' 507' ' ' LYS . 0.2 OUTLIER -119.2 132.57 55.96 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 118.79 0.723 . . . . 0.0 111.776 -179.323 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 504' ' ' THR . . . . . 0.575 HG21 ' HB3' ' A' ' 563' ' ' LYS . 4.6 m -72.96 -75.62 0.14 Allowed 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 505' ' ' PHE . . . . . 0.641 ' CE1' ' HA ' ' A' ' 558' ' ' THR . 0.0 OUTLIER -74.71 -62.69 1.45 Allowed 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 -179.107 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 506' ' ' SER . . . . . 0.758 ' O ' ' CD1' ' A' ' 510' ' ' TRP . 66.6 m -49.15 -72.81 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -175.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 507' ' ' LYS . . . . . 0.712 ' HD3' ' N ' ' A' ' 508' ' ' VAL . 0.0 OUTLIER -48.7 -48.49 40.24 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -176.153 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 508' ' ' VAL . . . . . 0.947 ' CG1' HD21 ' A' ' 574' ' ' LEU . 61.3 t -54.76 -57.76 5.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -179.213 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 509' ' ' LEU . . . . . 0.734 HD12 ' N ' ' A' ' 510' ' ' TRP . 2.0 pp -59.64 -63.45 1.3 Allowed 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 -177.027 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 510' ' ' TRP . . . . . 0.766 ' CD1' ' HA ' ' A' ' 518' ' ' LYS . 63.7 p-90 -72.75 -49.69 29.34 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -176.327 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 511' ' ' SER . . . . . 0.523 ' N ' ' CD2' ' A' ' 510' ' ' TRP . 0.3 OUTLIER -62.75 -48.24 80.06 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.658 -177.014 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 512' ' ' ALA . . . . . 0.774 ' HB2' ' CD2' ' A' ' 495' ' ' LEU . . . -71.79 -75.18 0.14 Allowed 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 117.011 2.226 . . . . 0.0 117.011 -174.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 513' ' ' GLY . . . . . 0.838 ' HA3' HG21 ' A' ' 493' ' ' VAL . . . -117.63 -35.23 1.09 Allowed Glycine 0 CA--C 1.501 -0.787 0 N-CA-C 120.778 3.071 . . . . 0.0 120.778 -173.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 514' ' ' LEU . . . . . 0.741 ' HB3' HG23 ' A' ' 515' ' ' VAL . 0.0 OUTLIER -96.67 -46.95 6.09 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 119.542 3.164 . . . . 0.0 119.542 -168.746 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 515' ' ' VAL . . . . . 0.741 HG23 ' HB3' ' A' ' 514' ' ' LEU . 22.0 t -151.2 171.25 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 117.196 2.295 . . . . 0.0 117.196 -172.422 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 516' ' ' ALA . . . . . 0.631 ' N ' HG12 ' A' ' 515' ' ' VAL . . . -73.59 2.88 7.07 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 112.558 -2.11 . . . . 0.0 108.67 175.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 517' ' ' SER . . . . . 0.851 ' HA ' ' HB2' ' A' ' 520' ' ' GLU . 0.6 OUTLIER -58.33 9.6 0.01 OUTLIER 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 116.004 1.853 . . . . 0.0 116.004 -172.024 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 518' ' ' LYS . . . . . 0.766 ' HA ' ' CD1' ' A' ' 510' ' ' TRP . 0.0 OUTLIER -45.1 -48.26 12.04 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 175.841 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 519' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -75.21 -56.31 4.85 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.172 173.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 520' ' ' GLU . . . . . 0.851 ' HB2' ' HA ' ' A' ' 517' ' ' SER . 2.0 mm-40 -59.64 -47.58 85.05 Favored 'General case' 0 C--N 1.35 0.588 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.228 -178.502 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 521' ' ' GLY . . . . . 0.785 ' N ' ' O ' ' A' ' 517' ' ' SER . . . -49.01 -54.2 15.52 Favored Glycine 0 CA--C 1.496 -1.108 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -48.62 -47.3 40.2 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.041 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 523' ' ' ARG . . . . . 0.402 ' O ' ' HB2' ' A' ' 526' ' ' ASN . 0.0 OUTLIER -49.9 -48.92 51.27 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.725 178.667 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 524' ' ' ILE . . . . . 0.769 HD12 ' HG2' ' A' ' 580' ' ' LYS . 28.1 mm -57.33 -55.92 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 CA-C-O 121.403 0.62 . . . . 0.0 109.725 179.041 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 525' ' ' ILE . . . . . 0.589 HD13 ' N ' ' A' ' 525' ' ' ILE . 1.5 mm -50.28 -47.4 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 177.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 526' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 523' ' ' ARG . 9.1 m120 -57.63 -47.76 81.32 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 114.633 -1.167 . . . . 0.0 108.5 177.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -47.94 -39.54 19.52 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 113.971 -1.468 . . . . 0.0 107.715 176.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 528' ' ' ASN . . . . . 1.088 ' HA ' HG21 ' A' ' 556' ' ' ILE . 2.5 t30 74.31 39.99 0.45 Allowed 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 114.631 -1.168 . . . . 0.0 111.633 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 529' ' ' GLY . . . . . . . . . . . . . . . -114.22 25.6 10.46 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 114.324 -1.307 . . . . 0.0 111.192 177.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 530' ' ' ALA . . . . . 0.83 ' O ' ' HB ' ' A' ' 556' ' ' ILE . . . -133.49 159.48 40.27 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.095 0.474 . . . . 0.0 112.046 -179.16 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 531' ' ' TYR . . . . . 0.52 ' CE2' ' CD2' ' A' ' 553' ' ' PHE . 0.0 OUTLIER -134.04 158.52 43.34 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 177.508 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 532' ' ' VAL . . . . . 0.742 HG12 ' OG1' ' A' ' 554' ' ' THR . 0.4 OUTLIER -126.69 135.59 63.26 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 C-N-CA 119.401 -0.919 . . . . 0.0 112.356 -179.758 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 533' ' ' GLY . . . . . 0.672 ' HA2' ' O ' ' A' ' 552' ' ' THR . . . -133.83 154.07 21.16 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 114.43 -1.259 . . . . 0.0 114.078 -179.4 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 534' ' ' SER . . . . . 0.501 ' N ' ' HB ' ' A' ' 552' ' ' THR . 44.7 t -134.16 137.08 44.23 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.303 -0.449 . . . . 0.0 111.37 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 535' ' ' ARG . . . . . 0.703 ' O ' ' HB3' ' A' ' 573' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.326 0 C-N-CA 120.305 -0.558 . . . . 0.0 112.452 178.118 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 . . . . . 0 N--CA 1.45 -0.45 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 550' ' ' ASP . . . . . 0.519 ' O ' ' HA ' ' A' ' 535' ' ' ARG . 4.4 m-20 -59.34 -46.95 87.2 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.23 179.129 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 551' ' ' LEU . . . . . . . . . . . . . 15.9 tp -131.48 139.87 49.43 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.184 -0.917 . . . . 0.0 108.968 178.005 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 552' ' ' THR . . . . . 0.672 ' O ' ' HA2' ' A' ' 533' ' ' GLY . 23.6 m -133.43 148.15 51.76 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.667 0.746 . . . . 0.0 111.933 179.307 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 553' ' ' PHE . . . . . 0.52 ' CD2' ' CE2' ' A' ' 531' ' ' TYR . 9.6 m-85 -134.59 137.07 43.42 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 176.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 554' ' ' THR . . . . . 0.894 HG22 ' H ' ' A' ' 556' ' ' ILE . 2.8 m -133.21 139.03 32.95 Favored Pre-proline 0 C--N 1.306 -1.309 0 C-N-CA 119.745 -0.782 . . . . 0.0 109.554 178.537 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 555' ' ' PRO . . . . . 0.8 ' O ' HG22 ' A' ' 556' ' ' ILE . 81.2 Cg_endo -83.37 21.76 1.0 Allowed 'Trans proline' 0 N--CA 1.445 -1.324 0 C-N-CA 121.493 1.462 . . . . 0.0 111.878 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 556' ' ' ILE . . . . . 1.088 HG21 ' HA ' ' A' ' 528' ' ' ASN . 2.0 tp 63.74 32.65 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 177.259 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 4.0 tttm -104.07 120.06 40.28 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 558' ' ' THR . . . . . 0.641 ' HA ' ' CE1' ' A' ' 505' ' ' PHE . 8.4 t -57.85 116.66 3.6 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 115.988 1.847 . . . . 0.0 115.988 -172.319 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 559' ' ' TRP . . . . . 0.52 ' HB2' ' HB2' ' A' ' 563' ' ' LYS . 1.0 OUTLIER -138.4 111.19 7.68 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 103.638 -2.727 . . . . 0.0 103.638 173.796 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 560' ' ' ASN . . . . . 0.673 ' O ' HG22 ' A' ' 564' ' ' THR . 30.2 m120 -68.91 -75.87 0.1 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 -174.402 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 561' ' ' ALA . . . . . 0.683 ' HA ' ' CG2' ' A' ' 564' ' ' THR . . . -74.24 -48.77 26.59 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 -177.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 562' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.41 -54.72 16.03 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -177.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 563' ' ' LYS . . . . . 0.575 ' HB3' HG21 ' A' ' 504' ' ' THR . 0.0 OUTLIER -69.32 -48.63 60.91 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.087 0.402 . . . . 0.0 112.087 -178.653 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 564' ' ' THR . . . . . 0.833 HG23 ' H ' ' A' ' 565' ' ' GLN . 5.5 t -49.77 -71.32 0.07 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.661 0.267 . . . . 0.0 111.698 -178.51 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 565' ' ' GLN . . . . . 0.833 ' H ' HG23 ' A' ' 564' ' ' THR . 0.0 OUTLIER -48.73 -46.91 41.59 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.658 0.266 . . . . 0.0 111.66 179.966 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -49.98 -61.75 1.96 Allowed 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -178.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 567' ' ' PHE . . . . . 0.863 ' CE1' HD13 ' A' ' 568' ' ' ILE . 0.1 OUTLIER -96.66 -31.23 12.81 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -177.145 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 568' ' ' ILE . . . . . 0.897 HD11 HD13 ' A' ' 574' ' ' LEU . 1.0 OUTLIER -73.12 8.73 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.06 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -179.24 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 569' ' ' ILE . . . . . 0.705 HD12 ' N ' ' A' ' 570' ' ' ASP . 2.7 pp -53.57 -38.52 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 N-CA-C 104.709 -2.33 . . . . 0.0 104.709 178.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 570' ' ' ASP . . . . . 0.705 ' N ' HD12 ' A' ' 569' ' ' ILE . 9.7 t0 33.14 60.29 0.44 Allowed 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 114.179 -1.373 . . . . 0.0 111.936 172.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 571' ' ' GLY . . . . . 0.483 ' H ' HD12 ' A' ' 569' ' ' ILE . . . -55.06 -46.27 78.56 Favored Glycine 0 N--CA 1.439 -1.152 0 C-N-CA 116.861 -2.59 . . . . 0.0 107.784 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 572' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -120.85 -17.42 7.91 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 174.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 573' ' ' LEU . . . . . 0.703 ' HB3' ' O ' ' A' ' 535' ' ' ARG . 0.7 OUTLIER -140.57 137.49 33.76 Favored 'General case' 0 C--N 1.355 0.83 0 N-CA-C 116.175 1.917 . . . . 0.0 116.175 -177.848 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 574' ' ' LEU . . . . . 0.947 HD21 ' CG1' ' A' ' 508' ' ' VAL . 0.0 OUTLIER -134.92 134.1 40.28 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 173.612 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 575' ' ' ILE . . . . . 0.93 ' N ' HD12 ' A' ' 574' ' ' LEU . 0.0 OUTLIER -133.13 137.07 54.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-O 121.564 0.697 . . . . 0.0 111.818 179.393 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 576' ' ' LEU . . . . . 0.585 HD22 ' HB3' ' A' ' 509' ' ' LEU . 0.0 OUTLIER -133.19 135.8 45.3 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 177.25 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 577' ' ' LYS . . . . . . . . . . . . . 3.9 mtpt -129.98 135.38 48.24 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.656 178.075 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.475 HD21 HD11 ' A' ' 576' ' ' LEU . 0.2 OUTLIER -124.99 131.79 53.36 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 177.739 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 579' ' ' GLY . . . . . . . . . . . . . . . -90.78 -1.94 72.93 Favored Glycine 0 N--CA 1.442 -0.965 0 CA-C-N 115.169 -0.923 . . . . 0.0 113.494 -178.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 580' ' ' LYS . . . . . 0.769 ' HG2' HD12 ' A' ' 524' ' ' ILE . 3.0 pptp? -72.53 -47.73 46.0 Favored 'General case' 0 N--CA 1.438 -1.046 0 C-N-CA 118.851 -1.14 . . . . 0.0 108.726 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 581' ' ' TRP . . . . . 0.565 ' CG ' ' HD2' ' A' ' 580' ' ' LYS . 33.3 m0 -138.84 -53.21 0.58 Allowed 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 177.21 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 582' ' ' LYS . . . . . 0.63 ' HD3' HD11 ' A' ' 514' ' ' LEU . 0.0 OUTLIER -140.44 165.53 27.17 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 -174.316 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 583' ' ' MET . . . . . . . . . . . . . 1.1 ttt -109.32 134.89 51.24 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 173.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 584' ' ' LYS . . . . . 0.57 ' HB2' ' HG ' ' A' ' 514' ' ' LEU . 5.5 tppt? -120.08 133.77 55.43 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 178.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 585' ' ' LEU . . . . . 0.862 HD22 ' CD ' ' A' ' 492' ' ' ARG . 5.8 tt -120.0 136.38 54.57 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 -179.653 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 586' ' ' VAL . . . . . 0.764 HG22 HG23 ' A' ' 493' ' ' VAL . 72.0 t -133.31 137.65 52.82 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.813 -178.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 587' ' ' SER . . . . . . . . . . . . . 1.9 m -109.83 136.5 49.04 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 177.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.742 HG21 HG21 ' A' ' 500' ' ' VAL . 3.3 pt -133.35 136.35 54.95 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 -178.217 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 3.8 t -133.74 138.15 51.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 114.022 -1.445 . . . . 0.0 110.287 178.083 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 590' ' ' SER . . . . . . . . . . . . . 6.9 m . . . . . 0 C--N 1.325 -0.472 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.254 179.805 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 491' ' ' ALA . . . . . 0.412 ' CB ' HD21 ' A' ' 514' ' ' LEU . . . . . . . . 0 N--CA 1.457 -0.12 0 CA-C-O 120.57 0.224 . . . . 0.0 110.967 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 492' ' ' ARG . . . . . 0.692 ' HD3' HD22 ' A' ' 585' ' ' LEU . 10.6 tpt180 -136.25 134.38 38.01 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 178.479 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 493' ' ' VAL . . . . . 0.984 ' CG2' HG22 ' A' ' 586' ' ' VAL . 25.3 m -136.98 163.87 31.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 116.212 -0.449 . . . . 0.0 112.026 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 70.0 p -115.89 132.82 56.53 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 176.043 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 495' ' ' LEU . . . . . 0.994 ' O ' HG22 ' A' ' 588' ' ' ILE . 0.0 OUTLIER -136.62 162.84 53.76 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.637 -179.667 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 496' ' ' PRO . . . . . 0.696 ' HD2' HD12 ' A' ' 495' ' ' LEU . 9.8 Cg_exo -71.84 120.0 6.58 Favored 'Trans proline' 0 CA--C 1.534 0.481 0 C-N-CA 122.376 2.051 . . . . 0.0 111.328 178.624 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 497' ' ' LYS . . . . . 0.883 ' O ' HG12 ' A' ' 500' ' ' VAL . 0.1 OUTLIER -56.6 -30.25 63.0 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -178.739 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 498' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.56 -48.47 79.35 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -177.14 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 499' ' ' LEU . . . . . 0.824 HD11 HD11 ' A' ' 495' ' ' LEU . 2.6 pp -73.85 -9.08 58.29 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -178.396 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 500' ' ' VAL . . . . . 0.883 HG12 ' O ' ' A' ' 497' ' ' LYS . 3.5 p -75.34 -25.38 17.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.507 0.67 . . . . 0.0 111.595 -179.352 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 501' ' ' TYR . . . . . 0.676 ' O ' ' CG2' ' A' ' 564' ' ' THR . 2.6 m-30 -53.72 -29.27 38.54 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -178.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -76.67 -50.2 14.29 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 116.176 1.917 . . . . 0.0 116.176 -175.537 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 503' ' ' LYS . . . . . 0.579 ' O ' ' CG ' ' A' ' 507' ' ' LYS . 8.9 mttt -119.81 136.41 54.48 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 119.178 0.899 . . . . 0.0 112.561 -178.518 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 504' ' ' THR . . . . . 0.799 HG23 ' CE1' ' A' ' 567' ' ' PHE . 51.0 m -74.07 -76.61 0.13 Allowed 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 179.396 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 505' ' ' PHE . . . . . 0.617 ' CZ ' HD13 ' A' ' 556' ' ' ILE . 0.2 OUTLIER -75.31 -60.98 2.06 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -178.965 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 506' ' ' SER . . . . . 0.783 ' O ' ' CD1' ' A' ' 510' ' ' TRP . 0.7 OUTLIER -49.6 -73.07 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 114.833 1.419 . . . . 0.0 114.833 -176.264 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 507' ' ' LYS . . . . . 0.698 ' HD3' ' N ' ' A' ' 508' ' ' VAL . 0.0 OUTLIER -49.18 -48.61 45.0 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -176.756 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 508' ' ' VAL . . . . . 0.87 HG13 HD21 ' A' ' 574' ' ' LEU . 98.0 t -53.91 -59.48 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 509' ' ' LEU . . . . . 0.797 HD12 ' N ' ' A' ' 510' ' ' TRP . 2.2 pp -56.52 -61.8 2.17 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 115.477 1.658 . . . . 0.0 115.477 -177.115 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 510' ' ' TRP . . . . . 0.859 ' CD1' ' HA ' ' A' ' 518' ' ' LYS . 67.1 p-90 -72.79 -51.46 18.9 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -176.102 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 511' ' ' SER . . . . . 0.497 ' N ' ' CE3' ' A' ' 510' ' ' TRP . 0.6 OUTLIER -64.18 -47.45 79.78 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.363 -0.835 . . . . 0.0 113.174 -176.854 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 512' ' ' ALA . . . . . 0.761 ' HB3' ' O ' ' A' ' 508' ' ' VAL . . . -70.95 -73.04 0.18 Allowed 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 117.796 2.517 . . . . 0.0 117.796 -174.085 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 513' ' ' GLY . . . . . 0.859 ' CA ' HG21 ' A' ' 493' ' ' VAL . . . -114.76 -35.2 1.42 Allowed Glycine 0 CA--C 1.5 -0.897 0 N-CA-C 120.853 3.101 . . . . 0.0 120.853 -172.645 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 514' ' ' LEU . . . . . 0.606 HD23 ' CG ' ' A' ' 584' ' ' LYS . 0.1 OUTLIER -107.14 -46.84 3.81 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 119.506 3.151 . . . . 0.0 119.506 -170.056 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 515' ' ' VAL . . . . . 1.012 HG13 ' HB2' ' A' ' 517' ' ' SER . 2.5 p -154.71 172.72 0.61 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.589 0 N-CA-C 117.887 2.551 . . . . 0.0 117.887 -172.687 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 516' ' ' ALA . . . . . 0.554 ' N ' HG22 ' A' ' 515' ' ' VAL . . . -67.89 4.18 1.26 Allowed 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 126.761 2.025 . . . . 0.0 109.696 177.099 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 517' ' ' SER . . . . . 1.012 ' HB2' HG13 ' A' ' 515' ' ' VAL . 0.5 OUTLIER -57.55 9.28 0.01 OUTLIER 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 115.775 1.769 . . . . 0.0 115.775 -172.043 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 518' ' ' LYS . . . . . 0.859 ' HA ' ' CD1' ' A' ' 510' ' ' TRP . 0.0 OUTLIER -45.06 -46.82 11.73 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 104.351 -2.463 . . . . 0.0 104.351 175.413 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 519' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.16 -58.29 3.37 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.962 173.372 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 520' ' ' GLU . . . . . 0.846 ' HB2' ' HA ' ' A' ' 517' ' ' SER . 2.6 mm-40 -59.05 -47.44 85.21 Favored 'General case' 0 C--N 1.351 0.659 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.941 -178.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 521' ' ' GLY . . . . . 0.841 ' N ' ' O ' ' A' ' 517' ' ' SER . . . -49.12 -55.16 12.57 Favored Glycine 0 CA--C 1.493 -1.333 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.25 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -48.02 -47.42 33.45 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.255 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 523' ' ' ARG . . . . . 0.475 ' O ' ' HB3' ' A' ' 526' ' ' ASN . 0.1 OUTLIER -50.2 -48.94 54.02 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.988 178.463 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 524' ' ' ILE . . . . . 0.655 HD12 ' HD3' ' A' ' 580' ' ' LYS . 12.8 mm -58.24 -54.82 27.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.424 0.63 . . . . 0.0 109.717 179.323 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 525' ' ' ILE . . . . . 0.819 HG23 ' CD1' ' A' ' 556' ' ' ILE . 0.7 OUTLIER -50.4 -47.42 26.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 177.683 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 526' ' ' ASN . . . . . 0.475 ' HB3' ' O ' ' A' ' 523' ' ' ARG . 16.8 t-20 -55.8 -47.99 76.16 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 114.122 -1.399 . . . . 0.0 108.228 177.393 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -48.13 -40.13 22.75 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.076 -1.42 . . . . 0.0 107.189 176.517 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 528' ' ' ASN . . . . . 0.559 ' HA ' ' CG2' ' A' ' 556' ' ' ILE . 1.4 t30 73.67 40.47 0.49 Allowed 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 114.631 -1.168 . . . . 0.0 111.736 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 529' ' ' GLY . . . . . . . . . . . . . . . -115.69 27.64 8.23 Favored Glycine 0 CA--C 1.523 0.583 0 C-N-CA 120.337 -0.935 . . . . 0.0 112.779 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 530' ' ' ALA . . . . . 0.969 ' O ' ' HB ' ' A' ' 556' ' ' ILE . . . -133.96 164.03 28.21 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 112.524 0.565 . . . . 0.0 112.524 -179.322 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 531' ' ' TYR . . . . . 0.538 ' CE2' ' CD2' ' A' ' 553' ' ' PHE . 0.0 OUTLIER -133.99 156.02 48.93 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 177.875 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 532' ' ' VAL . . . . . 0.647 HG12 ' OG1' ' A' ' 554' ' ' THR . 0.5 OUTLIER -127.33 135.5 63.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 C-N-CA 119.537 -0.865 . . . . 0.0 112.123 -179.647 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 533' ' ' GLY . . . . . 0.685 ' O ' HG13 ' A' ' 575' ' ' ILE . . . -133.88 155.64 21.91 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 114.367 -1.288 . . . . 0.0 113.841 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 534' ' ' SER . . . . . 0.555 ' HB2' ' OG1' ' A' ' 552' ' ' THR . 0.6 OUTLIER -134.54 141.24 46.63 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.176 -0.512 . . . . 0.0 110.936 178.605 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 535' ' ' ARG . . . . . 0.569 ' O ' ' HB3' ' A' ' 573' ' ' LEU . 9.2 tpp85 . . . . . 0 CA--C 1.531 0.232 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 179.011 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 549' ' ' ASP . . . . . 0.69 ' HB3' HD11 ' A' ' 569' ' ' ILE . 9.9 m-20 . . . . . 0 N--CA 1.451 -0.423 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 550' ' ' ASP . . . . . 0.512 ' O ' ' HA ' ' A' ' 535' ' ' ARG . 1.2 p30 -51.85 -41.89 62.19 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.106 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 551' ' ' LEU . . . . . 0.622 HD21 ' HE1' ' A' ' 553' ' ' PHE . 10.7 tp -131.62 139.47 49.14 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.661 -1.154 . . . . 0.0 108.53 177.534 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 552' ' ' THR . . . . . 0.799 HG21 ' CB ' ' A' ' 567' ' ' PHE . 5.6 m -133.83 148.31 51.29 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.598 0.713 . . . . 0.0 111.756 179.345 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 553' ' ' PHE . . . . . 0.622 ' HE1' HD21 ' A' ' 551' ' ' LEU . 21.8 m-85 -134.25 137.65 44.48 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.07 -0.968 . . . . 0.0 108.613 177.539 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 554' ' ' THR . . . . . 0.849 HG22 ' H ' ' A' ' 556' ' ' ILE . 2.8 m -132.5 139.04 33.49 Favored Pre-proline 0 C--N 1.307 -1.253 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.173 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 555' ' ' PRO . . . . . 0.937 ' O ' HG22 ' A' ' 556' ' ' ILE . 77.5 Cg_endo -83.78 24.0 0.79 Allowed 'Trans proline' 0 N--CA 1.444 -1.411 0 C-N-CA 121.573 1.516 . . . . 0.0 112.142 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 556' ' ' ILE . . . . . 0.969 ' HB ' ' O ' ' A' ' 530' ' ' ALA . 7.3 tp 61.38 30.9 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 177.488 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 557' ' ' LYS . . . . . 0.505 ' HB3' ' CE2' ' A' ' 559' ' ' TRP . 0.3 OUTLIER -105.79 117.85 35.08 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 105.096 -2.187 . . . . 0.0 105.096 179.257 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 558' ' ' THR . . . . . . . . . . . . . 2.3 t -56.89 117.82 4.33 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -172.382 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 559' ' ' TRP . . . . . 0.512 ' HB2' ' CB ' ' A' ' 563' ' ' LYS . 5.4 m0 -136.58 111.8 9.08 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 104.981 -2.229 . . . . 0.0 104.981 175.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 560' ' ' ASN . . . . . 0.512 ' O ' ' HB ' ' A' ' 564' ' ' THR . 75.9 m-20 -78.25 -74.4 0.27 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -175.018 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 561' ' ' ALA . . . . . . . . . . . . . . . -73.16 -64.01 1.06 Allowed 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 115.752 1.76 . . . . 0.0 115.752 -176.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 562' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.01 -50.65 35.05 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -176.594 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 563' ' ' LYS . . . . . 0.638 ' CG ' HG21 ' A' ' 504' ' ' THR . 0.0 OUTLIER -70.67 -49.07 51.18 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.392 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 564' ' ' THR . . . . . 0.676 ' CG2' ' O ' ' A' ' 501' ' ' TYR . 2.0 t -53.7 -64.33 0.86 Allowed 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 121.114 -0.235 . . . . 0.0 110.922 -178.377 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 565' ' ' GLN . . . . . 0.521 ' N ' HG23 ' A' ' 564' ' ' THR . 0.0 OUTLIER -48.51 -47.46 38.89 Favored 'General case' 0 C--N 1.321 -0.643 0 O-C-N 122.135 -0.353 . . . . 0.0 111.195 179.012 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 566' ' ' GLU . . . . . 0.419 ' O ' ' CD1' ' A' ' 569' ' ' ILE . 1.8 tt0 -49.61 -56.13 11.12 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -178.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 567' ' ' PHE . . . . . 0.799 ' CB ' HG21 ' A' ' 552' ' ' THR . 0.4 OUTLIER -97.22 -45.09 6.65 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.417 0.627 . . . . 0.0 112.156 -178.387 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 568' ' ' ILE . . . . . 0.947 HD11 HD22 ' A' ' 574' ' ' LEU . 1.5 tp -58.0 9.29 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 569' ' ' ILE . . . . . 0.69 HD11 ' HB3' ' A' ' 549' ' ' ASP . 0.0 OUTLIER -55.09 -39.22 49.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 104.525 -2.398 . . . . 0.0 104.525 179.009 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 570' ' ' ASP . . . . . 0.649 ' CG ' HD11 ' A' ' 588' ' ' ILE . 15.1 p30 31.77 55.75 0.3 Allowed 'General case' 0 CA--C 1.51 -0.587 0 CA-C-N 114.04 -1.436 . . . . 0.0 112.643 173.295 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -51.39 -44.88 53.22 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 117.316 -2.373 . . . . 0.0 108.505 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 572' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -119.6 -16.44 8.85 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 175.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 573' ' ' LEU . . . . . 0.569 ' HB3' ' O ' ' A' ' 535' ' ' ARG . 1.3 tp -139.86 137.29 34.78 Favored 'General case' 0 C--N 1.353 0.746 0 N-CA-C 116.39 1.996 . . . . 0.0 116.39 -177.377 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 574' ' ' LEU . . . . . 0.947 HD22 HD11 ' A' ' 568' ' ' ILE . 0.2 OUTLIER -134.81 133.39 39.74 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 173.048 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 575' ' ' ILE . . . . . 0.925 ' N ' HD12 ' A' ' 574' ' ' LEU . 0.0 OUTLIER -134.09 138.24 50.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 118.86 0.754 . . . . 0.0 112.007 179.297 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 576' ' ' LEU . . . . . 0.551 HD11 ' HG ' ' A' ' 578' ' ' LEU . 0.1 OUTLIER -132.99 135.53 45.52 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 177.181 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 577' ' ' LYS . . . . . 0.406 ' N ' HD12 ' A' ' 576' ' ' LEU . 25.2 mttt -132.2 135.45 46.34 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 119.009 -1.076 . . . . 0.0 110.359 177.438 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.551 ' HG ' HD11 ' A' ' 576' ' ' LEU . 0.3 OUTLIER -124.45 131.91 53.5 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 177.84 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 579' ' ' GLY . . . . . . . . . . . . . . . -89.1 -2.2 78.04 Favored Glycine 0 CA--C 1.498 -0.976 0 CA-C-N 115.236 -0.893 . . . . 0.0 113.335 -178.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 580' ' ' LYS . . . . . 0.655 ' HD3' HD12 ' A' ' 524' ' ' ILE . 0.0 OUTLIER -72.41 -48.16 43.52 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 119.087 -1.045 . . . . 0.0 108.889 179.233 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 581' ' ' TRP . . . . . 0.449 ' CD1' ' O ' ' A' ' 580' ' ' LYS . 23.6 m0 -139.7 -53.12 0.53 Allowed 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 177.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 582' ' ' LYS . . . . . 0.486 ' O ' HD12 ' A' ' 578' ' ' LEU . 0.0 OUTLIER -140.26 165.37 27.58 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -174.636 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 583' ' ' MET . . . . . . . . . . . . . 1.9 ttt -110.76 134.52 52.41 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.468 -1.679 . . . . 0.0 106.468 173.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 584' ' ' LYS . . . . . 0.792 ' NZ ' HG12 ' A' ' 508' ' ' VAL . 0.5 OUTLIER -119.66 134.73 55.11 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 178.787 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 585' ' ' LEU . . . . . 0.721 ' HG ' HG23 ' A' ' 575' ' ' ILE . 5.7 tt -121.4 136.96 54.9 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 586' ' ' VAL . . . . . 0.984 HG22 ' CG2' ' A' ' 493' ' ' VAL . 30.7 t -132.19 137.07 55.4 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.734 -178.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 587' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -112.87 134.32 54.44 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 177.168 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.994 HG22 ' O ' ' A' ' 495' ' ' LEU . 0.1 OUTLIER -135.17 140.58 44.81 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.568 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -178.257 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 6.2 p -133.14 145.73 33.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 114.369 -1.287 . . . . 0.0 110.473 178.219 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 590' ' ' SER . . . . . . . . . . . . . 6.0 t . . . . . 0 C--N 1.326 -0.417 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.672 179.983 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 491' ' ' ALA . . . . . 0.467 ' CB ' HD21 ' A' ' 514' ' ' LEU . . . . . . . . 0 N--CA 1.463 0.216 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 492' ' ' ARG . . . . . 0.458 ' HD3' HD23 ' A' ' 585' ' ' LEU . 1.0 OUTLIER -136.49 131.69 34.32 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 175.561 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 493' ' ' VAL . . . . . 1.142 HG23 HG22 ' A' ' 586' ' ' VAL . 2.5 m -139.33 164.02 25.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.688 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 79.7 p -130.63 132.9 45.72 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.604 176.514 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 495' ' ' LEU . . . . . 1.002 HD23 ' HB2' ' A' ' 512' ' ' ALA . 2.2 pp -137.04 163.23 50.84 Favored Pre-proline 0 CA--C 1.53 0.18 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.588 178.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 496' ' ' PRO . . . . . 0.685 ' HB2' HD23 ' A' ' 499' ' ' LEU . 19.8 Cg_exo -63.29 119.21 6.19 Favored 'Trans proline' 0 CA--C 1.533 0.428 0 C-N-CA 121.921 1.747 . . . . 0.0 111.658 179.014 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 497' ' ' LYS . . . . . 0.462 ' CA ' ' HB ' ' A' ' 588' ' ' ILE . 23.7 ttpt -56.62 -30.39 63.23 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -178.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 498' ' ' SER . . . . . . . . . . . . . 12.2 t -55.94 -48.0 76.55 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -177.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 499' ' ' LEU . . . . . 0.757 HD12 ' NZ ' ' A' ' 507' ' ' LYS . 1.1 pp -73.45 -8.36 55.58 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -178.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 500' ' ' VAL . . . . . 0.796 HG22 HD11 ' A' ' 495' ' ' LEU . 12.0 t -74.59 -25.28 19.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.31 0.576 . . . . 0.0 111.793 -179.007 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 501' ' ' TYR . . . . . 0.627 ' O ' ' CG2' ' A' ' 564' ' ' THR . 3.1 m-85 -53.55 -29.69 38.18 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -178.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 502' ' ' ASP . . . . . 0.421 ' O ' ' HB2' ' A' ' 560' ' ' ASN . 2.1 m-20 -76.36 -50.09 15.12 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 115.807 1.78 . . . . 0.0 115.807 -175.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 503' ' ' LYS . . . . . 0.553 ' O ' ' CG ' ' A' ' 507' ' ' LYS . 0.1 OUTLIER -119.65 135.39 54.83 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-N 119.153 0.888 . . . . 0.0 111.939 -178.896 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 504' ' ' THR . . . . . 0.696 HG21 ' CG ' ' A' ' 563' ' ' LYS . 69.7 m -73.21 -76.63 0.12 Allowed 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 505' ' ' PHE . . . . . 0.612 ' CZ ' ' HB1' ' A' ' 530' ' ' ALA . 0.3 OUTLIER -75.78 -59.12 2.89 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -179.416 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 506' ' ' SER . . . . . 0.817 ' O ' ' CD1' ' A' ' 510' ' ' TRP . 8.0 t -49.0 -71.48 0.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 -175.76 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 507' ' ' LYS . . . . . 0.757 ' NZ ' HD12 ' A' ' 499' ' ' LEU . 0.0 OUTLIER -48.01 -49.07 32.22 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -174.782 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 508' ' ' VAL . . . . . 0.758 HG21 HD11 ' A' ' 574' ' ' LEU . 0.2 OUTLIER -64.23 -49.57 80.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 C-N-CA 120.299 -0.561 . . . . 0.0 111.964 -178.467 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 509' ' ' LEU . . . . . 0.761 HD12 ' N ' ' A' ' 510' ' ' TRP . 1.1 pp -55.99 -62.07 1.95 Allowed 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 -178.04 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 510' ' ' TRP . . . . . 0.878 ' CD1' ' HA ' ' A' ' 518' ' ' LYS . 67.4 p-90 -73.08 -49.67 27.26 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 114.722 1.378 . . . . 0.0 114.722 -176.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 511' ' ' SER . . . . . 0.506 ' N ' ' CE3' ' A' ' 510' ' ' TRP . 0.3 OUTLIER -63.5 -47.61 81.0 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -176.606 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 512' ' ' ALA . . . . . 1.002 ' HB2' HD23 ' A' ' 495' ' ' LEU . . . -70.89 -73.62 0.17 Allowed 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 117.841 2.534 . . . . 0.0 117.841 -174.091 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 513' ' ' GLY . . . . . 0.938 ' HA2' HG11 ' A' ' 493' ' ' VAL . . . -115.05 -35.06 1.39 Allowed Glycine 0 CA--C 1.499 -0.945 0 N-CA-C 120.696 3.038 . . . . 0.0 120.696 -173.039 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 514' ' ' LEU . . . . . 0.672 HD23 ' CG ' ' A' ' 584' ' ' LYS . 0.1 OUTLIER -103.08 -47.97 4.18 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 119.105 3.002 . . . . 0.0 119.105 -170.171 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 515' ' ' VAL . . . . . 1.03 HG13 ' HB2' ' A' ' 517' ' ' SER . 2.4 p -155.99 172.26 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 117.606 2.447 . . . . 0.0 117.606 -173.128 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 516' ' ' ALA . . . . . 0.544 ' N ' ' CG2' ' A' ' 515' ' ' VAL . . . -68.06 4.08 1.36 Allowed 'General case' 0 C--O 1.231 0.104 0 C-N-CA 126.57 1.948 . . . . 0.0 109.636 176.525 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 517' ' ' SER . . . . . 1.03 ' HB2' HG13 ' A' ' 515' ' ' VAL . 0.6 OUTLIER -57.63 8.89 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 116.065 1.876 . . . . 0.0 116.065 -171.984 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 518' ' ' LYS . . . . . 0.878 ' HA ' ' CD1' ' A' ' 510' ' ' TRP . 0.0 OUTLIER -45.4 -46.7 13.47 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 104.432 -2.433 . . . . 0.0 104.432 175.41 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 519' ' ' SER . . . . . . . . . . . . . 1.4 p -75.08 -59.11 2.89 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.607 -1.178 . . . . 0.0 109.966 173.253 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 520' ' ' GLU . . . . . 0.808 ' HB2' ' HA ' ' A' ' 517' ' ' SER . 2.7 mm-40 -58.28 -47.43 83.65 Favored 'General case' 0 C--N 1.35 0.629 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.75 -179.152 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 521' ' ' GLY . . . . . 0.839 ' N ' ' O ' ' A' ' 517' ' ' SER . . . -49.01 -53.98 16.37 Favored Glycine 0 CA--C 1.493 -1.317 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.072 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 522' ' ' GLN . . . . . 0.434 ' HA ' HG12 ' A' ' 525' ' ' ILE . 2.0 mm100 -47.91 -47.28 32.31 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.176 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 523' ' ' ARG . . . . . 0.478 ' O ' ' HB3' ' A' ' 526' ' ' ASN . 0.4 OUTLIER -50.33 -48.82 55.21 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.818 178.266 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 524' ' ' ILE . . . . . 0.591 HG21 HD22 ' A' ' 578' ' ' LEU . 18.2 mt -57.56 -54.86 25.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.518 0.675 . . . . 0.0 109.585 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 525' ' ' ILE . . . . . 0.825 HG23 ' CD1' ' A' ' 556' ' ' ILE . 0.6 OUTLIER -50.39 -47.47 26.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.834 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 526' ' ' ASN . . . . . 0.478 ' HB3' ' O ' ' A' ' 523' ' ' ARG . 16.6 t-20 -56.28 -47.44 78.63 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 113.987 -1.461 . . . . 0.0 108.434 177.651 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 527' ' ' ASN . . . . . 0.493 ' ND2' ' O ' ' A' ' 524' ' ' ILE . 0.0 OUTLIER -47.52 -39.85 17.28 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.115 -1.402 . . . . 0.0 107.523 177.056 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 528' ' ' ASN . . . . . 0.646 ' HA ' ' CG2' ' A' ' 556' ' ' ILE . 1.9 t30 73.79 40.21 0.49 Allowed 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.384 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 529' ' ' GLY . . . . . . . . . . . . . . . -118.05 31.22 5.75 Favored Glycine 0 CA--C 1.523 0.585 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.657 178.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 530' ' ' ALA . . . . . 0.921 ' O ' ' HB ' ' A' ' 556' ' ' ILE . . . -133.54 164.38 27.3 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.333 0.587 . . . . 0.0 112.541 -179.027 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 531' ' ' TYR . . . . . 0.581 ' CE1' ' HA ' ' A' ' 553' ' ' PHE . 0.0 OUTLIER -134.36 152.88 52.06 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 177.752 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 532' ' ' VAL . . . . . 0.628 HG12 ' OG1' ' A' ' 554' ' ' THR . 0.4 OUTLIER -126.04 135.82 62.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 CA-C-O 121.871 0.844 . . . . 0.0 111.745 179.75 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 533' ' ' GLY . . . . . 0.724 ' O ' HG13 ' A' ' 575' ' ' ILE . . . -133.31 152.86 20.54 Favored Glycine 0 N--CA 1.443 -0.844 0 CA-C-N 114.472 -1.24 . . . . 0.0 113.783 -179.582 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 534' ' ' SER . . . . . 0.582 ' HB2' ' OG1' ' A' ' 552' ' ' THR . 0.5 OUTLIER -134.26 141.83 47.12 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.147 -0.527 . . . . 0.0 110.903 179.079 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 535' ' ' ARG . . . . . 0.6 ' HB3' HD22 ' A' ' 573' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.27 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 179.225 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 549' ' ' ASP . . . . . 0.495 ' HB3' HD11 ' A' ' 569' ' ' ILE . 65.8 m-20 . . . . . 0 N--CA 1.449 -0.524 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 550' ' ' ASP . . . . . 0.582 ' O ' ' HA ' ' A' ' 535' ' ' ARG . 40.6 m-20 -54.55 -38.62 66.83 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.09 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 551' ' ' LEU . . . . . 0.602 HD21 ' HE1' ' A' ' 553' ' ' PHE . 14.7 tp -131.47 139.61 49.39 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.35 177.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 552' ' ' THR . . . . . 0.695 ' O ' ' HA2' ' A' ' 533' ' ' GLY . 28.9 m -133.54 146.67 51.26 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.714 0.769 . . . . 0.0 112.166 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 553' ' ' PHE . . . . . 0.602 ' HE1' HD21 ' A' ' 551' ' ' LEU . 24.8 m-85 -133.99 136.88 44.41 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 176.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 554' ' ' THR . . . . . 0.891 HG22 ' H ' ' A' ' 556' ' ' ILE . 1.9 m -133.55 138.98 32.41 Favored Pre-proline 0 C--N 1.304 -1.377 0 C-N-CA 120.042 -0.663 . . . . 0.0 109.515 178.715 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 555' ' ' PRO . . . . . 0.851 ' O ' HG22 ' A' ' 556' ' ' ILE . 81.3 Cg_endo -82.47 19.43 1.28 Allowed 'Trans proline' 0 N--CA 1.447 -1.216 0 C-N-CA 121.486 1.457 . . . . 0.0 111.561 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 556' ' ' ILE . . . . . 0.921 ' HB ' ' O ' ' A' ' 530' ' ' ALA . 4.1 tp 61.92 32.36 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 177.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 4.3 tttt -104.09 122.0 44.38 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 105.183 -2.155 . . . . 0.0 105.183 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 558' ' ' THR . . . . . . . . . . . . . 6.5 t -56.88 117.55 4.07 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 -171.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 559' ' ' TRP . . . . . 0.474 ' CH2' ' HD2' ' A' ' 555' ' ' PRO . 5.3 m0 -136.89 112.05 9.06 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 104.408 -2.442 . . . . 0.0 104.408 175.618 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 560' ' ' ASN . . . . . 0.514 ' O ' ' HB ' ' A' ' 564' ' ' THR . 2.5 p30 -80.93 -74.8 0.3 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 115.372 1.619 . . . . 0.0 115.372 -174.5 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 561' ' ' ALA . . . . . . . . . . . . . . . -72.9 -61.97 1.62 Allowed 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 115.181 1.548 . . . . 0.0 115.181 -176.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 562' ' ' SER . . . . . . . . . . . . . 85.5 p -49.27 -50.37 39.23 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -177.241 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 563' ' ' LYS . . . . . 0.696 ' CG ' HG21 ' A' ' 504' ' ' THR . 0.0 OUTLIER -70.98 -48.95 50.41 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -178.449 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 564' ' ' THR . . . . . 0.627 ' CG2' ' O ' ' A' ' 501' ' ' TYR . 2.0 t -54.09 -65.03 0.64 Allowed 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 121.218 -0.193 . . . . 0.0 111.35 -178.395 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 565' ' ' GLN . . . . . 0.709 ' O ' HG23 ' A' ' 569' ' ' ILE . 0.0 OUTLIER -49.0 -47.41 44.36 Favored 'General case' 0 C--N 1.321 -0.649 0 O-C-N 122.067 -0.395 . . . . 0.0 111.367 179.028 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -49.71 -67.0 0.3 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -178.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 567' ' ' PHE . . . . . 0.917 ' CZ ' HD13 ' A' ' 568' ' ' ILE . 0.2 OUTLIER -86.99 -43.25 12.49 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -178.056 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 568' ' ' ILE . . . . . 1.062 HD11 HD13 ' A' ' 574' ' ' LEU . 1.0 OUTLIER -62.05 8.69 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 -179.64 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 569' ' ' ILE . . . . . 0.709 HG23 ' O ' ' A' ' 565' ' ' GLN . 0.9 OUTLIER -54.72 -40.8 53.06 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 N-CA-C 105.048 -2.204 . . . . 0.0 105.048 178.905 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 570' ' ' ASP . . . . . 0.817 ' CB ' HD11 ' A' ' 588' ' ' ILE . 5.6 m-20 33.8 59.93 0.53 Allowed 'General case' 0 CA--C 1.507 -0.68 0 CA-C-N 113.833 -1.53 . . . . 0.0 112.994 173.113 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 571' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 570' ' ' ASP . . . -51.84 -45.06 55.84 Favored Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 116.865 -2.588 . . . . 0.0 108.088 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 572' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -120.41 -16.15 8.44 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 175.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 573' ' ' LEU . . . . . 0.6 HD22 ' HB3' ' A' ' 535' ' ' ARG . 2.0 tp -139.85 137.05 34.61 Favored 'General case' 0 C--N 1.354 0.772 0 N-CA-C 116.627 2.084 . . . . 0.0 116.627 -176.646 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 574' ' ' LEU . . . . . 1.062 HD13 HD11 ' A' ' 568' ' ' ILE . 0.1 OUTLIER -135.18 132.97 38.62 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 173.605 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 575' ' ' ILE . . . . . 1.057 HG23 HD13 ' A' ' 585' ' ' LEU . 0.0 OUTLIER -134.58 138.12 50.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 119.222 0.919 . . . . 0.0 111.763 178.786 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 576' ' ' LEU . . . . . 0.523 ' CD1' ' CE2' ' A' ' 505' ' ' PHE . 0.0 OUTLIER -132.93 135.35 45.49 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 176.875 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 577' ' ' LYS . . . . . 0.406 ' CG ' ' HE3' ' A' ' 583' ' ' MET . 0.9 OUTLIER -132.8 135.59 45.77 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 119.057 -1.057 . . . . 0.0 110.533 177.808 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.591 HD22 HG21 ' A' ' 524' ' ' ILE . 0.3 OUTLIER -123.86 131.87 53.66 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 177.749 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 579' ' ' GLY . . . . . . . . . . . . . . . -89.1 -2.06 78.29 Favored Glycine 0 N--CA 1.441 -1.007 0 CA-C-N 115.192 -0.913 . . . . 0.0 113.495 -178.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 580' ' ' LYS . . . . . 0.509 ' HD3' HG23 ' A' ' 524' ' ' ILE . 0.1 OUTLIER -74.33 -47.55 33.74 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 118.968 -1.093 . . . . 0.0 109.151 179.373 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 581' ' ' TRP . . . . . 0.462 ' CD1' ' O ' ' A' ' 580' ' ' LYS . 26.6 m0 -139.34 -52.63 0.55 Allowed 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 178.156 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 582' ' ' LYS . . . . . 0.564 ' O ' HD12 ' A' ' 578' ' ' LEU . 0.0 OUTLIER -139.81 165.25 27.79 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 -174.327 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 583' ' ' MET . . . . . 0.406 ' HE3' ' CG ' ' A' ' 577' ' ' LYS . 0.0 OUTLIER -113.75 134.53 54.7 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 174.099 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 584' ' ' LYS . . . . . 0.683 ' HE2' ' H ' ' A' ' 513' ' ' GLY . 0.3 OUTLIER -123.69 134.43 53.72 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.302 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 585' ' ' LEU . . . . . 1.057 HD13 HG23 ' A' ' 575' ' ' ILE . 6.1 tp -121.05 137.05 54.84 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -179.131 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 586' ' ' VAL . . . . . 1.142 HG22 HG23 ' A' ' 493' ' ' VAL . 6.0 t -131.56 136.75 56.72 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.67 -179.064 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 587' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.92 134.21 53.62 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 176.254 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.817 HD11 ' CB ' ' A' ' 570' ' ' ASP . 0.2 OUTLIER -134.96 147.74 29.33 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 -178.503 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 8.0 m -132.46 148.05 31.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 113.916 -1.493 . . . . 0.0 110.334 178.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 590' ' ' SER . . . . . . . . . . . . . 4.2 t . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.978 -179.706 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 454' ' ' MET . . . . . 0.448 ' N ' HG22 ' A' ' 457' ' ' THR . 1.5 mtt . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 120.62 0.248 . . . . 0.0 111.48 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 455' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -73.52 -43.89 0.6 Allowed 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.407 2.071 . . . . 0.0 112.351 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 456' ' ' ARG . . . . . . . . . . . . . 4.7 ptm180 -75.74 -26.49 57.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.014 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 457' ' ' THR . . . . . 0.448 HG22 ' N ' ' A' ' 454' ' ' MET . 4.9 t -105.89 32.4 4.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.941 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -62.51 170.27 2.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.091 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 7.5 t -110.17 97.01 28.41 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.899 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.25 117.1 3.28 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.527 2.151 . . . . 0.0 112.278 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . 86.84 56.58 2.19 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.522 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -100.43 149.22 35.9 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.718 0.294 . . . . 0.0 110.874 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.78 -174.08 1.02 Allowed 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.555 2.17 . . . . 0.0 112.308 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 15.7 mttt -101.48 -176.51 3.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.899 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 38.2 t -103.34 -73.31 0.67 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.959 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 77.8 p -59.67 -36.02 75.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.913 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 467' ' ' LEU . . . . . 0.979 HD21 HG23 ' A' ' 471' ' ' VAL . 8.6 mp -114.63 71.04 0.75 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.811 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 77.8 p -99.37 43.36 1.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.838 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 129.04 -36.88 2.31 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.246 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -110.54 117.51 33.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.866 0.365 . . . . 0.0 110.618 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 471' ' ' VAL . . . . . 0.979 HG23 HD21 ' A' ' 467' ' ' LEU . 11.1 p -113.24 108.34 25.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.136 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -162.6 99.23 1.09 Allowed Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.943 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -68.71 -167.87 0.21 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.406 2.071 . . . . 0.0 112.28 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -135.91 36.77 2.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.87 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 43.6 t -100.54 -30.96 11.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.985 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 476' ' ' GLY . . . . . . . . . . . . . . . 120.48 -11.27 10.47 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.803 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 477' ' ' ASN . . . . . 0.486 ' N ' ' HD2' ' A' ' 478' ' ' PRO . 0.1 OUTLIER -50.11 -51.58 60.97 Favored Pre-proline 0 CA--C 1.53 0.193 0 CA-C-O 120.496 0.188 . . . . 0.0 111.48 -179.967 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 478' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' A' ' 477' ' ' ASN . 71.3 Cg_endo -75.45 -24.83 11.76 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.353 2.035 . . . . 0.0 112.524 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -62.86 84.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.921 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -77.13 113.69 33.11 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.996 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -49.76 -77.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.42 2.08 . . . . 0.0 112.461 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 482' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.56 -72.31 0.46 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.995 0.426 . . . . 0.0 110.719 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 483' ' ' THR . . . . . 0.805 HG23 ' HB2' ' A' ' 486' ' ' ALA . 1.7 t -136.79 139.43 41.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.712 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 484' ' ' ASN . . . . . 0.647 ' O ' ' CD ' ' A' ' 489' ' ' PRO . 1.9 m-80 -51.03 -55.66 16.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.096 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 485' ' ' PHE . . . . . 0.672 ' HA ' ' HG2' ' A' ' 489' ' ' PRO . 90.7 m-85 -49.01 -45.57 42.65 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.158 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 486' ' ' ALA . . . . . 0.805 ' HB2' HG23 ' A' ' 483' ' ' THR . . . -50.35 -70.0 0.1 Allowed 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -176.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -72.79 -76.51 0.12 Allowed 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 116.249 1.944 . . . . 0.0 116.249 -175.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 488' ' ' MET . . . . . 0.495 ' CB ' ' HD3' ' A' ' 489' ' ' PRO . 0.1 OUTLIER -54.95 -53.58 59.64 Favored Pre-proline 0 N--CA 1.474 0.755 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -177.346 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 489' ' ' PRO . . . . . 0.672 ' HG2' ' HA ' ' A' ' 485' ' ' PHE . 4.9 Cg_exo -88.31 41.85 0.66 Allowed 'Trans proline' 0 CA--C 1.528 0.178 0 C-N-CA 124.538 3.492 . . . . 0.0 114.306 -176.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 490' ' ' SER . . . . . 0.563 ' HB2' ' O ' ' A' ' 486' ' ' ALA . 11.5 t -120.84 39.05 3.88 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 491' ' ' ALA . . . . . . . . . . . . . . . -106.04 135.1 48.09 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.687 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 492' ' ' ARG . . . . . 0.666 ' NE ' HD12 ' A' ' 585' ' ' LEU . 0.1 OUTLIER -135.31 136.01 41.25 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.661 -179.835 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 493' ' ' VAL . . . . . 0.577 ' O ' HG13 ' A' ' 586' ' ' VAL . 46.7 t -134.02 163.45 37.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.938 178.504 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 494' ' ' THR . . . . . 0.57 ' N ' HG12 ' A' ' 493' ' ' VAL . 6.1 t -123.35 134.51 54.01 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 121.184 0.516 . . . . 0.0 111.377 178.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 495' ' ' LEU . . . . . 0.723 ' O ' HG22 ' A' ' 588' ' ' ILE . 0.2 OUTLIER -135.47 163.31 51.74 Favored Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.422 179.235 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 496' ' ' PRO . . . . . 0.548 ' HG2' ' CD2' ' A' ' 499' ' ' LEU . 19.5 Cg_endo -58.51 119.87 7.39 Favored 'Trans proline' 0 CA--C 1.532 0.409 0 C-N-CA 122.235 1.957 . . . . 0.0 112.214 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 497' ' ' LYS . . . . . 0.484 ' CA ' ' HB ' ' A' ' 588' ' ' ILE . 2.1 ttpp -57.72 -30.04 65.22 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -179.133 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 498' ' ' SER . . . . . 0.401 ' O ' ' CD1' ' A' ' 501' ' ' TYR . 0.3 OUTLIER -60.86 -48.9 79.71 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -176.59 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 499' ' ' LEU . . . . . 0.576 HD12 ' C ' ' A' ' 499' ' ' LEU . 3.1 pp -73.97 -8.24 55.38 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -178.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 500' ' ' VAL . . . . . 0.626 HG22 ' HZ1' ' A' ' 507' ' ' LYS . 26.6 t -73.0 -25.8 22.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.286 0.565 . . . . 0.0 111.355 -179.157 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 501' ' ' TYR . . . . . 0.704 ' O ' HG21 ' A' ' 564' ' ' THR . 0.4 OUTLIER -53.88 -29.72 42.85 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 -178.69 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -72.04 -50.05 31.62 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 -175.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 503' ' ' LYS . . . . . 0.599 ' O ' ' CG ' ' A' ' 507' ' ' LYS . 7.4 mttt -119.38 133.94 55.47 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 118.694 0.679 . . . . 0.0 111.142 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 504' ' ' THR . . . . . 0.755 HG21 ' HB3' ' A' ' 563' ' ' LYS . 6.8 m -73.32 -76.61 0.12 Allowed 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 505' ' ' PHE . . . . . 0.821 ' CZ ' ' HB1' ' A' ' 530' ' ' ALA . 0.3 OUTLIER -75.52 -60.08 2.46 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -179.471 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 506' ' ' SER . . . . . 0.722 ' O ' ' CD1' ' A' ' 510' ' ' TRP . 8.0 t -48.97 -72.69 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 -176.114 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 507' ' ' LYS . . . . . 0.698 ' HD3' ' N ' ' A' ' 508' ' ' VAL . 0.0 OUTLIER -48.82 -48.38 41.57 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -176.893 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 508' ' ' VAL . . . . . 0.829 HG13 HD21 ' A' ' 574' ' ' LEU . 50.1 t -55.07 -58.71 3.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 509' ' ' LEU . . . . . 0.748 HD12 ' N ' ' A' ' 510' ' ' TRP . 2.0 pp -56.98 -60.1 4.08 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 -177.026 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 510' ' ' TRP . . . . . 0.913 ' CD1' ' HA ' ' A' ' 518' ' ' LYS . 63.2 p-90 -72.47 -51.77 18.73 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -176.01 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 511' ' ' SER . . . . . 0.525 ' N ' ' CE3' ' A' ' 510' ' ' TRP . 0.5 OUTLIER -66.35 -47.48 73.32 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -176.818 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 512' ' ' ALA . . . . . 0.785 ' HB3' ' O ' ' A' ' 508' ' ' VAL . . . -71.24 -72.81 0.2 Allowed 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 117.756 2.502 . . . . 0.0 117.756 -174.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 513' ' ' GLY . . . . . 0.59 ' H ' ' HE2' ' A' ' 584' ' ' LYS . . . -114.6 -35.57 1.4 Allowed Glycine 0 CA--C 1.5 -0.877 0 N-CA-C 121.39 3.316 . . . . 0.0 121.39 -172.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 514' ' ' LEU . . . . . 0.613 HD13 ' HG3' ' A' ' 582' ' ' LYS . 2.8 mt -108.16 -47.03 3.62 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 119.798 3.258 . . . . 0.0 119.798 -170.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 515' ' ' VAL . . . . . 0.613 HG12 ' N ' ' A' ' 516' ' ' ALA . 90.1 t -153.06 171.88 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.582 0 N-CA-C 117.073 2.249 . . . . 0.0 117.073 -172.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 516' ' ' ALA . . . . . 0.613 ' N ' HG12 ' A' ' 515' ' ' VAL . . . -69.09 3.04 2.3 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 113.012 -1.904 . . . . 0.0 109.366 175.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 517' ' ' SER . . . . . 0.881 ' O ' ' N ' ' A' ' 521' ' ' GLY . 0.4 OUTLIER -58.35 8.75 0.01 OUTLIER 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 115.43 1.641 . . . . 0.0 115.43 -172.122 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 518' ' ' LYS . . . . . 0.913 ' HA ' ' CD1' ' A' ' 510' ' ' TRP . 0.0 OUTLIER -45.8 -45.41 14.79 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 104.321 -2.474 . . . . 0.0 104.321 175.74 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 519' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.32 -56.43 4.88 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.427 -1.26 . . . . 0.0 109.706 173.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 520' ' ' GLU . . . . . 0.809 ' HB2' ' HA ' ' A' ' 517' ' ' SER . 9.3 mm-40 -63.64 -48.31 77.81 Favored 'General case' 0 C--N 1.351 0.654 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.02 -179.042 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 521' ' ' GLY . . . . . 0.881 ' N ' ' O ' ' A' ' 517' ' ' SER . . . -54.9 -53.55 39.14 Favored Glycine 0 CA--C 1.499 -0.929 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.443 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 522' ' ' GLN . . . . . 0.494 ' HA ' HG12 ' A' ' 525' ' ' ILE . 0.1 OUTLIER -47.82 -48.31 30.75 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.109 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 523' ' ' ARG . . . . . 0.452 ' HB3' ' O ' ' A' ' 520' ' ' GLU . 1.5 tpt180 -50.67 -48.71 58.32 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.095 178.228 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 524' ' ' ILE . . . . . 0.536 HG23 ' HG2' ' A' ' 580' ' ' LYS . 34.0 mm -55.12 -54.07 28.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.352 0.596 . . . . 0.0 110.029 179.104 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 525' ' ' ILE . . . . . 1.007 HG23 HD11 ' A' ' 556' ' ' ILE . 0.6 OUTLIER -50.5 -47.48 27.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 177.715 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 526' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -56.56 -48.28 77.69 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 113.996 -1.456 . . . . 0.0 108.521 177.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 527' ' ' ASN . . . . . 0.422 ' N ' ' O ' ' A' ' 523' ' ' ARG . 0.0 OUTLIER -48.35 -39.45 22.18 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 113.784 -1.553 . . . . 0.0 108.003 176.924 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 528' ' ' ASN . . . . . 0.71 ' HA ' HG23 ' A' ' 556' ' ' ILE . 1.4 t30 74.51 40.19 0.42 Allowed 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.185 -178.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 529' ' ' GLY . . . . . . . . . . . . . . . -119.26 37.96 2.99 Favored Glycine 0 CA--C 1.521 0.466 0 CA-C-N 114.595 -1.184 . . . . 0.0 111.826 178.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 530' ' ' ALA . . . . . 0.826 ' HB3' HG12 ' A' ' 556' ' ' ILE . . . -132.76 164.53 26.6 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.834 0.826 . . . . 0.0 112.42 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 531' ' ' TYR . . . . . 0.716 ' HA ' HG22 ' A' ' 554' ' ' THR . 2.2 t80 -135.02 152.89 52.13 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 124.89 1.276 . . . . 0.0 109.061 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 532' ' ' VAL . . . . . 0.535 ' HB ' HG21 ' A' ' 554' ' ' THR . 0.4 OUTLIER -133.42 135.67 55.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 CA-C-O 121.807 0.813 . . . . 0.0 111.564 178.69 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 533' ' ' GLY . . . . . 0.767 ' O ' HG13 ' A' ' 575' ' ' ILE . . . -133.16 150.08 19.74 Favored Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 114.464 -1.244 . . . . 0.0 113.414 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 534' ' ' SER . . . . . 0.551 ' OG ' ' O ' ' A' ' 567' ' ' PHE . 0.5 OUTLIER -134.92 137.21 42.93 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.51 -0.345 . . . . 0.0 111.307 178.848 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 535' ' ' ARG . . . . . 0.547 ' O ' ' HB3' ' A' ' 573' ' ' LEU . 24.8 tpt85 -159.55 90.49 1.91 Allowed Pre-proline 0 C--N 1.33 -0.257 0 C-N-CA 120.657 -0.417 . . . . 0.0 112.077 178.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 536' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -78.31 -43.65 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.686 2.257 . . . . 0.0 112.446 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 92.17 50.49 2.61 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.447 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 538' ' ' VAL . . . . . 0.53 HG13 ' N ' ' A' ' 539' ' ' LYS . 11.8 p -116.19 -45.98 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 CA-C-O 121.033 0.444 . . . . 0.0 111.357 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 539' ' ' LYS . . . . . 0.53 ' N ' HG13 ' A' ' 538' ' ' VAL . 0.1 OUTLIER -107.99 162.04 14.4 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.253 -178.589 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.35 30.79 5.67 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.741 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 541' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -94.04 99.86 12.09 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.178 0.514 . . . . 0.0 110.657 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 542' ' ' GLU . . . . . 0.424 ' CG ' ' HD2' ' A' ' 543' ' ' PRO . 0.0 OUTLIER -49.12 176.85 0.04 OUTLIER Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.119 179.884 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 543' ' ' PRO . . . . . 0.497 ' HA ' ' CB ' ' A' ' 548' ' ' PRO . 91.8 Cg_exo -44.22 -51.87 6.32 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.556 2.171 . . . . 0.0 112.59 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 544' ' ' GLY . . . . . 0.651 ' O ' ' N ' ' A' ' 546' ' ' GLY . . . 47.43 23.95 2.28 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 121.01 -0.614 . . . . 0.0 113.542 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 545' ' ' GLY . . . . . 0.648 ' O ' ' N ' ' A' ' 547' ' ' MET . . . 52.81 -48.69 0.01 OUTLIER Glycine 0 CA--C 1.53 1.031 0 N-CA-C 115.472 0.949 . . . . 0.0 115.472 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 546' ' ' GLY . . . . . 0.651 ' N ' ' O ' ' A' ' 544' ' ' GLY . . . -50.25 55.21 0.01 OUTLIER Glycine 0 CA--C 1.528 0.866 0 N-CA-C 115.599 1.0 . . . . 0.0 115.599 -178.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 547' ' ' MET . . . . . 0.648 ' N ' ' O ' ' A' ' 545' ' ' GLY . 0.3 OUTLIER 51.6 53.9 13.88 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 117.822 0.811 . . . . 0.0 111.637 179.2 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 548' ' ' PRO . . . . . 0.497 ' CB ' ' HA ' ' A' ' 543' ' ' PRO . 6.5 Cg_endo -47.63 166.84 0.1 OUTLIER 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 123.114 2.543 . . . . 0.0 112.584 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -123.85 -24.69 4.4 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.486 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 550' ' ' ASP . . . . . 0.492 ' O ' ' HA ' ' A' ' 535' ' ' ARG . 96.2 m-20 -65.37 -46.24 80.92 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.487 179.126 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 551' ' ' LEU . . . . . . . . . . . . . 19.4 tp -131.57 141.96 49.81 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.426 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 552' ' ' THR . . . . . 0.591 ' O ' ' HA2' ' A' ' 533' ' ' GLY . 37.9 m -132.23 147.83 52.43 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.486 0.66 . . . . 0.0 111.441 179.203 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 553' ' ' PHE . . . . . 0.69 ' CD1' ' HE2' ' A' ' 531' ' ' TYR . 8.9 m-30 -132.27 139.45 48.25 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.463 -1.244 . . . . 0.0 107.927 179.117 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 554' ' ' THR . . . . . 0.922 HG23 ' H ' ' A' ' 556' ' ' ILE . 0.4 OUTLIER -130.43 141.73 42.95 Favored Pre-proline 0 C--N 1.326 -0.434 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -178.727 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 555' ' ' PRO . . . . . 0.842 ' O ' HG22 ' A' ' 556' ' ' ILE . 78.8 Cg_endo -87.77 1.12 6.96 Favored 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 123.055 2.503 . . . . 0.0 110.152 177.378 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 556' ' ' ILE . . . . . 1.007 HD11 HG23 ' A' ' 525' ' ' ILE . 7.0 tp 62.71 34.02 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.312 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 178.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 557' ' ' LYS . . . . . 0.643 ' O ' ' CE2' ' A' ' 559' ' ' TRP . 33.5 mttt -103.48 142.21 34.66 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 558' ' ' THR . . . . . . . . . . . . . 3.4 t -57.42 116.22 3.2 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 -171.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 559' ' ' TRP . . . . . 0.643 ' CE2' ' O ' ' A' ' 557' ' ' LYS . 0.0 OUTLIER -139.5 112.27 7.91 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 112.827 -1.988 . . . . 0.0 105.803 174.442 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 560' ' ' ASN . . . . . 0.71 ' O ' HG22 ' A' ' 564' ' ' THR . 77.6 m-20 -84.0 -76.64 0.29 Allowed 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 118.123 -1.431 . . . . 0.0 113.541 -176.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 561' ' ' ALA . . . . . 0.649 ' HA ' ' CG2' ' A' ' 564' ' ' THR . . . -75.57 -50.33 15.91 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 -178.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 562' ' ' SER . . . . . . . . . . . . . 38.8 m -49.57 -54.83 16.0 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -177.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 563' ' ' LYS . . . . . 0.755 ' HB3' HG21 ' A' ' 504' ' ' THR . 2.1 mmpt? -70.5 -47.79 58.79 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -178.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 564' ' ' THR . . . . . 0.881 HG23 ' H ' ' A' ' 565' ' ' GLN . 3.9 t -49.27 -71.35 0.07 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.578 0.227 . . . . 0.0 111.556 -178.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 565' ' ' GLN . . . . . 0.881 ' H ' HG23 ' A' ' 564' ' ' THR . 0.0 OUTLIER -49.37 -46.45 47.2 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.785 0.326 . . . . 0.0 111.518 179.786 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -49.15 -61.32 2.14 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 567' ' ' PHE . . . . . 0.882 ' CZ ' HD13 ' A' ' 568' ' ' ILE . 0.2 OUTLIER -96.78 -40.68 8.84 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -177.529 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 568' ' ' ILE . . . . . 1.108 HD11 HD13 ' A' ' 574' ' ' LEU . 0.9 OUTLIER -62.81 8.09 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -179.413 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 569' ' ' ILE . . . . . 0.771 HG23 ' O ' ' A' ' 565' ' ' GLN . 0.8 OUTLIER -55.04 -40.39 54.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 178.482 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 570' ' ' ASP . . . . . 0.586 ' OD2' ' HB2' ' A' ' 574' ' ' LEU . 5.7 m-20 33.85 61.27 0.49 Allowed 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 114.04 -1.436 . . . . 0.0 112.576 173.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 571' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 570' ' ' ASP . . . -51.94 -45.45 56.07 Favored Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 116.856 -2.592 . . . . 0.0 108.222 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 572' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -120.8 -16.07 8.24 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 175.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 573' ' ' LEU . . . . . 0.547 ' HB3' ' O ' ' A' ' 535' ' ' ARG . 1.5 tp -139.87 136.95 34.48 Favored 'General case' 0 C--N 1.354 0.794 0 N-CA-C 116.591 2.071 . . . . 0.0 116.591 -176.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 574' ' ' LEU . . . . . 1.108 HD13 HD11 ' A' ' 568' ' ' ILE . 0.1 OUTLIER -135.11 133.24 39.03 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 173.503 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 575' ' ' ILE . . . . . 0.909 HG22 ' HB3' ' A' ' 585' ' ' LEU . 0.0 OUTLIER -134.72 138.3 49.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 119.087 0.858 . . . . 0.0 111.448 177.893 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 576' ' ' LEU . . . . . 0.532 ' CD1' ' CE2' ' A' ' 505' ' ' PHE . 0.1 OUTLIER -132.52 135.61 46.1 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 177.889 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 577' ' ' LYS . . . . . . . . . . . . . 12.0 mtpt -132.6 135.8 46.12 Favored 'General case' 0 C--N 1.31 -1.125 0 C-N-CA 119.593 -0.843 . . . . 0.0 110.582 178.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.543 HD12 ' O ' ' A' ' 582' ' ' LYS . 0.5 OUTLIER -126.75 131.83 51.23 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 177.579 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 579' ' ' GLY . . . . . . . . . . . . . . . -90.49 -2.27 73.41 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 115.432 -0.804 . . . . 0.0 113.424 -178.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 580' ' ' LYS . . . . . 0.536 ' HG2' HG23 ' A' ' 524' ' ' ILE . 0.0 OUTLIER -73.33 -48.22 36.14 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 119.043 -1.063 . . . . 0.0 109.097 179.338 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 581' ' ' TRP . . . . . 0.488 ' CD1' ' O ' ' A' ' 580' ' ' LYS . 24.1 m0 -139.07 -52.38 0.55 Allowed 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 114.606 1.335 . . . . 0.0 114.606 177.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 582' ' ' LYS . . . . . 0.613 ' HG3' HD13 ' A' ' 514' ' ' LEU . 0.0 OUTLIER -139.55 165.44 27.24 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -174.263 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 583' ' ' MET . . . . . 0.692 ' CE ' HD22 ' A' ' 585' ' ' LEU . 7.6 ttt -117.46 134.29 55.01 Favored 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 106.46 -1.681 . . . . 0.0 106.46 174.239 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 584' ' ' LYS . . . . . 0.662 ' HZ1' HG12 ' A' ' 508' ' ' VAL . 1.4 tmmt? -128.41 133.6 48.62 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 178.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 585' ' ' LEU . . . . . 0.909 ' HB3' HG22 ' A' ' 575' ' ' ILE . 0.0 OUTLIER -125.98 136.72 53.32 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.921 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 586' ' ' VAL . . . . . 0.641 HG23 ' HD3' ' A' ' 584' ' ' LYS . 24.8 t -131.06 144.91 36.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.554 -177.088 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 587' ' ' SER . . . . . . . . . . . . . 49.8 m -107.21 135.63 48.4 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 177.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.723 HG22 ' O ' ' A' ' 495' ' ' LEU . 23.0 pt -133.58 137.63 52.46 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.508 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -178.406 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 7.7 m -132.63 137.1 54.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 114.31 -1.314 . . . . 0.0 110.603 178.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 590' ' ' SER . . . . . . . . . . . . . 1.7 t -73.51 131.03 41.31 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.753 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 591' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -50.35 -49.0 55.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.413 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -51.54 -49.62 61.62 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.045 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 8.8 mmtp -51.57 -48.75 63.03 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.705 0.764 . . . . 0.0 109.363 179.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 594' ' ' PHE . . . . . 0.762 ' CD1' HD11 ' A' ' 597' ' ' LEU . 1.0 OUTLIER -50.19 -48.45 54.18 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.85 178.5 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 595' ' ' LYS . . . . . 0.568 ' HA ' ' CE2' ' A' ' 604' ' ' TRP . 4.4 mmpt? -49.6 -47.61 49.42 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.004 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 596' ' ' GLU . . . . . 0.549 ' O ' HD23 ' A' ' 599' ' ' LEU . 0.0 OUTLIER -53.44 -59.03 5.1 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -179.819 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 597' ' ' LEU . . . . . 0.762 HD11 ' CD1' ' A' ' 594' ' ' PHE . 1.9 pp -60.41 -58.0 10.36 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 121.239 0.543 . . . . 0.0 112.259 -178.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 598' ' ' GLY . . . . . 0.666 ' N ' HD12 ' A' ' 597' ' ' LEU . . . -82.0 13.28 38.72 Favored Glycine 0 C--N 1.32 -0.325 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.909 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 599' ' ' LEU . . . . . 0.565 HD12 ' N ' ' A' ' 600' ' ' THR . 3.7 pp -48.21 -11.42 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -175.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 600' ' ' THR . . . . . 0.576 HG22 ' O ' ' A' ' 600' ' ' THR . 29.1 m -140.32 65.99 1.4 Allowed 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.999 0.904 . . . . 0.0 110.897 177.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 601' ' ' ALA . . . . . 0.886 ' HB1' ' HD2' ' A' ' 602' ' ' PRO . . . -132.36 179.79 1.27 Allowed Pre-proline 0 N--CA 1.446 -0.664 0 CA-C-N 113.904 -1.498 . . . . 0.0 109.343 178.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 602' ' ' PRO . . . . . 0.886 ' HD2' ' HB1' ' A' ' 601' ' ' ALA . 87.6 Cg_endo -78.97 -7.31 15.36 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 121.891 1.727 . . . . 0.0 111.274 178.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 603' ' ' GLY . . . . . 0.662 ' O ' HG23 ' A' ' 607' ' ' VAL . . . -71.28 -50.13 23.17 Favored Glycine 0 C--N 1.335 0.491 0 CA-C-N 115.773 -0.649 . . . . 0.0 113.84 -179.399 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 604' ' ' TRP . . . . . 0.568 ' CE2' ' HA ' ' A' ' 595' ' ' LYS . 4.2 m95 -71.33 -46.22 61.1 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 117.339 0.57 . . . . 0.0 111.613 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 605' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -50.78 -54.95 19.28 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.901 0.382 . . . . 0.0 110.243 -179.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -60.86 -63.62 1.24 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.663 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 607' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 603' ' ' GLY . 52.2 t -50.82 -71.37 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -178.385 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 608' ' ' VAL . . . . . . . . . . . . . 98.6 t -69.38 -59.35 3.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -177.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 609' ' ' GLY . . . . . . . . . . . . . . . -57.94 -63.48 5.23 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 121.044 -0.598 . . . . 0.0 113.137 -178.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 610' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.02 -58.59 3.89 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.864 0.364 . . . . 0.0 110.857 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 57.63 29.04 60.65 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.553 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 11.2 pttt -126.63 38.99 4.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.841 0.353 . . . . 0.0 110.912 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 613' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -98.53 157.28 16.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.854 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -59.74 -60.78 9.48 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.884 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 615' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.24 96.17 0.79 Allowed 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.483 2.122 . . . . 0.0 112.291 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 616' ' ' SER . . . . . . . . . . . . . 6.9 m -67.61 149.35 98.35 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.865 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo . . . . . 0 C--O 1.248 1.015 0 C-N-CA 122.535 2.156 . . . . 0.0 112.342 179.992 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 2.3 mtm . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 120.609 0.242 . . . . 0.0 111.465 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 455' ' ' PRO . . . . . 0.604 ' HB2' ' HB2' ' A' ' 458' ' ' ALA . 77.3 Cg_exo -50.43 164.94 0.43 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.414 2.076 . . . . 0.0 112.307 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 456' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -82.47 -26.49 32.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.995 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 5.0 t -119.23 36.0 4.63 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.891 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 458' ' ' ALA . . . . . 0.604 ' HB2' ' HB2' ' A' ' 455' ' ' PRO . . . -84.07 130.71 34.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.111 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.46 174.79 5.13 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.877 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.4 139.17 55.86 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.599 2.2 . . . . 0.0 112.291 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . 130.49 43.11 0.2 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.539 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -109.69 155.2 41.84 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 120.715 0.293 . . . . 0.0 110.896 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.38 154.4 65.33 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.619 2.213 . . . . 0.0 112.322 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 4.5 pttt -59.8 152.4 23.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.892 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 1.9 m -96.81 22.17 8.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.174 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 6.8 t -69.88 -20.93 63.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.029 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 467' ' ' LEU . . . . . 0.672 ' O ' HD12 ' A' ' 467' ' ' LEU . 1.1 pp -71.44 74.53 0.75 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.874 0.369 . . . . 0.0 110.91 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 74.9 m -125.02 43.27 3.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.894 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 129.02 -36.95 2.3 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.276 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -116.76 117.71 30.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.865 0.364 . . . . 0.0 110.695 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 471' ' ' VAL . . . . . 0.582 ' O ' HG13 ' A' ' 471' ' ' VAL . 9.6 p -112.94 108.05 24.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.182 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -111.22 92.0 14.74 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.844 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -68.16 178.46 3.58 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.505 2.137 . . . . 0.0 112.289 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -97.93 36.7 1.51 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.921 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 1.2 p -60.15 -30.87 69.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.868 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 476' ' ' GLY . . . . . . . . . . . . . . . 119.84 -29.83 5.91 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.52 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 477' ' ' ASN . . . . . 0.461 ' N ' ' HD3' ' A' ' 478' ' ' PRO . 49.1 t30 50.97 53.31 13.67 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-O 120.653 0.263 . . . . 0.0 111.277 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 478' ' ' PRO . . . . . 0.461 ' HD3' ' N ' ' A' ' 477' ' ' ASN . 85.7 Cg_endo -84.36 34.23 0.51 Allowed 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.774 2.316 . . . . 0.0 112.918 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 -104.14 85.45 2.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.791 0.329 . . . . 0.0 111.008 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -117.27 149.99 45.53 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.038 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -85.15 39.81 0.76 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.799 2.333 . . . . 0.0 112.882 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 482' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.32 -39.84 61.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.094 0.473 . . . . 0.0 110.68 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 483' ' ' THR . . . . . . . . . . . . . 9.0 t -135.67 171.83 13.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.534 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 484' ' ' ASN . . . . . 0.55 ' O ' ' CD ' ' A' ' 489' ' ' PRO . 35.0 m-20 -104.7 -20.38 13.65 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.1 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 485' ' ' PHE . . . . . 0.66 ' HA ' ' HG2' ' A' ' 489' ' ' PRO . 2.6 m-85 -49.32 -47.2 47.31 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.575 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -71.78 -47.6 52.39 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -178.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -70.94 -74.24 0.15 Allowed 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 -176.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 488' ' ' MET . . . . . 0.541 ' HB2' ' HD3' ' A' ' 489' ' ' PRO . 2.1 mtt -52.52 -52.44 63.59 Favored Pre-proline 0 N--CA 1.472 0.672 0 O-C-N 122.09 -0.381 . . . . 0.0 112.001 -178.065 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 489' ' ' PRO . . . . . 0.66 ' HG2' ' HA ' ' A' ' 485' ' ' PHE . 15.3 Cg_exo -74.5 42.39 0.78 Allowed 'Trans proline' 0 N--CA 1.472 0.252 0 C-N-CA 124.114 3.209 . . . . 0.0 112.789 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 84.5 p -38.29 -36.23 0.21 Allowed 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -179.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 491' ' ' ALA . . . . . . . . . . . . . . . -132.87 135.97 45.92 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.631 -0.427 . . . . 0.0 112.081 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 492' ' ' ARG . . . . . 0.514 ' CG ' ' HG ' ' A' ' 585' ' ' LEU . 0.0 OUTLIER -135.27 134.05 39.56 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.061 178.759 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 493' ' ' VAL . . . . . 0.563 HG12 ' N ' ' A' ' 494' ' ' THR . 39.4 t -136.06 163.41 34.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.373 178.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 494' ' ' THR . . . . . 0.805 HG23 ' O ' ' A' ' 587' ' ' SER . 53.5 m -125.41 133.66 52.42 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.119 0.485 . . . . 0.0 110.298 177.372 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 495' ' ' LEU . . . . . 0.913 HD11 HD11 ' A' ' 499' ' ' LEU . 0.0 OUTLIER -136.08 163.89 47.02 Favored Pre-proline 0 CA--C 1.53 0.196 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.578 179.686 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 496' ' ' PRO . . . . . 0.798 ' HB2' HD23 ' A' ' 499' ' ' LEU . 46.1 Cg_exo -54.37 119.65 6.73 Favored 'Trans proline' 0 CA--C 1.532 0.414 0 C-N-CA 121.931 1.754 . . . . 0.0 111.515 178.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 497' ' ' LYS . . . . . 0.502 ' CA ' ' HB ' ' A' ' 588' ' ' ILE . 0.8 OUTLIER -62.0 -30.28 70.83 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -179.204 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 498' ' ' SER . . . . . . . . . . . . . 2.1 m -58.15 -47.4 83.48 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -178.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 499' ' ' LEU . . . . . 0.913 HD11 HD11 ' A' ' 495' ' ' LEU . 2.2 pp -72.81 -7.83 52.61 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -178.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 500' ' ' VAL . . . . . 0.621 HG22 ' NZ ' ' A' ' 507' ' ' LYS . 42.9 t -74.46 -25.83 19.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.374 0.607 . . . . 0.0 111.243 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 501' ' ' TYR . . . . . 0.698 ' O ' HG21 ' A' ' 564' ' ' THR . 0.3 OUTLIER -53.86 -29.46 41.48 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 -178.449 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 502' ' ' ASP . . . . . 0.406 ' N ' ' CD1' ' A' ' 501' ' ' TYR . 8.6 m-20 -75.56 -50.15 16.45 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 -175.227 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 503' ' ' LYS . . . . . 0.588 ' O ' ' CG ' ' A' ' 507' ' ' LYS . 0.2 OUTLIER -119.23 135.11 54.84 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 118.868 0.758 . . . . 0.0 111.298 -179.656 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 504' ' ' THR . . . . . 0.667 HG21 ' HB3' ' A' ' 563' ' ' LYS . 2.2 m -73.32 -76.52 0.12 Allowed 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 505' ' ' PHE . . . . . 0.644 ' CE1' HG23 ' A' ' 532' ' ' VAL . 0.3 OUTLIER -75.61 -60.39 2.33 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 -179.414 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 506' ' ' SER . . . . . 0.775 ' O ' ' CD1' ' A' ' 510' ' ' TRP . 8.0 t -48.97 -72.79 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -175.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 507' ' ' LYS . . . . . 0.694 ' HD3' ' N ' ' A' ' 508' ' ' VAL . 0.0 OUTLIER -49.37 -48.28 46.96 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -177.021 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 508' ' ' VAL . . . . . 0.88 ' CG2' HD21 ' A' ' 574' ' ' LEU . 50.9 t -51.65 -60.72 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 509' ' ' LEU . . . . . 0.806 HD12 ' N ' ' A' ' 510' ' ' TRP . 2.6 pp -58.37 -61.06 2.86 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 115.753 1.76 . . . . 0.0 115.753 -176.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 510' ' ' TRP . . . . . 0.856 ' CD1' ' HA ' ' A' ' 518' ' ' LYS . 66.7 p-90 -72.38 -52.14 17.34 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -176.019 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 511' ' ' SER . . . . . 0.509 ' N ' ' CE3' ' A' ' 510' ' ' TRP . 1.4 t -64.79 -47.8 76.77 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -177.156 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 512' ' ' ALA . . . . . 0.815 ' HB3' ' O ' ' A' ' 508' ' ' VAL . . . -71.4 -72.84 0.2 Allowed 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 117.728 2.492 . . . . 0.0 117.728 -174.554 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 513' ' ' GLY . . . . . 0.649 ' H ' ' HE2' ' A' ' 584' ' ' LYS . . . -114.55 -35.06 1.47 Allowed Glycine 0 CA--C 1.503 -0.701 0 N-CA-C 121.24 3.256 . . . . 0.0 121.24 -172.482 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 514' ' ' LEU . . . . . 0.522 ' HG ' ' CG ' ' A' ' 584' ' ' LYS . 3.2 mt -107.5 -46.37 3.86 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 119.356 3.095 . . . . 0.0 119.356 -170.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 515' ' ' VAL . . . . . 1.049 HG13 ' HB2' ' A' ' 517' ' ' SER . 2.4 p -154.6 173.1 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.646 0 N-CA-C 117.619 2.451 . . . . 0.0 117.619 -172.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 516' ' ' ALA . . . . . 0.551 ' N ' ' CG2' ' A' ' 515' ' ' VAL . . . -67.94 4.05 1.32 Allowed 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 126.599 1.96 . . . . 0.0 109.864 177.272 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 517' ' ' SER . . . . . 1.049 ' HB2' HG13 ' A' ' 515' ' ' VAL . 0.6 OUTLIER -57.7 9.19 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 116.133 1.901 . . . . 0.0 116.133 -171.972 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 518' ' ' LYS . . . . . 0.856 ' HA ' ' CD1' ' A' ' 510' ' ' TRP . 0.6 OUTLIER -45.43 -47.42 13.75 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 104.268 -2.493 . . . . 0.0 104.268 175.398 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 519' ' ' SER . . . . . . . . . . . . . 68.5 p -74.98 -58.16 3.45 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 114.531 -1.213 . . . . 0.0 110.178 173.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 520' ' ' GLU . . . . . 0.822 ' HB3' ' HA ' ' A' ' 517' ' ' SER . 2.7 tp10 -59.9 -47.61 85.07 Favored 'General case' 0 C--N 1.35 0.598 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.747 -178.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 521' ' ' GLY . . . . . 0.832 ' N ' ' O ' ' A' ' 517' ' ' SER . . . -49.75 -55.4 14.37 Favored Glycine 0 CA--C 1.493 -1.3 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 522' ' ' GLN . . . . . 0.466 ' HA ' HG12 ' A' ' 525' ' ' ILE . 14.3 mt-30 -47.68 -47.82 29.47 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 523' ' ' ARG . . . . . 0.522 ' HB3' ' O ' ' A' ' 520' ' ' GLU . 0.1 OUTLIER -50.7 -49.01 58.56 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.536 178.475 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 524' ' ' ILE . . . . . 0.637 HG21 HD22 ' A' ' 578' ' ' LEU . 36.0 mm -56.65 -54.99 22.09 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 CA-C-O 121.352 0.596 . . . . 0.0 109.883 179.182 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 525' ' ' ILE . . . . . 0.819 HG23 ' CD1' ' A' ' 556' ' ' ILE . 0.5 OUTLIER -50.22 -47.2 25.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 177.739 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 526' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -55.03 -48.05 73.92 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 113.764 -1.562 . . . . 0.0 108.506 177.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 527' ' ' ASN . . . . . 0.492 ' ND2' ' O ' ' A' ' 524' ' ' ILE . 0.0 OUTLIER -48.17 -39.99 22.6 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 113.957 -1.474 . . . . 0.0 107.734 177.124 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 528' ' ' ASN . . . . . 0.645 ' HA ' ' CG2' ' A' ' 556' ' ' ILE . 0.2 OUTLIER 73.65 40.26 0.5 Allowed 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.349 -179.373 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 529' ' ' GLY . . . . . . . . . . . . . . . -119.68 32.71 4.9 Favored Glycine 0 CA--C 1.524 0.616 0 CA-C-N 115.0 -1.0 . . . . 0.0 112.597 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 530' ' ' ALA . . . . . 0.909 ' O ' ' HB ' ' A' ' 556' ' ' ILE . . . -133.48 164.57 26.85 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.246 0.546 . . . . 0.0 112.438 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 531' ' ' TYR . . . . . 0.582 ' HA ' ' O ' ' A' ' 554' ' ' THR . 0.0 OUTLIER -133.99 155.82 49.28 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 177.648 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 532' ' ' VAL . . . . . 0.644 HG23 ' CE1' ' A' ' 505' ' ' PHE . 0.5 OUTLIER -129.17 136.34 59.79 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 CA-C-O 121.789 0.804 . . . . 0.0 111.894 179.929 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 533' ' ' GLY . . . . . 0.752 ' O ' HG13 ' A' ' 575' ' ' ILE . . . -132.33 147.13 18.69 Favored Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 114.442 -1.254 . . . . 0.0 113.504 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 534' ' ' SER . . . . . 0.425 ' C ' ' HD2' ' A' ' 535' ' ' ARG . 3.4 m -134.7 136.73 42.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.248 -0.476 . . . . 0.0 111.43 179.54 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 535' ' ' ARG . . . . . 0.853 ' HG2' HD22 ' A' ' 573' ' ' LEU . 0.0 OUTLIER -160.17 91.41 1.73 Allowed Pre-proline 0 C--N 1.33 -0.266 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.966 178.349 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 536' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -77.72 -32.53 2.7 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.559 2.173 . . . . 0.0 112.16 179.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 72.22 54.62 7.73 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.575 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 538' ' ' VAL . . . . . 0.535 HG13 ' N ' ' A' ' 539' ' ' LYS . 12.3 p -116.2 -45.95 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 CA-C-O 121.005 0.431 . . . . 0.0 111.686 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 539' ' ' LYS . . . . . 0.535 ' N ' HG13 ' A' ' 538' ' ' VAL . 9.9 mtmm -107.7 152.21 24.63 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.948 -178.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 6.0 mtmt -98.03 30.65 2.98 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.739 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 541' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -88.71 100.12 12.88 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.53 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -48.46 153.81 1.26 Allowed Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.004 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 543' ' ' PRO . . . . . 0.411 ' CA ' ' HG3' ' A' ' 548' ' ' PRO . 75.1 Cg_exo -50.27 -52.25 9.33 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.575 2.183 . . . . 0.0 113.021 -179.137 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 544' ' ' GLY . . . . . 0.567 ' O ' ' N ' ' A' ' 546' ' ' GLY . . . 39.88 41.0 1.78 Allowed Glycine 0 CA--C 1.521 0.439 0 C-N-CA 121.047 -0.597 . . . . 0.0 113.121 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 545' ' ' GLY . . . . . 0.611 ' O ' ' N ' ' A' ' 547' ' ' MET . . . 53.86 -29.98 0.01 OUTLIER Glycine 0 CA--C 1.533 1.197 0 N-CA-C 115.355 0.902 . . . . 0.0 115.355 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 546' ' ' GLY . . . . . 0.567 ' N ' ' O ' ' A' ' 544' ' ' GLY . . . -51.91 55.37 0.01 OUTLIER Glycine 0 CA--C 1.528 0.904 0 N-CA-C 115.212 0.845 . . . . 0.0 115.212 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 547' ' ' MET . . . . . 0.611 ' N ' ' O ' ' A' ' 545' ' ' GLY . 0.0 OUTLIER 52.27 55.02 14.59 Favored Pre-proline 0 N--CA 1.464 0.233 0 CA-C-N 118.541 1.171 . . . . 0.0 110.959 -179.912 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 548' ' ' PRO . . . . . 0.461 ' HD3' ' N ' ' A' ' 547' ' ' MET . 84.9 Cg_exo -45.75 152.68 0.96 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 123.096 2.53 . . . . 0.0 113.433 -178.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 549' ' ' ASP . . . . . 0.476 ' HB2' HD11 ' A' ' 569' ' ' ILE . 2.3 p30 -124.66 -27.2 3.71 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.167 178.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 550' ' ' ASP . . . . . 0.507 ' O ' ' HB3' ' A' ' 535' ' ' ARG . 0.5 OUTLIER -58.66 -47.81 83.19 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.396 179.39 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 551' ' ' LEU . . . . . 0.634 HD21 ' HE1' ' A' ' 553' ' ' PHE . 7.1 tp -131.36 142.48 50.08 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.43 -0.805 . . . . 0.0 108.969 178.332 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 552' ' ' THR . . . . . 0.838 HG21 ' CG ' ' A' ' 567' ' ' PHE . 4.3 m -132.94 147.65 52.28 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.756 0.789 . . . . 0.0 112.395 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 553' ' ' PHE . . . . . 0.634 ' HE1' HD21 ' A' ' 551' ' ' LEU . 17.4 m-85 -133.71 136.95 44.99 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 176.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 554' ' ' THR . . . . . 0.863 HG22 ' H ' ' A' ' 556' ' ' ILE . 1.2 m -133.66 138.67 31.57 Favored Pre-proline 0 C--N 1.308 -1.224 0 C-N-CA 119.822 -0.751 . . . . 0.0 110.492 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 555' ' ' PRO . . . . . 0.827 ' O ' HG22 ' A' ' 556' ' ' ILE . 65.7 Cg_endo -83.49 19.24 1.37 Allowed 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 121.898 1.732 . . . . 0.0 111.764 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 556' ' ' ILE . . . . . 0.909 ' HB ' ' O ' ' A' ' 530' ' ' ALA . 4.5 tp 62.66 34.01 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.188 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 176.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 557' ' ' LYS . . . . . 0.599 ' O ' ' CE2' ' A' ' 559' ' ' TRP . 0.0 OUTLIER -103.82 126.03 50.66 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 179.897 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 558' ' ' THR . . . . . . . . . . . . . 3.6 t -57.81 118.22 5.09 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 115.413 1.634 . . . . 0.0 115.413 -172.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 559' ' ' TRP . . . . . 0.751 ' HZ2' HG23 ' A' ' 554' ' ' THR . 0.0 OUTLIER -138.5 130.7 28.56 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 175.214 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 560' ' ' ASN . . . . . 0.665 ' O ' HG22 ' A' ' 564' ' ' THR . 11.0 m-80 -90.88 -76.32 0.44 Allowed 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 118.305 -1.358 . . . . 0.0 114.116 -177.137 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 561' ' ' ALA . . . . . 0.526 ' HA ' ' CG2' ' A' ' 564' ' ' THR . . . -75.23 -57.29 3.98 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 116.368 1.988 . . . . 0.0 116.368 -177.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 562' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -49.0 -52.48 24.72 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -176.256 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 563' ' ' LYS . . . . . 0.667 ' HB3' HG21 ' A' ' 504' ' ' THR . 0.0 OUTLIER -70.8 -48.01 56.47 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -178.412 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 564' ' ' THR . . . . . 0.811 HG23 ' H ' ' A' ' 565' ' ' GLN . 6.8 t -49.63 -69.37 0.12 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.867 0.365 . . . . 0.0 111.288 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 565' ' ' GLN . . . . . 1.06 ' O ' HG23 ' A' ' 569' ' ' ILE . 2.0 tp60 -50.07 -46.62 53.48 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 566' ' ' GLU . . . . . 0.426 ' HG2' ' CD1' ' A' ' 567' ' ' PHE . 14.0 tt0 -49.24 -65.42 0.57 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 111.863 0.319 . . . . 0.0 111.863 -178.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 567' ' ' PHE . . . . . 0.838 ' CG ' HG21 ' A' ' 552' ' ' THR . 0.0 OUTLIER -97.18 -51.52 4.17 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.747 0.784 . . . . 0.0 112.007 -178.973 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 568' ' ' ILE . . . . . 0.643 ' CG1' HG23 ' A' ' 504' ' ' THR . 12.0 mm -57.26 9.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 114.321 -1.309 . . . . 0.0 113.321 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 569' ' ' ILE . . . . . 1.06 HG23 ' O ' ' A' ' 565' ' ' GLN . 0.9 OUTLIER -53.87 -39.03 38.23 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.845 0 N-CA-C 104.266 -2.494 . . . . 0.0 104.266 178.154 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 570' ' ' ASP . . . . . 0.916 ' CB ' HD11 ' A' ' 588' ' ' ILE . 32.5 m-20 35.45 50.0 0.53 Allowed 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 113.726 -1.579 . . . . 0.0 111.342 174.01 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -50.54 -44.13 46.03 Favored Glycine 0 N--CA 1.439 -1.101 0 C-N-CA 118.37 -1.871 . . . . 0.0 109.051 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 572' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -118.44 -18.09 9.24 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 120.252 -0.579 . . . . 0.0 112.16 175.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 573' ' ' LEU . . . . . 0.853 HD22 ' HG2' ' A' ' 535' ' ' ARG . 0.7 OUTLIER -141.2 137.68 32.8 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 574' ' ' LEU . . . . . 0.88 HD21 ' CG2' ' A' ' 508' ' ' VAL . 1.1 tp -133.98 131.94 39.54 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 174.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 575' ' ' ILE . . . . . 1.077 HG23 HD13 ' A' ' 585' ' ' LEU . 0.0 OUTLIER -134.64 137.19 51.58 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-N 118.557 0.617 . . . . 0.0 111.612 178.802 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 576' ' ' LEU . . . . . 0.547 HD22 ' CB ' ' A' ' 509' ' ' LEU . 0.0 OUTLIER -133.08 135.67 45.44 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 177.375 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 577' ' ' LYS . . . . . 0.44 ' HG2' ' HB2' ' A' ' 583' ' ' MET . 7.5 mttt -130.62 135.59 48.02 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.254 177.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.637 HD22 HG21 ' A' ' 524' ' ' ILE . 0.3 OUTLIER -124.88 132.01 53.36 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.871 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 579' ' ' GLY . . . . . . . . . . . . . . . -89.55 -2.19 76.6 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 115.229 -0.896 . . . . 0.0 113.251 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 580' ' ' LYS . . . . . 0.621 ' HG2' HG23 ' A' ' 524' ' ' ILE . 0.0 OUTLIER -72.56 -48.46 39.9 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 118.957 -1.097 . . . . 0.0 108.815 179.27 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 581' ' ' TRP . . . . . 0.491 ' CD1' ' O ' ' A' ' 580' ' ' LYS . 25.5 m0 -139.29 -53.02 0.55 Allowed 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 114.452 1.278 . . . . 0.0 114.452 177.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 582' ' ' LYS . . . . . 0.589 ' O ' HD12 ' A' ' 578' ' ' LEU . 0.1 OUTLIER -140.38 165.18 28.13 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -174.636 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 583' ' ' MET . . . . . 0.44 ' HB2' ' HG2' ' A' ' 577' ' ' LYS . 0.3 OUTLIER -113.97 134.78 54.62 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 174.156 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 584' ' ' LYS . . . . . 0.842 ' HD3' HG23 ' A' ' 586' ' ' VAL . 1.4 tmmt? -120.77 133.85 55.31 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 177.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 585' ' ' LEU . . . . . 1.077 HD13 HG23 ' A' ' 575' ' ' ILE . 1.4 tp -118.8 136.32 54.06 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 586' ' ' VAL . . . . . 0.848 ' N ' HD12 ' A' ' 585' ' ' LEU . 2.5 t -132.88 137.15 54.46 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -177.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 587' ' ' SER . . . . . 0.805 ' O ' HG23 ' A' ' 494' ' ' THR . 55.6 m -109.35 134.95 51.19 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 177.108 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.916 HD11 ' CB ' ' A' ' 570' ' ' ASP . 0.2 OUTLIER -134.6 152.63 33.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -178.649 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 4.6 t -122.6 138.82 51.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 114.031 -1.441 . . . . 0.0 110.781 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 590' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.62 143.96 55.78 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.163 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 591' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -52.81 -51.57 60.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.949 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 592' ' ' GLU . . . . . 0.441 ' HA ' ' HG3' ' A' ' 595' ' ' LYS . 0.9 OUTLIER -51.08 -50.52 58.57 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.18 -179.703 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 1.9 mmtp -50.3 -48.47 55.11 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.833 0.825 . . . . 0.0 109.102 178.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 594' ' ' PHE . . . . . 0.721 ' CD1' HD11 ' A' ' 597' ' ' LEU . 0.9 OUTLIER -50.06 -48.41 52.96 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.645 178.372 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 595' ' ' LYS . . . . . 0.497 ' HA ' ' CE2' ' A' ' 604' ' ' TRP . 6.3 mmpt? -49.43 -47.64 47.92 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 596' ' ' GLU . . . . . 0.496 ' O ' HD23 ' A' ' 599' ' ' LEU . 0.4 OUTLIER -50.93 -60.54 2.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.245 179.723 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 597' ' ' LEU . . . . . 0.721 HD11 ' CD1' ' A' ' 594' ' ' PHE . 0.6 OUTLIER -62.85 -63.31 1.25 Allowed 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 121.309 0.576 . . . . 0.0 112.105 -178.77 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 598' ' ' GLY . . . . . 0.45 ' N ' HD12 ' A' ' 597' ' ' LEU . . . -75.24 13.8 5.62 Favored Glycine 0 C--N 1.32 -0.349 0 CA-C-N 115.132 -0.94 . . . . 0.0 113.657 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 599' ' ' LEU . . . . . 0.664 HD12 ' N ' ' A' ' 600' ' ' THR . 2.6 pp -47.86 -14.89 0.05 Allowed 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -175.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 600' ' ' THR . . . . . 0.664 ' N ' HD12 ' A' ' 599' ' ' LEU . 11.1 t -131.69 66.75 1.54 Allowed 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.074 -0.65 . . . . 0.0 110.642 177.047 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 601' ' ' ALA . . . . . 0.724 ' HB1' ' HD2' ' A' ' 602' ' ' PRO . . . -131.33 166.57 26.88 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.441 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 602' ' ' PRO . . . . . 0.724 ' HD2' ' HB1' ' A' ' 601' ' ' ALA . 55.0 Cg_endo -68.5 -13.4 37.32 Favored 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 122.154 1.903 . . . . 0.0 111.437 178.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 603' ' ' GLY . . . . . 0.457 ' O ' HG23 ' A' ' 607' ' ' VAL . . . -69.1 -48.95 43.73 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.549 -0.75 . . . . 0.0 113.184 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 604' ' ' TRP . . . . . 0.515 ' CD1' ' HA ' ' A' ' 599' ' ' LEU . 0.9 OUTLIER -64.12 -46.57 83.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.799 0.333 . . . . 0.0 111.223 -179.557 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 605' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -50.3 -60.0 3.42 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.386 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 606' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 610' ' ' LYS . 0.3 OUTLIER -61.28 -59.06 5.88 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -179.614 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 607' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 603' ' ' GLY . 90.3 t -50.66 -71.95 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 113.801 1.038 . . . . 0.0 113.801 -178.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 608' ' ' VAL . . . . . . . . . . . . . 76.2 t -70.56 -60.17 2.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -177.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 609' ' ' GLY . . . . . . . . . . . . . . . -55.42 -64.7 4.14 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 121.326 -0.464 . . . . 0.0 113.529 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 610' ' ' LYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 606' ' ' GLU . 19.8 mttt -70.42 -63.05 1.16 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.771 0.32 . . . . 0.0 110.951 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 79.71 56.51 3.32 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.693 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.25 37.37 1.25 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.844 0.354 . . . . 0.0 110.95 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 613' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -120.01 -173.69 2.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.777 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 614' ' ' GLU . . . . . 0.411 ' CB ' ' CD ' ' A' ' 615' ' ' PRO . 13.0 mt-10 -68.72 -60.71 4.3 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.948 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 615' ' ' PRO . . . . . 0.411 ' CD ' ' CB ' ' A' ' 614' ' ' GLU . 59.9 Cg_endo -72.41 111.09 3.13 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.529 2.153 . . . . 0.0 112.271 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 616' ' ' SER . . . . . . . . . . . . . 4.1 m -130.12 149.47 73.32 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.867 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo . . . . . 0 C--O 1.249 1.059 0 C-N-CA 122.569 2.179 . . . . 0.0 112.285 179.998 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 454' ' ' MET . . . . . 0.682 ' O ' HG22 ' A' ' 457' ' ' THR . 4.8 mtp . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.759 0.314 . . . . 0.0 111.215 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 455' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -69.61 -26.45 28.28 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.578 2.185 . . . . 0.0 112.396 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 456' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.31 -26.53 61.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.033 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 457' ' ' THR . . . . . 0.682 HG22 ' O ' ' A' ' 454' ' ' MET . 10.4 t -97.03 39.48 1.18 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.916 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -91.13 119.59 31.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.153 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 7.5 t -61.84 111.39 4.39 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.897 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -50.84 160.27 1.94 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.462 2.108 . . . . 0.0 112.368 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . 107.34 50.6 0.81 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.447 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -103.57 91.38 3.33 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 120.636 0.255 . . . . 0.0 110.978 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.08 142.04 54.84 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.39 2.06 . . . . 0.0 112.321 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.83 123.52 17.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.0 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 1.4 m -113.39 -45.6 3.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.846 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 13.0 t -123.5 31.31 5.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.83 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 467' ' ' LEU . . . . . 0.429 HD11 HG23 ' A' ' 471' ' ' VAL . 0.5 OUTLIER -108.23 86.01 2.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.875 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -120.08 43.46 2.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.758 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 129.05 -36.96 2.3 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.089 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -106.41 117.52 34.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.848 0.356 . . . . 0.0 110.424 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 471' ' ' VAL . . . . . 0.589 ' O ' HG13 ' A' ' 471' ' ' VAL . 10.4 p -113.17 108.18 24.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.23 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 31.8 m-20 -155.68 87.86 3.07 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.808 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -60.54 77.43 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.784 2.323 . . . . 0.0 112.402 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -136.19 30.01 3.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.893 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 44.1 m -89.0 -52.35 5.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.979 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 476' ' ' GLY . . . . . . . . . . . . . . . 106.89 44.03 1.34 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.412 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 477' ' ' ASN . . . . . 0.468 ' N ' ' CD ' ' A' ' 478' ' ' PRO . 0.7 OUTLIER -50.45 -47.99 82.41 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 478' ' ' PRO . . . . . 0.468 ' CD ' ' N ' ' A' ' 477' ' ' ASN . 81.5 Cg_exo -45.05 -67.51 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.784 2.323 . . . . 0.0 113.366 -179.307 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -124.41 175.53 7.05 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.816 0.341 . . . . 0.0 111.255 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -56.83 108.28 1.17 Allowed Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.04 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 481' ' ' PRO . . . . . 0.414 ' HB2' ' H ' ' A' ' 482' ' ' GLN . 78.4 Cg_exo -52.25 -79.02 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.496 2.131 . . . . 0.0 112.576 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 482' ' ' GLN . . . . . 0.414 ' H ' ' HB2' ' A' ' 481' ' ' PRO . 1.4 tm0? -136.07 -50.4 0.7 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.35 0.595 . . . . 0.0 109.569 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 483' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.04 172.0 9.32 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.157 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 484' ' ' ASN . . . . . . . . . . . . . 19.4 m-20 -85.44 18.99 2.48 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.76 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 485' ' ' PHE . . . . . 0.884 ' HB3' HD11 ' A' ' 573' ' ' LEU . 45.0 p90 -58.46 -52.02 67.38 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.745 0.307 . . . . 0.0 110.433 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 486' ' ' ALA . . . . . 0.431 ' N ' ' CG ' ' A' ' 485' ' ' PHE . . . -72.41 -47.3 50.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.357 0.598 . . . . 0.0 110.05 178.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -50.05 -48.34 52.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.622 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 488' ' ' MET . . . . . 0.479 ' N ' ' CD ' ' A' ' 489' ' ' PRO . 2.5 mtt 52.57 51.35 9.3 Favored Pre-proline 0 CA--C 1.529 0.149 0 CA-C-O 121.102 0.477 . . . . 0.0 110.381 -178.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 489' ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' A' ' 488' ' ' MET . 40.3 Cg_exo -33.16 -57.07 0.34 Allowed 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.901 3.067 . . . . 0.0 114.41 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 3.5 m -120.07 -66.92 1.02 Allowed 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -178.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 491' ' ' ALA . . . . . 0.402 ' CB ' HD21 ' A' ' 514' ' ' LEU . . . -134.0 139.75 46.26 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -178.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 492' ' ' ARG . . . . . 0.477 ' HD3' HD23 ' A' ' 585' ' ' LEU . 0.0 OUTLIER -134.32 133.12 40.34 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.726 177.366 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 493' ' ' VAL . . . . . 0.637 HG21 ' CA ' ' A' ' 513' ' ' GLY . 44.5 t -136.98 163.69 31.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 494' ' ' THR . . . . . 0.587 ' N ' HG12 ' A' ' 493' ' ' VAL . 32.3 p -117.69 134.25 55.09 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 121.147 0.498 . . . . 0.0 110.127 177.187 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 495' ' ' LEU . . . . . 1.056 HD22 ' HB2' ' A' ' 512' ' ' ALA . 0.0 OUTLIER -135.22 164.4 44.08 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.377 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 496' ' ' PRO . . . . . 0.898 ' HD2' HD12 ' A' ' 495' ' ' LEU . 11.9 Cg_exo -69.63 119.39 6.35 Favored 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 122.065 1.844 . . . . 0.0 111.199 178.501 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 497' ' ' LYS . . . . . 0.503 ' HB2' ' N ' ' A' ' 589' ' ' VAL . 2.4 ttpt -57.43 -30.21 64.79 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -178.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 498' ' ' SER . . . . . 0.418 ' O ' ' CD1' ' A' ' 501' ' ' TYR . 0.3 OUTLIER -59.14 -48.7 80.66 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 114.414 1.264 . . . . 0.0 114.414 -176.757 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 499' ' ' LEU . . . . . 0.548 HD21 ' HD2' ' A' ' 496' ' ' PRO . 1.5 pp -74.2 -10.24 59.41 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -178.277 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 500' ' ' VAL . . . . . 0.715 HG21 HG21 ' A' ' 588' ' ' ILE . 20.8 t -76.54 -27.21 17.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.337 0.589 . . . . 0.0 111.88 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 501' ' ' TYR . . . . . 0.596 ' O ' HG21 ' A' ' 564' ' ' THR . 0.3 OUTLIER -54.09 -30.6 49.03 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -177.704 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 502' ' ' ASP . . . . . 0.432 ' N ' ' CD1' ' A' ' 501' ' ' TYR . 4.6 t0 -75.78 -51.3 12.94 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 -175.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 503' ' ' LYS . . . . . 0.62 ' HB3' ' HG2' ' A' ' 507' ' ' LYS . 0.0 OUTLIER -120.59 140.6 51.28 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 118.76 0.709 . . . . 0.0 110.572 178.936 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 504' ' ' THR . . . . . 0.749 HG23 ' CG1' ' A' ' 568' ' ' ILE . 3.3 m -72.6 -74.4 0.17 Allowed 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -178.235 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 505' ' ' PHE . . . . . 0.743 ' CZ ' ' HB1' ' A' ' 530' ' ' ALA . 0.2 OUTLIER -73.3 -57.63 3.88 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -177.262 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 506' ' ' SER . . . . . 0.849 ' O ' ' CD1' ' A' ' 510' ' ' TRP . 10.1 t -48.8 -66.38 0.41 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -176.408 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 507' ' ' LYS . . . . . 0.62 ' HG2' ' HB3' ' A' ' 503' ' ' LYS . 0.0 OUTLIER -48.75 -56.13 9.51 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -176.849 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 508' ' ' VAL . . . . . 0.975 ' CG2' HD21 ' A' ' 574' ' ' LEU . 48.4 t -49.9 -61.14 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -179.175 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 509' ' ' LEU . . . . . 0.816 HD12 ' N ' ' A' ' 510' ' ' TRP . 2.5 pp -54.27 -63.07 1.27 Allowed 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 115.626 1.713 . . . . 0.0 115.626 -177.063 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 510' ' ' TRP . . . . . 0.873 ' CD1' ' HA ' ' A' ' 518' ' ' LYS . 66.3 p-90 -72.85 -51.39 18.95 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 -175.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 511' ' ' SER . . . . . 0.529 ' N ' ' CE3' ' A' ' 510' ' ' TRP . 0.3 OUTLIER -64.39 -47.19 80.18 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.299 -0.864 . . . . 0.0 113.305 -176.753 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 512' ' ' ALA . . . . . 1.056 ' HB2' HD22 ' A' ' 495' ' ' LEU . . . -70.92 -73.79 0.16 Allowed 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 118.158 2.651 . . . . 0.0 118.158 -173.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 513' ' ' GLY . . . . . 0.675 ' H ' ' HE2' ' A' ' 584' ' ' LYS . . . -115.48 -34.98 1.35 Allowed Glycine 0 CA--C 1.501 -0.825 0 N-CA-C 120.84 3.096 . . . . 0.0 120.84 -172.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 514' ' ' LEU . . . . . 0.619 ' HG ' ' HB2' ' A' ' 584' ' ' LYS . 0.1 OUTLIER -106.86 -46.53 3.93 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 119.473 3.138 . . . . 0.0 119.473 -169.887 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 515' ' ' VAL . . . . . 1.038 HG13 ' HB2' ' A' ' 517' ' ' SER . 2.5 p -154.4 172.29 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 N-CA-C 117.981 2.585 . . . . 0.0 117.981 -172.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 516' ' ' ALA . . . . . 0.546 ' N ' HG22 ' A' ' 515' ' ' VAL . . . -68.62 3.71 1.74 Allowed 'General case' 0 C--N 1.333 -0.109 0 C-N-CA 126.741 2.016 . . . . 0.0 110.012 177.376 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 517' ' ' SER . . . . . 1.038 ' HB2' HG13 ' A' ' 515' ' ' VAL . 0.6 OUTLIER -57.84 9.1 0.01 OUTLIER 'General case' 0 N--CA 1.428 -1.526 0 N-CA-C 116.153 1.909 . . . . 0.0 116.153 -171.797 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 518' ' ' LYS . . . . . 0.873 ' HA ' ' CD1' ' A' ' 510' ' ' TRP . 0.1 OUTLIER -45.3 -46.93 13.04 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 104.277 -2.49 . . . . 0.0 104.277 175.423 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 519' ' ' SER . . . . . . . . . . . . . 58.0 p -75.1 -60.05 2.47 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 114.658 -1.156 . . . . 0.0 110.15 173.299 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 520' ' ' GLU . . . . . 0.806 ' HB3' ' HA ' ' A' ' 517' ' ' SER . 5.7 tp10 -57.81 -47.47 82.52 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.497 -179.086 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 521' ' ' GLY . . . . . 0.834 ' N ' ' O ' ' A' ' 517' ' ' SER . . . -49.29 -54.37 16.02 Favored Glycine 0 CA--C 1.493 -1.328 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.033 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 522' ' ' GLN . . . . . 0.444 ' HA ' HG12 ' A' ' 525' ' ' ILE . 0.9 OUTLIER -47.42 -47.33 26.72 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.465 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 523' ' ' ARG . . . . . 0.463 ' O ' ' HB2' ' A' ' 526' ' ' ASN . 2.2 ttt180 -50.4 -48.78 55.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.844 178.327 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 524' ' ' ILE . . . . . 0.576 HD13 ' CE ' ' A' ' 580' ' ' LYS . 23.1 mt -58.25 -55.2 23.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.412 0.625 . . . . 0.0 109.827 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 525' ' ' ILE . . . . . 0.882 HG23 HD11 ' A' ' 556' ' ' ILE . 0.3 OUTLIER -50.02 -47.58 23.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 177.761 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 526' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 523' ' ' ARG . 8.2 m120 -56.17 -47.89 77.39 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 114.35 -1.295 . . . . 0.0 108.23 177.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -47.9 -40.24 21.27 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 113.986 -1.461 . . . . 0.0 107.534 176.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 528' ' ' ASN . . . . . 0.663 ' HA ' HG23 ' A' ' 556' ' ' ILE . 2.7 t30 73.44 40.28 0.53 Allowed 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.461 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 529' ' ' GLY . . . . . . . . . . . . . . . -116.33 31.68 5.9 Favored Glycine 0 CA--C 1.522 0.523 0 CA-C-N 114.994 -1.003 . . . . 0.0 112.436 178.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 530' ' ' ALA . . . . . 0.87 ' O ' ' HB ' ' A' ' 556' ' ' ILE . . . -133.44 164.42 27.17 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.532 0.682 . . . . 0.0 112.749 -179.015 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 531' ' ' TYR . . . . . 0.728 ' HA ' HG22 ' A' ' 554' ' ' THR . 0.0 OUTLIER -134.65 157.92 45.41 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.752 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 532' ' ' VAL . . . . . 0.674 HG23 ' CE1' ' A' ' 505' ' ' PHE . 0.5 OUTLIER -132.84 136.62 55.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-O 121.921 0.867 . . . . 0.0 112.133 179.886 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 533' ' ' GLY . . . . . 0.803 ' O ' HG13 ' A' ' 575' ' ' ILE . . . -128.64 148.63 18.07 Favored Glycine 0 N--CA 1.441 -1.01 0 CA-C-N 114.155 -1.384 . . . . 0.0 112.609 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 534' ' ' SER . . . . . 0.455 ' N ' ' HB ' ' A' ' 552' ' ' THR . 0.2 OUTLIER -134.73 146.88 49.84 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.528 -0.336 . . . . 0.0 110.617 179.62 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 535' ' ' ARG . . . . . 0.856 ' HB3' HD22 ' A' ' 573' ' ' LEU . 0.0 OUTLIER -159.52 89.71 1.95 Allowed Pre-proline 0 N--CA 1.464 0.233 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 178.961 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 536' ' ' PRO . . . . . 0.551 ' HD2' ' HA ' ' A' ' 550' ' ' ASP . 35.0 Cg_endo -63.8 -35.61 55.81 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.383 2.055 . . . . 0.0 112.002 178.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 91.7 57.05 1.56 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.727 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 538' ' ' VAL . . . . . 0.515 HG13 ' N ' ' A' ' 539' ' ' LYS . 11.8 p -116.28 -46.28 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 CA-C-O 121.084 0.469 . . . . 0.0 111.704 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 539' ' ' LYS . . . . . 0.515 ' N ' HG13 ' A' ' 538' ' ' VAL . 14.8 mtmm -108.37 119.01 38.28 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.935 -178.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -62.34 -55.84 24.17 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.848 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 541' ' ' ASN . . . . . . . . . . . . . 57.9 t-20 -96.15 98.86 10.67 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.098 0.475 . . . . 0.0 109.849 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -123.22 110.62 30.75 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.496 -179.402 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 543' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -50.82 -11.91 0.5 Allowed 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.903 2.402 . . . . 0.0 113.128 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 544' ' ' GLY . . . . . 0.686 ' O ' ' N ' ' A' ' 546' ' ' GLY . . . 52.52 17.32 4.31 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 121.318 -0.468 . . . . 0.0 113.631 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 545' ' ' GLY . . . . . 0.622 ' O ' ' N ' ' A' ' 547' ' ' MET . . . -52.45 55.03 0.01 OUTLIER Glycine 0 CA--C 1.526 0.745 0 CA-C-O 119.633 -0.537 . . . . 0.0 113.795 178.482 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 546' ' ' GLY . . . . . 0.686 ' N ' ' O ' ' A' ' 544' ' ' GLY . . . 53.73 -53.05 0.01 OUTLIER Glycine 0 CA--C 1.528 0.849 0 CA-C-N 117.423 0.612 . . . . 0.0 114.14 -178.293 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 547' ' ' MET . . . . . 0.622 ' N ' ' O ' ' A' ' 545' ' ' GLY . 0.6 OUTLIER -51.07 -51.35 68.67 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 118.13 0.965 . . . . 0.0 111.038 178.968 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 548' ' ' PRO . . . . . 0.446 ' CD ' ' N ' ' A' ' 547' ' ' MET . 79.8 Cg_exo -46.71 167.35 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.314 2.676 . . . . 0.0 112.924 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -119.99 -15.22 8.81 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.67 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 550' ' ' ASP . . . . . 0.551 ' HA ' ' HD2' ' A' ' 536' ' ' PRO . 0.1 OUTLIER -56.51 -37.84 70.99 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 121.764 0.793 . . . . 0.0 108.963 178.946 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 551' ' ' LEU . . . . . . . . . . . . . 14.6 tp -132.09 140.47 48.84 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.661 -1.154 . . . . 0.0 108.891 178.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 552' ' ' THR . . . . . 0.677 HG21 ' CG ' ' A' ' 567' ' ' PHE . 7.7 m -132.81 150.32 52.17 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.711 0.767 . . . . 0.0 111.728 179.233 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 553' ' ' PHE . . . . . 0.507 ' CD1' ' CE1' ' A' ' 531' ' ' TYR . 0.2 OUTLIER -132.92 138.54 46.99 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 114.442 -1.254 . . . . 0.0 108.166 178.135 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 554' ' ' THR . . . . . 0.929 HG23 ' H ' ' A' ' 556' ' ' ILE . 0.4 OUTLIER -131.3 140.78 39.58 Favored Pre-proline 0 C--N 1.312 -1.047 0 C-N-CA 120.304 -0.558 . . . . 0.0 111.173 -179.713 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 555' ' ' PRO . . . . . 0.843 ' O ' HG22 ' A' ' 556' ' ' ILE . 35.0 Cg_endo -91.15 7.7 3.43 Favored 'Trans proline' 0 N--CA 1.438 -1.785 0 C-N-CA 122.256 1.971 . . . . 0.0 110.338 178.065 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 556' ' ' ILE . . . . . 0.929 ' H ' HG23 ' A' ' 554' ' ' THR . 6.3 tp 62.4 33.21 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.302 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 177.484 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 557' ' ' LYS . . . . . 0.704 ' O ' ' CE2' ' A' ' 559' ' ' TRP . 0.0 OUTLIER -104.48 141.42 36.4 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 179.386 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 558' ' ' THR . . . . . . . . . . . . . 1.6 t -57.68 115.91 3.08 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 -172.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 559' ' ' TRP . . . . . 0.704 ' CE2' ' O ' ' A' ' 557' ' ' LYS . 0.0 OUTLIER -139.21 121.61 16.07 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 112.356 -2.202 . . . . 0.0 106.602 174.871 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 560' ' ' ASN . . . . . 0.619 ' O ' HG22 ' A' ' 564' ' ' THR . 81.2 m-20 -91.2 -76.8 0.43 Allowed 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 118.233 -1.387 . . . . 0.0 113.917 -177.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 561' ' ' ALA . . . . . 0.616 ' HA ' ' CG2' ' A' ' 564' ' ' THR . . . -75.53 -49.74 17.78 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 115.968 1.84 . . . . 0.0 115.968 -177.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 562' ' ' SER . . . . . 0.403 ' O ' ' HB2' ' A' ' 566' ' ' GLU . 9.9 t -48.8 -55.71 10.79 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -176.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 563' ' ' LYS . . . . . 0.569 ' HG3' ' CG ' ' A' ' 559' ' ' TRP . 0.1 OUTLIER -70.82 -47.97 56.61 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -178.307 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 564' ' ' THR . . . . . 0.834 HG23 ' H ' ' A' ' 565' ' ' GLN . 9.0 t -50.07 -72.0 0.06 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.81 0.338 . . . . 0.0 111.699 -179.226 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 565' ' ' GLN . . . . . 0.991 ' O ' HG23 ' A' ' 569' ' ' ILE . 1.1 tp60 -50.69 -46.66 58.91 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 566' ' ' GLU . . . . . 0.418 ' HG2' ' CD1' ' A' ' 567' ' ' PHE . 67.3 tt0 -49.17 -66.45 0.4 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.863 0.363 . . . . 0.0 111.696 -178.229 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 567' ' ' PHE . . . . . 0.677 ' CG ' HG21 ' A' ' 552' ' ' THR . 0.1 OUTLIER -97.39 -53.64 3.4 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.533 0.683 . . . . 0.0 111.701 -179.278 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 568' ' ' ILE . . . . . 0.848 HD12 ' CD1' ' A' ' 574' ' ' LEU . 14.9 mm -53.95 10.43 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.503 -0.841 0 CA-C-N 114.494 -1.23 . . . . 0.0 113.888 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 569' ' ' ILE . . . . . 0.991 HG23 ' O ' ' A' ' 565' ' ' GLN . 0.9 OUTLIER -55.73 -33.87 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 N-CA-C 103.815 -2.661 . . . . 0.0 103.815 177.7 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 570' ' ' ASP . . . . . 0.656 ' OD2' HD22 ' A' ' 574' ' ' LEU . 7.8 p30 34.56 42.82 0.08 Allowed 'General case' 0 CA--C 1.492 -1.264 0 CA-C-N 113.421 -1.718 . . . . 0.0 110.591 174.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 571' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' A' ' 570' ' ' ASP . . . -49.49 -43.46 35.93 Favored Glycine 0 N--CA 1.436 -1.342 0 N-CA-C 106.981 -2.448 . . . . 0.0 106.981 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 572' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -119.03 -17.99 8.88 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-O 118.937 -0.554 . . . . 0.0 112.298 174.648 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 573' ' ' LEU . . . . . 0.884 HD11 ' HB3' ' A' ' 485' ' ' PHE . 1.5 tp -142.21 136.55 30.0 Favored 'General case' 0 C--N 1.362 1.124 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 -178.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 574' ' ' LEU . . . . . 0.996 ' HB3' HD11 ' A' ' 588' ' ' ILE . 8.9 tp -136.22 133.84 37.49 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 114.339 -1.301 . . . . 0.0 107.613 173.344 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 575' ' ' ILE . . . . . 0.803 HG13 ' O ' ' A' ' 533' ' ' GLY . 0.0 OUTLIER -133.86 137.16 52.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 O-C-N 122.001 -0.437 . . . . 0.0 110.766 178.253 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 576' ' ' LEU . . . . . 0.614 HD22 ' HB3' ' A' ' 509' ' ' LEU . 0.1 OUTLIER -133.33 135.3 44.7 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 177.523 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 577' ' ' LYS . . . . . 0.403 ' N ' HD12 ' A' ' 576' ' ' LEU . 0.2 OUTLIER -132.99 135.24 45.36 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.194 -1.002 . . . . 0.0 109.979 177.026 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.574 ' HG ' HD11 ' A' ' 576' ' ' LEU . 0.4 OUTLIER -125.0 132.04 53.32 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.139 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 579' ' ' GLY . . . . . . . . . . . . . . . -89.81 -2.18 75.77 Favored Glycine 0 N--CA 1.442 -0.942 0 CA-C-N 115.294 -0.867 . . . . 0.0 113.173 -178.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 580' ' ' LYS . . . . . 0.576 ' CE ' HD13 ' A' ' 524' ' ' ILE . 0.0 OUTLIER -72.9 -48.1 40.17 Favored 'General case' 0 N--CA 1.441 -0.904 0 C-N-CA 119.17 -1.012 . . . . 0.0 108.908 179.256 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 581' ' ' TRP . . . . . 0.418 ' CD1' ' O ' ' A' ' 580' ' ' LYS . 13.6 m0 -139.64 -52.84 0.53 Allowed 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 177.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 582' ' ' LYS . . . . . 0.536 ' O ' HD12 ' A' ' 578' ' ' LEU . 3.1 ptpt -140.15 164.94 28.7 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 -175.063 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 583' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -113.7 134.68 54.6 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 174.198 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 584' ' ' LYS . . . . . 0.865 ' NZ ' HG12 ' A' ' 508' ' ' VAL . 0.5 OUTLIER -122.89 133.6 54.41 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 178.979 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 585' ' ' LEU . . . . . 0.727 ' HG ' HG23 ' A' ' 575' ' ' ILE . 9.8 tt -120.62 135.56 55.07 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 586' ' ' VAL . . . . . 0.747 HG12 ' CD1' ' A' ' 588' ' ' ILE . 55.2 t -134.04 144.15 36.3 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 112.991 0.738 . . . . 0.0 112.991 -177.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 587' ' ' SER . . . . . 0.873 ' C ' HD13 ' A' ' 588' ' ' ILE . 3.1 m -107.29 135.88 48.06 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 176.23 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.996 HD11 ' HB3' ' A' ' 574' ' ' LEU . 0.0 OUTLIER -132.77 136.93 55.0 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.47 0 CA-C-O 121.701 0.762 . . . . 0.0 112.785 -177.309 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 589' ' ' VAL . . . . . 0.58 HG11 ' HD1' ' A' ' 594' ' ' PHE . 7.1 p -125.26 150.34 30.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 114.376 -1.284 . . . . 0.0 110.843 179.155 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 590' ' ' SER . . . . . . . . . . . . . 3.3 p -73.32 156.37 38.49 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.172 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 591' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -50.74 -48.56 59.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.145 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 592' ' ' GLU . . . . . 0.435 ' O ' ' HG3' ' A' ' 595' ' ' LYS . 13.8 pt-20 -54.26 -49.2 70.1 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.031 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 593' ' ' LYS . . . . . 0.436 ' CB ' ' CG2' ' A' ' 589' ' ' VAL . 1.7 mmtp -62.17 -59.05 5.61 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -178.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 594' ' ' PHE . . . . . 0.58 ' HD1' HG11 ' A' ' 589' ' ' VAL . 3.1 t80 -50.24 -48.98 54.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.251 -179.182 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 595' ' ' LYS . . . . . 0.541 ' O ' ' N ' ' A' ' 599' ' ' LEU . 0.0 OUTLIER -52.78 -47.35 67.58 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.122 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 596' ' ' GLU . . . . . 0.688 ' O ' HD23 ' A' ' 599' ' ' LEU . 0.5 OUTLIER -50.1 -65.45 0.56 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.978 -179.738 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 597' ' ' LEU . . . . . 0.498 HD12 ' N ' ' A' ' 598' ' ' GLY . 0.5 OUTLIER -55.7 -59.54 4.7 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.146 0.498 . . . . 0.0 111.405 -179.2 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 598' ' ' GLY . . . . . 0.498 ' N ' HD12 ' A' ' 597' ' ' LEU . . . -77.95 11.77 20.22 Favored Glycine 0 CA--C 1.521 0.437 0 CA-C-N 115.43 -0.804 . . . . 0.0 113.143 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 599' ' ' LEU . . . . . 0.688 HD23 ' O ' ' A' ' 596' ' ' GLU . 3.4 pp -51.14 2.39 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -177.124 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 600' ' ' THR . . . . . 0.474 HG23 ' O ' ' A' ' 600' ' ' THR . 7.4 t -102.79 66.64 0.94 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 118.745 0.702 . . . . 0.0 109.855 178.077 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 601' ' ' ALA . . . . . 0.694 ' HB1' ' HD2' ' A' ' 602' ' ' PRO . . . -131.24 177.15 2.38 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.587 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 602' ' ' PRO . . . . . 0.694 ' HD2' ' HB1' ' A' ' 601' ' ' ALA . 32.1 Cg_exo -57.5 -44.98 37.22 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.299 1.999 . . . . 0.0 111.666 179.276 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 603' ' ' GLY . . . . . . . . . . . . . . . -71.14 -48.94 29.36 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.61 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 604' ' ' TRP . . . . . 0.512 ' CD1' ' HB3' ' A' ' 601' ' ' ALA . 10.4 m95 -65.31 -47.2 77.38 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 120.969 0.414 . . . . 0.0 111.153 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 605' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -50.57 -57.74 7.44 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.169 -178.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 606' ' ' GLU . . . . . 0.418 ' O ' ' CB ' ' A' ' 610' ' ' LYS . 6.5 pt-20 -59.71 -57.37 13.19 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 607' ' ' VAL . . . . . . . . . . . . . 59.9 t -58.48 -72.02 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -178.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 608' ' ' VAL . . . . . 0.473 HG21 ' NZ ' ' A' ' 595' ' ' LYS . 97.3 t -65.37 -58.28 7.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -177.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 609' ' ' GLY . . . . . . . . . . . . . . . -59.78 -61.59 7.04 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 116.156 -0.474 . . . . 0.0 113.646 -178.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 610' ' ' LYS . . . . . 0.418 ' CB ' ' O ' ' A' ' 606' ' ' GLU . 0.2 OUTLIER -58.81 -49.88 76.06 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.756 0.312 . . . . 0.0 110.808 -179.665 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 107.83 56.73 0.59 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.645 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 8.1 mtpt -93.34 39.09 1.05 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.781 0.324 . . . . 0.0 110.918 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 613' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -105.19 -166.71 1.25 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.793 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 614' ' ' GLU . . . . . 0.431 ' CB ' ' CD ' ' A' ' 615' ' ' PRO . 2.0 mp0 -54.99 -62.95 3.41 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.18 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 615' ' ' PRO . . . . . 0.431 ' CD ' ' CB ' ' A' ' 614' ' ' GLU . 42.3 Cg_endo -67.64 138.27 44.9 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.529 2.153 . . . . 0.0 112.266 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 616' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.96 154.27 40.39 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.924 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo . . . . . 0 C--O 1.249 1.063 0 C-N-CA 122.564 2.176 . . . . 0.0 112.328 -179.991 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.424 0 CA-C-O 120.719 0.295 . . . . 0.0 111.153 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 455' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.78 -175.49 1.18 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.541 2.161 . . . . 0.0 112.371 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 456' ' ' ARG . . . . . . . . . . . . . 3.8 mmt85 -59.94 -26.51 66.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.968 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 72.5 p -101.75 35.57 2.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.867 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -83.29 135.69 34.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.132 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -75.71 164.04 63.17 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.879 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -52.3 164.25 1.36 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.507 2.138 . . . . 0.0 112.296 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . 117.65 56.57 0.29 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.455 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 21.2 m-20 -88.16 163.18 38.11 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.753 0.311 . . . . 0.0 110.902 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -69.8 -175.84 1.3 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.546 2.164 . . . . 0.0 112.281 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -85.67 163.91 17.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.933 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 4.0 m -115.91 22.27 13.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.163 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -57.35 -29.59 64.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.031 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 467' ' ' LEU . . . . . 0.684 HD22 ' O ' ' A' ' 470' ' ' PHE . 0.2 OUTLIER -107.67 175.42 5.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.898 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 468' ' ' SER . . . . . 0.547 ' H ' HD23 ' A' ' 467' ' ' LEU . 3.1 p -81.56 43.85 0.77 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.896 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 129.1 -37.1 2.27 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.809 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 470' ' ' PHE . . . . . 0.684 ' O ' HD22 ' A' ' 467' ' ' LEU . 2.6 p90 -138.27 117.68 12.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.806 0.336 . . . . 0.0 110.856 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 471' ' ' VAL . . . . . 0.602 ' O ' HG13 ' A' ' 471' ' ' VAL . 11.9 p -113.14 107.55 23.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.155 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 176.27 108.92 0.11 Allowed Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.921 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -68.0 166.97 22.96 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.339 2.026 . . . . 0.0 112.216 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -81.48 -67.55 0.77 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.92 0.391 . . . . 0.0 110.9 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -138.28 -48.29 0.53 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.634 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 476' ' ' GLY . . . . . . . . . . . . . . . 87.91 -41.85 3.09 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.797 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 477' ' ' ASN . . . . . 0.417 ' N ' ' CD ' ' A' ' 478' ' ' PRO . 2.9 t30 -50.32 -51.51 62.87 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-O 120.621 0.248 . . . . 0.0 111.391 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 478' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' A' ' 477' ' ' ASN . 96.8 Cg_endo -85.26 34.37 0.49 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.836 2.357 . . . . 0.0 113.116 -179.532 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -85.04 84.28 7.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.804 0.335 . . . . 0.0 110.905 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -140.66 137.91 17.93 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.806 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -47.83 -79.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.432 2.088 . . . . 0.0 112.422 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 482' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -136.48 -68.91 0.48 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.349 0.595 . . . . 0.0 109.629 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 483' ' ' THR . . . . . . . . . . . . . 47.5 p -136.9 171.67 14.16 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.058 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 484' ' ' ASN . . . . . 0.514 ' O ' ' CD ' ' A' ' 489' ' ' PRO . 14.9 m120 -94.33 1.56 55.89 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.455 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 485' ' ' PHE . . . . . 0.713 ' HA ' ' HG2' ' A' ' 489' ' ' PRO . 3.3 m-85 -49.71 -47.01 50.76 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.549 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -70.47 -47.43 60.64 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -177.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -70.81 -74.53 0.14 Allowed 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 -176.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 488' ' ' MET . . . . . 0.515 ' CB ' ' HD3' ' A' ' 489' ' ' PRO . 0.0 OUTLIER -52.84 -52.95 59.97 Favored Pre-proline 0 N--CA 1.469 0.519 0 CA-C-O 121.12 0.486 . . . . 0.0 111.431 -178.653 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 489' ' ' PRO . . . . . 0.713 ' HG2' ' HA ' ' A' ' 485' ' ' PHE . 3.1 Cg_exo -79.9 43.33 1.49 Allowed 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 124.54 3.493 . . . . 0.0 112.132 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -37.2 -66.18 0.25 Allowed 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -178.201 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 491' ' ' ALA . . . . . . . . . . . . . . . -117.72 135.37 54.08 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 119.968 -0.693 . . . . 0.0 112.34 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 492' ' ' ARG . . . . . 0.565 ' HA ' ' O ' ' A' ' 585' ' ' LEU . 0.0 OUTLIER -135.81 136.97 41.1 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.085 178.944 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 493' ' ' VAL . . . . . 0.836 HG23 ' NZ ' ' A' ' 584' ' ' LYS . 89.4 t -133.13 163.57 37.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.354 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 494' ' ' THR . . . . . 0.581 ' N ' HG12 ' A' ' 493' ' ' VAL . 91.8 m -114.68 135.9 53.64 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.441 0.638 . . . . 0.0 111.74 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 495' ' ' LEU . . . . . 0.89 HD22 ' HB2' ' A' ' 512' ' ' ALA . 0.2 OUTLIER -134.27 164.66 42.37 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.086 179.869 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 496' ' ' PRO . . . . . 0.635 ' HD2' HD21 ' A' ' 499' ' ' LEU . 23.2 Cg_exo -63.68 119.56 6.66 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 121.982 1.788 . . . . 0.0 111.721 179.044 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 497' ' ' LYS . . . . . 0.896 ' O ' HG12 ' A' ' 500' ' ' VAL . 0.2 OUTLIER -53.07 -30.0 33.51 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -178.961 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 498' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -57.56 -48.66 78.75 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -177.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 499' ' ' LEU . . . . . 0.81 HD11 HD13 ' A' ' 495' ' ' LEU . 2.3 pp -74.37 -9.07 58.23 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -178.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 500' ' ' VAL . . . . . 0.896 HG12 ' O ' ' A' ' 497' ' ' LYS . 2.9 p -75.61 -26.43 18.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.352 0.596 . . . . 0.0 111.717 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 501' ' ' TYR . . . . . 0.665 ' O ' HG21 ' A' ' 564' ' ' THR . 0.3 OUTLIER -53.88 -29.69 42.7 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -178.71 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 502' ' ' ASP . . . . . 0.444 ' N ' ' CD1' ' A' ' 501' ' ' TYR . 0.4 OUTLIER -75.82 -49.92 16.63 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 -175.561 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 503' ' ' LYS . . . . . 0.631 ' O ' ' CG ' ' A' ' 507' ' ' LYS . 4.8 mttt -119.31 133.8 55.54 Favored 'General case' 0 CA--C 1.522 -0.113 0 CA-C-N 118.985 0.811 . . . . 0.0 112.094 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 504' ' ' THR . . . . . 0.629 HG23 HD13 ' A' ' 568' ' ' ILE . 2.0 m -73.56 -75.12 0.16 Allowed 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.635 -0.711 . . . . 0.0 112.918 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 505' ' ' PHE . . . . . 0.986 ' CE1' HG23 ' A' ' 532' ' ' VAL . 7.3 m-85 -74.37 -62.9 1.36 Allowed 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -178.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 506' ' ' SER . . . . . 0.772 ' O ' ' CD1' ' A' ' 510' ' ' TRP . 7.6 t -49.28 -72.59 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -175.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 507' ' ' LYS . . . . . 0.679 ' HD3' ' N ' ' A' ' 508' ' ' VAL . 0.0 OUTLIER -48.99 -48.52 43.39 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -176.37 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 508' ' ' VAL . . . . . 0.881 ' CG2' HD21 ' A' ' 574' ' ' LEU . 89.1 t -52.89 -59.03 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -179.316 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 509' ' ' LEU . . . . . 0.856 ' O ' HD23 ' A' ' 514' ' ' LEU . 3.0 pp -60.42 -61.84 2.3 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 -176.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 510' ' ' TRP . . . . . 0.847 ' N ' HD12 ' A' ' 509' ' ' LEU . 65.1 p-90 -72.2 -49.74 33.06 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -176.146 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 511' ' ' SER . . . . . 0.497 ' N ' ' CE3' ' A' ' 510' ' ' TRP . 0.5 OUTLIER -64.95 -47.39 77.81 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.164 -0.926 . . . . 0.0 112.898 -177.089 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 512' ' ' ALA . . . . . 0.89 ' HB2' HD22 ' A' ' 495' ' ' LEU . . . -71.19 -73.97 0.16 Allowed 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 117.398 2.37 . . . . 0.0 117.398 -174.307 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 513' ' ' GLY . . . . . 0.46 ' CA ' ' HB ' ' A' ' 493' ' ' VAL . . . -115.95 -36.11 1.18 Allowed Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 121.73 3.452 . . . . 0.0 121.73 -172.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 514' ' ' LEU . . . . . 0.856 HD23 ' O ' ' A' ' 509' ' ' LEU . 0.5 OUTLIER -108.96 -39.11 5.4 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 120.431 3.493 . . . . 0.0 120.431 -169.646 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 515' ' ' VAL . . . . . 0.957 HG13 ' HB2' ' A' ' 517' ' ' SER . 13.7 p -153.18 172.12 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 118.053 2.612 . . . . 0.0 118.053 -171.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 516' ' ' ALA . . . . . 0.629 ' N ' HG22 ' A' ' 515' ' ' VAL . . . -69.07 2.64 2.59 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 112.559 -2.11 . . . . 0.0 110.753 177.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 517' ' ' SER . . . . . 0.957 ' HB2' HG13 ' A' ' 515' ' ' VAL . 0.5 OUTLIER -57.68 8.5 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 -172.221 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 518' ' ' LYS . . . . . 0.738 ' HA ' ' CD1' ' A' ' 510' ' ' TRP . 0.0 OUTLIER -46.66 -51.78 15.17 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 104.369 -2.456 . . . . 0.0 104.369 174.989 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 519' ' ' SER . . . . . . . . . . . . . 3.5 m -75.35 -57.45 3.89 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.146 173.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 520' ' ' GLU . . . . . 0.626 ' CB ' ' HA ' ' A' ' 517' ' ' SER . 0.0 OUTLIER -55.91 -47.85 76.73 Favored 'General case' 0 C--N 1.349 0.578 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.71 -179.042 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 521' ' ' GLY . . . . . 0.809 ' HA2' HD12 ' A' ' 524' ' ' ILE . . . -49.55 -55.37 13.74 Favored Glycine 0 CA--C 1.491 -1.42 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.543 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -47.73 -47.45 30.19 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 523' ' ' ARG . . . . . . . . . . . . . 1.6 ttt85 -50.49 -49.03 56.55 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.0 178.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 524' ' ' ILE . . . . . 0.809 HD12 ' HA2' ' A' ' 521' ' ' GLY . 12.7 mt -59.36 -55.26 24.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.237 0.542 . . . . 0.0 110.253 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 525' ' ' ILE . . . . . 0.896 HG23 ' CD1' ' A' ' 556' ' ' ILE . 0.9 OUTLIER -50.26 -47.49 25.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 177.864 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 526' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -56.1 -48.58 75.87 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 114.112 -1.404 . . . . 0.0 108.276 177.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 527' ' ' ASN . . . . . 0.414 ' HB3' ' HA ' ' A' ' 524' ' ' ILE . 0.0 OUTLIER -48.62 -39.76 25.2 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 113.754 -1.566 . . . . 0.0 107.778 176.639 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 528' ' ' ASN . . . . . 0.526 ' C ' HG21 ' A' ' 556' ' ' ILE . 1.3 t30 74.07 40.3 0.46 Allowed 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.227 -179.043 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 529' ' ' GLY . . . . . . . . . . . . . . . -115.98 36.36 3.87 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 114.619 -1.173 . . . . 0.0 111.569 178.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 530' ' ' ALA . . . . . 0.764 ' O ' ' HB ' ' A' ' 556' ' ' ILE . . . -132.8 164.96 25.68 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.656 0.741 . . . . 0.0 112.363 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 531' ' ' TYR . . . . . 0.609 ' HE1' ' CD1' ' A' ' 553' ' ' PHE . 3.2 t80 -134.52 149.55 50.68 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 124.634 1.174 . . . . 0.0 108.871 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 532' ' ' VAL . . . . . 0.986 HG23 ' CE1' ' A' ' 505' ' ' PHE . 1.1 t -129.96 136.1 59.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 CA-C-N 119.485 1.039 . . . . 0.0 112.216 179.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 533' ' ' GLY . . . . . 0.768 ' O ' HG13 ' A' ' 575' ' ' ILE . . . -133.11 147.4 18.97 Favored Glycine 0 N--CA 1.441 -1.022 0 CA-C-N 114.0 -1.454 . . . . 0.0 112.961 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 534' ' ' SER . . . . . 0.609 ' HB2' ' OG1' ' A' ' 552' ' ' THR . 38.5 m -134.79 143.53 47.13 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.584 -0.308 . . . . 0.0 111.072 178.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 535' ' ' ARG . . . . . 0.57 ' HA ' ' O ' ' A' ' 550' ' ' ASP . 3.0 tpp180 -159.03 89.08 2.1 Favored Pre-proline 0 C--N 1.33 -0.251 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 178.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 536' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -102.53 77.1 0.03 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 124.118 3.212 . . . . 0.0 112.164 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 115.79 111.59 2.77 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.124 -1.036 . . . . 0.0 112.698 -179.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 538' ' ' VAL . . . . . . . . . . . . . 6.4 p -43.4 -24.65 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 539' ' ' LYS . . . . . . . . . . . . . 3.9 pttt -46.39 147.35 1.17 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.301 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -127.68 30.7 5.27 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.589 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 541' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -71.91 99.18 2.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.199 0.523 . . . . 0.0 110.171 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 542' ' ' GLU . . . . . 0.614 ' O ' ' N ' ' A' ' 544' ' ' GLY . 34.5 mm-40 -110.74 96.9 30.76 Favored Pre-proline 0 C--N 1.321 -0.674 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.571 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 543' ' ' PRO . . . . . 0.652 ' O ' ' N ' ' A' ' 545' ' ' GLY . 68.0 Cg_exo -51.57 55.22 0.02 OUTLIER 'Trans proline' 0 N--CA 1.481 0.79 0 C-N-CA 124.12 3.213 . . . . 0.0 114.225 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 544' ' ' GLY . . . . . 0.623 ' C ' ' H ' ' A' ' 546' ' ' GLY . . . 53.58 -53.13 0.01 OUTLIER Glycine 0 CA--C 1.527 0.794 0 CA-C-O 119.504 -0.609 . . . . 0.0 114.414 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 545' ' ' GLY . . . . . 0.652 ' N ' ' O ' ' A' ' 543' ' ' PRO . . . -53.41 21.33 0.01 OUTLIER Glycine 0 CA--C 1.533 1.211 0 CA-C-N 117.959 0.88 . . . . 0.0 114.725 178.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 546' ' ' GLY . . . . . 0.623 ' H ' ' C ' ' A' ' 544' ' ' GLY . . . 53.11 -54.61 0.01 OUTLIER Glycine 0 CA--C 1.525 0.676 0 CA-C-O 119.089 -0.84 . . . . 0.0 114.253 -178.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 547' ' ' MET . . . . . 0.641 ' N ' ' O ' ' A' ' 545' ' ' GLY . 33.3 mmt 14.52 56.43 0.08 OUTLIER Pre-proline 0 N--CA 1.473 0.712 0 CA-C-N 118.019 0.91 . . . . 0.0 112.606 178.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 548' ' ' PRO . . . . . 0.586 ' HD3' ' C ' ' A' ' 546' ' ' GLY . 81.8 Cg_exo -46.28 119.5 3.1 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 121.66 1.573 . . . . 0.0 113.178 -177.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -126.08 -37.1 2.28 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.282 178.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 550' ' ' ASP . . . . . 0.57 ' O ' ' HA ' ' A' ' 535' ' ' ARG . 1.8 m-20 -70.82 -41.09 72.02 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.953 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 551' ' ' LEU . . . . . 0.769 HD11 ' CE1' ' A' ' 553' ' ' PHE . 7.2 tp -131.26 140.28 49.79 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.416 178.628 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 552' ' ' THR . . . . . 0.884 HG21 ' CG ' ' A' ' 567' ' ' PHE . 6.2 m -133.32 147.34 51.86 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.573 0.701 . . . . 0.0 111.987 179.256 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 553' ' ' PHE . . . . . 0.769 ' CE1' HD11 ' A' ' 551' ' ' LEU . 17.6 m-30 -132.86 136.22 46.09 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 177.023 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 554' ' ' THR . . . . . 0.647 ' OG1' HG12 ' A' ' 532' ' ' VAL . 19.2 m -135.04 139.68 32.71 Favored Pre-proline 0 C--N 1.314 -0.975 0 C-N-CA 118.851 -1.14 . . . . 0.0 113.245 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 555' ' ' PRO . . . . . 0.851 ' O ' HG22 ' A' ' 556' ' ' ILE . 5.8 Cg_exo -77.58 11.99 2.02 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.78 2.32 . . . . 0.0 112.789 179.155 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 556' ' ' ILE . . . . . 0.896 ' CD1' HG23 ' A' ' 525' ' ' ILE . 4.9 tp 62.37 34.42 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.335 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 177.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 557' ' ' LYS . . . . . 0.704 ' O ' ' CE2' ' A' ' 559' ' ' TRP . 33.3 mttt -103.37 133.23 48.77 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 558' ' ' THR . . . . . . . . . . . . . 3.4 t -58.05 116.5 3.56 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -172.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 559' ' ' TRP . . . . . 0.704 ' CE2' ' O ' ' A' ' 557' ' ' LYS . 0.0 OUTLIER -139.87 112.4 7.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 113.142 -1.844 . . . . 0.0 106.28 175.1 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 560' ' ' ASN . . . . . 0.649 ' O ' HG22 ' A' ' 564' ' ' THR . 86.0 m-20 -77.82 -75.96 0.2 Allowed 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 118.659 -1.216 . . . . 0.0 113.351 -176.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 561' ' ' ALA . . . . . 0.544 ' HA ' ' CG2' ' A' ' 564' ' ' THR . . . -75.14 -53.12 9.39 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 115.951 1.834 . . . . 0.0 115.951 -178.092 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 562' ' ' SER . . . . . . . . . . . . . 69.4 m -49.23 -54.95 14.23 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -176.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 563' ' ' LYS . . . . . 0.609 ' HB3' HG21 ' A' ' 504' ' ' THR . 0.2 OUTLIER -70.65 -47.91 57.61 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -178.188 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 564' ' ' THR . . . . . 0.788 HG23 ' H ' ' A' ' 565' ' ' GLN . 7.9 t -49.79 -68.02 0.21 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.847 0.356 . . . . 0.0 111.276 -179.223 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 565' ' ' GLN . . . . . 1.033 ' O ' HG23 ' A' ' 569' ' ' ILE . 2.4 tp60 -49.88 -47.0 52.16 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -49.42 -61.72 1.94 Allowed 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.861 -178.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 567' ' ' PHE . . . . . 0.884 ' CG ' HG21 ' A' ' 552' ' ' THR . 0.0 OUTLIER -97.15 -54.32 3.21 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.68 0.752 . . . . 0.0 111.875 -178.95 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 568' ' ' ILE . . . . . 0.853 HG13 HD13 ' A' ' 574' ' ' LEU . 1.7 mp -56.18 9.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 114.487 -1.233 . . . . 0.0 113.72 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 569' ' ' ILE . . . . . 1.033 HG23 ' O ' ' A' ' 565' ' ' GLN . 0.9 OUTLIER -54.56 -36.47 35.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 104.292 -2.484 . . . . 0.0 104.292 177.354 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 570' ' ' ASP . . . . . 0.487 ' OD2' HG13 ' A' ' 588' ' ' ILE . 7.7 p30 34.1 57.8 0.62 Allowed 'General case' 0 CA--C 1.502 -0.903 0 CA-C-N 113.716 -1.584 . . . . 0.0 112.04 174.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 571' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 570' ' ' ASP . . . -51.02 -45.22 51.11 Favored Glycine 0 N--CA 1.438 -1.172 0 C-N-CA 117.469 -2.301 . . . . 0.0 107.982 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 572' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -120.3 -16.74 8.4 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 175.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 573' ' ' LEU . . . . . 0.485 ' O ' ' CB ' ' A' ' 570' ' ' ASP . 2.2 tp -140.55 136.34 32.75 Favored 'General case' 0 C--N 1.355 0.823 0 N-CA-C 115.912 1.819 . . . . 0.0 115.912 -177.388 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 574' ' ' LEU . . . . . 0.901 HD12 ' N ' ' A' ' 575' ' ' ILE . 0.5 OUTLIER -135.94 132.73 36.81 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 173.422 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 575' ' ' ILE . . . . . 1.031 HG23 HD13 ' A' ' 585' ' ' LEU . 0.0 OUTLIER -134.3 139.98 46.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 118.858 0.754 . . . . 0.0 111.928 178.53 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 576' ' ' LEU . . . . . 0.683 HD11 HD21 ' A' ' 578' ' ' LEU . 0.0 OUTLIER -133.01 136.62 46.12 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 114.944 -1.025 . . . . 0.0 108.767 177.945 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 577' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.02 135.44 51.79 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 177.284 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.683 HD21 HD11 ' A' ' 576' ' ' LEU . 0.5 OUTLIER -126.94 132.02 50.95 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 177.973 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 579' ' ' GLY . . . . . . . . . . . . . . . -90.45 -2.26 73.53 Favored Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 115.092 -0.958 . . . . 0.0 113.493 -178.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 580' ' ' LYS . . . . . 0.473 ' O ' ' CD1' ' A' ' 581' ' ' TRP . 0.0 OUTLIER -70.84 -48.38 54.3 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 118.738 -1.185 . . . . 0.0 108.564 179.083 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 581' ' ' TRP . . . . . 0.473 ' CD1' ' O ' ' A' ' 580' ' ' LYS . 27.1 m0 -139.81 -53.37 0.53 Allowed 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 177.09 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 582' ' ' LYS . . . . . 0.424 ' O ' ' HB2' ' A' ' 578' ' ' LEU . 0.0 OUTLIER -140.5 165.44 27.43 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 -175.19 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 583' ' ' MET . . . . . 0.41 ' HB3' ' O ' ' A' ' 488' ' ' MET . 1.7 ttt -109.04 135.0 50.93 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 173.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 584' ' ' LYS . . . . . 0.836 ' NZ ' HG23 ' A' ' 493' ' ' VAL . 10.9 tppt? -120.34 133.38 55.46 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 178.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 585' ' ' LEU . . . . . 1.031 HD13 HG23 ' A' ' 575' ' ' ILE . 0.9 OUTLIER -116.03 136.12 53.32 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.839 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 586' ' ' VAL . . . . . 0.859 ' N ' HD12 ' A' ' 585' ' ' LEU . 85.8 t -132.94 137.49 53.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-O 121.053 0.454 . . . . 0.0 111.721 -178.227 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 587' ' ' SER . . . . . 0.879 ' C ' HD13 ' A' ' 588' ' ' ILE . 58.8 m -106.63 135.79 47.53 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 177.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.879 HD13 ' C ' ' A' ' 587' ' ' SER . 0.0 OUTLIER -133.41 136.75 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -177.581 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 589' ' ' VAL . . . . . 0.488 ' N ' ' HB2' ' A' ' 497' ' ' LYS . 5.6 m -132.6 137.14 54.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.635 178.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 590' ' ' SER . . . . . . . . . . . . . 10.7 t -68.02 162.19 25.03 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.984 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 591' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -50.76 -48.87 59.12 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.879 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.1 -55.19 35.42 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -178.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 9.9 mttt -51.56 -55.16 20.72 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.45 0.643 . . . . 0.0 110.807 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 594' ' ' PHE . . . . . 0.972 ' CD1' HD11 ' A' ' 597' ' ' LEU . 13.2 t80 -50.31 -47.39 55.67 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.583 179.116 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 595' ' ' LYS . . . . . 0.816 ' HE3' HG21 ' A' ' 608' ' ' VAL . 0.6 OUTLIER -49.47 -48.15 47.93 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.315 179.422 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 596' ' ' GLU . . . . . 0.67 ' O ' HD23 ' A' ' 599' ' ' LEU . 3.8 tt0 -58.82 -62.92 1.51 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.572 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 597' ' ' LEU . . . . . 0.972 HD11 ' CD1' ' A' ' 594' ' ' PHE . 2.8 pp -48.77 -50.97 31.6 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.183 0.516 . . . . 0.0 112.12 -178.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 598' ' ' GLY . . . . . 0.893 ' N ' HD12 ' A' ' 597' ' ' LEU . . . -93.79 11.16 71.55 Favored Glycine 0 N--CA 1.446 -0.7 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.699 -179.316 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 599' ' ' LEU . . . . . 0.67 HD23 ' O ' ' A' ' 596' ' ' GLU . 4.0 pp -50.02 -5.32 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -177.113 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 600' ' ' THR . . . . . 0.57 HG22 ' O ' ' A' ' 600' ' ' THR . 31.5 m -129.8 67.38 1.46 Allowed 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 121.699 0.761 . . . . 0.0 110.964 178.222 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 601' ' ' ALA . . . . . 1.056 ' HB1' ' HD2' ' A' ' 602' ' ' PRO . . . -131.53 -173.51 0.34 Allowed Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 114.463 -1.244 . . . . 0.0 109.494 179.171 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 602' ' ' PRO . . . . . 1.056 ' HD2' ' HB1' ' A' ' 601' ' ' ALA . 49.2 Cg_endo -70.29 -33.82 13.91 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 121.609 1.539 . . . . 0.0 112.64 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 603' ' ' GLY . . . . . . . . . . . . . . . -71.47 -49.13 26.56 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.911 -0.662 . . . . 0.0 113.295 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 604' ' ' TRP . . . . . 0.895 ' CD1' ' HB3' ' A' ' 601' ' ' ALA . 1.5 m95 -71.36 -46.57 60.13 Favored 'General case' 0 CA--C 1.512 -0.503 0 C-N-CA 122.833 0.453 . . . . 0.0 111.47 -178.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 605' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -50.02 -57.31 7.84 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.315 -179.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 606' ' ' GLU . . . . . 0.418 ' O ' ' HB2' ' A' ' 610' ' ' LYS . 1.2 tt0 -61.1 -62.58 1.75 Allowed 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 607' ' ' VAL . . . . . . . . . . . . . 54.6 t -56.65 -72.55 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 114.53 1.307 . . . . 0.0 114.53 -178.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 608' ' ' VAL . . . . . 0.816 HG21 ' HE3' ' A' ' 595' ' ' LYS . 53.0 t -64.91 -54.13 33.39 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -177.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 609' ' ' GLY . . . . . . . . . . . . . . . -61.94 -63.95 4.35 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 121.196 -0.526 . . . . 0.0 113.656 -178.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 610' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 606' ' ' GLU . 1.7 mtpm? -67.57 -50.75 56.94 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.695 0.283 . . . . 0.0 111.151 -179.447 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 81.32 56.52 2.99 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.508 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 36.2 tttt -56.53 -28.58 60.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.737 0.303 . . . . 0.0 111.008 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 613' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -59.92 -174.79 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.879 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -72.75 -60.87 1.8 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.964 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 615' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.98 95.5 0.74 Allowed 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.541 2.161 . . . . 0.0 112.266 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 616' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -79.98 113.59 39.49 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.913 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo . . . . . 0 C--O 1.249 1.055 0 C-N-CA 122.39 2.06 . . . . 0.0 112.311 -179.984 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 81.6 mmm . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.756 0.313 . . . . 0.0 111.236 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 455' ' ' PRO . . . . . 0.677 ' HG2' ' HB2' ' A' ' 458' ' ' ALA . 54.9 Cg_endo -69.75 157.4 60.52 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.556 2.171 . . . . 0.0 112.308 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 456' ' ' ARG . . . . . . . . . . . . . 7.7 ptt85 -72.18 -25.69 61.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.047 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 40.8 p -95.84 39.54 1.13 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.964 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 458' ' ' ALA . . . . . 0.677 ' HB2' ' HG2' ' A' ' 455' ' ' PRO . . . -103.31 150.32 23.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.087 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.03 148.51 34.58 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.911 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -52.66 -178.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.558 2.172 . . . . 0.0 112.32 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . 94.07 56.62 1.37 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.492 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -82.64 143.26 46.89 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.613 0.244 . . . . 0.0 110.812 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.93 176.66 8.04 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.466 2.111 . . . . 0.0 112.303 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 464' ' ' LYS . . . . . 0.46 ' HD3' HG12 ' A' ' 471' ' ' VAL . 0.0 OUTLIER -119.43 168.01 11.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.893 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 2.7 m -99.76 -56.54 2.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.897 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.01 -40.16 92.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.919 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 467' ' ' LEU . . . . . 0.688 HD23 HG23 ' A' ' 471' ' ' VAL . 3.8 mm? -118.22 175.21 5.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.889 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 83.9 p -88.88 43.55 1.15 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.798 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 128.91 -37.1 2.28 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.885 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -131.74 117.74 19.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.784 0.326 . . . . 0.0 110.784 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 471' ' ' VAL . . . . . 0.688 HG23 HD23 ' A' ' 467' ' ' LEU . 10.7 p -113.03 108.27 25.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.21 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 34.1 p-10 -177.49 146.13 0.61 Allowed Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.906 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -73.48 95.77 0.88 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.611 2.207 . . . . 0.0 112.333 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 29.3 pt20 -136.04 34.13 2.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.914 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 1.9 t -137.99 35.75 2.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.868 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 476' ' ' GLY . . . . . . . . . . . . . . . 132.87 60.35 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.488 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 477' ' ' ASN . . . . . 0.422 ' N ' ' HD2' ' A' ' 478' ' ' PRO . 4.6 t30 -50.27 -51.58 61.93 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 120.577 0.227 . . . . 0.0 111.246 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 478' ' ' PRO . . . . . 0.422 ' HD2' ' N ' ' A' ' 477' ' ' ASN . 90.2 Cg_endo -81.67 -39.78 0.17 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.519 2.146 . . . . 0.0 112.543 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 25.7 m-70 -90.66 119.51 30.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.112 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 480' ' ' ALA . . . . . 0.915 ' HB1' ' CG2' ' A' ' 483' ' ' THR . . . -75.73 120.28 80.92 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.003 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -60.54 -78.39 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.328 2.018 . . . . 0.0 112.464 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 482' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.7 26.18 3.38 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.601 0.238 . . . . 0.0 111.065 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 483' ' ' THR . . . . . 0.915 ' CG2' ' HB1' ' A' ' 480' ' ' ALA . 1.9 t -70.85 66.63 0.37 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.952 0.405 . . . . 0.0 110.971 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 484' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -130.31 -69.48 0.66 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.619 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 485' ' ' PHE . . . . . 0.406 ' O ' ' CG ' ' A' ' 488' ' ' MET . 26.7 m-85 -70.84 -49.37 46.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.861 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -69.03 -47.79 64.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.919 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 487' ' ' ASN . . . . . 0.605 ' HB3' ' HD3' ' A' ' 489' ' ' PRO . 0.3 OUTLIER -66.78 -48.67 68.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.481 -179.829 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 488' ' ' MET . . . . . 0.541 ' N ' ' HD3' ' A' ' 489' ' ' PRO . 0.0 OUTLIER 52.12 51.63 10.04 Favored Pre-proline 0 N--CA 1.466 0.328 0 CA-C-O 120.669 0.271 . . . . 0.0 110.797 -179.669 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 489' ' ' PRO . . . . . 0.605 ' HD3' ' HB3' ' A' ' 487' ' ' ASN . 61.7 Cg_endo -88.59 22.76 0.82 Allowed 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.644 2.23 . . . . 0.0 114.226 -178.453 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.56 -69.62 0.76 Allowed 'General case' 0 N--CA 1.461 0.121 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.94 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 491' ' ' ALA . . . . . 0.506 ' HB1' ' HZ3' ' A' ' 584' ' ' LYS . . . -135.92 135.04 39.32 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.131 177.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 492' ' ' ARG . . . . . 0.882 ' CD ' HD22 ' A' ' 585' ' ' LEU . 2.7 mmm180 -137.8 132.67 33.0 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.535 176.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 493' ' ' VAL . . . . . 0.985 ' CG2' HG22 ' A' ' 586' ' ' VAL . 16.9 m -138.25 163.78 28.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 178.324 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 79.6 p -116.94 132.56 56.67 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 176.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 495' ' ' LEU . . . . . 0.832 HD12 ' HD2' ' A' ' 496' ' ' PRO . 0.0 OUTLIER -137.1 164.5 41.68 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.23 -179.556 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 496' ' ' PRO . . . . . 0.832 ' HD2' HD12 ' A' ' 495' ' ' LEU . 2.8 Cg_exo -76.94 119.95 5.28 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.045 2.497 . . . . 0.0 110.947 178.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 497' ' ' LYS . . . . . 0.82 ' N ' HG22 ' A' ' 588' ' ' ILE . 15.6 tttm -53.24 -29.78 34.5 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -177.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 498' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.9 -49.12 78.73 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -177.086 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 499' ' ' LEU . . . . . 0.774 HD21 ' HD2' ' A' ' 496' ' ' PRO . 2.0 pp -74.38 -8.82 57.55 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -178.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 500' ' ' VAL . . . . . 0.75 HG22 HG12 ' A' ' 568' ' ' ILE . 0.9 OUTLIER -74.98 -25.66 18.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.455 0.645 . . . . 0.0 111.678 -179.029 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 501' ' ' TYR . . . . . 0.631 ' O ' ' CG2' ' A' ' 564' ' ' THR . 0.3 OUTLIER -57.26 -29.48 63.86 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 114.981 1.475 . . . . 0.0 114.981 -178.288 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -75.99 -50.16 15.63 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 116.306 1.965 . . . . 0.0 116.306 -174.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 503' ' ' LYS . . . . . 0.576 ' O ' ' CG ' ' A' ' 507' ' ' LYS . 3.3 mttm -119.1 137.88 53.27 Favored 'General case' 0 N--CA 1.46 0.066 0 CA-C-N 119.27 0.941 . . . . 0.0 112.204 -178.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 504' ' ' THR . . . . . 0.819 HG23 ' CE1' ' A' ' 567' ' ' PHE . 24.8 m -73.52 -76.99 0.11 Allowed 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 505' ' ' PHE . . . . . 0.653 ' CZ ' ' HB1' ' A' ' 530' ' ' ALA . 0.2 OUTLIER -75.7 -61.12 2.03 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -179.164 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 506' ' ' SER . . . . . 0.668 ' O ' ' CD1' ' A' ' 510' ' ' TRP . 62.2 m -48.98 -72.75 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -175.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 507' ' ' LYS . . . . . 0.68 ' HD3' ' N ' ' A' ' 508' ' ' VAL . 0.0 OUTLIER -49.2 -48.22 45.51 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -176.673 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 508' ' ' VAL . . . . . 0.88 HG13 HD21 ' A' ' 574' ' ' LEU . 69.8 t -52.46 -59.2 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 509' ' ' LEU . . . . . 0.73 HD12 ' N ' ' A' ' 510' ' ' TRP . 1.9 pp -60.18 -60.89 3.1 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 -177.052 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 510' ' ' TRP . . . . . 0.73 ' N ' HD12 ' A' ' 509' ' ' LEU . 51.4 p-90 -72.26 -51.75 19.48 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -176.15 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 511' ' ' SER . . . . . 0.541 ' N ' ' CD2' ' A' ' 510' ' ' TRP . 0.4 OUTLIER -63.98 -47.99 78.18 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.884 -177.238 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 512' ' ' ALA . . . . . 0.759 ' HB3' ' O ' ' A' ' 508' ' ' VAL . . . -71.46 -73.66 0.17 Allowed 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 117.073 2.249 . . . . 0.0 117.073 -174.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 513' ' ' GLY . . . . . 0.816 ' CA ' HG21 ' A' ' 493' ' ' VAL . . . -115.84 -35.77 1.22 Allowed Glycine 0 CA--C 1.507 -0.468 0 N-CA-C 121.558 3.383 . . . . 0.0 121.558 -173.025 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 514' ' ' LEU . . . . . 0.661 ' HG ' ' HE2' ' A' ' 584' ' ' LYS . 0.0 OUTLIER -107.69 -45.45 4.02 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 119.898 3.296 . . . . 0.0 119.898 -169.195 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 515' ' ' VAL . . . . . 0.596 HG22 ' N ' ' A' ' 516' ' ' ALA . 9.9 p -145.1 172.3 4.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 117.927 2.566 . . . . 0.0 117.927 -171.223 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 516' ' ' ALA . . . . . 0.596 ' N ' HG22 ' A' ' 515' ' ' VAL . . . -89.87 0.53 56.99 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 113.25 -1.796 . . . . 0.0 108.663 178.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 517' ' ' SER . . . . . 0.996 ' O ' ' N ' ' A' ' 521' ' ' GLY . 4.0 p -61.44 10.26 0.02 OUTLIER 'General case' 0 N--CA 1.426 -1.64 0 C-N-CA 126.171 1.788 . . . . 0.0 115.289 -173.523 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 518' ' ' LYS . . . . . 0.626 ' HB2' ' CE2' ' A' ' 510' ' ' TRP . 0.8 OUTLIER -42.73 -39.75 2.55 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 105.426 -2.064 . . . . 0.0 105.426 178.221 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 519' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.68 -54.25 8.54 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 114.891 -1.049 . . . . 0.0 108.217 172.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 520' ' ' GLU . . . . . 0.708 ' O ' HD12 ' A' ' 524' ' ' ILE . 0.2 OUTLIER -67.67 -48.07 67.68 Favored 'General case' 0 C--N 1.35 0.626 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.373 179.845 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 521' ' ' GLY . . . . . 0.996 ' N ' ' O ' ' A' ' 517' ' ' SER . . . -49.6 -52.81 23.35 Favored Glycine 0 CA--C 1.494 -1.248 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 178.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 522' ' ' GLN . . . . . 0.497 ' HA ' HG12 ' A' ' 525' ' ' ILE . 3.8 mm-40 -48.19 -47.48 35.31 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.066 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 523' ' ' ARG . . . . . 0.418 ' O ' ' HB3' ' A' ' 526' ' ' ASN . 0.0 OUTLIER -49.99 -49.16 51.45 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.736 178.855 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 524' ' ' ILE . . . . . 0.708 HD12 ' O ' ' A' ' 520' ' ' GLU . 4.3 mp -59.3 -51.79 68.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.466 0.651 . . . . 0.0 109.412 179.045 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 525' ' ' ILE . . . . . 0.937 HG23 ' CD1' ' A' ' 556' ' ' ILE . 1.2 mm -50.66 -47.42 28.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 177.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 526' ' ' ASN . . . . . 0.418 ' HB3' ' O ' ' A' ' 523' ' ' ARG . 18.3 t-20 -58.69 -47.93 82.83 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 114.253 -1.339 . . . . 0.0 108.321 177.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 527' ' ' ASN . . . . . 0.454 ' HB3' ' HA ' ' A' ' 524' ' ' ILE . 0.0 OUTLIER -48.09 -39.57 20.68 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 113.994 -1.457 . . . . 0.0 107.477 176.604 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 528' ' ' ASN . . . . . 0.629 ' HA ' ' CG2' ' A' ' 556' ' ' ILE . 1.8 t30 74.2 40.98 0.41 Allowed 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.867 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 529' ' ' GLY . . . . . . . . . . . . . . . -113.96 29.3 7.83 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-N 115.118 -0.946 . . . . 0.0 112.516 178.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 530' ' ' ALA . . . . . 0.927 ' O ' ' HB ' ' A' ' 556' ' ' ILE . . . -133.53 164.27 27.53 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.216 0.532 . . . . 0.0 112.423 -179.11 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 531' ' ' TYR . . . . . 0.516 ' CE1' ' CD1' ' A' ' 553' ' ' PHE . 0.0 OUTLIER -134.59 152.53 51.84 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 177.601 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 532' ' ' VAL . . . . . 0.663 HG12 ' OG1' ' A' ' 554' ' ' THR . 0.5 OUTLIER -129.2 135.8 61.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 CA-C-O 122.003 0.906 . . . . 0.0 112.121 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 533' ' ' GLY . . . . . 0.65 ' O ' HG13 ' A' ' 575' ' ' ILE . . . -133.74 161.71 24.33 Favored Glycine 0 N--CA 1.441 -1.016 0 CA-C-N 114.32 -1.309 . . . . 0.0 114.48 -179.376 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 534' ' ' SER . . . . . 0.47 ' N ' ' HB ' ' A' ' 552' ' ' THR . 5.3 t -134.05 141.89 47.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.834 -0.683 . . . . 0.0 110.626 178.469 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 535' ' ' ARG . . . . . 0.734 ' HB3' HD22 ' A' ' 573' ' ' LEU . 0.0 OUTLIER -159.55 90.74 1.89 Allowed Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 178.829 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 536' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 550' ' ' ASP . 71.9 Cg_endo -75.71 -35.48 2.64 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.655 2.236 . . . . 0.0 112.413 178.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 115.47 22.19 4.87 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.666 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 538' ' ' VAL . . . . . 0.592 HG12 ' O ' ' A' ' 538' ' ' VAL . 16.0 t -116.28 18.55 7.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.719 0.295 . . . . 0.0 111.237 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 539' ' ' LYS . . . . . 0.539 ' CG ' ' O ' ' A' ' 539' ' ' LYS . 1.0 OUTLIER -46.81 97.9 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.677 0.751 . . . . 0.0 111.896 -179.114 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.29 17.04 6.59 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.566 179.199 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 541' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 -96.51 99.92 11.54 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 121.092 0.472 . . . . 0.0 111.062 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 542' ' ' GLU . . . . . 0.439 ' CB ' ' HD2' ' A' ' 543' ' ' PRO . 0.7 OUTLIER -49.11 177.22 0.04 OUTLIER Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.863 179.509 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 543' ' ' PRO . . . . . 0.439 ' HD2' ' CB ' ' A' ' 542' ' ' GLU . 59.8 Cg_exo -39.31 -41.1 2.07 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.744 2.296 . . . . 0.0 112.972 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 544' ' ' GLY . . . . . 0.606 ' O ' ' N ' ' A' ' 546' ' ' GLY . . . -50.58 -22.3 5.43 Favored Glycine 0 CA--C 1.521 0.424 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.747 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 545' ' ' GLY . . . . . 0.548 ' C ' ' HD3' ' A' ' 548' ' ' PRO . . . 52.93 -53.21 0.01 OUTLIER Glycine 0 CA--C 1.525 0.71 0 N-CA-C 114.878 0.711 . . . . 0.0 114.878 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 546' ' ' GLY . . . . . 0.606 ' N ' ' O ' ' A' ' 544' ' ' GLY . . . 51.62 55.07 21.87 Favored Glycine 0 CA--C 1.523 0.572 0 CA-C-N 118.225 1.012 . . . . 0.0 113.538 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 547' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER 53.09 55.73 13.94 Favored Pre-proline 0 N--CA 1.466 0.347 0 CA-C-N 117.264 0.532 . . . . 0.0 110.916 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 548' ' ' PRO . . . . . 0.548 ' HD3' ' C ' ' A' ' 545' ' ' GLY . 53.8 Cg_endo -70.5 166.77 27.42 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.05 2.5 . . . . 0.0 113.089 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 549' ' ' ASP . . . . . 0.534 ' HB3' HD11 ' A' ' 569' ' ' ILE . 16.7 m-20 -123.98 -15.39 6.88 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.786 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 550' ' ' ASP . . . . . 0.545 ' O ' ' HA ' ' A' ' 535' ' ' ARG . 3.9 p30 -50.89 -36.47 38.22 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.722 0.773 . . . . 0.0 108.995 178.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 551' ' ' LEU . . . . . . . . . . . . . 13.6 tp -131.39 139.22 49.41 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.524 -1.216 . . . . 0.0 107.881 177.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 552' ' ' THR . . . . . 0.883 HG21 ' CB ' ' A' ' 567' ' ' PHE . 6.9 m -133.76 148.07 51.35 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.683 0.754 . . . . 0.0 111.842 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 553' ' ' PHE . . . . . 0.516 ' CD1' ' CE1' ' A' ' 531' ' ' TYR . 9.9 m-85 -134.09 137.91 44.93 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.788 -1.097 . . . . 0.0 108.402 177.353 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 554' ' ' THR . . . . . 0.901 HG22 ' H ' ' A' ' 556' ' ' ILE . 2.0 m -132.23 138.57 32.57 Favored Pre-proline 0 C--N 1.307 -1.278 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 178.348 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 555' ' ' PRO . . . . . 0.837 ' O ' HG22 ' A' ' 556' ' ' ILE . 67.6 Cg_endo -84.54 19.21 1.42 Allowed 'Trans proline' 0 N--CA 1.446 -1.311 0 C-N-CA 121.664 1.576 . . . . 0.0 111.918 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 556' ' ' ILE . . . . . 0.937 ' CD1' HG23 ' A' ' 525' ' ' ILE . 3.8 tp 61.21 31.77 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 177.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.85 119.84 39.97 Favored 'General case' 0 CA--C 1.501 -0.925 0 N-CA-C 104.36 -2.459 . . . . 0.0 104.36 178.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 558' ' ' THR . . . . . . . . . . . . . 3.3 t -56.76 116.98 3.48 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-O 122.576 1.179 . . . . 0.0 114.084 -171.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 559' ' ' TRP . . . . . 0.447 ' HB2' ' CB ' ' A' ' 563' ' ' LYS . 5.3 m0 -137.05 111.49 8.57 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 104.521 -2.4 . . . . 0.0 104.521 175.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 560' ' ' ASN . . . . . 0.603 ' O ' HG22 ' A' ' 564' ' ' THR . 84.4 m-20 -77.15 -75.59 0.2 Allowed 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -174.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 561' ' ' ALA . . . . . 0.551 ' HA ' HG22 ' A' ' 564' ' ' THR . . . -74.19 -57.27 4.06 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 116.055 1.872 . . . . 0.0 116.055 -177.211 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 562' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -49.59 -53.59 23.03 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -177.154 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 563' ' ' LYS . . . . . 0.648 ' CG ' HG21 ' A' ' 504' ' ' THR . 0.0 OUTLIER -69.38 -49.03 59.17 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.489 -178.439 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 564' ' ' THR . . . . . 0.649 HG23 ' H ' ' A' ' 565' ' ' GLN . 13.8 t -51.07 -65.22 0.59 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.567 0.222 . . . . 0.0 111.451 -178.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 565' ' ' GLN . . . . . 0.649 ' H ' HG23 ' A' ' 564' ' ' THR . 8.4 tp60 -48.95 -47.05 44.18 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.848 0.356 . . . . 0.0 111.053 179.208 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -49.5 -55.65 12.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 0.0 112.21 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 567' ' ' PHE . . . . . 0.914 ' CZ ' HD13 ' A' ' 568' ' ' ILE . 0.6 OUTLIER -96.89 -42.63 7.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.347 0.594 . . . . 0.0 112.46 -178.296 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 568' ' ' ILE . . . . . 0.923 HD11 HD22 ' A' ' 574' ' ' LEU . 1.2 tp -61.2 9.06 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 N-CA-C 113.939 1.088 . . . . 0.0 113.939 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 569' ' ' ILE . . . . . 0.6 HG23 ' O ' ' A' ' 565' ' ' GLN . 0.7 OUTLIER -54.46 -40.25 48.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 N-CA-C 104.005 -2.591 . . . . 0.0 104.005 178.295 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 570' ' ' ASP . . . . . 0.954 ' CG ' HD13 ' A' ' 588' ' ' ILE . 17.2 p30 32.13 56.84 0.36 Allowed 'General case' 0 CA--C 1.509 -0.599 0 CA-C-N 113.738 -1.574 . . . . 0.0 113.527 172.064 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 571' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 570' ' ' ASP . . . -51.3 -44.79 52.64 Favored Glycine 0 N--CA 1.44 -1.035 0 C-N-CA 116.819 -2.61 . . . . 0.0 108.575 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 572' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -120.29 -15.89 8.55 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 175.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 573' ' ' LEU . . . . . 0.734 HD22 ' HB3' ' A' ' 535' ' ' ARG . 1.1 tp -139.75 139.9 36.6 Favored 'General case' 0 C--N 1.353 0.746 0 N-CA-C 116.913 2.19 . . . . 0.0 116.913 -176.449 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 574' ' ' LEU . . . . . 0.977 ' HB3' HD11 ' A' ' 588' ' ' ILE . 0.3 OUTLIER -135.07 133.6 39.49 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 172.642 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 575' ' ' ILE . . . . . 0.895 ' N ' HD12 ' A' ' 574' ' ' LEU . 0.0 OUTLIER -134.12 137.24 52.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 118.623 0.647 . . . . 0.0 111.596 178.812 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 576' ' ' LEU . . . . . 0.594 HD22 ' HB3' ' A' ' 509' ' ' LEU . 0.0 OUTLIER -133.15 135.41 45.14 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 177.361 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 577' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -131.45 134.8 46.57 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 119.089 -1.045 . . . . 0.0 110.036 177.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.45 ' CG ' HD11 ' A' ' 576' ' ' LEU . 0.3 OUTLIER -122.46 132.2 54.23 Favored 'General case' 0 C--O 1.243 0.732 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.076 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 579' ' ' GLY . . . . . . . . . . . . . . . -88.18 -2.0 80.96 Favored Glycine 0 N--CA 1.44 -1.047 0 CA-C-N 114.901 -1.045 . . . . 0.0 113.411 -178.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 580' ' ' LYS . . . . . 0.591 ' CD ' ' CE2' ' A' ' 581' ' ' TRP . 0.0 OUTLIER -71.22 -49.65 41.16 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 118.656 -1.217 . . . . 0.0 108.441 179.279 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 581' ' ' TRP . . . . . 0.591 ' CE2' ' CD ' ' A' ' 580' ' ' LYS . 0.7 OUTLIER -140.92 -51.32 0.45 Allowed 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 175.823 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 582' ' ' LYS . . . . . 0.567 ' HE2' ' CD1' ' A' ' 581' ' ' TRP . 0.0 OUTLIER -139.76 165.29 27.69 Favored 'General case' 0 CA--C 1.512 -0.511 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -175.079 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 583' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.13 135.08 51.49 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 175.167 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 584' ' ' LYS . . . . . 0.661 ' HE2' ' HG ' ' A' ' 514' ' ' LEU . 9.1 tppt? -116.44 133.67 55.75 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 585' ' ' LEU . . . . . 0.882 HD22 ' CD ' ' A' ' 492' ' ' ARG . 7.7 tt -120.88 137.07 54.76 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -179.611 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 586' ' ' VAL . . . . . 0.985 HG22 ' CG2' ' A' ' 493' ' ' VAL . 55.9 t -131.95 137.01 55.78 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.777 -178.336 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 587' ' ' SER . . . . . . . . . . . . . 1.4 m -107.31 134.63 50.1 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 177.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.977 HD11 ' HB3' ' A' ' 574' ' ' LEU . 0.0 OUTLIER -135.98 136.4 49.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -177.754 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 6.1 m -133.58 136.81 53.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.943 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 590' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -82.62 162.52 21.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.565 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 591' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -50.58 -49.36 56.56 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.233 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -51.95 -49.57 62.9 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 120.987 0.423 . . . . 0.0 111.343 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 10.2 mmtm -56.65 -49.39 75.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.541 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 594' ' ' PHE . . . . . 0.702 ' O ' ' HG ' ' A' ' 597' ' ' LEU . 1.2 t80 -50.51 -48.55 56.94 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.518 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 595' ' ' LYS . . . . . 0.532 ' O ' ' HB3' ' A' ' 599' ' ' LEU . 6.3 mtpt -51.18 -50.5 58.87 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.328 0.585 . . . . 0.0 110.027 179.05 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 596' ' ' GLU . . . . . 0.414 ' O ' ' HG ' ' A' ' 599' ' ' LEU . 0.7 OUTLIER -50.43 -48.44 56.3 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.103 -0.953 . . . . 0.0 112.965 -179.647 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 597' ' ' LEU . . . . . 0.783 HD12 ' N ' ' A' ' 598' ' ' GLY . 3.2 pp -72.09 -57.67 4.07 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -177.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 598' ' ' GLY . . . . . 0.786 ' O ' ' CD1' ' A' ' 604' ' ' TRP . . . -86.34 11.68 62.69 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.761 -0.654 . . . . 0.0 113.33 -178.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 599' ' ' LEU . . . . . 0.894 HD12 HG23 ' A' ' 600' ' ' THR . 2.2 pp -48.82 -12.59 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -176.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 600' ' ' THR . . . . . 0.894 HG23 HD12 ' A' ' 599' ' ' LEU . 47.8 p -106.55 64.39 0.66 Allowed 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.027 177.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 601' ' ' ALA . . . . . 0.952 ' HB3' ' CD1' ' A' ' 604' ' ' TRP . . . -133.41 -173.54 0.35 Allowed Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.297 178.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 602' ' ' PRO . . . . . 0.816 ' CD ' ' HB1' ' A' ' 601' ' ' ALA . 3.5 Cg_exo -76.28 -33.07 3.6 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.579 2.186 . . . . 0.0 111.624 178.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 603' ' ' GLY . . . . . . . . . . . . . . . -71.44 -49.33 25.84 Favored Glycine 0 C--N 1.334 0.425 0 C-N-CA 121.079 -0.581 . . . . 0.0 113.072 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 604' ' ' TRP . . . . . 0.952 ' CD1' ' HB3' ' A' ' 601' ' ' ALA . 1.3 m95 -70.94 -47.18 60.43 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 120.846 0.355 . . . . 0.0 111.176 -179.3 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 605' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -50.79 -56.74 10.67 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.24 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 606' ' ' GLU . . . . . 0.411 ' O ' ' CB ' ' A' ' 610' ' ' LYS . 1.3 tt0 -57.23 -62.15 1.97 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.754 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 607' ' ' VAL . . . . . . . . . . . . . 40.1 t -64.31 -71.68 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 114.379 1.252 . . . . 0.0 114.379 -177.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 608' ' ' VAL . . . . . . . . . . . . . 62.1 t -56.17 -56.94 10.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.796 -178.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 609' ' ' GLY . . . . . . . . . . . . . . . -64.98 -63.51 4.14 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 121.151 -0.547 . . . . 0.0 113.402 -178.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 610' ' ' LYS . . . . . 0.411 ' CB ' ' O ' ' A' ' 606' ' ' GLU . 3.2 tttm -61.56 -49.94 74.64 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.81 0.338 . . . . 0.0 110.921 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 75.24 56.53 4.69 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.592 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.0 -29.68 68.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.748 0.309 . . . . 0.0 110.865 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 613' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -67.91 176.95 2.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.908 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 614' ' ' GLU . . . . . 0.404 ' CB ' ' CD ' ' A' ' 615' ' ' PRO . 13.4 mt-10 -73.01 -60.94 1.66 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.018 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 615' ' ' PRO . . . . . 0.404 ' CD ' ' CB ' ' A' ' 614' ' ' GLU . 59.1 Cg_endo -72.08 94.95 0.73 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.519 2.146 . . . . 0.0 112.323 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 616' ' ' SER . . . . . . . . . . . . . 3.2 m -75.37 156.89 85.22 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.856 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo . . . . . 0 C--O 1.248 0.992 0 C-N-CA 122.584 2.189 . . . . 0.0 112.293 -179.989 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.718 0.294 . . . . 0.0 111.208 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 455' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.23 118.41 4.56 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.542 2.162 . . . . 0.0 112.337 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 456' ' ' ARG . . . . . . . . . . . . . 1.4 ttm180 -66.66 -26.5 67.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.03 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 20.0 p -70.52 -51.05 31.53 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.858 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -59.95 115.92 3.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.117 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 1.4 m -90.26 149.67 41.68 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.925 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.01 -169.59 0.35 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.606 2.204 . . . . 0.0 112.313 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . 90.33 56.55 1.78 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.557 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -152.17 156.63 33.94 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 120.743 0.306 . . . . 0.0 110.887 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -68.47 119.05 6.07 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.673 2.249 . . . . 0.0 112.273 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 27.9 mttt -99.67 126.24 45.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.9 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.03 -73.99 0.58 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.82 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 27.8 m -111.72 33.75 4.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.846 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -136.5 81.8 1.9 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.903 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.78 43.49 1.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.753 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 129.07 -34.76 2.75 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.053 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -112.82 117.8 33.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.822 0.344 . . . . 0.0 110.393 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 471' ' ' VAL . . . . . 0.572 ' O ' HG13 ' A' ' 471' ' ' VAL . 9.9 p -113.08 107.97 24.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.034 0.445 . . . . 0.0 111.255 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 23.3 t30 -177.89 85.63 0.24 Allowed Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.841 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -63.75 157.24 53.03 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.627 2.218 . . . . 0.0 112.213 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -85.23 -50.99 6.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.79 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 1.5 m -138.05 -46.35 0.52 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.835 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 476' ' ' GLY . . . . . . . . . . . . . . . 127.36 -41.71 1.56 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.527 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 477' ' ' ASN . . . . . 0.55 ' N ' ' HD3' ' A' ' 478' ' ' PRO . 27.9 t-20 47.78 53.37 13.99 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 120.511 0.196 . . . . 0.0 111.473 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 478' ' ' PRO . . . . . 0.55 ' HD3' ' N ' ' A' ' 477' ' ' ASN . 37.6 Cg_exo -55.77 -69.25 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.241 1.961 . . . . 0.0 112.314 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -124.68 85.06 2.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.05 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 480' ' ' ALA . . . . . 0.418 ' CB ' ' HB2' ' A' ' 485' ' ' PHE . . . -140.48 131.64 13.98 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.213 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 481' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 480' ' ' ALA . 39.0 Cg_exo -59.08 -69.5 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.211 1.941 . . . . 0.0 111.931 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 482' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -135.33 -73.46 0.46 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.661 179.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 483' ' ' THR . . . . . . . . . . . . . 1.9 t -137.61 65.26 1.49 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.072 0.463 . . . . 0.0 110.858 178.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 484' ' ' ASN . . . . . 0.444 ' O ' ' HD3' ' A' ' 489' ' ' PRO . 34.1 t30 -130.94 -69.22 0.65 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.481 0.658 . . . . 0.0 109.653 178.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 485' ' ' PHE . . . . . 0.54 ' HA ' ' HG2' ' A' ' 489' ' ' PRO . 3.6 m-85 -70.71 -46.73 62.56 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.871 179.021 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 486' ' ' ALA . . . . . 0.4 ' CB ' ' ND2' ' A' ' 477' ' ' ASN . . . -72.39 -47.42 49.44 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -177.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -68.06 -74.6 0.12 Allowed 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 -176.012 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 488' ' ' MET . . . . . 0.526 ' CB ' ' HD3' ' A' ' 489' ' ' PRO . 0.4 OUTLIER -52.86 -52.63 63.11 Favored Pre-proline 0 N--CA 1.469 0.522 0 CA-C-O 121.176 0.513 . . . . 0.0 111.335 -178.961 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 489' ' ' PRO . . . . . 0.54 ' HG2' ' HA ' ' A' ' 485' ' ' PHE . 2.5 Cg_endo -86.19 43.88 1.18 Allowed 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 124.646 3.564 . . . . 0.0 112.257 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 14.3 p -36.43 -37.16 0.12 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.631 -178.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 491' ' ' ALA . . . . . 0.422 ' CB ' ' NZ ' ' A' ' 584' ' ' LYS . . . -133.41 135.0 44.36 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.63 177.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 492' ' ' ARG . . . . . 0.46 ' HD3' ' HG ' ' A' ' 585' ' ' LEU . 0.0 OUTLIER -136.39 134.93 38.32 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 179.434 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 493' ' ' VAL . . . . . 0.585 ' HB ' ' CA ' ' A' ' 513' ' ' GLY . 75.2 t -135.2 163.48 35.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.68 177.496 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 494' ' ' THR . . . . . 0.579 ' N ' HG12 ' A' ' 493' ' ' VAL . 18.5 m -123.85 135.3 53.66 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.153 0.502 . . . . 0.0 111.201 178.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 495' ' ' LEU . . . . . 0.804 ' O ' HG22 ' A' ' 588' ' ' ILE . 0.0 OUTLIER -134.46 163.7 49.31 Favored Pre-proline 0 CA--C 1.531 0.239 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.298 179.546 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 496' ' ' PRO . . . . . 0.569 ' HB2' HD12 ' A' ' 499' ' ' LEU . 32.5 Cg_exo -57.45 120.06 7.72 Favored 'Trans proline' 0 CA--C 1.532 0.393 0 C-N-CA 122.225 1.95 . . . . 0.0 112.358 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 497' ' ' LYS . . . . . 0.54 ' CA ' ' HB ' ' A' ' 588' ' ' ILE . 0.9 OUTLIER -56.9 -30.31 63.81 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.663 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 498' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.79 -48.34 66.94 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.267 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 499' ' ' LEU . . . . . 0.612 ' O ' ' HE3' ' A' ' 507' ' ' LYS . 0.3 OUTLIER -73.45 -8.85 57.61 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.605 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 500' ' ' VAL . . . . . 0.833 HG22 ' CG2' ' A' ' 568' ' ' ILE . 0.3 OUTLIER -60.06 -24.98 31.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.362 0.601 . . . . 0.0 111.113 -179.836 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 501' ' ' TYR . . . . . 0.56 ' O ' ' CG2' ' A' ' 564' ' ' THR . 0.1 OUTLIER -71.24 -29.9 65.68 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 115.027 1.492 . . . . 0.0 115.027 -177.598 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 502' ' ' ASP . . . . . 0.402 ' OD1' ' CZ ' ' A' ' 501' ' ' TYR . 11.3 m-20 -75.2 -51.22 13.88 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 116.057 1.873 . . . . 0.0 116.057 -174.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 503' ' ' LYS . . . . . 0.627 ' O ' ' CG ' ' A' ' 507' ' ' LYS . 7.4 mttt -120.73 134.48 55.28 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-N 119.346 0.976 . . . . 0.0 111.576 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 504' ' ' THR . . . . . 0.689 HG23 HD13 ' A' ' 568' ' ' ILE . 4.2 m -72.91 -76.25 0.12 Allowed 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 505' ' ' PHE . . . . . 0.54 ' CD1' HG13 ' A' ' 525' ' ' ILE . 12.6 p90 -75.26 -59.12 2.88 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 506' ' ' SER . . . . . 0.783 ' O ' ' CD1' ' A' ' 510' ' ' TRP . 5.2 t -49.39 -72.28 0.05 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 -175.563 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 507' ' ' LYS . . . . . 0.732 ' HD3' ' N ' ' A' ' 508' ' ' VAL . 0.0 OUTLIER -48.96 -49.12 42.06 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -176.231 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 508' ' ' VAL . . . . . 0.931 ' CG2' HD21 ' A' ' 574' ' ' LEU . 51.5 t -53.33 -60.02 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -179.085 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 509' ' ' LEU . . . . . 0.776 HD12 ' N ' ' A' ' 510' ' ' TRP . 2.6 pp -60.59 -62.69 1.68 Allowed 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 -177.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 510' ' ' TRP . . . . . 0.783 ' CD1' ' O ' ' A' ' 506' ' ' SER . 63.9 p-90 -72.86 -53.63 10.92 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 114.66 1.355 . . . . 0.0 114.66 -176.198 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 511' ' ' SER . . . . . 0.517 ' N ' ' CE3' ' A' ' 510' ' ' TRP . 1.7 t -65.48 -47.92 74.4 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.89 -177.194 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 512' ' ' ALA . . . . . 0.916 ' HB3' ' O ' ' A' ' 508' ' ' VAL . . . -71.64 -72.46 0.22 Allowed 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 117.184 2.291 . . . . 0.0 117.184 -174.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 513' ' ' GLY . . . . . 0.631 ' HA3' ' HE3' ' A' ' 584' ' ' LYS . . . -114.57 -34.88 1.49 Allowed Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 121.369 3.308 . . . . 0.0 121.369 -172.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 514' ' ' LEU . . . . . 0.585 ' HG ' ' HE2' ' A' ' 584' ' ' LYS . 1.7 mt -107.12 -46.49 3.89 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 119.579 3.178 . . . . 0.0 119.579 -170.207 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 515' ' ' VAL . . . . . 1.089 HG13 ' HB2' ' A' ' 517' ' ' SER . 4.7 p -154.28 173.16 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 117.617 2.451 . . . . 0.0 117.617 -171.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 516' ' ' ALA . . . . . 0.59 ' N ' HG22 ' A' ' 515' ' ' VAL . . . -67.84 3.83 1.36 Allowed 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 126.515 1.926 . . . . 0.0 110.078 177.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 517' ' ' SER . . . . . 1.089 ' HB2' HG13 ' A' ' 515' ' ' VAL . 0.4 OUTLIER -57.8 9.11 0.01 OUTLIER 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 115.979 1.844 . . . . 0.0 115.979 -172.213 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 518' ' ' LYS . . . . . 0.781 ' HA ' ' CD1' ' A' ' 510' ' ' TRP . 0.0 OUTLIER -45.56 -49.78 13.63 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 104.248 -2.501 . . . . 0.0 104.248 175.304 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 519' ' ' SER . . . . . . . . . . . . . 11.3 p -75.15 -56.93 4.23 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.2 173.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 520' ' ' GLU . . . . . 0.851 ' HB2' ' HA ' ' A' ' 517' ' ' SER . 0.8 OUTLIER -58.1 -47.41 83.31 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.023 -178.892 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 521' ' ' GLY . . . . . 0.805 ' N ' ' O ' ' A' ' 517' ' ' SER . . . -49.18 -55.99 11.3 Favored Glycine 0 CA--C 1.492 -1.39 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.273 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -47.74 -47.42 30.31 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 178.39 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 523' ' ' ARG . . . . . 0.449 ' O ' ' HB3' ' A' ' 526' ' ' ASN . 0.1 OUTLIER -50.36 -48.9 55.49 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.786 178.534 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 524' ' ' ILE . . . . . 0.722 HD13 ' HE3' ' A' ' 580' ' ' LYS . 1.7 mt -57.33 -55.77 18.95 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 CA-C-O 121.571 0.7 . . . . 0.0 109.613 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 525' ' ' ILE . . . . . 0.595 HG12 ' O ' ' A' ' 521' ' ' GLY . 0.8 OUTLIER -50.15 -47.4 24.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.163 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 526' ' ' ASN . . . . . 0.449 ' HB3' ' O ' ' A' ' 523' ' ' ARG . 19.1 t-20 -56.84 -48.02 79.0 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-N 114.36 -1.291 . . . . 0.0 108.314 177.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -48.04 -40.09 21.86 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.087 -1.415 . . . . 0.0 107.49 176.658 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 528' ' ' ASN . . . . . 1.036 ' HA ' HG21 ' A' ' 556' ' ' ILE . 1.8 t30 73.61 39.92 0.53 Allowed 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 114.638 -1.164 . . . . 0.0 111.529 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 529' ' ' GLY . . . . . . . . . . . . . . . -113.78 21.97 15.42 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 114.507 -1.224 . . . . 0.0 111.69 178.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 530' ' ' ALA . . . . . 0.795 ' O ' ' HB ' ' A' ' 556' ' ' ILE . . . -133.67 163.07 30.26 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.252 0.548 . . . . 0.0 112.231 -179.271 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 531' ' ' TYR . . . . . 0.558 ' HA ' ' O ' ' A' ' 554' ' ' THR . 0.0 OUTLIER -133.92 162.69 31.35 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 177.49 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 532' ' ' VAL . . . . . 0.553 HG12 ' OG1' ' A' ' 554' ' ' THR . 0.9 OUTLIER -131.37 135.48 59.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 CA-C-O 122.148 0.975 . . . . 0.0 111.862 179.772 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 533' ' ' GLY . . . . . 0.654 ' HA2' ' HB ' ' A' ' 552' ' ' THR . . . -133.66 153.88 21.05 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 114.189 -1.369 . . . . 0.0 113.966 -179.232 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 534' ' ' SER . . . . . 0.573 ' HB2' ' OG1' ' A' ' 552' ' ' THR . 19.1 m -134.31 136.39 43.45 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.389 -0.405 . . . . 0.0 111.437 178.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 535' ' ' ARG . . . . . 0.705 ' CG ' HD11 ' A' ' 575' ' ' ILE . 0.0 OUTLIER -160.63 90.92 1.65 Allowed Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 178.306 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 536' ' ' PRO . . . . . 0.443 ' O ' HG23 ' A' ' 538' ' ' VAL . 5.9 Cg_exo -78.22 52.03 3.93 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.903 2.402 . . . . 0.0 112.131 178.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 66.61 11.49 57.15 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.667 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 538' ' ' VAL . . . . . 0.604 HG12 ' O ' ' A' ' 538' ' ' VAL . 16.3 t -116.48 18.83 7.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.656 0.265 . . . . 0.0 111.357 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 539' ' ' LYS . . . . . 0.408 ' HA ' ' HB2' ' A' ' 550' ' ' ASP . 0.1 OUTLIER -45.92 119.74 2.38 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.276 0.56 . . . . 0.0 111.609 -178.931 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.18 31.25 5.09 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.91 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 541' ' ' ASN . . . . . 0.861 ' HB3' HD22 ' A' ' 551' ' ' LEU . 5.9 p30 -35.9 98.1 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.173 0 CA-C-O 121.684 0.754 . . . . 0.0 111.131 -179.248 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 542' ' ' GLU . . . . . 0.822 ' O ' ' N ' ' A' ' 544' ' ' GLY . 5.7 pt-20 -132.56 161.5 62.93 Favored Pre-proline 0 C--N 1.318 -0.761 0 CA-C-N 114.561 -1.2 . . . . 0.0 111.043 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 543' ' ' PRO . . . . . 0.527 ' HD2' ' HB2' ' A' ' 542' ' ' GLU . 30.6 Cg_exo -25.26 56.03 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.779 1 C-N-CA 125.345 4.03 . . . . 0.0 115.463 179.363 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 544' ' ' GLY . . . . . 0.822 ' N ' ' O ' ' A' ' 542' ' ' GLU . . . 52.26 53.69 30.09 Favored Glycine 0 C--O 1.229 -0.185 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.749 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 545' ' ' GLY . . . . . 0.5 ' C ' ' HD3' ' A' ' 548' ' ' PRO . . . -51.0 55.55 0.01 OUTLIER Glycine 0 CA--C 1.526 0.733 0 N-CA-C 114.931 0.732 . . . . 0.0 114.931 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 546' ' ' GLY . . . . . 0.634 ' N ' ' O ' ' A' ' 544' ' ' GLY . . . 53.68 55.83 23.31 Favored Glycine 0 CA--C 1.522 0.528 0 C-N-CA 120.444 -0.884 . . . . 0.0 113.806 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 547' ' ' MET . . . . . . . . . . . . . 1.2 mtt 53.44 55.77 13.41 Favored Pre-proline 0 N--CA 1.466 0.338 0 CA-C-O 121.026 0.441 . . . . 0.0 112.018 179.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 548' ' ' PRO . . . . . 0.5 ' HD3' ' C ' ' A' ' 545' ' ' GLY . 9.5 Cg_endo -50.4 167.67 0.23 Allowed 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 123.31 2.673 . . . . 0.0 112.419 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -110.51 -22.42 11.67 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 550' ' ' ASP . . . . . 0.614 ' O ' ' HA ' ' A' ' 535' ' ' ARG . 0.7 OUTLIER -56.04 -41.3 74.79 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.548 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 551' ' ' LEU . . . . . 0.861 HD22 ' HB3' ' A' ' 541' ' ' ASN . 7.6 tp -131.47 140.09 49.49 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.72 177.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 552' ' ' THR . . . . . 0.962 HG21 ' CG ' ' A' ' 567' ' ' PHE . 0.3 OUTLIER -133.71 149.46 51.5 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 122.118 0.961 . . . . 0.0 112.73 179.078 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 553' ' ' PHE . . . . . 0.532 ' HA ' ' CE2' ' A' ' 531' ' ' TYR . 3.4 m-85 -134.12 137.37 44.5 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 106.29 -1.745 . . . . 0.0 106.29 176.323 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 554' ' ' THR . . . . . 0.558 ' O ' ' HA ' ' A' ' 531' ' ' TYR . 1.8 m -132.53 138.38 31.96 Favored Pre-proline 0 C--N 1.304 -1.388 0 C-N-CA 119.197 -1.001 . . . . 0.0 110.582 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 555' ' ' PRO . . . . . 0.817 ' O ' HG22 ' A' ' 556' ' ' ILE . 65.3 Cg_endo -84.28 14.27 2.48 Favored 'Trans proline' 0 N--CA 1.439 -1.717 0 C-N-CA 121.647 1.564 . . . . 0.0 111.14 179.117 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 556' ' ' ILE . . . . . 1.036 HG21 ' HA ' ' A' ' 528' ' ' ASN . 1.2 tp 69.73 33.63 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 N-CA-C 115.065 1.506 . . . . 0.0 115.065 176.443 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 557' ' ' LYS . . . . . 0.61 ' O ' ' CE2' ' A' ' 559' ' ' TRP . 0.0 OUTLIER -103.87 148.46 26.12 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -179.289 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 558' ' ' THR . . . . . 0.492 ' HA ' ' CE2' ' A' ' 505' ' ' PHE . 3.7 t -69.96 115.9 9.71 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 -172.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 559' ' ' TRP . . . . . 0.61 ' CE2' ' O ' ' A' ' 557' ' ' LYS . 0.0 OUTLIER -141.24 123.07 15.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 112.642 -2.072 . . . . 0.0 105.599 174.184 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 560' ' ' ASN . . . . . 0.565 ' O ' HG22 ' A' ' 564' ' ' THR . 60.3 m-20 -90.54 -77.01 0.42 Allowed 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 117.627 -1.629 . . . . 0.0 113.129 -177.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 561' ' ' ALA . . . . . 0.524 ' HA ' HG22 ' A' ' 564' ' ' THR . . . -76.22 -50.44 14.45 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 115.502 1.667 . . . . 0.0 115.502 -179.017 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 562' ' ' SER . . . . . . . . . . . . . 5.1 t -49.37 -56.68 8.78 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -176.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 563' ' ' LYS . . . . . 0.5 ' HG3' ' CZ ' ' A' ' 567' ' ' PHE . 0.0 OUTLIER -69.17 -48.51 62.02 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -178.307 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 564' ' ' THR . . . . . 0.719 HG23 ' H ' ' A' ' 565' ' ' GLN . 10.6 t -50.22 -68.32 0.18 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.801 0.334 . . . . 0.0 111.842 -179.1 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 565' ' ' GLN . . . . . 0.984 ' O ' HG23 ' A' ' 569' ' ' ILE . 3.6 tp-100 -50.02 -47.17 53.27 Favored 'General case' 0 C--N 1.319 -0.721 0 O-C-N 122.173 -0.33 . . . . 0.0 111.635 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 566' ' ' GLU . . . . . 0.405 ' HG2' ' CD1' ' A' ' 567' ' ' PHE . 27.9 tt0 -49.54 -62.64 1.44 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -178.391 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 567' ' ' PHE . . . . . 0.962 ' CG ' HG21 ' A' ' 552' ' ' THR . 0.0 OUTLIER -97.27 -50.64 4.48 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.449 0.642 . . . . 0.0 112.132 -178.53 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 568' ' ' ILE . . . . . 0.833 ' CG2' HG22 ' A' ' 500' ' ' VAL . 1.7 mp -58.1 10.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 114.805 -1.089 . . . . 0.0 113.266 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 569' ' ' ILE . . . . . 0.984 HG23 ' O ' ' A' ' 565' ' ' GLN . 1.2 pt -52.8 -38.32 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 N-CA-C 104.253 -2.499 . . . . 0.0 104.253 178.221 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 570' ' ' ASP . . . . . 0.951 ' CB ' HD11 ' A' ' 588' ' ' ILE . 30.2 m-20 34.55 52.62 0.56 Allowed 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 113.701 -1.59 . . . . 0.0 112.149 173.047 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -51.48 -44.56 53.43 Favored Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 118.226 -1.94 . . . . 0.0 109.084 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 572' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -118.97 -17.33 9.07 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 176.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 573' ' ' LEU . . . . . 0.608 ' HB3' ' O ' ' A' ' 535' ' ' ARG . 1.1 tp -140.12 137.08 34.19 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -178.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 574' ' ' LEU . . . . . 0.931 HD21 ' CG2' ' A' ' 508' ' ' VAL . 0.3 OUTLIER -134.46 132.92 39.86 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 174.244 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 575' ' ' ILE . . . . . 1.094 HG23 HD13 ' A' ' 585' ' ' LEU . 0.0 OUTLIER -134.05 137.17 52.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 118.914 0.779 . . . . 0.0 112.074 179.125 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 576' ' ' LEU . . . . . 0.585 HD22 ' HB3' ' A' ' 509' ' ' LEU . 0.0 OUTLIER -133.58 135.59 44.37 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 176.948 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 577' ' ' LYS . . . . . 0.42 ' HD2' ' CE1' ' A' ' 531' ' ' TYR . 0.0 OUTLIER -132.8 135.34 45.62 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 118.906 -1.117 . . . . 0.0 110.548 177.99 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.604 HD12 ' O ' ' A' ' 582' ' ' LYS . 0.3 OUTLIER -123.63 131.72 53.68 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 177.834 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 579' ' ' GLY . . . . . . . . . . . . . . . -91.21 -2.38 71.07 Favored Glycine 0 CA--C 1.5 -0.857 0 CA-C-N 115.404 -0.816 . . . . 0.0 114.447 -177.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 580' ' ' LYS . . . . . 0.722 ' HE3' HD13 ' A' ' 524' ' ' ILE . 0.4 OUTLIER -75.32 -46.47 33.13 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 118.777 -1.169 . . . . 0.0 109.153 179.111 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 581' ' ' TRP . . . . . 0.444 ' H ' ' HG3' ' A' ' 580' ' ' LYS . 0.1 OUTLIER -138.74 -51.65 0.56 Allowed 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 177.911 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 582' ' ' LYS . . . . . 0.604 ' O ' HD12 ' A' ' 578' ' ' LEU . 1.1 ptpm? -139.56 165.0 28.4 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -175.324 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 583' ' ' MET . . . . . . . . . . . . . 2.3 ttt -118.85 134.81 54.91 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 174.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 584' ' ' LYS . . . . . 0.631 ' HE3' ' HA3' ' A' ' 513' ' ' GLY . 0.0 OUTLIER -121.71 133.05 54.94 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.023 -0.989 . . . . 0.0 108.335 179.53 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 585' ' ' LEU . . . . . 1.094 HD13 HG23 ' A' ' 575' ' ' ILE . 2.9 tp -119.46 136.68 54.21 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 179.251 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 586' ' ' VAL . . . . . 0.589 HG23 ' HD2' ' A' ' 584' ' ' LYS . 11.5 t -131.95 137.08 55.63 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.696 -178.249 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 587' ' ' SER . . . . . 0.564 ' O ' HG23 ' A' ' 494' ' ' THR . 7.6 m -110.24 135.79 50.44 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 177.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.951 HD11 ' CB ' ' A' ' 570' ' ' ASP . 0.2 OUTLIER -133.81 144.64 35.15 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.607 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -178.606 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 5.3 m -132.87 137.26 54.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 114.204 -1.362 . . . . 0.0 110.742 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 590' ' ' SER . . . . . . . . . . . . . 2.5 t -70.65 135.52 48.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.624 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 591' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -50.6 -50.5 53.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.044 0.45 . . . . 0.0 110.737 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 592' ' ' GLU . . . . . 0.4 ' HA ' ' HG3' ' A' ' 595' ' ' LYS . 18.6 mt-10 -51.55 -50.46 60.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.037 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -50.44 -48.65 56.34 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.708 0.766 . . . . 0.0 109.237 179.001 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 594' ' ' PHE . . . . . 0.75 ' CD1' HD11 ' A' ' 597' ' ' LEU . 0.9 OUTLIER -50.23 -48.53 54.42 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.687 178.47 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 595' ' ' LYS . . . . . 0.517 ' HA ' ' CE2' ' A' ' 604' ' ' TRP . 5.7 mmpt? -49.37 -47.65 47.45 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.034 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 596' ' ' GLU . . . . . 0.503 ' O ' HD23 ' A' ' 599' ' ' LEU . 0.7 OUTLIER -51.98 -60.28 3.37 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.434 179.846 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 597' ' ' LEU . . . . . 0.75 HD11 ' CD1' ' A' ' 594' ' ' PHE . 0.7 OUTLIER -61.66 -62.17 2.0 Allowed 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.417 0.627 . . . . 0.0 112.117 -178.699 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 598' ' ' GLY . . . . . 0.481 ' N ' HD12 ' A' ' 597' ' ' LEU . . . -77.13 14.03 8.72 Favored Glycine 0 C--N 1.32 -0.352 0 CA-C-N 115.043 -0.98 . . . . 0.0 113.401 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 599' ' ' LEU . . . . . 0.69 HD12 ' N ' ' A' ' 600' ' ' THR . 2.8 pp -47.45 -15.95 0.05 Allowed 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -175.333 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 600' ' ' THR . . . . . 0.69 ' N ' HD12 ' A' ' 599' ' ' LEU . 11.6 t -129.83 65.91 1.48 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 119.939 -0.704 . . . . 0.0 110.413 176.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 601' ' ' ALA . . . . . . . . . . . . . . . -131.99 155.64 81.1 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.442 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 602' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.3 -19.86 44.84 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 121.942 1.761 . . . . 0.0 111.129 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 603' ' ' GLY . . . . . 0.645 ' O ' HG23 ' A' ' 607' ' ' VAL . . . -61.33 -49.1 81.14 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.628 -0.714 . . . . 0.0 113.071 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 604' ' ' TRP . . . . . 0.517 ' CE2' ' HA ' ' A' ' 595' ' ' LYS . 1.2 m95 -66.91 -46.72 73.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.775 0.321 . . . . 0.0 111.427 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 605' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -52.17 -55.45 20.92 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.626 -179.006 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -59.85 -63.34 1.34 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.739 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 607' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 603' ' ' GLY . 46.3 t -50.79 -69.85 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 -178.391 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 608' ' ' VAL . . . . . . . . . . . . . 97.4 t -70.59 -60.72 2.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -177.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 609' ' ' GLY . . . . . . . . . . . . . . . -57.65 -62.43 6.34 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.085 -0.579 . . . . 0.0 113.222 -178.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 610' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.93 -70.17 0.29 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.824 0.345 . . . . 0.0 110.877 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 93.49 54.0 1.75 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.499 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 31.5 mtpt -60.0 -31.62 70.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.928 0.394 . . . . 0.0 111.0 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 613' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -92.11 171.15 9.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.924 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 614' ' ' GLU . . . . . 0.402 ' CB ' ' CD ' ' A' ' 615' ' ' PRO . 21.6 mm-40 -61.29 -61.09 8.61 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.956 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 615' ' ' PRO . . . . . 0.402 ' CD ' ' CB ' ' A' ' 614' ' ' GLU . 57.4 Cg_endo -71.23 117.49 5.18 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.541 2.16 . . . . 0.0 112.312 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 616' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -106.27 87.44 2.58 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.932 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo . . . . . 0 C--O 1.25 1.091 0 C-N-CA 122.585 2.19 . . . . 0.0 112.242 -179.953 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.625 0.25 . . . . 0.0 111.156 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 455' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.23 -28.06 23.46 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.505 2.137 . . . . 0.0 112.381 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 456' ' ' ARG . . . . . . . . . . . . . 5.6 ttt180 -83.69 -26.45 29.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.071 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 55.4 m -84.39 -31.31 24.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.939 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -67.99 121.85 16.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.141 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -114.94 96.91 46.32 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.871 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -56.02 174.34 0.33 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.57 2.18 . . . . 0.0 112.27 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . 115.22 56.55 0.36 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.595 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -158.68 143.2 11.54 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.713 0.292 . . . . 0.0 110.916 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.0 119.93 6.33 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.536 2.157 . . . . 0.0 112.274 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 4.7 mmtp -120.22 -173.55 2.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.126 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 465' ' ' SER . . . . . 0.592 ' O ' HD23 ' A' ' 467' ' ' LEU . 14.5 m -94.96 22.8 6.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.068 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 5.0 m -75.77 43.86 0.27 Allowed 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 467' ' ' LEU . . . . . 0.615 HD13 ' HB ' ' A' ' 471' ' ' VAL . 0.5 OUTLIER -36.64 152.04 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.723 0.296 . . . . 0.0 111.613 179.774 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 58.3 p -97.16 27.07 4.31 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.693 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 128.93 -25.85 4.58 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.259 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -116.56 116.8 28.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.863 0.363 . . . . 0.0 110.947 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 471' ' ' VAL . . . . . 0.615 ' HB ' HD13 ' A' ' 467' ' ' LEU . 12.0 p -114.23 108.36 25.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.069 179.465 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -177.25 144.97 0.58 Allowed Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.139 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -57.4 174.64 0.48 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.408 2.072 . . . . 0.0 112.267 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 4.4 pm0 -111.5 36.89 3.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.986 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 12.8 p -49.9 -58.05 6.2 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.298 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 476' ' ' GLY . . . . . . . . . . . . . . . 96.33 -20.81 48.67 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.909 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 477' ' ' ASN . . . . . 0.442 ' N ' ' HD3' ' A' ' 478' ' ' PRO . 6.5 m-20 51.23 53.38 13.53 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-O 120.775 0.321 . . . . 0.0 111.196 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 478' ' ' PRO . . . . . 0.442 ' HD3' ' N ' ' A' ' 477' ' ' ASN . 93.3 Cg_endo -82.53 34.36 0.55 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.803 2.335 . . . . 0.0 113.31 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -53.13 137.92 32.62 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.75 0.31 . . . . 0.0 110.806 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 480' ' ' ALA . . . . . 0.651 ' HB1' ' CD ' ' A' ' 481' ' ' PRO . . . -140.39 176.22 2.65 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.552 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 481' ' ' PRO . . . . . 0.651 ' CD ' ' HB1' ' A' ' 480' ' ' ALA . 3.0 Cg_endo -81.35 40.71 1.02 Allowed 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.627 2.884 . . . . 0.0 112.675 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 482' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -34.9 -31.2 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 483' ' ' THR . . . . . 0.424 ' N ' ' O ' ' A' ' 481' ' ' PRO . 0.2 OUTLIER -46.27 171.71 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.713 0.292 . . . . 0.0 111.444 179.912 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 484' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -33.94 -35.24 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -57.07 -60.63 3.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.884 0.373 . . . . 0.0 110.208 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 486' ' ' ALA . . . . . 0.418 ' CB ' ' O ' ' A' ' 481' ' ' PRO . . . -71.59 -47.37 55.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.912 178.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 487' ' ' ASN . . . . . 0.449 ' HB3' ' HD3' ' A' ' 489' ' ' PRO . 9.2 t-20 -50.04 -48.52 52.81 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.779 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 488' ' ' MET . . . . . 0.42 ' N ' ' CD ' ' A' ' 489' ' ' PRO . 3.4 mtt 52.27 52.04 10.55 Favored Pre-proline 0 C--N 1.332 -0.155 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.014 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 489' ' ' PRO . . . . . 0.449 ' HD3' ' HB3' ' A' ' 487' ' ' ASN . 67.8 Cg_exo -23.51 -58.9 0.05 OUTLIER 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 124.223 3.282 . . . . 0.0 113.437 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 58.7 m -138.9 -68.16 0.45 Allowed 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.214 178.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 491' ' ' ALA . . . . . . . . . . . . . . . -135.45 135.6 40.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.673 -0.24 . . . . 0.0 111.606 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 492' ' ' ARG . . . . . 0.655 ' HD3' HD22 ' A' ' 585' ' ' LEU . 0.0 OUTLIER -136.05 132.02 35.65 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.583 0.23 . . . . 0.0 110.807 177.49 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 493' ' ' VAL . . . . . 0.764 HG21 ' CA ' ' A' ' 513' ' ' GLY . 39.5 t -138.0 163.11 30.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.492 177.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 494' ' ' THR . . . . . 0.5 ' N ' ' CG1' ' A' ' 493' ' ' VAL . 41.9 p -127.19 133.87 50.22 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 120.399 -0.521 . . . . 0.0 110.344 176.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 495' ' ' LEU . . . . . 1.045 ' O ' HG22 ' A' ' 588' ' ' ILE . 0.3 OUTLIER -135.89 164.57 42.26 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.558 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 496' ' ' PRO . . . . . 0.684 ' HD2' HD21 ' A' ' 499' ' ' LEU . 24.3 Cg_exo -61.72 119.31 6.37 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 121.676 1.584 . . . . 0.0 111.185 178.574 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 497' ' ' LYS . . . . . 0.494 ' CA ' ' HB ' ' A' ' 588' ' ' ILE . 15.0 ttmt -52.33 -30.23 27.45 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -178.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 498' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.3 -48.11 81.55 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -177.487 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 499' ' ' LEU . . . . . 0.872 HD11 HD13 ' A' ' 495' ' ' LEU . 2.2 pp -73.53 -8.16 54.79 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -178.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 500' ' ' VAL . . . . . 0.654 HG21 HG21 ' A' ' 588' ' ' ILE . 36.3 t -74.57 -25.45 19.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.435 0.636 . . . . 0.0 111.498 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 501' ' ' TYR . . . . . 0.665 ' O ' ' CG2' ' A' ' 564' ' ' THR . 3.7 m-30 -53.45 -29.13 34.02 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -178.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -76.15 -50.28 15.03 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 116.45 2.019 . . . . 0.0 116.45 -175.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 503' ' ' LYS . . . . . 0.575 ' O ' ' CG ' ' A' ' 507' ' ' LYS . 0.2 OUTLIER -120.27 136.44 54.66 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 119.59 1.086 . . . . 0.0 112.676 -178.51 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 504' ' ' THR . . . . . 0.921 HG23 ' CE1' ' A' ' 567' ' ' PHE . 23.7 m -73.61 -77.2 0.11 Allowed 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 179.265 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 505' ' ' PHE . . . . . 0.765 ' CZ ' ' HB1' ' A' ' 530' ' ' ALA . 0.2 OUTLIER -75.74 -60.33 2.36 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -179.18 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 506' ' ' SER . . . . . 0.703 ' O ' ' CD1' ' A' ' 510' ' ' TRP . 6.1 t -48.7 -72.04 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 -175.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 507' ' ' LYS . . . . . 0.679 ' HD3' ' N ' ' A' ' 508' ' ' VAL . 0.0 OUTLIER -48.9 -48.58 42.27 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -176.479 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 508' ' ' VAL . . . . . 0.824 HG13 HD21 ' A' ' 574' ' ' LEU . 55.3 t -52.63 -58.02 3.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 C-N-CA 120.668 -0.413 . . . . 0.0 112.081 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 509' ' ' LEU . . . . . 0.679 HD12 ' N ' ' A' ' 510' ' ' TRP . 2.6 pp -59.66 -66.0 0.58 Allowed 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 -177.469 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 510' ' ' TRP . . . . . 0.71 ' CD1' ' HA ' ' A' ' 518' ' ' LYS . 68.3 p-90 -73.18 -50.74 20.89 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 -176.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 511' ' ' SER . . . . . 0.504 ' N ' ' CD2' ' A' ' 510' ' ' TRP . 0.3 OUTLIER -62.27 -46.23 89.72 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 114.437 -1.256 . . . . 0.0 113.022 -177.024 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 512' ' ' ALA . . . . . 0.755 ' HB3' ' O ' ' A' ' 508' ' ' VAL . . . -71.13 -74.87 0.14 Allowed 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 116.305 1.965 . . . . 0.0 116.305 -174.167 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 513' ' ' GLY . . . . . 0.764 ' CA ' HG21 ' A' ' 493' ' ' VAL . . . -116.88 -39.56 0.82 Allowed Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 121.837 3.495 . . . . 0.0 121.837 -173.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 514' ' ' LEU . . . . . 0.761 HD21 ' HB2' ' A' ' 584' ' ' LYS . 4.1 pp -112.83 -36.65 5.09 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 121.11 3.744 . . . . 0.0 121.11 -171.13 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 515' ' ' VAL . . . . . 0.771 ' CG1' ' HB2' ' A' ' 517' ' ' SER . 9.9 p -125.76 165.86 22.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 117.99 2.589 . . . . 0.0 117.99 -171.41 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 516' ' ' ALA . . . . . 0.533 ' N ' HG22 ' A' ' 515' ' ' VAL . . . -90.44 1.01 57.07 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 112.46 -2.154 . . . . 0.0 109.078 178.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 517' ' ' SER . . . . . 0.925 ' O ' ' N ' ' A' ' 521' ' ' GLY . 0.1 OUTLIER -60.15 10.19 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 126.072 1.749 . . . . 0.0 115.224 -172.957 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 518' ' ' LYS . . . . . 0.71 ' HA ' ' CD1' ' A' ' 510' ' ' TRP . 0.0 OUTLIER -43.54 -46.76 7.17 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 177.232 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 519' ' ' SER . . . . . . . . . . . . . 85.2 p -74.63 -56.15 5.13 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.462 173.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 520' ' ' GLU . . . . . 0.821 ' HB2' ' HA ' ' A' ' 517' ' ' SER . 4.8 mm-40 -62.03 -47.25 85.57 Favored 'General case' 0 C--N 1.349 0.573 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.848 -179.158 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 521' ' ' GLY . . . . . 0.925 ' N ' ' O ' ' A' ' 517' ' ' SER . . . -49.16 -53.09 20.51 Favored Glycine 0 CA--C 1.493 -1.292 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 522' ' ' GLN . . . . . 0.413 ' HA ' HG12 ' A' ' 525' ' ' ILE . 3.7 mt-30 -48.09 -47.52 34.19 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 177.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 523' ' ' ARG . . . . . 0.467 ' HB3' ' O ' ' A' ' 520' ' ' GLU . 2.4 tpt85 -50.25 -48.92 54.45 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.848 178.505 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 524' ' ' ILE . . . . . 0.507 HG13 ' HZ2' ' A' ' 580' ' ' LYS . 30.1 mm -57.44 -54.06 35.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.441 0.639 . . . . 0.0 109.592 179.256 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 525' ' ' ILE . . . . . 0.893 HG23 ' CD1' ' A' ' 556' ' ' ILE . 1.1 mm -50.27 -47.56 25.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 177.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 526' ' ' ASN . . . . . 0.456 ' HB2' ' O ' ' A' ' 523' ' ' ARG . 9.2 m120 -57.82 -47.33 82.92 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-N 114.225 -1.352 . . . . 0.0 108.575 177.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -47.3 -39.32 14.42 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 113.988 -1.46 . . . . 0.0 107.741 177.239 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 528' ' ' ASN . . . . . 0.696 ' HA ' ' CG2' ' A' ' 556' ' ' ILE . 0.5 OUTLIER 74.25 40.42 0.43 Allowed 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.491 -179.369 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 529' ' ' GLY . . . . . . . . . . . . . . . -117.61 31.55 5.71 Favored Glycine 0 CA--C 1.523 0.593 0 CA-C-N 114.922 -1.035 . . . . 0.0 112.497 178.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 530' ' ' ALA . . . . . 0.886 ' O ' ' HB ' ' A' ' 556' ' ' ILE . . . -133.43 163.93 28.26 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 121.161 0.505 . . . . 0.0 112.263 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 531' ' ' TYR . . . . . 0.592 ' HA ' ' O ' ' A' ' 554' ' ' THR . 0.0 OUTLIER -134.61 152.93 52.13 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.667 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 532' ' ' VAL . . . . . 0.72 HG23 ' CE1' ' A' ' 505' ' ' PHE . 0.5 OUTLIER -127.09 135.64 63.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 CA-C-O 121.981 0.896 . . . . 0.0 112.093 179.635 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 533' ' ' GLY . . . . . 0.702 ' O ' HG13 ' A' ' 575' ' ' ILE . . . -133.68 151.73 20.26 Favored Glycine 0 N--CA 1.441 -0.98 0 CA-C-N 114.251 -1.34 . . . . 0.0 113.4 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 534' ' ' SER . . . . . 0.484 ' N ' ' HB ' ' A' ' 552' ' ' THR . 0.6 OUTLIER -134.57 137.55 43.86 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.447 -0.376 . . . . 0.0 111.016 179.109 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 535' ' ' ARG . . . . . 0.639 ' O ' ' HB3' ' A' ' 573' ' ' LEU . 12.4 tpt180 -159.26 90.98 1.94 Allowed Pre-proline 0 C--N 1.331 -0.202 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 536' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 535' ' ' ARG . 38.1 Cg_endo -65.86 -51.46 1.26 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.464 2.109 . . . . 0.0 112.009 178.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 112.54 -18.52 22.63 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 120.71 -0.757 . . . . 0.0 113.273 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 538' ' ' VAL . . . . . 0.651 HG12 ' O ' ' A' ' 538' ' ' VAL . 17.6 t -116.29 18.52 7.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.951 0.376 . . . . 0.0 111.98 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 539' ' ' LYS . . . . . . . . . . . . . 46.7 mttp -107.38 111.02 23.15 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.463 0.649 . . . . 0.0 112.129 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 4.4 mtpt -99.96 30.75 3.57 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.619 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 541' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -48.34 99.0 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.495 0.664 . . . . 0.0 111.06 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 542' ' ' GLU . . . . . 0.459 ' CB ' ' HD2' ' A' ' 543' ' ' PRO . 0.7 OUTLIER -49.04 177.26 0.04 OUTLIER Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.722 179.469 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 543' ' ' PRO . . . . . 0.459 ' HD2' ' CB ' ' A' ' 542' ' ' GLU . 49.6 Cg_exo -37.19 -52.27 1.43 Allowed 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.578 2.185 . . . . 0.0 112.741 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 544' ' ' GLY . . . . . 0.448 ' C ' ' O ' ' A' ' 543' ' ' PRO . . . 27.47 55.02 0.1 Allowed Glycine 0 C--N 1.335 0.485 0 C-N-CA 121.468 -0.396 . . . . 0.0 114.015 178.264 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 545' ' ' GLY . . . . . 0.568 ' O ' ' N ' ' A' ' 547' ' ' MET . . . 52.95 54.64 27.68 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.055 -1.069 . . . . 0.0 111.617 -178.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 546' ' ' GLY . . . . . 0.549 ' C ' ' HD3' ' A' ' 548' ' ' PRO . . . 53.62 -54.12 0.01 OUTLIER Glycine 0 CA--C 1.522 0.515 0 CA-C-O 119.107 -0.829 . . . . 0.0 114.585 -178.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 547' ' ' MET . . . . . 0.568 ' N ' ' O ' ' A' ' 545' ' ' GLY . 0.0 OUTLIER 19.22 55.74 0.17 Allowed Pre-proline 0 N--CA 1.473 0.71 0 CA-C-N 118.333 1.066 . . . . 0.0 111.796 178.704 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 548' ' ' PRO . . . . . 0.549 ' HD3' ' C ' ' A' ' 546' ' ' GLY . 83.4 Cg_exo -46.2 119.93 3.35 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.012 1.808 . . . . 0.0 113.479 -177.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.8 -36.48 2.4 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.124 -0.943 . . . . 0.0 108.645 178.357 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 550' ' ' ASP . . . . . 0.557 ' O ' ' HA ' ' A' ' 535' ' ' ARG . 0.6 OUTLIER -72.54 -42.17 65.01 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.263 179.739 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 551' ' ' LEU . . . . . 0.479 HD21 ' HE2' ' A' ' 553' ' ' PHE . 8.8 tp -131.37 140.57 49.71 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.335 178.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 552' ' ' THR . . . . . 0.674 ' O ' ' HA2' ' A' ' 533' ' ' GLY . 27.1 m -133.04 147.93 52.22 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.618 0.723 . . . . 0.0 111.912 179.322 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 553' ' ' PHE . . . . . 0.528 ' CD1' ' CE1' ' A' ' 531' ' ' TYR . 14.3 m-85 -133.86 136.77 44.59 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 177.122 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 554' ' ' THR . . . . . 0.633 ' CG2' ' H ' ' A' ' 556' ' ' ILE . 0.8 OUTLIER -134.0 138.96 31.83 Favored Pre-proline 0 C--N 1.308 -1.214 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.327 179.544 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 555' ' ' PRO . . . . . 0.805 ' O ' HG22 ' A' ' 556' ' ' ILE . 79.8 Cg_endo -86.22 20.33 1.25 Allowed 'Trans proline' 0 N--CA 1.445 -1.33 0 C-N-CA 121.972 1.782 . . . . 0.0 111.043 178.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 556' ' ' ILE . . . . . 0.893 ' CD1' HG23 ' A' ' 525' ' ' ILE . 4.2 tp 63.27 35.17 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 177.451 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 2.2 mtmp? -102.86 122.11 43.86 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 558' ' ' THR . . . . . . . . . . . . . 12.0 m -56.91 118.57 5.08 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 115.61 1.707 . . . . 0.0 115.61 -171.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 559' ' ' TRP . . . . . 0.601 ' CZ2' ' HD2' ' A' ' 555' ' ' PRO . 0.0 OUTLIER -138.24 111.96 8.29 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 112.441 -2.163 . . . . 0.0 105.715 175.486 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 560' ' ' ASN . . . . . 0.559 ' O ' ' HB ' ' A' ' 564' ' ' THR . 51.2 m-20 -80.44 -74.82 0.29 Allowed 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 -175.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 561' ' ' ALA . . . . . 0.431 ' O ' HG22 ' A' ' 564' ' ' THR . . . -73.94 -65.33 0.85 Allowed 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 -176.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 562' ' ' SER . . . . . . . . . . . . . 1.4 p -49.06 -52.19 26.97 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -175.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 563' ' ' LYS . . . . . 0.538 ' HG2' ' CE2' ' A' ' 559' ' ' TRP . 9.3 tppt? -70.93 -49.13 48.97 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.173 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 564' ' ' THR . . . . . 0.665 ' CG2' ' O ' ' A' ' 501' ' ' TYR . 1.7 t -50.03 -62.4 1.59 Allowed 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.563 -178.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 565' ' ' GLN . . . . . 0.59 ' O ' HG23 ' A' ' 569' ' ' ILE . 0.0 OUTLIER -49.13 -47.6 45.4 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 122.282 -0.261 . . . . 0.0 111.355 178.495 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 566' ' ' GLU . . . . . 0.433 ' O ' HD13 ' A' ' 569' ' ' ILE . 1.8 tt0 -49.66 -56.27 10.71 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -178.623 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 567' ' ' PHE . . . . . 0.921 ' CE1' HG23 ' A' ' 504' ' ' THR . 1.4 p90 -96.83 -46.0 6.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.433 0.635 . . . . 0.0 111.944 -178.225 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 568' ' ' ILE . . . . . 0.966 HD11 HD13 ' A' ' 574' ' ' LEU . 1.3 tp -58.11 9.44 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.504 -0.822 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 569' ' ' ILE . . . . . 0.59 HG23 ' O ' ' A' ' 565' ' ' GLN . 0.0 OUTLIER -55.0 -38.94 47.51 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 N-CA-C 104.967 -2.234 . . . . 0.0 104.967 179.184 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 570' ' ' ASP . . . . . 0.609 ' CG ' HD11 ' A' ' 588' ' ' ILE . 13.4 p30 31.61 58.12 0.3 Allowed 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 114.289 -1.323 . . . . 0.0 112.307 173.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -51.62 -45.1 54.55 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 117.288 -2.387 . . . . 0.0 108.79 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 572' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -119.57 -16.81 8.82 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 112.411 0.522 . . . . 0.0 112.411 175.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 573' ' ' LEU . . . . . 0.639 ' HB3' ' O ' ' A' ' 535' ' ' ARG . 1.2 tp -140.14 136.9 33.98 Favored 'General case' 0 C--N 1.351 0.659 0 N-CA-C 115.756 1.761 . . . . 0.0 115.756 -177.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 574' ' ' LEU . . . . . 0.966 HD13 HD11 ' A' ' 568' ' ' ILE . 0.1 OUTLIER -134.77 133.83 40.29 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 105.847 -1.908 . . . . 0.0 105.847 173.707 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 575' ' ' ILE . . . . . 0.931 ' N ' HD12 ' A' ' 574' ' ' LEU . 0.0 OUTLIER -133.55 136.08 54.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.401 178.65 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 576' ' ' LEU . . . . . 0.566 ' CD2' ' HB3' ' A' ' 509' ' ' LEU . 0.0 OUTLIER -133.99 135.63 43.56 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 177.1 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 577' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.32 135.26 46.08 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 118.88 -1.128 . . . . 0.0 110.513 177.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.613 HD12 ' O ' ' A' ' 582' ' ' LYS . 0.3 OUTLIER -123.01 132.12 54.0 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 177.892 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 579' ' ' GLY . . . . . . . . . . . . . . . -89.8 -2.15 75.85 Favored Glycine 0 CA--C 1.499 -0.92 0 CA-C-N 115.244 -0.889 . . . . 0.0 113.431 -178.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 580' ' ' LYS . . . . . 0.507 ' HZ2' HG13 ' A' ' 524' ' ' ILE . 0.0 OUTLIER -72.67 -48.15 41.49 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 118.998 -1.081 . . . . 0.0 108.964 179.426 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 581' ' ' TRP . . . . . 0.48 ' CD1' ' O ' ' A' ' 580' ' ' LYS . 28.4 m0 -139.03 -52.82 0.56 Allowed 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 177.516 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 582' ' ' LYS . . . . . 0.613 ' O ' HD12 ' A' ' 578' ' ' LEU . 0.3 OUTLIER -139.84 165.22 27.88 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 -174.878 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 583' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.2 135.06 53.33 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 174.211 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 584' ' ' LYS . . . . . 0.761 ' HB2' HD21 ' A' ' 514' ' ' LEU . 2.3 tppt? -117.25 134.27 54.99 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.457 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 585' ' ' LEU . . . . . 0.757 ' HG ' HG23 ' A' ' 575' ' ' ILE . 4.2 tt -121.68 135.9 54.95 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 178.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 586' ' ' VAL . . . . . 0.668 HG23 ' HD2' ' A' ' 584' ' ' LYS . 16.9 t -133.31 137.07 53.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.204 -178.063 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 587' ' ' SER . . . . . . . . . . . . . 70.8 m -109.98 135.02 51.49 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 176.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 1.045 HG22 ' O ' ' A' ' 495' ' ' LEU . 0.0 OUTLIER -134.53 141.85 42.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -177.868 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 5.2 m -133.28 137.02 54.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 114.166 -1.379 . . . . 0.0 110.422 177.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 590' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.12 125.2 30.58 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.445 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 591' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -50.32 -49.34 54.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.16 0.505 . . . . 0.0 110.237 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -51.91 -49.58 62.78 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.176 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.01 -48.57 61.38 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.756 0.789 . . . . 0.0 109.156 179.065 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 594' ' ' PHE . . . . . 0.768 ' CD1' HD11 ' A' ' 597' ' ' LEU . 0.9 OUTLIER -50.2 -48.39 54.23 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.572 178.281 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 595' ' ' LYS . . . . . 0.582 ' HZ2' HG21 ' A' ' 608' ' ' VAL . 0.0 OUTLIER -49.42 -48.18 47.5 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.911 0.386 . . . . 0.0 110.067 179.215 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 596' ' ' GLU . . . . . 0.491 ' O ' HD23 ' A' ' 599' ' ' LEU . 1.5 mt-10 -53.07 -55.06 26.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.618 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 597' ' ' LEU . . . . . 0.768 HD11 ' CD1' ' A' ' 594' ' ' PHE . 0.8 OUTLIER -65.9 -60.92 2.37 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.283 0.563 . . . . 0.0 112.051 -178.64 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 598' ' ' GLY . . . . . 0.507 ' N ' HD12 ' A' ' 597' ' ' LEU . . . -78.88 13.08 20.43 Favored Glycine 0 C--N 1.32 -0.315 0 CA-C-N 115.279 -0.873 . . . . 0.0 113.459 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 599' ' ' LEU . . . . . 0.616 HD12 ' N ' ' A' ' 600' ' ' THR . 2.8 pp -48.03 -11.49 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -175.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 600' ' ' THR . . . . . 0.616 ' N ' HD12 ' A' ' 599' ' ' LEU . 30.0 m -141.38 66.27 1.36 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.854 0.835 . . . . 0.0 110.962 177.623 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 601' ' ' ALA . . . . . 0.912 ' HB1' ' HD2' ' A' ' 602' ' ' PRO . . . -132.15 177.91 2.01 Favored Pre-proline 0 N--CA 1.447 -0.592 0 CA-C-N 114.094 -1.412 . . . . 0.0 109.593 178.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 602' ' ' PRO . . . . . 0.912 ' HD2' ' HB1' ' A' ' 601' ' ' ALA . 97.6 Cg_endo -76.63 -8.29 18.1 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 121.908 1.739 . . . . 0.0 111.215 178.371 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 603' ' ' GLY . . . . . 0.708 ' O ' HG23 ' A' ' 607' ' ' VAL . . . -71.19 -49.7 25.59 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 115.697 -0.683 . . . . 0.0 113.593 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 604' ' ' TRP . . . . . 0.547 ' CD1' ' HA ' ' A' ' 599' ' ' LEU . 2.1 m95 -69.51 -46.08 67.38 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 117.16 0.48 . . . . 0.0 111.67 -179.25 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 605' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -49.51 -53.69 22.0 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.68 -0.236 . . . . 0.0 110.836 -178.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -64.79 -56.37 13.96 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 607' ' ' VAL . . . . . 0.708 HG23 ' O ' ' A' ' 603' ' ' GLY . 51.9 t -54.67 -72.15 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -178.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 608' ' ' VAL . . . . . 0.582 HG21 ' HZ2' ' A' ' 595' ' ' LYS . 70.7 t -68.62 -55.16 16.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -177.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 609' ' ' GLY . . . . . . . . . . . . . . . -63.72 -62.97 4.79 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.975 -0.631 . . . . 0.0 113.385 -178.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 610' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.77 -68.07 0.41 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.807 0.337 . . . . 0.0 110.964 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 104.59 56.39 0.72 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.483 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.74 38.24 1.23 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.795 0.331 . . . . 0.0 110.954 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 613' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -119.95 -177.48 3.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.899 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -58.81 -60.78 9.33 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.948 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 615' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.35 -168.32 0.38 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.562 2.175 . . . . 0.0 112.313 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 616' ' ' SER . . . . . . . . . . . . . 1.3 m -156.62 86.19 2.95 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.92 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo . . . . . 0 C--O 1.25 1.084 0 C-N-CA 122.571 2.181 . . . . 0.0 112.221 -179.923 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 120.509 0.195 . . . . 0.0 111.424 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 455' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.13 -173.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.445 2.097 . . . . 0.0 112.314 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 456' ' ' ARG . . . . . . . . . . . . . 5.0 mtp180 -58.09 -26.46 62.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.08 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.65 -31.16 66.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.98 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -81.43 108.58 15.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.008 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 10.6 t -88.99 149.32 43.1 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.943 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -52.91 -174.59 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.562 2.175 . . . . 0.0 112.295 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . 129.74 -28.56 3.93 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.521 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -132.16 88.05 41.77 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.761 0.315 . . . . 0.0 110.932 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -69.29 90.58 0.47 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.523 2.149 . . . . 0.0 112.271 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 6.2 mtmp? -117.92 119.36 34.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.877 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -105.05 -75.1 0.63 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.896 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 1.4 m -120.5 30.53 6.89 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.965 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 4.7 tp -136.49 71.23 1.41 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.868 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 73.8 m -138.19 35.85 2.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.95 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 128.83 -36.87 2.33 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.357 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -120.83 117.86 28.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.841 0.353 . . . . 0.0 110.727 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 471' ' ' VAL . . . . . 0.573 ' O ' HG13 ' A' ' 471' ' ' VAL . 9.4 p -112.98 108.11 24.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.097 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 22.0 m-80 -162.6 161.88 19.42 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.866 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -64.56 76.42 0.19 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.535 2.157 . . . . 0.0 112.139 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -97.56 36.72 1.46 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.951 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 15.9 m -54.25 -58.05 8.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.902 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 476' ' ' GLY . . . . . . . . . . . . . . . 57.41 70.07 1.09 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.678 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 477' ' ' ASN . . . . . 0.431 ' N ' ' CD ' ' A' ' 478' ' ' PRO . 0.2 OUTLIER -48.47 -51.41 51.75 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-O 120.698 0.285 . . . . 0.0 111.066 179.923 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 478' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 477' ' ' ASN . 85.4 Cg_endo -86.91 34.41 0.44 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.905 2.403 . . . . 0.0 112.638 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 12.7 p80 -47.26 170.54 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.853 0.358 . . . . 0.0 111.424 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 480' ' ' ALA . . . . . 0.886 ' HB1' ' HD2' ' A' ' 481' ' ' PRO . . . -90.5 176.46 2.94 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.192 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 481' ' ' PRO . . . . . 0.886 ' HD2' ' HB1' ' A' ' 480' ' ' ALA . 65.7 Cg_exo -42.0 -70.45 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.919 2.412 . . . . 0.0 112.884 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 482' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -135.12 -49.59 0.74 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.236 0.541 . . . . 0.0 109.844 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 483' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.66 141.6 43.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.088 179.38 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 484' ' ' ASN . . . . . 0.587 ' O ' ' CD ' ' A' ' 489' ' ' PRO . 1.3 m120 -86.7 -11.47 51.1 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.081 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 485' ' ' PHE . . . . . 0.682 ' HA ' ' HG2' ' A' ' 489' ' ' PRO . 55.2 m-85 -49.35 -47.33 47.52 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.576 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -72.2 -47.69 48.66 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -178.006 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -70.91 -74.33 0.15 Allowed 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 -176.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 488' ' ' MET . . . . . 0.519 ' HB2' ' HD3' ' A' ' 489' ' ' PRO . 0.0 OUTLIER -52.88 -52.24 66.81 Favored Pre-proline 0 N--CA 1.473 0.682 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.688 -178.454 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 489' ' ' PRO . . . . . 0.682 ' HG2' ' HA ' ' A' ' 485' ' ' PHE . 6.5 Cg_exo -79.6 41.64 1.15 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 124.18 3.253 . . . . 0.0 112.532 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -42.72 -36.77 1.53 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.904 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 491' ' ' ALA . . . . . . . . . . . . . . . -132.92 136.8 46.35 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.879 0.371 . . . . 0.0 111.934 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 492' ' ' ARG . . . . . 0.522 ' CD ' ' HG ' ' A' ' 585' ' ' LEU . 0.0 OUTLIER -134.37 134.86 42.2 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.855 179.101 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 493' ' ' VAL . . . . . 0.673 HG21 ' CA ' ' A' ' 513' ' ' GLY . 85.9 t -135.28 163.73 35.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.242 178.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 494' ' ' THR . . . . . 0.553 ' N ' HG12 ' A' ' 493' ' ' VAL . 1.3 m -125.72 135.89 52.58 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.323 0.582 . . . . 0.0 111.231 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 495' ' ' LEU . . . . . 0.955 ' O ' HG22 ' A' ' 588' ' ' ILE . 2.1 pp -133.93 163.3 52.12 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 115.239 -0.892 . . . . 0.0 110.122 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 496' ' ' PRO . . . . . 0.819 ' HD2' HD21 ' A' ' 499' ' ' LEU . 20.4 Cg_exo -63.36 118.67 5.58 Favored 'Trans proline' 0 CA--C 1.534 0.477 0 C-N-CA 121.712 1.608 . . . . 0.0 111.327 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 497' ' ' LYS . . . . . 0.815 ' O ' HG12 ' A' ' 500' ' ' VAL . 8.6 tttm -50.19 -29.87 10.22 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -179.118 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 498' ' ' SER . . . . . 0.44 ' HA ' ' CE2' ' A' ' 501' ' ' TYR . 1.0 OUTLIER -56.3 -48.45 76.64 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 113.758 1.022 . . . . 0.0 113.758 -177.345 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 499' ' ' LEU . . . . . 0.819 HD21 ' HD2' ' A' ' 496' ' ' PRO . 0.7 OUTLIER -73.71 -8.43 55.95 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -178.542 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 500' ' ' VAL . . . . . 0.815 HG12 ' O ' ' A' ' 497' ' ' LYS . 1.7 p -74.73 -25.58 19.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.275 0.56 . . . . 0.0 111.613 -179.016 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 501' ' ' TYR . . . . . 0.635 ' O ' ' CG2' ' A' ' 564' ' ' THR . 6.7 m-30 -53.96 -30.61 47.61 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 114.217 1.192 . . . . 0.0 114.217 -178.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -77.38 -51.16 11.28 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.059 1.874 . . . . 0.0 116.059 -175.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 503' ' ' LYS . . . . . 0.558 ' O ' ' CG ' ' A' ' 507' ' ' LYS . 0.0 OUTLIER -121.2 136.12 55.03 Favored 'General case' 0 C--N 1.339 0.132 0 CA-C-N 118.885 0.766 . . . . 0.0 112.375 -179.109 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 504' ' ' THR . . . . . 0.769 HG23 ' CD1' ' A' ' 568' ' ' ILE . 90.5 m -73.29 -75.68 0.14 Allowed 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 179.047 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 505' ' ' PHE . . . . . 0.74 ' HE2' HG21 ' A' ' 554' ' ' THR . 0.0 OUTLIER -74.87 -62.48 1.53 Allowed 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -178.888 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 506' ' ' SER . . . . . 0.802 ' O ' ' CD1' ' A' ' 510' ' ' TRP . 66.5 m -49.59 -73.23 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -175.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 507' ' ' LYS . . . . . 0.723 ' HD3' ' N ' ' A' ' 508' ' ' VAL . 0.0 OUTLIER -49.05 -48.89 43.59 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -176.425 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 508' ' ' VAL . . . . . 0.755 HG21 HD21 ' A' ' 574' ' ' LEU . 47.7 t -55.83 -62.33 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.722 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 509' ' ' LEU . . . . . 0.791 HD12 ' N ' ' A' ' 510' ' ' TRP . 1.9 pp -49.9 -63.01 1.24 Allowed 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -177.323 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 510' ' ' TRP . . . . . 0.867 ' CD1' ' HA ' ' A' ' 518' ' ' LYS . 67.4 p-90 -72.89 -49.74 27.98 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 -176.044 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 511' ' ' SER . . . . . 0.507 ' N ' ' CE3' ' A' ' 510' ' ' TRP . 0.3 OUTLIER -62.87 -47.07 84.94 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.289 -0.869 . . . . 0.0 113.178 -176.81 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 512' ' ' ALA . . . . . 0.881 ' HB2' HD23 ' A' ' 495' ' ' LEU . . . -70.97 -73.5 0.17 Allowed 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 118.242 2.682 . . . . 0.0 118.242 -173.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 513' ' ' GLY . . . . . 0.673 ' CA ' HG21 ' A' ' 493' ' ' VAL . . . -114.67 -36.05 1.33 Allowed Glycine 0 CA--C 1.502 -0.743 0 N-CA-C 121.295 3.278 . . . . 0.0 121.295 -172.082 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 514' ' ' LEU . . . . . 0.809 HD12 ' HB2' ' A' ' 584' ' ' LYS . 1.6 mt -108.94 -43.21 4.26 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 120.053 3.353 . . . . 0.0 120.053 -170.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 515' ' ' VAL . . . . . 0.97 HG13 ' HB2' ' A' ' 517' ' ' SER . 3.8 p -154.0 172.12 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 117.721 2.489 . . . . 0.0 117.721 -171.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 516' ' ' ALA . . . . . 0.581 ' N ' HG22 ' A' ' 515' ' ' VAL . . . -68.42 3.97 1.54 Allowed 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 127.054 2.142 . . . . 0.0 110.238 177.318 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 517' ' ' SER . . . . . 0.97 ' HB2' HG13 ' A' ' 515' ' ' VAL . 0.4 OUTLIER -57.32 8.81 0.01 OUTLIER 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 115.575 1.695 . . . . 0.0 115.575 -171.853 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 518' ' ' LYS . . . . . 0.867 ' HA ' ' CD1' ' A' ' 510' ' ' TRP . 2.3 ttpt -46.37 -51.4 14.96 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 104.462 -2.422 . . . . 0.0 104.462 174.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 519' ' ' SER . . . . . . . . . . . . . 35.2 t -75.0 -57.01 4.17 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.101 173.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 520' ' ' GLU . . . . . 0.735 ' HB2' ' HA ' ' A' ' 517' ' ' SER . 0.3 OUTLIER -57.47 -48.0 80.35 Favored 'General case' 0 C--N 1.348 0.536 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.926 -178.97 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 521' ' ' GLY . . . . . 0.813 ' N ' ' O ' ' A' ' 517' ' ' SER . . . -49.46 -56.81 10.22 Favored Glycine 0 CA--C 1.493 -1.296 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.525 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -47.82 -47.32 31.24 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 523' ' ' ARG . . . . . 0.432 ' O ' ' HB3' ' A' ' 526' ' ' ASN . 0.5 OUTLIER -50.12 -48.79 53.32 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.785 178.557 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 524' ' ' ILE . . . . . 0.526 HD12 ' HD3' ' A' ' 580' ' ' LYS . 29.8 mm -59.36 -54.05 39.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.325 0.583 . . . . 0.0 110.043 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 525' ' ' ILE . . . . . 0.596 HD13 ' N ' ' A' ' 525' ' ' ILE . 1.3 mm -50.27 -47.3 25.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 177.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 526' ' ' ASN . . . . . 0.432 ' HB3' ' O ' ' A' ' 523' ' ' ARG . 18.9 t-20 -57.93 -47.85 81.63 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 114.607 -1.179 . . . . 0.0 108.325 177.142 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 527' ' ' ASN . . . . . 0.493 ' HB3' ' HA ' ' A' ' 524' ' ' ILE . 0.0 OUTLIER -47.73 -39.13 16.88 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 113.965 -1.471 . . . . 0.0 107.931 176.807 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 528' ' ' ASN . . . . . 1.03 ' HA ' HG21 ' A' ' 556' ' ' ILE . 1.6 t30 75.17 40.61 0.33 Allowed 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 114.854 -1.066 . . . . 0.0 112.088 -179.116 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 529' ' ' GLY . . . . . . . . . . . . . . . -112.46 20.25 21.02 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 114.524 -1.217 . . . . 0.0 111.661 177.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 530' ' ' ALA . . . . . 0.804 ' O ' ' HB ' ' A' ' 556' ' ' ILE . . . -133.76 163.68 28.92 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -179.099 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 531' ' ' TYR . . . . . 0.533 ' CE2' ' HA ' ' A' ' 553' ' ' PHE . 0.0 OUTLIER -133.76 162.59 31.57 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 177.578 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 532' ' ' VAL . . . . . 0.662 HG12 ' OG1' ' A' ' 554' ' ' THR . 0.6 OUTLIER -127.47 135.06 64.32 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 CA-C-O 121.956 0.884 . . . . 0.0 111.819 179.131 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 533' ' ' GLY . . . . . 0.729 ' HA2' ' O ' ' A' ' 552' ' ' THR . . . -133.62 148.44 19.39 Favored Glycine 0 N--CA 1.445 -0.7 0 CA-C-N 114.252 -1.34 . . . . 0.0 113.496 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 534' ' ' SER . . . . . 0.434 ' HB2' ' OG1' ' A' ' 552' ' ' THR . 0.1 OUTLIER -135.14 141.28 45.92 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 179.724 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 535' ' ' ARG . . . . . 0.674 ' O ' ' HB3' ' A' ' 573' ' ' LEU . 26.2 tpt85 -159.51 89.46 1.97 Allowed Pre-proline 0 N--CA 1.464 0.248 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.848 178.277 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 536' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -92.21 -84.94 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.364 2.71 . . . . 0.0 112.816 179.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 114.12 -10.04 22.71 Favored Glycine 0 C--N 1.334 0.418 0 C-N-CA 120.558 -0.83 . . . . 0.0 113.102 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 538' ' ' VAL . . . . . 0.554 HG13 ' O ' ' A' ' 538' ' ' VAL . 0.4 OUTLIER -116.07 5.3 7.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-O 121.043 0.449 . . . . 0.0 111.569 -179.767 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 539' ' ' LYS . . . . . 0.408 ' HE2' ' HB3' ' A' ' 549' ' ' ASP . 0.0 OUTLIER -46.81 146.54 1.58 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.708 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -127.78 -73.39 0.6 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.406 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 541' ' ' ASN . . . . . 0.524 ' O ' ' HD3' ' A' ' 543' ' ' PRO . 0.2 OUTLIER -59.62 102.27 0.14 Allowed 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.582 179.032 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 542' ' ' GLU . . . . . 0.554 ' O ' ' N ' ' A' ' 544' ' ' GLY . 1.1 mp0 -47.21 97.86 0.16 Allowed Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.768 -178.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 543' ' ' PRO . . . . . 0.524 ' HD3' ' O ' ' A' ' 541' ' ' ASN . 14.3 Cg_endo -52.66 55.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 124.407 3.404 . . . . 0.0 114.398 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 544' ' ' GLY . . . . . 0.571 ' O ' ' N ' ' A' ' 546' ' ' GLY . . . 52.91 56.07 20.44 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 119.366 -1.397 . . . . 0.0 111.394 -179.392 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 545' ' ' GLY . . . . . 0.487 ' O ' ' C ' ' A' ' 546' ' ' GLY . . . 55.65 -53.01 0.01 OUTLIER Glycine 0 CA--C 1.523 0.562 0 CA-C-O 119.015 -0.88 . . . . 0.0 113.86 -177.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 546' ' ' GLY . . . . . 0.583 ' O ' ' N ' ' A' ' 548' ' ' PRO . . . 31.02 55.87 0.27 Allowed Glycine 0 C--N 1.336 0.555 0 CA-C-N 118.742 1.271 . . . . 0.0 113.164 177.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 547' ' ' MET . . . . . 0.489 ' C ' ' O ' ' A' ' 546' ' ' GLY . 0.1 OUTLIER -6.88 -55.35 0.0 OUTLIER Pre-proline 0 N--CA 1.477 0.925 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 -177.437 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 548' ' ' PRO . . . . . 0.583 ' N ' ' O ' ' A' ' 546' ' ' GLY . 5.9 Cg_endo -88.14 119.56 1.23 Allowed 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 121.756 1.637 . . . . 0.0 110.992 178.528 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 549' ' ' ASP . . . . . 0.408 ' HB3' ' HE2' ' A' ' 539' ' ' LYS . 3.2 m-20 -126.14 -41.02 1.95 Allowed 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 550' ' ' ASP . . . . . 0.501 ' O ' ' HA ' ' A' ' 535' ' ' ARG . 11.4 m-20 -77.78 -39.37 44.22 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.053 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 551' ' ' LEU . . . . . 0.78 HD11 ' CE1' ' A' ' 553' ' ' PHE . 3.0 tp -131.25 140.76 49.89 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.951 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 552' ' ' THR . . . . . 0.729 ' O ' ' HA2' ' A' ' 533' ' ' GLY . 1.9 m -132.87 146.09 51.5 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.491 0.663 . . . . 0.0 110.98 178.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 553' ' ' PHE . . . . . 0.78 ' CE1' HD11 ' A' ' 551' ' ' LEU . 9.8 m-85 -134.39 137.01 43.75 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 177.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 554' ' ' THR . . . . . 0.896 HG22 ' H ' ' A' ' 556' ' ' ILE . 21.7 m -133.94 138.62 31.14 Favored Pre-proline 0 C--N 1.303 -1.423 0 C-N-CA 119.42 -0.912 . . . . 0.0 110.045 178.14 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 555' ' ' PRO . . . . . 0.811 ' O ' HG22 ' A' ' 556' ' ' ILE . 85.6 Cg_endo -85.48 25.29 0.7 Allowed 'Trans proline' 0 N--CA 1.438 -1.771 0 C-N-CA 121.452 1.434 . . . . 0.0 109.857 178.021 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 556' ' ' ILE . . . . . 1.03 HG21 ' HA ' ' A' ' 528' ' ' ASN . 1.4 tp 64.59 32.6 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 177.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -103.96 131.19 51.45 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 558' ' ' THR . . . . . 0.514 ' HA ' ' CE1' ' A' ' 505' ' ' PHE . 3.5 t -58.17 116.38 3.52 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 116.071 1.878 . . . . 0.0 116.071 -172.157 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 559' ' ' TRP . . . . . 0.645 ' CE3' ' HG3' ' A' ' 563' ' ' LYS . 1.3 m0 -139.33 111.49 7.46 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 104.414 -2.439 . . . . 0.0 104.414 173.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 560' ' ' ASN . . . . . 0.51 ' O ' ' HB ' ' A' ' 564' ' ' THR . 51.1 m-80 -90.98 -75.32 0.47 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 115.116 1.524 . . . . 0.0 115.116 -175.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 561' ' ' ALA . . . . . 0.451 ' O ' HG22 ' A' ' 564' ' ' THR . . . -73.76 -63.42 1.21 Allowed 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 115.729 1.751 . . . . 0.0 115.729 -176.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 562' ' ' SER . . . . . . . . . . . . . 69.2 m -48.83 -50.84 32.65 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -176.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 563' ' ' LYS . . . . . 0.645 ' HG3' ' CE3' ' A' ' 559' ' ' TRP . 1.2 mmpt? -71.2 -49.01 48.02 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -178.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 564' ' ' THR . . . . . 0.706 ' O ' ' HB ' ' A' ' 568' ' ' ILE . 3.4 t -51.17 -62.93 1.31 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.794 0.331 . . . . 0.0 110.709 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 565' ' ' GLN . . . . . 1.014 ' O ' HG23 ' A' ' 569' ' ' ILE . 3.7 tp-100 -50.23 -47.34 54.99 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.858 0.361 . . . . 0.0 111.28 178.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 566' ' ' GLU . . . . . 0.423 ' HG2' ' CD1' ' A' ' 567' ' ' PHE . 23.3 tt0 -49.2 -68.54 0.17 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -178.48 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 567' ' ' PHE . . . . . 0.714 ' CD2' HG21 ' A' ' 552' ' ' THR . 0.2 OUTLIER -91.01 -51.85 5.14 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.397 0.618 . . . . 0.0 111.57 -179.094 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 568' ' ' ILE . . . . . 0.769 ' CD1' HG23 ' A' ' 504' ' ' THR . 1.9 mp -56.17 8.98 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 114.83 -1.077 . . . . 0.0 113.259 -179.315 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 569' ' ' ILE . . . . . 1.014 HG23 ' O ' ' A' ' 565' ' ' GLN . 1.3 pt -54.13 -36.39 32.13 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.728 0 N-CA-C 104.146 -2.538 . . . . 0.0 104.146 177.415 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 570' ' ' ASP . . . . . 0.662 ' OD2' HD22 ' A' ' 574' ' ' LEU . 28.4 m-20 35.39 54.84 0.83 Allowed 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 113.453 -1.703 . . . . 0.0 111.661 174.13 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -51.28 -44.89 52.62 Favored Glycine 0 N--CA 1.438 -1.169 0 C-N-CA 118.045 -2.026 . . . . 0.0 108.455 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 572' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -119.89 -17.12 8.57 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 175.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 573' ' ' LEU . . . . . 0.674 ' HB3' ' O ' ' A' ' 535' ' ' ARG . 0.9 OUTLIER -140.7 136.65 32.83 Favored 'General case' 0 C--N 1.354 0.768 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 -177.937 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 574' ' ' LEU . . . . . 0.977 ' HB2' HD11 ' A' ' 588' ' ' ILE . 0.7 OUTLIER -135.29 133.48 38.92 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 173.865 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 575' ' ' ILE . . . . . 1.012 HG23 HD13 ' A' ' 585' ' ' LEU . 0.0 OUTLIER -133.48 137.19 53.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 119.133 0.879 . . . . 0.0 111.745 178.736 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 576' ' ' LEU . . . . . 0.64 HD11 HD21 ' A' ' 578' ' ' LEU . 0.0 OUTLIER -133.31 135.32 44.75 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 177.255 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 577' ' ' LYS . . . . . 0.451 ' CD ' ' CD1' ' A' ' 531' ' ' TYR . 0.2 OUTLIER -128.22 135.48 49.74 Favored 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.104 178.044 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.64 HD21 HD11 ' A' ' 576' ' ' LEU . 0.4 OUTLIER -125.81 132.7 52.2 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.537 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 579' ' ' GLY . . . . . . . . . . . . . . . -88.51 -2.14 79.86 Favored Glycine 0 N--CA 1.438 -1.169 0 CA-C-N 114.759 -1.11 . . . . 0.0 112.962 -179.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 580' ' ' LYS . . . . . 0.526 ' HD3' HD12 ' A' ' 524' ' ' ILE . 18.9 pttt -66.1 -50.46 63.96 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 118.891 -1.124 . . . . 0.0 108.047 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 581' ' ' TRP . . . . . 0.458 ' CZ2' ' HD2' ' A' ' 580' ' ' LYS . 0.0 OUTLIER -142.35 -52.03 0.4 Allowed 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 175.815 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 582' ' ' LYS . . . . . 0.433 ' HE3' ' CD1' ' A' ' 581' ' ' TRP . 0.4 OUTLIER -139.56 166.06 25.58 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 114.398 1.258 . . . . 0.0 114.398 -174.508 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 583' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -109.2 135.24 50.63 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 174.64 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 584' ' ' LYS . . . . . 0.809 ' HB2' HD12 ' A' ' 514' ' ' LEU . 1.1 tmmt? -114.8 133.85 55.6 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 178.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 585' ' ' LEU . . . . . 1.012 HD13 HG23 ' A' ' 575' ' ' ILE . 5.0 tp -122.38 136.69 54.94 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 586' ' ' VAL . . . . . 0.54 HG21 ' HZ3' ' A' ' 584' ' ' LYS . 9.5 t -132.91 144.58 36.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -178.043 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 587' ' ' SER . . . . . 0.484 ' C ' HD13 ' A' ' 588' ' ' ILE . 2.9 m -109.83 136.35 49.28 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 177.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.977 HD11 ' HB2' ' A' ' 574' ' ' LEU . 0.0 OUTLIER -132.7 136.74 55.38 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -177.958 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 5.6 m -133.07 137.06 54.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 114.356 -1.293 . . . . 0.0 110.688 178.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 590' ' ' SER . . . . . . . . . . . . . 2.6 m -82.27 147.58 28.84 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.449 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 591' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -50.67 -50.87 53.76 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.034 0.445 . . . . 0.0 110.776 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -52.2 -50.64 61.49 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.311 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 12.2 mmmt -50.13 -48.49 53.59 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.766 0.794 . . . . 0.0 108.927 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 594' ' ' PHE . . . . . 0.778 ' CD1' HD11 ' A' ' 597' ' ' LEU . 0.9 OUTLIER -50.33 -47.83 55.66 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.465 -1.243 . . . . 0.0 109.694 178.125 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 595' ' ' LYS . . . . . 0.503 ' HE3' ' CE2' ' A' ' 604' ' ' TRP . 0.0 OUTLIER -48.7 -47.72 40.84 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.428 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 596' ' ' GLU . . . . . 0.686 ' O ' HD23 ' A' ' 599' ' ' LEU . 2.5 mm-40 -55.67 -62.5 1.65 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.744 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 597' ' ' LEU . . . . . 0.778 HD11 ' CD1' ' A' ' 594' ' ' PHE . 0.8 OUTLIER -56.87 -60.94 2.83 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 121.445 0.641 . . . . 0.0 112.108 -178.619 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 598' ' ' GLY . . . . . 0.508 ' N ' HD12 ' A' ' 597' ' ' LEU . . . -78.95 14.01 16.11 Favored Glycine 0 C--N 1.32 -0.34 0 CA-C-N 114.956 -1.02 . . . . 0.0 113.162 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 599' ' ' LEU . . . . . 0.686 HD23 ' O ' ' A' ' 596' ' ' GLU . 4.5 pp -47.48 -15.73 0.05 Allowed 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -175.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 600' ' ' THR . . . . . 0.575 HG23 ' O ' ' A' ' 600' ' ' THR . 9.9 t -129.4 66.11 1.46 Allowed 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.247 176.422 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 601' ' ' ALA . . . . . . . . . . . . . . . -131.9 154.3 81.69 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.489 179.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 602' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.63 -21.19 45.7 Favored 'Trans proline' 0 N--CA 1.464 -0.207 0 C-N-CA 121.976 1.784 . . . . 0.0 111.097 178.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 603' ' ' GLY . . . . . 0.664 ' O ' HG23 ' A' ' 607' ' ' VAL . . . -61.01 -49.14 81.88 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.669 -0.696 . . . . 0.0 113.079 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 604' ' ' TRP . . . . . 0.503 ' CE2' ' HE3' ' A' ' 595' ' ' LYS . 1.1 m95 -65.58 -46.74 78.26 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 120.856 0.36 . . . . 0.0 111.206 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 605' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -50.38 -59.8 3.63 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.271 -178.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 606' ' ' GLU . . . . . 0.408 ' HA ' ' HB2' ' A' ' 610' ' ' LYS . 0.0 OUTLIER -60.85 -58.69 7.39 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -179.569 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 607' ' ' VAL . . . . . 0.664 HG23 ' O ' ' A' ' 603' ' ' GLY . 60.6 t -50.85 -71.86 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -178.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 608' ' ' VAL . . . . . . . . . . . . . 74.8 t -70.44 -60.34 2.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -177.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 609' ' ' GLY . . . . . . . . . . . . . . . -57.17 -62.87 5.87 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 121.146 -0.55 . . . . 0.0 113.291 -178.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 610' ' ' LYS . . . . . 0.408 ' HB2' ' HA ' ' A' ' 606' ' ' GLU . 17.6 tttt -62.72 -49.82 73.56 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.785 0.326 . . . . 0.0 110.98 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 74.32 54.45 6.18 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.552 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 29.2 mttt -59.0 -25.66 63.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.768 0.318 . . . . 0.0 111.036 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 613' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -77.0 172.94 12.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.824 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 614' ' ' GLU . . . . . 0.442 ' CB ' ' HD3' ' A' ' 615' ' ' PRO . 0.5 OUTLIER -58.44 -53.26 67.98 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.942 -179.95 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 615' ' ' PRO . . . . . 0.442 ' HD3' ' CB ' ' A' ' 614' ' ' GLU . 36.7 Cg_exo -59.92 85.54 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.402 2.068 . . . . 0.0 112.093 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 616' ' ' SER . . . . . . . . . . . . . 1.2 m -73.71 150.53 88.71 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.844 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo . . . . . 0 C--O 1.248 1.019 0 C-N-CA 122.651 2.234 . . . . 0.0 112.267 179.957 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 454' ' ' MET . . . . . 0.405 ' N ' ' HD2' ' A' ' 455' ' ' PRO . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 120.686 0.279 . . . . 0.0 111.523 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 455' ' ' PRO . . . . . 0.663 ' HB2' HG22 ' A' ' 457' ' ' THR . 94.7 Cg_endo -81.56 153.52 17.9 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.527 2.152 . . . . 0.0 112.349 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 456' ' ' ARG . . . . . . . . . . . . . 29.4 mtm180 -71.18 -26.57 63.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.993 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 457' ' ' THR . . . . . 0.663 HG22 ' HB2' ' A' ' 455' ' ' PRO . 6.0 t -62.04 -31.31 71.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.96 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -59.7 126.74 28.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.111 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 25.1 p -89.27 155.46 49.07 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.866 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -52.13 151.65 16.34 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.649 2.233 . . . . 0.0 112.351 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . 102.67 56.6 0.81 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.499 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 41.5 p30 -86.74 148.56 46.31 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 120.657 0.265 . . . . 0.0 110.896 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -52.82 155.7 10.41 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.591 2.194 . . . . 0.0 112.279 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 5.8 tttt -75.75 160.15 30.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.863 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.74 22.15 8.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.104 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 7.0 p -63.43 -24.82 68.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.999 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.43 71.06 0.73 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.885 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -119.84 43.32 2.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.728 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 128.96 -35.83 2.54 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.261 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -119.03 117.78 29.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.88 0.372 . . . . 0.0 110.686 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 471' ' ' VAL . . . . . 0.573 ' O ' HG13 ' A' ' 471' ' ' VAL . 10.7 p -113.11 108.41 25.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.138 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -151.09 85.79 4.99 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.946 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.79 159.77 47.67 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.545 2.164 . . . . 0.0 112.302 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -59.61 -42.92 93.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.873 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.02 -48.14 0.55 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.678 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 476' ' ' GLY . . . . . . . . . . . . . . . 92.21 -41.7 2.77 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.731 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 477' ' ' ASN . . . . . 0.419 ' N ' ' CD ' ' A' ' 478' ' ' PRO . 3.7 m-20 51.0 52.43 12.22 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-O 120.736 0.303 . . . . 0.0 111.151 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 478' ' ' PRO . . . . . 0.419 ' CD ' ' N ' ' A' ' 477' ' ' ASN . 73.6 Cg_endo -76.29 -44.16 0.26 Allowed 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.516 2.144 . . . . 0.0 112.469 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 33.5 t-80 -99.15 119.78 38.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.064 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 480' ' ' ALA . . . . . 0.414 ' HA ' ' HD3' ' A' ' 481' ' ' PRO . . . -65.79 109.24 2.9 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.974 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 481' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 480' ' ' ALA . 5.6 Cg_exo -79.0 39.88 0.87 Allowed 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.956 2.437 . . . . 0.0 112.89 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 482' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.28 -40.03 64.38 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.127 0.489 . . . . 0.0 110.644 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 483' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -136.29 171.89 13.82 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.442 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 484' ' ' ASN . . . . . 0.543 ' O ' ' CD ' ' A' ' 489' ' ' PRO . 28.0 m-20 -105.0 -17.91 14.34 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.014 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 485' ' ' PHE . . . . . 0.679 ' HA ' ' HG2' ' A' ' 489' ' ' PRO . 18.4 m-85 -49.36 -47.44 47.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.514 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -70.81 -47.99 56.49 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -178.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.66 -73.83 0.17 Allowed 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -176.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 488' ' ' MET . . . . . 0.496 ' CB ' ' HD3' ' A' ' 489' ' ' PRO . 0.0 OUTLIER -52.42 -53.5 52.44 Favored Pre-proline 0 N--CA 1.47 0.567 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -177.354 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 489' ' ' PRO . . . . . 0.679 ' HG2' ' HA ' ' A' ' 485' ' ' PHE . 32.3 Cg_exo -65.09 43.28 0.14 Allowed 'Trans proline' 0 N--CA 1.476 0.485 0 C-N-CA 123.964 3.109 . . . . 0.0 113.979 -179.267 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 3.8 t -37.96 -42.44 0.63 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.672 0.272 . . . . 0.0 111.211 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 491' ' ' ALA . . . . . 0.417 ' CB ' ' NZ ' ' A' ' 584' ' ' LYS . . . -132.8 135.64 45.8 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.574 178.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 492' ' ' ARG . . . . . 0.66 ' CD ' HD22 ' A' ' 585' ' ' LEU . 0.0 OUTLIER -135.85 135.23 39.61 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.981 0.419 . . . . 0.0 111.851 179.883 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 493' ' ' VAL . . . . . 0.569 HG12 ' N ' ' A' ' 494' ' ' THR . 84.8 t -134.93 163.2 37.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.135 177.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 494' ' ' THR . . . . . 0.569 ' N ' HG12 ' A' ' 493' ' ' VAL . 5.3 t -122.49 134.86 54.56 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.143 0.497 . . . . 0.0 111.147 178.387 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 495' ' ' LEU . . . . . 0.919 HD22 ' HB2' ' A' ' 512' ' ' ALA . 0.0 OUTLIER -135.49 164.57 42.62 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.401 179.593 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 496' ' ' PRO . . . . . 0.737 ' HD2' HD21 ' A' ' 499' ' ' LEU . 15.4 Cg_exo -66.69 119.42 6.45 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 121.759 1.639 . . . . 0.0 110.918 178.479 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 497' ' ' LYS . . . . . 0.455 ' HB2' ' N ' ' A' ' 589' ' ' VAL . 5.6 tmtt? -53.81 -30.02 43.2 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -178.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 498' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.92 -48.36 82.01 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -177.155 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 499' ' ' LEU . . . . . 0.757 HD11 ' CD1' ' A' ' 495' ' ' LEU . 2.2 pp -73.52 -8.87 57.71 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -178.491 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 500' ' ' VAL . . . . . 0.857 HG21 HG21 ' A' ' 588' ' ' ILE . 39.8 t -75.41 -25.4 17.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.21 0.528 . . . . 0.0 111.922 -179.337 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 501' ' ' TYR . . . . . 0.83 ' O ' HG21 ' A' ' 564' ' ' THR . 0.7 OUTLIER -52.95 -28.7 24.84 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -178.201 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.4 -50.08 17.0 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 115.563 1.69 . . . . 0.0 115.563 -175.556 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 503' ' ' LYS . . . . . 0.569 ' O ' ' CG ' ' A' ' 507' ' ' LYS . 0.5 OUTLIER -119.44 135.29 54.82 Favored 'General case' 0 C--N 1.338 0.074 0 CA-C-N 119.201 0.909 . . . . 0.0 111.843 -179.41 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 504' ' ' THR . . . . . 0.764 HG23 ' CE1' ' A' ' 567' ' ' PHE . 62.5 m -73.18 -76.61 0.12 Allowed 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 505' ' ' PHE . . . . . 0.653 ' CE2' HG23 ' A' ' 532' ' ' VAL . 0.2 OUTLIER -75.08 -60.87 2.1 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -179.25 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 506' ' ' SER . . . . . 0.466 ' O ' ' HG ' ' A' ' 509' ' ' LEU . 1.4 m -48.82 -72.72 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 -176.039 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 507' ' ' LYS . . . . . 0.804 ' HZ1' HG22 ' A' ' 500' ' ' VAL . 0.0 OUTLIER -50.41 -48.92 55.96 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -176.878 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 508' ' ' VAL . . . . . 0.831 HG13 HD21 ' A' ' 574' ' ' LEU . 47.9 t -52.66 -58.84 2.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -178.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 509' ' ' LEU . . . . . 0.812 HD12 ' N ' ' A' ' 510' ' ' TRP . 1.5 pp -58.16 -62.84 1.53 Allowed 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 -177.1 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 510' ' ' TRP . . . . . 0.812 ' N ' HD12 ' A' ' 509' ' ' LEU . 6.0 p-90 -73.06 -52.49 14.15 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 114.706 1.372 . . . . 0.0 114.706 -176.227 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 511' ' ' SER . . . . . 0.486 ' N ' ' CE3' ' A' ' 510' ' ' TRP . 0.2 OUTLIER -61.87 -48.41 80.62 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.684 -176.893 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 512' ' ' ALA . . . . . 0.919 ' HB2' HD22 ' A' ' 495' ' ' LEU . . . -72.1 -73.77 0.18 Allowed 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 117.162 2.282 . . . . 0.0 117.162 -174.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 513' ' ' GLY . . . . . 0.681 ' HA3' ' HE3' ' A' ' 584' ' ' LYS . . . -115.23 -35.13 1.36 Allowed Glycine 0 N--CA 1.449 -0.477 0 N-CA-C 121.408 3.323 . . . . 0.0 121.408 -172.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 514' ' ' LEU . . . . . 0.606 ' HG ' ' HE2' ' A' ' 584' ' ' LYS . 1.3 mt -107.58 -38.73 5.82 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 120.09 3.367 . . . . 0.0 120.09 -170.013 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 515' ' ' VAL . . . . . 0.592 HG22 ' N ' ' A' ' 516' ' ' ALA . 14.3 p -152.95 172.08 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 N-CA-C 118.108 2.633 . . . . 0.0 118.108 -172.062 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 516' ' ' ALA . . . . . 0.592 ' N ' HG22 ' A' ' 515' ' ' VAL . . . -85.94 2.69 45.15 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 127.055 2.142 . . . . 0.0 108.956 178.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 517' ' ' SER . . . . . 0.882 ' O ' ' N ' ' A' ' 521' ' ' GLY . 10.4 p -59.82 13.0 0.01 OUTLIER 'General case' 0 N--CA 1.424 -1.729 0 C-N-CA 126.326 1.85 . . . . 0.0 115.49 -173.07 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 518' ' ' LYS . . . . . 0.631 ' C ' ' O ' ' A' ' 517' ' ' SER . 2.1 mppt? -40.61 -44.36 2.1 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 178.2 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 519' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.37 -52.46 12.07 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.323 173.362 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 520' ' ' GLU . . . . . 0.809 ' HB2' ' HA ' ' A' ' 517' ' ' SER . 9.0 mm-40 -63.1 -46.81 85.6 Favored 'General case' 0 C--N 1.35 0.591 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.277 -179.16 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 521' ' ' GLY . . . . . 0.891 ' HA2' HD12 ' A' ' 524' ' ' ILE . . . -49.16 -58.75 7.58 Favored Glycine 0 CA--C 1.495 -1.172 0 N-CA-C 111.344 -0.702 . . . . 0.0 111.344 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 522' ' ' GLN . . . . . 0.412 ' HA ' HG12 ' A' ' 525' ' ' ILE . 3.8 mt-30 -47.99 -47.89 32.8 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 178.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 523' ' ' ARG . . . . . 0.477 ' HB3' ' O ' ' A' ' 520' ' ' GLU . 0.4 OUTLIER -50.26 -48.75 54.67 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.823 178.945 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 524' ' ' ILE . . . . . 0.891 HD12 ' HA2' ' A' ' 521' ' ' GLY . 6.0 mt -58.31 -54.86 27.06 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 CA-C-O 121.341 0.591 . . . . 0.0 109.745 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 525' ' ' ILE . . . . . 0.565 ' HA ' HG13 ' A' ' 556' ' ' ILE . 1.0 OUTLIER -50.37 -47.6 26.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.091 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 526' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -58.2 -47.78 82.4 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 114.373 -1.285 . . . . 0.0 108.643 177.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -47.69 -39.83 18.45 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 113.971 -1.468 . . . . 0.0 108.028 177.282 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 528' ' ' ASN . . . . . 1.028 ' HA ' HG21 ' A' ' 556' ' ' ILE . 1.6 t30 73.99 39.85 0.49 Allowed 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.187 -179.187 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 529' ' ' GLY . . . . . . . . . . . . . . . -114.83 20.52 14.77 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 114.265 -1.334 . . . . 0.0 111.54 178.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 530' ' ' ALA . . . . . 0.799 ' O ' ' HB ' ' A' ' 556' ' ' ILE . . . -133.71 156.76 47.36 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.86 0.362 . . . . 0.0 111.649 -179.294 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 531' ' ' TYR . . . . . 0.532 ' HA ' ' O ' ' A' ' 554' ' ' THR . 0.1 OUTLIER -133.28 158.8 42.03 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 178.039 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 532' ' ' VAL . . . . . 0.653 HG23 ' CE2' ' A' ' 505' ' ' PHE . 0.5 OUTLIER -125.52 135.78 62.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-O 122.025 0.917 . . . . 0.0 112.958 -178.301 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 533' ' ' GLY . . . . . 0.635 ' HA2' ' O ' ' A' ' 552' ' ' THR . . . -134.41 161.14 24.4 Favored Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 114.381 -1.281 . . . . 0.0 114.865 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 534' ' ' SER . . . . . 0.601 ' O ' ' HA ' ' A' ' 551' ' ' LEU . 6.7 t -133.8 137.28 45.01 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 114.912 -0.644 . . . . 0.0 110.628 178.435 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 535' ' ' ARG . . . . . 0.758 ' O ' ' HB3' ' A' ' 573' ' ' LEU . 7.1 tpt85 -159.83 90.46 1.85 Allowed Pre-proline 0 C--N 1.33 -0.276 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 178.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 536' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -71.25 -31.77 13.85 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.526 2.15 . . . . 0.0 112.21 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 69.08 55.99 9.7 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.528 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 538' ' ' VAL . . . . . 0.546 HG13 ' N ' ' A' ' 539' ' ' LYS . 12.9 p -116.22 -45.93 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 CA-C-O 121.021 0.438 . . . . 0.0 111.458 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 539' ' ' LYS . . . . . 0.546 ' N ' HG13 ' A' ' 538' ' ' VAL . 16.3 mttt -107.93 161.76 14.63 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.636 -178.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.81 30.56 4.3 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.93 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 541' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -96.24 99.52 11.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.106 0.479 . . . . 0.0 110.446 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -49.77 152.21 2.71 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.294 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 543' ' ' PRO . . . . . 0.792 ' HG3' HD23 ' A' ' 551' ' ' LEU . 9.2 Cg_endo -50.29 -44.0 40.86 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.953 2.435 . . . . 0.0 112.555 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 544' ' ' GLY . . . . . 0.556 ' O ' ' N ' ' A' ' 546' ' ' GLY . . . 51.2 27.26 14.93 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.879 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 545' ' ' GLY . . . . . 0.66 ' O ' ' N ' ' A' ' 547' ' ' MET . . . 53.7 -30.67 0.01 OUTLIER Glycine 0 CA--C 1.532 1.135 0 N-CA-C 115.749 1.06 . . . . 0.0 115.749 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 546' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 544' ' ' GLY . . . -51.75 54.48 0.01 OUTLIER Glycine 0 CA--C 1.528 0.888 0 CA-C-N 118.136 0.968 . . . . 0.0 115.051 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 547' ' ' MET . . . . . 0.66 ' N ' ' O ' ' A' ' 545' ' ' GLY . 35.5 mmt 51.14 53.3 13.51 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 117.963 0.882 . . . . 0.0 111.04 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 548' ' ' PRO . . . . . 0.418 ' HB3' ' HA ' ' A' ' 543' ' ' PRO . 59.4 Cg_endo -71.55 166.5 29.2 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.853 2.368 . . . . 0.0 112.912 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -124.31 -21.71 4.89 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.187 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 550' ' ' ASP . . . . . 0.692 ' O ' ' HA ' ' A' ' 535' ' ' ARG . 1.3 t70 -58.75 -47.94 82.93 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 551' ' ' LEU . . . . . 0.792 HD23 ' HG3' ' A' ' 543' ' ' PRO . 7.9 tp -120.37 140.06 51.87 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.149 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 552' ' ' THR . . . . . 0.635 ' O ' ' HA2' ' A' ' 533' ' ' GLY . 3.2 m -133.39 148.0 51.79 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.861 0.839 . . . . 0.0 112.295 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 553' ' ' PHE . . . . . 0.514 ' CD1' ' CE1' ' A' ' 531' ' ' TYR . 0.3 OUTLIER -134.66 137.46 43.62 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 176.554 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 554' ' ' THR . . . . . 0.619 HG23 ' HZ2' ' A' ' 559' ' ' TRP . 0.9 OUTLIER -132.83 138.11 31.18 Favored Pre-proline 0 C--N 1.31 -1.124 0 C-N-CA 119.474 -0.89 . . . . 0.0 110.338 179.304 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 555' ' ' PRO . . . . . 0.825 ' O ' HG22 ' A' ' 556' ' ' ILE . 61.0 Cg_endo -86.33 25.07 0.7 Allowed 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 122.208 1.938 . . . . 0.0 112.064 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 556' ' ' ILE . . . . . 1.028 HG21 ' HA ' ' A' ' 528' ' ' ASN . 1.5 tp 64.4 33.11 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 115.714 1.746 . . . . 0.0 115.714 176.433 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 557' ' ' LYS . . . . . 0.59 ' O ' ' CE2' ' A' ' 559' ' ' TRP . 3.7 mttt -104.24 125.86 50.87 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 -179.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 558' ' ' THR . . . . . . . . . . . . . 2.8 t -58.13 117.64 4.6 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -173.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 559' ' ' TRP . . . . . 0.619 ' HZ2' HG23 ' A' ' 554' ' ' THR . 0.0 OUTLIER -138.72 112.16 8.17 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 175.479 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 560' ' ' ASN . . . . . 0.716 ' O ' HG22 ' A' ' 564' ' ' THR . 26.2 m-80 -76.26 -76.27 0.17 Allowed 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 118.829 -1.149 . . . . 0.0 113.934 -175.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 561' ' ' ALA . . . . . 0.587 ' HA ' ' CG2' ' A' ' 564' ' ' THR . . . -75.16 -55.04 6.13 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 116.241 1.941 . . . . 0.0 116.241 -177.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 562' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -49.31 -53.77 20.39 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -176.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 563' ' ' LYS . . . . . 0.597 ' HG3' ' CE2' ' A' ' 559' ' ' TRP . 2.4 mmtt -70.86 -47.55 58.7 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -178.4 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 564' ' ' THR . . . . . 0.83 HG21 ' O ' ' A' ' 501' ' ' TYR . 3.3 t -48.53 -67.45 0.27 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.7 0.286 . . . . 0.0 110.879 -178.659 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 565' ' ' GLN . . . . . 0.823 ' H ' HG23 ' A' ' 564' ' ' THR . 0.0 OUTLIER -48.86 -46.77 42.84 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.757 0.313 . . . . 0.0 111.055 179.16 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -49.66 -67.18 0.28 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -178.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 567' ' ' PHE . . . . . 0.959 ' CZ ' HD13 ' A' ' 568' ' ' ILE . 0.3 OUTLIER -89.13 -41.02 12.52 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -177.932 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 568' ' ' ILE . . . . . 0.969 HD11 HD13 ' A' ' 574' ' ' LEU . 0.6 OUTLIER -61.59 9.84 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 179.63 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 569' ' ' ILE . . . . . 0.717 HD12 ' N ' ' A' ' 570' ' ' ASP . 2.7 pp -55.56 -45.02 78.57 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.317 0 N-CA-C 104.112 -2.551 . . . . 0.0 104.112 177.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 570' ' ' ASP . . . . . 0.717 ' N ' HD12 ' A' ' 569' ' ' ILE . 1.3 p30 31.29 60.17 0.27 Allowed 'General case' 0 CA--C 1.511 -0.554 0 CA-C-N 114.236 -1.347 . . . . 0.0 112.16 173.476 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -51.49 -45.22 53.77 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 117.423 -2.323 . . . . 0.0 109.08 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 572' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -119.35 -16.94 8.93 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 175.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 573' ' ' LEU . . . . . 0.758 ' HB3' ' O ' ' A' ' 535' ' ' ARG . 0.7 OUTLIER -140.29 137.94 34.57 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 -178.116 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 574' ' ' LEU . . . . . 0.969 HD13 HD11 ' A' ' 568' ' ' ILE . 0.1 OUTLIER -133.55 134.84 43.86 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 174.223 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 575' ' ' ILE . . . . . 0.862 ' N ' HD12 ' A' ' 574' ' ' LEU . 0.0 OUTLIER -133.04 136.98 54.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 C-N-CA 119.799 -0.76 . . . . 0.0 112.469 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 576' ' ' LEU . . . . . 0.494 ' CD1' ' CE1' ' A' ' 505' ' ' PHE . 0.0 OUTLIER -133.16 135.03 44.9 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 176.73 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 577' ' ' LYS . . . . . 0.542 ' HE2' ' HE2' ' A' ' 583' ' ' MET . 2.9 mtpm? -133.4 135.4 44.61 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 118.762 -1.175 . . . . 0.0 111.232 178.258 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.615 HD12 ' O ' ' A' ' 582' ' ' LYS . 0.3 OUTLIER -125.62 131.66 52.63 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.068 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 579' ' ' GLY . . . . . . . . . . . . . . . -91.3 -2.19 71.09 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.396 -0.82 . . . . 0.0 113.582 -178.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 580' ' ' LYS . . . . . 0.655 ' HG2' HG23 ' A' ' 524' ' ' ILE . 0.0 OUTLIER -72.8 -47.36 47.12 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 119.123 -1.031 . . . . 0.0 108.945 179.387 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 581' ' ' TRP . . . . . 0.561 ' CG ' ' HD2' ' A' ' 580' ' ' LYS . 32.5 m0 -138.49 -52.93 0.6 Allowed 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 177.658 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 582' ' ' LYS . . . . . 0.615 ' O ' HD12 ' A' ' 578' ' ' LEU . 0.0 OUTLIER -139.68 165.29 27.65 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 -174.894 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 583' ' ' MET . . . . . 0.542 ' HE2' ' HE2' ' A' ' 577' ' ' LYS . 0.3 OUTLIER -117.15 134.29 54.96 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 174.236 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 584' ' ' LYS . . . . . 0.681 ' HE3' ' HA3' ' A' ' 513' ' ' GLY . 0.1 OUTLIER -121.22 133.66 55.17 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.988 -1.005 . . . . 0.0 108.762 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 585' ' ' LEU . . . . . 0.701 ' HG ' HG23 ' A' ' 575' ' ' ILE . 6.2 tt -118.23 135.55 54.2 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 178.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 586' ' ' VAL . . . . . 0.587 HG11 HD23 ' A' ' 495' ' ' LEU . 77.4 t -133.26 138.57 51.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 C-N-CA 120.506 -0.477 . . . . 0.0 111.538 -178.199 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 587' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.73 135.53 48.11 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 177.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.857 HG21 HG21 ' A' ' 500' ' ' VAL . 0.1 OUTLIER -133.67 137.12 53.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -177.992 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 589' ' ' VAL . . . . . 0.455 ' N ' ' HB2' ' A' ' 497' ' ' LYS . 5.4 m -127.52 137.37 57.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 114.334 -1.303 . . . . 0.0 110.804 178.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 590' ' ' SER . . . . . . . . . . . . . 28.0 t -56.38 152.79 10.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.279 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 591' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -50.68 -48.98 58.37 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.859 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -60.74 -51.76 67.96 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -178.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 2.4 mttt -54.31 -56.54 17.48 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.466 0.65 . . . . 0.0 110.941 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 594' ' ' PHE . . . . . 0.973 ' CD1' HD11 ' A' ' 597' ' ' LEU . 13.0 t80 -50.2 -47.11 54.83 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.569 179.071 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 595' ' ' LYS . . . . . 0.796 ' HE3' HG21 ' A' ' 608' ' ' VAL . 0.6 OUTLIER -49.41 -48.32 47.3 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.345 179.405 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 596' ' ' GLU . . . . . 0.555 ' O ' HD23 ' A' ' 599' ' ' LEU . 54.1 tt0 -58.97 -59.66 5.1 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -179.226 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 597' ' ' LEU . . . . . 0.973 HD11 ' CD1' ' A' ' 594' ' ' PHE . 2.9 pp -52.23 -50.38 62.12 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.182 0.515 . . . . 0.0 112.131 -178.501 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 598' ' ' GLY . . . . . 0.897 ' N ' HD12 ' A' ' 597' ' ' LEU . . . -94.49 11.38 70.24 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.769 -179.16 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 599' ' ' LEU . . . . . 0.555 HD23 ' O ' ' A' ' 596' ' ' GLU . 4.4 pp -50.04 -2.25 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -177.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 600' ' ' THR . . . . . 0.591 HG22 ' O ' ' A' ' 600' ' ' THR . 23.2 m -131.75 67.23 1.53 Allowed 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.883 0.849 . . . . 0.0 110.948 178.007 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 601' ' ' ALA . . . . . 1.038 ' HB1' ' HD2' ' A' ' 602' ' ' PRO . . . -131.63 -173.45 0.34 Allowed Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 114.231 -1.35 . . . . 0.0 109.563 179.259 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 602' ' ' PRO . . . . . 1.038 ' HD2' ' HB1' ' A' ' 601' ' ' ALA . 57.1 Cg_endo -72.23 -31.81 11.34 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 121.609 1.54 . . . . 0.0 112.529 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 603' ' ' GLY . . . . . . . . . . . . . . . -71.57 -48.78 27.64 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.983 -0.627 . . . . 0.0 113.201 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 604' ' ' TRP . . . . . 0.867 ' CD1' ' HB3' ' A' ' 601' ' ' ALA . 2.1 m95 -70.99 -46.43 62.32 Favored 'General case' 0 CA--C 1.511 -0.547 0 C-N-CA 122.916 0.487 . . . . 0.0 111.554 -178.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 605' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -49.87 -60.6 2.76 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.665 -179.164 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.55 -60.68 3.33 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 607' ' ' VAL . . . . . . . . . . . . . 54.2 t -54.4 -72.27 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -178.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 608' ' ' VAL . . . . . 0.796 HG21 ' HE3' ' A' ' 595' ' ' LYS . 61.9 t -65.58 -58.84 5.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.384 -0.826 . . . . 0.0 113.202 -177.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 609' ' ' GLY . . . . . . . . . . . . . . . -59.14 -63.8 4.85 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 121.084 -0.579 . . . . 0.0 113.175 -178.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 610' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.67 -49.91 75.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.823 0.345 . . . . 0.0 110.837 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 85.8 56.42 2.35 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.569 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 8.4 pttt -97.81 37.01 1.44 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.825 0.345 . . . . 0.0 110.951 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 613' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -119.93 133.41 55.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.897 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 614' ' ' GLU . . . . . 0.409 ' CB ' ' CD ' ' A' ' 615' ' ' PRO . 2.8 mt-10 -59.62 -60.72 9.66 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.931 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 615' ' ' PRO . . . . . 0.409 ' CD ' ' CB ' ' A' ' 614' ' ' GLU . 62.9 Cg_endo -73.39 85.56 1.25 Allowed 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.484 2.123 . . . . 0.0 112.303 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 616' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.52 112.57 10.61 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.792 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo . . . . . 0 C--O 1.251 1.128 0 C-N-CA 122.421 2.081 . . . . 0.0 112.369 179.906 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 120.737 0.304 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 455' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.04 -30.05 21.58 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.541 2.161 . . . . 0.0 112.27 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 456' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -66.29 -26.58 67.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.004 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 73.4 p -100.03 31.6 3.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.975 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -107.08 130.37 54.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.101 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 59.6 p -104.43 154.05 38.65 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.814 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.1 117.37 5.07 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.495 2.13 . . . . 0.0 112.298 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . 99.8 56.59 0.95 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.544 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -97.61 148.51 34.55 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 120.74 0.305 . . . . 0.0 110.874 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -52.53 144.41 41.55 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.564 2.176 . . . . 0.0 112.293 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 6.7 tttt -107.77 128.71 54.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.928 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.63 22.31 15.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.123 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 38.3 p -54.05 -24.91 18.94 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.111 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 8.1 mp -102.88 83.69 2.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.878 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.17 43.46 2.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.954 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 129.1 -36.97 2.29 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.314 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -107.1 117.53 34.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.948 0.404 . . . . 0.0 110.526 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 471' ' ' VAL . . . . . 0.568 ' O ' HG13 ' A' ' 471' ' ' VAL . 12.3 p -113.32 109.94 30.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.136 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -89.32 154.35 48.93 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.952 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -51.37 136.13 47.22 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.633 2.222 . . . . 0.0 112.429 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -136.08 -45.75 0.64 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.967 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.9 -27.24 51.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.08 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 476' ' ' GLY . . . . . . . . . . . . . . . 104.57 -24.98 27.18 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.62 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 7.3 p-10 43.97 53.16 10.09 Favored Pre-proline 0 CA--C 1.53 0.202 0 CA-C-O 120.796 0.331 . . . . 0.0 111.445 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -68.43 -18.82 43.78 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.584 2.189 . . . . 0.0 112.585 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -56.47 127.1 29.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.974 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 480' ' ' ALA . . . . . 0.666 ' HB1' ' CD ' ' A' ' 481' ' ' PRO . . . -140.35 177.91 1.8 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.087 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 481' ' ' PRO . . . . . 0.666 ' CD ' ' HB1' ' A' ' 480' ' ' ALA . 5.8 Cg_exo -78.64 40.01 0.86 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 123.167 2.578 . . . . 0.0 112.76 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 482' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -71.36 -61.12 1.89 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.716 0.293 . . . . 0.0 110.69 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 483' ' ' THR . . . . . 0.401 ' HB ' ' HB2' ' A' ' 487' ' ' ASN . 16.2 p -116.01 65.79 0.7 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.174 0.511 . . . . 0.0 111.137 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 484' ' ' ASN . . . . . 0.577 ' O ' ' HD3' ' A' ' 489' ' ' PRO . 2.2 m120 -130.73 -69.5 0.64 Allowed 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.219 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 485' ' ' PHE . . . . . 0.52 ' O ' ' HG2' ' A' ' 489' ' ' PRO . 67.6 m-85 -71.67 -46.73 57.99 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.731 177.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -72.13 -47.47 50.86 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.073 -0.967 . . . . 0.0 113.287 -178.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 487' ' ' ASN . . . . . 0.401 ' HB2' ' HB ' ' A' ' 483' ' ' THR . 1.1 t-20 -70.76 -72.65 0.2 Allowed 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -176.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 488' ' ' MET . . . . . 0.477 ' CB ' ' HD3' ' A' ' 489' ' ' PRO . 2.5 ttt -51.29 -52.77 56.1 Favored Pre-proline 0 N--CA 1.47 0.531 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -177.346 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 489' ' ' PRO . . . . . 0.577 ' HD3' ' O ' ' A' ' 484' ' ' ASN . 11.1 Cg_exo -76.45 42.34 1.02 Allowed 'Trans proline' 0 CA--C 1.528 0.219 0 C-N-CA 123.82 3.013 . . . . 0.0 112.38 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -38.39 -30.66 0.04 OUTLIER 'General case' 0 C--O 1.232 0.134 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -179.036 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 491' ' ' ALA . . . . . . . . . . . . . . . -132.77 136.51 46.37 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.44 -0.504 . . . . 0.0 112.1 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 492' ' ' ARG . . . . . 0.862 ' CD ' HD22 ' A' ' 585' ' ' LEU . 0.0 OUTLIER -136.12 134.37 38.24 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.957 178.438 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 493' ' ' VAL . . . . . 0.838 HG21 ' HA3' ' A' ' 513' ' ' GLY . 11.2 m -136.2 163.81 33.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.816 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 9.0 t -120.2 133.36 55.51 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 121.043 0.449 . . . . 0.0 110.305 177.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 495' ' ' LEU . . . . . 1.033 HD11 ' CG2' ' A' ' 500' ' ' VAL . 1.6 pp -136.2 163.16 52.07 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.928 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 496' ' ' PRO . . . . . 0.791 ' HD2' HD21 ' A' ' 499' ' ' LEU . 14.7 Cg_exo -67.35 119.3 6.31 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 122.313 2.008 . . . . 0.0 112.152 178.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 497' ' ' LYS . . . . . 0.526 ' HA ' ' HB ' ' A' ' 588' ' ' ILE . 20.1 tttt -51.85 -30.37 23.37 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -179.142 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 498' ' ' SER . . . . . . . . . . . . . 11.9 t -60.29 -48.35 82.11 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -177.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 499' ' ' LEU . . . . . 0.791 HD21 ' HD2' ' A' ' 496' ' ' PRO . 2.0 pp -74.18 -8.67 57.0 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -178.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 500' ' ' VAL . . . . . 1.033 ' CG2' HD11 ' A' ' 495' ' ' LEU . 13.8 t -75.45 -26.01 18.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.099 0.476 . . . . 0.0 112.239 -178.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 501' ' ' TYR . . . . . 0.669 ' O ' HG21 ' A' ' 564' ' ' THR . 6.3 m-85 -53.94 -30.61 47.27 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -178.142 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -75.82 -50.21 15.82 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 115.456 1.651 . . . . 0.0 115.456 -175.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 503' ' ' LYS . . . . . 0.61 ' O ' ' CG ' ' A' ' 507' ' ' LYS . 0.2 OUTLIER -119.2 132.57 55.96 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 118.79 0.723 . . . . 0.0 111.776 -179.323 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 504' ' ' THR . . . . . 0.575 HG21 ' HB3' ' A' ' 563' ' ' LYS . 4.6 m -72.96 -75.62 0.14 Allowed 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 505' ' ' PHE . . . . . 0.641 ' CE1' ' HA ' ' A' ' 558' ' ' THR . 0.0 OUTLIER -74.71 -62.69 1.45 Allowed 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 -179.107 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 506' ' ' SER . . . . . 0.758 ' O ' ' CD1' ' A' ' 510' ' ' TRP . 66.6 m -49.15 -72.81 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -175.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 507' ' ' LYS . . . . . 0.712 ' HD3' ' N ' ' A' ' 508' ' ' VAL . 0.0 OUTLIER -48.7 -48.49 40.24 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -176.153 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 508' ' ' VAL . . . . . 0.947 ' CG1' HD21 ' A' ' 574' ' ' LEU . 61.3 t -54.76 -57.76 5.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -179.213 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 509' ' ' LEU . . . . . 0.734 HD12 ' N ' ' A' ' 510' ' ' TRP . 2.0 pp -59.64 -63.45 1.3 Allowed 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 -177.027 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 510' ' ' TRP . . . . . 0.766 ' CD1' ' HA ' ' A' ' 518' ' ' LYS . 63.7 p-90 -72.75 -49.69 29.34 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -176.327 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 511' ' ' SER . . . . . 0.523 ' N ' ' CD2' ' A' ' 510' ' ' TRP . 0.3 OUTLIER -62.75 -48.24 80.06 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.658 -177.014 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 512' ' ' ALA . . . . . 0.774 ' HB2' ' CD2' ' A' ' 495' ' ' LEU . . . -71.79 -75.18 0.14 Allowed 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 117.011 2.226 . . . . 0.0 117.011 -174.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 513' ' ' GLY . . . . . 0.838 ' HA3' HG21 ' A' ' 493' ' ' VAL . . . -117.63 -35.23 1.09 Allowed Glycine 0 CA--C 1.501 -0.787 0 N-CA-C 120.778 3.071 . . . . 0.0 120.778 -173.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 514' ' ' LEU . . . . . 0.741 ' HB3' HG23 ' A' ' 515' ' ' VAL . 0.0 OUTLIER -96.67 -46.95 6.09 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 119.542 3.164 . . . . 0.0 119.542 -168.746 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 515' ' ' VAL . . . . . 0.741 HG23 ' HB3' ' A' ' 514' ' ' LEU . 22.0 t -151.2 171.25 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 117.196 2.295 . . . . 0.0 117.196 -172.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 516' ' ' ALA . . . . . 0.631 ' N ' HG12 ' A' ' 515' ' ' VAL . . . -73.59 2.88 7.07 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 112.558 -2.11 . . . . 0.0 108.67 175.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 517' ' ' SER . . . . . 0.851 ' HA ' ' HB2' ' A' ' 520' ' ' GLU . 0.6 OUTLIER -58.33 9.6 0.01 OUTLIER 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 116.004 1.853 . . . . 0.0 116.004 -172.024 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 518' ' ' LYS . . . . . 0.766 ' HA ' ' CD1' ' A' ' 510' ' ' TRP . 0.0 OUTLIER -45.1 -48.26 12.04 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 175.841 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 519' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -75.21 -56.31 4.85 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.172 173.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 520' ' ' GLU . . . . . 0.851 ' HB2' ' HA ' ' A' ' 517' ' ' SER . 2.0 mm-40 -59.64 -47.58 85.05 Favored 'General case' 0 C--N 1.35 0.588 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.228 -178.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 521' ' ' GLY . . . . . 0.785 ' N ' ' O ' ' A' ' 517' ' ' SER . . . -49.01 -54.2 15.52 Favored Glycine 0 CA--C 1.496 -1.108 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -48.62 -47.3 40.2 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 523' ' ' ARG . . . . . 0.402 ' O ' ' HB2' ' A' ' 526' ' ' ASN . 0.0 OUTLIER -49.9 -48.92 51.27 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.725 178.667 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 524' ' ' ILE . . . . . 0.769 HD12 ' HG2' ' A' ' 580' ' ' LYS . 28.1 mm -57.33 -55.92 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 CA-C-O 121.403 0.62 . . . . 0.0 109.725 179.041 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 525' ' ' ILE . . . . . 0.589 HD13 ' N ' ' A' ' 525' ' ' ILE . 1.5 mm -50.28 -47.4 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 177.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 526' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 523' ' ' ARG . 9.1 m120 -57.63 -47.76 81.32 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 114.633 -1.167 . . . . 0.0 108.5 177.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -47.94 -39.54 19.52 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 113.971 -1.468 . . . . 0.0 107.715 176.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 528' ' ' ASN . . . . . 1.088 ' HA ' HG21 ' A' ' 556' ' ' ILE . 2.5 t30 74.31 39.99 0.45 Allowed 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 114.631 -1.168 . . . . 0.0 111.633 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 529' ' ' GLY . . . . . . . . . . . . . . . -114.22 25.6 10.46 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 114.324 -1.307 . . . . 0.0 111.192 177.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 530' ' ' ALA . . . . . 0.83 ' O ' ' HB ' ' A' ' 556' ' ' ILE . . . -133.49 159.48 40.27 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.095 0.474 . . . . 0.0 112.046 -179.16 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 531' ' ' TYR . . . . . 0.52 ' CE2' ' CD2' ' A' ' 553' ' ' PHE . 0.0 OUTLIER -134.04 158.52 43.34 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 177.508 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 532' ' ' VAL . . . . . 0.742 HG12 ' OG1' ' A' ' 554' ' ' THR . 0.4 OUTLIER -126.69 135.59 63.26 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 C-N-CA 119.401 -0.919 . . . . 0.0 112.356 -179.758 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 533' ' ' GLY . . . . . 0.672 ' HA2' ' O ' ' A' ' 552' ' ' THR . . . -133.83 154.07 21.16 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 114.43 -1.259 . . . . 0.0 114.078 -179.4 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 534' ' ' SER . . . . . 0.501 ' N ' ' HB ' ' A' ' 552' ' ' THR . 44.7 t -134.16 137.08 44.23 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.303 -0.449 . . . . 0.0 111.37 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 535' ' ' ARG . . . . . 0.703 ' O ' ' HB3' ' A' ' 573' ' ' LEU . 0.0 OUTLIER -160.38 90.56 1.72 Allowed Pre-proline 0 C--N 1.329 -0.326 0 C-N-CA 120.305 -0.558 . . . . 0.0 112.452 178.118 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 536' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -72.63 -38.0 3.6 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.521 2.147 . . . . 0.0 112.18 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 537' ' ' GLY . . . . . 0.4 ' N ' ' HD2' ' A' ' 535' ' ' ARG . . . 84.23 52.62 3.54 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.476 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 538' ' ' VAL . . . . . 0.531 HG13 ' N ' ' A' ' 539' ' ' LYS . 11.9 p -116.23 -45.98 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 CA-C-O 121.06 0.457 . . . . 0.0 111.413 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 539' ' ' LYS . . . . . 0.531 ' N ' HG13 ' A' ' 538' ' ' VAL . 0.3 OUTLIER -107.97 162.06 14.37 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.359 -178.66 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.52 30.77 5.12 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.876 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 541' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -95.12 99.72 11.66 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.174 0.512 . . . . 0.0 110.668 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 542' ' ' GLU . . . . . 0.401 ' CB ' ' CD ' ' A' ' 543' ' ' PRO . 0.1 OUTLIER -49.06 176.05 0.04 OUTLIER Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.269 -179.84 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 543' ' ' PRO . . . . . 0.493 ' HA ' ' CB ' ' A' ' 548' ' ' PRO . 86.3 Cg_exo -45.0 -51.59 7.38 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.636 2.224 . . . . 0.0 112.781 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 544' ' ' GLY . . . . . 0.612 ' O ' ' N ' ' A' ' 546' ' ' GLY . . . 50.97 23.32 7.1 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.782 -0.723 . . . . 0.0 113.212 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 545' ' ' GLY . . . . . 0.66 ' O ' ' N ' ' A' ' 547' ' ' MET . . . 53.15 -46.13 0.01 OUTLIER Glycine 0 CA--C 1.531 1.046 0 N-CA-C 115.594 0.998 . . . . 0.0 115.594 179.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 546' ' ' GLY . . . . . 0.612 ' N ' ' O ' ' A' ' 544' ' ' GLY . . . -50.51 54.95 0.01 OUTLIER Glycine 0 CA--C 1.529 0.913 0 N-CA-C 115.522 0.969 . . . . 0.0 115.522 -178.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 547' ' ' MET . . . . . 0.66 ' N ' ' O ' ' A' ' 545' ' ' GLY . 11.6 mmt 51.24 53.67 13.94 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 117.804 0.802 . . . . 0.0 111.51 179.214 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 548' ' ' PRO . . . . . 0.493 ' CB ' ' HA ' ' A' ' 543' ' ' PRO . 9.5 Cg_endo -52.67 166.56 0.79 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.944 2.429 . . . . 0.0 112.754 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -124.21 -25.57 4.12 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.216 179.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 550' ' ' ASP . . . . . 0.519 ' O ' ' HA ' ' A' ' 535' ' ' ARG . 4.4 m-20 -59.34 -46.95 87.2 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.23 179.129 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 551' ' ' LEU . . . . . . . . . . . . . 15.9 tp -131.48 139.87 49.43 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.184 -0.917 . . . . 0.0 108.968 178.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 552' ' ' THR . . . . . 0.672 ' O ' ' HA2' ' A' ' 533' ' ' GLY . 23.6 m -133.43 148.15 51.76 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.667 0.746 . . . . 0.0 111.933 179.307 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 553' ' ' PHE . . . . . 0.52 ' CD2' ' CE2' ' A' ' 531' ' ' TYR . 9.6 m-85 -134.59 137.07 43.42 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 176.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 554' ' ' THR . . . . . 0.894 HG22 ' H ' ' A' ' 556' ' ' ILE . 2.8 m -133.21 139.03 32.95 Favored Pre-proline 0 C--N 1.306 -1.309 0 C-N-CA 119.745 -0.782 . . . . 0.0 109.554 178.537 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 555' ' ' PRO . . . . . 0.8 ' O ' HG22 ' A' ' 556' ' ' ILE . 81.2 Cg_endo -83.37 21.76 1.0 Allowed 'Trans proline' 0 N--CA 1.445 -1.324 0 C-N-CA 121.493 1.462 . . . . 0.0 111.878 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 556' ' ' ILE . . . . . 1.088 HG21 ' HA ' ' A' ' 528' ' ' ASN . 2.0 tp 63.74 32.65 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 177.259 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 4.0 tttm -104.07 120.06 40.28 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 558' ' ' THR . . . . . 0.641 ' HA ' ' CE1' ' A' ' 505' ' ' PHE . 8.4 t -57.85 116.66 3.6 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 115.988 1.847 . . . . 0.0 115.988 -172.319 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 559' ' ' TRP . . . . . 0.52 ' HB2' ' HB2' ' A' ' 563' ' ' LYS . 1.0 OUTLIER -138.4 111.19 7.68 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 103.638 -2.727 . . . . 0.0 103.638 173.796 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 560' ' ' ASN . . . . . 0.673 ' O ' HG22 ' A' ' 564' ' ' THR . 30.2 m120 -68.91 -75.87 0.1 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 -174.402 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 561' ' ' ALA . . . . . 0.683 ' HA ' ' CG2' ' A' ' 564' ' ' THR . . . -74.24 -48.77 26.59 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 -177.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 562' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.41 -54.72 16.03 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -177.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 563' ' ' LYS . . . . . 0.575 ' HB3' HG21 ' A' ' 504' ' ' THR . 0.0 OUTLIER -69.32 -48.63 60.91 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.087 0.402 . . . . 0.0 112.087 -178.653 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 564' ' ' THR . . . . . 0.833 HG23 ' H ' ' A' ' 565' ' ' GLN . 5.5 t -49.77 -71.32 0.07 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.661 0.267 . . . . 0.0 111.698 -178.51 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 565' ' ' GLN . . . . . 0.833 ' H ' HG23 ' A' ' 564' ' ' THR . 0.0 OUTLIER -48.73 -46.91 41.59 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.658 0.266 . . . . 0.0 111.66 179.966 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -49.98 -61.75 1.96 Allowed 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -178.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 567' ' ' PHE . . . . . 0.863 ' CE1' HD13 ' A' ' 568' ' ' ILE . 0.1 OUTLIER -96.66 -31.23 12.81 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -177.145 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 568' ' ' ILE . . . . . 0.897 HD11 HD13 ' A' ' 574' ' ' LEU . 1.0 OUTLIER -73.12 8.73 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.06 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -179.24 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 569' ' ' ILE . . . . . 0.705 HD12 ' N ' ' A' ' 570' ' ' ASP . 2.7 pp -53.57 -38.52 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 N-CA-C 104.709 -2.33 . . . . 0.0 104.709 178.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 570' ' ' ASP . . . . . 0.705 ' N ' HD12 ' A' ' 569' ' ' ILE . 9.7 t0 33.14 60.29 0.44 Allowed 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 114.179 -1.373 . . . . 0.0 111.936 172.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 571' ' ' GLY . . . . . 0.483 ' H ' HD12 ' A' ' 569' ' ' ILE . . . -55.06 -46.27 78.56 Favored Glycine 0 N--CA 1.439 -1.152 0 C-N-CA 116.861 -2.59 . . . . 0.0 107.784 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 572' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -120.85 -17.42 7.91 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 174.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 573' ' ' LEU . . . . . 0.703 ' HB3' ' O ' ' A' ' 535' ' ' ARG . 0.7 OUTLIER -140.57 137.49 33.76 Favored 'General case' 0 C--N 1.355 0.83 0 N-CA-C 116.175 1.917 . . . . 0.0 116.175 -177.848 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 574' ' ' LEU . . . . . 0.947 HD21 ' CG1' ' A' ' 508' ' ' VAL . 0.0 OUTLIER -134.92 134.1 40.28 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 173.612 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 575' ' ' ILE . . . . . 0.93 ' N ' HD12 ' A' ' 574' ' ' LEU . 0.0 OUTLIER -133.13 137.07 54.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-O 121.564 0.697 . . . . 0.0 111.818 179.393 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 576' ' ' LEU . . . . . 0.585 HD22 ' HB3' ' A' ' 509' ' ' LEU . 0.0 OUTLIER -133.19 135.8 45.3 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 177.25 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 577' ' ' LYS . . . . . . . . . . . . . 3.9 mtpt -129.98 135.38 48.24 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.656 178.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.475 HD21 HD11 ' A' ' 576' ' ' LEU . 0.2 OUTLIER -124.99 131.79 53.36 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 177.739 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 579' ' ' GLY . . . . . . . . . . . . . . . -90.78 -1.94 72.93 Favored Glycine 0 N--CA 1.442 -0.965 0 CA-C-N 115.169 -0.923 . . . . 0.0 113.494 -178.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 580' ' ' LYS . . . . . 0.769 ' HG2' HD12 ' A' ' 524' ' ' ILE . 3.0 pptp? -72.53 -47.73 46.0 Favored 'General case' 0 N--CA 1.438 -1.046 0 C-N-CA 118.851 -1.14 . . . . 0.0 108.726 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 581' ' ' TRP . . . . . 0.565 ' CG ' ' HD2' ' A' ' 580' ' ' LYS . 33.3 m0 -138.84 -53.21 0.58 Allowed 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 177.21 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 582' ' ' LYS . . . . . 0.63 ' HD3' HD11 ' A' ' 514' ' ' LEU . 0.0 OUTLIER -140.44 165.53 27.17 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 -174.316 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 583' ' ' MET . . . . . . . . . . . . . 1.1 ttt -109.32 134.89 51.24 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 173.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 584' ' ' LYS . . . . . 0.57 ' HB2' ' HG ' ' A' ' 514' ' ' LEU . 5.5 tppt? -120.08 133.77 55.43 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 178.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 585' ' ' LEU . . . . . 0.862 HD22 ' CD ' ' A' ' 492' ' ' ARG . 5.8 tt -120.0 136.38 54.57 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 -179.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 586' ' ' VAL . . . . . 0.764 HG22 HG23 ' A' ' 493' ' ' VAL . 72.0 t -133.31 137.65 52.82 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.813 -178.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 587' ' ' SER . . . . . . . . . . . . . 1.9 m -109.83 136.5 49.04 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 177.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.742 HG21 HG21 ' A' ' 500' ' ' VAL . 3.3 pt -133.35 136.35 54.95 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 -178.217 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 3.8 t -133.74 138.15 51.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 114.022 -1.445 . . . . 0.0 110.287 178.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 590' ' ' SER . . . . . . . . . . . . . 6.9 m -68.12 126.77 30.57 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.254 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 591' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -50.24 -50.05 51.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.136 0.493 . . . . 0.0 110.063 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -51.64 -49.52 62.12 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.176 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 25.4 mtpt -51.08 -48.77 61.55 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.781 0.8 . . . . 0.0 109.257 179.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 594' ' ' PHE . . . . . 0.741 ' CD1' HD11 ' A' ' 597' ' ' LEU . 0.8 OUTLIER -50.24 -48.41 54.65 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 114.543 -1.208 . . . . 0.0 109.648 178.153 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 595' ' ' LYS . . . . . 0.521 ' O ' ' HB3' ' A' ' 599' ' ' LEU . 0.0 OUTLIER -49.42 -48.2 47.45 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.263 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 596' ' ' GLU . . . . . 0.473 ' O ' HD23 ' A' ' 599' ' ' LEU . 0.5 OUTLIER -52.56 -56.88 12.2 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.43 -179.672 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 597' ' ' LEU . . . . . 0.741 HD11 ' CD1' ' A' ' 594' ' ' PHE . 0.6 OUTLIER -64.82 -62.46 1.55 Allowed 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.376 0.608 . . . . 0.0 112.015 -178.767 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 598' ' ' GLY . . . . . 0.487 ' O ' ' CD1' ' A' ' 604' ' ' TRP . . . -77.8 13.45 13.08 Favored Glycine 0 C--N 1.32 -0.324 0 CA-C-N 115.119 -0.946 . . . . 0.0 113.573 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 599' ' ' LEU . . . . . 0.673 HD12 ' N ' ' A' ' 600' ' ' THR . 2.6 pp -47.47 -15.18 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -175.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 600' ' ' THR . . . . . 0.673 ' N ' HD12 ' A' ' 599' ' ' LEU . 11.0 t -131.98 66.79 1.54 Allowed 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.827 176.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 601' ' ' ALA . . . . . 0.741 ' HB1' ' HD2' ' A' ' 602' ' ' PRO . . . -131.47 167.56 21.33 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.477 179.085 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 602' ' ' PRO . . . . . 0.741 ' HD2' ' HB1' ' A' ' 601' ' ' ALA . 58.4 Cg_endo -70.01 -12.15 31.88 Favored 'Trans proline' 0 N--CA 1.465 -0.2 0 C-N-CA 122.225 1.95 . . . . 0.0 111.262 178.558 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 603' ' ' GLY . . . . . 0.615 ' O ' HG23 ' A' ' 607' ' ' VAL . . . -70.81 -48.95 31.53 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.675 -0.693 . . . . 0.0 113.037 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 604' ' ' TRP . . . . . 0.533 ' HA ' ' HE3' ' A' ' 604' ' ' TRP . 1.0 OUTLIER -64.03 -46.41 84.58 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 120.734 0.302 . . . . 0.0 111.58 -179.344 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 605' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -50.75 -52.29 42.01 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.863 0.364 . . . . 0.0 110.363 -178.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -61.18 -63.06 1.42 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.482 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 607' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 603' ' ' GLY . 41.9 t -50.75 -71.31 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -178.548 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 608' ' ' VAL . . . . . 0.429 HG21 ' HZ2' ' A' ' 595' ' ' LYS . 96.1 t -69.59 -58.66 4.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -177.333 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 609' ' ' GLY . . . . . . . . . . . . . . . -59.83 -63.58 4.96 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.007 -0.616 . . . . 0.0 113.381 -178.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 610' ' ' LYS . . . . . . . . . . . . . 11.4 mttt -70.5 -71.77 0.23 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.785 0.326 . . . . 0.0 111.036 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 101.99 46.85 1.54 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.456 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 20.5 tttt -99.34 38.93 1.34 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.839 0.352 . . . . 0.0 110.999 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 613' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -74.88 172.37 12.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.858 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 614' ' ' GLU . . . . . 0.404 ' CB ' ' CD ' ' A' ' 615' ' ' PRO . 7.3 mt-10 -62.74 -60.81 8.85 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.904 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 615' ' ' PRO . . . . . 0.404 ' CD ' ' CB ' ' A' ' 614' ' ' GLU . 59.1 Cg_endo -72.0 108.4 2.45 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.625 2.217 . . . . 0.0 112.267 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 616' ' ' SER . . . . . . . . . . . . . 43.2 t -67.52 111.1 6.5 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.902 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo . . . . . 0 C--O 1.249 1.046 0 C-N-CA 122.435 2.09 . . . . 0.0 112.306 -179.996 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 4.0 ptt? . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.741 0.305 . . . . 0.0 111.211 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 455' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.89 161.67 45.06 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.629 2.219 . . . . 0.0 112.288 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 456' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -85.1 -26.54 26.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.065 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 20.6 p -97.38 38.69 1.24 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.916 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -75.43 93.07 2.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.084 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 1.2 m -90.62 163.62 29.71 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.966 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -69.49 -174.7 0.9 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.604 2.202 . . . . 0.0 112.25 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . 107.04 40.77 1.77 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.507 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -94.71 162.83 24.26 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.775 0.321 . . . . 0.0 110.897 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -51.74 112.46 0.84 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.63 2.22 . . . . 0.0 112.308 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.21 119.81 39.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.852 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 1.3 m -115.83 -76.42 0.57 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.952 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -75.43 -25.97 57.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.981 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 467' ' ' LEU . . . . . 0.48 HD23 ' H ' ' A' ' 467' ' ' LEU . 0.7 OUTLIER -106.31 71.13 0.86 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.889 -179.962 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -114.93 42.89 2.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.785 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 128.96 -36.93 2.31 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.251 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -114.63 117.75 31.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.823 0.344 . . . . 0.0 110.603 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 471' ' ' VAL . . . . . 0.569 ' O ' HG13 ' A' ' 471' ' ' VAL . 10.9 p -113.19 108.34 25.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.092 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 22.7 p30 -136.0 148.43 64.83 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.868 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.16 108.69 0.28 Allowed 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.561 2.174 . . . . 0.0 112.283 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -107.16 -34.03 7.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.833 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 11.1 p -103.27 -30.14 10.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.96 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 476' ' ' GLY . . . . . . . . . . . . . . . 130.96 -23.51 4.39 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.649 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 477' ' ' ASN . . . . . 0.422 ' N ' ' CD ' ' A' ' 478' ' ' PRO . 7.2 p-10 43.93 51.87 8.37 Favored Pre-proline 0 N--CA 1.463 0.202 0 CA-C-O 120.776 0.322 . . . . 0.0 111.442 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 478' ' ' PRO . . . . . 0.422 ' CD ' ' N ' ' A' ' 477' ' ' ASN . 72.0 Cg_endo -76.76 -22.67 11.66 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.614 2.209 . . . . 0.0 112.498 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -61.72 84.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.005 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -140.47 131.54 13.95 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.801 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 481' ' ' PRO . . . . . 0.411 ' HB2' ' H ' ' A' ' 482' ' ' GLN . 84.5 Cg_exo -47.03 -79.12 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.315 2.01 . . . . 0.0 112.359 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 482' ' ' GLN . . . . . 0.411 ' H ' ' HB2' ' A' ' 481' ' ' PRO . 0.0 OUTLIER -136.09 -72.01 0.46 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.294 0.569 . . . . 0.0 109.724 179.092 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 483' ' ' THR . . . . . 0.496 HG22 ' H ' ' A' ' 485' ' ' PHE . 88.3 m -137.12 157.49 46.57 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.294 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 484' ' ' ASN . . . . . 0.484 ' O ' ' CD ' ' A' ' 489' ' ' PRO . 7.4 t-20 -94.59 -34.7 12.53 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.029 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 485' ' ' PHE . . . . . 0.742 ' HA ' ' HG2' ' A' ' 489' ' ' PRO . 19.5 m-85 -49.87 -46.8 51.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.02 178.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -68.96 -47.7 65.0 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -178.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -71.15 -74.81 0.14 Allowed 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 114.962 1.467 . . . . 0.0 114.962 -176.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 488' ' ' MET . . . . . 0.535 ' CB ' ' HD3' ' A' ' 489' ' ' PRO . 3.3 tpp -52.95 -53.13 58.49 Favored Pre-proline 0 N--CA 1.47 0.556 0 CA-C-O 121.204 0.526 . . . . 0.0 111.576 -178.584 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 489' ' ' PRO . . . . . 0.742 ' HG2' ' HA ' ' A' ' 485' ' ' PHE . 12.3 Cg_exo -75.13 44.18 1.14 Allowed 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 124.566 3.511 . . . . 0.0 112.661 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -36.78 -31.15 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -178.553 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 491' ' ' ALA . . . . . 0.412 ' CB ' HD21 ' A' ' 514' ' ' LEU . . . -132.02 135.7 46.72 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.499 -0.481 . . . . 0.0 110.967 178.564 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 492' ' ' ARG . . . . . 0.692 ' HD3' HD22 ' A' ' 585' ' ' LEU . 10.6 tpt180 -136.25 134.38 38.01 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 178.479 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 493' ' ' VAL . . . . . 0.984 ' CG2' HG22 ' A' ' 586' ' ' VAL . 25.3 m -136.98 163.87 31.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 116.212 -0.449 . . . . 0.0 112.026 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 70.0 p -115.89 132.82 56.53 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 176.043 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 495' ' ' LEU . . . . . 0.994 ' O ' HG22 ' A' ' 588' ' ' ILE . 0.0 OUTLIER -136.62 162.84 53.76 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.637 -179.667 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 496' ' ' PRO . . . . . 0.696 ' HD2' HD12 ' A' ' 495' ' ' LEU . 9.8 Cg_exo -71.84 120.0 6.58 Favored 'Trans proline' 0 CA--C 1.534 0.481 0 C-N-CA 122.376 2.051 . . . . 0.0 111.328 178.624 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 497' ' ' LYS . . . . . 0.883 ' O ' HG12 ' A' ' 500' ' ' VAL . 0.1 OUTLIER -56.6 -30.25 63.0 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -178.739 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 498' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.56 -48.47 79.35 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -177.14 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 499' ' ' LEU . . . . . 0.824 HD11 HD11 ' A' ' 495' ' ' LEU . 2.6 pp -73.85 -9.08 58.29 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -178.396 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 500' ' ' VAL . . . . . 0.883 HG12 ' O ' ' A' ' 497' ' ' LYS . 3.5 p -75.34 -25.38 17.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.507 0.67 . . . . 0.0 111.595 -179.352 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 501' ' ' TYR . . . . . 0.676 ' O ' ' CG2' ' A' ' 564' ' ' THR . 2.6 m-30 -53.72 -29.27 38.54 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -178.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -76.67 -50.2 14.29 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 116.176 1.917 . . . . 0.0 116.176 -175.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 503' ' ' LYS . . . . . 0.579 ' O ' ' CG ' ' A' ' 507' ' ' LYS . 8.9 mttt -119.81 136.41 54.48 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 119.178 0.899 . . . . 0.0 112.561 -178.518 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 504' ' ' THR . . . . . 0.799 HG23 ' CE1' ' A' ' 567' ' ' PHE . 51.0 m -74.07 -76.61 0.13 Allowed 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 179.396 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 505' ' ' PHE . . . . . 0.617 ' CZ ' HD13 ' A' ' 556' ' ' ILE . 0.2 OUTLIER -75.31 -60.98 2.06 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -178.965 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 506' ' ' SER . . . . . 0.783 ' O ' ' CD1' ' A' ' 510' ' ' TRP . 0.7 OUTLIER -49.6 -73.07 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 114.833 1.419 . . . . 0.0 114.833 -176.264 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 507' ' ' LYS . . . . . 0.698 ' HD3' ' N ' ' A' ' 508' ' ' VAL . 0.0 OUTLIER -49.18 -48.61 45.0 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -176.756 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 508' ' ' VAL . . . . . 0.87 HG13 HD21 ' A' ' 574' ' ' LEU . 98.0 t -53.91 -59.48 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 509' ' ' LEU . . . . . 0.797 HD12 ' N ' ' A' ' 510' ' ' TRP . 2.2 pp -56.52 -61.8 2.17 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 115.477 1.658 . . . . 0.0 115.477 -177.115 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 510' ' ' TRP . . . . . 0.859 ' CD1' ' HA ' ' A' ' 518' ' ' LYS . 67.1 p-90 -72.79 -51.46 18.9 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -176.102 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 511' ' ' SER . . . . . 0.497 ' N ' ' CE3' ' A' ' 510' ' ' TRP . 0.6 OUTLIER -64.18 -47.45 79.78 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.363 -0.835 . . . . 0.0 113.174 -176.854 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 512' ' ' ALA . . . . . 0.761 ' HB3' ' O ' ' A' ' 508' ' ' VAL . . . -70.95 -73.04 0.18 Allowed 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 117.796 2.517 . . . . 0.0 117.796 -174.085 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 513' ' ' GLY . . . . . 0.859 ' CA ' HG21 ' A' ' 493' ' ' VAL . . . -114.76 -35.2 1.42 Allowed Glycine 0 CA--C 1.5 -0.897 0 N-CA-C 120.853 3.101 . . . . 0.0 120.853 -172.645 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 514' ' ' LEU . . . . . 0.606 HD23 ' CG ' ' A' ' 584' ' ' LYS . 0.1 OUTLIER -107.14 -46.84 3.81 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 119.506 3.151 . . . . 0.0 119.506 -170.056 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 515' ' ' VAL . . . . . 1.012 HG13 ' HB2' ' A' ' 517' ' ' SER . 2.5 p -154.71 172.72 0.61 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.589 0 N-CA-C 117.887 2.551 . . . . 0.0 117.887 -172.687 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 516' ' ' ALA . . . . . 0.554 ' N ' HG22 ' A' ' 515' ' ' VAL . . . -67.89 4.18 1.26 Allowed 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 126.761 2.025 . . . . 0.0 109.696 177.099 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 517' ' ' SER . . . . . 1.012 ' HB2' HG13 ' A' ' 515' ' ' VAL . 0.5 OUTLIER -57.55 9.28 0.01 OUTLIER 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 115.775 1.769 . . . . 0.0 115.775 -172.043 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 518' ' ' LYS . . . . . 0.859 ' HA ' ' CD1' ' A' ' 510' ' ' TRP . 0.0 OUTLIER -45.06 -46.82 11.73 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 104.351 -2.463 . . . . 0.0 104.351 175.413 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 519' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.16 -58.29 3.37 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.962 173.372 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 520' ' ' GLU . . . . . 0.846 ' HB2' ' HA ' ' A' ' 517' ' ' SER . 2.6 mm-40 -59.05 -47.44 85.21 Favored 'General case' 0 C--N 1.351 0.659 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.941 -178.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 521' ' ' GLY . . . . . 0.841 ' N ' ' O ' ' A' ' 517' ' ' SER . . . -49.12 -55.16 12.57 Favored Glycine 0 CA--C 1.493 -1.333 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.25 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -48.02 -47.42 33.45 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.255 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 523' ' ' ARG . . . . . 0.475 ' O ' ' HB3' ' A' ' 526' ' ' ASN . 0.1 OUTLIER -50.2 -48.94 54.02 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.988 178.463 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 524' ' ' ILE . . . . . 0.655 HD12 ' HD3' ' A' ' 580' ' ' LYS . 12.8 mm -58.24 -54.82 27.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.424 0.63 . . . . 0.0 109.717 179.323 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 525' ' ' ILE . . . . . 0.819 HG23 ' CD1' ' A' ' 556' ' ' ILE . 0.7 OUTLIER -50.4 -47.42 26.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 177.683 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 526' ' ' ASN . . . . . 0.475 ' HB3' ' O ' ' A' ' 523' ' ' ARG . 16.8 t-20 -55.8 -47.99 76.16 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 114.122 -1.399 . . . . 0.0 108.228 177.393 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -48.13 -40.13 22.75 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.076 -1.42 . . . . 0.0 107.189 176.517 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 528' ' ' ASN . . . . . 0.559 ' HA ' ' CG2' ' A' ' 556' ' ' ILE . 1.4 t30 73.67 40.47 0.49 Allowed 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 114.631 -1.168 . . . . 0.0 111.736 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 529' ' ' GLY . . . . . . . . . . . . . . . -115.69 27.64 8.23 Favored Glycine 0 CA--C 1.523 0.583 0 C-N-CA 120.337 -0.935 . . . . 0.0 112.779 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 530' ' ' ALA . . . . . 0.969 ' O ' ' HB ' ' A' ' 556' ' ' ILE . . . -133.96 164.03 28.21 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 112.524 0.565 . . . . 0.0 112.524 -179.322 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 531' ' ' TYR . . . . . 0.538 ' CE2' ' CD2' ' A' ' 553' ' ' PHE . 0.0 OUTLIER -133.99 156.02 48.93 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 177.875 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 532' ' ' VAL . . . . . 0.647 HG12 ' OG1' ' A' ' 554' ' ' THR . 0.5 OUTLIER -127.33 135.5 63.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 C-N-CA 119.537 -0.865 . . . . 0.0 112.123 -179.647 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 533' ' ' GLY . . . . . 0.685 ' O ' HG13 ' A' ' 575' ' ' ILE . . . -133.88 155.64 21.91 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 114.367 -1.288 . . . . 0.0 113.841 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 534' ' ' SER . . . . . 0.555 ' HB2' ' OG1' ' A' ' 552' ' ' THR . 0.6 OUTLIER -134.54 141.24 46.63 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.176 -0.512 . . . . 0.0 110.936 178.605 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 535' ' ' ARG . . . . . 0.569 ' O ' ' HB3' ' A' ' 573' ' ' LEU . 9.2 tpp85 -159.47 90.92 1.9 Allowed Pre-proline 0 CA--C 1.531 0.232 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 179.011 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 536' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.17 -46.23 1.56 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.511 2.141 . . . . 0.0 111.961 178.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 94.86 13.81 51.81 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.865 -0.683 . . . . 0.0 113.03 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 538' ' ' VAL . . . . . 0.658 HG12 ' O ' ' A' ' 538' ' ' VAL . 21.8 t -116.35 18.39 7.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.878 0.37 . . . . 0.0 111.679 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 539' ' ' LYS . . . . . . . . . . . . . 28.6 mttm -107.34 111.36 23.67 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.313 0.578 . . . . 0.0 112.181 -179.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 17.9 mmtt -110.38 -3.2 16.26 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.904 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 541' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -96.43 104.33 16.29 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.001 0.429 . . . . 0.0 109.922 179.362 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -47.62 101.6 0.27 Allowed Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.974 -179.254 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 543' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -51.28 -10.51 0.42 Allowed 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.353 2.702 . . . . 0.0 114.263 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 544' ' ' GLY . . . . . 0.528 ' C ' ' H ' ' A' ' 546' ' ' GLY . . . 52.04 54.64 25.01 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 119.806 -1.188 . . . . 0.0 111.639 -179.159 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 545' ' ' GLY . . . . . 0.621 ' O ' ' N ' ' A' ' 547' ' ' MET . . . 54.58 -7.07 0.01 OUTLIER Glycine 0 CA--C 1.528 0.881 0 CA-C-O 119.614 -0.548 . . . . 0.0 114.364 -178.297 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 546' ' ' GLY . . . . . 0.528 ' H ' ' C ' ' A' ' 544' ' ' GLY . . . -53.42 54.79 0.01 OUTLIER Glycine 0 CA--C 1.528 0.847 0 CA-C-N 117.474 0.637 . . . . 0.0 114.231 177.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 547' ' ' MET . . . . . 0.621 ' N ' ' O ' ' A' ' 545' ' ' GLY . 1.3 mpt? 52.06 54.3 13.92 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 118.568 1.184 . . . . 0.0 110.677 -179.01 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 548' ' ' PRO . . . . . 0.497 ' HD3' ' N ' ' A' ' 547' ' ' MET . 81.7 Cg_exo -46.44 166.46 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 123.171 2.58 . . . . 0.0 113.559 -179.201 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 549' ' ' ASP . . . . . 0.69 ' HB3' HD11 ' A' ' 569' ' ' ILE . 9.9 m-20 -124.36 -20.28 5.25 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.404 178.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 550' ' ' ASP . . . . . 0.512 ' O ' ' HA ' ' A' ' 535' ' ' ARG . 1.2 p30 -51.85 -41.89 62.19 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.106 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 551' ' ' LEU . . . . . 0.622 HD21 ' HE1' ' A' ' 553' ' ' PHE . 10.7 tp -131.62 139.47 49.14 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.661 -1.154 . . . . 0.0 108.53 177.534 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 552' ' ' THR . . . . . 0.799 HG21 ' CB ' ' A' ' 567' ' ' PHE . 5.6 m -133.83 148.31 51.29 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.598 0.713 . . . . 0.0 111.756 179.345 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 553' ' ' PHE . . . . . 0.622 ' HE1' HD21 ' A' ' 551' ' ' LEU . 21.8 m-85 -134.25 137.65 44.48 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.07 -0.968 . . . . 0.0 108.613 177.539 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 554' ' ' THR . . . . . 0.849 HG22 ' H ' ' A' ' 556' ' ' ILE . 2.8 m -132.5 139.04 33.49 Favored Pre-proline 0 C--N 1.307 -1.253 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.173 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 555' ' ' PRO . . . . . 0.937 ' O ' HG22 ' A' ' 556' ' ' ILE . 77.5 Cg_endo -83.78 24.0 0.79 Allowed 'Trans proline' 0 N--CA 1.444 -1.411 0 C-N-CA 121.573 1.516 . . . . 0.0 112.142 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 556' ' ' ILE . . . . . 0.969 ' HB ' ' O ' ' A' ' 530' ' ' ALA . 7.3 tp 61.38 30.9 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 177.488 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 557' ' ' LYS . . . . . 0.505 ' HB3' ' CE2' ' A' ' 559' ' ' TRP . 0.3 OUTLIER -105.79 117.85 35.08 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 105.096 -2.187 . . . . 0.0 105.096 179.257 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 558' ' ' THR . . . . . . . . . . . . . 2.3 t -56.89 117.82 4.33 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -172.382 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 559' ' ' TRP . . . . . 0.512 ' HB2' ' CB ' ' A' ' 563' ' ' LYS . 5.4 m0 -136.58 111.8 9.08 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 104.981 -2.229 . . . . 0.0 104.981 175.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 560' ' ' ASN . . . . . 0.512 ' O ' ' HB ' ' A' ' 564' ' ' THR . 75.9 m-20 -78.25 -74.4 0.27 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -175.018 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 561' ' ' ALA . . . . . . . . . . . . . . . -73.16 -64.01 1.06 Allowed 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 115.752 1.76 . . . . 0.0 115.752 -176.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 562' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.01 -50.65 35.05 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -176.594 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 563' ' ' LYS . . . . . 0.638 ' CG ' HG21 ' A' ' 504' ' ' THR . 0.0 OUTLIER -70.67 -49.07 51.18 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.392 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 564' ' ' THR . . . . . 0.676 ' CG2' ' O ' ' A' ' 501' ' ' TYR . 2.0 t -53.7 -64.33 0.86 Allowed 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 121.114 -0.235 . . . . 0.0 110.922 -178.377 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 565' ' ' GLN . . . . . 0.521 ' N ' HG23 ' A' ' 564' ' ' THR . 0.0 OUTLIER -48.51 -47.46 38.89 Favored 'General case' 0 C--N 1.321 -0.643 0 O-C-N 122.135 -0.353 . . . . 0.0 111.195 179.012 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 566' ' ' GLU . . . . . 0.419 ' O ' ' CD1' ' A' ' 569' ' ' ILE . 1.8 tt0 -49.61 -56.13 11.12 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -178.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 567' ' ' PHE . . . . . 0.799 ' CB ' HG21 ' A' ' 552' ' ' THR . 0.4 OUTLIER -97.22 -45.09 6.65 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.417 0.627 . . . . 0.0 112.156 -178.387 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 568' ' ' ILE . . . . . 0.947 HD11 HD22 ' A' ' 574' ' ' LEU . 1.5 tp -58.0 9.29 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 569' ' ' ILE . . . . . 0.69 HD11 ' HB3' ' A' ' 549' ' ' ASP . 0.0 OUTLIER -55.09 -39.22 49.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 104.525 -2.398 . . . . 0.0 104.525 179.009 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 570' ' ' ASP . . . . . 0.649 ' CG ' HD11 ' A' ' 588' ' ' ILE . 15.1 p30 31.77 55.75 0.3 Allowed 'General case' 0 CA--C 1.51 -0.587 0 CA-C-N 114.04 -1.436 . . . . 0.0 112.643 173.295 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -51.39 -44.88 53.22 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 117.316 -2.373 . . . . 0.0 108.505 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 572' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -119.6 -16.44 8.85 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 175.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 573' ' ' LEU . . . . . 0.569 ' HB3' ' O ' ' A' ' 535' ' ' ARG . 1.3 tp -139.86 137.29 34.78 Favored 'General case' 0 C--N 1.353 0.746 0 N-CA-C 116.39 1.996 . . . . 0.0 116.39 -177.377 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 574' ' ' LEU . . . . . 0.947 HD22 HD11 ' A' ' 568' ' ' ILE . 0.2 OUTLIER -134.81 133.39 39.74 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 173.048 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 575' ' ' ILE . . . . . 0.925 ' N ' HD12 ' A' ' 574' ' ' LEU . 0.0 OUTLIER -134.09 138.24 50.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 118.86 0.754 . . . . 0.0 112.007 179.297 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 576' ' ' LEU . . . . . 0.551 HD11 ' HG ' ' A' ' 578' ' ' LEU . 0.1 OUTLIER -132.99 135.53 45.52 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 177.181 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 577' ' ' LYS . . . . . 0.44 ' HE3' ' HE3' ' A' ' 583' ' ' MET . 25.2 mttt -132.2 135.45 46.34 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 119.009 -1.076 . . . . 0.0 110.359 177.438 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.551 ' HG ' HD11 ' A' ' 576' ' ' LEU . 0.3 OUTLIER -124.45 131.91 53.5 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 177.84 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 579' ' ' GLY . . . . . . . . . . . . . . . -89.1 -2.2 78.04 Favored Glycine 0 CA--C 1.498 -0.976 0 CA-C-N 115.236 -0.893 . . . . 0.0 113.335 -178.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 580' ' ' LYS . . . . . 0.655 ' HD3' HD12 ' A' ' 524' ' ' ILE . 0.0 OUTLIER -72.41 -48.16 43.52 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 119.087 -1.045 . . . . 0.0 108.889 179.233 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 581' ' ' TRP . . . . . 0.449 ' CD1' ' O ' ' A' ' 580' ' ' LYS . 23.6 m0 -139.7 -53.12 0.53 Allowed 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 177.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 582' ' ' LYS . . . . . 0.486 ' O ' HD12 ' A' ' 578' ' ' LEU . 0.0 OUTLIER -140.26 165.37 27.58 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -174.636 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 583' ' ' MET . . . . . 0.44 ' HE3' ' HE3' ' A' ' 577' ' ' LYS . 1.9 ttt -110.76 134.52 52.41 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.468 -1.679 . . . . 0.0 106.468 173.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 584' ' ' LYS . . . . . 0.792 ' NZ ' HG12 ' A' ' 508' ' ' VAL . 0.5 OUTLIER -119.66 134.73 55.11 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 178.787 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 585' ' ' LEU . . . . . 0.721 ' HG ' HG23 ' A' ' 575' ' ' ILE . 5.7 tt -121.4 136.96 54.9 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 586' ' ' VAL . . . . . 0.984 HG22 ' CG2' ' A' ' 493' ' ' VAL . 30.7 t -132.19 137.07 55.4 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.734 -178.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 587' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -112.87 134.32 54.44 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 177.168 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.994 HG22 ' O ' ' A' ' 495' ' ' LEU . 0.1 OUTLIER -135.17 140.58 44.81 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.568 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -178.257 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 6.2 p -133.14 145.73 33.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 114.369 -1.287 . . . . 0.0 110.473 178.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 590' ' ' SER . . . . . . . . . . . . . 6.0 t -52.95 142.81 18.56 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.672 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 591' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -50.38 -49.16 55.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.094 0.473 . . . . 0.0 110.541 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -52.85 -50.95 62.73 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.194 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.36 -48.3 55.75 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.733 0.778 . . . . 0.0 109.132 179.039 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 594' ' ' PHE . . . . . 0.777 ' CD1' HD11 ' A' ' 597' ' ' LEU . 0.9 OUTLIER -49.98 -48.07 52.51 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.495 178.326 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 595' ' ' LYS . . . . . 0.502 ' HA ' ' CE2' ' A' ' 604' ' ' TRP . 0.0 OUTLIER -49.09 -47.7 44.96 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.945 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 596' ' ' GLU . . . . . 0.525 ' O ' HD23 ' A' ' 599' ' ' LEU . 3.2 tp10 -53.14 -63.45 1.14 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.497 -179.579 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 597' ' ' LEU . . . . . 0.777 HD11 ' CD1' ' A' ' 594' ' ' PHE . 0.7 OUTLIER -57.31 -60.6 3.39 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 121.364 0.602 . . . . 0.0 112.12 -178.682 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 598' ' ' GLY . . . . . 0.516 ' N ' HD12 ' A' ' 597' ' ' LEU . . . -79.78 13.56 23.48 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.056 -0.974 . . . . 0.0 113.365 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 599' ' ' LEU . . . . . 0.619 HD12 ' N ' ' A' ' 600' ' ' THR . 3.6 pp -47.46 -14.05 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -175.49 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 600' ' ' THR . . . . . 0.619 ' N ' HD12 ' A' ' 599' ' ' LEU . 11.8 t -131.73 66.75 1.54 Allowed 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.775 176.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 601' ' ' ALA . . . . . 0.725 ' HB1' ' HD2' ' A' ' 602' ' ' PRO . . . -131.37 166.79 25.3 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.447 179.049 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 602' ' ' PRO . . . . . 0.725 ' HD2' ' HB1' ' A' ' 601' ' ' ALA . 56.8 Cg_endo -69.39 -12.61 33.99 Favored 'Trans proline' 0 N--CA 1.465 -0.204 0 C-N-CA 122.215 1.943 . . . . 0.0 111.273 178.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 603' ' ' GLY . . . . . 0.645 ' O ' HG23 ' A' ' 607' ' ' VAL . . . -70.83 -49.14 30.38 Favored Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 115.715 -0.675 . . . . 0.0 113.099 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 604' ' ' TRP . . . . . 0.502 ' CE2' ' HA ' ' A' ' 595' ' ' LYS . 1.3 m95 -65.09 -46.78 79.68 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 120.889 0.375 . . . . 0.0 111.186 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 605' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -50.24 -57.82 6.97 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.329 -178.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -61.78 -56.75 16.19 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 607' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 603' ' ' GLY . 40.0 t -54.97 -71.86 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -178.68 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 608' ' ' VAL . . . . . . . . . . . . . 78.4 t -68.2 -58.69 5.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -177.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 609' ' ' GLY . . . . . . . . . . . . . . . -59.1 -62.51 6.12 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 121.043 -0.599 . . . . 0.0 113.165 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 610' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.29 -49.88 70.05 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.783 0.325 . . . . 0.0 110.807 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 111.05 55.55 0.51 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.456 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -87.52 -31.12 20.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.795 0.331 . . . . 0.0 110.889 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 613' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -72.96 154.41 40.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.905 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 614' ' ' GLU . . . . . 0.409 ' CB ' ' CD ' ' A' ' 615' ' ' PRO . 0.0 OUTLIER -60.2 -60.7 9.77 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.885 -179.988 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 615' ' ' PRO . . . . . 0.409 ' CD ' ' CB ' ' A' ' 614' ' ' GLU . 60.3 Cg_endo -72.68 85.57 1.12 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.503 2.136 . . . . 0.0 112.372 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 616' ' ' SER . . . . . . . . . . . . . 1.3 m -87.3 149.65 47.49 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.874 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo . . . . . 0 C--O 1.249 1.054 0 C-N-CA 122.592 2.194 . . . . 0.0 112.292 179.963 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 1.3 tmm? . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.692 0.282 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 455' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.03 121.93 8.55 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.561 2.174 . . . . 0.0 112.303 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 456' ' ' ARG . . . . . . . . . . . . . 32.9 mtt180 -85.24 -26.53 26.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.977 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -82.42 -38.1 24.54 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.882 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -59.92 110.44 1.18 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.063 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 79.0 p -109.79 147.7 36.68 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.844 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.36 -170.41 0.57 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.532 2.155 . . . . 0.0 112.307 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . 83.27 27.62 39.45 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.574 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -164.93 145.42 6.09 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.633 0.254 . . . . 0.0 110.92 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -73.96 -174.11 1.62 Allowed 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.528 2.152 . . . . 0.0 112.324 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.77 179.35 5.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.885 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -98.29 22.14 10.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.117 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 2.4 m -61.45 -26.74 68.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.978 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 467' ' ' LEU . . . . . 0.451 HD21 HG23 ' A' ' 471' ' ' VAL . 3.1 mt -102.33 81.26 2.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.936 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 2.5 m -137.95 43.29 2.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.808 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 129.0 -36.85 2.32 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.217 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -115.92 117.72 30.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.766 0.317 . . . . 0.0 110.674 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 471' ' ' VAL . . . . . 0.586 ' O ' HG13 ' A' ' 471' ' ' VAL . 9.7 p -112.93 108.12 24.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.158 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -113.75 90.18 17.89 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.86 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -68.72 145.67 64.06 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.499 2.133 . . . . 0.0 112.227 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -97.82 36.78 1.48 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.989 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 3.5 m -90.03 -29.87 18.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.882 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 476' ' ' GLY . . . . . . . . . . . . . . . 124.09 44.51 0.3 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.487 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 477' ' ' ASN . . . . . 0.438 ' N ' ' HD2' ' A' ' 478' ' ' PRO . 0.7 OUTLIER -50.18 -51.69 60.39 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 120.635 0.255 . . . . 0.0 111.393 179.937 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 478' ' ' PRO . . . . . 0.438 ' HD2' ' N ' ' A' ' 477' ' ' ASN . 91.2 Cg_endo -79.64 -27.73 3.89 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.453 2.102 . . . . 0.0 112.431 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 5.2 m170 -62.81 115.95 4.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.932 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -73.46 155.63 89.41 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.066 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.49 -71.32 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.478 2.119 . . . . 0.0 112.252 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 482' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -135.33 28.99 3.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.859 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 483' ' ' THR . . . . . 0.549 HG23 ' HB2' ' A' ' 487' ' ' ASN . 55.5 m -70.39 66.77 0.32 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.073 0.463 . . . . 0.0 110.613 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 484' ' ' ASN . . . . . 0.411 ' CB ' ' CE ' ' A' ' 577' ' ' LYS . 13.6 m120 -130.22 -68.97 0.68 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.91 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 485' ' ' PHE . . . . . 0.918 ' HB2' HD13 ' A' ' 575' ' ' ILE . 51.1 p90 -70.34 -51.37 30.54 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.814 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 486' ' ' ALA . . . . . 0.452 ' N ' ' CD2' ' A' ' 485' ' ' PHE . . . -59.31 -47.61 84.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.179 0.514 . . . . 0.0 110.071 179.358 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 487' ' ' ASN . . . . . 0.549 ' HB2' HG23 ' A' ' 483' ' ' THR . 2.1 t-20 -69.12 -48.44 62.49 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.03 179.592 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 488' ' ' MET . . . . . 0.499 ' HB3' HD22 ' A' ' 585' ' ' LEU . 2.0 ptt? 51.26 51.28 10.05 Favored Pre-proline 0 N--CA 1.465 0.285 0 CA-C-O 121.229 0.538 . . . . 0.0 110.576 -179.128 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 489' ' ' PRO . . . . . 0.463 ' CD ' ' N ' ' A' ' 488' ' ' MET . 71.7 Cg_endo -80.0 13.86 2.06 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.087 2.525 . . . . 0.0 114.414 -178.465 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.71 -69.48 0.83 Allowed 'General case' 0 C--O 1.232 0.136 0 C-N-CA 119.647 -0.821 . . . . 0.0 112.494 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 491' ' ' ALA . . . . . 0.467 ' CB ' HD21 ' A' ' 514' ' ' LEU . . . -136.12 136.49 40.14 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 179.499 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 492' ' ' ARG . . . . . 0.458 ' HD3' HD23 ' A' ' 585' ' ' LEU . 1.0 OUTLIER -136.49 131.69 34.32 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 175.561 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 493' ' ' VAL . . . . . 1.142 HG23 HG22 ' A' ' 586' ' ' VAL . 2.5 m -139.33 164.02 25.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.688 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 79.7 p -130.63 132.9 45.72 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.604 176.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 495' ' ' LEU . . . . . 1.002 HD23 ' HB2' ' A' ' 512' ' ' ALA . 2.2 pp -137.04 163.23 50.84 Favored Pre-proline 0 CA--C 1.53 0.18 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.588 178.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 496' ' ' PRO . . . . . 0.685 ' HB2' HD23 ' A' ' 499' ' ' LEU . 19.8 Cg_exo -63.29 119.21 6.19 Favored 'Trans proline' 0 CA--C 1.533 0.428 0 C-N-CA 121.921 1.747 . . . . 0.0 111.658 179.014 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 497' ' ' LYS . . . . . 0.462 ' CA ' ' HB ' ' A' ' 588' ' ' ILE . 23.7 ttpt -56.62 -30.39 63.23 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -178.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 498' ' ' SER . . . . . . . . . . . . . 12.2 t -55.94 -48.0 76.55 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -177.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 499' ' ' LEU . . . . . 0.757 HD12 ' NZ ' ' A' ' 507' ' ' LYS . 1.1 pp -73.45 -8.36 55.58 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -178.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 500' ' ' VAL . . . . . 0.796 HG22 HD11 ' A' ' 495' ' ' LEU . 12.0 t -74.59 -25.28 19.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.31 0.576 . . . . 0.0 111.793 -179.007 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 501' ' ' TYR . . . . . 0.627 ' O ' ' CG2' ' A' ' 564' ' ' THR . 3.1 m-85 -53.55 -29.69 38.18 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -178.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 502' ' ' ASP . . . . . 0.421 ' O ' ' HB2' ' A' ' 560' ' ' ASN . 2.1 m-20 -76.36 -50.09 15.12 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 115.807 1.78 . . . . 0.0 115.807 -175.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 503' ' ' LYS . . . . . 0.553 ' O ' ' CG ' ' A' ' 507' ' ' LYS . 0.1 OUTLIER -119.65 135.39 54.83 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-N 119.153 0.888 . . . . 0.0 111.939 -178.896 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 504' ' ' THR . . . . . 0.696 HG21 ' CG ' ' A' ' 563' ' ' LYS . 69.7 m -73.21 -76.63 0.12 Allowed 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 505' ' ' PHE . . . . . 0.612 ' CZ ' ' HB1' ' A' ' 530' ' ' ALA . 0.3 OUTLIER -75.78 -59.12 2.89 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -179.416 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 506' ' ' SER . . . . . 0.817 ' O ' ' CD1' ' A' ' 510' ' ' TRP . 8.0 t -49.0 -71.48 0.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 -175.76 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 507' ' ' LYS . . . . . 0.757 ' NZ ' HD12 ' A' ' 499' ' ' LEU . 0.0 OUTLIER -48.01 -49.07 32.22 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -174.782 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 508' ' ' VAL . . . . . 0.758 HG21 HD11 ' A' ' 574' ' ' LEU . 0.2 OUTLIER -64.23 -49.57 80.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 C-N-CA 120.299 -0.561 . . . . 0.0 111.964 -178.467 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 509' ' ' LEU . . . . . 0.761 HD12 ' N ' ' A' ' 510' ' ' TRP . 1.1 pp -55.99 -62.07 1.95 Allowed 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 -178.04 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 510' ' ' TRP . . . . . 0.878 ' CD1' ' HA ' ' A' ' 518' ' ' LYS . 67.4 p-90 -73.08 -49.67 27.26 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 114.722 1.378 . . . . 0.0 114.722 -176.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 511' ' ' SER . . . . . 0.506 ' N ' ' CE3' ' A' ' 510' ' ' TRP . 0.3 OUTLIER -63.5 -47.61 81.0 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -176.606 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 512' ' ' ALA . . . . . 1.002 ' HB2' HD23 ' A' ' 495' ' ' LEU . . . -70.89 -73.62 0.17 Allowed 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 117.841 2.534 . . . . 0.0 117.841 -174.091 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 513' ' ' GLY . . . . . 0.938 ' HA2' HG11 ' A' ' 493' ' ' VAL . . . -115.05 -35.06 1.39 Allowed Glycine 0 CA--C 1.499 -0.945 0 N-CA-C 120.696 3.038 . . . . 0.0 120.696 -173.039 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 514' ' ' LEU . . . . . 0.672 HD23 ' CG ' ' A' ' 584' ' ' LYS . 0.1 OUTLIER -103.08 -47.97 4.18 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 119.105 3.002 . . . . 0.0 119.105 -170.171 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 515' ' ' VAL . . . . . 1.03 HG13 ' HB2' ' A' ' 517' ' ' SER . 2.4 p -155.99 172.26 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 117.606 2.447 . . . . 0.0 117.606 -173.128 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 516' ' ' ALA . . . . . 0.544 ' N ' ' CG2' ' A' ' 515' ' ' VAL . . . -68.06 4.08 1.36 Allowed 'General case' 0 C--O 1.231 0.104 0 C-N-CA 126.57 1.948 . . . . 0.0 109.636 176.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 517' ' ' SER . . . . . 1.03 ' HB2' HG13 ' A' ' 515' ' ' VAL . 0.6 OUTLIER -57.63 8.89 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 116.065 1.876 . . . . 0.0 116.065 -171.984 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 518' ' ' LYS . . . . . 0.878 ' HA ' ' CD1' ' A' ' 510' ' ' TRP . 0.0 OUTLIER -45.4 -46.7 13.47 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 104.432 -2.433 . . . . 0.0 104.432 175.41 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 519' ' ' SER . . . . . . . . . . . . . 1.4 p -75.08 -59.11 2.89 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.607 -1.178 . . . . 0.0 109.966 173.253 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 520' ' ' GLU . . . . . 0.808 ' HB2' ' HA ' ' A' ' 517' ' ' SER . 2.7 mm-40 -58.28 -47.43 83.65 Favored 'General case' 0 C--N 1.35 0.629 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.75 -179.152 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 521' ' ' GLY . . . . . 0.839 ' N ' ' O ' ' A' ' 517' ' ' SER . . . -49.01 -53.98 16.37 Favored Glycine 0 CA--C 1.493 -1.317 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.072 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 522' ' ' GLN . . . . . 0.434 ' HA ' HG12 ' A' ' 525' ' ' ILE . 2.0 mm100 -47.91 -47.28 32.31 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.176 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 523' ' ' ARG . . . . . 0.478 ' O ' ' HB3' ' A' ' 526' ' ' ASN . 0.4 OUTLIER -50.33 -48.82 55.21 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.818 178.266 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 524' ' ' ILE . . . . . 0.591 HG21 HD22 ' A' ' 578' ' ' LEU . 18.2 mt -57.56 -54.86 25.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.518 0.675 . . . . 0.0 109.585 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 525' ' ' ILE . . . . . 0.825 HG23 ' CD1' ' A' ' 556' ' ' ILE . 0.6 OUTLIER -50.39 -47.47 26.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.834 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 526' ' ' ASN . . . . . 0.478 ' HB3' ' O ' ' A' ' 523' ' ' ARG . 16.6 t-20 -56.28 -47.44 78.63 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 113.987 -1.461 . . . . 0.0 108.434 177.651 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 527' ' ' ASN . . . . . 0.493 ' ND2' ' O ' ' A' ' 524' ' ' ILE . 0.0 OUTLIER -47.52 -39.85 17.28 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.115 -1.402 . . . . 0.0 107.523 177.056 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 528' ' ' ASN . . . . . 0.646 ' HA ' ' CG2' ' A' ' 556' ' ' ILE . 1.9 t30 73.79 40.21 0.49 Allowed 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.384 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 529' ' ' GLY . . . . . . . . . . . . . . . -118.05 31.22 5.75 Favored Glycine 0 CA--C 1.523 0.585 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.657 178.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 530' ' ' ALA . . . . . 0.921 ' O ' ' HB ' ' A' ' 556' ' ' ILE . . . -133.54 164.38 27.3 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.333 0.587 . . . . 0.0 112.541 -179.027 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 531' ' ' TYR . . . . . 0.581 ' CE1' ' HA ' ' A' ' 553' ' ' PHE . 0.0 OUTLIER -134.36 152.88 52.06 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 177.752 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 532' ' ' VAL . . . . . 0.628 HG12 ' OG1' ' A' ' 554' ' ' THR . 0.4 OUTLIER -126.04 135.82 62.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 CA-C-O 121.871 0.844 . . . . 0.0 111.745 179.75 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 533' ' ' GLY . . . . . 0.724 ' O ' HG13 ' A' ' 575' ' ' ILE . . . -133.31 152.86 20.54 Favored Glycine 0 N--CA 1.443 -0.844 0 CA-C-N 114.472 -1.24 . . . . 0.0 113.783 -179.582 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 534' ' ' SER . . . . . 0.582 ' HB2' ' OG1' ' A' ' 552' ' ' THR . 0.5 OUTLIER -134.26 141.83 47.12 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.147 -0.527 . . . . 0.0 110.903 179.079 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 535' ' ' ARG . . . . . 0.6 ' HB3' HD22 ' A' ' 573' ' ' LEU . 0.0 OUTLIER -159.26 90.71 1.96 Allowed Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 179.225 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 536' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -59.04 -58.77 0.57 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.608 2.205 . . . . 0.0 111.86 178.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 114.64 8.36 16.29 Favored Glycine 0 CA--C 1.519 0.344 0 C-N-CA 120.829 -0.701 . . . . 0.0 113.119 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 538' ' ' VAL . . . . . 0.609 HG12 ' O ' ' A' ' 538' ' ' VAL . 14.2 t -116.26 18.03 7.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.862 0.331 . . . . 0.0 111.653 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 539' ' ' LYS . . . . . . . . . . . . . 4.2 ptpp? -57.39 118.28 4.98 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.039 0.447 . . . . 0.0 111.194 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -128.27 -40.0 1.67 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.975 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 541' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -96.16 100.44 12.09 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.15 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -47.71 103.78 0.38 Allowed Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.884 -179.415 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 543' ' ' PRO . . . . . 0.459 ' HB2' ' HG3' ' A' ' 548' ' ' PRO . 77.1 Cg_exo -51.1 -7.43 0.14 Allowed 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.336 2.691 . . . . 0.0 114.522 -179.383 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 544' ' ' GLY . . . . . 0.525 ' C ' ' H ' ' A' ' 546' ' ' GLY . . . 52.09 54.74 24.69 Favored Glycine 0 C--N 1.335 0.513 0 C-N-CA 119.786 -1.197 . . . . 0.0 111.714 -179.307 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 545' ' ' GLY . . . . . 0.632 ' O ' ' N ' ' A' ' 547' ' ' MET . . . 54.48 -5.43 0.01 OUTLIER Glycine 0 CA--C 1.528 0.863 0 N-CA-C 114.395 0.518 . . . . 0.0 114.395 -178.4 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 546' ' ' GLY . . . . . 0.525 ' H ' ' C ' ' A' ' 544' ' ' GLY . . . -53.47 54.95 0.01 OUTLIER Glycine 0 CA--C 1.528 0.849 0 CA-C-N 117.355 0.578 . . . . 0.0 114.229 177.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 547' ' ' MET . . . . . 0.632 ' N ' ' O ' ' A' ' 545' ' ' GLY . 21.2 ttm 52.33 54.19 13.49 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 118.565 1.183 . . . . 0.0 110.502 -178.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 548' ' ' PRO . . . . . 0.501 ' HD3' ' N ' ' A' ' 547' ' ' MET . 74.4 Cg_exo -46.59 166.46 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.317 2.678 . . . . 0.0 113.639 -179.197 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 549' ' ' ASP . . . . . 0.495 ' HB3' HD11 ' A' ' 569' ' ' ILE . 65.8 m-20 -124.21 -18.11 5.95 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.229 178.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 550' ' ' ASP . . . . . 0.582 ' O ' ' HA ' ' A' ' 535' ' ' ARG . 40.6 m-20 -54.55 -38.62 66.83 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.09 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 551' ' ' LEU . . . . . 0.602 HD21 ' HE1' ' A' ' 553' ' ' PHE . 14.7 tp -131.47 139.61 49.39 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.35 177.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 552' ' ' THR . . . . . 0.695 ' O ' ' HA2' ' A' ' 533' ' ' GLY . 28.9 m -133.54 146.67 51.26 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.714 0.769 . . . . 0.0 112.166 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 553' ' ' PHE . . . . . 0.602 ' HE1' HD21 ' A' ' 551' ' ' LEU . 24.8 m-85 -133.99 136.88 44.41 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 176.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 554' ' ' THR . . . . . 0.891 HG22 ' H ' ' A' ' 556' ' ' ILE . 1.9 m -133.55 138.98 32.41 Favored Pre-proline 0 C--N 1.304 -1.377 0 C-N-CA 120.042 -0.663 . . . . 0.0 109.515 178.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 555' ' ' PRO . . . . . 0.851 ' O ' HG22 ' A' ' 556' ' ' ILE . 81.3 Cg_endo -82.47 19.43 1.28 Allowed 'Trans proline' 0 N--CA 1.447 -1.216 0 C-N-CA 121.486 1.457 . . . . 0.0 111.561 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 556' ' ' ILE . . . . . 0.921 ' HB ' ' O ' ' A' ' 530' ' ' ALA . 4.1 tp 61.92 32.36 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 177.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 4.3 tttt -104.09 122.0 44.38 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 105.183 -2.155 . . . . 0.0 105.183 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 558' ' ' THR . . . . . . . . . . . . . 6.5 t -56.88 117.55 4.07 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 -171.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 559' ' ' TRP . . . . . 0.474 ' CH2' ' HD2' ' A' ' 555' ' ' PRO . 5.3 m0 -136.89 112.05 9.06 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 104.408 -2.442 . . . . 0.0 104.408 175.618 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 560' ' ' ASN . . . . . 0.514 ' O ' ' HB ' ' A' ' 564' ' ' THR . 2.5 p30 -80.93 -74.8 0.3 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 115.372 1.619 . . . . 0.0 115.372 -174.5 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 561' ' ' ALA . . . . . . . . . . . . . . . -72.9 -61.97 1.62 Allowed 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 115.181 1.548 . . . . 0.0 115.181 -176.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 562' ' ' SER . . . . . . . . . . . . . 85.5 p -49.27 -50.37 39.23 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -177.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 563' ' ' LYS . . . . . 0.696 ' CG ' HG21 ' A' ' 504' ' ' THR . 0.0 OUTLIER -70.98 -48.95 50.41 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -178.449 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 564' ' ' THR . . . . . 0.627 ' CG2' ' O ' ' A' ' 501' ' ' TYR . 2.0 t -54.09 -65.03 0.64 Allowed 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 121.218 -0.193 . . . . 0.0 111.35 -178.395 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 565' ' ' GLN . . . . . 0.709 ' O ' HG23 ' A' ' 569' ' ' ILE . 0.0 OUTLIER -49.0 -47.41 44.36 Favored 'General case' 0 C--N 1.321 -0.649 0 O-C-N 122.067 -0.395 . . . . 0.0 111.367 179.028 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -49.71 -67.0 0.3 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -178.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 567' ' ' PHE . . . . . 0.917 ' CZ ' HD13 ' A' ' 568' ' ' ILE . 0.2 OUTLIER -86.99 -43.25 12.49 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -178.056 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 568' ' ' ILE . . . . . 1.062 HD11 HD13 ' A' ' 574' ' ' LEU . 1.0 OUTLIER -62.05 8.69 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 -179.64 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 569' ' ' ILE . . . . . 0.709 HG23 ' O ' ' A' ' 565' ' ' GLN . 0.9 OUTLIER -54.72 -40.8 53.06 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 N-CA-C 105.048 -2.204 . . . . 0.0 105.048 178.905 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 570' ' ' ASP . . . . . 0.817 ' CB ' HD11 ' A' ' 588' ' ' ILE . 5.6 m-20 33.8 59.93 0.53 Allowed 'General case' 0 CA--C 1.507 -0.68 0 CA-C-N 113.833 -1.53 . . . . 0.0 112.994 173.113 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 571' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 570' ' ' ASP . . . -51.84 -45.06 55.84 Favored Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 116.865 -2.588 . . . . 0.0 108.088 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 572' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -120.41 -16.15 8.44 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 175.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 573' ' ' LEU . . . . . 0.6 HD22 ' HB3' ' A' ' 535' ' ' ARG . 2.0 tp -139.85 137.05 34.61 Favored 'General case' 0 C--N 1.354 0.772 0 N-CA-C 116.627 2.084 . . . . 0.0 116.627 -176.646 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 574' ' ' LEU . . . . . 1.062 HD13 HD11 ' A' ' 568' ' ' ILE . 0.1 OUTLIER -135.18 132.97 38.62 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 173.605 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 575' ' ' ILE . . . . . 1.057 HG23 HD13 ' A' ' 585' ' ' LEU . 0.0 OUTLIER -134.58 138.12 50.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 119.222 0.919 . . . . 0.0 111.763 178.786 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 576' ' ' LEU . . . . . 0.523 ' CD1' ' CE2' ' A' ' 505' ' ' PHE . 0.0 OUTLIER -132.93 135.35 45.49 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 176.875 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 577' ' ' LYS . . . . . 0.558 ' HE3' ' HE1' ' A' ' 583' ' ' MET . 0.9 OUTLIER -132.8 135.59 45.77 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 119.057 -1.057 . . . . 0.0 110.533 177.808 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.591 HD22 HG21 ' A' ' 524' ' ' ILE . 0.3 OUTLIER -123.86 131.87 53.66 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 177.749 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 579' ' ' GLY . . . . . . . . . . . . . . . -89.1 -2.06 78.29 Favored Glycine 0 N--CA 1.441 -1.007 0 CA-C-N 115.192 -0.913 . . . . 0.0 113.495 -178.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 580' ' ' LYS . . . . . 0.509 ' HD3' HG23 ' A' ' 524' ' ' ILE . 0.1 OUTLIER -74.33 -47.55 33.74 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 118.968 -1.093 . . . . 0.0 109.151 179.373 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 581' ' ' TRP . . . . . 0.462 ' CD1' ' O ' ' A' ' 580' ' ' LYS . 26.6 m0 -139.34 -52.63 0.55 Allowed 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 178.156 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 582' ' ' LYS . . . . . 0.564 ' O ' HD12 ' A' ' 578' ' ' LEU . 0.0 OUTLIER -139.81 165.25 27.79 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 -174.327 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 583' ' ' MET . . . . . 0.558 ' HE1' ' HE3' ' A' ' 577' ' ' LYS . 0.0 OUTLIER -113.75 134.53 54.7 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 174.099 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 584' ' ' LYS . . . . . 0.683 ' HE2' ' H ' ' A' ' 513' ' ' GLY . 0.3 OUTLIER -123.69 134.43 53.72 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.302 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 585' ' ' LEU . . . . . 1.057 HD13 HG23 ' A' ' 575' ' ' ILE . 6.1 tp -121.05 137.05 54.84 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -179.131 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 586' ' ' VAL . . . . . 1.142 HG22 HG23 ' A' ' 493' ' ' VAL . 6.0 t -131.56 136.75 56.72 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.67 -179.064 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 587' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.92 134.21 53.62 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 176.254 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.817 HD11 ' CB ' ' A' ' 570' ' ' ASP . 0.2 OUTLIER -134.96 147.74 29.33 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 -178.503 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 8.0 m -132.46 148.05 31.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 113.916 -1.493 . . . . 0.0 110.334 178.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 590' ' ' SER . . . . . . . . . . . . . 4.2 t -45.99 145.99 1.37 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.978 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 591' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -50.49 -50.05 53.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.044 0.45 . . . . 0.0 110.494 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -51.51 -49.65 61.48 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.876 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.19 -48.55 54.12 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.725 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 594' ' ' PHE . . . . . 0.759 ' CD1' HD11 ' A' ' 597' ' ' LEU . 0.9 OUTLIER -50.04 -48.23 52.95 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 114.583 -1.19 . . . . 0.0 109.541 178.251 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 595' ' ' LYS . . . . . 0.484 ' HD3' ' CD1' ' A' ' 604' ' ' TRP . 0.0 OUTLIER -49.07 -47.71 44.8 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 179.029 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 596' ' ' GLU . . . . . 0.513 ' O ' HD23 ' A' ' 599' ' ' LEU . 3.6 tp10 -52.73 -63.48 1.13 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.395 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 597' ' ' LEU . . . . . 0.759 HD11 ' CD1' ' A' ' 594' ' ' PHE . 0.5 OUTLIER -58.06 -62.09 2.07 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 121.535 0.683 . . . . 0.0 112.103 -178.798 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 598' ' ' GLY . . . . . 0.459 ' O ' ' CD1' ' A' ' 604' ' ' TRP . . . -77.96 13.74 12.98 Favored Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 114.966 -1.015 . . . . 0.0 113.623 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 599' ' ' LEU . . . . . 0.657 HD12 ' N ' ' A' ' 600' ' ' THR . 3.3 pp -47.26 -15.82 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -175.463 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 600' ' ' THR . . . . . 0.657 ' N ' HD12 ' A' ' 599' ' ' LEU . 10.1 t -128.37 66.15 1.39 Allowed 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 119.994 -0.683 . . . . 0.0 110.324 176.479 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 601' ' ' ALA . . . . . . . . . . . . . . . -131.83 153.19 81.36 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.548 179.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 602' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -57.05 -21.37 41.71 Favored 'Trans proline' 0 N--CA 1.465 -0.199 0 C-N-CA 122.023 1.816 . . . . 0.0 111.199 178.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 603' ' ' GLY . . . . . 0.656 ' O ' HG23 ' A' ' 607' ' ' VAL . . . -61.3 -49.2 80.13 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.641 -0.708 . . . . 0.0 113.007 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 604' ' ' TRP . . . . . 0.501 ' CD1' ' HA ' ' A' ' 599' ' ' LEU . 1.1 m95 -64.91 -46.91 79.68 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 120.904 0.383 . . . . 0.0 111.123 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 605' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -50.32 -58.32 5.92 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.264 -178.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -60.77 -57.19 13.73 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -179.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 607' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 603' ' ' GLY . 39.0 t -55.43 -71.93 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -178.687 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 608' ' ' VAL . . . . . . . . . . . . . 78.8 t -67.69 -58.63 5.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -177.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 609' ' ' GLY . . . . . . . . . . . . . . . -59.51 -62.16 6.46 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 121.132 -0.556 . . . . 0.0 113.197 -178.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 610' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.56 -58.32 6.05 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.848 0.356 . . . . 0.0 110.89 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 121.63 56.41 0.22 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.576 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -97.41 32.0 2.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.793 0.33 . . . . 0.0 110.976 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 613' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -103.22 179.93 4.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.925 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 614' ' ' GLU . . . . . 0.407 ' CB ' ' CD ' ' A' ' 615' ' ' PRO . 7.4 mt-10 -62.18 -60.6 9.65 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.886 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 615' ' ' PRO . . . . . 0.407 ' CD ' ' CB ' ' A' ' 614' ' ' GLU . 60.9 Cg_endo -72.81 85.54 1.15 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.558 2.172 . . . . 0.0 112.298 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 616' ' ' SER . . . . . . . . . . . . . 49.0 m -75.49 149.4 83.92 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.915 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo . . . . . 0 C--O 1.249 1.041 0 C-N-CA 122.515 2.143 . . . . 0.0 112.307 -179.964 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 491' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.94 0.4 . . . . 0.0 110.687 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 492' ' ' ARG . . . . . 0.666 ' NE ' HD12 ' A' ' 585' ' ' LEU . 0.1 OUTLIER -135.31 136.01 41.25 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.661 -179.835 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 493' ' ' VAL . . . . . 0.577 ' O ' HG13 ' A' ' 586' ' ' VAL . 46.7 t -134.02 163.45 37.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.938 178.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . 0.57 ' N ' HG12 ' A' ' 493' ' ' VAL . 6.1 t -123.35 134.51 54.01 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 121.184 0.516 . . . . 0.0 111.377 178.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 495' ' ' LEU . . . . . 0.723 ' O ' HG22 ' A' ' 588' ' ' ILE . 0.2 OUTLIER -135.47 163.31 51.74 Favored Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.422 179.235 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 496' ' ' PRO . . . . . 0.548 ' HG2' ' CD2' ' A' ' 499' ' ' LEU . 19.5 Cg_endo -58.51 119.87 7.39 Favored 'Trans proline' 0 CA--C 1.532 0.409 0 C-N-CA 122.235 1.957 . . . . 0.0 112.214 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 497' ' ' LYS . . . . . 0.484 ' CA ' ' HB ' ' A' ' 588' ' ' ILE . 2.1 ttpp -57.72 -30.04 65.22 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -179.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 498' ' ' SER . . . . . 0.401 ' O ' ' CD1' ' A' ' 501' ' ' TYR . 0.3 OUTLIER -60.86 -48.9 79.71 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -176.59 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 499' ' ' LEU . . . . . 0.576 HD12 ' C ' ' A' ' 499' ' ' LEU . 3.1 pp -73.97 -8.24 55.38 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -178.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . 0.626 HG22 ' HZ1' ' A' ' 507' ' ' LYS . 26.6 t -73.0 -25.8 22.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.286 0.565 . . . . 0.0 111.355 -179.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 501' ' ' TYR . . . . . 0.704 ' O ' HG21 ' A' ' 564' ' ' THR . 0.4 OUTLIER -53.88 -29.72 42.85 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 -178.69 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -72.04 -50.05 31.62 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 -175.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 503' ' ' LYS . . . . . 0.599 ' O ' ' CG ' ' A' ' 507' ' ' LYS . 7.4 mttt -119.38 133.94 55.47 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 118.694 0.679 . . . . 0.0 111.142 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . 0.755 HG21 ' HB3' ' A' ' 563' ' ' LYS . 6.8 m -73.32 -76.61 0.12 Allowed 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . 0.821 ' CZ ' ' HB1' ' A' ' 530' ' ' ALA . 0.3 OUTLIER -75.52 -60.08 2.46 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -179.471 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 506' ' ' SER . . . . . 0.722 ' O ' ' CD1' ' A' ' 510' ' ' TRP . 8.0 t -48.97 -72.69 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 -176.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 507' ' ' LYS . . . . . 0.698 ' HD3' ' N ' ' A' ' 508' ' ' VAL . 0.0 OUTLIER -48.82 -48.38 41.57 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -176.893 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 508' ' ' VAL . . . . . 0.829 HG13 HD21 ' A' ' 574' ' ' LEU . 50.1 t -55.07 -58.71 3.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 509' ' ' LEU . . . . . 0.748 HD12 ' N ' ' A' ' 510' ' ' TRP . 2.0 pp -56.98 -60.1 4.08 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 -177.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 510' ' ' TRP . . . . . 0.913 ' CD1' ' HA ' ' A' ' 518' ' ' LYS . 63.2 p-90 -72.47 -51.77 18.73 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -176.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 511' ' ' SER . . . . . 0.525 ' N ' ' CE3' ' A' ' 510' ' ' TRP . 0.5 OUTLIER -66.35 -47.48 73.32 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -176.818 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 512' ' ' ALA . . . . . 0.785 ' HB3' ' O ' ' A' ' 508' ' ' VAL . . . -71.24 -72.81 0.2 Allowed 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 117.756 2.502 . . . . 0.0 117.756 -174.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 513' ' ' GLY . . . . . 0.59 ' H ' ' HE2' ' A' ' 584' ' ' LYS . . . -114.6 -35.57 1.4 Allowed Glycine 0 CA--C 1.5 -0.877 0 N-CA-C 121.39 3.316 . . . . 0.0 121.39 -172.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 514' ' ' LEU . . . . . 0.613 HD13 ' HG3' ' A' ' 582' ' ' LYS . 2.8 mt -108.16 -47.03 3.62 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 119.798 3.258 . . . . 0.0 119.798 -170.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 515' ' ' VAL . . . . . 0.613 HG12 ' N ' ' A' ' 516' ' ' ALA . 90.1 t -153.06 171.88 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.582 0 N-CA-C 117.073 2.249 . . . . 0.0 117.073 -172.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 516' ' ' ALA . . . . . 0.613 ' N ' HG12 ' A' ' 515' ' ' VAL . . . -69.09 3.04 2.3 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 113.012 -1.904 . . . . 0.0 109.366 175.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . 0.881 ' O ' ' N ' ' A' ' 521' ' ' GLY . 0.4 OUTLIER -58.35 8.75 0.01 OUTLIER 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 115.43 1.641 . . . . 0.0 115.43 -172.122 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 518' ' ' LYS . . . . . 0.913 ' HA ' ' CD1' ' A' ' 510' ' ' TRP . 0.0 OUTLIER -45.8 -45.41 14.79 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 104.321 -2.474 . . . . 0.0 104.321 175.74 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 519' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.32 -56.43 4.88 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.427 -1.26 . . . . 0.0 109.706 173.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 520' ' ' GLU . . . . . 0.809 ' HB2' ' HA ' ' A' ' 517' ' ' SER . 9.3 mm-40 -63.64 -48.31 77.81 Favored 'General case' 0 C--N 1.351 0.654 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.02 -179.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 521' ' ' GLY . . . . . 0.881 ' N ' ' O ' ' A' ' 517' ' ' SER . . . -54.9 -53.55 39.14 Favored Glycine 0 CA--C 1.499 -0.929 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.443 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . 0.494 ' HA ' HG12 ' A' ' 525' ' ' ILE . 0.1 OUTLIER -47.82 -48.31 30.75 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.109 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 523' ' ' ARG . . . . . 0.452 ' HB3' ' O ' ' A' ' 520' ' ' GLU . 1.5 tpt180 -50.67 -48.71 58.32 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.095 178.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 524' ' ' ILE . . . . . 0.536 HG23 ' HG2' ' A' ' 580' ' ' LYS . 34.0 mm -55.12 -54.07 28.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.352 0.596 . . . . 0.0 110.029 179.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 525' ' ' ILE . . . . . 1.007 HG23 HD11 ' A' ' 556' ' ' ILE . 0.6 OUTLIER -50.5 -47.48 27.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 177.715 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 526' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -56.56 -48.28 77.69 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 113.996 -1.456 . . . . 0.0 108.521 177.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 527' ' ' ASN . . . . . 0.445 ' ND2' ' O ' ' A' ' 524' ' ' ILE . 0.0 OUTLIER -48.35 -39.45 22.18 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 113.784 -1.553 . . . . 0.0 108.003 176.924 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 528' ' ' ASN . . . . . 0.71 ' HA ' HG23 ' A' ' 556' ' ' ILE . 0.5 OUTLIER 74.51 40.19 0.42 Allowed 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.185 -178.775 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 529' ' ' GLY . . . . . . . . . . . . . . . -119.26 37.96 2.99 Favored Glycine 0 CA--C 1.521 0.466 0 CA-C-N 114.595 -1.184 . . . . 0.0 111.826 178.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 530' ' ' ALA . . . . . 0.826 ' HB3' HG12 ' A' ' 556' ' ' ILE . . . -132.76 164.53 26.6 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.834 0.826 . . . . 0.0 112.42 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 531' ' ' TYR . . . . . 0.716 ' HA ' HG22 ' A' ' 554' ' ' THR . 2.2 t80 -135.02 152.89 52.13 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 124.89 1.276 . . . . 0.0 109.061 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 532' ' ' VAL . . . . . 0.535 ' HB ' HG21 ' A' ' 554' ' ' THR . 0.4 OUTLIER -133.42 135.67 55.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 CA-C-O 121.807 0.813 . . . . 0.0 111.564 178.69 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 533' ' ' GLY . . . . . 0.767 ' O ' HG13 ' A' ' 575' ' ' ILE . . . -133.16 150.08 19.74 Favored Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 114.464 -1.244 . . . . 0.0 113.414 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 534' ' ' SER . . . . . 0.551 ' OG ' ' O ' ' A' ' 567' ' ' PHE . 0.5 OUTLIER -134.92 137.21 42.93 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.51 -0.345 . . . . 0.0 111.307 178.848 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 535' ' ' ARG . . . . . 0.547 ' O ' ' HB3' ' A' ' 573' ' ' LEU . 24.8 tpt85 . . . . . 0 C--N 1.33 -0.257 0 C-N-CA 120.657 -0.417 . . . . 0.0 112.077 178.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 . . . . . 0 N--CA 1.451 -0.396 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 550' ' ' ASP . . . . . 0.492 ' O ' ' HA ' ' A' ' 535' ' ' ARG . 96.2 m-20 -65.37 -46.24 80.92 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.487 179.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 551' ' ' LEU . . . . . . . . . . . . . 19.4 tp -131.57 141.96 49.81 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.426 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 552' ' ' THR . . . . . 0.591 ' O ' ' HA2' ' A' ' 533' ' ' GLY . 37.9 m -132.23 147.83 52.43 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.486 0.66 . . . . 0.0 111.441 179.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 553' ' ' PHE . . . . . 0.69 ' CD1' ' HE2' ' A' ' 531' ' ' TYR . 8.9 m-30 -132.27 139.45 48.25 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.463 -1.244 . . . . 0.0 107.927 179.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 554' ' ' THR . . . . . 0.922 HG23 ' H ' ' A' ' 556' ' ' ILE . 0.4 OUTLIER -130.43 141.73 42.95 Favored Pre-proline 0 C--N 1.326 -0.434 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -178.727 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 555' ' ' PRO . . . . . 0.842 ' O ' HG22 ' A' ' 556' ' ' ILE . 78.8 Cg_endo -87.77 1.12 6.96 Favored 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 123.055 2.503 . . . . 0.0 110.152 177.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 556' ' ' ILE . . . . . 1.007 HD11 HG23 ' A' ' 525' ' ' ILE . 7.0 tp 62.71 34.02 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.312 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 178.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . 0.643 ' O ' ' CE2' ' A' ' 559' ' ' TRP . 33.5 mttt -103.48 142.21 34.66 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 558' ' ' THR . . . . . . . . . . . . . 3.4 t -57.42 116.22 3.2 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 -171.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 559' ' ' TRP . . . . . 0.643 ' CE2' ' O ' ' A' ' 557' ' ' LYS . 0.0 OUTLIER -139.5 112.27 7.91 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 112.827 -1.988 . . . . 0.0 105.803 174.442 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 560' ' ' ASN . . . . . 0.71 ' O ' HG22 ' A' ' 564' ' ' THR . 77.6 m-20 -84.0 -76.64 0.29 Allowed 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 118.123 -1.431 . . . . 0.0 113.541 -176.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 561' ' ' ALA . . . . . 0.649 ' HA ' ' CG2' ' A' ' 564' ' ' THR . . . -75.57 -50.33 15.91 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 -178.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 562' ' ' SER . . . . . . . . . . . . . 38.8 m -49.57 -54.83 16.0 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -177.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 563' ' ' LYS . . . . . 0.755 ' HB3' HG21 ' A' ' 504' ' ' THR . 2.1 mmpt? -70.5 -47.79 58.79 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -178.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 564' ' ' THR . . . . . 0.881 HG23 ' H ' ' A' ' 565' ' ' GLN . 3.9 t -49.27 -71.35 0.07 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.578 0.227 . . . . 0.0 111.556 -178.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 565' ' ' GLN . . . . . 0.881 ' H ' HG23 ' A' ' 564' ' ' THR . 0.0 OUTLIER -49.37 -46.45 47.2 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.785 0.326 . . . . 0.0 111.518 179.786 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -49.15 -61.32 2.14 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 567' ' ' PHE . . . . . 0.882 ' CZ ' HD13 ' A' ' 568' ' ' ILE . 0.2 OUTLIER -96.78 -40.68 8.84 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -177.529 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 568' ' ' ILE . . . . . 1.108 HD11 HD13 ' A' ' 574' ' ' LEU . 0.9 OUTLIER -62.81 8.09 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -179.413 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 569' ' ' ILE . . . . . 0.771 HG23 ' O ' ' A' ' 565' ' ' GLN . 0.8 OUTLIER -55.04 -40.39 54.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 178.482 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 570' ' ' ASP . . . . . 0.586 ' OD2' ' HB2' ' A' ' 574' ' ' LEU . 5.7 m-20 33.85 61.27 0.49 Allowed 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 114.04 -1.436 . . . . 0.0 112.576 173.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 571' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 570' ' ' ASP . . . -51.94 -45.45 56.07 Favored Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 116.856 -2.592 . . . . 0.0 108.222 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 572' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -120.8 -16.07 8.24 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 175.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 573' ' ' LEU . . . . . 0.547 ' HB3' ' O ' ' A' ' 535' ' ' ARG . 1.5 tp -139.87 136.95 34.48 Favored 'General case' 0 C--N 1.354 0.794 0 N-CA-C 116.591 2.071 . . . . 0.0 116.591 -176.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 574' ' ' LEU . . . . . 1.108 HD13 HD11 ' A' ' 568' ' ' ILE . 0.1 OUTLIER -135.11 133.24 39.03 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 173.503 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 575' ' ' ILE . . . . . 0.909 HG22 ' HB3' ' A' ' 585' ' ' LEU . 0.0 OUTLIER -134.72 138.3 49.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 119.087 0.858 . . . . 0.0 111.448 177.893 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 576' ' ' LEU . . . . . 0.532 ' CD1' ' CE2' ' A' ' 505' ' ' PHE . 0.1 OUTLIER -132.52 135.61 46.1 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 177.889 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 577' ' ' LYS . . . . . . . . . . . . . 12.0 mtpt -132.6 135.8 46.12 Favored 'General case' 0 C--N 1.31 -1.125 0 C-N-CA 119.593 -0.843 . . . . 0.0 110.582 178.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.543 HD12 ' O ' ' A' ' 582' ' ' LYS . 0.5 OUTLIER -126.75 131.83 51.23 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 177.579 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 579' ' ' GLY . . . . . . . . . . . . . . . -90.49 -2.27 73.41 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 115.432 -0.804 . . . . 0.0 113.424 -178.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 580' ' ' LYS . . . . . 0.536 ' HG2' HG23 ' A' ' 524' ' ' ILE . 0.0 OUTLIER -73.33 -48.22 36.14 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 119.043 -1.063 . . . . 0.0 109.097 179.338 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 581' ' ' TRP . . . . . 0.488 ' CD1' ' O ' ' A' ' 580' ' ' LYS . 24.1 m0 -139.07 -52.38 0.55 Allowed 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 114.606 1.335 . . . . 0.0 114.606 177.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 582' ' ' LYS . . . . . 0.613 ' HG3' HD13 ' A' ' 514' ' ' LEU . 0.0 OUTLIER -139.55 165.44 27.24 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -174.263 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 583' ' ' MET . . . . . 0.692 ' CE ' HD22 ' A' ' 585' ' ' LEU . 7.6 ttt -117.46 134.29 55.01 Favored 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 106.46 -1.681 . . . . 0.0 106.46 174.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 584' ' ' LYS . . . . . 0.662 ' HZ1' HG12 ' A' ' 508' ' ' VAL . 1.4 tmmt? -128.41 133.6 48.62 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 178.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 585' ' ' LEU . . . . . 0.909 ' HB3' HG22 ' A' ' 575' ' ' ILE . 0.0 OUTLIER -125.98 136.72 53.32 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.921 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 586' ' ' VAL . . . . . 0.641 HG23 ' HD3' ' A' ' 584' ' ' LYS . 24.8 t -131.06 144.91 36.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.554 -177.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 587' ' ' SER . . . . . . . . . . . . . 49.8 m -107.21 135.63 48.4 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 177.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.723 HG22 ' O ' ' A' ' 495' ' ' LEU . 23.0 pt -133.58 137.63 52.46 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.508 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -178.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 7.7 m -132.63 137.1 54.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 114.31 -1.314 . . . . 0.0 110.603 178.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 590' ' ' SER . . . . . . . . . . . . . 1.7 t . . . . . 0 C--N 1.326 -0.445 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.753 -179.819 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 491' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.113 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 492' ' ' ARG . . . . . 0.514 ' CG ' ' HG ' ' A' ' 585' ' ' LEU . 0.0 OUTLIER -135.27 134.05 39.56 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.061 178.759 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 493' ' ' VAL . . . . . 0.563 HG12 ' N ' ' A' ' 494' ' ' THR . 39.4 t -136.06 163.41 34.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.373 178.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . 0.805 HG23 ' O ' ' A' ' 587' ' ' SER . 53.5 m -125.41 133.66 52.42 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.119 0.485 . . . . 0.0 110.298 177.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 495' ' ' LEU . . . . . 0.913 HD11 HD11 ' A' ' 499' ' ' LEU . 0.0 OUTLIER -136.08 163.89 47.02 Favored Pre-proline 0 CA--C 1.53 0.196 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.578 179.686 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 496' ' ' PRO . . . . . 0.798 ' HB2' HD23 ' A' ' 499' ' ' LEU . 46.1 Cg_exo -54.37 119.65 6.73 Favored 'Trans proline' 0 CA--C 1.532 0.414 0 C-N-CA 121.931 1.754 . . . . 0.0 111.515 178.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 497' ' ' LYS . . . . . 0.502 ' CA ' ' HB ' ' A' ' 588' ' ' ILE . 0.8 OUTLIER -62.0 -30.28 70.83 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -179.204 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 498' ' ' SER . . . . . . . . . . . . . 2.1 m -58.15 -47.4 83.48 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -178.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 499' ' ' LEU . . . . . 0.913 HD11 HD11 ' A' ' 495' ' ' LEU . 2.2 pp -72.81 -7.83 52.61 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -178.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . 0.621 HG22 ' NZ ' ' A' ' 507' ' ' LYS . 42.9 t -74.46 -25.83 19.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.374 0.607 . . . . 0.0 111.243 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 501' ' ' TYR . . . . . 0.698 ' O ' HG21 ' A' ' 564' ' ' THR . 0.3 OUTLIER -53.86 -29.46 41.48 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 -178.449 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 502' ' ' ASP . . . . . 0.406 ' N ' ' CD1' ' A' ' 501' ' ' TYR . 8.6 m-20 -75.56 -50.15 16.45 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 -175.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 503' ' ' LYS . . . . . 0.588 ' O ' ' CG ' ' A' ' 507' ' ' LYS . 0.2 OUTLIER -119.23 135.11 54.84 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 118.868 0.758 . . . . 0.0 111.298 -179.656 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . 0.667 HG21 ' HB3' ' A' ' 563' ' ' LYS . 2.2 m -73.32 -76.52 0.12 Allowed 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . 0.644 ' CE1' HG23 ' A' ' 532' ' ' VAL . 0.3 OUTLIER -75.61 -60.39 2.33 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 -179.414 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 506' ' ' SER . . . . . 0.775 ' O ' ' CD1' ' A' ' 510' ' ' TRP . 8.0 t -48.97 -72.79 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -175.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 507' ' ' LYS . . . . . 0.694 ' HD3' ' N ' ' A' ' 508' ' ' VAL . 0.0 OUTLIER -49.37 -48.28 46.96 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -177.021 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 508' ' ' VAL . . . . . 0.88 ' CG2' HD21 ' A' ' 574' ' ' LEU . 50.9 t -51.65 -60.72 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 509' ' ' LEU . . . . . 0.806 HD12 ' N ' ' A' ' 510' ' ' TRP . 2.6 pp -58.37 -61.06 2.86 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 115.753 1.76 . . . . 0.0 115.753 -176.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 510' ' ' TRP . . . . . 0.856 ' CD1' ' HA ' ' A' ' 518' ' ' LYS . 66.7 p-90 -72.38 -52.14 17.34 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -176.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 511' ' ' SER . . . . . 0.509 ' N ' ' CE3' ' A' ' 510' ' ' TRP . 1.4 t -64.79 -47.8 76.77 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -177.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 512' ' ' ALA . . . . . 0.815 ' HB3' ' O ' ' A' ' 508' ' ' VAL . . . -71.4 -72.84 0.2 Allowed 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 117.728 2.492 . . . . 0.0 117.728 -174.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 513' ' ' GLY . . . . . 0.649 ' H ' ' HE2' ' A' ' 584' ' ' LYS . . . -114.55 -35.06 1.47 Allowed Glycine 0 CA--C 1.503 -0.701 0 N-CA-C 121.24 3.256 . . . . 0.0 121.24 -172.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 514' ' ' LEU . . . . . 0.522 ' HG ' ' CG ' ' A' ' 584' ' ' LYS . 3.2 mt -107.5 -46.37 3.86 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 119.356 3.095 . . . . 0.0 119.356 -170.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 515' ' ' VAL . . . . . 1.049 HG13 ' HB2' ' A' ' 517' ' ' SER . 2.4 p -154.6 173.1 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.646 0 N-CA-C 117.619 2.451 . . . . 0.0 117.619 -172.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 516' ' ' ALA . . . . . 0.551 ' N ' ' CG2' ' A' ' 515' ' ' VAL . . . -67.94 4.05 1.32 Allowed 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 126.599 1.96 . . . . 0.0 109.864 177.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . 1.049 ' HB2' HG13 ' A' ' 515' ' ' VAL . 0.6 OUTLIER -57.7 9.19 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 116.133 1.901 . . . . 0.0 116.133 -171.972 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 518' ' ' LYS . . . . . 0.856 ' HA ' ' CD1' ' A' ' 510' ' ' TRP . 0.6 OUTLIER -45.43 -47.42 13.75 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 104.268 -2.493 . . . . 0.0 104.268 175.398 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 519' ' ' SER . . . . . . . . . . . . . 68.5 p -74.98 -58.16 3.45 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 114.531 -1.213 . . . . 0.0 110.178 173.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 520' ' ' GLU . . . . . 0.822 ' HB3' ' HA ' ' A' ' 517' ' ' SER . 2.7 tp10 -59.9 -47.61 85.07 Favored 'General case' 0 C--N 1.35 0.598 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.747 -178.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 521' ' ' GLY . . . . . 0.832 ' N ' ' O ' ' A' ' 517' ' ' SER . . . -49.75 -55.4 14.37 Favored Glycine 0 CA--C 1.493 -1.3 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . 0.466 ' HA ' HG12 ' A' ' 525' ' ' ILE . 14.3 mt-30 -47.68 -47.82 29.47 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 523' ' ' ARG . . . . . 0.522 ' HB3' ' O ' ' A' ' 520' ' ' GLU . 0.1 OUTLIER -50.7 -49.01 58.56 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.536 178.475 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 524' ' ' ILE . . . . . 0.637 HG21 HD22 ' A' ' 578' ' ' LEU . 36.0 mm -56.65 -54.99 22.09 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 CA-C-O 121.352 0.596 . . . . 0.0 109.883 179.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 525' ' ' ILE . . . . . 0.819 HG23 ' CD1' ' A' ' 556' ' ' ILE . 0.5 OUTLIER -50.22 -47.2 25.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 177.739 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 526' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -55.03 -48.05 73.92 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 113.764 -1.562 . . . . 0.0 108.506 177.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 527' ' ' ASN . . . . . 0.492 ' ND2' ' O ' ' A' ' 524' ' ' ILE . 0.0 OUTLIER -48.17 -39.99 22.6 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 113.957 -1.474 . . . . 0.0 107.734 177.124 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 528' ' ' ASN . . . . . 0.645 ' HA ' ' CG2' ' A' ' 556' ' ' ILE . 0.2 OUTLIER 73.65 40.26 0.5 Allowed 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.349 -179.373 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 529' ' ' GLY . . . . . . . . . . . . . . . -119.68 32.71 4.9 Favored Glycine 0 CA--C 1.524 0.616 0 CA-C-N 115.0 -1.0 . . . . 0.0 112.597 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 530' ' ' ALA . . . . . 0.909 ' O ' ' HB ' ' A' ' 556' ' ' ILE . . . -133.48 164.57 26.85 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.246 0.546 . . . . 0.0 112.438 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 531' ' ' TYR . . . . . 0.582 ' HA ' ' O ' ' A' ' 554' ' ' THR . 0.0 OUTLIER -133.99 155.82 49.28 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 177.648 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 532' ' ' VAL . . . . . 0.644 HG23 ' CE1' ' A' ' 505' ' ' PHE . 0.5 OUTLIER -129.17 136.34 59.79 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 CA-C-O 121.789 0.804 . . . . 0.0 111.894 179.929 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 533' ' ' GLY . . . . . 0.752 ' O ' HG13 ' A' ' 575' ' ' ILE . . . -132.33 147.13 18.69 Favored Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 114.442 -1.254 . . . . 0.0 113.504 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 534' ' ' SER . . . . . 0.425 ' C ' ' HD2' ' A' ' 535' ' ' ARG . 3.4 m -134.7 136.73 42.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.248 -0.476 . . . . 0.0 111.43 179.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 535' ' ' ARG . . . . . 0.853 ' HG2' HD22 ' A' ' 573' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.266 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.966 178.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 549' ' ' ASP . . . . . 0.476 ' HB2' HD11 ' A' ' 569' ' ' ILE . 2.3 p30 . . . . . 0 N--CA 1.451 -0.424 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 550' ' ' ASP . . . . . 0.507 ' O ' ' HB3' ' A' ' 535' ' ' ARG . 0.5 OUTLIER -58.66 -47.81 83.19 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.396 179.39 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 551' ' ' LEU . . . . . 0.634 HD21 ' HE1' ' A' ' 553' ' ' PHE . 7.1 tp -131.36 142.48 50.08 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.43 -0.805 . . . . 0.0 108.969 178.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 552' ' ' THR . . . . . 0.838 HG21 ' CG ' ' A' ' 567' ' ' PHE . 4.3 m -132.94 147.65 52.28 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.756 0.789 . . . . 0.0 112.395 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 553' ' ' PHE . . . . . 0.634 ' HE1' HD21 ' A' ' 551' ' ' LEU . 17.4 m-85 -133.71 136.95 44.99 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 176.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 554' ' ' THR . . . . . 0.863 HG22 ' H ' ' A' ' 556' ' ' ILE . 1.2 m -133.66 138.67 31.57 Favored Pre-proline 0 C--N 1.308 -1.224 0 C-N-CA 119.822 -0.751 . . . . 0.0 110.492 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 555' ' ' PRO . . . . . 0.827 ' O ' HG22 ' A' ' 556' ' ' ILE . 65.7 Cg_endo -83.49 19.24 1.37 Allowed 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 121.898 1.732 . . . . 0.0 111.764 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 556' ' ' ILE . . . . . 0.909 ' HB ' ' O ' ' A' ' 530' ' ' ALA . 4.5 tp 62.66 34.01 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.188 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 176.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . 0.599 ' O ' ' CE2' ' A' ' 559' ' ' TRP . 0.0 OUTLIER -103.82 126.03 50.66 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 179.897 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 558' ' ' THR . . . . . . . . . . . . . 3.6 t -57.81 118.22 5.09 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 115.413 1.634 . . . . 0.0 115.413 -172.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 559' ' ' TRP . . . . . 0.751 ' HZ2' HG23 ' A' ' 554' ' ' THR . 0.0 OUTLIER -138.5 130.7 28.56 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 175.214 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 560' ' ' ASN . . . . . 0.665 ' O ' HG22 ' A' ' 564' ' ' THR . 11.0 m-80 -90.88 -76.32 0.44 Allowed 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 118.305 -1.358 . . . . 0.0 114.116 -177.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 561' ' ' ALA . . . . . 0.526 ' HA ' ' CG2' ' A' ' 564' ' ' THR . . . -75.23 -57.29 3.98 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 116.368 1.988 . . . . 0.0 116.368 -177.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 562' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -49.0 -52.48 24.72 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -176.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 563' ' ' LYS . . . . . 0.667 ' HB3' HG21 ' A' ' 504' ' ' THR . 0.0 OUTLIER -70.8 -48.01 56.47 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -178.412 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 564' ' ' THR . . . . . 0.811 HG23 ' H ' ' A' ' 565' ' ' GLN . 6.8 t -49.63 -69.37 0.12 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.867 0.365 . . . . 0.0 111.288 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 565' ' ' GLN . . . . . 1.06 ' O ' HG23 ' A' ' 569' ' ' ILE . 2.0 tp60 -50.07 -46.62 53.48 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 566' ' ' GLU . . . . . 0.426 ' HG2' ' CD1' ' A' ' 567' ' ' PHE . 14.0 tt0 -49.24 -65.42 0.57 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 111.863 0.319 . . . . 0.0 111.863 -178.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 567' ' ' PHE . . . . . 0.838 ' CG ' HG21 ' A' ' 552' ' ' THR . 0.0 OUTLIER -97.18 -51.52 4.17 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.747 0.784 . . . . 0.0 112.007 -178.973 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 568' ' ' ILE . . . . . 0.643 ' CG1' HG23 ' A' ' 504' ' ' THR . 12.0 mm -57.26 9.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 114.321 -1.309 . . . . 0.0 113.321 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 569' ' ' ILE . . . . . 1.06 HG23 ' O ' ' A' ' 565' ' ' GLN . 0.9 OUTLIER -53.87 -39.03 38.23 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.845 0 N-CA-C 104.266 -2.494 . . . . 0.0 104.266 178.154 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 570' ' ' ASP . . . . . 0.916 ' CB ' HD11 ' A' ' 588' ' ' ILE . 32.5 m-20 35.45 50.0 0.53 Allowed 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 113.726 -1.579 . . . . 0.0 111.342 174.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -50.54 -44.13 46.03 Favored Glycine 0 N--CA 1.439 -1.101 0 C-N-CA 118.37 -1.871 . . . . 0.0 109.051 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 572' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -118.44 -18.09 9.24 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 120.252 -0.579 . . . . 0.0 112.16 175.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 573' ' ' LEU . . . . . 0.853 HD22 ' HG2' ' A' ' 535' ' ' ARG . 0.7 OUTLIER -141.2 137.68 32.8 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 574' ' ' LEU . . . . . 0.88 HD21 ' CG2' ' A' ' 508' ' ' VAL . 1.1 tp -133.98 131.94 39.54 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 174.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 575' ' ' ILE . . . . . 1.077 HG23 HD13 ' A' ' 585' ' ' LEU . 0.0 OUTLIER -134.64 137.19 51.58 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-N 118.557 0.617 . . . . 0.0 111.612 178.802 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 576' ' ' LEU . . . . . 0.547 HD22 ' CB ' ' A' ' 509' ' ' LEU . 0.0 OUTLIER -133.08 135.67 45.44 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 177.375 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 577' ' ' LYS . . . . . 0.44 ' HG2' ' HB2' ' A' ' 583' ' ' MET . 7.5 mttt -130.62 135.59 48.02 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.254 177.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.637 HD22 HG21 ' A' ' 524' ' ' ILE . 0.3 OUTLIER -124.88 132.01 53.36 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.871 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 579' ' ' GLY . . . . . . . . . . . . . . . -89.55 -2.19 76.6 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 115.229 -0.896 . . . . 0.0 113.251 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 580' ' ' LYS . . . . . 0.621 ' HG2' HG23 ' A' ' 524' ' ' ILE . 0.0 OUTLIER -72.56 -48.46 39.9 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 118.957 -1.097 . . . . 0.0 108.815 179.27 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 581' ' ' TRP . . . . . 0.491 ' CD1' ' O ' ' A' ' 580' ' ' LYS . 25.5 m0 -139.29 -53.02 0.55 Allowed 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 114.452 1.278 . . . . 0.0 114.452 177.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 582' ' ' LYS . . . . . 0.589 ' O ' HD12 ' A' ' 578' ' ' LEU . 0.1 OUTLIER -140.38 165.18 28.13 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -174.636 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 583' ' ' MET . . . . . 0.44 ' HB2' ' HG2' ' A' ' 577' ' ' LYS . 0.3 OUTLIER -113.97 134.78 54.62 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 174.156 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 584' ' ' LYS . . . . . 0.842 ' HD3' HG23 ' A' ' 586' ' ' VAL . 1.4 tmmt? -120.77 133.85 55.31 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 177.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 585' ' ' LEU . . . . . 1.077 HD13 HG23 ' A' ' 575' ' ' ILE . 1.4 tp -118.8 136.32 54.06 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 586' ' ' VAL . . . . . 0.848 ' N ' HD12 ' A' ' 585' ' ' LEU . 2.5 t -132.88 137.15 54.46 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -177.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 587' ' ' SER . . . . . 0.805 ' O ' HG23 ' A' ' 494' ' ' THR . 55.6 m -109.35 134.95 51.19 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 177.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.916 HD11 ' CB ' ' A' ' 570' ' ' ASP . 0.2 OUTLIER -134.6 152.63 33.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -178.649 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 4.6 t -122.6 138.82 51.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 114.031 -1.441 . . . . 0.0 110.781 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 590' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.327 -0.381 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.163 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 491' ' ' ALA . . . . . 0.402 ' CB ' HD21 ' A' ' 514' ' ' LEU . . . . . . . . 0 N--CA 1.465 0.284 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 492' ' ' ARG . . . . . 0.477 ' HD3' HD23 ' A' ' 585' ' ' LEU . 0.0 OUTLIER -134.32 133.12 40.34 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.726 177.366 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 493' ' ' VAL . . . . . 0.637 HG21 ' CA ' ' A' ' 513' ' ' GLY . 44.5 t -136.98 163.69 31.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . 0.587 ' N ' HG12 ' A' ' 493' ' ' VAL . 32.3 p -117.69 134.25 55.09 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 121.147 0.498 . . . . 0.0 110.127 177.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 495' ' ' LEU . . . . . 1.056 HD22 ' HB2' ' A' ' 512' ' ' ALA . 0.0 OUTLIER -135.22 164.4 44.08 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.377 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 496' ' ' PRO . . . . . 0.898 ' HD2' HD12 ' A' ' 495' ' ' LEU . 11.9 Cg_exo -69.63 119.39 6.35 Favored 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 122.065 1.844 . . . . 0.0 111.199 178.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 497' ' ' LYS . . . . . 0.503 ' HB2' ' N ' ' A' ' 589' ' ' VAL . 2.4 ttpt -57.43 -30.21 64.79 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -178.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 498' ' ' SER . . . . . 0.418 ' O ' ' CD1' ' A' ' 501' ' ' TYR . 0.3 OUTLIER -59.14 -48.7 80.66 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 114.414 1.264 . . . . 0.0 114.414 -176.757 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 499' ' ' LEU . . . . . 0.548 HD21 ' HD2' ' A' ' 496' ' ' PRO . 1.5 pp -74.2 -10.24 59.41 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -178.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . 0.715 HG21 HG21 ' A' ' 588' ' ' ILE . 20.8 t -76.54 -27.21 17.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.337 0.589 . . . . 0.0 111.88 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 501' ' ' TYR . . . . . 0.596 ' O ' HG21 ' A' ' 564' ' ' THR . 0.3 OUTLIER -54.09 -30.6 49.03 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -177.704 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 502' ' ' ASP . . . . . 0.432 ' N ' ' CD1' ' A' ' 501' ' ' TYR . 4.6 t0 -75.78 -51.3 12.94 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 -175.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 503' ' ' LYS . . . . . 0.62 ' HB3' ' HG2' ' A' ' 507' ' ' LYS . 0.0 OUTLIER -120.59 140.6 51.28 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 118.76 0.709 . . . . 0.0 110.572 178.936 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . 0.749 HG23 ' CG1' ' A' ' 568' ' ' ILE . 3.3 m -72.6 -74.4 0.17 Allowed 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -178.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . 0.743 ' CZ ' ' HB1' ' A' ' 530' ' ' ALA . 0.2 OUTLIER -73.3 -57.63 3.88 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -177.262 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 506' ' ' SER . . . . . 0.849 ' O ' ' CD1' ' A' ' 510' ' ' TRP . 10.1 t -48.8 -66.38 0.41 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -176.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 507' ' ' LYS . . . . . 0.62 ' HG2' ' HB3' ' A' ' 503' ' ' LYS . 0.0 OUTLIER -48.75 -56.13 9.51 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -176.849 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 508' ' ' VAL . . . . . 0.975 ' CG2' HD21 ' A' ' 574' ' ' LEU . 48.4 t -49.9 -61.14 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -179.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 509' ' ' LEU . . . . . 0.816 HD12 ' N ' ' A' ' 510' ' ' TRP . 2.5 pp -54.27 -63.07 1.27 Allowed 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 115.626 1.713 . . . . 0.0 115.626 -177.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 510' ' ' TRP . . . . . 0.873 ' CD1' ' HA ' ' A' ' 518' ' ' LYS . 66.3 p-90 -72.85 -51.39 18.95 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 -175.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 511' ' ' SER . . . . . 0.529 ' N ' ' CE3' ' A' ' 510' ' ' TRP . 0.3 OUTLIER -64.39 -47.19 80.18 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.299 -0.864 . . . . 0.0 113.305 -176.753 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 512' ' ' ALA . . . . . 1.056 ' HB2' HD22 ' A' ' 495' ' ' LEU . . . -70.92 -73.79 0.16 Allowed 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 118.158 2.651 . . . . 0.0 118.158 -173.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 513' ' ' GLY . . . . . 0.675 ' H ' ' HE2' ' A' ' 584' ' ' LYS . . . -115.48 -34.98 1.35 Allowed Glycine 0 CA--C 1.501 -0.825 0 N-CA-C 120.84 3.096 . . . . 0.0 120.84 -172.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 514' ' ' LEU . . . . . 0.619 ' HG ' ' HB2' ' A' ' 584' ' ' LYS . 0.1 OUTLIER -106.86 -46.53 3.93 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 119.473 3.138 . . . . 0.0 119.473 -169.887 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 515' ' ' VAL . . . . . 1.038 HG13 ' HB2' ' A' ' 517' ' ' SER . 2.5 p -154.4 172.29 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 N-CA-C 117.981 2.585 . . . . 0.0 117.981 -172.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 516' ' ' ALA . . . . . 0.546 ' N ' HG22 ' A' ' 515' ' ' VAL . . . -68.62 3.71 1.74 Allowed 'General case' 0 C--N 1.333 -0.109 0 C-N-CA 126.741 2.016 . . . . 0.0 110.012 177.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . 1.038 ' HB2' HG13 ' A' ' 515' ' ' VAL . 0.6 OUTLIER -57.84 9.1 0.01 OUTLIER 'General case' 0 N--CA 1.428 -1.526 0 N-CA-C 116.153 1.909 . . . . 0.0 116.153 -171.797 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 518' ' ' LYS . . . . . 0.873 ' HA ' ' CD1' ' A' ' 510' ' ' TRP . 0.1 OUTLIER -45.3 -46.93 13.04 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 104.277 -2.49 . . . . 0.0 104.277 175.423 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 519' ' ' SER . . . . . . . . . . . . . 58.0 p -75.1 -60.05 2.47 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 114.658 -1.156 . . . . 0.0 110.15 173.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 520' ' ' GLU . . . . . 0.806 ' HB3' ' HA ' ' A' ' 517' ' ' SER . 5.7 tp10 -57.81 -47.47 82.52 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.497 -179.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 521' ' ' GLY . . . . . 0.834 ' N ' ' O ' ' A' ' 517' ' ' SER . . . -49.29 -54.37 16.02 Favored Glycine 0 CA--C 1.493 -1.328 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.033 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . 0.444 ' HA ' HG12 ' A' ' 525' ' ' ILE . 0.9 OUTLIER -47.42 -47.33 26.72 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.465 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 523' ' ' ARG . . . . . 0.463 ' O ' ' HB2' ' A' ' 526' ' ' ASN . 2.2 ttt180 -50.4 -48.78 55.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.844 178.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 524' ' ' ILE . . . . . 0.576 HD13 ' CE ' ' A' ' 580' ' ' LYS . 23.1 mt -58.25 -55.2 23.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.412 0.625 . . . . 0.0 109.827 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 525' ' ' ILE . . . . . 0.882 HG23 HD11 ' A' ' 556' ' ' ILE . 0.3 OUTLIER -50.02 -47.58 23.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 177.761 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 526' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 523' ' ' ARG . 32.1 m-20 -56.17 -47.89 77.39 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 114.35 -1.295 . . . . 0.0 108.23 177.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 527' ' ' ASN . . . . . 0.47 ' ND2' ' O ' ' A' ' 524' ' ' ILE . 0.0 OUTLIER -47.9 -40.24 21.27 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 113.986 -1.461 . . . . 0.0 107.534 176.817 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 528' ' ' ASN . . . . . 0.663 ' HA ' HG23 ' A' ' 556' ' ' ILE . 1.7 t-20 73.44 40.28 0.53 Allowed 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.461 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 529' ' ' GLY . . . . . . . . . . . . . . . -116.33 31.68 5.9 Favored Glycine 0 CA--C 1.522 0.523 0 CA-C-N 114.994 -1.003 . . . . 0.0 112.436 178.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 530' ' ' ALA . . . . . 0.87 ' O ' ' HB ' ' A' ' 556' ' ' ILE . . . -133.44 164.42 27.17 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.532 0.682 . . . . 0.0 112.749 -179.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 531' ' ' TYR . . . . . 0.728 ' HA ' HG22 ' A' ' 554' ' ' THR . 0.0 OUTLIER -134.65 157.92 45.41 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.752 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 532' ' ' VAL . . . . . 0.674 HG23 ' CE1' ' A' ' 505' ' ' PHE . 0.5 OUTLIER -132.84 136.62 55.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-O 121.921 0.867 . . . . 0.0 112.133 179.886 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 533' ' ' GLY . . . . . 0.803 ' O ' HG13 ' A' ' 575' ' ' ILE . . . -128.64 148.63 18.07 Favored Glycine 0 N--CA 1.441 -1.01 0 CA-C-N 114.155 -1.384 . . . . 0.0 112.609 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 534' ' ' SER . . . . . 0.455 ' N ' ' HB ' ' A' ' 552' ' ' THR . 0.2 OUTLIER -134.73 146.88 49.84 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.528 -0.336 . . . . 0.0 110.617 179.62 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 535' ' ' ARG . . . . . 0.856 ' HB3' HD22 ' A' ' 573' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.233 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 178.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 . . . . . 0 N--CA 1.452 -0.359 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 550' ' ' ASP . . . . . 0.491 ' O ' ' HG2' ' A' ' 535' ' ' ARG . 0.1 OUTLIER -56.51 -37.84 70.99 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 121.764 0.793 . . . . 0.0 108.963 178.946 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 551' ' ' LEU . . . . . . . . . . . . . 14.6 tp -132.09 140.47 48.84 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.661 -1.154 . . . . 0.0 108.891 178.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 552' ' ' THR . . . . . 0.677 HG21 ' CG ' ' A' ' 567' ' ' PHE . 7.7 m -132.81 150.32 52.17 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.711 0.767 . . . . 0.0 111.728 179.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 553' ' ' PHE . . . . . 0.507 ' CD1' ' CE1' ' A' ' 531' ' ' TYR . 0.2 OUTLIER -132.92 138.54 46.99 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 114.442 -1.254 . . . . 0.0 108.166 178.135 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 554' ' ' THR . . . . . 0.929 HG23 ' H ' ' A' ' 556' ' ' ILE . 0.4 OUTLIER -131.3 140.78 39.58 Favored Pre-proline 0 C--N 1.312 -1.047 0 C-N-CA 120.304 -0.558 . . . . 0.0 111.173 -179.713 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 555' ' ' PRO . . . . . 0.843 ' O ' HG22 ' A' ' 556' ' ' ILE . 35.0 Cg_endo -91.15 7.7 3.43 Favored 'Trans proline' 0 N--CA 1.438 -1.785 0 C-N-CA 122.256 1.971 . . . . 0.0 110.338 178.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 556' ' ' ILE . . . . . 0.929 ' H ' HG23 ' A' ' 554' ' ' THR . 6.3 tp 62.4 33.21 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.302 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 177.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . 0.704 ' O ' ' CE2' ' A' ' 559' ' ' TRP . 0.0 OUTLIER -104.48 141.42 36.4 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 179.386 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 558' ' ' THR . . . . . . . . . . . . . 1.6 t -57.68 115.91 3.08 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 -172.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 559' ' ' TRP . . . . . 0.704 ' CE2' ' O ' ' A' ' 557' ' ' LYS . 0.0 OUTLIER -139.21 121.61 16.07 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 112.356 -2.202 . . . . 0.0 106.602 174.871 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 560' ' ' ASN . . . . . 0.619 ' O ' HG22 ' A' ' 564' ' ' THR . 81.2 m-20 -91.2 -76.8 0.43 Allowed 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 118.233 -1.387 . . . . 0.0 113.917 -177.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 561' ' ' ALA . . . . . 0.616 ' HA ' ' CG2' ' A' ' 564' ' ' THR . . . -75.53 -49.74 17.78 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 115.968 1.84 . . . . 0.0 115.968 -177.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 562' ' ' SER . . . . . 0.403 ' O ' ' HB2' ' A' ' 566' ' ' GLU . 9.9 t -48.8 -55.71 10.79 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -176.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 563' ' ' LYS . . . . . 0.569 ' HG3' ' CG ' ' A' ' 559' ' ' TRP . 0.1 OUTLIER -70.82 -47.97 56.61 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -178.307 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 564' ' ' THR . . . . . 0.834 HG23 ' H ' ' A' ' 565' ' ' GLN . 9.0 t -50.07 -72.0 0.06 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.81 0.338 . . . . 0.0 111.699 -179.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 565' ' ' GLN . . . . . 0.991 ' O ' HG23 ' A' ' 569' ' ' ILE . 1.1 tp60 -50.69 -46.66 58.91 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 566' ' ' GLU . . . . . 0.418 ' HG2' ' CD1' ' A' ' 567' ' ' PHE . 67.3 tt0 -49.17 -66.45 0.4 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.863 0.363 . . . . 0.0 111.696 -178.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 567' ' ' PHE . . . . . 0.677 ' CG ' HG21 ' A' ' 552' ' ' THR . 0.1 OUTLIER -97.39 -53.64 3.4 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.533 0.683 . . . . 0.0 111.701 -179.278 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 568' ' ' ILE . . . . . 0.848 HD12 ' CD1' ' A' ' 574' ' ' LEU . 14.9 mm -53.95 10.43 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.503 -0.841 0 CA-C-N 114.494 -1.23 . . . . 0.0 113.888 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 569' ' ' ILE . . . . . 0.991 HG23 ' O ' ' A' ' 565' ' ' GLN . 0.9 OUTLIER -55.73 -33.87 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 N-CA-C 103.815 -2.661 . . . . 0.0 103.815 177.7 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 570' ' ' ASP . . . . . 0.656 ' OD2' HD22 ' A' ' 574' ' ' LEU . 7.8 p30 34.56 42.82 0.08 Allowed 'General case' 0 CA--C 1.492 -1.264 0 CA-C-N 113.421 -1.718 . . . . 0.0 110.591 174.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 571' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' A' ' 570' ' ' ASP . . . -49.49 -43.46 35.93 Favored Glycine 0 N--CA 1.436 -1.342 0 N-CA-C 106.981 -2.448 . . . . 0.0 106.981 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 572' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -119.03 -17.99 8.88 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-O 118.937 -0.554 . . . . 0.0 112.298 174.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 573' ' ' LEU . . . . . 0.856 HD22 ' HB3' ' A' ' 535' ' ' ARG . 1.5 tp -142.21 136.55 30.0 Favored 'General case' 0 C--N 1.362 1.124 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 -178.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 574' ' ' LEU . . . . . 0.996 ' HB3' HD11 ' A' ' 588' ' ' ILE . 8.9 tp -136.22 133.84 37.49 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 114.339 -1.301 . . . . 0.0 107.613 173.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 575' ' ' ILE . . . . . 0.803 HG13 ' O ' ' A' ' 533' ' ' GLY . 0.0 OUTLIER -133.86 137.16 52.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 O-C-N 122.001 -0.437 . . . . 0.0 110.766 178.253 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 576' ' ' LEU . . . . . 0.614 HD22 ' HB3' ' A' ' 509' ' ' LEU . 0.1 OUTLIER -133.33 135.3 44.7 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 177.523 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 577' ' ' LYS . . . . . 0.403 ' N ' HD12 ' A' ' 576' ' ' LEU . 0.2 OUTLIER -132.99 135.24 45.36 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.194 -1.002 . . . . 0.0 109.979 177.026 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.574 ' HG ' HD11 ' A' ' 576' ' ' LEU . 0.4 OUTLIER -125.0 132.04 53.32 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.139 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 579' ' ' GLY . . . . . . . . . . . . . . . -89.81 -2.18 75.77 Favored Glycine 0 N--CA 1.442 -0.942 0 CA-C-N 115.294 -0.867 . . . . 0.0 113.173 -178.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 580' ' ' LYS . . . . . 0.576 ' CE ' HD13 ' A' ' 524' ' ' ILE . 0.0 OUTLIER -72.9 -48.1 40.17 Favored 'General case' 0 N--CA 1.441 -0.904 0 C-N-CA 119.17 -1.012 . . . . 0.0 108.908 179.256 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 581' ' ' TRP . . . . . 0.418 ' CD1' ' O ' ' A' ' 580' ' ' LYS . 13.6 m0 -139.64 -52.84 0.53 Allowed 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 177.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 582' ' ' LYS . . . . . 0.536 ' O ' HD12 ' A' ' 578' ' ' LEU . 3.1 ptpt -140.15 164.94 28.7 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 -175.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 583' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -113.7 134.68 54.6 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 174.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 584' ' ' LYS . . . . . 0.865 ' NZ ' HG12 ' A' ' 508' ' ' VAL . 0.5 OUTLIER -122.89 133.6 54.41 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 178.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 585' ' ' LEU . . . . . 0.727 ' HG ' HG23 ' A' ' 575' ' ' ILE . 9.8 tt -120.62 135.56 55.07 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 586' ' ' VAL . . . . . 0.747 HG12 ' CD1' ' A' ' 588' ' ' ILE . 55.2 t -134.04 144.15 36.3 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 112.991 0.738 . . . . 0.0 112.991 -177.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 587' ' ' SER . . . . . 0.873 ' C ' HD13 ' A' ' 588' ' ' ILE . 3.1 m -107.29 135.88 48.06 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 176.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.996 HD11 ' HB3' ' A' ' 574' ' ' LEU . 0.0 OUTLIER -132.77 136.93 55.0 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.47 0 CA-C-O 121.701 0.762 . . . . 0.0 112.785 -177.309 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 589' ' ' VAL . . . . . 0.503 ' N ' ' HB2' ' A' ' 497' ' ' LYS . 7.1 p -125.26 150.34 30.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 114.376 -1.284 . . . . 0.0 110.843 179.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 590' ' ' SER . . . . . . . . . . . . . 3.3 p . . . . . 0 C--N 1.326 -0.441 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.172 -179.491 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 491' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.165 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 492' ' ' ARG . . . . . 0.565 ' HA ' ' O ' ' A' ' 585' ' ' LEU . 0.0 OUTLIER -135.81 136.97 41.1 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.085 178.944 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 493' ' ' VAL . . . . . 0.836 HG23 ' NZ ' ' A' ' 584' ' ' LYS . 89.4 t -133.13 163.57 37.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.354 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . 0.581 ' N ' HG12 ' A' ' 493' ' ' VAL . 91.8 m -114.68 135.9 53.64 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.441 0.638 . . . . 0.0 111.74 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 495' ' ' LEU . . . . . 0.89 HD22 ' HB2' ' A' ' 512' ' ' ALA . 0.2 OUTLIER -134.27 164.66 42.37 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.086 179.869 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 496' ' ' PRO . . . . . 0.635 ' HD2' HD21 ' A' ' 499' ' ' LEU . 23.2 Cg_exo -63.68 119.56 6.66 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 121.982 1.788 . . . . 0.0 111.721 179.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 497' ' ' LYS . . . . . 0.896 ' O ' HG12 ' A' ' 500' ' ' VAL . 0.2 OUTLIER -53.07 -30.0 33.51 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -178.961 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 498' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -57.56 -48.66 78.75 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -177.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 499' ' ' LEU . . . . . 0.81 HD11 HD13 ' A' ' 495' ' ' LEU . 2.3 pp -74.37 -9.07 58.23 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -178.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . 0.896 HG12 ' O ' ' A' ' 497' ' ' LYS . 2.9 p -75.61 -26.43 18.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.352 0.596 . . . . 0.0 111.717 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 501' ' ' TYR . . . . . 0.665 ' O ' HG21 ' A' ' 564' ' ' THR . 0.3 OUTLIER -53.88 -29.69 42.7 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -178.71 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 502' ' ' ASP . . . . . 0.444 ' N ' ' CD1' ' A' ' 501' ' ' TYR . 0.4 OUTLIER -75.82 -49.92 16.63 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 -175.561 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 503' ' ' LYS . . . . . 0.631 ' O ' ' CG ' ' A' ' 507' ' ' LYS . 4.8 mttt -119.31 133.8 55.54 Favored 'General case' 0 CA--C 1.522 -0.113 0 CA-C-N 118.985 0.811 . . . . 0.0 112.094 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . 0.629 HG23 HD13 ' A' ' 568' ' ' ILE . 2.0 m -73.56 -75.12 0.16 Allowed 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.635 -0.711 . . . . 0.0 112.918 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . 0.986 ' CE1' HG23 ' A' ' 532' ' ' VAL . 7.3 m-85 -74.37 -62.9 1.36 Allowed 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -178.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 506' ' ' SER . . . . . 0.772 ' O ' ' CD1' ' A' ' 510' ' ' TRP . 7.6 t -49.28 -72.59 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -175.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 507' ' ' LYS . . . . . 0.679 ' HD3' ' N ' ' A' ' 508' ' ' VAL . 0.0 OUTLIER -48.99 -48.52 43.39 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -176.37 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 508' ' ' VAL . . . . . 0.881 ' CG2' HD21 ' A' ' 574' ' ' LEU . 89.1 t -52.89 -59.03 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -179.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 509' ' ' LEU . . . . . 0.856 ' O ' HD23 ' A' ' 514' ' ' LEU . 3.0 pp -60.42 -61.84 2.3 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 -176.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 510' ' ' TRP . . . . . 0.847 ' N ' HD12 ' A' ' 509' ' ' LEU . 65.1 p-90 -72.2 -49.74 33.06 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -176.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 511' ' ' SER . . . . . 0.497 ' N ' ' CD2' ' A' ' 510' ' ' TRP . 0.5 OUTLIER -64.95 -47.39 77.81 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.164 -0.926 . . . . 0.0 112.898 -177.089 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 512' ' ' ALA . . . . . 0.89 ' HB2' HD22 ' A' ' 495' ' ' LEU . . . -71.19 -73.97 0.16 Allowed 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 117.398 2.37 . . . . 0.0 117.398 -174.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 513' ' ' GLY . . . . . 0.46 ' CA ' ' HB ' ' A' ' 493' ' ' VAL . . . -115.95 -36.11 1.18 Allowed Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 121.73 3.452 . . . . 0.0 121.73 -172.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 514' ' ' LEU . . . . . 0.856 HD23 ' O ' ' A' ' 509' ' ' LEU . 0.5 OUTLIER -108.96 -39.11 5.4 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 120.431 3.493 . . . . 0.0 120.431 -169.646 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 515' ' ' VAL . . . . . 0.957 HG13 ' HB2' ' A' ' 517' ' ' SER . 13.7 p -153.18 172.12 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 118.053 2.612 . . . . 0.0 118.053 -171.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 516' ' ' ALA . . . . . 0.629 ' N ' HG22 ' A' ' 515' ' ' VAL . . . -69.07 2.64 2.59 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 112.559 -2.11 . . . . 0.0 110.753 177.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . 0.957 ' HB2' HG13 ' A' ' 515' ' ' VAL . 0.5 OUTLIER -57.68 8.5 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 -172.221 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 518' ' ' LYS . . . . . 0.738 ' HA ' ' CD1' ' A' ' 510' ' ' TRP . 0.0 OUTLIER -46.66 -51.78 15.17 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 104.369 -2.456 . . . . 0.0 104.369 174.989 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 519' ' ' SER . . . . . . . . . . . . . 3.5 m -75.35 -57.45 3.89 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.146 173.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 520' ' ' GLU . . . . . 0.626 ' CB ' ' HA ' ' A' ' 517' ' ' SER . 0.0 OUTLIER -55.91 -47.85 76.73 Favored 'General case' 0 C--N 1.349 0.578 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.71 -179.042 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 521' ' ' GLY . . . . . 0.809 ' HA2' HD12 ' A' ' 524' ' ' ILE . . . -49.55 -55.37 13.74 Favored Glycine 0 CA--C 1.491 -1.42 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.543 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -47.73 -47.45 30.19 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 523' ' ' ARG . . . . . . . . . . . . . 1.6 ttt85 -50.49 -49.03 56.55 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.0 178.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 524' ' ' ILE . . . . . 0.809 HD12 ' HA2' ' A' ' 521' ' ' GLY . 12.7 mt -59.36 -55.26 24.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.237 0.542 . . . . 0.0 110.253 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 525' ' ' ILE . . . . . 0.896 HG23 ' CD1' ' A' ' 556' ' ' ILE . 0.9 OUTLIER -50.26 -47.49 25.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 177.864 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 526' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -56.1 -48.58 75.87 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 114.112 -1.404 . . . . 0.0 108.276 177.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 527' ' ' ASN . . . . . 0.431 ' ND2' ' O ' ' A' ' 524' ' ' ILE . 0.0 OUTLIER -48.62 -39.76 25.2 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 113.754 -1.566 . . . . 0.0 107.778 176.639 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 528' ' ' ASN . . . . . 0.526 ' C ' HG21 ' A' ' 556' ' ' ILE . 12.6 t-20 74.07 40.3 0.46 Allowed 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.227 -179.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 529' ' ' GLY . . . . . . . . . . . . . . . -115.98 36.36 3.87 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 114.619 -1.173 . . . . 0.0 111.569 178.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 530' ' ' ALA . . . . . 0.764 ' O ' ' HB ' ' A' ' 556' ' ' ILE . . . -132.8 164.96 25.68 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.656 0.741 . . . . 0.0 112.363 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 531' ' ' TYR . . . . . 0.609 ' HE1' ' CD1' ' A' ' 553' ' ' PHE . 3.2 t80 -134.52 149.55 50.68 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 124.634 1.174 . . . . 0.0 108.871 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 532' ' ' VAL . . . . . 0.986 HG23 ' CE1' ' A' ' 505' ' ' PHE . 1.1 t -129.96 136.1 59.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 CA-C-N 119.485 1.039 . . . . 0.0 112.216 179.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 533' ' ' GLY . . . . . 0.768 ' O ' HG13 ' A' ' 575' ' ' ILE . . . -133.11 147.4 18.97 Favored Glycine 0 N--CA 1.441 -1.022 0 CA-C-N 114.0 -1.454 . . . . 0.0 112.961 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 534' ' ' SER . . . . . 0.609 ' HB2' ' OG1' ' A' ' 552' ' ' THR . 38.5 m -134.79 143.53 47.13 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.584 -0.308 . . . . 0.0 111.072 178.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 535' ' ' ARG . . . . . 0.57 ' HA ' ' O ' ' A' ' 550' ' ' ASP . 3.0 tpp180 . . . . . 0 C--N 1.33 -0.251 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 178.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 . . . . . 0 N--CA 1.448 -0.53 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 550' ' ' ASP . . . . . 0.57 ' O ' ' HA ' ' A' ' 535' ' ' ARG . 1.8 m-20 -70.82 -41.09 72.02 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.953 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 551' ' ' LEU . . . . . 0.769 HD11 ' CE1' ' A' ' 553' ' ' PHE . 7.2 tp -131.26 140.28 49.79 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.416 178.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 552' ' ' THR . . . . . 0.884 HG21 ' CG ' ' A' ' 567' ' ' PHE . 6.2 m -133.32 147.34 51.86 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.573 0.701 . . . . 0.0 111.987 179.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 553' ' ' PHE . . . . . 0.769 ' CE1' HD11 ' A' ' 551' ' ' LEU . 17.6 m-30 -132.86 136.22 46.09 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 177.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 554' ' ' THR . . . . . 0.647 ' OG1' HG12 ' A' ' 532' ' ' VAL . 19.2 m -135.04 139.68 32.71 Favored Pre-proline 0 C--N 1.314 -0.975 0 C-N-CA 118.851 -1.14 . . . . 0.0 113.245 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 555' ' ' PRO . . . . . 0.851 ' O ' HG22 ' A' ' 556' ' ' ILE . 5.8 Cg_exo -77.58 11.99 2.02 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.78 2.32 . . . . 0.0 112.789 179.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 556' ' ' ILE . . . . . 0.896 ' CD1' HG23 ' A' ' 525' ' ' ILE . 4.9 tp 62.37 34.42 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.335 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 177.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . 0.704 ' O ' ' CE2' ' A' ' 559' ' ' TRP . 33.3 mttt -103.37 133.23 48.77 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 558' ' ' THR . . . . . . . . . . . . . 3.4 t -58.05 116.5 3.56 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -172.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 559' ' ' TRP . . . . . 0.704 ' CE2' ' O ' ' A' ' 557' ' ' LYS . 0.0 OUTLIER -139.87 112.4 7.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 113.142 -1.844 . . . . 0.0 106.28 175.1 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 560' ' ' ASN . . . . . 0.649 ' O ' HG22 ' A' ' 564' ' ' THR . 86.0 m-20 -77.82 -75.96 0.2 Allowed 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 118.659 -1.216 . . . . 0.0 113.351 -176.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 561' ' ' ALA . . . . . 0.544 ' HA ' ' CG2' ' A' ' 564' ' ' THR . . . -75.14 -53.12 9.39 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 115.951 1.834 . . . . 0.0 115.951 -178.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 562' ' ' SER . . . . . . . . . . . . . 69.4 m -49.23 -54.95 14.23 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -176.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 563' ' ' LYS . . . . . 0.609 ' HB3' HG21 ' A' ' 504' ' ' THR . 0.2 OUTLIER -70.65 -47.91 57.61 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -178.188 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 564' ' ' THR . . . . . 0.788 HG23 ' H ' ' A' ' 565' ' ' GLN . 7.9 t -49.79 -68.02 0.21 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.847 0.356 . . . . 0.0 111.276 -179.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 565' ' ' GLN . . . . . 1.033 ' O ' HG23 ' A' ' 569' ' ' ILE . 2.4 tp60 -49.88 -47.0 52.16 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -49.42 -61.72 1.94 Allowed 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.861 -178.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 567' ' ' PHE . . . . . 0.884 ' CG ' HG21 ' A' ' 552' ' ' THR . 0.0 OUTLIER -97.15 -54.32 3.21 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.68 0.752 . . . . 0.0 111.875 -178.95 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 568' ' ' ILE . . . . . 0.853 HG13 HD13 ' A' ' 574' ' ' LEU . 1.7 mp -56.18 9.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 114.487 -1.233 . . . . 0.0 113.72 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 569' ' ' ILE . . . . . 1.033 HG23 ' O ' ' A' ' 565' ' ' GLN . 0.9 OUTLIER -54.56 -36.47 35.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 104.292 -2.484 . . . . 0.0 104.292 177.354 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 570' ' ' ASP . . . . . 0.487 ' OD2' HG13 ' A' ' 588' ' ' ILE . 7.7 p30 34.1 57.8 0.62 Allowed 'General case' 0 CA--C 1.502 -0.903 0 CA-C-N 113.716 -1.584 . . . . 0.0 112.04 174.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 571' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 570' ' ' ASP . . . -51.02 -45.22 51.11 Favored Glycine 0 N--CA 1.438 -1.172 0 C-N-CA 117.469 -2.301 . . . . 0.0 107.982 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 572' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -120.3 -16.74 8.4 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 175.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 573' ' ' LEU . . . . . 0.485 ' O ' ' CB ' ' A' ' 570' ' ' ASP . 2.2 tp -140.55 136.34 32.75 Favored 'General case' 0 C--N 1.355 0.823 0 N-CA-C 115.912 1.819 . . . . 0.0 115.912 -177.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 574' ' ' LEU . . . . . 0.901 HD12 ' N ' ' A' ' 575' ' ' ILE . 0.5 OUTLIER -135.94 132.73 36.81 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 173.422 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 575' ' ' ILE . . . . . 1.031 HG23 HD13 ' A' ' 585' ' ' LEU . 0.0 OUTLIER -134.3 139.98 46.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 118.858 0.754 . . . . 0.0 111.928 178.53 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 576' ' ' LEU . . . . . 0.683 HD11 HD21 ' A' ' 578' ' ' LEU . 0.0 OUTLIER -133.01 136.62 46.12 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 114.944 -1.025 . . . . 0.0 108.767 177.945 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 577' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.02 135.44 51.79 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 177.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.683 HD21 HD11 ' A' ' 576' ' ' LEU . 0.5 OUTLIER -126.94 132.02 50.95 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 177.973 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 579' ' ' GLY . . . . . . . . . . . . . . . -90.45 -2.26 73.53 Favored Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 115.092 -0.958 . . . . 0.0 113.493 -178.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 580' ' ' LYS . . . . . 0.473 ' O ' ' CD1' ' A' ' 581' ' ' TRP . 0.0 OUTLIER -70.84 -48.38 54.3 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 118.738 -1.185 . . . . 0.0 108.564 179.083 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 581' ' ' TRP . . . . . 0.473 ' CD1' ' O ' ' A' ' 580' ' ' LYS . 27.1 m0 -139.81 -53.37 0.53 Allowed 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 177.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 582' ' ' LYS . . . . . 0.424 ' O ' ' HB2' ' A' ' 578' ' ' LEU . 0.0 OUTLIER -140.5 165.44 27.43 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 -175.19 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 583' ' ' MET . . . . . . . . . . . . . 1.7 ttt -109.04 135.0 50.93 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 173.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 584' ' ' LYS . . . . . 0.836 ' NZ ' HG23 ' A' ' 493' ' ' VAL . 10.9 tppt? -120.34 133.38 55.46 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 178.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 585' ' ' LEU . . . . . 1.031 HD13 HG23 ' A' ' 575' ' ' ILE . 0.9 OUTLIER -116.03 136.12 53.32 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.839 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 586' ' ' VAL . . . . . 0.859 ' N ' HD12 ' A' ' 585' ' ' LEU . 85.8 t -132.94 137.49 53.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-O 121.053 0.454 . . . . 0.0 111.721 -178.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 587' ' ' SER . . . . . 0.879 ' C ' HD13 ' A' ' 588' ' ' ILE . 58.8 m -106.63 135.79 47.53 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 177.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.879 HD13 ' C ' ' A' ' 587' ' ' SER . 0.0 OUTLIER -133.41 136.75 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -177.581 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 589' ' ' VAL . . . . . 0.488 ' N ' ' HB2' ' A' ' 497' ' ' LYS . 5.6 m -132.6 137.14 54.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.635 178.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 590' ' ' SER . . . . . . . . . . . . . 10.7 t . . . . . 0 C--N 1.327 -0.396 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.984 -179.795 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 491' ' ' ALA . . . . . 0.506 ' HB1' ' HZ3' ' A' ' 584' ' ' LYS . . . . . . . . 0 C--O 1.232 0.149 0 N-CA-C 111.131 0.049 . . . . 0.0 111.131 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 492' ' ' ARG . . . . . 0.882 ' CD ' HD22 ' A' ' 585' ' ' LEU . 2.7 mmm180 -137.8 132.67 33.0 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.535 176.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 493' ' ' VAL . . . . . 0.985 ' CG2' HG22 ' A' ' 586' ' ' VAL . 16.9 m -138.25 163.78 28.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 178.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 79.6 p -116.94 132.56 56.67 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 176.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 495' ' ' LEU . . . . . 0.832 HD12 ' HD2' ' A' ' 496' ' ' PRO . 0.0 OUTLIER -137.1 164.5 41.68 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.23 -179.556 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 496' ' ' PRO . . . . . 0.832 ' HD2' HD12 ' A' ' 495' ' ' LEU . 2.8 Cg_exo -76.94 119.95 5.28 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.045 2.497 . . . . 0.0 110.947 178.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 497' ' ' LYS . . . . . 0.82 ' N ' HG22 ' A' ' 588' ' ' ILE . 15.6 tttm -53.24 -29.78 34.5 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -177.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 498' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.9 -49.12 78.73 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -177.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 499' ' ' LEU . . . . . 0.774 HD21 ' HD2' ' A' ' 496' ' ' PRO . 2.0 pp -74.38 -8.82 57.55 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -178.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . 0.75 HG22 HG12 ' A' ' 568' ' ' ILE . 0.9 OUTLIER -74.98 -25.66 18.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.455 0.645 . . . . 0.0 111.678 -179.029 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 501' ' ' TYR . . . . . 0.631 ' O ' ' CG2' ' A' ' 564' ' ' THR . 0.3 OUTLIER -57.26 -29.48 63.86 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 114.981 1.475 . . . . 0.0 114.981 -178.288 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -75.99 -50.16 15.63 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 116.306 1.965 . . . . 0.0 116.306 -174.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 503' ' ' LYS . . . . . 0.576 ' O ' ' CG ' ' A' ' 507' ' ' LYS . 3.3 mttm -119.1 137.88 53.27 Favored 'General case' 0 N--CA 1.46 0.066 0 CA-C-N 119.27 0.941 . . . . 0.0 112.204 -178.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . 0.819 HG23 ' CE1' ' A' ' 567' ' ' PHE . 24.8 m -73.52 -76.99 0.11 Allowed 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . 0.653 ' CZ ' ' HB1' ' A' ' 530' ' ' ALA . 0.2 OUTLIER -75.7 -61.12 2.03 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -179.164 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 506' ' ' SER . . . . . 0.668 ' O ' ' CD1' ' A' ' 510' ' ' TRP . 62.2 m -48.98 -72.75 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -175.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 507' ' ' LYS . . . . . 0.68 ' HD3' ' N ' ' A' ' 508' ' ' VAL . 0.0 OUTLIER -49.2 -48.22 45.51 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -176.673 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 508' ' ' VAL . . . . . 0.88 HG13 HD21 ' A' ' 574' ' ' LEU . 69.8 t -52.46 -59.2 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 509' ' ' LEU . . . . . 0.73 HD12 ' N ' ' A' ' 510' ' ' TRP . 1.9 pp -60.18 -60.89 3.1 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 -177.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 510' ' ' TRP . . . . . 0.73 ' N ' HD12 ' A' ' 509' ' ' LEU . 51.4 p-90 -72.26 -51.75 19.48 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -176.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 511' ' ' SER . . . . . 0.541 ' N ' ' CD2' ' A' ' 510' ' ' TRP . 0.4 OUTLIER -63.98 -47.99 78.18 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.884 -177.238 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 512' ' ' ALA . . . . . 0.759 ' HB3' ' O ' ' A' ' 508' ' ' VAL . . . -71.46 -73.66 0.17 Allowed 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 117.073 2.249 . . . . 0.0 117.073 -174.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 513' ' ' GLY . . . . . 0.816 ' CA ' HG21 ' A' ' 493' ' ' VAL . . . -115.84 -35.77 1.22 Allowed Glycine 0 CA--C 1.507 -0.468 0 N-CA-C 121.558 3.383 . . . . 0.0 121.558 -173.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 514' ' ' LEU . . . . . 0.661 ' HG ' ' HE2' ' A' ' 584' ' ' LYS . 0.0 OUTLIER -107.69 -45.45 4.02 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 119.898 3.296 . . . . 0.0 119.898 -169.195 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 515' ' ' VAL . . . . . 0.596 HG22 ' N ' ' A' ' 516' ' ' ALA . 9.9 p -145.1 172.3 4.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 117.927 2.566 . . . . 0.0 117.927 -171.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 516' ' ' ALA . . . . . 0.596 ' N ' HG22 ' A' ' 515' ' ' VAL . . . -89.87 0.53 56.99 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 113.25 -1.796 . . . . 0.0 108.663 178.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . 0.996 ' O ' ' N ' ' A' ' 521' ' ' GLY . 4.0 p -61.44 10.26 0.02 OUTLIER 'General case' 0 N--CA 1.426 -1.64 0 C-N-CA 126.171 1.788 . . . . 0.0 115.289 -173.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 518' ' ' LYS . . . . . 0.626 ' HB2' ' CE2' ' A' ' 510' ' ' TRP . 0.8 OUTLIER -42.73 -39.75 2.55 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 105.426 -2.064 . . . . 0.0 105.426 178.221 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 519' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.68 -54.25 8.54 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 114.891 -1.049 . . . . 0.0 108.217 172.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 520' ' ' GLU . . . . . 0.708 ' O ' HD12 ' A' ' 524' ' ' ILE . 0.2 OUTLIER -67.67 -48.07 67.68 Favored 'General case' 0 C--N 1.35 0.626 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.373 179.845 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 521' ' ' GLY . . . . . 0.996 ' N ' ' O ' ' A' ' 517' ' ' SER . . . -49.6 -52.81 23.35 Favored Glycine 0 CA--C 1.494 -1.248 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 178.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . 0.497 ' HA ' HG12 ' A' ' 525' ' ' ILE . 3.8 mm-40 -48.19 -47.48 35.31 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 523' ' ' ARG . . . . . 0.418 ' O ' ' HB3' ' A' ' 526' ' ' ASN . 0.0 OUTLIER -49.99 -49.16 51.45 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.736 178.855 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 524' ' ' ILE . . . . . 0.708 HD12 ' O ' ' A' ' 520' ' ' GLU . 4.3 mp -59.3 -51.79 68.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.466 0.651 . . . . 0.0 109.412 179.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 525' ' ' ILE . . . . . 0.937 HG23 ' CD1' ' A' ' 556' ' ' ILE . 1.2 mm -50.66 -47.42 28.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 177.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 526' ' ' ASN . . . . . 0.418 ' HB3' ' O ' ' A' ' 523' ' ' ARG . 1.0 OUTLIER -58.69 -47.93 82.83 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 114.253 -1.339 . . . . 0.0 108.321 177.51 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 527' ' ' ASN . . . . . 0.454 ' HB3' ' HA ' ' A' ' 524' ' ' ILE . 0.0 OUTLIER -48.09 -39.57 20.68 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 113.994 -1.457 . . . . 0.0 107.477 176.604 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 528' ' ' ASN . . . . . 0.629 ' HA ' ' CG2' ' A' ' 556' ' ' ILE . 13.2 t-20 74.2 40.98 0.41 Allowed 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.867 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 529' ' ' GLY . . . . . . . . . . . . . . . -113.96 29.3 7.83 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-N 115.118 -0.946 . . . . 0.0 112.516 178.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 530' ' ' ALA . . . . . 0.927 ' O ' ' HB ' ' A' ' 556' ' ' ILE . . . -133.53 164.27 27.53 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.216 0.532 . . . . 0.0 112.423 -179.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 531' ' ' TYR . . . . . 0.516 ' CE1' ' CD1' ' A' ' 553' ' ' PHE . 0.0 OUTLIER -134.59 152.53 51.84 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 177.601 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 532' ' ' VAL . . . . . 0.663 HG12 ' OG1' ' A' ' 554' ' ' THR . 0.5 OUTLIER -129.2 135.8 61.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 CA-C-O 122.003 0.906 . . . . 0.0 112.121 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 533' ' ' GLY . . . . . 0.65 ' O ' HG13 ' A' ' 575' ' ' ILE . . . -133.74 161.71 24.33 Favored Glycine 0 N--CA 1.441 -1.016 0 CA-C-N 114.32 -1.309 . . . . 0.0 114.48 -179.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 534' ' ' SER . . . . . 0.47 ' N ' ' HB ' ' A' ' 552' ' ' THR . 5.3 t -134.05 141.89 47.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.834 -0.683 . . . . 0.0 110.626 178.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 535' ' ' ARG . . . . . 0.734 ' HB3' HD22 ' A' ' 573' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.358 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 178.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 549' ' ' ASP . . . . . 0.534 ' HB3' HD11 ' A' ' 569' ' ' ILE . 16.7 m-20 . . . . . 0 N--CA 1.451 -0.407 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 550' ' ' ASP . . . . . 0.545 ' O ' ' HA ' ' A' ' 535' ' ' ARG . 3.9 p30 -50.89 -36.47 38.22 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.722 0.773 . . . . 0.0 108.995 178.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 551' ' ' LEU . . . . . . . . . . . . . 13.6 tp -131.39 139.22 49.41 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.524 -1.216 . . . . 0.0 107.881 177.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 552' ' ' THR . . . . . 0.883 HG21 ' CB ' ' A' ' 567' ' ' PHE . 6.9 m -133.76 148.07 51.35 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.683 0.754 . . . . 0.0 111.842 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 553' ' ' PHE . . . . . 0.516 ' CD1' ' CE1' ' A' ' 531' ' ' TYR . 9.9 m-85 -134.09 137.91 44.93 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.788 -1.097 . . . . 0.0 108.402 177.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 554' ' ' THR . . . . . 0.901 HG22 ' H ' ' A' ' 556' ' ' ILE . 2.0 m -132.23 138.57 32.57 Favored Pre-proline 0 C--N 1.307 -1.278 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 178.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 555' ' ' PRO . . . . . 0.837 ' O ' HG22 ' A' ' 556' ' ' ILE . 67.6 Cg_endo -84.54 19.21 1.42 Allowed 'Trans proline' 0 N--CA 1.446 -1.311 0 C-N-CA 121.664 1.576 . . . . 0.0 111.918 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 556' ' ' ILE . . . . . 0.937 ' CD1' HG23 ' A' ' 525' ' ' ILE . 3.8 tp 61.21 31.77 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 177.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.85 119.84 39.97 Favored 'General case' 0 CA--C 1.501 -0.925 0 N-CA-C 104.36 -2.459 . . . . 0.0 104.36 178.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 558' ' ' THR . . . . . . . . . . . . . 3.3 t -56.76 116.98 3.48 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-O 122.576 1.179 . . . . 0.0 114.084 -171.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 559' ' ' TRP . . . . . 0.447 ' HB2' ' CB ' ' A' ' 563' ' ' LYS . 5.3 m0 -137.05 111.49 8.57 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 104.521 -2.4 . . . . 0.0 104.521 175.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 560' ' ' ASN . . . . . 0.603 ' O ' HG22 ' A' ' 564' ' ' THR . 84.4 m-20 -77.15 -75.59 0.2 Allowed 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -174.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 561' ' ' ALA . . . . . 0.551 ' HA ' HG22 ' A' ' 564' ' ' THR . . . -74.19 -57.27 4.06 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 116.055 1.872 . . . . 0.0 116.055 -177.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 562' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -49.59 -53.59 23.03 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -177.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 563' ' ' LYS . . . . . 0.648 ' CG ' HG21 ' A' ' 504' ' ' THR . 0.0 OUTLIER -69.38 -49.03 59.17 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.489 -178.439 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 564' ' ' THR . . . . . 0.649 HG23 ' H ' ' A' ' 565' ' ' GLN . 13.8 t -51.07 -65.22 0.59 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.567 0.222 . . . . 0.0 111.451 -178.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 565' ' ' GLN . . . . . 0.649 ' H ' HG23 ' A' ' 564' ' ' THR . 8.4 tp60 -48.95 -47.05 44.18 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.848 0.356 . . . . 0.0 111.053 179.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -49.5 -55.65 12.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 0.0 112.21 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 567' ' ' PHE . . . . . 0.914 ' CZ ' HD13 ' A' ' 568' ' ' ILE . 0.6 OUTLIER -96.89 -42.63 7.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.347 0.594 . . . . 0.0 112.46 -178.296 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 568' ' ' ILE . . . . . 0.923 HD11 HD22 ' A' ' 574' ' ' LEU . 1.2 tp -61.2 9.06 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 N-CA-C 113.939 1.088 . . . . 0.0 113.939 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 569' ' ' ILE . . . . . 0.6 HG23 ' O ' ' A' ' 565' ' ' GLN . 0.7 OUTLIER -54.46 -40.25 48.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 N-CA-C 104.005 -2.591 . . . . 0.0 104.005 178.295 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 570' ' ' ASP . . . . . 0.954 ' CG ' HD13 ' A' ' 588' ' ' ILE . 17.2 p30 32.13 56.84 0.36 Allowed 'General case' 0 CA--C 1.509 -0.599 0 CA-C-N 113.738 -1.574 . . . . 0.0 113.527 172.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 571' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 570' ' ' ASP . . . -51.3 -44.79 52.64 Favored Glycine 0 N--CA 1.44 -1.035 0 C-N-CA 116.819 -2.61 . . . . 0.0 108.575 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 572' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -120.29 -15.89 8.55 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 175.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 573' ' ' LEU . . . . . 0.734 HD22 ' HB3' ' A' ' 535' ' ' ARG . 1.1 tp -139.75 139.9 36.6 Favored 'General case' 0 C--N 1.353 0.746 0 N-CA-C 116.913 2.19 . . . . 0.0 116.913 -176.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 574' ' ' LEU . . . . . 0.977 ' HB3' HD11 ' A' ' 588' ' ' ILE . 0.3 OUTLIER -135.07 133.6 39.49 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 172.642 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 575' ' ' ILE . . . . . 0.895 ' N ' HD12 ' A' ' 574' ' ' LEU . 0.0 OUTLIER -134.12 137.24 52.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 118.623 0.647 . . . . 0.0 111.596 178.812 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 576' ' ' LEU . . . . . 0.594 HD22 ' HB3' ' A' ' 509' ' ' LEU . 0.0 OUTLIER -133.15 135.41 45.14 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 177.361 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 577' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -131.45 134.8 46.57 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 119.089 -1.045 . . . . 0.0 110.036 177.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.45 ' CG ' HD11 ' A' ' 576' ' ' LEU . 0.3 OUTLIER -122.46 132.2 54.23 Favored 'General case' 0 C--O 1.243 0.732 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.076 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 579' ' ' GLY . . . . . . . . . . . . . . . -88.18 -2.0 80.96 Favored Glycine 0 N--CA 1.44 -1.047 0 CA-C-N 114.901 -1.045 . . . . 0.0 113.411 -178.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 580' ' ' LYS . . . . . 0.591 ' CD ' ' CE2' ' A' ' 581' ' ' TRP . 0.0 OUTLIER -71.22 -49.65 41.16 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 118.656 -1.217 . . . . 0.0 108.441 179.279 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 581' ' ' TRP . . . . . 0.591 ' CE2' ' CD ' ' A' ' 580' ' ' LYS . 0.7 OUTLIER -140.92 -51.32 0.45 Allowed 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 175.823 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 582' ' ' LYS . . . . . 0.567 ' HE2' ' CD1' ' A' ' 581' ' ' TRP . 0.0 OUTLIER -139.76 165.29 27.69 Favored 'General case' 0 CA--C 1.512 -0.511 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -175.079 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 583' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.13 135.08 51.49 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 175.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 584' ' ' LYS . . . . . 0.661 ' HE2' ' HG ' ' A' ' 514' ' ' LEU . 9.1 tppt? -116.44 133.67 55.75 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 585' ' ' LEU . . . . . 0.882 HD22 ' CD ' ' A' ' 492' ' ' ARG . 7.7 tt -120.88 137.07 54.76 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -179.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 586' ' ' VAL . . . . . 0.985 HG22 ' CG2' ' A' ' 493' ' ' VAL . 55.9 t -131.95 137.01 55.78 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.777 -178.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 587' ' ' SER . . . . . . . . . . . . . 1.4 m -107.31 134.63 50.1 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 177.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.977 HD11 ' HB3' ' A' ' 574' ' ' LEU . 0.0 OUTLIER -135.98 136.4 49.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -177.754 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 6.1 m -133.58 136.81 53.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.943 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 590' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.565 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 491' ' ' ALA . . . . . 0.422 ' CB ' ' NZ ' ' A' ' 584' ' ' LYS . . . . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.62 0.248 . . . . 0.0 110.63 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 492' ' ' ARG . . . . . 0.46 ' HD3' ' HG ' ' A' ' 585' ' ' LEU . 0.0 OUTLIER -136.39 134.93 38.32 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 179.434 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 493' ' ' VAL . . . . . 0.585 ' HB ' ' CA ' ' A' ' 513' ' ' GLY . 75.2 t -135.2 163.48 35.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.68 177.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . 0.579 ' N ' HG12 ' A' ' 493' ' ' VAL . 18.5 m -123.85 135.3 53.66 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.153 0.502 . . . . 0.0 111.201 178.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 495' ' ' LEU . . . . . 0.804 ' O ' HG22 ' A' ' 588' ' ' ILE . 0.0 OUTLIER -134.46 163.7 49.31 Favored Pre-proline 0 CA--C 1.531 0.239 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.298 179.546 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 496' ' ' PRO . . . . . 0.569 ' HB2' HD12 ' A' ' 499' ' ' LEU . 32.5 Cg_exo -57.45 120.06 7.72 Favored 'Trans proline' 0 CA--C 1.532 0.393 0 C-N-CA 122.225 1.95 . . . . 0.0 112.358 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 497' ' ' LYS . . . . . 0.54 ' CA ' ' HB ' ' A' ' 588' ' ' ILE . 0.9 OUTLIER -56.9 -30.31 63.81 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.663 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 498' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.79 -48.34 66.94 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 499' ' ' LEU . . . . . 0.612 ' O ' ' HE3' ' A' ' 507' ' ' LYS . 0.3 OUTLIER -73.45 -8.85 57.61 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.605 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . 0.833 HG22 ' CG2' ' A' ' 568' ' ' ILE . 0.3 OUTLIER -60.06 -24.98 31.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.362 0.601 . . . . 0.0 111.113 -179.836 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 501' ' ' TYR . . . . . 0.56 ' O ' ' CG2' ' A' ' 564' ' ' THR . 0.1 OUTLIER -71.24 -29.9 65.68 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 115.027 1.492 . . . . 0.0 115.027 -177.598 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 502' ' ' ASP . . . . . 0.402 ' OD1' ' CZ ' ' A' ' 501' ' ' TYR . 11.3 m-20 -75.2 -51.22 13.88 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 116.057 1.873 . . . . 0.0 116.057 -174.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 503' ' ' LYS . . . . . 0.627 ' O ' ' CG ' ' A' ' 507' ' ' LYS . 7.4 mttt -120.73 134.48 55.28 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-N 119.346 0.976 . . . . 0.0 111.576 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . 0.689 HG23 HD13 ' A' ' 568' ' ' ILE . 4.2 m -72.91 -76.25 0.12 Allowed 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . 0.54 ' CD1' HG13 ' A' ' 525' ' ' ILE . 12.6 p90 -75.26 -59.12 2.88 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 506' ' ' SER . . . . . 0.783 ' O ' ' CD1' ' A' ' 510' ' ' TRP . 5.2 t -49.39 -72.28 0.05 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 -175.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 507' ' ' LYS . . . . . 0.732 ' HD3' ' N ' ' A' ' 508' ' ' VAL . 0.0 OUTLIER -48.96 -49.12 42.06 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -176.231 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 508' ' ' VAL . . . . . 0.931 ' CG2' HD21 ' A' ' 574' ' ' LEU . 51.5 t -53.33 -60.02 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -179.085 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 509' ' ' LEU . . . . . 0.776 HD12 ' N ' ' A' ' 510' ' ' TRP . 2.6 pp -60.59 -62.69 1.68 Allowed 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 -177.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 510' ' ' TRP . . . . . 0.783 ' CD1' ' O ' ' A' ' 506' ' ' SER . 63.9 p-90 -72.86 -53.63 10.92 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 114.66 1.355 . . . . 0.0 114.66 -176.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 511' ' ' SER . . . . . 0.517 ' N ' ' CE3' ' A' ' 510' ' ' TRP . 1.7 t -65.48 -47.92 74.4 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.89 -177.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 512' ' ' ALA . . . . . 0.916 ' HB3' ' O ' ' A' ' 508' ' ' VAL . . . -71.64 -72.46 0.22 Allowed 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 117.184 2.291 . . . . 0.0 117.184 -174.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 513' ' ' GLY . . . . . 0.631 ' HA3' ' HE3' ' A' ' 584' ' ' LYS . . . -114.57 -34.88 1.49 Allowed Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 121.369 3.308 . . . . 0.0 121.369 -172.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 514' ' ' LEU . . . . . 0.585 ' HG ' ' HE2' ' A' ' 584' ' ' LYS . 1.7 mt -107.12 -46.49 3.89 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 119.579 3.178 . . . . 0.0 119.579 -170.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 515' ' ' VAL . . . . . 1.089 HG13 ' HB2' ' A' ' 517' ' ' SER . 4.7 p -154.28 173.16 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 117.617 2.451 . . . . 0.0 117.617 -171.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 516' ' ' ALA . . . . . 0.59 ' N ' HG22 ' A' ' 515' ' ' VAL . . . -67.84 3.83 1.36 Allowed 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 126.515 1.926 . . . . 0.0 110.078 177.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . 1.089 ' HB2' HG13 ' A' ' 515' ' ' VAL . 0.4 OUTLIER -57.8 9.11 0.01 OUTLIER 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 115.979 1.844 . . . . 0.0 115.979 -172.213 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 518' ' ' LYS . . . . . 0.781 ' HA ' ' CD1' ' A' ' 510' ' ' TRP . 0.0 OUTLIER -45.56 -49.78 13.63 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 104.248 -2.501 . . . . 0.0 104.248 175.304 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 519' ' ' SER . . . . . . . . . . . . . 11.3 p -75.15 -56.93 4.23 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.2 173.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 520' ' ' GLU . . . . . 0.851 ' HB2' ' HA ' ' A' ' 517' ' ' SER . 0.8 OUTLIER -58.1 -47.41 83.31 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.023 -178.892 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 521' ' ' GLY . . . . . 0.805 ' N ' ' O ' ' A' ' 517' ' ' SER . . . -49.18 -55.99 11.3 Favored Glycine 0 CA--C 1.492 -1.39 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.273 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -47.74 -47.42 30.31 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 178.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 523' ' ' ARG . . . . . 0.449 ' O ' ' HB3' ' A' ' 526' ' ' ASN . 0.1 OUTLIER -50.36 -48.9 55.49 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.786 178.534 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 524' ' ' ILE . . . . . 0.722 HD13 ' HE3' ' A' ' 580' ' ' LYS . 1.7 mt -57.33 -55.77 18.95 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 CA-C-O 121.571 0.7 . . . . 0.0 109.613 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 525' ' ' ILE . . . . . 0.595 HG12 ' O ' ' A' ' 521' ' ' GLY . 0.8 OUTLIER -50.15 -47.4 24.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.163 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 526' ' ' ASN . . . . . 0.449 ' HB3' ' O ' ' A' ' 523' ' ' ARG . 1.1 t30 -56.84 -48.02 79.0 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-N 114.36 -1.291 . . . . 0.0 108.314 177.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 527' ' ' ASN . . . . . 0.453 ' ND2' ' O ' ' A' ' 524' ' ' ILE . 0.0 OUTLIER -48.04 -40.09 21.86 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.087 -1.415 . . . . 0.0 107.49 176.658 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 528' ' ' ASN . . . . . 1.036 ' HA ' HG21 ' A' ' 556' ' ' ILE . 1.8 t30 73.61 39.92 0.53 Allowed 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 114.638 -1.164 . . . . 0.0 111.529 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 529' ' ' GLY . . . . . . . . . . . . . . . -113.78 21.97 15.42 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 114.507 -1.224 . . . . 0.0 111.69 178.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 530' ' ' ALA . . . . . 0.795 ' O ' ' HB ' ' A' ' 556' ' ' ILE . . . -133.67 163.07 30.26 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.252 0.548 . . . . 0.0 112.231 -179.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 531' ' ' TYR . . . . . 0.558 ' HA ' ' O ' ' A' ' 554' ' ' THR . 0.0 OUTLIER -133.92 162.69 31.35 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 177.49 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 532' ' ' VAL . . . . . 0.553 HG12 ' OG1' ' A' ' 554' ' ' THR . 0.9 OUTLIER -131.37 135.48 59.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 CA-C-O 122.148 0.975 . . . . 0.0 111.862 179.772 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 533' ' ' GLY . . . . . 0.654 ' HA2' ' HB ' ' A' ' 552' ' ' THR . . . -133.66 153.88 21.05 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 114.189 -1.369 . . . . 0.0 113.966 -179.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 534' ' ' SER . . . . . 0.573 ' HB2' ' OG1' ' A' ' 552' ' ' THR . 19.1 m -134.31 136.39 43.45 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.389 -0.405 . . . . 0.0 111.437 178.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 535' ' ' ARG . . . . . 0.705 ' CG ' HD11 ' A' ' 575' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.411 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 178.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 . . . . . 0 N--CA 1.448 -0.557 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 550' ' ' ASP . . . . . 0.614 ' O ' ' HA ' ' A' ' 535' ' ' ARG . 0.7 OUTLIER -56.04 -41.3 74.79 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.548 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 551' ' ' LEU . . . . . 0.536 ' HA ' ' HD2' ' A' ' 535' ' ' ARG . 7.6 tp -131.47 140.09 49.49 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.72 177.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 552' ' ' THR . . . . . 0.962 HG21 ' CG ' ' A' ' 567' ' ' PHE . 0.3 OUTLIER -133.71 149.46 51.5 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 122.118 0.961 . . . . 0.0 112.73 179.078 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 553' ' ' PHE . . . . . 0.532 ' HA ' ' CE2' ' A' ' 531' ' ' TYR . 3.4 m-85 -134.12 137.37 44.5 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 106.29 -1.745 . . . . 0.0 106.29 176.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 554' ' ' THR . . . . . 0.558 ' O ' ' HA ' ' A' ' 531' ' ' TYR . 1.8 m -132.53 138.38 31.96 Favored Pre-proline 0 C--N 1.304 -1.388 0 C-N-CA 119.197 -1.001 . . . . 0.0 110.582 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 555' ' ' PRO . . . . . 0.817 ' O ' HG22 ' A' ' 556' ' ' ILE . 65.3 Cg_endo -84.28 14.27 2.48 Favored 'Trans proline' 0 N--CA 1.439 -1.717 0 C-N-CA 121.647 1.564 . . . . 0.0 111.14 179.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 556' ' ' ILE . . . . . 1.036 HG21 ' HA ' ' A' ' 528' ' ' ASN . 1.2 tp 69.73 33.63 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 N-CA-C 115.065 1.506 . . . . 0.0 115.065 176.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . 0.61 ' O ' ' CE2' ' A' ' 559' ' ' TRP . 0.0 OUTLIER -103.87 148.46 26.12 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -179.289 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 558' ' ' THR . . . . . 0.492 ' HA ' ' CE2' ' A' ' 505' ' ' PHE . 3.7 t -69.96 115.9 9.71 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 -172.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 559' ' ' TRP . . . . . 0.61 ' CE2' ' O ' ' A' ' 557' ' ' LYS . 0.0 OUTLIER -141.24 123.07 15.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 112.642 -2.072 . . . . 0.0 105.599 174.184 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 560' ' ' ASN . . . . . 0.565 ' O ' HG22 ' A' ' 564' ' ' THR . 60.3 m-20 -90.54 -77.01 0.42 Allowed 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 117.627 -1.629 . . . . 0.0 113.129 -177.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 561' ' ' ALA . . . . . 0.524 ' HA ' HG22 ' A' ' 564' ' ' THR . . . -76.22 -50.44 14.45 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 115.502 1.667 . . . . 0.0 115.502 -179.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 562' ' ' SER . . . . . . . . . . . . . 5.1 t -49.37 -56.68 8.78 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -176.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 563' ' ' LYS . . . . . 0.5 ' HG3' ' CZ ' ' A' ' 567' ' ' PHE . 0.0 OUTLIER -69.17 -48.51 62.02 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -178.307 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 564' ' ' THR . . . . . 0.719 HG23 ' H ' ' A' ' 565' ' ' GLN . 10.6 t -50.22 -68.32 0.18 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.801 0.334 . . . . 0.0 111.842 -179.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 565' ' ' GLN . . . . . 0.984 ' O ' HG23 ' A' ' 569' ' ' ILE . 3.8 tp60 -50.02 -47.17 53.27 Favored 'General case' 0 C--N 1.319 -0.721 0 O-C-N 122.173 -0.33 . . . . 0.0 111.635 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 566' ' ' GLU . . . . . 0.405 ' HG2' ' CD1' ' A' ' 567' ' ' PHE . 27.9 tt0 -49.54 -62.64 1.44 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -178.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 567' ' ' PHE . . . . . 0.962 ' CG ' HG21 ' A' ' 552' ' ' THR . 0.0 OUTLIER -97.27 -50.64 4.48 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.449 0.642 . . . . 0.0 112.132 -178.53 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 568' ' ' ILE . . . . . 0.833 ' CG2' HG22 ' A' ' 500' ' ' VAL . 1.7 mp -58.1 10.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 114.805 -1.089 . . . . 0.0 113.266 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 569' ' ' ILE . . . . . 0.984 HG23 ' O ' ' A' ' 565' ' ' GLN . 1.2 pt -52.8 -38.32 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 N-CA-C 104.253 -2.499 . . . . 0.0 104.253 178.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 570' ' ' ASP . . . . . 0.951 ' CB ' HD11 ' A' ' 588' ' ' ILE . 30.2 m-20 34.55 52.62 0.56 Allowed 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 113.701 -1.59 . . . . 0.0 112.149 173.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -51.48 -44.56 53.43 Favored Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 118.226 -1.94 . . . . 0.0 109.084 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 572' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -118.97 -17.33 9.07 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 176.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 573' ' ' LEU . . . . . 0.608 ' HB3' ' O ' ' A' ' 535' ' ' ARG . 1.1 tp -140.12 137.08 34.19 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -178.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 574' ' ' LEU . . . . . 0.931 HD21 ' CG2' ' A' ' 508' ' ' VAL . 0.3 OUTLIER -134.46 132.92 39.86 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 174.244 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 575' ' ' ILE . . . . . 1.094 HG23 HD13 ' A' ' 585' ' ' LEU . 0.0 OUTLIER -134.05 137.17 52.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 118.914 0.779 . . . . 0.0 112.074 179.125 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 576' ' ' LEU . . . . . 0.585 HD22 ' HB3' ' A' ' 509' ' ' LEU . 0.0 OUTLIER -133.58 135.59 44.37 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 176.948 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 577' ' ' LYS . . . . . 0.42 ' HD2' ' CE1' ' A' ' 531' ' ' TYR . 0.0 OUTLIER -132.8 135.34 45.62 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 118.906 -1.117 . . . . 0.0 110.548 177.99 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.604 HD12 ' O ' ' A' ' 582' ' ' LYS . 0.3 OUTLIER -123.63 131.72 53.68 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 177.834 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 579' ' ' GLY . . . . . . . . . . . . . . . -91.21 -2.38 71.07 Favored Glycine 0 CA--C 1.5 -0.857 0 CA-C-N 115.404 -0.816 . . . . 0.0 114.447 -177.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 580' ' ' LYS . . . . . 0.722 ' HE3' HD13 ' A' ' 524' ' ' ILE . 0.4 OUTLIER -75.32 -46.47 33.13 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 118.777 -1.169 . . . . 0.0 109.153 179.111 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 581' ' ' TRP . . . . . 0.444 ' H ' ' HG3' ' A' ' 580' ' ' LYS . 0.1 OUTLIER -138.74 -51.65 0.56 Allowed 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 177.911 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 582' ' ' LYS . . . . . 0.604 ' O ' HD12 ' A' ' 578' ' ' LEU . 1.1 ptpm? -139.56 165.0 28.4 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -175.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 583' ' ' MET . . . . . . . . . . . . . 2.3 ttt -118.85 134.81 54.91 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 174.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 584' ' ' LYS . . . . . 0.631 ' HE3' ' HA3' ' A' ' 513' ' ' GLY . 0.0 OUTLIER -121.71 133.05 54.94 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.023 -0.989 . . . . 0.0 108.335 179.53 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 585' ' ' LEU . . . . . 1.094 HD13 HG23 ' A' ' 575' ' ' ILE . 2.9 tp -119.46 136.68 54.21 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 179.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 586' ' ' VAL . . . . . 0.589 HG23 ' HD2' ' A' ' 584' ' ' LYS . 11.5 t -131.95 137.08 55.63 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.696 -178.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 587' ' ' SER . . . . . 0.564 ' O ' HG23 ' A' ' 494' ' ' THR . 7.6 m -110.24 135.79 50.44 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 177.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.951 HD11 ' CB ' ' A' ' 570' ' ' ASP . 0.2 OUTLIER -133.81 144.64 35.15 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.607 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -178.606 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 5.3 m -132.87 137.26 54.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 114.204 -1.362 . . . . 0.0 110.742 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 590' ' ' SER . . . . . . . . . . . . . 2.5 t . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.624 -179.956 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 491' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.07 0 N-CA-C 111.606 0.224 . . . . 0.0 111.606 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 492' ' ' ARG . . . . . 0.655 ' HD3' HD22 ' A' ' 585' ' ' LEU . 0.0 OUTLIER -136.05 132.02 35.65 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.583 0.23 . . . . 0.0 110.807 177.49 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 493' ' ' VAL . . . . . 0.764 HG21 ' CA ' ' A' ' 513' ' ' GLY . 39.5 t -138.0 163.11 30.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.492 177.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . 0.5 ' N ' ' CG1' ' A' ' 493' ' ' VAL . 41.9 p -127.19 133.87 50.22 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 120.399 -0.521 . . . . 0.0 110.344 176.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 495' ' ' LEU . . . . . 1.045 ' O ' HG22 ' A' ' 588' ' ' ILE . 0.3 OUTLIER -135.89 164.57 42.26 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.558 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 496' ' ' PRO . . . . . 0.684 ' HD2' HD21 ' A' ' 499' ' ' LEU . 24.3 Cg_exo -61.72 119.31 6.37 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 121.676 1.584 . . . . 0.0 111.185 178.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 497' ' ' LYS . . . . . 0.494 ' CA ' ' HB ' ' A' ' 588' ' ' ILE . 15.0 ttmt -52.33 -30.23 27.45 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -178.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 498' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.3 -48.11 81.55 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -177.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 499' ' ' LEU . . . . . 0.872 HD11 HD13 ' A' ' 495' ' ' LEU . 2.2 pp -73.53 -8.16 54.79 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -178.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . 0.654 HG21 HG21 ' A' ' 588' ' ' ILE . 36.3 t -74.57 -25.45 19.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.435 0.636 . . . . 0.0 111.498 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 501' ' ' TYR . . . . . 0.665 ' O ' ' CG2' ' A' ' 564' ' ' THR . 3.7 m-30 -53.45 -29.13 34.02 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -178.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -76.15 -50.28 15.03 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 116.45 2.019 . . . . 0.0 116.45 -175.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 503' ' ' LYS . . . . . 0.575 ' O ' ' CG ' ' A' ' 507' ' ' LYS . 0.2 OUTLIER -120.27 136.44 54.66 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 119.59 1.086 . . . . 0.0 112.676 -178.51 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . 0.921 HG23 ' CE1' ' A' ' 567' ' ' PHE . 23.7 m -73.61 -77.2 0.11 Allowed 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 179.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . 0.765 ' CZ ' ' HB1' ' A' ' 530' ' ' ALA . 0.2 OUTLIER -75.74 -60.33 2.36 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -179.18 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 506' ' ' SER . . . . . 0.703 ' O ' ' CD1' ' A' ' 510' ' ' TRP . 6.1 t -48.7 -72.04 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 -175.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 507' ' ' LYS . . . . . 0.679 ' HD3' ' N ' ' A' ' 508' ' ' VAL . 0.0 OUTLIER -48.9 -48.58 42.27 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -176.479 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 508' ' ' VAL . . . . . 0.824 HG13 HD21 ' A' ' 574' ' ' LEU . 55.3 t -52.63 -58.02 3.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 C-N-CA 120.668 -0.413 . . . . 0.0 112.081 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 509' ' ' LEU . . . . . 0.679 HD12 ' N ' ' A' ' 510' ' ' TRP . 2.6 pp -59.66 -66.0 0.58 Allowed 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 -177.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 510' ' ' TRP . . . . . 0.71 ' CD1' ' HA ' ' A' ' 518' ' ' LYS . 68.3 p-90 -73.18 -50.74 20.89 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 -176.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 511' ' ' SER . . . . . 0.504 ' N ' ' CD2' ' A' ' 510' ' ' TRP . 0.3 OUTLIER -62.27 -46.23 89.72 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 114.437 -1.256 . . . . 0.0 113.022 -177.024 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 512' ' ' ALA . . . . . 0.755 ' HB3' ' O ' ' A' ' 508' ' ' VAL . . . -71.13 -74.87 0.14 Allowed 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 116.305 1.965 . . . . 0.0 116.305 -174.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 513' ' ' GLY . . . . . 0.764 ' CA ' HG21 ' A' ' 493' ' ' VAL . . . -116.88 -39.56 0.82 Allowed Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 121.837 3.495 . . . . 0.0 121.837 -173.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 514' ' ' LEU . . . . . 0.761 HD21 ' HB2' ' A' ' 584' ' ' LYS . 4.1 pp -112.83 -36.65 5.09 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 121.11 3.744 . . . . 0.0 121.11 -171.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 515' ' ' VAL . . . . . 0.771 ' CG1' ' HB2' ' A' ' 517' ' ' SER . 9.9 p -125.76 165.86 22.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 117.99 2.589 . . . . 0.0 117.99 -171.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 516' ' ' ALA . . . . . 0.533 ' N ' HG22 ' A' ' 515' ' ' VAL . . . -90.44 1.01 57.07 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 112.46 -2.154 . . . . 0.0 109.078 178.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . 0.925 ' O ' ' N ' ' A' ' 521' ' ' GLY . 0.1 OUTLIER -60.15 10.19 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 126.072 1.749 . . . . 0.0 115.224 -172.957 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 518' ' ' LYS . . . . . 0.71 ' HA ' ' CD1' ' A' ' 510' ' ' TRP . 0.0 OUTLIER -43.54 -46.76 7.17 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 177.232 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 519' ' ' SER . . . . . . . . . . . . . 85.2 p -74.63 -56.15 5.13 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.462 173.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 520' ' ' GLU . . . . . 0.821 ' HB2' ' HA ' ' A' ' 517' ' ' SER . 4.8 mm-40 -62.03 -47.25 85.57 Favored 'General case' 0 C--N 1.349 0.573 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.848 -179.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 521' ' ' GLY . . . . . 0.925 ' N ' ' O ' ' A' ' 517' ' ' SER . . . -49.16 -53.09 20.51 Favored Glycine 0 CA--C 1.493 -1.292 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . 0.413 ' HA ' HG12 ' A' ' 525' ' ' ILE . 3.7 mt-30 -48.09 -47.52 34.19 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 177.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 523' ' ' ARG . . . . . 0.467 ' HB3' ' O ' ' A' ' 520' ' ' GLU . 2.4 tpt85 -50.25 -48.92 54.45 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.848 178.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 524' ' ' ILE . . . . . 0.507 HG13 ' HZ2' ' A' ' 580' ' ' LYS . 30.1 mm -57.44 -54.06 35.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.441 0.639 . . . . 0.0 109.592 179.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 525' ' ' ILE . . . . . 0.893 HG23 ' CD1' ' A' ' 556' ' ' ILE . 1.1 mm -50.27 -47.56 25.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 177.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 526' ' ' ASN . . . . . 0.456 ' HB2' ' O ' ' A' ' 523' ' ' ARG . 34.8 m-80 -57.82 -47.33 82.92 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-N 114.225 -1.352 . . . . 0.0 108.575 177.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 527' ' ' ASN . . . . . 0.454 ' ND2' ' O ' ' A' ' 524' ' ' ILE . 0.0 OUTLIER -47.3 -39.32 14.42 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 113.988 -1.46 . . . . 0.0 107.741 177.239 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 528' ' ' ASN . . . . . 0.696 ' HA ' ' CG2' ' A' ' 556' ' ' ILE . 7.9 t-20 74.25 40.42 0.43 Allowed 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.491 -179.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 529' ' ' GLY . . . . . . . . . . . . . . . -117.61 31.55 5.71 Favored Glycine 0 CA--C 1.523 0.593 0 CA-C-N 114.922 -1.035 . . . . 0.0 112.497 178.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 530' ' ' ALA . . . . . 0.886 ' O ' ' HB ' ' A' ' 556' ' ' ILE . . . -133.43 163.93 28.26 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 121.161 0.505 . . . . 0.0 112.263 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 531' ' ' TYR . . . . . 0.592 ' HA ' ' O ' ' A' ' 554' ' ' THR . 0.0 OUTLIER -134.61 152.93 52.13 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.667 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 532' ' ' VAL . . . . . 0.72 HG23 ' CE1' ' A' ' 505' ' ' PHE . 0.5 OUTLIER -127.09 135.64 63.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 CA-C-O 121.981 0.896 . . . . 0.0 112.093 179.635 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 533' ' ' GLY . . . . . 0.702 ' O ' HG13 ' A' ' 575' ' ' ILE . . . -133.68 151.73 20.26 Favored Glycine 0 N--CA 1.441 -0.98 0 CA-C-N 114.251 -1.34 . . . . 0.0 113.4 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 534' ' ' SER . . . . . 0.484 ' N ' ' HB ' ' A' ' 552' ' ' THR . 0.6 OUTLIER -134.57 137.55 43.86 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.447 -0.376 . . . . 0.0 111.016 179.109 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 535' ' ' ARG . . . . . 0.639 ' O ' ' HB3' ' A' ' 573' ' ' LEU . 12.4 tpt180 . . . . . 0 C--N 1.331 -0.202 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.449 -0.524 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 550' ' ' ASP . . . . . 0.557 ' O ' ' HA ' ' A' ' 535' ' ' ARG . 0.6 OUTLIER -72.54 -42.17 65.01 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.263 179.739 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 551' ' ' LEU . . . . . 0.479 HD21 ' HE2' ' A' ' 553' ' ' PHE . 8.8 tp -131.37 140.57 49.71 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.335 178.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 552' ' ' THR . . . . . 0.674 ' O ' ' HA2' ' A' ' 533' ' ' GLY . 27.1 m -133.04 147.93 52.22 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.618 0.723 . . . . 0.0 111.912 179.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 553' ' ' PHE . . . . . 0.528 ' CD1' ' CE1' ' A' ' 531' ' ' TYR . 14.3 m-85 -133.86 136.77 44.59 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 177.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 554' ' ' THR . . . . . 0.633 ' CG2' ' H ' ' A' ' 556' ' ' ILE . 0.8 OUTLIER -134.0 138.96 31.83 Favored Pre-proline 0 C--N 1.308 -1.214 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.327 179.544 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 555' ' ' PRO . . . . . 0.805 ' O ' HG22 ' A' ' 556' ' ' ILE . 79.8 Cg_endo -86.22 20.33 1.25 Allowed 'Trans proline' 0 N--CA 1.445 -1.33 0 C-N-CA 121.972 1.782 . . . . 0.0 111.043 178.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 556' ' ' ILE . . . . . 0.893 ' CD1' HG23 ' A' ' 525' ' ' ILE . 4.2 tp 63.27 35.17 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 177.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 2.2 mtmp? -102.86 122.11 43.86 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 558' ' ' THR . . . . . . . . . . . . . 12.0 m -56.91 118.57 5.08 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 115.61 1.707 . . . . 0.0 115.61 -171.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 559' ' ' TRP . . . . . 0.601 ' CZ2' ' HD2' ' A' ' 555' ' ' PRO . 0.0 OUTLIER -138.24 111.96 8.29 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 112.441 -2.163 . . . . 0.0 105.715 175.486 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 560' ' ' ASN . . . . . 0.559 ' O ' ' HB ' ' A' ' 564' ' ' THR . 51.2 m-20 -80.44 -74.82 0.29 Allowed 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 -175.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 561' ' ' ALA . . . . . 0.431 ' O ' HG22 ' A' ' 564' ' ' THR . . . -73.94 -65.33 0.85 Allowed 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 -176.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 562' ' ' SER . . . . . . . . . . . . . 1.4 p -49.06 -52.19 26.97 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -175.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 563' ' ' LYS . . . . . 0.538 ' HG2' ' CE2' ' A' ' 559' ' ' TRP . 9.3 tppt? -70.93 -49.13 48.97 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 564' ' ' THR . . . . . 0.665 ' CG2' ' O ' ' A' ' 501' ' ' TYR . 1.7 t -50.03 -62.4 1.59 Allowed 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.563 -178.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 565' ' ' GLN . . . . . 0.59 ' O ' HG23 ' A' ' 569' ' ' ILE . 0.0 OUTLIER -49.13 -47.6 45.4 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 122.282 -0.261 . . . . 0.0 111.355 178.495 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 566' ' ' GLU . . . . . 0.433 ' O ' HD13 ' A' ' 569' ' ' ILE . 1.8 tt0 -49.66 -56.27 10.71 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -178.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 567' ' ' PHE . . . . . 0.921 ' CE1' HG23 ' A' ' 504' ' ' THR . 1.4 p90 -96.83 -46.0 6.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.433 0.635 . . . . 0.0 111.944 -178.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 568' ' ' ILE . . . . . 0.966 HD11 HD13 ' A' ' 574' ' ' LEU . 1.3 tp -58.11 9.44 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.504 -0.822 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 569' ' ' ILE . . . . . 0.59 HG23 ' O ' ' A' ' 565' ' ' GLN . 0.0 OUTLIER -55.0 -38.94 47.51 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 N-CA-C 104.967 -2.234 . . . . 0.0 104.967 179.184 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 570' ' ' ASP . . . . . 0.609 ' CG ' HD11 ' A' ' 588' ' ' ILE . 13.4 p30 31.61 58.12 0.3 Allowed 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 114.289 -1.323 . . . . 0.0 112.307 173.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -51.62 -45.1 54.55 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 117.288 -2.387 . . . . 0.0 108.79 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 572' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -119.57 -16.81 8.82 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 112.411 0.522 . . . . 0.0 112.411 175.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 573' ' ' LEU . . . . . 0.639 ' HB3' ' O ' ' A' ' 535' ' ' ARG . 1.2 tp -140.14 136.9 33.98 Favored 'General case' 0 C--N 1.351 0.659 0 N-CA-C 115.756 1.761 . . . . 0.0 115.756 -177.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 574' ' ' LEU . . . . . 0.966 HD13 HD11 ' A' ' 568' ' ' ILE . 0.1 OUTLIER -134.77 133.83 40.29 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 105.847 -1.908 . . . . 0.0 105.847 173.707 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 575' ' ' ILE . . . . . 0.931 ' N ' HD12 ' A' ' 574' ' ' LEU . 0.0 OUTLIER -133.55 136.08 54.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.401 178.65 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 576' ' ' LEU . . . . . 0.566 ' CD2' ' HB3' ' A' ' 509' ' ' LEU . 0.0 OUTLIER -133.99 135.63 43.56 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 177.1 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 577' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.32 135.26 46.08 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 118.88 -1.128 . . . . 0.0 110.513 177.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.613 HD12 ' O ' ' A' ' 582' ' ' LYS . 0.3 OUTLIER -123.01 132.12 54.0 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 177.892 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 579' ' ' GLY . . . . . . . . . . . . . . . -89.8 -2.15 75.85 Favored Glycine 0 CA--C 1.499 -0.92 0 CA-C-N 115.244 -0.889 . . . . 0.0 113.431 -178.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 580' ' ' LYS . . . . . 0.507 ' HZ2' HG13 ' A' ' 524' ' ' ILE . 0.0 OUTLIER -72.67 -48.15 41.49 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 118.998 -1.081 . . . . 0.0 108.964 179.426 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 581' ' ' TRP . . . . . 0.48 ' CD1' ' O ' ' A' ' 580' ' ' LYS . 28.4 m0 -139.03 -52.82 0.56 Allowed 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 177.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 582' ' ' LYS . . . . . 0.613 ' O ' HD12 ' A' ' 578' ' ' LEU . 0.3 OUTLIER -139.84 165.22 27.88 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 -174.878 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 583' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.2 135.06 53.33 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 174.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 584' ' ' LYS . . . . . 0.761 ' HB2' HD21 ' A' ' 514' ' ' LEU . 2.3 tppt? -117.25 134.27 54.99 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 585' ' ' LEU . . . . . 0.757 ' HG ' HG23 ' A' ' 575' ' ' ILE . 4.2 tt -121.68 135.9 54.95 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 178.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 586' ' ' VAL . . . . . 0.668 HG23 ' HD2' ' A' ' 584' ' ' LYS . 16.9 t -133.31 137.07 53.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.204 -178.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 587' ' ' SER . . . . . . . . . . . . . 70.8 m -109.98 135.02 51.49 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 176.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 1.045 HG22 ' O ' ' A' ' 495' ' ' LEU . 0.0 OUTLIER -134.53 141.85 42.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -177.868 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 5.2 m -133.28 137.02 54.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 114.166 -1.379 . . . . 0.0 110.422 177.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 590' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.326 -0.441 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.445 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 491' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.879 0.371 . . . . 0.0 111.934 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 492' ' ' ARG . . . . . 0.522 ' CD ' ' HG ' ' A' ' 585' ' ' LEU . 0.0 OUTLIER -134.37 134.86 42.2 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.855 179.101 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 493' ' ' VAL . . . . . 0.673 HG21 ' CA ' ' A' ' 513' ' ' GLY . 85.9 t -135.28 163.73 35.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.242 178.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . 0.553 ' N ' HG12 ' A' ' 493' ' ' VAL . 1.3 m -125.72 135.89 52.58 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.323 0.582 . . . . 0.0 111.231 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 495' ' ' LEU . . . . . 0.955 ' O ' HG22 ' A' ' 588' ' ' ILE . 2.1 pp -133.93 163.3 52.12 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 115.239 -0.892 . . . . 0.0 110.122 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 496' ' ' PRO . . . . . 0.819 ' HD2' HD21 ' A' ' 499' ' ' LEU . 20.4 Cg_exo -63.36 118.67 5.58 Favored 'Trans proline' 0 CA--C 1.534 0.477 0 C-N-CA 121.712 1.608 . . . . 0.0 111.327 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 497' ' ' LYS . . . . . 0.815 ' O ' HG12 ' A' ' 500' ' ' VAL . 8.6 tttm -50.19 -29.87 10.22 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -179.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 498' ' ' SER . . . . . 0.44 ' HA ' ' CE2' ' A' ' 501' ' ' TYR . 1.0 OUTLIER -56.3 -48.45 76.64 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 113.758 1.022 . . . . 0.0 113.758 -177.345 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 499' ' ' LEU . . . . . 0.819 HD21 ' HD2' ' A' ' 496' ' ' PRO . 0.7 OUTLIER -73.71 -8.43 55.95 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -178.542 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . 0.815 HG12 ' O ' ' A' ' 497' ' ' LYS . 1.7 p -74.73 -25.58 19.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.275 0.56 . . . . 0.0 111.613 -179.016 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 501' ' ' TYR . . . . . 0.635 ' O ' ' CG2' ' A' ' 564' ' ' THR . 6.7 m-30 -53.96 -30.61 47.61 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 114.217 1.192 . . . . 0.0 114.217 -178.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -77.38 -51.16 11.28 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.059 1.874 . . . . 0.0 116.059 -175.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 503' ' ' LYS . . . . . 0.558 ' O ' ' CG ' ' A' ' 507' ' ' LYS . 0.0 OUTLIER -121.2 136.12 55.03 Favored 'General case' 0 C--N 1.339 0.132 0 CA-C-N 118.885 0.766 . . . . 0.0 112.375 -179.109 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . 0.769 HG23 ' CD1' ' A' ' 568' ' ' ILE . 90.5 m -73.29 -75.68 0.14 Allowed 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 179.047 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . 0.74 ' HE2' HG21 ' A' ' 554' ' ' THR . 0.0 OUTLIER -74.87 -62.48 1.53 Allowed 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -178.888 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 506' ' ' SER . . . . . 0.802 ' O ' ' CD1' ' A' ' 510' ' ' TRP . 66.5 m -49.59 -73.23 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -175.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 507' ' ' LYS . . . . . 0.723 ' HD3' ' N ' ' A' ' 508' ' ' VAL . 0.0 OUTLIER -49.05 -48.89 43.59 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -176.425 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 508' ' ' VAL . . . . . 0.755 HG21 HD21 ' A' ' 574' ' ' LEU . 47.7 t -55.83 -62.33 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.722 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 509' ' ' LEU . . . . . 0.791 HD12 ' N ' ' A' ' 510' ' ' TRP . 1.9 pp -49.9 -63.01 1.24 Allowed 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -177.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 510' ' ' TRP . . . . . 0.867 ' CD1' ' HA ' ' A' ' 518' ' ' LYS . 67.4 p-90 -72.89 -49.74 27.98 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 -176.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 511' ' ' SER . . . . . 0.507 ' N ' ' CE3' ' A' ' 510' ' ' TRP . 0.3 OUTLIER -62.87 -47.07 84.94 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.289 -0.869 . . . . 0.0 113.178 -176.81 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 512' ' ' ALA . . . . . 0.881 ' HB2' HD23 ' A' ' 495' ' ' LEU . . . -70.97 -73.5 0.17 Allowed 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 118.242 2.682 . . . . 0.0 118.242 -173.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 513' ' ' GLY . . . . . 0.673 ' CA ' HG21 ' A' ' 493' ' ' VAL . . . -114.67 -36.05 1.33 Allowed Glycine 0 CA--C 1.502 -0.743 0 N-CA-C 121.295 3.278 . . . . 0.0 121.295 -172.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 514' ' ' LEU . . . . . 0.809 HD12 ' HB2' ' A' ' 584' ' ' LYS . 1.6 mt -108.94 -43.21 4.26 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 120.053 3.353 . . . . 0.0 120.053 -170.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 515' ' ' VAL . . . . . 0.97 HG13 ' HB2' ' A' ' 517' ' ' SER . 3.8 p -154.0 172.12 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 117.721 2.489 . . . . 0.0 117.721 -171.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 516' ' ' ALA . . . . . 0.581 ' N ' HG22 ' A' ' 515' ' ' VAL . . . -68.42 3.97 1.54 Allowed 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 127.054 2.142 . . . . 0.0 110.238 177.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . 0.97 ' HB2' HG13 ' A' ' 515' ' ' VAL . 0.4 OUTLIER -57.32 8.81 0.01 OUTLIER 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 115.575 1.695 . . . . 0.0 115.575 -171.853 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 518' ' ' LYS . . . . . 0.867 ' HA ' ' CD1' ' A' ' 510' ' ' TRP . 2.3 ttpt -46.37 -51.4 14.96 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 104.462 -2.422 . . . . 0.0 104.462 174.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 519' ' ' SER . . . . . . . . . . . . . 35.2 t -75.0 -57.01 4.17 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.101 173.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 520' ' ' GLU . . . . . 0.735 ' HB2' ' HA ' ' A' ' 517' ' ' SER . 0.3 OUTLIER -57.47 -48.0 80.35 Favored 'General case' 0 C--N 1.348 0.536 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.926 -178.97 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 521' ' ' GLY . . . . . 0.813 ' N ' ' O ' ' A' ' 517' ' ' SER . . . -49.46 -56.81 10.22 Favored Glycine 0 CA--C 1.493 -1.296 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.525 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -47.82 -47.32 31.24 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 523' ' ' ARG . . . . . 0.432 ' O ' ' HB3' ' A' ' 526' ' ' ASN . 0.5 OUTLIER -50.12 -48.79 53.32 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.785 178.557 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 524' ' ' ILE . . . . . 0.526 HD12 ' HD3' ' A' ' 580' ' ' LYS . 29.8 mm -59.36 -54.05 39.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.325 0.583 . . . . 0.0 110.043 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 525' ' ' ILE . . . . . 0.596 ' N ' HD13 ' A' ' 525' ' ' ILE . 1.3 mm -50.27 -47.3 25.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 177.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 526' ' ' ASN . . . . . 0.432 ' HB3' ' O ' ' A' ' 523' ' ' ARG . 1.0 OUTLIER -57.93 -47.85 81.63 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 114.607 -1.179 . . . . 0.0 108.325 177.142 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 527' ' ' ASN . . . . . 0.493 ' HB3' ' HA ' ' A' ' 524' ' ' ILE . 0.0 OUTLIER -47.73 -39.13 16.88 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 113.965 -1.471 . . . . 0.0 107.931 176.807 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 528' ' ' ASN . . . . . 1.03 ' HA ' HG21 ' A' ' 556' ' ' ILE . 14.1 t-20 75.17 40.61 0.33 Allowed 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 114.854 -1.066 . . . . 0.0 112.088 -179.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 529' ' ' GLY . . . . . . . . . . . . . . . -112.46 20.25 21.02 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 114.524 -1.217 . . . . 0.0 111.661 177.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 530' ' ' ALA . . . . . 0.804 ' O ' ' HB ' ' A' ' 556' ' ' ILE . . . -133.76 163.68 28.92 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -179.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 531' ' ' TYR . . . . . 0.533 ' CE2' ' HA ' ' A' ' 553' ' ' PHE . 0.0 OUTLIER -133.76 162.59 31.57 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 177.578 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 532' ' ' VAL . . . . . 0.662 HG12 ' OG1' ' A' ' 554' ' ' THR . 0.6 OUTLIER -127.47 135.06 64.32 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 CA-C-O 121.956 0.884 . . . . 0.0 111.819 179.131 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 533' ' ' GLY . . . . . 0.729 ' HA2' ' O ' ' A' ' 552' ' ' THR . . . -133.62 148.44 19.39 Favored Glycine 0 N--CA 1.445 -0.7 0 CA-C-N 114.252 -1.34 . . . . 0.0 113.496 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 534' ' ' SER . . . . . 0.434 ' HB2' ' OG1' ' A' ' 552' ' ' THR . 0.1 OUTLIER -135.14 141.28 45.92 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 179.724 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 535' ' ' ARG . . . . . 0.674 ' O ' ' HB3' ' A' ' 573' ' ' LEU . 26.2 tpt85 . . . . . 0 N--CA 1.464 0.248 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.848 178.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 . . . . . 0 CA--C 1.512 -0.506 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 550' ' ' ASP . . . . . 0.501 ' O ' ' HA ' ' A' ' 535' ' ' ARG . 11.4 m-20 -77.78 -39.37 44.22 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.053 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 551' ' ' LEU . . . . . 0.78 HD11 ' CE1' ' A' ' 553' ' ' PHE . 3.0 tp -131.25 140.76 49.89 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.951 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 552' ' ' THR . . . . . 0.729 ' O ' ' HA2' ' A' ' 533' ' ' GLY . 1.9 m -132.87 146.09 51.5 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.491 0.663 . . . . 0.0 110.98 178.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 553' ' ' PHE . . . . . 0.78 ' CE1' HD11 ' A' ' 551' ' ' LEU . 9.8 m-85 -134.39 137.01 43.75 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 177.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 554' ' ' THR . . . . . 0.896 HG22 ' H ' ' A' ' 556' ' ' ILE . 21.7 m -133.94 138.62 31.14 Favored Pre-proline 0 C--N 1.303 -1.423 0 C-N-CA 119.42 -0.912 . . . . 0.0 110.045 178.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 555' ' ' PRO . . . . . 0.811 ' O ' HG22 ' A' ' 556' ' ' ILE . 85.6 Cg_endo -85.48 25.29 0.7 Allowed 'Trans proline' 0 N--CA 1.438 -1.771 0 C-N-CA 121.452 1.434 . . . . 0.0 109.857 178.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 556' ' ' ILE . . . . . 1.03 HG21 ' HA ' ' A' ' 528' ' ' ASN . 1.4 tp 64.59 32.6 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 177.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -103.96 131.19 51.45 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 558' ' ' THR . . . . . 0.514 ' HA ' ' CE1' ' A' ' 505' ' ' PHE . 3.5 t -58.17 116.38 3.52 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 116.071 1.878 . . . . 0.0 116.071 -172.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 559' ' ' TRP . . . . . 0.645 ' CE3' ' HG3' ' A' ' 563' ' ' LYS . 1.3 m0 -139.33 111.49 7.46 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 104.414 -2.439 . . . . 0.0 104.414 173.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 560' ' ' ASN . . . . . 0.51 ' O ' ' HB ' ' A' ' 564' ' ' THR . 51.1 m-80 -90.98 -75.32 0.47 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 115.116 1.524 . . . . 0.0 115.116 -175.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 561' ' ' ALA . . . . . 0.451 ' O ' HG22 ' A' ' 564' ' ' THR . . . -73.76 -63.42 1.21 Allowed 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 115.729 1.751 . . . . 0.0 115.729 -176.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 562' ' ' SER . . . . . . . . . . . . . 69.2 m -48.83 -50.84 32.65 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -176.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 563' ' ' LYS . . . . . 0.645 ' HG3' ' CE3' ' A' ' 559' ' ' TRP . 1.2 mmpt? -71.2 -49.01 48.02 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -178.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 564' ' ' THR . . . . . 0.706 ' O ' ' HB ' ' A' ' 568' ' ' ILE . 3.4 t -51.17 -62.93 1.31 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.794 0.331 . . . . 0.0 110.709 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 565' ' ' GLN . . . . . 1.014 ' O ' HG23 ' A' ' 569' ' ' ILE . 3.6 tp60 -50.23 -47.34 54.99 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.858 0.361 . . . . 0.0 111.28 178.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 566' ' ' GLU . . . . . 0.423 ' HG2' ' CD1' ' A' ' 567' ' ' PHE . 23.3 tt0 -49.2 -68.54 0.17 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -178.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 567' ' ' PHE . . . . . 0.714 ' CD2' HG21 ' A' ' 552' ' ' THR . 0.2 OUTLIER -91.01 -51.85 5.14 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.397 0.618 . . . . 0.0 111.57 -179.094 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 568' ' ' ILE . . . . . 0.769 ' CD1' HG23 ' A' ' 504' ' ' THR . 1.9 mp -56.17 8.98 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 114.83 -1.077 . . . . 0.0 113.259 -179.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 569' ' ' ILE . . . . . 1.014 HG23 ' O ' ' A' ' 565' ' ' GLN . 1.3 pt -54.13 -36.39 32.13 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.728 0 N-CA-C 104.146 -2.538 . . . . 0.0 104.146 177.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 570' ' ' ASP . . . . . 0.662 ' OD2' HD22 ' A' ' 574' ' ' LEU . 28.4 m-20 35.39 54.84 0.83 Allowed 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 113.453 -1.703 . . . . 0.0 111.661 174.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -51.28 -44.89 52.62 Favored Glycine 0 N--CA 1.438 -1.169 0 C-N-CA 118.045 -2.026 . . . . 0.0 108.455 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 572' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -119.89 -17.12 8.57 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 175.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 573' ' ' LEU . . . . . 0.674 ' HB3' ' O ' ' A' ' 535' ' ' ARG . 0.9 OUTLIER -140.7 136.65 32.83 Favored 'General case' 0 C--N 1.354 0.768 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 -177.937 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 574' ' ' LEU . . . . . 0.977 ' HB2' HD11 ' A' ' 588' ' ' ILE . 0.7 OUTLIER -135.29 133.48 38.92 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 173.865 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 575' ' ' ILE . . . . . 1.012 HG23 HD13 ' A' ' 585' ' ' LEU . 0.0 OUTLIER -133.48 137.19 53.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 119.133 0.879 . . . . 0.0 111.745 178.736 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 576' ' ' LEU . . . . . 0.64 HD11 HD21 ' A' ' 578' ' ' LEU . 0.0 OUTLIER -133.31 135.32 44.75 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 177.255 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 577' ' ' LYS . . . . . 0.451 ' CD ' ' CD1' ' A' ' 531' ' ' TYR . 0.2 OUTLIER -128.22 135.48 49.74 Favored 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.104 178.044 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.64 HD21 HD11 ' A' ' 576' ' ' LEU . 0.4 OUTLIER -125.81 132.7 52.2 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.537 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 579' ' ' GLY . . . . . . . . . . . . . . . -88.51 -2.14 79.86 Favored Glycine 0 N--CA 1.438 -1.169 0 CA-C-N 114.759 -1.11 . . . . 0.0 112.962 -179.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 580' ' ' LYS . . . . . 0.526 ' HD3' HD12 ' A' ' 524' ' ' ILE . 18.9 pttt -66.1 -50.46 63.96 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 118.891 -1.124 . . . . 0.0 108.047 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 581' ' ' TRP . . . . . 0.458 ' CZ2' ' HD2' ' A' ' 580' ' ' LYS . 0.0 OUTLIER -142.35 -52.03 0.4 Allowed 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 175.815 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 582' ' ' LYS . . . . . 0.433 ' HE3' ' CD1' ' A' ' 581' ' ' TRP . 0.4 OUTLIER -139.56 166.06 25.58 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 114.398 1.258 . . . . 0.0 114.398 -174.508 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 583' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -109.2 135.24 50.63 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 174.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 584' ' ' LYS . . . . . 0.809 ' HB2' HD12 ' A' ' 514' ' ' LEU . 1.1 tmmt? -114.8 133.85 55.6 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 178.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 585' ' ' LEU . . . . . 1.012 HD13 HG23 ' A' ' 575' ' ' ILE . 5.0 tp -122.38 136.69 54.94 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 586' ' ' VAL . . . . . 0.54 HG21 ' HZ3' ' A' ' 584' ' ' LYS . 9.5 t -132.91 144.58 36.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -178.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 587' ' ' SER . . . . . 0.484 ' C ' HD13 ' A' ' 588' ' ' ILE . 2.9 m -109.83 136.35 49.28 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 177.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.977 HD11 ' HB2' ' A' ' 574' ' ' LEU . 0.0 OUTLIER -132.7 136.74 55.38 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -177.958 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 5.6 m -133.07 137.06 54.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 114.356 -1.293 . . . . 0.0 110.688 178.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 590' ' ' SER . . . . . . . . . . . . . 2.6 m . . . . . 0 C--N 1.327 -0.394 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.449 179.914 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 491' ' ' ALA . . . . . 0.417 ' CB ' ' NZ ' ' A' ' 584' ' ' LYS . . . . . . . . 0 C--O 1.23 0.048 0 CA-C-O 120.454 0.169 . . . . 0.0 110.574 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 492' ' ' ARG . . . . . 0.66 ' CD ' HD22 ' A' ' 585' ' ' LEU . 0.0 OUTLIER -135.85 135.23 39.61 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.981 0.419 . . . . 0.0 111.851 179.883 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 493' ' ' VAL . . . . . 0.569 HG12 ' N ' ' A' ' 494' ' ' THR . 84.8 t -134.93 163.2 37.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.135 177.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . 0.569 ' N ' HG12 ' A' ' 493' ' ' VAL . 5.3 t -122.49 134.86 54.56 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.143 0.497 . . . . 0.0 111.147 178.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 495' ' ' LEU . . . . . 0.919 HD22 ' HB2' ' A' ' 512' ' ' ALA . 0.0 OUTLIER -135.49 164.57 42.62 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.401 179.593 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 496' ' ' PRO . . . . . 0.737 ' HD2' HD21 ' A' ' 499' ' ' LEU . 15.4 Cg_exo -66.69 119.42 6.45 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 121.759 1.639 . . . . 0.0 110.918 178.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 497' ' ' LYS . . . . . 0.455 ' HB2' ' N ' ' A' ' 589' ' ' VAL . 5.6 tmtt? -53.81 -30.02 43.2 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -178.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 498' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.92 -48.36 82.01 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -177.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 499' ' ' LEU . . . . . 0.757 HD11 ' CD1' ' A' ' 495' ' ' LEU . 2.2 pp -73.52 -8.87 57.71 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -178.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . 0.857 HG21 HG21 ' A' ' 588' ' ' ILE . 39.8 t -75.41 -25.4 17.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.21 0.528 . . . . 0.0 111.922 -179.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 501' ' ' TYR . . . . . 0.83 ' O ' HG21 ' A' ' 564' ' ' THR . 0.7 OUTLIER -52.95 -28.7 24.84 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -178.201 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.4 -50.08 17.0 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 115.563 1.69 . . . . 0.0 115.563 -175.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 503' ' ' LYS . . . . . 0.569 ' O ' ' CG ' ' A' ' 507' ' ' LYS . 0.5 OUTLIER -119.44 135.29 54.82 Favored 'General case' 0 C--N 1.338 0.074 0 CA-C-N 119.201 0.909 . . . . 0.0 111.843 -179.41 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . 0.764 HG23 ' CE1' ' A' ' 567' ' ' PHE . 62.5 m -73.18 -76.61 0.12 Allowed 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . 0.653 ' CE2' HG23 ' A' ' 532' ' ' VAL . 0.2 OUTLIER -75.08 -60.87 2.1 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -179.25 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 506' ' ' SER . . . . . 0.466 ' O ' ' HG ' ' A' ' 509' ' ' LEU . 1.4 m -48.82 -72.72 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 -176.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 507' ' ' LYS . . . . . 0.804 ' HZ1' HG22 ' A' ' 500' ' ' VAL . 0.0 OUTLIER -50.41 -48.92 55.96 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -176.878 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 508' ' ' VAL . . . . . 0.831 HG13 HD21 ' A' ' 574' ' ' LEU . 47.9 t -52.66 -58.84 2.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -178.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 509' ' ' LEU . . . . . 0.812 HD12 ' N ' ' A' ' 510' ' ' TRP . 1.5 pp -58.16 -62.84 1.53 Allowed 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 -177.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 510' ' ' TRP . . . . . 0.812 ' N ' HD12 ' A' ' 509' ' ' LEU . 6.0 p-90 -73.06 -52.49 14.15 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 114.706 1.372 . . . . 0.0 114.706 -176.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 511' ' ' SER . . . . . 0.486 ' N ' ' CE3' ' A' ' 510' ' ' TRP . 0.2 OUTLIER -61.87 -48.41 80.62 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.684 -176.893 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 512' ' ' ALA . . . . . 0.919 ' HB2' HD22 ' A' ' 495' ' ' LEU . . . -72.1 -73.77 0.18 Allowed 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 117.162 2.282 . . . . 0.0 117.162 -174.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 513' ' ' GLY . . . . . 0.681 ' HA3' ' HE3' ' A' ' 584' ' ' LYS . . . -115.23 -35.13 1.36 Allowed Glycine 0 N--CA 1.449 -0.477 0 N-CA-C 121.408 3.323 . . . . 0.0 121.408 -172.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 514' ' ' LEU . . . . . 0.606 ' HG ' ' HE2' ' A' ' 584' ' ' LYS . 1.3 mt -107.58 -38.73 5.82 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 120.09 3.367 . . . . 0.0 120.09 -170.013 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 515' ' ' VAL . . . . . 0.592 HG22 ' N ' ' A' ' 516' ' ' ALA . 14.3 p -152.95 172.08 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 N-CA-C 118.108 2.633 . . . . 0.0 118.108 -172.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 516' ' ' ALA . . . . . 0.592 ' N ' HG22 ' A' ' 515' ' ' VAL . . . -85.94 2.69 45.15 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 127.055 2.142 . . . . 0.0 108.956 178.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . 0.882 ' O ' ' N ' ' A' ' 521' ' ' GLY . 10.4 p -59.82 13.0 0.01 OUTLIER 'General case' 0 N--CA 1.424 -1.729 0 C-N-CA 126.326 1.85 . . . . 0.0 115.49 -173.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 518' ' ' LYS . . . . . 0.631 ' HG3' ' CE3' ' A' ' 510' ' ' TRP . 2.1 mppt? -40.61 -44.36 2.1 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 178.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 519' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.37 -52.46 12.07 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.323 173.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 520' ' ' GLU . . . . . 0.809 ' HB2' ' HA ' ' A' ' 517' ' ' SER . 9.0 mm-40 -63.1 -46.81 85.6 Favored 'General case' 0 C--N 1.35 0.591 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.277 -179.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 521' ' ' GLY . . . . . 0.891 ' HA2' HD12 ' A' ' 524' ' ' ILE . . . -49.16 -58.75 7.58 Favored Glycine 0 CA--C 1.495 -1.172 0 N-CA-C 111.344 -0.702 . . . . 0.0 111.344 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . 0.412 ' HA ' HG12 ' A' ' 525' ' ' ILE . 3.8 mt-30 -47.99 -47.89 32.8 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 178.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 523' ' ' ARG . . . . . 0.477 ' HB3' ' O ' ' A' ' 520' ' ' GLU . 0.4 OUTLIER -50.26 -48.75 54.67 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.823 178.945 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 524' ' ' ILE . . . . . 0.891 HD12 ' HA2' ' A' ' 521' ' ' GLY . 6.0 mt -58.31 -54.86 27.06 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 CA-C-O 121.341 0.591 . . . . 0.0 109.745 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 525' ' ' ILE . . . . . 0.565 ' HA ' HG13 ' A' ' 556' ' ' ILE . 1.0 OUTLIER -50.37 -47.6 26.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.091 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 526' ' ' ASN . . . . . . . . . . . . . 36.7 m-20 -58.2 -47.78 82.4 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 114.373 -1.285 . . . . 0.0 108.643 177.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 527' ' ' ASN . . . . . 0.418 ' ND2' ' O ' ' A' ' 524' ' ' ILE . 0.0 OUTLIER -47.69 -39.83 18.45 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 113.971 -1.468 . . . . 0.0 108.028 177.282 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 528' ' ' ASN . . . . . 1.028 ' HA ' HG21 ' A' ' 556' ' ' ILE . 14.6 t-20 73.99 39.85 0.49 Allowed 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.187 -179.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 529' ' ' GLY . . . . . 0.416 ' H ' ' ND2' ' A' ' 527' ' ' ASN . . . -114.83 20.52 14.77 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 114.265 -1.334 . . . . 0.0 111.54 178.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 530' ' ' ALA . . . . . 0.799 ' O ' ' HB ' ' A' ' 556' ' ' ILE . . . -133.71 156.76 47.36 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.86 0.362 . . . . 0.0 111.649 -179.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 531' ' ' TYR . . . . . 0.532 ' HA ' ' O ' ' A' ' 554' ' ' THR . 0.1 OUTLIER -133.28 158.8 42.03 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 178.039 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 532' ' ' VAL . . . . . 0.653 HG23 ' CE2' ' A' ' 505' ' ' PHE . 0.5 OUTLIER -125.52 135.78 62.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-O 122.025 0.917 . . . . 0.0 112.958 -178.301 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 533' ' ' GLY . . . . . 0.635 ' HA2' ' O ' ' A' ' 552' ' ' THR . . . -134.41 161.14 24.4 Favored Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 114.381 -1.281 . . . . 0.0 114.865 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 534' ' ' SER . . . . . 0.601 ' O ' ' HA ' ' A' ' 551' ' ' LEU . 6.7 t -133.8 137.28 45.01 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 114.912 -0.644 . . . . 0.0 110.628 178.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 535' ' ' ARG . . . . . 0.758 ' O ' ' HB3' ' A' ' 573' ' ' LEU . 7.1 tpt85 . . . . . 0 C--N 1.33 -0.276 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 178.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 2.6 p30 . . . . . 0 N--CA 1.449 -0.493 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 550' ' ' ASP . . . . . 0.692 ' O ' ' HA ' ' A' ' 535' ' ' ARG . 1.3 t70 -58.75 -47.94 82.93 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 551' ' ' LEU . . . . . 0.601 ' HA ' ' O ' ' A' ' 534' ' ' SER . 7.9 tp -120.37 140.06 51.87 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 552' ' ' THR . . . . . 0.635 ' O ' ' HA2' ' A' ' 533' ' ' GLY . 3.2 m -133.39 148.0 51.79 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.861 0.839 . . . . 0.0 112.295 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 553' ' ' PHE . . . . . 0.514 ' CD1' ' CE1' ' A' ' 531' ' ' TYR . 0.3 OUTLIER -134.66 137.46 43.62 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 176.554 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 554' ' ' THR . . . . . 0.619 HG23 ' HZ2' ' A' ' 559' ' ' TRP . 0.9 OUTLIER -132.83 138.11 31.18 Favored Pre-proline 0 C--N 1.31 -1.124 0 C-N-CA 119.474 -0.89 . . . . 0.0 110.338 179.304 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 555' ' ' PRO . . . . . 0.825 ' O ' HG22 ' A' ' 556' ' ' ILE . 61.0 Cg_endo -86.33 25.07 0.7 Allowed 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 122.208 1.938 . . . . 0.0 112.064 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 556' ' ' ILE . . . . . 1.028 HG21 ' HA ' ' A' ' 528' ' ' ASN . 1.5 tp 64.4 33.11 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 115.714 1.746 . . . . 0.0 115.714 176.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . 0.59 ' O ' ' CE2' ' A' ' 559' ' ' TRP . 3.7 mttt -104.24 125.86 50.87 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 -179.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 558' ' ' THR . . . . . . . . . . . . . 2.8 t -58.13 117.64 4.6 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -173.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 559' ' ' TRP . . . . . 0.619 ' HZ2' HG23 ' A' ' 554' ' ' THR . 0.0 OUTLIER -138.72 112.16 8.17 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 175.479 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 560' ' ' ASN . . . . . 0.716 ' O ' HG22 ' A' ' 564' ' ' THR . 26.2 m-80 -76.26 -76.27 0.17 Allowed 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 118.829 -1.149 . . . . 0.0 113.934 -175.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 561' ' ' ALA . . . . . 0.587 ' HA ' ' CG2' ' A' ' 564' ' ' THR . . . -75.16 -55.04 6.13 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 116.241 1.941 . . . . 0.0 116.241 -177.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 562' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -49.31 -53.77 20.39 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -176.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 563' ' ' LYS . . . . . 0.597 ' HG3' ' CE2' ' A' ' 559' ' ' TRP . 2.4 mmtt -70.86 -47.55 58.7 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -178.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 564' ' ' THR . . . . . 0.83 HG21 ' O ' ' A' ' 501' ' ' TYR . 3.3 t -48.53 -67.45 0.27 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.7 0.286 . . . . 0.0 110.879 -178.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 565' ' ' GLN . . . . . 0.823 ' H ' HG23 ' A' ' 564' ' ' THR . 0.0 OUTLIER -48.86 -46.77 42.84 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.757 0.313 . . . . 0.0 111.055 179.16 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -49.66 -67.18 0.28 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -178.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 567' ' ' PHE . . . . . 0.959 ' CZ ' HD13 ' A' ' 568' ' ' ILE . 0.3 OUTLIER -89.13 -41.02 12.52 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -177.932 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 568' ' ' ILE . . . . . 0.969 HD11 HD13 ' A' ' 574' ' ' LEU . 0.6 OUTLIER -61.59 9.84 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 179.63 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 569' ' ' ILE . . . . . 0.717 HD12 ' N ' ' A' ' 570' ' ' ASP . 2.7 pp -55.56 -45.02 78.57 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.317 0 N-CA-C 104.112 -2.551 . . . . 0.0 104.112 177.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 570' ' ' ASP . . . . . 0.717 ' N ' HD12 ' A' ' 569' ' ' ILE . 1.3 p30 31.29 60.17 0.27 Allowed 'General case' 0 CA--C 1.511 -0.554 0 CA-C-N 114.236 -1.347 . . . . 0.0 112.16 173.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -51.49 -45.22 53.77 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 117.423 -2.323 . . . . 0.0 109.08 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 572' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -119.35 -16.94 8.93 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 175.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 573' ' ' LEU . . . . . 0.758 ' HB3' ' O ' ' A' ' 535' ' ' ARG . 0.7 OUTLIER -140.29 137.94 34.57 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 -178.116 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 574' ' ' LEU . . . . . 0.969 HD13 HD11 ' A' ' 568' ' ' ILE . 0.1 OUTLIER -133.55 134.84 43.86 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 174.223 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 575' ' ' ILE . . . . . 0.862 ' N ' HD12 ' A' ' 574' ' ' LEU . 0.0 OUTLIER -133.04 136.98 54.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 C-N-CA 119.799 -0.76 . . . . 0.0 112.469 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 576' ' ' LEU . . . . . 0.494 ' CD1' ' CE1' ' A' ' 505' ' ' PHE . 0.0 OUTLIER -133.16 135.03 44.9 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 176.73 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 577' ' ' LYS . . . . . 0.542 ' HE2' ' HE2' ' A' ' 583' ' ' MET . 2.9 mtpm? -133.4 135.4 44.61 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 118.762 -1.175 . . . . 0.0 111.232 178.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.615 HD12 ' O ' ' A' ' 582' ' ' LYS . 0.3 OUTLIER -125.62 131.66 52.63 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.068 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 579' ' ' GLY . . . . . . . . . . . . . . . -91.3 -2.19 71.09 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.396 -0.82 . . . . 0.0 113.582 -178.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 580' ' ' LYS . . . . . 0.655 ' HG2' HG23 ' A' ' 524' ' ' ILE . 0.0 OUTLIER -72.8 -47.36 47.12 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 119.123 -1.031 . . . . 0.0 108.945 179.387 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 581' ' ' TRP . . . . . 0.561 ' CG ' ' HD2' ' A' ' 580' ' ' LYS . 32.5 m0 -138.49 -52.93 0.6 Allowed 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 177.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 582' ' ' LYS . . . . . 0.615 ' O ' HD12 ' A' ' 578' ' ' LEU . 0.0 OUTLIER -139.68 165.29 27.65 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 -174.894 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 583' ' ' MET . . . . . 0.542 ' HE2' ' HE2' ' A' ' 577' ' ' LYS . 0.3 OUTLIER -117.15 134.29 54.96 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 174.236 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 584' ' ' LYS . . . . . 0.681 ' HE3' ' HA3' ' A' ' 513' ' ' GLY . 0.1 OUTLIER -121.22 133.66 55.17 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.988 -1.005 . . . . 0.0 108.762 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 585' ' ' LEU . . . . . 0.701 ' HG ' HG23 ' A' ' 575' ' ' ILE . 6.2 tt -118.23 135.55 54.2 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 178.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 586' ' ' VAL . . . . . 0.587 HG11 HD23 ' A' ' 495' ' ' LEU . 77.4 t -133.26 138.57 51.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 C-N-CA 120.506 -0.477 . . . . 0.0 111.538 -178.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 587' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.73 135.53 48.11 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 177.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.857 HG21 HG21 ' A' ' 500' ' ' VAL . 0.1 OUTLIER -133.67 137.12 53.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -177.992 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 589' ' ' VAL . . . . . 0.455 ' N ' ' HB2' ' A' ' 497' ' ' LYS . 5.4 m -127.52 137.37 57.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 114.334 -1.303 . . . . 0.0 110.804 178.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 590' ' ' SER . . . . . . . . . . . . . 28.0 t . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.279 -179.59 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 491' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.099 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 492' ' ' ARG . . . . . 0.862 ' CD ' HD22 ' A' ' 585' ' ' LEU . 0.0 OUTLIER -136.12 134.37 38.24 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.957 178.438 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 493' ' ' VAL . . . . . 0.838 HG21 ' HA3' ' A' ' 513' ' ' GLY . 11.2 m -136.2 163.81 33.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.816 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 9.0 t -120.2 133.36 55.51 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 121.043 0.449 . . . . 0.0 110.305 177.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 495' ' ' LEU . . . . . 1.033 HD11 ' CG2' ' A' ' 500' ' ' VAL . 1.6 pp -136.2 163.16 52.07 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.928 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 496' ' ' PRO . . . . . 0.791 ' HD2' HD21 ' A' ' 499' ' ' LEU . 14.7 Cg_exo -67.35 119.3 6.31 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 122.313 2.008 . . . . 0.0 112.152 178.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 497' ' ' LYS . . . . . 0.526 ' HA ' ' HB ' ' A' ' 588' ' ' ILE . 20.1 tttt -51.85 -30.37 23.37 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -179.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 498' ' ' SER . . . . . . . . . . . . . 11.9 t -60.29 -48.35 82.11 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -177.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 499' ' ' LEU . . . . . 0.791 HD21 ' HD2' ' A' ' 496' ' ' PRO . 2.0 pp -74.18 -8.67 57.0 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -178.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . 1.033 ' CG2' HD11 ' A' ' 495' ' ' LEU . 13.8 t -75.45 -26.01 18.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.099 0.476 . . . . 0.0 112.239 -178.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 501' ' ' TYR . . . . . 0.669 ' O ' HG21 ' A' ' 564' ' ' THR . 6.3 m-85 -53.94 -30.61 47.27 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -178.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -75.82 -50.21 15.82 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 115.456 1.651 . . . . 0.0 115.456 -175.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 503' ' ' LYS . . . . . 0.61 ' O ' ' CG ' ' A' ' 507' ' ' LYS . 0.2 OUTLIER -119.2 132.57 55.96 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 118.79 0.723 . . . . 0.0 111.776 -179.323 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . 0.575 HG21 ' HB3' ' A' ' 563' ' ' LYS . 4.6 m -72.96 -75.62 0.14 Allowed 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . 0.641 ' CE1' ' HA ' ' A' ' 558' ' ' THR . 0.0 OUTLIER -74.71 -62.69 1.45 Allowed 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 -179.107 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 506' ' ' SER . . . . . 0.758 ' O ' ' CD1' ' A' ' 510' ' ' TRP . 66.6 m -49.15 -72.81 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -175.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 507' ' ' LYS . . . . . 0.712 ' HD3' ' N ' ' A' ' 508' ' ' VAL . 0.0 OUTLIER -48.7 -48.49 40.24 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -176.153 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 508' ' ' VAL . . . . . 0.947 ' CG1' HD21 ' A' ' 574' ' ' LEU . 61.3 t -54.76 -57.76 5.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -179.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 509' ' ' LEU . . . . . 0.734 HD12 ' N ' ' A' ' 510' ' ' TRP . 2.0 pp -59.64 -63.45 1.3 Allowed 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 -177.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 510' ' ' TRP . . . . . 0.766 ' CD1' ' HA ' ' A' ' 518' ' ' LYS . 63.7 p-90 -72.75 -49.69 29.34 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -176.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 511' ' ' SER . . . . . 0.523 ' N ' ' CD2' ' A' ' 510' ' ' TRP . 0.3 OUTLIER -62.75 -48.24 80.06 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.658 -177.014 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 512' ' ' ALA . . . . . 0.774 ' HB2' ' CD2' ' A' ' 495' ' ' LEU . . . -71.79 -75.18 0.14 Allowed 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 117.011 2.226 . . . . 0.0 117.011 -174.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 513' ' ' GLY . . . . . 0.838 ' HA3' HG21 ' A' ' 493' ' ' VAL . . . -117.63 -35.23 1.09 Allowed Glycine 0 CA--C 1.501 -0.787 0 N-CA-C 120.778 3.071 . . . . 0.0 120.778 -173.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 514' ' ' LEU . . . . . 0.741 ' HB3' HG23 ' A' ' 515' ' ' VAL . 0.0 OUTLIER -96.67 -46.95 6.09 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 119.542 3.164 . . . . 0.0 119.542 -168.746 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 515' ' ' VAL . . . . . 0.741 HG23 ' HB3' ' A' ' 514' ' ' LEU . 22.0 t -151.2 171.25 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 117.196 2.295 . . . . 0.0 117.196 -172.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 516' ' ' ALA . . . . . 0.631 ' N ' HG12 ' A' ' 515' ' ' VAL . . . -73.59 2.88 7.07 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 112.558 -2.11 . . . . 0.0 108.67 175.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . 0.851 ' HA ' ' HB2' ' A' ' 520' ' ' GLU . 0.6 OUTLIER -58.33 9.6 0.01 OUTLIER 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 116.004 1.853 . . . . 0.0 116.004 -172.024 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 518' ' ' LYS . . . . . 0.766 ' HA ' ' CD1' ' A' ' 510' ' ' TRP . 0.0 OUTLIER -45.1 -48.26 12.04 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 175.841 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 519' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -75.21 -56.31 4.85 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.172 173.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 520' ' ' GLU . . . . . 0.851 ' HB2' ' HA ' ' A' ' 517' ' ' SER . 2.0 mm-40 -59.64 -47.58 85.05 Favored 'General case' 0 C--N 1.35 0.588 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.228 -178.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 521' ' ' GLY . . . . . 0.785 ' N ' ' O ' ' A' ' 517' ' ' SER . . . -49.01 -54.2 15.52 Favored Glycine 0 CA--C 1.496 -1.108 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -48.62 -47.3 40.2 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 523' ' ' ARG . . . . . 0.402 ' O ' ' HB2' ' A' ' 526' ' ' ASN . 0.0 OUTLIER -49.9 -48.92 51.27 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.725 178.667 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 524' ' ' ILE . . . . . 0.769 HD12 ' HG2' ' A' ' 580' ' ' LYS . 28.1 mm -57.33 -55.92 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 CA-C-O 121.403 0.62 . . . . 0.0 109.725 179.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 525' ' ' ILE . . . . . 0.589 ' N ' HD13 ' A' ' 525' ' ' ILE . 1.5 mm -50.28 -47.4 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 177.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 526' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 523' ' ' ARG . 36.6 m-20 -57.63 -47.76 81.32 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 114.633 -1.167 . . . . 0.0 108.5 177.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 527' ' ' ASN . . . . . 0.427 ' ND2' ' O ' ' A' ' 524' ' ' ILE . 0.0 OUTLIER -47.94 -39.54 19.52 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 113.971 -1.468 . . . . 0.0 107.715 176.891 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 528' ' ' ASN . . . . . 1.088 ' HA ' HG21 ' A' ' 556' ' ' ILE . 2.5 t30 74.31 39.99 0.45 Allowed 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 114.631 -1.168 . . . . 0.0 111.633 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 529' ' ' GLY . . . . . 0.405 ' H ' ' ND2' ' A' ' 527' ' ' ASN . . . -114.22 25.6 10.46 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 114.324 -1.307 . . . . 0.0 111.192 177.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 530' ' ' ALA . . . . . 0.83 ' O ' ' HB ' ' A' ' 556' ' ' ILE . . . -133.49 159.48 40.27 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.095 0.474 . . . . 0.0 112.046 -179.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 531' ' ' TYR . . . . . 0.52 ' CE2' ' CD2' ' A' ' 553' ' ' PHE . 0.0 OUTLIER -134.04 158.52 43.34 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 177.508 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 532' ' ' VAL . . . . . 0.742 HG12 ' OG1' ' A' ' 554' ' ' THR . 0.4 OUTLIER -126.69 135.59 63.26 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 C-N-CA 119.401 -0.919 . . . . 0.0 112.356 -179.758 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 533' ' ' GLY . . . . . 0.672 ' HA2' ' O ' ' A' ' 552' ' ' THR . . . -133.83 154.07 21.16 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 114.43 -1.259 . . . . 0.0 114.078 -179.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 534' ' ' SER . . . . . 0.501 ' N ' ' HB ' ' A' ' 552' ' ' THR . 44.7 t -134.16 137.08 44.23 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.303 -0.449 . . . . 0.0 111.37 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 535' ' ' ARG . . . . . 0.703 ' O ' ' HB3' ' A' ' 573' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.326 0 C-N-CA 120.305 -0.558 . . . . 0.0 112.452 178.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 . . . . . 0 N--CA 1.45 -0.45 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 550' ' ' ASP . . . . . 0.519 ' O ' ' HA ' ' A' ' 535' ' ' ARG . 4.4 m-20 -59.34 -46.95 87.2 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.23 179.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 551' ' ' LEU . . . . . . . . . . . . . 15.9 tp -131.48 139.87 49.43 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.184 -0.917 . . . . 0.0 108.968 178.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 552' ' ' THR . . . . . 0.672 ' O ' ' HA2' ' A' ' 533' ' ' GLY . 23.6 m -133.43 148.15 51.76 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.667 0.746 . . . . 0.0 111.933 179.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 553' ' ' PHE . . . . . 0.52 ' CD2' ' CE2' ' A' ' 531' ' ' TYR . 9.6 m-85 -134.59 137.07 43.42 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 176.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 554' ' ' THR . . . . . 0.894 HG22 ' H ' ' A' ' 556' ' ' ILE . 2.8 m -133.21 139.03 32.95 Favored Pre-proline 0 C--N 1.306 -1.309 0 C-N-CA 119.745 -0.782 . . . . 0.0 109.554 178.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 555' ' ' PRO . . . . . 0.8 ' O ' HG22 ' A' ' 556' ' ' ILE . 81.2 Cg_endo -83.37 21.76 1.0 Allowed 'Trans proline' 0 N--CA 1.445 -1.324 0 C-N-CA 121.493 1.462 . . . . 0.0 111.878 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 556' ' ' ILE . . . . . 1.088 HG21 ' HA ' ' A' ' 528' ' ' ASN . 2.0 tp 63.74 32.65 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 177.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 4.0 tttm -104.07 120.06 40.28 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 558' ' ' THR . . . . . 0.641 ' HA ' ' CE1' ' A' ' 505' ' ' PHE . 8.4 t -57.85 116.66 3.6 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 115.988 1.847 . . . . 0.0 115.988 -172.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 559' ' ' TRP . . . . . 0.52 ' HB2' ' HB2' ' A' ' 563' ' ' LYS . 1.0 OUTLIER -138.4 111.19 7.68 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 103.638 -2.727 . . . . 0.0 103.638 173.796 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 560' ' ' ASN . . . . . 0.673 ' O ' HG22 ' A' ' 564' ' ' THR . 30.2 m120 -68.91 -75.87 0.1 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 -174.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 561' ' ' ALA . . . . . 0.683 ' HA ' ' CG2' ' A' ' 564' ' ' THR . . . -74.24 -48.77 26.59 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 -177.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 562' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.41 -54.72 16.03 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -177.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 563' ' ' LYS . . . . . 0.575 ' HB3' HG21 ' A' ' 504' ' ' THR . 0.0 OUTLIER -69.32 -48.63 60.91 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.087 0.402 . . . . 0.0 112.087 -178.653 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 564' ' ' THR . . . . . 0.833 HG23 ' H ' ' A' ' 565' ' ' GLN . 5.5 t -49.77 -71.32 0.07 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.661 0.267 . . . . 0.0 111.698 -178.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 565' ' ' GLN . . . . . 0.833 ' H ' HG23 ' A' ' 564' ' ' THR . 0.0 OUTLIER -48.73 -46.91 41.59 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.658 0.266 . . . . 0.0 111.66 179.966 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -49.98 -61.75 1.96 Allowed 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -178.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 567' ' ' PHE . . . . . 0.863 ' CE1' HD13 ' A' ' 568' ' ' ILE . 0.1 OUTLIER -96.66 -31.23 12.81 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -177.145 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 568' ' ' ILE . . . . . 0.897 HD11 HD13 ' A' ' 574' ' ' LEU . 1.0 OUTLIER -73.12 8.73 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.06 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -179.24 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 569' ' ' ILE . . . . . 0.705 HD12 ' N ' ' A' ' 570' ' ' ASP . 2.7 pp -53.57 -38.52 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 N-CA-C 104.709 -2.33 . . . . 0.0 104.709 178.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 570' ' ' ASP . . . . . 0.705 ' N ' HD12 ' A' ' 569' ' ' ILE . 9.7 t0 33.14 60.29 0.44 Allowed 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 114.179 -1.373 . . . . 0.0 111.936 172.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 571' ' ' GLY . . . . . 0.483 ' H ' HD12 ' A' ' 569' ' ' ILE . . . -55.06 -46.27 78.56 Favored Glycine 0 N--CA 1.439 -1.152 0 C-N-CA 116.861 -2.59 . . . . 0.0 107.784 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 572' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -120.85 -17.42 7.91 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 174.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 573' ' ' LEU . . . . . 0.703 ' HB3' ' O ' ' A' ' 535' ' ' ARG . 0.7 OUTLIER -140.57 137.49 33.76 Favored 'General case' 0 C--N 1.355 0.83 0 N-CA-C 116.175 1.917 . . . . 0.0 116.175 -177.848 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 574' ' ' LEU . . . . . 0.947 HD21 ' CG1' ' A' ' 508' ' ' VAL . 0.0 OUTLIER -134.92 134.1 40.28 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 173.612 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 575' ' ' ILE . . . . . 0.93 ' N ' HD12 ' A' ' 574' ' ' LEU . 0.0 OUTLIER -133.13 137.07 54.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-O 121.564 0.697 . . . . 0.0 111.818 179.393 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 576' ' ' LEU . . . . . 0.585 HD22 ' HB3' ' A' ' 509' ' ' LEU . 0.0 OUTLIER -133.19 135.8 45.3 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 177.25 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 577' ' ' LYS . . . . . . . . . . . . . 3.9 mtpt -129.98 135.38 48.24 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.656 178.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.475 HD21 HD11 ' A' ' 576' ' ' LEU . 0.2 OUTLIER -124.99 131.79 53.36 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 177.739 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 579' ' ' GLY . . . . . . . . . . . . . . . -90.78 -1.94 72.93 Favored Glycine 0 N--CA 1.442 -0.965 0 CA-C-N 115.169 -0.923 . . . . 0.0 113.494 -178.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 580' ' ' LYS . . . . . 0.769 ' HG2' HD12 ' A' ' 524' ' ' ILE . 3.0 pptp? -72.53 -47.73 46.0 Favored 'General case' 0 N--CA 1.438 -1.046 0 C-N-CA 118.851 -1.14 . . . . 0.0 108.726 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 581' ' ' TRP . . . . . 0.565 ' CG ' ' HD2' ' A' ' 580' ' ' LYS . 33.3 m0 -138.84 -53.21 0.58 Allowed 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 177.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 582' ' ' LYS . . . . . 0.63 ' HD3' HD11 ' A' ' 514' ' ' LEU . 0.0 OUTLIER -140.44 165.53 27.17 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 -174.316 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 583' ' ' MET . . . . . . . . . . . . . 1.1 ttt -109.32 134.89 51.24 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 173.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 584' ' ' LYS . . . . . 0.57 ' HB2' ' HG ' ' A' ' 514' ' ' LEU . 5.5 tppt? -120.08 133.77 55.43 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 178.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 585' ' ' LEU . . . . . 0.862 HD22 ' CD ' ' A' ' 492' ' ' ARG . 5.8 tt -120.0 136.38 54.57 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 -179.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 586' ' ' VAL . . . . . 0.764 HG22 HG23 ' A' ' 493' ' ' VAL . 72.0 t -133.31 137.65 52.82 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.813 -178.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 587' ' ' SER . . . . . . . . . . . . . 1.9 m -109.83 136.5 49.04 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 177.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.742 HG21 HG21 ' A' ' 500' ' ' VAL . 3.3 pt -133.35 136.35 54.95 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 -178.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 3.8 t -133.74 138.15 51.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 114.022 -1.445 . . . . 0.0 110.287 178.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 590' ' ' SER . . . . . . . . . . . . . 6.9 m . . . . . 0 C--N 1.325 -0.472 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.254 179.805 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 491' ' ' ALA . . . . . 0.412 ' CB ' HD21 ' A' ' 514' ' ' LEU . . . . . . . . 0 N--CA 1.457 -0.12 0 CA-C-O 120.57 0.224 . . . . 0.0 110.967 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 492' ' ' ARG . . . . . 0.692 ' HD3' HD22 ' A' ' 585' ' ' LEU . 10.6 tpt180 -136.25 134.38 38.01 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 178.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 493' ' ' VAL . . . . . 0.984 ' CG2' HG22 ' A' ' 586' ' ' VAL . 25.3 m -136.98 163.87 31.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 116.212 -0.449 . . . . 0.0 112.026 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 70.0 p -115.89 132.82 56.53 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 176.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 495' ' ' LEU . . . . . 0.994 ' O ' HG22 ' A' ' 588' ' ' ILE . 0.0 OUTLIER -136.62 162.84 53.76 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.637 -179.667 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 496' ' ' PRO . . . . . 0.696 ' HD2' HD12 ' A' ' 495' ' ' LEU . 9.8 Cg_exo -71.84 120.0 6.58 Favored 'Trans proline' 0 CA--C 1.534 0.481 0 C-N-CA 122.376 2.051 . . . . 0.0 111.328 178.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 497' ' ' LYS . . . . . 0.883 ' O ' HG12 ' A' ' 500' ' ' VAL . 0.1 OUTLIER -56.6 -30.25 63.0 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -178.739 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 498' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.56 -48.47 79.35 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -177.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 499' ' ' LEU . . . . . 0.824 HD11 HD11 ' A' ' 495' ' ' LEU . 2.6 pp -73.85 -9.08 58.29 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -178.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . 0.883 HG12 ' O ' ' A' ' 497' ' ' LYS . 3.5 p -75.34 -25.38 17.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.507 0.67 . . . . 0.0 111.595 -179.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 501' ' ' TYR . . . . . 0.676 ' O ' ' CG2' ' A' ' 564' ' ' THR . 2.6 m-30 -53.72 -29.27 38.54 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -178.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -76.67 -50.2 14.29 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 116.176 1.917 . . . . 0.0 116.176 -175.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 503' ' ' LYS . . . . . 0.579 ' O ' ' CG ' ' A' ' 507' ' ' LYS . 8.9 mttt -119.81 136.41 54.48 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 119.178 0.899 . . . . 0.0 112.561 -178.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . 0.799 HG23 ' CE1' ' A' ' 567' ' ' PHE . 51.0 m -74.07 -76.61 0.13 Allowed 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 179.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . 0.617 ' CZ ' HD13 ' A' ' 556' ' ' ILE . 0.2 OUTLIER -75.31 -60.98 2.06 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -178.965 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 506' ' ' SER . . . . . 0.783 ' O ' ' CD1' ' A' ' 510' ' ' TRP . 0.7 OUTLIER -49.6 -73.07 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 114.833 1.419 . . . . 0.0 114.833 -176.264 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 507' ' ' LYS . . . . . 0.698 ' HD3' ' N ' ' A' ' 508' ' ' VAL . 0.0 OUTLIER -49.18 -48.61 45.0 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -176.756 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 508' ' ' VAL . . . . . 0.87 HG13 HD21 ' A' ' 574' ' ' LEU . 98.0 t -53.91 -59.48 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 509' ' ' LEU . . . . . 0.797 HD12 ' N ' ' A' ' 510' ' ' TRP . 2.2 pp -56.52 -61.8 2.17 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 115.477 1.658 . . . . 0.0 115.477 -177.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 510' ' ' TRP . . . . . 0.859 ' CD1' ' HA ' ' A' ' 518' ' ' LYS . 67.1 p-90 -72.79 -51.46 18.9 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -176.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 511' ' ' SER . . . . . 0.497 ' N ' ' CE3' ' A' ' 510' ' ' TRP . 0.6 OUTLIER -64.18 -47.45 79.78 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.363 -0.835 . . . . 0.0 113.174 -176.854 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 512' ' ' ALA . . . . . 0.761 ' HB3' ' O ' ' A' ' 508' ' ' VAL . . . -70.95 -73.04 0.18 Allowed 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 117.796 2.517 . . . . 0.0 117.796 -174.085 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 513' ' ' GLY . . . . . 0.859 ' CA ' HG21 ' A' ' 493' ' ' VAL . . . -114.76 -35.2 1.42 Allowed Glycine 0 CA--C 1.5 -0.897 0 N-CA-C 120.853 3.101 . . . . 0.0 120.853 -172.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 514' ' ' LEU . . . . . 0.606 HD23 ' CG ' ' A' ' 584' ' ' LYS . 0.1 OUTLIER -107.14 -46.84 3.81 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 119.506 3.151 . . . . 0.0 119.506 -170.056 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 515' ' ' VAL . . . . . 1.012 HG13 ' HB2' ' A' ' 517' ' ' SER . 2.5 p -154.71 172.72 0.61 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.589 0 N-CA-C 117.887 2.551 . . . . 0.0 117.887 -172.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 516' ' ' ALA . . . . . 0.554 ' N ' HG22 ' A' ' 515' ' ' VAL . . . -67.89 4.18 1.26 Allowed 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 126.761 2.025 . . . . 0.0 109.696 177.099 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . 1.012 ' HB2' HG13 ' A' ' 515' ' ' VAL . 0.5 OUTLIER -57.55 9.28 0.01 OUTLIER 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 115.775 1.769 . . . . 0.0 115.775 -172.043 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 518' ' ' LYS . . . . . 0.859 ' HA ' ' CD1' ' A' ' 510' ' ' TRP . 0.0 OUTLIER -45.06 -46.82 11.73 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 104.351 -2.463 . . . . 0.0 104.351 175.413 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 519' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.16 -58.29 3.37 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.962 173.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 520' ' ' GLU . . . . . 0.846 ' HB2' ' HA ' ' A' ' 517' ' ' SER . 2.6 mm-40 -59.05 -47.44 85.21 Favored 'General case' 0 C--N 1.351 0.659 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.941 -178.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 521' ' ' GLY . . . . . 0.841 ' N ' ' O ' ' A' ' 517' ' ' SER . . . -49.12 -55.16 12.57 Favored Glycine 0 CA--C 1.493 -1.333 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.25 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -48.02 -47.42 33.45 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 523' ' ' ARG . . . . . 0.475 ' O ' ' HB3' ' A' ' 526' ' ' ASN . 0.1 OUTLIER -50.2 -48.94 54.02 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.988 178.463 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 524' ' ' ILE . . . . . 0.655 HD12 ' HD3' ' A' ' 580' ' ' LYS . 12.8 mm -58.24 -54.82 27.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.424 0.63 . . . . 0.0 109.717 179.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 525' ' ' ILE . . . . . 0.819 HG23 ' CD1' ' A' ' 556' ' ' ILE . 0.7 OUTLIER -50.4 -47.42 26.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 177.683 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 526' ' ' ASN . . . . . 0.475 ' HB3' ' O ' ' A' ' 523' ' ' ARG . 0.9 OUTLIER -55.8 -47.99 76.16 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 114.122 -1.399 . . . . 0.0 108.228 177.393 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 527' ' ' ASN . . . . . 0.483 ' ND2' ' O ' ' A' ' 524' ' ' ILE . 0.0 OUTLIER -48.13 -40.13 22.75 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.076 -1.42 . . . . 0.0 107.189 176.517 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 528' ' ' ASN . . . . . 0.559 ' HA ' ' CG2' ' A' ' 556' ' ' ILE . 13.5 t-20 73.67 40.47 0.49 Allowed 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 114.631 -1.168 . . . . 0.0 111.736 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 529' ' ' GLY . . . . . . . . . . . . . . . -115.69 27.64 8.23 Favored Glycine 0 CA--C 1.523 0.583 0 C-N-CA 120.337 -0.935 . . . . 0.0 112.779 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 530' ' ' ALA . . . . . 0.969 ' O ' ' HB ' ' A' ' 556' ' ' ILE . . . -133.96 164.03 28.21 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 112.524 0.565 . . . . 0.0 112.524 -179.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 531' ' ' TYR . . . . . 0.538 ' CE2' ' CD2' ' A' ' 553' ' ' PHE . 0.0 OUTLIER -133.99 156.02 48.93 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 177.875 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 532' ' ' VAL . . . . . 0.647 HG12 ' OG1' ' A' ' 554' ' ' THR . 0.5 OUTLIER -127.33 135.5 63.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 C-N-CA 119.537 -0.865 . . . . 0.0 112.123 -179.647 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 533' ' ' GLY . . . . . 0.685 ' O ' HG13 ' A' ' 575' ' ' ILE . . . -133.88 155.64 21.91 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 114.367 -1.288 . . . . 0.0 113.841 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 534' ' ' SER . . . . . 0.555 ' HB2' ' OG1' ' A' ' 552' ' ' THR . 0.6 OUTLIER -134.54 141.24 46.63 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.176 -0.512 . . . . 0.0 110.936 178.605 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 535' ' ' ARG . . . . . 0.569 ' O ' ' HB3' ' A' ' 573' ' ' LEU . 9.2 tpp85 . . . . . 0 CA--C 1.531 0.232 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 179.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 549' ' ' ASP . . . . . 0.69 ' HB3' HD11 ' A' ' 569' ' ' ILE . 9.9 m-20 . . . . . 0 N--CA 1.451 -0.423 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 550' ' ' ASP . . . . . 0.512 ' O ' ' HA ' ' A' ' 535' ' ' ARG . 1.2 p30 -51.85 -41.89 62.19 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.106 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 551' ' ' LEU . . . . . 0.622 HD21 ' HE1' ' A' ' 553' ' ' PHE . 10.7 tp -131.62 139.47 49.14 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.661 -1.154 . . . . 0.0 108.53 177.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 552' ' ' THR . . . . . 0.799 HG21 ' CB ' ' A' ' 567' ' ' PHE . 5.6 m -133.83 148.31 51.29 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.598 0.713 . . . . 0.0 111.756 179.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 553' ' ' PHE . . . . . 0.622 ' HE1' HD21 ' A' ' 551' ' ' LEU . 21.8 m-85 -134.25 137.65 44.48 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.07 -0.968 . . . . 0.0 108.613 177.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 554' ' ' THR . . . . . 0.849 HG22 ' H ' ' A' ' 556' ' ' ILE . 2.8 m -132.5 139.04 33.49 Favored Pre-proline 0 C--N 1.307 -1.253 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 555' ' ' PRO . . . . . 0.937 ' O ' HG22 ' A' ' 556' ' ' ILE . 77.5 Cg_endo -83.78 24.0 0.79 Allowed 'Trans proline' 0 N--CA 1.444 -1.411 0 C-N-CA 121.573 1.516 . . . . 0.0 112.142 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 556' ' ' ILE . . . . . 0.969 ' HB ' ' O ' ' A' ' 530' ' ' ALA . 7.3 tp 61.38 30.9 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 177.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . 0.505 ' HB3' ' CE2' ' A' ' 559' ' ' TRP . 0.3 OUTLIER -105.79 117.85 35.08 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 105.096 -2.187 . . . . 0.0 105.096 179.257 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 558' ' ' THR . . . . . . . . . . . . . 2.3 t -56.89 117.82 4.33 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -172.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 559' ' ' TRP . . . . . 0.512 ' HB2' ' CB ' ' A' ' 563' ' ' LYS . 5.4 m0 -136.58 111.8 9.08 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 104.981 -2.229 . . . . 0.0 104.981 175.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 560' ' ' ASN . . . . . 0.512 ' O ' ' HB ' ' A' ' 564' ' ' THR . 75.9 m-20 -78.25 -74.4 0.27 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -175.018 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 561' ' ' ALA . . . . . . . . . . . . . . . -73.16 -64.01 1.06 Allowed 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 115.752 1.76 . . . . 0.0 115.752 -176.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 562' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.01 -50.65 35.05 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -176.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 563' ' ' LYS . . . . . 0.638 ' CG ' HG21 ' A' ' 504' ' ' THR . 0.0 OUTLIER -70.67 -49.07 51.18 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.392 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 564' ' ' THR . . . . . 0.676 ' CG2' ' O ' ' A' ' 501' ' ' TYR . 2.0 t -53.7 -64.33 0.86 Allowed 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 121.114 -0.235 . . . . 0.0 110.922 -178.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 565' ' ' GLN . . . . . 0.521 ' N ' HG23 ' A' ' 564' ' ' THR . 0.0 OUTLIER -48.51 -47.46 38.89 Favored 'General case' 0 C--N 1.321 -0.643 0 O-C-N 122.135 -0.353 . . . . 0.0 111.195 179.012 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 566' ' ' GLU . . . . . 0.419 ' O ' ' CD1' ' A' ' 569' ' ' ILE . 1.8 tt0 -49.61 -56.13 11.12 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -178.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 567' ' ' PHE . . . . . 0.799 ' CB ' HG21 ' A' ' 552' ' ' THR . 0.4 OUTLIER -97.22 -45.09 6.65 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.417 0.627 . . . . 0.0 112.156 -178.387 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 568' ' ' ILE . . . . . 0.947 HD11 HD22 ' A' ' 574' ' ' LEU . 1.5 tp -58.0 9.29 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 569' ' ' ILE . . . . . 0.69 HD11 ' HB3' ' A' ' 549' ' ' ASP . 0.0 OUTLIER -55.09 -39.22 49.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 104.525 -2.398 . . . . 0.0 104.525 179.009 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 570' ' ' ASP . . . . . 0.649 ' CG ' HD11 ' A' ' 588' ' ' ILE . 15.1 p30 31.77 55.75 0.3 Allowed 'General case' 0 CA--C 1.51 -0.587 0 CA-C-N 114.04 -1.436 . . . . 0.0 112.643 173.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -51.39 -44.88 53.22 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 117.316 -2.373 . . . . 0.0 108.505 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 572' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -119.6 -16.44 8.85 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 175.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 573' ' ' LEU . . . . . 0.569 ' HB3' ' O ' ' A' ' 535' ' ' ARG . 1.3 tp -139.86 137.29 34.78 Favored 'General case' 0 C--N 1.353 0.746 0 N-CA-C 116.39 1.996 . . . . 0.0 116.39 -177.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 574' ' ' LEU . . . . . 0.947 HD22 HD11 ' A' ' 568' ' ' ILE . 0.2 OUTLIER -134.81 133.39 39.74 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 173.048 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 575' ' ' ILE . . . . . 0.925 ' N ' HD12 ' A' ' 574' ' ' LEU . 0.0 OUTLIER -134.09 138.24 50.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 118.86 0.754 . . . . 0.0 112.007 179.297 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 576' ' ' LEU . . . . . 0.551 HD11 ' HG ' ' A' ' 578' ' ' LEU . 0.1 OUTLIER -132.99 135.53 45.52 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 177.181 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 577' ' ' LYS . . . . . 0.406 ' N ' HD12 ' A' ' 576' ' ' LEU . 25.2 mttt -132.2 135.45 46.34 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 119.009 -1.076 . . . . 0.0 110.359 177.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.551 ' HG ' HD11 ' A' ' 576' ' ' LEU . 0.3 OUTLIER -124.45 131.91 53.5 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 177.84 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 579' ' ' GLY . . . . . . . . . . . . . . . -89.1 -2.2 78.04 Favored Glycine 0 CA--C 1.498 -0.976 0 CA-C-N 115.236 -0.893 . . . . 0.0 113.335 -178.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 580' ' ' LYS . . . . . 0.655 ' HD3' HD12 ' A' ' 524' ' ' ILE . 0.0 OUTLIER -72.41 -48.16 43.52 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 119.087 -1.045 . . . . 0.0 108.889 179.233 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 581' ' ' TRP . . . . . 0.449 ' CD1' ' O ' ' A' ' 580' ' ' LYS . 23.6 m0 -139.7 -53.12 0.53 Allowed 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 177.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 582' ' ' LYS . . . . . 0.486 ' O ' HD12 ' A' ' 578' ' ' LEU . 0.0 OUTLIER -140.26 165.37 27.58 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -174.636 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 583' ' ' MET . . . . . . . . . . . . . 1.9 ttt -110.76 134.52 52.41 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.468 -1.679 . . . . 0.0 106.468 173.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 584' ' ' LYS . . . . . 0.792 ' NZ ' HG12 ' A' ' 508' ' ' VAL . 0.5 OUTLIER -119.66 134.73 55.11 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 178.787 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 585' ' ' LEU . . . . . 0.721 ' HG ' HG23 ' A' ' 575' ' ' ILE . 5.7 tt -121.4 136.96 54.9 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 586' ' ' VAL . . . . . 0.984 HG22 ' CG2' ' A' ' 493' ' ' VAL . 30.7 t -132.19 137.07 55.4 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.734 -178.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 587' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -112.87 134.32 54.44 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 177.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.994 HG22 ' O ' ' A' ' 495' ' ' LEU . 0.1 OUTLIER -135.17 140.58 44.81 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.568 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -178.257 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 6.2 p -133.14 145.73 33.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 114.369 -1.287 . . . . 0.0 110.473 178.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 590' ' ' SER . . . . . . . . . . . . . 6.0 t . . . . . 0 C--N 1.326 -0.417 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.672 179.983 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 491' ' ' ALA . . . . . 0.467 ' CB ' HD21 ' A' ' 514' ' ' LEU . . . . . . . . 0 N--CA 1.463 0.216 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 492' ' ' ARG . . . . . 0.458 ' HD3' HD23 ' A' ' 585' ' ' LEU . 1.0 OUTLIER -136.49 131.69 34.32 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 175.561 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 493' ' ' VAL . . . . . 1.142 HG23 HG22 ' A' ' 586' ' ' VAL . 2.5 m -139.33 164.02 25.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.688 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 79.7 p -130.63 132.9 45.72 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.604 176.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 495' ' ' LEU . . . . . 1.002 HD23 ' HB2' ' A' ' 512' ' ' ALA . 2.2 pp -137.04 163.23 50.84 Favored Pre-proline 0 CA--C 1.53 0.18 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.588 178.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 496' ' ' PRO . . . . . 0.685 ' HB2' HD23 ' A' ' 499' ' ' LEU . 19.8 Cg_exo -63.29 119.21 6.19 Favored 'Trans proline' 0 CA--C 1.533 0.428 0 C-N-CA 121.921 1.747 . . . . 0.0 111.658 179.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 497' ' ' LYS . . . . . 0.462 ' CA ' ' HB ' ' A' ' 588' ' ' ILE . 23.7 ttpt -56.62 -30.39 63.23 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -178.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 498' ' ' SER . . . . . . . . . . . . . 12.2 t -55.94 -48.0 76.55 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -177.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 499' ' ' LEU . . . . . 0.757 HD12 ' NZ ' ' A' ' 507' ' ' LYS . 1.1 pp -73.45 -8.36 55.58 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -178.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 500' ' ' VAL . . . . . 0.796 HG22 HD11 ' A' ' 495' ' ' LEU . 12.0 t -74.59 -25.28 19.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.31 0.576 . . . . 0.0 111.793 -179.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 501' ' ' TYR . . . . . 0.627 ' O ' ' CG2' ' A' ' 564' ' ' THR . 3.1 m-85 -53.55 -29.69 38.18 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -178.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 502' ' ' ASP . . . . . 0.421 ' O ' ' HB2' ' A' ' 560' ' ' ASN . 2.1 m-20 -76.36 -50.09 15.12 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 115.807 1.78 . . . . 0.0 115.807 -175.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 503' ' ' LYS . . . . . 0.553 ' O ' ' CG ' ' A' ' 507' ' ' LYS . 0.1 OUTLIER -119.65 135.39 54.83 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-N 119.153 0.888 . . . . 0.0 111.939 -178.896 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . 0.696 HG21 ' CG ' ' A' ' 563' ' ' LYS . 69.7 m -73.21 -76.63 0.12 Allowed 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . 0.612 ' CZ ' ' HB1' ' A' ' 530' ' ' ALA . 0.3 OUTLIER -75.78 -59.12 2.89 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -179.416 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 506' ' ' SER . . . . . 0.817 ' O ' ' CD1' ' A' ' 510' ' ' TRP . 8.0 t -49.0 -71.48 0.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 -175.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 507' ' ' LYS . . . . . 0.757 ' NZ ' HD12 ' A' ' 499' ' ' LEU . 0.0 OUTLIER -48.01 -49.07 32.22 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -174.782 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 508' ' ' VAL . . . . . 0.758 HG21 HD11 ' A' ' 574' ' ' LEU . 0.2 OUTLIER -64.23 -49.57 80.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 C-N-CA 120.299 -0.561 . . . . 0.0 111.964 -178.467 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 509' ' ' LEU . . . . . 0.761 HD12 ' N ' ' A' ' 510' ' ' TRP . 1.1 pp -55.99 -62.07 1.95 Allowed 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 -178.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 510' ' ' TRP . . . . . 0.878 ' CD1' ' HA ' ' A' ' 518' ' ' LYS . 67.4 p-90 -73.08 -49.67 27.26 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 114.722 1.378 . . . . 0.0 114.722 -176.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 511' ' ' SER . . . . . 0.506 ' N ' ' CE3' ' A' ' 510' ' ' TRP . 0.3 OUTLIER -63.5 -47.61 81.0 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -176.606 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 512' ' ' ALA . . . . . 1.002 ' HB2' HD23 ' A' ' 495' ' ' LEU . . . -70.89 -73.62 0.17 Allowed 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 117.841 2.534 . . . . 0.0 117.841 -174.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 513' ' ' GLY . . . . . 0.938 ' HA2' HG11 ' A' ' 493' ' ' VAL . . . -115.05 -35.06 1.39 Allowed Glycine 0 CA--C 1.499 -0.945 0 N-CA-C 120.696 3.038 . . . . 0.0 120.696 -173.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 514' ' ' LEU . . . . . 0.672 HD23 ' CG ' ' A' ' 584' ' ' LYS . 0.1 OUTLIER -103.08 -47.97 4.18 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 119.105 3.002 . . . . 0.0 119.105 -170.171 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 515' ' ' VAL . . . . . 1.03 HG13 ' HB2' ' A' ' 517' ' ' SER . 2.4 p -155.99 172.26 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 117.606 2.447 . . . . 0.0 117.606 -173.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 516' ' ' ALA . . . . . 0.544 ' N ' ' CG2' ' A' ' 515' ' ' VAL . . . -68.06 4.08 1.36 Allowed 'General case' 0 C--O 1.231 0.104 0 C-N-CA 126.57 1.948 . . . . 0.0 109.636 176.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . 1.03 ' HB2' HG13 ' A' ' 515' ' ' VAL . 0.6 OUTLIER -57.63 8.89 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 116.065 1.876 . . . . 0.0 116.065 -171.984 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 518' ' ' LYS . . . . . 0.878 ' HA ' ' CD1' ' A' ' 510' ' ' TRP . 0.0 OUTLIER -45.4 -46.7 13.47 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 104.432 -2.433 . . . . 0.0 104.432 175.41 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 519' ' ' SER . . . . . . . . . . . . . 1.4 p -75.08 -59.11 2.89 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.607 -1.178 . . . . 0.0 109.966 173.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 520' ' ' GLU . . . . . 0.808 ' HB2' ' HA ' ' A' ' 517' ' ' SER . 2.7 mm-40 -58.28 -47.43 83.65 Favored 'General case' 0 C--N 1.35 0.629 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.75 -179.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 521' ' ' GLY . . . . . 0.839 ' N ' ' O ' ' A' ' 517' ' ' SER . . . -49.01 -53.98 16.37 Favored Glycine 0 CA--C 1.493 -1.317 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.072 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 522' ' ' GLN . . . . . 0.434 ' HA ' HG12 ' A' ' 525' ' ' ILE . 2.0 mm100 -47.91 -47.28 32.31 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 523' ' ' ARG . . . . . 0.478 ' O ' ' HB3' ' A' ' 526' ' ' ASN . 0.4 OUTLIER -50.33 -48.82 55.21 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.818 178.266 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 524' ' ' ILE . . . . . 0.591 HG21 HD22 ' A' ' 578' ' ' LEU . 18.2 mt -57.56 -54.86 25.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.518 0.675 . . . . 0.0 109.585 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 525' ' ' ILE . . . . . 0.825 HG23 ' CD1' ' A' ' 556' ' ' ILE . 0.6 OUTLIER -50.39 -47.47 26.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.834 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 526' ' ' ASN . . . . . 0.478 ' HB3' ' O ' ' A' ' 523' ' ' ARG . 0.9 OUTLIER -56.28 -47.44 78.63 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 113.987 -1.461 . . . . 0.0 108.434 177.651 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 527' ' ' ASN . . . . . 0.493 ' ND2' ' O ' ' A' ' 524' ' ' ILE . 0.0 OUTLIER -47.52 -39.85 17.28 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.115 -1.402 . . . . 0.0 107.523 177.056 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 528' ' ' ASN . . . . . 0.646 ' HA ' ' CG2' ' A' ' 556' ' ' ILE . 1.9 t30 73.79 40.21 0.49 Allowed 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.384 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 529' ' ' GLY . . . . . . . . . . . . . . . -118.05 31.22 5.75 Favored Glycine 0 CA--C 1.523 0.585 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.657 178.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 530' ' ' ALA . . . . . 0.921 ' O ' ' HB ' ' A' ' 556' ' ' ILE . . . -133.54 164.38 27.3 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.333 0.587 . . . . 0.0 112.541 -179.027 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 531' ' ' TYR . . . . . 0.581 ' CE1' ' HA ' ' A' ' 553' ' ' PHE . 0.0 OUTLIER -134.36 152.88 52.06 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 177.752 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 532' ' ' VAL . . . . . 0.628 HG12 ' OG1' ' A' ' 554' ' ' THR . 0.4 OUTLIER -126.04 135.82 62.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 CA-C-O 121.871 0.844 . . . . 0.0 111.745 179.75 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 533' ' ' GLY . . . . . 0.724 ' O ' HG13 ' A' ' 575' ' ' ILE . . . -133.31 152.86 20.54 Favored Glycine 0 N--CA 1.443 -0.844 0 CA-C-N 114.472 -1.24 . . . . 0.0 113.783 -179.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 534' ' ' SER . . . . . 0.582 ' HB2' ' OG1' ' A' ' 552' ' ' THR . 0.5 OUTLIER -134.26 141.83 47.12 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.147 -0.527 . . . . 0.0 110.903 179.079 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 535' ' ' ARG . . . . . 0.6 ' HB3' HD22 ' A' ' 573' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.27 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 179.225 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 549' ' ' ASP . . . . . 0.495 ' HB3' HD11 ' A' ' 569' ' ' ILE . 65.8 m-20 . . . . . 0 N--CA 1.449 -0.524 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 550' ' ' ASP . . . . . 0.582 ' O ' ' HA ' ' A' ' 535' ' ' ARG . 40.6 m-20 -54.55 -38.62 66.83 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 551' ' ' LEU . . . . . 0.602 HD21 ' HE1' ' A' ' 553' ' ' PHE . 14.7 tp -131.47 139.61 49.39 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.35 177.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 552' ' ' THR . . . . . 0.695 ' O ' ' HA2' ' A' ' 533' ' ' GLY . 28.9 m -133.54 146.67 51.26 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.714 0.769 . . . . 0.0 112.166 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 553' ' ' PHE . . . . . 0.602 ' HE1' HD21 ' A' ' 551' ' ' LEU . 24.8 m-85 -133.99 136.88 44.41 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 176.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 554' ' ' THR . . . . . 0.891 HG22 ' H ' ' A' ' 556' ' ' ILE . 1.9 m -133.55 138.98 32.41 Favored Pre-proline 0 C--N 1.304 -1.377 0 C-N-CA 120.042 -0.663 . . . . 0.0 109.515 178.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 555' ' ' PRO . . . . . 0.851 ' O ' HG22 ' A' ' 556' ' ' ILE . 81.3 Cg_endo -82.47 19.43 1.28 Allowed 'Trans proline' 0 N--CA 1.447 -1.216 0 C-N-CA 121.486 1.457 . . . . 0.0 111.561 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 556' ' ' ILE . . . . . 0.921 ' HB ' ' O ' ' A' ' 530' ' ' ALA . 4.1 tp 61.92 32.36 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 177.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 4.3 tttt -104.09 122.0 44.38 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 105.183 -2.155 . . . . 0.0 105.183 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 558' ' ' THR . . . . . . . . . . . . . 6.5 t -56.88 117.55 4.07 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 -171.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 559' ' ' TRP . . . . . 0.474 ' CH2' ' HD2' ' A' ' 555' ' ' PRO . 5.3 m0 -136.89 112.05 9.06 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 104.408 -2.442 . . . . 0.0 104.408 175.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 560' ' ' ASN . . . . . 0.514 ' O ' ' HB ' ' A' ' 564' ' ' THR . 2.5 p30 -80.93 -74.8 0.3 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 115.372 1.619 . . . . 0.0 115.372 -174.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 561' ' ' ALA . . . . . . . . . . . . . . . -72.9 -61.97 1.62 Allowed 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 115.181 1.548 . . . . 0.0 115.181 -176.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 562' ' ' SER . . . . . . . . . . . . . 85.5 p -49.27 -50.37 39.23 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -177.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 563' ' ' LYS . . . . . 0.696 ' CG ' HG21 ' A' ' 504' ' ' THR . 0.0 OUTLIER -70.98 -48.95 50.41 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -178.449 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 564' ' ' THR . . . . . 0.627 ' CG2' ' O ' ' A' ' 501' ' ' TYR . 2.0 t -54.09 -65.03 0.64 Allowed 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 121.218 -0.193 . . . . 0.0 111.35 -178.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 565' ' ' GLN . . . . . 0.709 ' O ' HG23 ' A' ' 569' ' ' ILE . 0.0 OUTLIER -49.0 -47.41 44.36 Favored 'General case' 0 C--N 1.321 -0.649 0 O-C-N 122.067 -0.395 . . . . 0.0 111.367 179.028 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -49.71 -67.0 0.3 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -178.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 567' ' ' PHE . . . . . 0.917 ' CZ ' HD13 ' A' ' 568' ' ' ILE . 0.2 OUTLIER -86.99 -43.25 12.49 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -178.056 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 568' ' ' ILE . . . . . 1.062 HD11 HD13 ' A' ' 574' ' ' LEU . 1.0 OUTLIER -62.05 8.69 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 -179.64 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 569' ' ' ILE . . . . . 0.709 HG23 ' O ' ' A' ' 565' ' ' GLN . 0.9 OUTLIER -54.72 -40.8 53.06 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 N-CA-C 105.048 -2.204 . . . . 0.0 105.048 178.905 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 570' ' ' ASP . . . . . 0.817 ' CB ' HD11 ' A' ' 588' ' ' ILE . 5.6 m-20 33.8 59.93 0.53 Allowed 'General case' 0 CA--C 1.507 -0.68 0 CA-C-N 113.833 -1.53 . . . . 0.0 112.994 173.113 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 571' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 570' ' ' ASP . . . -51.84 -45.06 55.84 Favored Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 116.865 -2.588 . . . . 0.0 108.088 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 572' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -120.41 -16.15 8.44 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 175.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 573' ' ' LEU . . . . . 0.6 HD22 ' HB3' ' A' ' 535' ' ' ARG . 2.0 tp -139.85 137.05 34.61 Favored 'General case' 0 C--N 1.354 0.772 0 N-CA-C 116.627 2.084 . . . . 0.0 116.627 -176.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 574' ' ' LEU . . . . . 1.062 HD13 HD11 ' A' ' 568' ' ' ILE . 0.1 OUTLIER -135.18 132.97 38.62 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 173.605 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 575' ' ' ILE . . . . . 1.057 HG23 HD13 ' A' ' 585' ' ' LEU . 0.0 OUTLIER -134.58 138.12 50.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 119.222 0.919 . . . . 0.0 111.763 178.786 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 576' ' ' LEU . . . . . 0.523 ' CD1' ' CE2' ' A' ' 505' ' ' PHE . 0.0 OUTLIER -132.93 135.35 45.49 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 176.875 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 577' ' ' LYS . . . . . 0.406 ' CG ' ' HE3' ' A' ' 583' ' ' MET . 0.9 OUTLIER -132.8 135.59 45.77 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 119.057 -1.057 . . . . 0.0 110.533 177.808 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.591 HD22 HG21 ' A' ' 524' ' ' ILE . 0.3 OUTLIER -123.86 131.87 53.66 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 177.749 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 579' ' ' GLY . . . . . . . . . . . . . . . -89.1 -2.06 78.29 Favored Glycine 0 N--CA 1.441 -1.007 0 CA-C-N 115.192 -0.913 . . . . 0.0 113.495 -178.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 580' ' ' LYS . . . . . 0.509 ' HD3' HG23 ' A' ' 524' ' ' ILE . 0.1 OUTLIER -74.33 -47.55 33.74 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 118.968 -1.093 . . . . 0.0 109.151 179.373 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 581' ' ' TRP . . . . . 0.462 ' CD1' ' O ' ' A' ' 580' ' ' LYS . 26.6 m0 -139.34 -52.63 0.55 Allowed 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 178.156 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 582' ' ' LYS . . . . . 0.564 ' O ' HD12 ' A' ' 578' ' ' LEU . 0.0 OUTLIER -139.81 165.25 27.79 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 -174.327 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 583' ' ' MET . . . . . 0.406 ' HE3' ' CG ' ' A' ' 577' ' ' LYS . 0.0 OUTLIER -113.75 134.53 54.7 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 174.099 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 584' ' ' LYS . . . . . 0.683 ' HE2' ' H ' ' A' ' 513' ' ' GLY . 0.3 OUTLIER -123.69 134.43 53.72 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.302 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 585' ' ' LEU . . . . . 1.057 HD13 HG23 ' A' ' 575' ' ' ILE . 6.1 tp -121.05 137.05 54.84 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -179.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 586' ' ' VAL . . . . . 1.142 HG22 HG23 ' A' ' 493' ' ' VAL . 6.0 t -131.56 136.75 56.72 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.67 -179.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 587' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.92 134.21 53.62 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 176.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.817 HD11 ' CB ' ' A' ' 570' ' ' ASP . 0.2 OUTLIER -134.96 147.74 29.33 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 -178.503 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 8.0 m -132.46 148.05 31.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 113.916 -1.493 . . . . 0.0 110.334 178.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 590' ' ' SER . . . . . . . . . . . . . 4.2 t . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.978 -179.706 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 454' ' ' MET . . . . . 0.448 ' N ' HG22 ' A' ' 457' ' ' THR . 1.5 mtt . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 120.62 0.248 . . . . 0.0 111.48 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 455' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -73.52 -43.89 0.6 Allowed 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.407 2.071 . . . . 0.0 112.351 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 456' ' ' ARG . . . . . . . . . . . . . 4.7 ptm180 -75.74 -26.49 57.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.014 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 457' ' ' THR . . . . . 0.448 HG22 ' N ' ' A' ' 454' ' ' MET . 4.9 t -105.89 32.4 4.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.941 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -62.51 170.27 2.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.091 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 7.5 t -110.17 97.01 28.41 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.899 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.25 117.1 3.28 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.527 2.151 . . . . 0.0 112.278 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . 86.84 56.58 2.19 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.522 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -100.43 149.22 35.9 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.718 0.294 . . . . 0.0 110.874 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.78 -174.08 1.02 Allowed 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.555 2.17 . . . . 0.0 112.308 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 15.7 mttt -101.48 -176.51 3.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.899 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 38.2 t -103.34 -73.31 0.67 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.959 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 77.8 p -59.67 -36.02 75.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.913 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . 0.979 HD21 HG23 ' A' ' 471' ' ' VAL . 8.6 mp -114.63 71.04 0.75 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.811 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 77.8 p -99.37 43.36 1.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.838 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 129.04 -36.88 2.31 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.246 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -110.54 117.51 33.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.866 0.365 . . . . 0.0 110.618 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 471' ' ' VAL . . . . . 0.979 HG23 HD21 ' A' ' 467' ' ' LEU . 11.1 p -113.24 108.34 25.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.136 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 6.9 p-10 -162.6 99.23 1.09 Allowed Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.943 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -68.71 -167.87 0.21 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.406 2.071 . . . . 0.0 112.28 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -135.91 36.77 2.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.87 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 43.6 t -100.54 -30.96 11.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.985 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 476' ' ' GLY . . . . . . . . . . . . . . . 120.48 -11.27 10.47 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.803 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 477' ' ' ASN . . . . . 0.486 ' N ' ' HD2' ' A' ' 478' ' ' PRO . 0.1 OUTLIER -50.11 -51.58 60.97 Favored Pre-proline 0 CA--C 1.53 0.193 0 CA-C-O 120.496 0.188 . . . . 0.0 111.48 -179.967 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 478' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' A' ' 477' ' ' ASN . 71.3 Cg_endo -75.45 -24.83 11.76 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.353 2.035 . . . . 0.0 112.524 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -62.86 84.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.921 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -77.13 113.69 33.11 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.996 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -49.76 -77.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.42 2.08 . . . . 0.0 112.461 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 482' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.56 -72.31 0.46 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.995 0.426 . . . . 0.0 110.719 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 483' ' ' THR . . . . . 0.805 HG23 ' HB2' ' A' ' 486' ' ' ALA . 1.7 t -136.79 139.43 41.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.712 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 484' ' ' ASN . . . . . 0.647 ' O ' ' CD ' ' A' ' 489' ' ' PRO . 1.9 m-80 -51.03 -55.66 16.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.096 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 485' ' ' PHE . . . . . 0.672 ' HA ' ' HG2' ' A' ' 489' ' ' PRO . 90.7 m-85 -49.01 -45.57 42.65 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.158 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 486' ' ' ALA . . . . . 0.805 ' HB2' HG23 ' A' ' 483' ' ' THR . . . -50.35 -70.0 0.1 Allowed 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -176.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -72.79 -76.51 0.12 Allowed 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 116.249 1.944 . . . . 0.0 116.249 -175.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 488' ' ' MET . . . . . 0.495 ' CB ' ' HD3' ' A' ' 489' ' ' PRO . 0.1 OUTLIER -54.95 -53.58 59.64 Favored Pre-proline 0 N--CA 1.474 0.755 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -177.346 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 489' ' ' PRO . . . . . 0.672 ' HG2' ' HA ' ' A' ' 485' ' ' PHE . 4.9 Cg_exo -88.31 41.85 0.66 Allowed 'Trans proline' 0 CA--C 1.528 0.178 0 C-N-CA 124.538 3.492 . . . . 0.0 114.306 -176.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . 0.563 ' HB2' ' O ' ' A' ' 486' ' ' ALA . 11.5 t -120.84 39.05 3.88 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 491' ' ' ALA . . . . . . . . . . . . . . . -106.04 135.1 48.09 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.687 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 492' ' ' ARG . . . . . 0.666 ' NE ' HD12 ' A' ' 585' ' ' LEU . 0.1 OUTLIER -135.31 136.01 41.25 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.661 -179.835 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 493' ' ' VAL . . . . . 0.577 ' O ' HG13 ' A' ' 586' ' ' VAL . 46.7 t -134.02 163.45 37.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.938 178.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . 0.57 ' N ' HG12 ' A' ' 493' ' ' VAL . 6.1 t -123.35 134.51 54.01 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 121.184 0.516 . . . . 0.0 111.377 178.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 495' ' ' LEU . . . . . 0.723 ' O ' HG22 ' A' ' 588' ' ' ILE . 0.2 OUTLIER -135.47 163.31 51.74 Favored Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.422 179.235 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 496' ' ' PRO . . . . . 0.548 ' HG2' ' CD2' ' A' ' 499' ' ' LEU . 19.5 Cg_endo -58.51 119.87 7.39 Favored 'Trans proline' 0 CA--C 1.532 0.409 0 C-N-CA 122.235 1.957 . . . . 0.0 112.214 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 497' ' ' LYS . . . . . 0.484 ' CA ' ' HB ' ' A' ' 588' ' ' ILE . 2.1 ttpp -57.72 -30.04 65.22 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -179.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 498' ' ' SER . . . . . 0.401 ' O ' ' CD1' ' A' ' 501' ' ' TYR . 0.3 OUTLIER -60.86 -48.9 79.71 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -176.59 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 499' ' ' LEU . . . . . 0.576 HD12 ' C ' ' A' ' 499' ' ' LEU . 3.1 pp -73.97 -8.24 55.38 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -178.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . 0.626 HG22 ' HZ1' ' A' ' 507' ' ' LYS . 26.6 t -73.0 -25.8 22.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.286 0.565 . . . . 0.0 111.355 -179.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 501' ' ' TYR . . . . . 0.704 ' O ' HG21 ' A' ' 564' ' ' THR . 0.4 OUTLIER -53.88 -29.72 42.85 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 -178.69 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -72.04 -50.05 31.62 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 -175.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 503' ' ' LYS . . . . . 0.599 ' O ' ' CG ' ' A' ' 507' ' ' LYS . 7.4 mttt -119.38 133.94 55.47 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 118.694 0.679 . . . . 0.0 111.142 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . 0.755 HG21 ' HB3' ' A' ' 563' ' ' LYS . 6.8 m -73.32 -76.61 0.12 Allowed 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . 0.821 ' CZ ' ' HB1' ' A' ' 530' ' ' ALA . 0.3 OUTLIER -75.52 -60.08 2.46 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -179.471 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 506' ' ' SER . . . . . 0.722 ' O ' ' CD1' ' A' ' 510' ' ' TRP . 8.0 t -48.97 -72.69 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 -176.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 507' ' ' LYS . . . . . 0.698 ' HD3' ' N ' ' A' ' 508' ' ' VAL . 0.0 OUTLIER -48.82 -48.38 41.57 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -176.893 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 508' ' ' VAL . . . . . 0.829 HG13 HD21 ' A' ' 574' ' ' LEU . 50.1 t -55.07 -58.71 3.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 509' ' ' LEU . . . . . 0.748 HD12 ' N ' ' A' ' 510' ' ' TRP . 2.0 pp -56.98 -60.1 4.08 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 -177.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 510' ' ' TRP . . . . . 0.913 ' CD1' ' HA ' ' A' ' 518' ' ' LYS . 63.2 p-90 -72.47 -51.77 18.73 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -176.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 511' ' ' SER . . . . . 0.525 ' N ' ' CE3' ' A' ' 510' ' ' TRP . 0.5 OUTLIER -66.35 -47.48 73.32 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -176.818 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 512' ' ' ALA . . . . . 0.785 ' HB3' ' O ' ' A' ' 508' ' ' VAL . . . -71.24 -72.81 0.2 Allowed 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 117.756 2.502 . . . . 0.0 117.756 -174.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 513' ' ' GLY . . . . . 0.59 ' H ' ' HE2' ' A' ' 584' ' ' LYS . . . -114.6 -35.57 1.4 Allowed Glycine 0 CA--C 1.5 -0.877 0 N-CA-C 121.39 3.316 . . . . 0.0 121.39 -172.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 514' ' ' LEU . . . . . 0.613 HD13 ' HG3' ' A' ' 582' ' ' LYS . 2.8 mt -108.16 -47.03 3.62 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 119.798 3.258 . . . . 0.0 119.798 -170.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 515' ' ' VAL . . . . . 0.613 HG12 ' N ' ' A' ' 516' ' ' ALA . 90.1 t -153.06 171.88 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.582 0 N-CA-C 117.073 2.249 . . . . 0.0 117.073 -172.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 516' ' ' ALA . . . . . 0.613 ' N ' HG12 ' A' ' 515' ' ' VAL . . . -69.09 3.04 2.3 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 113.012 -1.904 . . . . 0.0 109.366 175.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . 0.881 ' O ' ' N ' ' A' ' 521' ' ' GLY . 0.4 OUTLIER -58.35 8.75 0.01 OUTLIER 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 115.43 1.641 . . . . 0.0 115.43 -172.122 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 518' ' ' LYS . . . . . 0.913 ' HA ' ' CD1' ' A' ' 510' ' ' TRP . 0.0 OUTLIER -45.8 -45.41 14.79 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 104.321 -2.474 . . . . 0.0 104.321 175.74 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 519' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.32 -56.43 4.88 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.427 -1.26 . . . . 0.0 109.706 173.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 520' ' ' GLU . . . . . 0.809 ' HB2' ' HA ' ' A' ' 517' ' ' SER . 9.3 mm-40 -63.64 -48.31 77.81 Favored 'General case' 0 C--N 1.351 0.654 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.02 -179.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 521' ' ' GLY . . . . . 0.881 ' N ' ' O ' ' A' ' 517' ' ' SER . . . -54.9 -53.55 39.14 Favored Glycine 0 CA--C 1.499 -0.929 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.443 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . 0.494 ' HA ' HG12 ' A' ' 525' ' ' ILE . 0.1 OUTLIER -47.82 -48.31 30.75 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.109 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 523' ' ' ARG . . . . . 0.452 ' HB3' ' O ' ' A' ' 520' ' ' GLU . 1.5 tpt180 -50.67 -48.71 58.32 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.095 178.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 524' ' ' ILE . . . . . 0.536 HG23 ' HG2' ' A' ' 580' ' ' LYS . 34.0 mm -55.12 -54.07 28.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.352 0.596 . . . . 0.0 110.029 179.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 525' ' ' ILE . . . . . 1.007 HG23 HD11 ' A' ' 556' ' ' ILE . 0.6 OUTLIER -50.5 -47.48 27.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 177.715 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 526' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -56.56 -48.28 77.69 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 113.996 -1.456 . . . . 0.0 108.521 177.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 527' ' ' ASN . . . . . 0.445 ' ND2' ' O ' ' A' ' 524' ' ' ILE . 0.0 OUTLIER -48.35 -39.45 22.18 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 113.784 -1.553 . . . . 0.0 108.003 176.924 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 528' ' ' ASN . . . . . 0.71 ' HA ' HG23 ' A' ' 556' ' ' ILE . 0.5 OUTLIER 74.51 40.19 0.42 Allowed 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.185 -178.775 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 529' ' ' GLY . . . . . . . . . . . . . . . -119.26 37.96 2.99 Favored Glycine 0 CA--C 1.521 0.466 0 CA-C-N 114.595 -1.184 . . . . 0.0 111.826 178.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 530' ' ' ALA . . . . . 0.826 ' HB3' HG12 ' A' ' 556' ' ' ILE . . . -132.76 164.53 26.6 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.834 0.826 . . . . 0.0 112.42 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 531' ' ' TYR . . . . . 0.716 ' HA ' HG22 ' A' ' 554' ' ' THR . 2.2 t80 -135.02 152.89 52.13 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 124.89 1.276 . . . . 0.0 109.061 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 532' ' ' VAL . . . . . 0.535 ' HB ' HG21 ' A' ' 554' ' ' THR . 0.4 OUTLIER -133.42 135.67 55.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 CA-C-O 121.807 0.813 . . . . 0.0 111.564 178.69 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 533' ' ' GLY . . . . . 0.767 ' O ' HG13 ' A' ' 575' ' ' ILE . . . -133.16 150.08 19.74 Favored Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 114.464 -1.244 . . . . 0.0 113.414 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 534' ' ' SER . . . . . 0.551 ' OG ' ' O ' ' A' ' 567' ' ' PHE . 0.5 OUTLIER -134.92 137.21 42.93 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.51 -0.345 . . . . 0.0 111.307 178.848 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 535' ' ' ARG . . . . . 0.547 ' O ' ' HB3' ' A' ' 573' ' ' LEU . 24.8 tpt85 -159.55 90.49 1.91 Allowed Pre-proline 0 C--N 1.33 -0.257 0 C-N-CA 120.657 -0.417 . . . . 0.0 112.077 178.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 536' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -78.31 -43.65 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.686 2.257 . . . . 0.0 112.446 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 92.17 50.49 2.61 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.447 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 538' ' ' VAL . . . . . 0.53 HG13 ' N ' ' A' ' 539' ' ' LYS . 11.8 p -116.19 -45.98 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 CA-C-O 121.033 0.444 . . . . 0.0 111.357 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 539' ' ' LYS . . . . . 0.53 ' N ' HG13 ' A' ' 538' ' ' VAL . 0.1 OUTLIER -107.99 162.04 14.4 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.253 -178.589 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.35 30.79 5.67 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.741 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 541' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -94.04 99.86 12.09 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.178 0.514 . . . . 0.0 110.657 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 542' ' ' GLU . . . . . 0.424 ' CG ' ' HD2' ' A' ' 543' ' ' PRO . 0.0 OUTLIER -49.12 176.85 0.04 OUTLIER Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.119 179.884 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 543' ' ' PRO . . . . . 0.497 ' HA ' ' CB ' ' A' ' 548' ' ' PRO . 91.8 Cg_exo -44.22 -51.87 6.32 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.556 2.171 . . . . 0.0 112.59 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . 0.651 ' O ' ' N ' ' A' ' 546' ' ' GLY . . . 47.43 23.95 2.28 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 121.01 -0.614 . . . . 0.0 113.542 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 545' ' ' GLY . . . . . 0.648 ' O ' ' N ' ' A' ' 547' ' ' MET . . . 52.81 -48.69 0.01 OUTLIER Glycine 0 CA--C 1.53 1.031 0 N-CA-C 115.472 0.949 . . . . 0.0 115.472 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . 0.651 ' N ' ' O ' ' A' ' 544' ' ' GLY . . . -50.25 55.21 0.01 OUTLIER Glycine 0 CA--C 1.528 0.866 0 N-CA-C 115.599 1.0 . . . . 0.0 115.599 -178.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 547' ' ' MET . . . . . 0.648 ' N ' ' O ' ' A' ' 545' ' ' GLY . 0.3 OUTLIER 51.6 53.9 13.88 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 117.822 0.811 . . . . 0.0 111.637 179.2 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 548' ' ' PRO . . . . . 0.497 ' CB ' ' HA ' ' A' ' 543' ' ' PRO . 6.5 Cg_endo -47.63 166.84 0.1 OUTLIER 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 123.114 2.543 . . . . 0.0 112.584 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -123.85 -24.69 4.4 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.486 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 550' ' ' ASP . . . . . 0.492 ' O ' ' HA ' ' A' ' 535' ' ' ARG . 96.2 m-20 -65.37 -46.24 80.92 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.487 179.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 551' ' ' LEU . . . . . . . . . . . . . 19.4 tp -131.57 141.96 49.81 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.426 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 552' ' ' THR . . . . . 0.591 ' O ' ' HA2' ' A' ' 533' ' ' GLY . 37.9 m -132.23 147.83 52.43 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.486 0.66 . . . . 0.0 111.441 179.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 553' ' ' PHE . . . . . 0.69 ' CD1' ' HE2' ' A' ' 531' ' ' TYR . 8.9 m-30 -132.27 139.45 48.25 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.463 -1.244 . . . . 0.0 107.927 179.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 554' ' ' THR . . . . . 0.922 HG23 ' H ' ' A' ' 556' ' ' ILE . 0.4 OUTLIER -130.43 141.73 42.95 Favored Pre-proline 0 C--N 1.326 -0.434 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -178.727 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 555' ' ' PRO . . . . . 0.842 ' O ' HG22 ' A' ' 556' ' ' ILE . 78.8 Cg_endo -87.77 1.12 6.96 Favored 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 123.055 2.503 . . . . 0.0 110.152 177.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 556' ' ' ILE . . . . . 1.007 HD11 HG23 ' A' ' 525' ' ' ILE . 7.0 tp 62.71 34.02 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.312 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 178.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . 0.643 ' O ' ' CE2' ' A' ' 559' ' ' TRP . 33.5 mttt -103.48 142.21 34.66 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 558' ' ' THR . . . . . . . . . . . . . 3.4 t -57.42 116.22 3.2 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 -171.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 559' ' ' TRP . . . . . 0.643 ' CE2' ' O ' ' A' ' 557' ' ' LYS . 0.0 OUTLIER -139.5 112.27 7.91 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 112.827 -1.988 . . . . 0.0 105.803 174.442 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 560' ' ' ASN . . . . . 0.71 ' O ' HG22 ' A' ' 564' ' ' THR . 77.6 m-20 -84.0 -76.64 0.29 Allowed 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 118.123 -1.431 . . . . 0.0 113.541 -176.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 561' ' ' ALA . . . . . 0.649 ' HA ' ' CG2' ' A' ' 564' ' ' THR . . . -75.57 -50.33 15.91 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 -178.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 562' ' ' SER . . . . . . . . . . . . . 38.8 m -49.57 -54.83 16.0 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -177.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 563' ' ' LYS . . . . . 0.755 ' HB3' HG21 ' A' ' 504' ' ' THR . 2.1 mmpt? -70.5 -47.79 58.79 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -178.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 564' ' ' THR . . . . . 0.881 HG23 ' H ' ' A' ' 565' ' ' GLN . 3.9 t -49.27 -71.35 0.07 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.578 0.227 . . . . 0.0 111.556 -178.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 565' ' ' GLN . . . . . 0.881 ' H ' HG23 ' A' ' 564' ' ' THR . 0.0 OUTLIER -49.37 -46.45 47.2 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.785 0.326 . . . . 0.0 111.518 179.786 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -49.15 -61.32 2.14 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 567' ' ' PHE . . . . . 0.882 ' CZ ' HD13 ' A' ' 568' ' ' ILE . 0.2 OUTLIER -96.78 -40.68 8.84 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -177.529 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 568' ' ' ILE . . . . . 1.108 HD11 HD13 ' A' ' 574' ' ' LEU . 0.9 OUTLIER -62.81 8.09 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -179.413 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 569' ' ' ILE . . . . . 0.771 HG23 ' O ' ' A' ' 565' ' ' GLN . 0.8 OUTLIER -55.04 -40.39 54.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 178.482 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 570' ' ' ASP . . . . . 0.586 ' OD2' ' HB2' ' A' ' 574' ' ' LEU . 5.7 m-20 33.85 61.27 0.49 Allowed 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 114.04 -1.436 . . . . 0.0 112.576 173.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 571' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 570' ' ' ASP . . . -51.94 -45.45 56.07 Favored Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 116.856 -2.592 . . . . 0.0 108.222 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 572' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -120.8 -16.07 8.24 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 175.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 573' ' ' LEU . . . . . 0.547 ' HB3' ' O ' ' A' ' 535' ' ' ARG . 1.5 tp -139.87 136.95 34.48 Favored 'General case' 0 C--N 1.354 0.794 0 N-CA-C 116.591 2.071 . . . . 0.0 116.591 -176.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 574' ' ' LEU . . . . . 1.108 HD13 HD11 ' A' ' 568' ' ' ILE . 0.1 OUTLIER -135.11 133.24 39.03 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 173.503 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 575' ' ' ILE . . . . . 0.909 HG22 ' HB3' ' A' ' 585' ' ' LEU . 0.0 OUTLIER -134.72 138.3 49.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 119.087 0.858 . . . . 0.0 111.448 177.893 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 576' ' ' LEU . . . . . 0.532 ' CD1' ' CE2' ' A' ' 505' ' ' PHE . 0.1 OUTLIER -132.52 135.61 46.1 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 177.889 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 577' ' ' LYS . . . . . . . . . . . . . 12.0 mtpt -132.6 135.8 46.12 Favored 'General case' 0 C--N 1.31 -1.125 0 C-N-CA 119.593 -0.843 . . . . 0.0 110.582 178.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.543 HD12 ' O ' ' A' ' 582' ' ' LYS . 0.5 OUTLIER -126.75 131.83 51.23 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 177.579 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 579' ' ' GLY . . . . . . . . . . . . . . . -90.49 -2.27 73.41 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 115.432 -0.804 . . . . 0.0 113.424 -178.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 580' ' ' LYS . . . . . 0.536 ' HG2' HG23 ' A' ' 524' ' ' ILE . 0.0 OUTLIER -73.33 -48.22 36.14 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 119.043 -1.063 . . . . 0.0 109.097 179.338 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 581' ' ' TRP . . . . . 0.488 ' CD1' ' O ' ' A' ' 580' ' ' LYS . 24.1 m0 -139.07 -52.38 0.55 Allowed 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 114.606 1.335 . . . . 0.0 114.606 177.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 582' ' ' LYS . . . . . 0.613 ' HG3' HD13 ' A' ' 514' ' ' LEU . 0.0 OUTLIER -139.55 165.44 27.24 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -174.263 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 583' ' ' MET . . . . . 0.692 ' CE ' HD22 ' A' ' 585' ' ' LEU . 7.6 ttt -117.46 134.29 55.01 Favored 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 106.46 -1.681 . . . . 0.0 106.46 174.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 584' ' ' LYS . . . . . 0.662 ' HZ1' HG12 ' A' ' 508' ' ' VAL . 1.4 tmmt? -128.41 133.6 48.62 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 178.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 585' ' ' LEU . . . . . 0.909 ' HB3' HG22 ' A' ' 575' ' ' ILE . 0.0 OUTLIER -125.98 136.72 53.32 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.921 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 586' ' ' VAL . . . . . 0.641 HG23 ' HD3' ' A' ' 584' ' ' LYS . 24.8 t -131.06 144.91 36.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.554 -177.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 587' ' ' SER . . . . . . . . . . . . . 49.8 m -107.21 135.63 48.4 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 177.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.723 HG22 ' O ' ' A' ' 495' ' ' LEU . 23.0 pt -133.58 137.63 52.46 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.508 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -178.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 7.7 m -132.63 137.1 54.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 114.31 -1.314 . . . . 0.0 110.603 178.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 590' ' ' SER . . . . . . . . . . . . . 1.7 t -73.51 131.03 41.31 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.753 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 591' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -50.35 -49.0 55.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.413 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -51.54 -49.62 61.62 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.045 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 8.8 mmtp -51.57 -48.75 63.03 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.705 0.764 . . . . 0.0 109.363 179.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 594' ' ' PHE . . . . . 0.762 ' CD1' HD11 ' A' ' 597' ' ' LEU . 1.0 OUTLIER -50.19 -48.45 54.18 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.85 178.5 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 595' ' ' LYS . . . . . 0.568 ' HA ' ' CE2' ' A' ' 604' ' ' TRP . 4.4 mmpt? -49.6 -47.61 49.42 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 596' ' ' GLU . . . . . 0.549 ' O ' HD23 ' A' ' 599' ' ' LEU . 0.0 OUTLIER -53.44 -59.03 5.1 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -179.819 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 597' ' ' LEU . . . . . 0.762 HD11 ' CD1' ' A' ' 594' ' ' PHE . 1.9 pp -60.41 -58.0 10.36 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 121.239 0.543 . . . . 0.0 112.259 -178.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 598' ' ' GLY . . . . . 0.666 ' N ' HD12 ' A' ' 597' ' ' LEU . . . -82.0 13.28 38.72 Favored Glycine 0 C--N 1.32 -0.325 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.909 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 599' ' ' LEU . . . . . 0.565 HD12 ' N ' ' A' ' 600' ' ' THR . 3.7 pp -48.21 -11.42 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -175.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 600' ' ' THR . . . . . 0.576 HG22 ' O ' ' A' ' 600' ' ' THR . 29.1 m -140.32 65.99 1.4 Allowed 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.999 0.904 . . . . 0.0 110.897 177.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 601' ' ' ALA . . . . . 0.886 ' HB1' ' HD2' ' A' ' 602' ' ' PRO . . . -132.36 179.79 1.27 Allowed Pre-proline 0 N--CA 1.446 -0.664 0 CA-C-N 113.904 -1.498 . . . . 0.0 109.343 178.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 602' ' ' PRO . . . . . 0.886 ' HD2' ' HB1' ' A' ' 601' ' ' ALA . 87.6 Cg_endo -78.97 -7.31 15.36 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 121.891 1.727 . . . . 0.0 111.274 178.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 603' ' ' GLY . . . . . 0.662 ' O ' HG23 ' A' ' 607' ' ' VAL . . . -71.28 -50.13 23.17 Favored Glycine 0 C--N 1.335 0.491 0 CA-C-N 115.773 -0.649 . . . . 0.0 113.84 -179.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 604' ' ' TRP . . . . . 0.568 ' CE2' ' HA ' ' A' ' 595' ' ' LYS . 4.2 m95 -71.33 -46.22 61.1 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 117.339 0.57 . . . . 0.0 111.613 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 605' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -50.78 -54.95 19.28 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.901 0.382 . . . . 0.0 110.243 -179.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -60.86 -63.62 1.24 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.663 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 607' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 603' ' ' GLY . 52.2 t -50.82 -71.37 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -178.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 608' ' ' VAL . . . . . . . . . . . . . 98.6 t -69.38 -59.35 3.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -177.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 609' ' ' GLY . . . . . . . . . . . . . . . -57.94 -63.48 5.23 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 121.044 -0.598 . . . . 0.0 113.137 -178.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 610' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.02 -58.59 3.89 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.864 0.364 . . . . 0.0 110.857 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 57.63 29.04 60.65 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.553 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 11.2 pttt -126.63 38.99 4.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.841 0.353 . . . . 0.0 110.912 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 613' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -98.53 157.28 16.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.854 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -59.74 -60.78 9.48 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.884 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 615' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.24 96.17 0.79 Allowed 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.483 2.122 . . . . 0.0 112.291 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 616' ' ' SER . . . . . . . . . . . . . 6.9 m -67.61 149.35 98.35 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.865 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo . . . . . 0 C--O 1.248 1.015 0 C-N-CA 122.535 2.156 . . . . 0.0 112.342 179.992 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 2.3 mtm . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 120.609 0.242 . . . . 0.0 111.465 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 455' ' ' PRO . . . . . 0.604 ' HB2' ' HB2' ' A' ' 458' ' ' ALA . 77.3 Cg_exo -50.43 164.94 0.43 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.414 2.076 . . . . 0.0 112.307 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 456' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -82.47 -26.49 32.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.995 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 5.0 t -119.23 36.0 4.63 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.891 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 458' ' ' ALA . . . . . 0.604 ' HB2' ' HB2' ' A' ' 455' ' ' PRO . . . -84.07 130.71 34.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.111 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.46 174.79 5.13 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.877 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.4 139.17 55.86 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.599 2.2 . . . . 0.0 112.291 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . 130.49 43.11 0.2 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.539 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -109.69 155.2 41.84 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 120.715 0.293 . . . . 0.0 110.896 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.38 154.4 65.33 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.619 2.213 . . . . 0.0 112.322 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 4.5 pttt -59.8 152.4 23.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.892 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 1.9 m -96.81 22.17 8.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.174 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 6.8 t -69.88 -20.93 63.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.029 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . 0.672 ' O ' HD12 ' A' ' 467' ' ' LEU . 1.1 pp -71.44 74.53 0.75 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.874 0.369 . . . . 0.0 110.91 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 74.9 m -125.02 43.27 3.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.894 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 129.02 -36.95 2.3 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.276 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -116.76 117.71 30.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.865 0.364 . . . . 0.0 110.695 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 471' ' ' VAL . . . . . 0.582 HG13 ' O ' ' A' ' 471' ' ' VAL . 9.6 p -112.94 108.05 24.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.182 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -111.22 92.0 14.74 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.844 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -68.16 178.46 3.58 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.505 2.137 . . . . 0.0 112.289 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -97.93 36.7 1.51 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.921 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 1.2 p -60.15 -30.87 69.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.868 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 476' ' ' GLY . . . . . . . . . . . . . . . 119.84 -29.83 5.91 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.52 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 477' ' ' ASN . . . . . 0.461 ' N ' ' HD3' ' A' ' 478' ' ' PRO . 49.1 t30 50.97 53.31 13.67 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-O 120.653 0.263 . . . . 0.0 111.277 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 478' ' ' PRO . . . . . 0.461 ' HD3' ' N ' ' A' ' 477' ' ' ASN . 85.7 Cg_endo -84.36 34.23 0.51 Allowed 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.774 2.316 . . . . 0.0 112.918 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 -104.14 85.45 2.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.791 0.329 . . . . 0.0 111.008 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -117.27 149.99 45.53 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.038 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -85.15 39.81 0.76 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.799 2.333 . . . . 0.0 112.882 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 482' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.32 -39.84 61.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.094 0.473 . . . . 0.0 110.68 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 483' ' ' THR . . . . . . . . . . . . . 9.0 t -135.67 171.83 13.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.534 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 484' ' ' ASN . . . . . 0.55 ' O ' ' CD ' ' A' ' 489' ' ' PRO . 35.0 m-20 -104.7 -20.38 13.65 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.1 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 485' ' ' PHE . . . . . 0.66 ' HA ' ' HG2' ' A' ' 489' ' ' PRO . 2.6 m-85 -49.32 -47.2 47.31 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.575 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -71.78 -47.6 52.39 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -178.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -70.94 -74.24 0.15 Allowed 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 -176.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 488' ' ' MET . . . . . 0.541 ' HB2' ' HD3' ' A' ' 489' ' ' PRO . 2.1 mtt -52.52 -52.44 63.59 Favored Pre-proline 0 N--CA 1.472 0.672 0 O-C-N 122.09 -0.381 . . . . 0.0 112.001 -178.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 489' ' ' PRO . . . . . 0.66 ' HG2' ' HA ' ' A' ' 485' ' ' PHE . 15.3 Cg_exo -74.5 42.39 0.78 Allowed 'Trans proline' 0 N--CA 1.472 0.252 0 C-N-CA 124.114 3.209 . . . . 0.0 112.789 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 84.5 p -38.29 -36.23 0.21 Allowed 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -179.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 491' ' ' ALA . . . . . . . . . . . . . . . -132.87 135.97 45.92 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.631 -0.427 . . . . 0.0 112.081 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 492' ' ' ARG . . . . . 0.514 ' CG ' ' HG ' ' A' ' 585' ' ' LEU . 0.0 OUTLIER -135.27 134.05 39.56 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.061 178.759 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 493' ' ' VAL . . . . . 0.563 HG12 ' N ' ' A' ' 494' ' ' THR . 39.4 t -136.06 163.41 34.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.373 178.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . 0.805 HG23 ' O ' ' A' ' 587' ' ' SER . 53.5 m -125.41 133.66 52.42 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.119 0.485 . . . . 0.0 110.298 177.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 495' ' ' LEU . . . . . 0.913 HD11 HD11 ' A' ' 499' ' ' LEU . 0.0 OUTLIER -136.08 163.89 47.02 Favored Pre-proline 0 CA--C 1.53 0.196 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.578 179.686 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 496' ' ' PRO . . . . . 0.798 ' HB2' HD23 ' A' ' 499' ' ' LEU . 46.1 Cg_exo -54.37 119.65 6.73 Favored 'Trans proline' 0 CA--C 1.532 0.414 0 C-N-CA 121.931 1.754 . . . . 0.0 111.515 178.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 497' ' ' LYS . . . . . 0.502 ' CA ' ' HB ' ' A' ' 588' ' ' ILE . 0.8 OUTLIER -62.0 -30.28 70.83 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -179.204 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 498' ' ' SER . . . . . . . . . . . . . 2.1 m -58.15 -47.4 83.48 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -178.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 499' ' ' LEU . . . . . 0.913 HD11 HD11 ' A' ' 495' ' ' LEU . 2.2 pp -72.81 -7.83 52.61 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -178.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . 0.621 HG22 ' NZ ' ' A' ' 507' ' ' LYS . 42.9 t -74.46 -25.83 19.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.374 0.607 . . . . 0.0 111.243 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 501' ' ' TYR . . . . . 0.698 ' O ' HG21 ' A' ' 564' ' ' THR . 0.3 OUTLIER -53.86 -29.46 41.48 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 -178.449 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 502' ' ' ASP . . . . . 0.406 ' N ' ' CD1' ' A' ' 501' ' ' TYR . 8.6 m-20 -75.56 -50.15 16.45 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 -175.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 503' ' ' LYS . . . . . 0.588 ' O ' ' CG ' ' A' ' 507' ' ' LYS . 0.2 OUTLIER -119.23 135.11 54.84 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 118.868 0.758 . . . . 0.0 111.298 -179.656 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . 0.667 HG21 ' HB3' ' A' ' 563' ' ' LYS . 2.2 m -73.32 -76.52 0.12 Allowed 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . 0.644 ' CE1' HG23 ' A' ' 532' ' ' VAL . 0.3 OUTLIER -75.61 -60.39 2.33 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 -179.414 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 506' ' ' SER . . . . . 0.775 ' O ' ' CD1' ' A' ' 510' ' ' TRP . 8.0 t -48.97 -72.79 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -175.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 507' ' ' LYS . . . . . 0.694 ' HD3' ' N ' ' A' ' 508' ' ' VAL . 0.0 OUTLIER -49.37 -48.28 46.96 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -177.021 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 508' ' ' VAL . . . . . 0.88 ' CG2' HD21 ' A' ' 574' ' ' LEU . 50.9 t -51.65 -60.72 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 509' ' ' LEU . . . . . 0.806 HD12 ' N ' ' A' ' 510' ' ' TRP . 2.6 pp -58.37 -61.06 2.86 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 115.753 1.76 . . . . 0.0 115.753 -176.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 510' ' ' TRP . . . . . 0.856 ' CD1' ' HA ' ' A' ' 518' ' ' LYS . 66.7 p-90 -72.38 -52.14 17.34 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -176.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 511' ' ' SER . . . . . 0.509 ' N ' ' CE3' ' A' ' 510' ' ' TRP . 1.4 t -64.79 -47.8 76.77 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -177.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 512' ' ' ALA . . . . . 0.815 ' HB3' ' O ' ' A' ' 508' ' ' VAL . . . -71.4 -72.84 0.2 Allowed 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 117.728 2.492 . . . . 0.0 117.728 -174.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 513' ' ' GLY . . . . . 0.649 ' H ' ' HE2' ' A' ' 584' ' ' LYS . . . -114.55 -35.06 1.47 Allowed Glycine 0 CA--C 1.503 -0.701 0 N-CA-C 121.24 3.256 . . . . 0.0 121.24 -172.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 514' ' ' LEU . . . . . 0.522 ' HG ' ' CG ' ' A' ' 584' ' ' LYS . 3.2 mt -107.5 -46.37 3.86 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 119.356 3.095 . . . . 0.0 119.356 -170.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 515' ' ' VAL . . . . . 1.049 HG13 ' HB2' ' A' ' 517' ' ' SER . 2.4 p -154.6 173.1 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.646 0 N-CA-C 117.619 2.451 . . . . 0.0 117.619 -172.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 516' ' ' ALA . . . . . 0.551 ' N ' ' CG2' ' A' ' 515' ' ' VAL . . . -67.94 4.05 1.32 Allowed 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 126.599 1.96 . . . . 0.0 109.864 177.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . 1.049 ' HB2' HG13 ' A' ' 515' ' ' VAL . 0.6 OUTLIER -57.7 9.19 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 116.133 1.901 . . . . 0.0 116.133 -171.972 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 518' ' ' LYS . . . . . 0.856 ' HA ' ' CD1' ' A' ' 510' ' ' TRP . 0.6 OUTLIER -45.43 -47.42 13.75 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 104.268 -2.493 . . . . 0.0 104.268 175.398 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 519' ' ' SER . . . . . . . . . . . . . 68.5 p -74.98 -58.16 3.45 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 114.531 -1.213 . . . . 0.0 110.178 173.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 520' ' ' GLU . . . . . 0.822 ' HB3' ' HA ' ' A' ' 517' ' ' SER . 2.7 tp10 -59.9 -47.61 85.07 Favored 'General case' 0 C--N 1.35 0.598 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.747 -178.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 521' ' ' GLY . . . . . 0.832 ' N ' ' O ' ' A' ' 517' ' ' SER . . . -49.75 -55.4 14.37 Favored Glycine 0 CA--C 1.493 -1.3 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . 0.466 ' HA ' HG12 ' A' ' 525' ' ' ILE . 14.3 mt-30 -47.68 -47.82 29.47 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 523' ' ' ARG . . . . . 0.522 ' HB3' ' O ' ' A' ' 520' ' ' GLU . 0.1 OUTLIER -50.7 -49.01 58.56 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.536 178.475 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 524' ' ' ILE . . . . . 0.637 HG21 HD22 ' A' ' 578' ' ' LEU . 36.0 mm -56.65 -54.99 22.09 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 CA-C-O 121.352 0.596 . . . . 0.0 109.883 179.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 525' ' ' ILE . . . . . 0.819 HG23 ' CD1' ' A' ' 556' ' ' ILE . 0.5 OUTLIER -50.22 -47.2 25.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 177.739 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 526' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -55.03 -48.05 73.92 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 113.764 -1.562 . . . . 0.0 108.506 177.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 527' ' ' ASN . . . . . 0.492 ' ND2' ' O ' ' A' ' 524' ' ' ILE . 0.0 OUTLIER -48.17 -39.99 22.6 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 113.957 -1.474 . . . . 0.0 107.734 177.124 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 528' ' ' ASN . . . . . 0.645 ' HA ' ' CG2' ' A' ' 556' ' ' ILE . 0.2 OUTLIER 73.65 40.26 0.5 Allowed 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.349 -179.373 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 529' ' ' GLY . . . . . . . . . . . . . . . -119.68 32.71 4.9 Favored Glycine 0 CA--C 1.524 0.616 0 CA-C-N 115.0 -1.0 . . . . 0.0 112.597 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 530' ' ' ALA . . . . . 0.909 ' O ' ' HB ' ' A' ' 556' ' ' ILE . . . -133.48 164.57 26.85 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.246 0.546 . . . . 0.0 112.438 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 531' ' ' TYR . . . . . 0.582 ' HA ' ' O ' ' A' ' 554' ' ' THR . 0.0 OUTLIER -133.99 155.82 49.28 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 177.648 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 532' ' ' VAL . . . . . 0.644 HG23 ' CE1' ' A' ' 505' ' ' PHE . 0.5 OUTLIER -129.17 136.34 59.79 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 CA-C-O 121.789 0.804 . . . . 0.0 111.894 179.929 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 533' ' ' GLY . . . . . 0.752 ' O ' HG13 ' A' ' 575' ' ' ILE . . . -132.33 147.13 18.69 Favored Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 114.442 -1.254 . . . . 0.0 113.504 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 534' ' ' SER . . . . . 0.425 ' C ' ' HD2' ' A' ' 535' ' ' ARG . 3.4 m -134.7 136.73 42.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.248 -0.476 . . . . 0.0 111.43 179.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 535' ' ' ARG . . . . . 0.853 ' HG2' HD22 ' A' ' 573' ' ' LEU . 0.0 OUTLIER -160.17 91.41 1.73 Allowed Pre-proline 0 C--N 1.33 -0.266 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.966 178.349 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 536' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -77.72 -32.53 2.7 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.559 2.173 . . . . 0.0 112.16 179.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 72.22 54.62 7.73 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.575 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 538' ' ' VAL . . . . . 0.535 HG13 ' N ' ' A' ' 539' ' ' LYS . 12.3 p -116.2 -45.95 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 CA-C-O 121.005 0.431 . . . . 0.0 111.686 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 539' ' ' LYS . . . . . 0.535 ' N ' HG13 ' A' ' 538' ' ' VAL . 9.9 mtmm -107.7 152.21 24.63 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.948 -178.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 6.0 mtmt -98.03 30.65 2.98 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.739 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 541' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -88.71 100.12 12.88 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.53 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -48.46 153.81 1.26 Allowed Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.004 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 543' ' ' PRO . . . . . 0.411 ' CA ' ' HG3' ' A' ' 548' ' ' PRO . 75.1 Cg_exo -50.27 -52.25 9.33 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.575 2.183 . . . . 0.0 113.021 -179.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . 0.567 ' O ' ' N ' ' A' ' 546' ' ' GLY . . . 39.88 41.0 1.78 Allowed Glycine 0 CA--C 1.521 0.439 0 C-N-CA 121.047 -0.597 . . . . 0.0 113.121 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 545' ' ' GLY . . . . . 0.611 ' O ' ' N ' ' A' ' 547' ' ' MET . . . 53.86 -29.98 0.01 OUTLIER Glycine 0 CA--C 1.533 1.197 0 N-CA-C 115.355 0.902 . . . . 0.0 115.355 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . 0.567 ' N ' ' O ' ' A' ' 544' ' ' GLY . . . -51.91 55.37 0.01 OUTLIER Glycine 0 CA--C 1.528 0.904 0 N-CA-C 115.212 0.845 . . . . 0.0 115.212 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 547' ' ' MET . . . . . 0.611 ' N ' ' O ' ' A' ' 545' ' ' GLY . 0.0 OUTLIER 52.27 55.02 14.59 Favored Pre-proline 0 N--CA 1.464 0.233 0 CA-C-N 118.541 1.171 . . . . 0.0 110.959 -179.912 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 548' ' ' PRO . . . . . 0.461 ' HD3' ' N ' ' A' ' 547' ' ' MET . 84.9 Cg_exo -45.75 152.68 0.96 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 123.096 2.53 . . . . 0.0 113.433 -178.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 549' ' ' ASP . . . . . 0.476 ' HB2' HD11 ' A' ' 569' ' ' ILE . 2.3 p30 -124.66 -27.2 3.71 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.167 178.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 550' ' ' ASP . . . . . 0.507 ' O ' ' HB3' ' A' ' 535' ' ' ARG . 0.5 OUTLIER -58.66 -47.81 83.19 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.396 179.39 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 551' ' ' LEU . . . . . 0.634 HD21 ' HE1' ' A' ' 553' ' ' PHE . 7.1 tp -131.36 142.48 50.08 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.43 -0.805 . . . . 0.0 108.969 178.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 552' ' ' THR . . . . . 0.838 HG21 ' CG ' ' A' ' 567' ' ' PHE . 4.3 m -132.94 147.65 52.28 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.756 0.789 . . . . 0.0 112.395 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 553' ' ' PHE . . . . . 0.634 ' HE1' HD21 ' A' ' 551' ' ' LEU . 17.4 m-85 -133.71 136.95 44.99 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 176.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 554' ' ' THR . . . . . 0.863 HG22 ' H ' ' A' ' 556' ' ' ILE . 1.2 m -133.66 138.67 31.57 Favored Pre-proline 0 C--N 1.308 -1.224 0 C-N-CA 119.822 -0.751 . . . . 0.0 110.492 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 555' ' ' PRO . . . . . 0.827 ' O ' HG22 ' A' ' 556' ' ' ILE . 65.7 Cg_endo -83.49 19.24 1.37 Allowed 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 121.898 1.732 . . . . 0.0 111.764 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 556' ' ' ILE . . . . . 0.909 ' HB ' ' O ' ' A' ' 530' ' ' ALA . 4.5 tp 62.66 34.01 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.188 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 176.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . 0.599 ' O ' ' CE2' ' A' ' 559' ' ' TRP . 0.0 OUTLIER -103.82 126.03 50.66 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 179.897 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 558' ' ' THR . . . . . . . . . . . . . 3.6 t -57.81 118.22 5.09 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 115.413 1.634 . . . . 0.0 115.413 -172.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 559' ' ' TRP . . . . . 0.751 ' HZ2' HG23 ' A' ' 554' ' ' THR . 0.0 OUTLIER -138.5 130.7 28.56 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 175.214 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 560' ' ' ASN . . . . . 0.665 ' O ' HG22 ' A' ' 564' ' ' THR . 11.0 m-80 -90.88 -76.32 0.44 Allowed 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 118.305 -1.358 . . . . 0.0 114.116 -177.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 561' ' ' ALA . . . . . 0.526 ' HA ' ' CG2' ' A' ' 564' ' ' THR . . . -75.23 -57.29 3.98 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 116.368 1.988 . . . . 0.0 116.368 -177.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 562' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -49.0 -52.48 24.72 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -176.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 563' ' ' LYS . . . . . 0.667 ' HB3' HG21 ' A' ' 504' ' ' THR . 0.0 OUTLIER -70.8 -48.01 56.47 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -178.412 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 564' ' ' THR . . . . . 0.811 HG23 ' H ' ' A' ' 565' ' ' GLN . 6.8 t -49.63 -69.37 0.12 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.867 0.365 . . . . 0.0 111.288 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 565' ' ' GLN . . . . . 1.06 ' O ' HG23 ' A' ' 569' ' ' ILE . 2.0 tp60 -50.07 -46.62 53.48 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . 0.426 ' HG2' ' CD1' ' A' ' 567' ' ' PHE . 14.0 tt0 -49.24 -65.42 0.57 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 111.863 0.319 . . . . 0.0 111.863 -178.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 567' ' ' PHE . . . . . 0.838 ' CG ' HG21 ' A' ' 552' ' ' THR . 0.0 OUTLIER -97.18 -51.52 4.17 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.747 0.784 . . . . 0.0 112.007 -178.973 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 568' ' ' ILE . . . . . 0.643 ' CG1' HG23 ' A' ' 504' ' ' THR . 12.0 mm -57.26 9.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 114.321 -1.309 . . . . 0.0 113.321 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 569' ' ' ILE . . . . . 1.06 HG23 ' O ' ' A' ' 565' ' ' GLN . 0.9 OUTLIER -53.87 -39.03 38.23 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.845 0 N-CA-C 104.266 -2.494 . . . . 0.0 104.266 178.154 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 570' ' ' ASP . . . . . 0.916 ' CB ' HD11 ' A' ' 588' ' ' ILE . 32.5 m-20 35.45 50.0 0.53 Allowed 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 113.726 -1.579 . . . . 0.0 111.342 174.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -50.54 -44.13 46.03 Favored Glycine 0 N--CA 1.439 -1.101 0 C-N-CA 118.37 -1.871 . . . . 0.0 109.051 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 572' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -118.44 -18.09 9.24 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 120.252 -0.579 . . . . 0.0 112.16 175.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 573' ' ' LEU . . . . . 0.853 HD22 ' HG2' ' A' ' 535' ' ' ARG . 0.7 OUTLIER -141.2 137.68 32.8 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 574' ' ' LEU . . . . . 0.88 HD21 ' CG2' ' A' ' 508' ' ' VAL . 1.1 tp -133.98 131.94 39.54 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 174.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 575' ' ' ILE . . . . . 1.077 HG23 HD13 ' A' ' 585' ' ' LEU . 0.0 OUTLIER -134.64 137.19 51.58 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-N 118.557 0.617 . . . . 0.0 111.612 178.802 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 576' ' ' LEU . . . . . 0.547 HD22 ' CB ' ' A' ' 509' ' ' LEU . 0.0 OUTLIER -133.08 135.67 45.44 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 177.375 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 577' ' ' LYS . . . . . 0.44 ' HG2' ' HB2' ' A' ' 583' ' ' MET . 7.5 mttt -130.62 135.59 48.02 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.254 177.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.637 HD22 HG21 ' A' ' 524' ' ' ILE . 0.3 OUTLIER -124.88 132.01 53.36 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.871 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 579' ' ' GLY . . . . . . . . . . . . . . . -89.55 -2.19 76.6 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 115.229 -0.896 . . . . 0.0 113.251 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 580' ' ' LYS . . . . . 0.621 ' HG2' HG23 ' A' ' 524' ' ' ILE . 0.0 OUTLIER -72.56 -48.46 39.9 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 118.957 -1.097 . . . . 0.0 108.815 179.27 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 581' ' ' TRP . . . . . 0.491 ' CD1' ' O ' ' A' ' 580' ' ' LYS . 25.5 m0 -139.29 -53.02 0.55 Allowed 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 114.452 1.278 . . . . 0.0 114.452 177.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 582' ' ' LYS . . . . . 0.589 ' O ' HD12 ' A' ' 578' ' ' LEU . 0.1 OUTLIER -140.38 165.18 28.13 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -174.636 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 583' ' ' MET . . . . . 0.44 ' HB2' ' HG2' ' A' ' 577' ' ' LYS . 0.3 OUTLIER -113.97 134.78 54.62 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 174.156 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 584' ' ' LYS . . . . . 0.842 ' HD3' HG23 ' A' ' 586' ' ' VAL . 1.4 tmmt? -120.77 133.85 55.31 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 177.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 585' ' ' LEU . . . . . 1.077 HD13 HG23 ' A' ' 575' ' ' ILE . 1.4 tp -118.8 136.32 54.06 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 586' ' ' VAL . . . . . 0.848 ' N ' HD12 ' A' ' 585' ' ' LEU . 2.5 t -132.88 137.15 54.46 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -177.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 587' ' ' SER . . . . . 0.805 ' O ' HG23 ' A' ' 494' ' ' THR . 55.6 m -109.35 134.95 51.19 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 177.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.916 HD11 ' CB ' ' A' ' 570' ' ' ASP . 0.2 OUTLIER -134.6 152.63 33.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -178.649 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 4.6 t -122.6 138.82 51.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 114.031 -1.441 . . . . 0.0 110.781 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 590' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.62 143.96 55.78 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.163 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 591' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -52.81 -51.57 60.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.949 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 592' ' ' GLU . . . . . 0.441 ' HA ' ' HG3' ' A' ' 595' ' ' LYS . 0.9 OUTLIER -51.08 -50.52 58.57 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.18 -179.703 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 1.9 mmtp -50.3 -48.47 55.11 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.833 0.825 . . . . 0.0 109.102 178.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 594' ' ' PHE . . . . . 0.721 ' CD1' HD11 ' A' ' 597' ' ' LEU . 0.9 OUTLIER -50.06 -48.41 52.96 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.645 178.372 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 595' ' ' LYS . . . . . 0.497 ' HA ' ' CE2' ' A' ' 604' ' ' TRP . 6.3 mmpt? -49.43 -47.64 47.92 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 596' ' ' GLU . . . . . 0.496 ' O ' HD23 ' A' ' 599' ' ' LEU . 0.4 OUTLIER -50.93 -60.54 2.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.245 179.723 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 597' ' ' LEU . . . . . 0.721 HD11 ' CD1' ' A' ' 594' ' ' PHE . 0.6 OUTLIER -62.85 -63.31 1.25 Allowed 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 121.309 0.576 . . . . 0.0 112.105 -178.77 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 598' ' ' GLY . . . . . 0.45 ' N ' HD12 ' A' ' 597' ' ' LEU . . . -75.24 13.8 5.62 Favored Glycine 0 C--N 1.32 -0.349 0 CA-C-N 115.132 -0.94 . . . . 0.0 113.657 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 599' ' ' LEU . . . . . 0.664 HD12 ' N ' ' A' ' 600' ' ' THR . 2.6 pp -47.86 -14.89 0.05 Allowed 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -175.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 600' ' ' THR . . . . . 0.664 ' N ' HD12 ' A' ' 599' ' ' LEU . 11.1 t -131.69 66.75 1.54 Allowed 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.074 -0.65 . . . . 0.0 110.642 177.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 601' ' ' ALA . . . . . 0.724 ' HB1' ' HD2' ' A' ' 602' ' ' PRO . . . -131.33 166.57 26.88 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.441 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 602' ' ' PRO . . . . . 0.724 ' HD2' ' HB1' ' A' ' 601' ' ' ALA . 55.0 Cg_endo -68.5 -13.4 37.32 Favored 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 122.154 1.903 . . . . 0.0 111.437 178.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 603' ' ' GLY . . . . . 0.457 ' O ' HG23 ' A' ' 607' ' ' VAL . . . -69.1 -48.95 43.73 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.549 -0.75 . . . . 0.0 113.184 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 604' ' ' TRP . . . . . 0.515 ' CD1' ' HA ' ' A' ' 599' ' ' LEU . 0.9 OUTLIER -64.12 -46.57 83.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.799 0.333 . . . . 0.0 111.223 -179.557 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 605' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -50.3 -60.0 3.42 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.386 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 606' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 610' ' ' LYS . 0.3 OUTLIER -61.28 -59.06 5.88 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -179.614 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 607' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 603' ' ' GLY . 90.3 t -50.66 -71.95 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 113.801 1.038 . . . . 0.0 113.801 -178.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 608' ' ' VAL . . . . . . . . . . . . . 76.2 t -70.56 -60.17 2.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -177.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 609' ' ' GLY . . . . . . . . . . . . . . . -55.42 -64.7 4.14 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 121.326 -0.464 . . . . 0.0 113.529 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 610' ' ' LYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 606' ' ' GLU . 19.8 mttt -70.42 -63.05 1.16 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.771 0.32 . . . . 0.0 110.951 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 79.71 56.51 3.32 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.693 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.25 37.37 1.25 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.844 0.354 . . . . 0.0 110.95 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 613' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -120.01 -173.69 2.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.777 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . 0.411 ' CB ' ' CD ' ' A' ' 615' ' ' PRO . 13.0 mt-10 -68.72 -60.71 4.3 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.948 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 615' ' ' PRO . . . . . 0.411 ' CD ' ' CB ' ' A' ' 614' ' ' GLU . 59.9 Cg_endo -72.41 111.09 3.13 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.529 2.153 . . . . 0.0 112.271 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 616' ' ' SER . . . . . . . . . . . . . 4.1 m -130.12 149.47 73.32 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.867 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo . . . . . 0 C--O 1.249 1.059 0 C-N-CA 122.569 2.179 . . . . 0.0 112.285 179.998 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 454' ' ' MET . . . . . 0.682 ' O ' HG22 ' A' ' 457' ' ' THR . 4.8 mtp . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.759 0.314 . . . . 0.0 111.215 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 455' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -69.61 -26.45 28.28 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.578 2.185 . . . . 0.0 112.396 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 456' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.31 -26.53 61.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.033 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 457' ' ' THR . . . . . 0.682 HG22 ' O ' ' A' ' 454' ' ' MET . 10.4 t -97.03 39.48 1.18 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.916 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -91.13 119.59 31.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.153 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 7.5 t -61.84 111.39 4.39 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.897 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -50.84 160.27 1.94 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.462 2.108 . . . . 0.0 112.368 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . 107.34 50.6 0.81 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.447 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -103.57 91.38 3.33 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 120.636 0.255 . . . . 0.0 110.978 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.08 142.04 54.84 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.39 2.06 . . . . 0.0 112.321 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.83 123.52 17.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.0 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 1.4 m -113.39 -45.6 3.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.846 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 13.0 t -123.5 31.31 5.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.83 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . 0.429 HD11 HG23 ' A' ' 471' ' ' VAL . 0.5 OUTLIER -108.23 86.01 2.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.875 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -120.08 43.46 2.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.758 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 129.05 -36.96 2.3 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.089 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -106.41 117.52 34.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.848 0.356 . . . . 0.0 110.424 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 471' ' ' VAL . . . . . 0.589 HG13 ' O ' ' A' ' 471' ' ' VAL . 10.4 p -113.17 108.18 24.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.23 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 31.8 m-20 -155.68 87.86 3.07 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.808 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -60.54 77.43 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.784 2.323 . . . . 0.0 112.402 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -136.19 30.01 3.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.893 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 44.1 m -89.0 -52.35 5.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.979 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 476' ' ' GLY . . . . . . . . . . . . . . . 106.89 44.03 1.34 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.412 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 477' ' ' ASN . . . . . 0.468 ' N ' ' CD ' ' A' ' 478' ' ' PRO . 0.7 OUTLIER -50.45 -47.99 82.41 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 478' ' ' PRO . . . . . 0.468 ' CD ' ' N ' ' A' ' 477' ' ' ASN . 81.5 Cg_exo -45.05 -67.51 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.784 2.323 . . . . 0.0 113.366 -179.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -124.41 175.53 7.05 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.816 0.341 . . . . 0.0 111.255 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -56.83 108.28 1.17 Allowed Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.04 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 481' ' ' PRO . . . . . 0.414 ' HB2' ' H ' ' A' ' 482' ' ' GLN . 78.4 Cg_exo -52.25 -79.02 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.496 2.131 . . . . 0.0 112.576 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 482' ' ' GLN . . . . . 0.414 ' H ' ' HB2' ' A' ' 481' ' ' PRO . 1.4 tm0? -136.07 -50.4 0.7 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.35 0.595 . . . . 0.0 109.569 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 483' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.04 172.0 9.32 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.157 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 484' ' ' ASN . . . . . . . . . . . . . 19.4 m-20 -85.44 18.99 2.48 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.76 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 485' ' ' PHE . . . . . 0.884 ' HB3' HD11 ' A' ' 573' ' ' LEU . 45.0 p90 -58.46 -52.02 67.38 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.745 0.307 . . . . 0.0 110.433 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 486' ' ' ALA . . . . . 0.431 ' N ' ' CG ' ' A' ' 485' ' ' PHE . . . -72.41 -47.3 50.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.357 0.598 . . . . 0.0 110.05 178.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -50.05 -48.34 52.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.622 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 488' ' ' MET . . . . . 0.479 ' N ' ' CD ' ' A' ' 489' ' ' PRO . 2.5 mtt 52.57 51.35 9.3 Favored Pre-proline 0 CA--C 1.529 0.149 0 CA-C-O 121.102 0.477 . . . . 0.0 110.381 -178.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 489' ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' A' ' 488' ' ' MET . 40.3 Cg_exo -33.16 -57.07 0.34 Allowed 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.901 3.067 . . . . 0.0 114.41 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 3.5 m -120.07 -66.92 1.02 Allowed 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -178.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 491' ' ' ALA . . . . . 0.402 ' CB ' HD21 ' A' ' 514' ' ' LEU . . . -134.0 139.75 46.26 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -178.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 492' ' ' ARG . . . . . 0.477 ' HD3' HD23 ' A' ' 585' ' ' LEU . 0.0 OUTLIER -134.32 133.12 40.34 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.726 177.366 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 493' ' ' VAL . . . . . 0.637 HG21 ' CA ' ' A' ' 513' ' ' GLY . 44.5 t -136.98 163.69 31.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . 0.587 ' N ' HG12 ' A' ' 493' ' ' VAL . 32.3 p -117.69 134.25 55.09 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 121.147 0.498 . . . . 0.0 110.127 177.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 495' ' ' LEU . . . . . 1.056 HD22 ' HB2' ' A' ' 512' ' ' ALA . 0.0 OUTLIER -135.22 164.4 44.08 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.377 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 496' ' ' PRO . . . . . 0.898 ' HD2' HD12 ' A' ' 495' ' ' LEU . 11.9 Cg_exo -69.63 119.39 6.35 Favored 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 122.065 1.844 . . . . 0.0 111.199 178.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 497' ' ' LYS . . . . . 0.503 ' HB2' ' N ' ' A' ' 589' ' ' VAL . 2.4 ttpt -57.43 -30.21 64.79 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -178.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 498' ' ' SER . . . . . 0.418 ' O ' ' CD1' ' A' ' 501' ' ' TYR . 0.3 OUTLIER -59.14 -48.7 80.66 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 114.414 1.264 . . . . 0.0 114.414 -176.757 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 499' ' ' LEU . . . . . 0.548 HD21 ' HD2' ' A' ' 496' ' ' PRO . 1.5 pp -74.2 -10.24 59.41 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -178.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . 0.715 HG21 HG21 ' A' ' 588' ' ' ILE . 20.8 t -76.54 -27.21 17.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.337 0.589 . . . . 0.0 111.88 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 501' ' ' TYR . . . . . 0.596 ' O ' HG21 ' A' ' 564' ' ' THR . 0.3 OUTLIER -54.09 -30.6 49.03 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -177.704 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 502' ' ' ASP . . . . . 0.432 ' N ' ' CD1' ' A' ' 501' ' ' TYR . 4.6 t0 -75.78 -51.3 12.94 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 -175.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 503' ' ' LYS . . . . . 0.62 ' HB3' ' HG2' ' A' ' 507' ' ' LYS . 0.0 OUTLIER -120.59 140.6 51.28 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 118.76 0.709 . . . . 0.0 110.572 178.936 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . 0.749 HG23 ' CG1' ' A' ' 568' ' ' ILE . 3.3 m -72.6 -74.4 0.17 Allowed 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -178.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . 0.743 ' CZ ' ' HB1' ' A' ' 530' ' ' ALA . 0.2 OUTLIER -73.3 -57.63 3.88 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -177.262 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 506' ' ' SER . . . . . 0.849 ' O ' ' CD1' ' A' ' 510' ' ' TRP . 10.1 t -48.8 -66.38 0.41 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -176.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 507' ' ' LYS . . . . . 0.62 ' HG2' ' HB3' ' A' ' 503' ' ' LYS . 0.0 OUTLIER -48.75 -56.13 9.51 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -176.849 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 508' ' ' VAL . . . . . 0.975 ' CG2' HD21 ' A' ' 574' ' ' LEU . 48.4 t -49.9 -61.14 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -179.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 509' ' ' LEU . . . . . 0.816 HD12 ' N ' ' A' ' 510' ' ' TRP . 2.5 pp -54.27 -63.07 1.27 Allowed 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 115.626 1.713 . . . . 0.0 115.626 -177.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 510' ' ' TRP . . . . . 0.873 ' CD1' ' HA ' ' A' ' 518' ' ' LYS . 66.3 p-90 -72.85 -51.39 18.95 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 -175.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 511' ' ' SER . . . . . 0.529 ' N ' ' CE3' ' A' ' 510' ' ' TRP . 0.3 OUTLIER -64.39 -47.19 80.18 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.299 -0.864 . . . . 0.0 113.305 -176.753 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 512' ' ' ALA . . . . . 1.056 ' HB2' HD22 ' A' ' 495' ' ' LEU . . . -70.92 -73.79 0.16 Allowed 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 118.158 2.651 . . . . 0.0 118.158 -173.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 513' ' ' GLY . . . . . 0.675 ' H ' ' HE2' ' A' ' 584' ' ' LYS . . . -115.48 -34.98 1.35 Allowed Glycine 0 CA--C 1.501 -0.825 0 N-CA-C 120.84 3.096 . . . . 0.0 120.84 -172.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 514' ' ' LEU . . . . . 0.619 ' HG ' ' HB2' ' A' ' 584' ' ' LYS . 0.1 OUTLIER -106.86 -46.53 3.93 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 119.473 3.138 . . . . 0.0 119.473 -169.887 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 515' ' ' VAL . . . . . 1.038 HG13 ' HB2' ' A' ' 517' ' ' SER . 2.5 p -154.4 172.29 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 N-CA-C 117.981 2.585 . . . . 0.0 117.981 -172.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 516' ' ' ALA . . . . . 0.546 ' N ' HG22 ' A' ' 515' ' ' VAL . . . -68.62 3.71 1.74 Allowed 'General case' 0 C--N 1.333 -0.109 0 C-N-CA 126.741 2.016 . . . . 0.0 110.012 177.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . 1.038 ' HB2' HG13 ' A' ' 515' ' ' VAL . 0.6 OUTLIER -57.84 9.1 0.01 OUTLIER 'General case' 0 N--CA 1.428 -1.526 0 N-CA-C 116.153 1.909 . . . . 0.0 116.153 -171.797 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 518' ' ' LYS . . . . . 0.873 ' HA ' ' CD1' ' A' ' 510' ' ' TRP . 0.1 OUTLIER -45.3 -46.93 13.04 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 104.277 -2.49 . . . . 0.0 104.277 175.423 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 519' ' ' SER . . . . . . . . . . . . . 58.0 p -75.1 -60.05 2.47 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 114.658 -1.156 . . . . 0.0 110.15 173.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 520' ' ' GLU . . . . . 0.806 ' HB3' ' HA ' ' A' ' 517' ' ' SER . 5.7 tp10 -57.81 -47.47 82.52 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.497 -179.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 521' ' ' GLY . . . . . 0.834 ' N ' ' O ' ' A' ' 517' ' ' SER . . . -49.29 -54.37 16.02 Favored Glycine 0 CA--C 1.493 -1.328 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.033 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . 0.444 ' HA ' HG12 ' A' ' 525' ' ' ILE . 0.9 OUTLIER -47.42 -47.33 26.72 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.465 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 523' ' ' ARG . . . . . 0.463 ' O ' ' HB2' ' A' ' 526' ' ' ASN . 2.2 ttt180 -50.4 -48.78 55.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.844 178.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 524' ' ' ILE . . . . . 0.576 HD13 ' CE ' ' A' ' 580' ' ' LYS . 23.1 mt -58.25 -55.2 23.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.412 0.625 . . . . 0.0 109.827 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 525' ' ' ILE . . . . . 0.882 HG23 HD11 ' A' ' 556' ' ' ILE . 0.3 OUTLIER -50.02 -47.58 23.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 177.761 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 526' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 523' ' ' ARG . 32.1 m-20 -56.17 -47.89 77.39 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 114.35 -1.295 . . . . 0.0 108.23 177.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 527' ' ' ASN . . . . . 0.47 ' ND2' ' O ' ' A' ' 524' ' ' ILE . 0.0 OUTLIER -47.9 -40.24 21.27 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 113.986 -1.461 . . . . 0.0 107.534 176.817 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 528' ' ' ASN . . . . . 0.663 ' HA ' HG23 ' A' ' 556' ' ' ILE . 1.7 t-20 73.44 40.28 0.53 Allowed 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.461 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 529' ' ' GLY . . . . . . . . . . . . . . . -116.33 31.68 5.9 Favored Glycine 0 CA--C 1.522 0.523 0 CA-C-N 114.994 -1.003 . . . . 0.0 112.436 178.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 530' ' ' ALA . . . . . 0.87 ' O ' ' HB ' ' A' ' 556' ' ' ILE . . . -133.44 164.42 27.17 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.532 0.682 . . . . 0.0 112.749 -179.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 531' ' ' TYR . . . . . 0.728 ' HA ' HG22 ' A' ' 554' ' ' THR . 0.0 OUTLIER -134.65 157.92 45.41 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.752 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 532' ' ' VAL . . . . . 0.674 HG23 ' CE1' ' A' ' 505' ' ' PHE . 0.5 OUTLIER -132.84 136.62 55.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-O 121.921 0.867 . . . . 0.0 112.133 179.886 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 533' ' ' GLY . . . . . 0.803 ' O ' HG13 ' A' ' 575' ' ' ILE . . . -128.64 148.63 18.07 Favored Glycine 0 N--CA 1.441 -1.01 0 CA-C-N 114.155 -1.384 . . . . 0.0 112.609 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 534' ' ' SER . . . . . 0.455 ' N ' ' HB ' ' A' ' 552' ' ' THR . 0.2 OUTLIER -134.73 146.88 49.84 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.528 -0.336 . . . . 0.0 110.617 179.62 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 535' ' ' ARG . . . . . 0.856 ' HB3' HD22 ' A' ' 573' ' ' LEU . 0.0 OUTLIER -159.52 89.71 1.95 Allowed Pre-proline 0 N--CA 1.464 0.233 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 178.961 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 536' ' ' PRO . . . . . 0.551 ' HD2' ' HA ' ' A' ' 550' ' ' ASP . 35.0 Cg_endo -63.8 -35.61 55.81 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.383 2.055 . . . . 0.0 112.002 178.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 91.7 57.05 1.56 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.727 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 538' ' ' VAL . . . . . 0.515 HG13 ' N ' ' A' ' 539' ' ' LYS . 11.8 p -116.28 -46.28 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 CA-C-O 121.084 0.469 . . . . 0.0 111.704 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 539' ' ' LYS . . . . . 0.515 ' N ' HG13 ' A' ' 538' ' ' VAL . 14.8 mtmm -108.37 119.01 38.28 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.935 -178.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -62.34 -55.84 24.17 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.848 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 541' ' ' ASN . . . . . . . . . . . . . 57.9 t-20 -96.15 98.86 10.67 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.098 0.475 . . . . 0.0 109.849 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -123.22 110.62 30.75 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.496 -179.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 543' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -50.82 -11.91 0.5 Allowed 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.903 2.402 . . . . 0.0 113.128 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . 0.686 ' O ' ' N ' ' A' ' 546' ' ' GLY . . . 52.52 17.32 4.31 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 121.318 -0.468 . . . . 0.0 113.631 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 545' ' ' GLY . . . . . 0.622 ' O ' ' N ' ' A' ' 547' ' ' MET . . . -52.45 55.03 0.01 OUTLIER Glycine 0 CA--C 1.526 0.745 0 CA-C-O 119.633 -0.537 . . . . 0.0 113.795 178.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . 0.686 ' N ' ' O ' ' A' ' 544' ' ' GLY . . . 53.73 -53.05 0.01 OUTLIER Glycine 0 CA--C 1.528 0.849 0 CA-C-N 117.423 0.612 . . . . 0.0 114.14 -178.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 547' ' ' MET . . . . . 0.622 ' N ' ' O ' ' A' ' 545' ' ' GLY . 0.6 OUTLIER -51.07 -51.35 68.67 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 118.13 0.965 . . . . 0.0 111.038 178.968 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 548' ' ' PRO . . . . . 0.446 ' CD ' ' N ' ' A' ' 547' ' ' MET . 79.8 Cg_exo -46.71 167.35 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.314 2.676 . . . . 0.0 112.924 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -119.99 -15.22 8.81 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.67 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 550' ' ' ASP . . . . . 0.551 ' HA ' ' HD2' ' A' ' 536' ' ' PRO . 0.1 OUTLIER -56.51 -37.84 70.99 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 121.764 0.793 . . . . 0.0 108.963 178.946 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 551' ' ' LEU . . . . . . . . . . . . . 14.6 tp -132.09 140.47 48.84 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.661 -1.154 . . . . 0.0 108.891 178.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 552' ' ' THR . . . . . 0.677 HG21 ' CG ' ' A' ' 567' ' ' PHE . 7.7 m -132.81 150.32 52.17 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.711 0.767 . . . . 0.0 111.728 179.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 553' ' ' PHE . . . . . 0.507 ' CD1' ' CE1' ' A' ' 531' ' ' TYR . 0.2 OUTLIER -132.92 138.54 46.99 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 114.442 -1.254 . . . . 0.0 108.166 178.135 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 554' ' ' THR . . . . . 0.929 HG23 ' H ' ' A' ' 556' ' ' ILE . 0.4 OUTLIER -131.3 140.78 39.58 Favored Pre-proline 0 C--N 1.312 -1.047 0 C-N-CA 120.304 -0.558 . . . . 0.0 111.173 -179.713 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 555' ' ' PRO . . . . . 0.843 ' O ' HG22 ' A' ' 556' ' ' ILE . 35.0 Cg_endo -91.15 7.7 3.43 Favored 'Trans proline' 0 N--CA 1.438 -1.785 0 C-N-CA 122.256 1.971 . . . . 0.0 110.338 178.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 556' ' ' ILE . . . . . 0.929 ' H ' HG23 ' A' ' 554' ' ' THR . 6.3 tp 62.4 33.21 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.302 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 177.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . 0.704 ' O ' ' CE2' ' A' ' 559' ' ' TRP . 0.0 OUTLIER -104.48 141.42 36.4 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 179.386 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 558' ' ' THR . . . . . . . . . . . . . 1.6 t -57.68 115.91 3.08 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 -172.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 559' ' ' TRP . . . . . 0.704 ' CE2' ' O ' ' A' ' 557' ' ' LYS . 0.0 OUTLIER -139.21 121.61 16.07 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 112.356 -2.202 . . . . 0.0 106.602 174.871 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 560' ' ' ASN . . . . . 0.619 ' O ' HG22 ' A' ' 564' ' ' THR . 81.2 m-20 -91.2 -76.8 0.43 Allowed 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 118.233 -1.387 . . . . 0.0 113.917 -177.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 561' ' ' ALA . . . . . 0.616 ' HA ' ' CG2' ' A' ' 564' ' ' THR . . . -75.53 -49.74 17.78 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 115.968 1.84 . . . . 0.0 115.968 -177.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 562' ' ' SER . . . . . 0.403 ' O ' ' HB2' ' A' ' 566' ' ' GLU . 9.9 t -48.8 -55.71 10.79 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -176.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 563' ' ' LYS . . . . . 0.569 ' HG3' ' CG ' ' A' ' 559' ' ' TRP . 0.1 OUTLIER -70.82 -47.97 56.61 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -178.307 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 564' ' ' THR . . . . . 0.834 HG23 ' H ' ' A' ' 565' ' ' GLN . 9.0 t -50.07 -72.0 0.06 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.81 0.338 . . . . 0.0 111.699 -179.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 565' ' ' GLN . . . . . 0.991 ' O ' HG23 ' A' ' 569' ' ' ILE . 1.1 tp60 -50.69 -46.66 58.91 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . 0.418 ' HG2' ' CD1' ' A' ' 567' ' ' PHE . 67.3 tt0 -49.17 -66.45 0.4 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.863 0.363 . . . . 0.0 111.696 -178.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 567' ' ' PHE . . . . . 0.677 ' CG ' HG21 ' A' ' 552' ' ' THR . 0.1 OUTLIER -97.39 -53.64 3.4 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.533 0.683 . . . . 0.0 111.701 -179.278 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 568' ' ' ILE . . . . . 0.848 HD12 ' CD1' ' A' ' 574' ' ' LEU . 14.9 mm -53.95 10.43 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.503 -0.841 0 CA-C-N 114.494 -1.23 . . . . 0.0 113.888 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 569' ' ' ILE . . . . . 0.991 HG23 ' O ' ' A' ' 565' ' ' GLN . 0.9 OUTLIER -55.73 -33.87 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 N-CA-C 103.815 -2.661 . . . . 0.0 103.815 177.7 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 570' ' ' ASP . . . . . 0.656 ' OD2' HD22 ' A' ' 574' ' ' LEU . 7.8 p30 34.56 42.82 0.08 Allowed 'General case' 0 CA--C 1.492 -1.264 0 CA-C-N 113.421 -1.718 . . . . 0.0 110.591 174.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 571' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' A' ' 570' ' ' ASP . . . -49.49 -43.46 35.93 Favored Glycine 0 N--CA 1.436 -1.342 0 N-CA-C 106.981 -2.448 . . . . 0.0 106.981 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 572' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -119.03 -17.99 8.88 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-O 118.937 -0.554 . . . . 0.0 112.298 174.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 573' ' ' LEU . . . . . 0.884 HD11 ' HB3' ' A' ' 485' ' ' PHE . 1.5 tp -142.21 136.55 30.0 Favored 'General case' 0 C--N 1.362 1.124 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 -178.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 574' ' ' LEU . . . . . 0.996 ' HB3' HD11 ' A' ' 588' ' ' ILE . 8.9 tp -136.22 133.84 37.49 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 114.339 -1.301 . . . . 0.0 107.613 173.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 575' ' ' ILE . . . . . 0.803 HG13 ' O ' ' A' ' 533' ' ' GLY . 0.0 OUTLIER -133.86 137.16 52.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 O-C-N 122.001 -0.437 . . . . 0.0 110.766 178.253 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 576' ' ' LEU . . . . . 0.614 HD22 ' HB3' ' A' ' 509' ' ' LEU . 0.1 OUTLIER -133.33 135.3 44.7 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 177.523 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 577' ' ' LYS . . . . . 0.403 ' N ' HD12 ' A' ' 576' ' ' LEU . 0.2 OUTLIER -132.99 135.24 45.36 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.194 -1.002 . . . . 0.0 109.979 177.026 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.574 ' HG ' HD11 ' A' ' 576' ' ' LEU . 0.4 OUTLIER -125.0 132.04 53.32 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.139 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 579' ' ' GLY . . . . . . . . . . . . . . . -89.81 -2.18 75.77 Favored Glycine 0 N--CA 1.442 -0.942 0 CA-C-N 115.294 -0.867 . . . . 0.0 113.173 -178.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 580' ' ' LYS . . . . . 0.576 ' CE ' HD13 ' A' ' 524' ' ' ILE . 0.0 OUTLIER -72.9 -48.1 40.17 Favored 'General case' 0 N--CA 1.441 -0.904 0 C-N-CA 119.17 -1.012 . . . . 0.0 108.908 179.256 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 581' ' ' TRP . . . . . 0.418 ' CD1' ' O ' ' A' ' 580' ' ' LYS . 13.6 m0 -139.64 -52.84 0.53 Allowed 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 177.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 582' ' ' LYS . . . . . 0.536 ' O ' HD12 ' A' ' 578' ' ' LEU . 3.1 ptpt -140.15 164.94 28.7 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 -175.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 583' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -113.7 134.68 54.6 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 174.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 584' ' ' LYS . . . . . 0.865 ' NZ ' HG12 ' A' ' 508' ' ' VAL . 0.5 OUTLIER -122.89 133.6 54.41 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 178.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 585' ' ' LEU . . . . . 0.727 ' HG ' HG23 ' A' ' 575' ' ' ILE . 9.8 tt -120.62 135.56 55.07 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 586' ' ' VAL . . . . . 0.747 HG12 ' CD1' ' A' ' 588' ' ' ILE . 55.2 t -134.04 144.15 36.3 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 112.991 0.738 . . . . 0.0 112.991 -177.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 587' ' ' SER . . . . . 0.873 ' C ' HD13 ' A' ' 588' ' ' ILE . 3.1 m -107.29 135.88 48.06 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 176.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.996 HD11 ' HB3' ' A' ' 574' ' ' LEU . 0.0 OUTLIER -132.77 136.93 55.0 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.47 0 CA-C-O 121.701 0.762 . . . . 0.0 112.785 -177.309 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 589' ' ' VAL . . . . . 0.58 HG11 ' HD1' ' A' ' 594' ' ' PHE . 7.1 p -125.26 150.34 30.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 114.376 -1.284 . . . . 0.0 110.843 179.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 590' ' ' SER . . . . . . . . . . . . . 3.3 p -73.32 156.37 38.49 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.172 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 591' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -50.74 -48.56 59.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.145 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 592' ' ' GLU . . . . . 0.435 ' O ' ' HG3' ' A' ' 595' ' ' LYS . 13.8 pt-20 -54.26 -49.2 70.1 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.031 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 593' ' ' LYS . . . . . 0.436 ' CB ' ' CG2' ' A' ' 589' ' ' VAL . 1.7 mmtp -62.17 -59.05 5.61 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -178.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 594' ' ' PHE . . . . . 0.58 ' HD1' HG11 ' A' ' 589' ' ' VAL . 3.1 t80 -50.24 -48.98 54.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.251 -179.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 595' ' ' LYS . . . . . 0.541 ' O ' ' N ' ' A' ' 599' ' ' LEU . 0.0 OUTLIER -52.78 -47.35 67.58 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.122 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 596' ' ' GLU . . . . . 0.688 ' O ' HD23 ' A' ' 599' ' ' LEU . 0.5 OUTLIER -50.1 -65.45 0.56 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.978 -179.738 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 597' ' ' LEU . . . . . 0.498 HD12 ' N ' ' A' ' 598' ' ' GLY . 0.5 OUTLIER -55.7 -59.54 4.7 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.146 0.498 . . . . 0.0 111.405 -179.2 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 598' ' ' GLY . . . . . 0.498 ' N ' HD12 ' A' ' 597' ' ' LEU . . . -77.95 11.77 20.22 Favored Glycine 0 CA--C 1.521 0.437 0 CA-C-N 115.43 -0.804 . . . . 0.0 113.143 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 599' ' ' LEU . . . . . 0.688 HD23 ' O ' ' A' ' 596' ' ' GLU . 3.4 pp -51.14 2.39 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -177.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 600' ' ' THR . . . . . 0.474 HG23 ' O ' ' A' ' 600' ' ' THR . 7.4 t -102.79 66.64 0.94 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 118.745 0.702 . . . . 0.0 109.855 178.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 601' ' ' ALA . . . . . 0.694 ' HB1' ' HD2' ' A' ' 602' ' ' PRO . . . -131.24 177.15 2.38 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.587 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 602' ' ' PRO . . . . . 0.694 ' HD2' ' HB1' ' A' ' 601' ' ' ALA . 32.1 Cg_exo -57.5 -44.98 37.22 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.299 1.999 . . . . 0.0 111.666 179.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 603' ' ' GLY . . . . . . . . . . . . . . . -71.14 -48.94 29.36 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.61 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 604' ' ' TRP . . . . . 0.512 ' CD1' ' HB3' ' A' ' 601' ' ' ALA . 10.4 m95 -65.31 -47.2 77.38 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 120.969 0.414 . . . . 0.0 111.153 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 605' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -50.57 -57.74 7.44 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.169 -178.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 606' ' ' GLU . . . . . 0.418 ' O ' ' CB ' ' A' ' 610' ' ' LYS . 6.5 pt-20 -59.71 -57.37 13.19 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 607' ' ' VAL . . . . . . . . . . . . . 59.9 t -58.48 -72.02 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -178.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 608' ' ' VAL . . . . . 0.473 HG21 ' NZ ' ' A' ' 595' ' ' LYS . 97.3 t -65.37 -58.28 7.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -177.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 609' ' ' GLY . . . . . . . . . . . . . . . -59.78 -61.59 7.04 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 116.156 -0.474 . . . . 0.0 113.646 -178.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 610' ' ' LYS . . . . . 0.418 ' CB ' ' O ' ' A' ' 606' ' ' GLU . 0.2 OUTLIER -58.81 -49.88 76.06 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.756 0.312 . . . . 0.0 110.808 -179.665 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 107.83 56.73 0.59 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.645 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 8.1 mtpt -93.34 39.09 1.05 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.781 0.324 . . . . 0.0 110.918 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 613' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -105.19 -166.71 1.25 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.793 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . 0.431 ' CB ' ' CD ' ' A' ' 615' ' ' PRO . 2.0 mp0 -54.99 -62.95 3.41 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.18 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 615' ' ' PRO . . . . . 0.431 ' CD ' ' CB ' ' A' ' 614' ' ' GLU . 42.3 Cg_endo -67.64 138.27 44.9 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.529 2.153 . . . . 0.0 112.266 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 616' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.96 154.27 40.39 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.924 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo . . . . . 0 C--O 1.249 1.063 0 C-N-CA 122.564 2.176 . . . . 0.0 112.328 -179.991 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.424 0 CA-C-O 120.719 0.295 . . . . 0.0 111.153 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 455' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.78 -175.49 1.18 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.541 2.161 . . . . 0.0 112.371 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 456' ' ' ARG . . . . . . . . . . . . . 3.8 mmt85 -59.94 -26.51 66.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.968 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 72.5 p -101.75 35.57 2.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.867 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -83.29 135.69 34.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.132 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -75.71 164.04 63.17 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.879 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -52.3 164.25 1.36 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.507 2.138 . . . . 0.0 112.296 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . 117.65 56.57 0.29 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.455 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 21.2 m-20 -88.16 163.18 38.11 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.753 0.311 . . . . 0.0 110.902 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -69.8 -175.84 1.3 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.546 2.164 . . . . 0.0 112.281 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -85.67 163.91 17.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.933 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 4.0 m -115.91 22.27 13.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.163 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -57.35 -29.59 64.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.031 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . 0.684 HD22 ' O ' ' A' ' 470' ' ' PHE . 0.2 OUTLIER -107.67 175.42 5.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.898 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 468' ' ' SER . . . . . 0.547 ' H ' HD23 ' A' ' 467' ' ' LEU . 3.1 p -81.56 43.85 0.77 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.896 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 129.1 -37.1 2.27 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.809 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 470' ' ' PHE . . . . . 0.684 ' O ' HD22 ' A' ' 467' ' ' LEU . 2.6 p90 -138.27 117.68 12.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.806 0.336 . . . . 0.0 110.856 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 471' ' ' VAL . . . . . 0.602 HG13 ' O ' ' A' ' 471' ' ' VAL . 11.9 p -113.14 107.55 23.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.155 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 176.27 108.92 0.11 Allowed Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.921 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -68.0 166.97 22.96 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.339 2.026 . . . . 0.0 112.216 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -81.48 -67.55 0.77 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.92 0.391 . . . . 0.0 110.9 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -138.28 -48.29 0.53 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.634 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 476' ' ' GLY . . . . . . . . . . . . . . . 87.91 -41.85 3.09 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.797 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 477' ' ' ASN . . . . . 0.417 ' N ' ' CD ' ' A' ' 478' ' ' PRO . 2.9 t30 -50.32 -51.51 62.87 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-O 120.621 0.248 . . . . 0.0 111.391 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 478' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' A' ' 477' ' ' ASN . 96.8 Cg_endo -85.26 34.37 0.49 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.836 2.357 . . . . 0.0 113.116 -179.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -85.04 84.28 7.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.804 0.335 . . . . 0.0 110.905 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -140.66 137.91 17.93 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.806 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -47.83 -79.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.432 2.088 . . . . 0.0 112.422 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 482' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -136.48 -68.91 0.48 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.349 0.595 . . . . 0.0 109.629 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 483' ' ' THR . . . . . . . . . . . . . 47.5 p -136.9 171.67 14.16 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.058 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 484' ' ' ASN . . . . . 0.514 ' O ' ' CD ' ' A' ' 489' ' ' PRO . 14.9 m120 -94.33 1.56 55.89 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.455 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 485' ' ' PHE . . . . . 0.713 ' HA ' ' HG2' ' A' ' 489' ' ' PRO . 3.3 m-85 -49.71 -47.01 50.76 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.549 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -70.47 -47.43 60.64 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -177.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -70.81 -74.53 0.14 Allowed 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 -176.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 488' ' ' MET . . . . . 0.515 ' CB ' ' HD3' ' A' ' 489' ' ' PRO . 0.0 OUTLIER -52.84 -52.95 59.97 Favored Pre-proline 0 N--CA 1.469 0.519 0 CA-C-O 121.12 0.486 . . . . 0.0 111.431 -178.653 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 489' ' ' PRO . . . . . 0.713 ' HG2' ' HA ' ' A' ' 485' ' ' PHE . 3.1 Cg_exo -79.9 43.33 1.49 Allowed 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 124.54 3.493 . . . . 0.0 112.132 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -37.2 -66.18 0.25 Allowed 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -178.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 491' ' ' ALA . . . . . . . . . . . . . . . -117.72 135.37 54.08 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 119.968 -0.693 . . . . 0.0 112.34 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 492' ' ' ARG . . . . . 0.565 ' HA ' ' O ' ' A' ' 585' ' ' LEU . 0.0 OUTLIER -135.81 136.97 41.1 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.085 178.944 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 493' ' ' VAL . . . . . 0.836 HG23 ' NZ ' ' A' ' 584' ' ' LYS . 89.4 t -133.13 163.57 37.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.354 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . 0.581 ' N ' HG12 ' A' ' 493' ' ' VAL . 91.8 m -114.68 135.9 53.64 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.441 0.638 . . . . 0.0 111.74 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 495' ' ' LEU . . . . . 0.89 HD22 ' HB2' ' A' ' 512' ' ' ALA . 0.2 OUTLIER -134.27 164.66 42.37 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.086 179.869 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 496' ' ' PRO . . . . . 0.635 ' HD2' HD21 ' A' ' 499' ' ' LEU . 23.2 Cg_exo -63.68 119.56 6.66 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 121.982 1.788 . . . . 0.0 111.721 179.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 497' ' ' LYS . . . . . 0.896 ' O ' HG12 ' A' ' 500' ' ' VAL . 0.2 OUTLIER -53.07 -30.0 33.51 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -178.961 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 498' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -57.56 -48.66 78.75 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -177.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 499' ' ' LEU . . . . . 0.81 HD11 HD13 ' A' ' 495' ' ' LEU . 2.3 pp -74.37 -9.07 58.23 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -178.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . 0.896 HG12 ' O ' ' A' ' 497' ' ' LYS . 2.9 p -75.61 -26.43 18.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.352 0.596 . . . . 0.0 111.717 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 501' ' ' TYR . . . . . 0.665 ' O ' HG21 ' A' ' 564' ' ' THR . 0.3 OUTLIER -53.88 -29.69 42.7 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -178.71 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 502' ' ' ASP . . . . . 0.444 ' N ' ' CD1' ' A' ' 501' ' ' TYR . 0.4 OUTLIER -75.82 -49.92 16.63 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 -175.561 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 503' ' ' LYS . . . . . 0.631 ' O ' ' CG ' ' A' ' 507' ' ' LYS . 4.8 mttt -119.31 133.8 55.54 Favored 'General case' 0 CA--C 1.522 -0.113 0 CA-C-N 118.985 0.811 . . . . 0.0 112.094 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . 0.629 HG23 HD13 ' A' ' 568' ' ' ILE . 2.0 m -73.56 -75.12 0.16 Allowed 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.635 -0.711 . . . . 0.0 112.918 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . 0.986 ' CE1' HG23 ' A' ' 532' ' ' VAL . 7.3 m-85 -74.37 -62.9 1.36 Allowed 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -178.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 506' ' ' SER . . . . . 0.772 ' O ' ' CD1' ' A' ' 510' ' ' TRP . 7.6 t -49.28 -72.59 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -175.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 507' ' ' LYS . . . . . 0.679 ' HD3' ' N ' ' A' ' 508' ' ' VAL . 0.0 OUTLIER -48.99 -48.52 43.39 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -176.37 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 508' ' ' VAL . . . . . 0.881 ' CG2' HD21 ' A' ' 574' ' ' LEU . 89.1 t -52.89 -59.03 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -179.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 509' ' ' LEU . . . . . 0.856 ' O ' HD23 ' A' ' 514' ' ' LEU . 3.0 pp -60.42 -61.84 2.3 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 -176.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 510' ' ' TRP . . . . . 0.847 ' N ' HD12 ' A' ' 509' ' ' LEU . 65.1 p-90 -72.2 -49.74 33.06 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -176.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 511' ' ' SER . . . . . 0.497 ' N ' ' CD2' ' A' ' 510' ' ' TRP . 0.5 OUTLIER -64.95 -47.39 77.81 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.164 -0.926 . . . . 0.0 112.898 -177.089 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 512' ' ' ALA . . . . . 0.89 ' HB2' HD22 ' A' ' 495' ' ' LEU . . . -71.19 -73.97 0.16 Allowed 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 117.398 2.37 . . . . 0.0 117.398 -174.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 513' ' ' GLY . . . . . 0.46 ' CA ' ' HB ' ' A' ' 493' ' ' VAL . . . -115.95 -36.11 1.18 Allowed Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 121.73 3.452 . . . . 0.0 121.73 -172.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 514' ' ' LEU . . . . . 0.856 HD23 ' O ' ' A' ' 509' ' ' LEU . 0.5 OUTLIER -108.96 -39.11 5.4 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 120.431 3.493 . . . . 0.0 120.431 -169.646 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 515' ' ' VAL . . . . . 0.957 HG13 ' HB2' ' A' ' 517' ' ' SER . 13.7 p -153.18 172.12 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 118.053 2.612 . . . . 0.0 118.053 -171.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 516' ' ' ALA . . . . . 0.629 ' N ' HG22 ' A' ' 515' ' ' VAL . . . -69.07 2.64 2.59 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 112.559 -2.11 . . . . 0.0 110.753 177.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . 0.957 ' HB2' HG13 ' A' ' 515' ' ' VAL . 0.5 OUTLIER -57.68 8.5 0.01 OUTLIER 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 -172.221 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 518' ' ' LYS . . . . . 0.738 ' HA ' ' CD1' ' A' ' 510' ' ' TRP . 0.0 OUTLIER -46.66 -51.78 15.17 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 104.369 -2.456 . . . . 0.0 104.369 174.989 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 519' ' ' SER . . . . . . . . . . . . . 3.5 m -75.35 -57.45 3.89 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.146 173.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 520' ' ' GLU . . . . . 0.626 ' CB ' ' HA ' ' A' ' 517' ' ' SER . 0.0 OUTLIER -55.91 -47.85 76.73 Favored 'General case' 0 C--N 1.349 0.578 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.71 -179.042 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 521' ' ' GLY . . . . . 0.809 ' HA2' HD12 ' A' ' 524' ' ' ILE . . . -49.55 -55.37 13.74 Favored Glycine 0 CA--C 1.491 -1.42 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.543 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -47.73 -47.45 30.19 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 523' ' ' ARG . . . . . . . . . . . . . 1.6 ttt85 -50.49 -49.03 56.55 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.0 178.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 524' ' ' ILE . . . . . 0.809 HD12 ' HA2' ' A' ' 521' ' ' GLY . 12.7 mt -59.36 -55.26 24.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.237 0.542 . . . . 0.0 110.253 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 525' ' ' ILE . . . . . 0.896 HG23 ' CD1' ' A' ' 556' ' ' ILE . 0.9 OUTLIER -50.26 -47.49 25.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 177.864 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 526' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -56.1 -48.58 75.87 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 114.112 -1.404 . . . . 0.0 108.276 177.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 527' ' ' ASN . . . . . 0.431 ' ND2' ' O ' ' A' ' 524' ' ' ILE . 0.0 OUTLIER -48.62 -39.76 25.2 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 113.754 -1.566 . . . . 0.0 107.778 176.639 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 528' ' ' ASN . . . . . 0.526 ' C ' HG21 ' A' ' 556' ' ' ILE . 12.6 t-20 74.07 40.3 0.46 Allowed 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.227 -179.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 529' ' ' GLY . . . . . . . . . . . . . . . -115.98 36.36 3.87 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 114.619 -1.173 . . . . 0.0 111.569 178.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 530' ' ' ALA . . . . . 0.764 ' O ' ' HB ' ' A' ' 556' ' ' ILE . . . -132.8 164.96 25.68 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.656 0.741 . . . . 0.0 112.363 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 531' ' ' TYR . . . . . 0.609 ' HE1' ' CD1' ' A' ' 553' ' ' PHE . 3.2 t80 -134.52 149.55 50.68 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 124.634 1.174 . . . . 0.0 108.871 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 532' ' ' VAL . . . . . 0.986 HG23 ' CE1' ' A' ' 505' ' ' PHE . 1.1 t -129.96 136.1 59.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 CA-C-N 119.485 1.039 . . . . 0.0 112.216 179.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 533' ' ' GLY . . . . . 0.768 ' O ' HG13 ' A' ' 575' ' ' ILE . . . -133.11 147.4 18.97 Favored Glycine 0 N--CA 1.441 -1.022 0 CA-C-N 114.0 -1.454 . . . . 0.0 112.961 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 534' ' ' SER . . . . . 0.609 ' HB2' ' OG1' ' A' ' 552' ' ' THR . 38.5 m -134.79 143.53 47.13 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.584 -0.308 . . . . 0.0 111.072 178.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 535' ' ' ARG . . . . . 0.57 ' HA ' ' O ' ' A' ' 550' ' ' ASP . 3.0 tpp180 -159.03 89.08 2.1 Favored Pre-proline 0 C--N 1.33 -0.251 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 178.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 536' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -102.53 77.1 0.03 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 124.118 3.212 . . . . 0.0 112.164 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 115.79 111.59 2.77 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.124 -1.036 . . . . 0.0 112.698 -179.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 538' ' ' VAL . . . . . . . . . . . . . 6.4 p -43.4 -24.65 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 539' ' ' LYS . . . . . . . . . . . . . 3.9 pttt -46.39 147.35 1.17 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.301 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -127.68 30.7 5.27 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.589 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 541' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -71.91 99.18 2.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.199 0.523 . . . . 0.0 110.171 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 542' ' ' GLU . . . . . 0.614 ' O ' ' N ' ' A' ' 544' ' ' GLY . 34.5 mm-40 -110.74 96.9 30.76 Favored Pre-proline 0 C--N 1.321 -0.674 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.571 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 543' ' ' PRO . . . . . 0.652 ' O ' ' N ' ' A' ' 545' ' ' GLY . 68.0 Cg_exo -51.57 55.22 0.02 OUTLIER 'Trans proline' 0 N--CA 1.481 0.79 0 C-N-CA 124.12 3.213 . . . . 0.0 114.225 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . 0.623 ' C ' ' H ' ' A' ' 546' ' ' GLY . . . 53.58 -53.13 0.01 OUTLIER Glycine 0 CA--C 1.527 0.794 0 CA-C-O 119.504 -0.609 . . . . 0.0 114.414 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 545' ' ' GLY . . . . . 0.652 ' N ' ' O ' ' A' ' 543' ' ' PRO . . . -53.41 21.33 0.01 OUTLIER Glycine 0 CA--C 1.533 1.211 0 CA-C-N 117.959 0.88 . . . . 0.0 114.725 178.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . 0.623 ' H ' ' C ' ' A' ' 544' ' ' GLY . . . 53.11 -54.61 0.01 OUTLIER Glycine 0 CA--C 1.525 0.676 0 CA-C-O 119.089 -0.84 . . . . 0.0 114.253 -178.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 547' ' ' MET . . . . . 0.641 ' N ' ' O ' ' A' ' 545' ' ' GLY . 33.3 mmt 14.52 56.43 0.08 OUTLIER Pre-proline 0 N--CA 1.473 0.712 0 CA-C-N 118.019 0.91 . . . . 0.0 112.606 178.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 548' ' ' PRO . . . . . 0.586 ' HD3' ' C ' ' A' ' 546' ' ' GLY . 81.8 Cg_exo -46.28 119.5 3.1 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 121.66 1.573 . . . . 0.0 113.178 -177.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -126.08 -37.1 2.28 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.282 178.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 550' ' ' ASP . . . . . 0.57 ' O ' ' HA ' ' A' ' 535' ' ' ARG . 1.8 m-20 -70.82 -41.09 72.02 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.953 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 551' ' ' LEU . . . . . 0.769 HD11 ' CE1' ' A' ' 553' ' ' PHE . 7.2 tp -131.26 140.28 49.79 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.416 178.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 552' ' ' THR . . . . . 0.884 HG21 ' CG ' ' A' ' 567' ' ' PHE . 6.2 m -133.32 147.34 51.86 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.573 0.701 . . . . 0.0 111.987 179.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 553' ' ' PHE . . . . . 0.769 ' CE1' HD11 ' A' ' 551' ' ' LEU . 17.6 m-30 -132.86 136.22 46.09 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 177.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 554' ' ' THR . . . . . 0.647 ' OG1' HG12 ' A' ' 532' ' ' VAL . 19.2 m -135.04 139.68 32.71 Favored Pre-proline 0 C--N 1.314 -0.975 0 C-N-CA 118.851 -1.14 . . . . 0.0 113.245 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 555' ' ' PRO . . . . . 0.851 ' O ' HG22 ' A' ' 556' ' ' ILE . 5.8 Cg_exo -77.58 11.99 2.02 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.78 2.32 . . . . 0.0 112.789 179.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 556' ' ' ILE . . . . . 0.896 ' CD1' HG23 ' A' ' 525' ' ' ILE . 4.9 tp 62.37 34.42 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.335 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 177.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . 0.704 ' O ' ' CE2' ' A' ' 559' ' ' TRP . 33.3 mttt -103.37 133.23 48.77 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 558' ' ' THR . . . . . . . . . . . . . 3.4 t -58.05 116.5 3.56 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -172.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 559' ' ' TRP . . . . . 0.704 ' CE2' ' O ' ' A' ' 557' ' ' LYS . 0.0 OUTLIER -139.87 112.4 7.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 113.142 -1.844 . . . . 0.0 106.28 175.1 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 560' ' ' ASN . . . . . 0.649 ' O ' HG22 ' A' ' 564' ' ' THR . 86.0 m-20 -77.82 -75.96 0.2 Allowed 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 118.659 -1.216 . . . . 0.0 113.351 -176.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 561' ' ' ALA . . . . . 0.544 ' HA ' ' CG2' ' A' ' 564' ' ' THR . . . -75.14 -53.12 9.39 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 115.951 1.834 . . . . 0.0 115.951 -178.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 562' ' ' SER . . . . . . . . . . . . . 69.4 m -49.23 -54.95 14.23 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -176.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 563' ' ' LYS . . . . . 0.609 ' HB3' HG21 ' A' ' 504' ' ' THR . 0.2 OUTLIER -70.65 -47.91 57.61 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -178.188 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 564' ' ' THR . . . . . 0.788 HG23 ' H ' ' A' ' 565' ' ' GLN . 7.9 t -49.79 -68.02 0.21 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.847 0.356 . . . . 0.0 111.276 -179.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 565' ' ' GLN . . . . . 1.033 ' O ' HG23 ' A' ' 569' ' ' ILE . 2.4 tp60 -49.88 -47.0 52.16 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -49.42 -61.72 1.94 Allowed 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.861 -178.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 567' ' ' PHE . . . . . 0.884 ' CG ' HG21 ' A' ' 552' ' ' THR . 0.0 OUTLIER -97.15 -54.32 3.21 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.68 0.752 . . . . 0.0 111.875 -178.95 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 568' ' ' ILE . . . . . 0.853 HG13 HD13 ' A' ' 574' ' ' LEU . 1.7 mp -56.18 9.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 114.487 -1.233 . . . . 0.0 113.72 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 569' ' ' ILE . . . . . 1.033 HG23 ' O ' ' A' ' 565' ' ' GLN . 0.9 OUTLIER -54.56 -36.47 35.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 104.292 -2.484 . . . . 0.0 104.292 177.354 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 570' ' ' ASP . . . . . 0.487 ' OD2' HG13 ' A' ' 588' ' ' ILE . 7.7 p30 34.1 57.8 0.62 Allowed 'General case' 0 CA--C 1.502 -0.903 0 CA-C-N 113.716 -1.584 . . . . 0.0 112.04 174.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 571' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 570' ' ' ASP . . . -51.02 -45.22 51.11 Favored Glycine 0 N--CA 1.438 -1.172 0 C-N-CA 117.469 -2.301 . . . . 0.0 107.982 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 572' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -120.3 -16.74 8.4 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 175.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 573' ' ' LEU . . . . . 0.485 ' O ' ' CB ' ' A' ' 570' ' ' ASP . 2.2 tp -140.55 136.34 32.75 Favored 'General case' 0 C--N 1.355 0.823 0 N-CA-C 115.912 1.819 . . . . 0.0 115.912 -177.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 574' ' ' LEU . . . . . 0.901 HD12 ' N ' ' A' ' 575' ' ' ILE . 0.5 OUTLIER -135.94 132.73 36.81 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 173.422 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 575' ' ' ILE . . . . . 1.031 HG23 HD13 ' A' ' 585' ' ' LEU . 0.0 OUTLIER -134.3 139.98 46.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 118.858 0.754 . . . . 0.0 111.928 178.53 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 576' ' ' LEU . . . . . 0.683 HD11 HD21 ' A' ' 578' ' ' LEU . 0.0 OUTLIER -133.01 136.62 46.12 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 114.944 -1.025 . . . . 0.0 108.767 177.945 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 577' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.02 135.44 51.79 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 177.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.683 HD21 HD11 ' A' ' 576' ' ' LEU . 0.5 OUTLIER -126.94 132.02 50.95 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 177.973 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 579' ' ' GLY . . . . . . . . . . . . . . . -90.45 -2.26 73.53 Favored Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 115.092 -0.958 . . . . 0.0 113.493 -178.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 580' ' ' LYS . . . . . 0.473 ' O ' ' CD1' ' A' ' 581' ' ' TRP . 0.0 OUTLIER -70.84 -48.38 54.3 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 118.738 -1.185 . . . . 0.0 108.564 179.083 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 581' ' ' TRP . . . . . 0.473 ' CD1' ' O ' ' A' ' 580' ' ' LYS . 27.1 m0 -139.81 -53.37 0.53 Allowed 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 177.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 582' ' ' LYS . . . . . 0.424 ' O ' ' HB2' ' A' ' 578' ' ' LEU . 0.0 OUTLIER -140.5 165.44 27.43 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 -175.19 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 583' ' ' MET . . . . . 0.41 ' HB3' ' O ' ' A' ' 488' ' ' MET . 1.7 ttt -109.04 135.0 50.93 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 173.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 584' ' ' LYS . . . . . 0.836 ' NZ ' HG23 ' A' ' 493' ' ' VAL . 10.9 tppt? -120.34 133.38 55.46 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 178.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 585' ' ' LEU . . . . . 1.031 HD13 HG23 ' A' ' 575' ' ' ILE . 0.9 OUTLIER -116.03 136.12 53.32 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.839 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 586' ' ' VAL . . . . . 0.859 ' N ' HD12 ' A' ' 585' ' ' LEU . 85.8 t -132.94 137.49 53.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-O 121.053 0.454 . . . . 0.0 111.721 -178.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 587' ' ' SER . . . . . 0.879 ' C ' HD13 ' A' ' 588' ' ' ILE . 58.8 m -106.63 135.79 47.53 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 177.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.879 HD13 ' C ' ' A' ' 587' ' ' SER . 0.0 OUTLIER -133.41 136.75 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -177.581 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 589' ' ' VAL . . . . . 0.488 ' N ' ' HB2' ' A' ' 497' ' ' LYS . 5.6 m -132.6 137.14 54.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.635 178.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 590' ' ' SER . . . . . . . . . . . . . 10.7 t -68.02 162.19 25.03 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.984 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 591' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -50.76 -48.87 59.12 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.879 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.1 -55.19 35.42 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -178.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 9.9 mttt -51.56 -55.16 20.72 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.45 0.643 . . . . 0.0 110.807 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 594' ' ' PHE . . . . . 0.972 ' CD1' HD11 ' A' ' 597' ' ' LEU . 13.2 t80 -50.31 -47.39 55.67 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.583 179.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 595' ' ' LYS . . . . . 0.816 ' HE3' HG21 ' A' ' 608' ' ' VAL . 0.6 OUTLIER -49.47 -48.15 47.93 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.315 179.422 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 596' ' ' GLU . . . . . 0.67 ' O ' HD23 ' A' ' 599' ' ' LEU . 3.8 tt0 -58.82 -62.92 1.51 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.572 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 597' ' ' LEU . . . . . 0.972 HD11 ' CD1' ' A' ' 594' ' ' PHE . 2.8 pp -48.77 -50.97 31.6 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.183 0.516 . . . . 0.0 112.12 -178.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 598' ' ' GLY . . . . . 0.893 ' N ' HD12 ' A' ' 597' ' ' LEU . . . -93.79 11.16 71.55 Favored Glycine 0 N--CA 1.446 -0.7 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.699 -179.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 599' ' ' LEU . . . . . 0.67 HD23 ' O ' ' A' ' 596' ' ' GLU . 4.0 pp -50.02 -5.32 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -177.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 600' ' ' THR . . . . . 0.57 HG22 ' O ' ' A' ' 600' ' ' THR . 31.5 m -129.8 67.38 1.46 Allowed 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 121.699 0.761 . . . . 0.0 110.964 178.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 601' ' ' ALA . . . . . 1.056 ' HB1' ' HD2' ' A' ' 602' ' ' PRO . . . -131.53 -173.51 0.34 Allowed Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 114.463 -1.244 . . . . 0.0 109.494 179.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 602' ' ' PRO . . . . . 1.056 ' HD2' ' HB1' ' A' ' 601' ' ' ALA . 49.2 Cg_endo -70.29 -33.82 13.91 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 121.609 1.539 . . . . 0.0 112.64 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 603' ' ' GLY . . . . . . . . . . . . . . . -71.47 -49.13 26.56 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.911 -0.662 . . . . 0.0 113.295 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 604' ' ' TRP . . . . . 0.895 ' CD1' ' HB3' ' A' ' 601' ' ' ALA . 1.5 m95 -71.36 -46.57 60.13 Favored 'General case' 0 CA--C 1.512 -0.503 0 C-N-CA 122.833 0.453 . . . . 0.0 111.47 -178.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 605' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -50.02 -57.31 7.84 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.315 -179.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 606' ' ' GLU . . . . . 0.418 ' O ' ' HB2' ' A' ' 610' ' ' LYS . 1.2 tt0 -61.1 -62.58 1.75 Allowed 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 607' ' ' VAL . . . . . . . . . . . . . 54.6 t -56.65 -72.55 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 114.53 1.307 . . . . 0.0 114.53 -178.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 608' ' ' VAL . . . . . 0.816 HG21 ' HE3' ' A' ' 595' ' ' LYS . 53.0 t -64.91 -54.13 33.39 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -177.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 609' ' ' GLY . . . . . . . . . . . . . . . -61.94 -63.95 4.35 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 121.196 -0.526 . . . . 0.0 113.656 -178.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 610' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 606' ' ' GLU . 1.7 mtpm? -67.57 -50.75 56.94 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.695 0.283 . . . . 0.0 111.151 -179.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 81.32 56.52 2.99 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.508 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 36.2 tttt -56.53 -28.58 60.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.737 0.303 . . . . 0.0 111.008 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 613' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -59.92 -174.79 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.879 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -72.75 -60.87 1.8 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.964 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 615' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.98 95.5 0.74 Allowed 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.541 2.161 . . . . 0.0 112.266 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 616' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -79.98 113.59 39.49 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.913 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo . . . . . 0 C--O 1.249 1.055 0 C-N-CA 122.39 2.06 . . . . 0.0 112.311 -179.984 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 81.6 mmm . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.756 0.313 . . . . 0.0 111.236 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 455' ' ' PRO . . . . . 0.677 ' HG2' ' HB2' ' A' ' 458' ' ' ALA . 54.9 Cg_endo -69.75 157.4 60.52 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.556 2.171 . . . . 0.0 112.308 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 456' ' ' ARG . . . . . . . . . . . . . 7.7 ptt85 -72.18 -25.69 61.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.047 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 40.8 p -95.84 39.54 1.13 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.964 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 458' ' ' ALA . . . . . 0.677 ' HB2' ' HG2' ' A' ' 455' ' ' PRO . . . -103.31 150.32 23.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.087 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.03 148.51 34.58 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.911 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -52.66 -178.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.558 2.172 . . . . 0.0 112.32 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . 94.07 56.62 1.37 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.492 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -82.64 143.26 46.89 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.613 0.244 . . . . 0.0 110.812 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.93 176.66 8.04 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.466 2.111 . . . . 0.0 112.303 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 464' ' ' LYS . . . . . 0.46 ' HD3' HG12 ' A' ' 471' ' ' VAL . 0.0 OUTLIER -119.43 168.01 11.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.893 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 2.7 m -99.76 -56.54 2.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.897 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.01 -40.16 92.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.919 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . 0.688 HD23 HG23 ' A' ' 471' ' ' VAL . 3.8 mm? -118.22 175.21 5.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.889 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 83.9 p -88.88 43.55 1.15 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.798 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 128.91 -37.1 2.28 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.885 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -131.74 117.74 19.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.784 0.326 . . . . 0.0 110.784 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 471' ' ' VAL . . . . . 0.688 HG23 HD23 ' A' ' 467' ' ' LEU . 10.7 p -113.03 108.27 25.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.21 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 34.1 p-10 -177.49 146.13 0.61 Allowed Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.906 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -73.48 95.77 0.88 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.611 2.207 . . . . 0.0 112.333 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -136.04 34.13 2.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.914 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 1.9 t -137.99 35.75 2.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.868 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 476' ' ' GLY . . . . . . . . . . . . . . . 132.87 60.35 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.488 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 477' ' ' ASN . . . . . 0.422 ' N ' ' HD2' ' A' ' 478' ' ' PRO . 4.6 t30 -50.27 -51.58 61.93 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 120.577 0.227 . . . . 0.0 111.246 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 478' ' ' PRO . . . . . 0.422 ' HD2' ' N ' ' A' ' 477' ' ' ASN . 90.2 Cg_endo -81.67 -39.78 0.17 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.519 2.146 . . . . 0.0 112.543 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 25.7 m-70 -90.66 119.51 30.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.112 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 480' ' ' ALA . . . . . 0.915 ' HB1' ' CG2' ' A' ' 483' ' ' THR . . . -75.73 120.28 80.92 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.003 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -60.54 -78.39 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.328 2.018 . . . . 0.0 112.464 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 482' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.7 26.18 3.38 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.601 0.238 . . . . 0.0 111.065 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 483' ' ' THR . . . . . 0.915 ' CG2' ' HB1' ' A' ' 480' ' ' ALA . 1.9 t -70.85 66.63 0.37 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.952 0.405 . . . . 0.0 110.971 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 484' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -130.31 -69.48 0.66 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.619 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 485' ' ' PHE . . . . . 0.406 ' O ' ' CG ' ' A' ' 488' ' ' MET . 26.7 m-85 -70.84 -49.37 46.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.861 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -69.03 -47.79 64.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.919 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 487' ' ' ASN . . . . . 0.605 ' HB3' ' HD3' ' A' ' 489' ' ' PRO . 0.3 OUTLIER -66.78 -48.67 68.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.481 -179.829 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 488' ' ' MET . . . . . 0.541 ' N ' ' HD3' ' A' ' 489' ' ' PRO . 0.0 OUTLIER 52.12 51.63 10.04 Favored Pre-proline 0 N--CA 1.466 0.328 0 CA-C-O 120.669 0.271 . . . . 0.0 110.797 -179.669 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 489' ' ' PRO . . . . . 0.605 ' HD3' ' HB3' ' A' ' 487' ' ' ASN . 61.7 Cg_endo -88.59 22.76 0.82 Allowed 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.644 2.23 . . . . 0.0 114.226 -178.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.56 -69.62 0.76 Allowed 'General case' 0 N--CA 1.461 0.121 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.94 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 491' ' ' ALA . . . . . 0.506 ' HB1' ' HZ3' ' A' ' 584' ' ' LYS . . . -135.92 135.04 39.32 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.131 177.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 492' ' ' ARG . . . . . 0.882 ' CD ' HD22 ' A' ' 585' ' ' LEU . 2.7 mmm180 -137.8 132.67 33.0 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.535 176.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 493' ' ' VAL . . . . . 0.985 ' CG2' HG22 ' A' ' 586' ' ' VAL . 16.9 m -138.25 163.78 28.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 178.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 79.6 p -116.94 132.56 56.67 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 176.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 495' ' ' LEU . . . . . 0.832 HD12 ' HD2' ' A' ' 496' ' ' PRO . 0.0 OUTLIER -137.1 164.5 41.68 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.23 -179.556 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 496' ' ' PRO . . . . . 0.832 ' HD2' HD12 ' A' ' 495' ' ' LEU . 2.8 Cg_exo -76.94 119.95 5.28 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.045 2.497 . . . . 0.0 110.947 178.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 497' ' ' LYS . . . . . 0.82 ' N ' HG22 ' A' ' 588' ' ' ILE . 15.6 tttm -53.24 -29.78 34.5 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -177.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 498' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.9 -49.12 78.73 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -177.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 499' ' ' LEU . . . . . 0.774 HD21 ' HD2' ' A' ' 496' ' ' PRO . 2.0 pp -74.38 -8.82 57.55 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -178.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . 0.75 HG22 HG12 ' A' ' 568' ' ' ILE . 0.9 OUTLIER -74.98 -25.66 18.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.455 0.645 . . . . 0.0 111.678 -179.029 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 501' ' ' TYR . . . . . 0.631 ' O ' ' CG2' ' A' ' 564' ' ' THR . 0.3 OUTLIER -57.26 -29.48 63.86 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 114.981 1.475 . . . . 0.0 114.981 -178.288 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -75.99 -50.16 15.63 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 116.306 1.965 . . . . 0.0 116.306 -174.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 503' ' ' LYS . . . . . 0.576 ' O ' ' CG ' ' A' ' 507' ' ' LYS . 3.3 mttm -119.1 137.88 53.27 Favored 'General case' 0 N--CA 1.46 0.066 0 CA-C-N 119.27 0.941 . . . . 0.0 112.204 -178.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . 0.819 HG23 ' CE1' ' A' ' 567' ' ' PHE . 24.8 m -73.52 -76.99 0.11 Allowed 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . 0.653 ' CZ ' ' HB1' ' A' ' 530' ' ' ALA . 0.2 OUTLIER -75.7 -61.12 2.03 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -179.164 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 506' ' ' SER . . . . . 0.668 ' O ' ' CD1' ' A' ' 510' ' ' TRP . 62.2 m -48.98 -72.75 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -175.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 507' ' ' LYS . . . . . 0.68 ' HD3' ' N ' ' A' ' 508' ' ' VAL . 0.0 OUTLIER -49.2 -48.22 45.51 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -176.673 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 508' ' ' VAL . . . . . 0.88 HG13 HD21 ' A' ' 574' ' ' LEU . 69.8 t -52.46 -59.2 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 509' ' ' LEU . . . . . 0.73 HD12 ' N ' ' A' ' 510' ' ' TRP . 1.9 pp -60.18 -60.89 3.1 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 -177.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 510' ' ' TRP . . . . . 0.73 ' N ' HD12 ' A' ' 509' ' ' LEU . 51.4 p-90 -72.26 -51.75 19.48 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -176.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 511' ' ' SER . . . . . 0.541 ' N ' ' CD2' ' A' ' 510' ' ' TRP . 0.4 OUTLIER -63.98 -47.99 78.18 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.884 -177.238 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 512' ' ' ALA . . . . . 0.759 ' HB3' ' O ' ' A' ' 508' ' ' VAL . . . -71.46 -73.66 0.17 Allowed 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 117.073 2.249 . . . . 0.0 117.073 -174.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 513' ' ' GLY . . . . . 0.816 ' CA ' HG21 ' A' ' 493' ' ' VAL . . . -115.84 -35.77 1.22 Allowed Glycine 0 CA--C 1.507 -0.468 0 N-CA-C 121.558 3.383 . . . . 0.0 121.558 -173.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 514' ' ' LEU . . . . . 0.661 ' HG ' ' HE2' ' A' ' 584' ' ' LYS . 0.0 OUTLIER -107.69 -45.45 4.02 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 119.898 3.296 . . . . 0.0 119.898 -169.195 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 515' ' ' VAL . . . . . 0.596 HG22 ' N ' ' A' ' 516' ' ' ALA . 9.9 p -145.1 172.3 4.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 117.927 2.566 . . . . 0.0 117.927 -171.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 516' ' ' ALA . . . . . 0.596 ' N ' HG22 ' A' ' 515' ' ' VAL . . . -89.87 0.53 56.99 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 113.25 -1.796 . . . . 0.0 108.663 178.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . 0.996 ' O ' ' N ' ' A' ' 521' ' ' GLY . 4.0 p -61.44 10.26 0.02 OUTLIER 'General case' 0 N--CA 1.426 -1.64 0 C-N-CA 126.171 1.788 . . . . 0.0 115.289 -173.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 518' ' ' LYS . . . . . 0.626 ' HB2' ' CE2' ' A' ' 510' ' ' TRP . 0.8 OUTLIER -42.73 -39.75 2.55 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 105.426 -2.064 . . . . 0.0 105.426 178.221 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 519' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.68 -54.25 8.54 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 114.891 -1.049 . . . . 0.0 108.217 172.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 520' ' ' GLU . . . . . 0.708 ' O ' HD12 ' A' ' 524' ' ' ILE . 0.2 OUTLIER -67.67 -48.07 67.68 Favored 'General case' 0 C--N 1.35 0.626 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.373 179.845 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 521' ' ' GLY . . . . . 0.996 ' N ' ' O ' ' A' ' 517' ' ' SER . . . -49.6 -52.81 23.35 Favored Glycine 0 CA--C 1.494 -1.248 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 178.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . 0.497 ' HA ' HG12 ' A' ' 525' ' ' ILE . 3.8 mm-40 -48.19 -47.48 35.31 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 523' ' ' ARG . . . . . 0.418 ' O ' ' HB3' ' A' ' 526' ' ' ASN . 0.0 OUTLIER -49.99 -49.16 51.45 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.736 178.855 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 524' ' ' ILE . . . . . 0.708 HD12 ' O ' ' A' ' 520' ' ' GLU . 4.3 mp -59.3 -51.79 68.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.466 0.651 . . . . 0.0 109.412 179.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 525' ' ' ILE . . . . . 0.937 HG23 ' CD1' ' A' ' 556' ' ' ILE . 1.2 mm -50.66 -47.42 28.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 177.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 526' ' ' ASN . . . . . 0.418 ' HB3' ' O ' ' A' ' 523' ' ' ARG . 1.0 OUTLIER -58.69 -47.93 82.83 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 114.253 -1.339 . . . . 0.0 108.321 177.51 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 527' ' ' ASN . . . . . 0.454 ' HB3' ' HA ' ' A' ' 524' ' ' ILE . 0.0 OUTLIER -48.09 -39.57 20.68 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 113.994 -1.457 . . . . 0.0 107.477 176.604 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 528' ' ' ASN . . . . . 0.629 ' HA ' ' CG2' ' A' ' 556' ' ' ILE . 13.2 t-20 74.2 40.98 0.41 Allowed 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.867 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 529' ' ' GLY . . . . . . . . . . . . . . . -113.96 29.3 7.83 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-N 115.118 -0.946 . . . . 0.0 112.516 178.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 530' ' ' ALA . . . . . 0.927 ' O ' ' HB ' ' A' ' 556' ' ' ILE . . . -133.53 164.27 27.53 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.216 0.532 . . . . 0.0 112.423 -179.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 531' ' ' TYR . . . . . 0.516 ' CE1' ' CD1' ' A' ' 553' ' ' PHE . 0.0 OUTLIER -134.59 152.53 51.84 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 177.601 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 532' ' ' VAL . . . . . 0.663 HG12 ' OG1' ' A' ' 554' ' ' THR . 0.5 OUTLIER -129.2 135.8 61.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 CA-C-O 122.003 0.906 . . . . 0.0 112.121 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 533' ' ' GLY . . . . . 0.65 ' O ' HG13 ' A' ' 575' ' ' ILE . . . -133.74 161.71 24.33 Favored Glycine 0 N--CA 1.441 -1.016 0 CA-C-N 114.32 -1.309 . . . . 0.0 114.48 -179.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 534' ' ' SER . . . . . 0.47 ' N ' ' HB ' ' A' ' 552' ' ' THR . 5.3 t -134.05 141.89 47.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.834 -0.683 . . . . 0.0 110.626 178.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 535' ' ' ARG . . . . . 0.734 ' HB3' HD22 ' A' ' 573' ' ' LEU . 0.0 OUTLIER -159.55 90.74 1.89 Allowed Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 178.829 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 536' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 550' ' ' ASP . 71.9 Cg_endo -75.71 -35.48 2.64 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.655 2.236 . . . . 0.0 112.413 178.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 115.47 22.19 4.87 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.666 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 538' ' ' VAL . . . . . 0.592 ' O ' HG12 ' A' ' 538' ' ' VAL . 16.0 t -116.28 18.55 7.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.719 0.295 . . . . 0.0 111.237 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 539' ' ' LYS . . . . . 0.539 ' O ' ' CG ' ' A' ' 539' ' ' LYS . 1.0 OUTLIER -46.81 97.9 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.677 0.751 . . . . 0.0 111.896 -179.114 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.29 17.04 6.59 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.566 179.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 541' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 -96.51 99.92 11.54 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 121.092 0.472 . . . . 0.0 111.062 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 542' ' ' GLU . . . . . 0.439 ' CB ' ' HD2' ' A' ' 543' ' ' PRO . 0.7 OUTLIER -49.11 177.22 0.04 OUTLIER Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.863 179.509 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 543' ' ' PRO . . . . . 0.439 ' HD2' ' CB ' ' A' ' 542' ' ' GLU . 59.8 Cg_exo -39.31 -41.1 2.07 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.744 2.296 . . . . 0.0 112.972 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . 0.606 ' O ' ' N ' ' A' ' 546' ' ' GLY . . . -50.58 -22.3 5.43 Favored Glycine 0 CA--C 1.521 0.424 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.747 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 545' ' ' GLY . . . . . 0.548 ' C ' ' HD3' ' A' ' 548' ' ' PRO . . . 52.93 -53.21 0.01 OUTLIER Glycine 0 CA--C 1.525 0.71 0 N-CA-C 114.878 0.711 . . . . 0.0 114.878 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . 0.606 ' N ' ' O ' ' A' ' 544' ' ' GLY . . . 51.62 55.07 21.87 Favored Glycine 0 CA--C 1.523 0.572 0 CA-C-N 118.225 1.012 . . . . 0.0 113.538 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 547' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER 53.09 55.73 13.94 Favored Pre-proline 0 N--CA 1.466 0.347 0 CA-C-N 117.264 0.532 . . . . 0.0 110.916 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 548' ' ' PRO . . . . . 0.548 ' HD3' ' C ' ' A' ' 545' ' ' GLY . 53.8 Cg_endo -70.5 166.77 27.42 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.05 2.5 . . . . 0.0 113.089 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 549' ' ' ASP . . . . . 0.534 ' HB3' HD11 ' A' ' 569' ' ' ILE . 16.7 m-20 -123.98 -15.39 6.88 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.786 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 550' ' ' ASP . . . . . 0.545 ' O ' ' HA ' ' A' ' 535' ' ' ARG . 3.9 p30 -50.89 -36.47 38.22 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.722 0.773 . . . . 0.0 108.995 178.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 551' ' ' LEU . . . . . . . . . . . . . 13.6 tp -131.39 139.22 49.41 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.524 -1.216 . . . . 0.0 107.881 177.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 552' ' ' THR . . . . . 0.883 HG21 ' CB ' ' A' ' 567' ' ' PHE . 6.9 m -133.76 148.07 51.35 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.683 0.754 . . . . 0.0 111.842 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 553' ' ' PHE . . . . . 0.516 ' CD1' ' CE1' ' A' ' 531' ' ' TYR . 9.9 m-85 -134.09 137.91 44.93 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.788 -1.097 . . . . 0.0 108.402 177.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 554' ' ' THR . . . . . 0.901 HG22 ' H ' ' A' ' 556' ' ' ILE . 2.0 m -132.23 138.57 32.57 Favored Pre-proline 0 C--N 1.307 -1.278 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 178.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 555' ' ' PRO . . . . . 0.837 ' O ' HG22 ' A' ' 556' ' ' ILE . 67.6 Cg_endo -84.54 19.21 1.42 Allowed 'Trans proline' 0 N--CA 1.446 -1.311 0 C-N-CA 121.664 1.576 . . . . 0.0 111.918 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 556' ' ' ILE . . . . . 0.937 ' CD1' HG23 ' A' ' 525' ' ' ILE . 3.8 tp 61.21 31.77 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 177.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.85 119.84 39.97 Favored 'General case' 0 CA--C 1.501 -0.925 0 N-CA-C 104.36 -2.459 . . . . 0.0 104.36 178.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 558' ' ' THR . . . . . . . . . . . . . 3.3 t -56.76 116.98 3.48 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-O 122.576 1.179 . . . . 0.0 114.084 -171.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 559' ' ' TRP . . . . . 0.447 ' HB2' ' CB ' ' A' ' 563' ' ' LYS . 5.3 m0 -137.05 111.49 8.57 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 104.521 -2.4 . . . . 0.0 104.521 175.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 560' ' ' ASN . . . . . 0.603 ' O ' HG22 ' A' ' 564' ' ' THR . 84.4 m-20 -77.15 -75.59 0.2 Allowed 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -174.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 561' ' ' ALA . . . . . 0.551 ' HA ' HG22 ' A' ' 564' ' ' THR . . . -74.19 -57.27 4.06 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 116.055 1.872 . . . . 0.0 116.055 -177.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 562' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -49.59 -53.59 23.03 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -177.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 563' ' ' LYS . . . . . 0.648 ' CG ' HG21 ' A' ' 504' ' ' THR . 0.0 OUTLIER -69.38 -49.03 59.17 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.489 -178.439 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 564' ' ' THR . . . . . 0.649 HG23 ' H ' ' A' ' 565' ' ' GLN . 13.8 t -51.07 -65.22 0.59 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.567 0.222 . . . . 0.0 111.451 -178.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 565' ' ' GLN . . . . . 0.649 ' H ' HG23 ' A' ' 564' ' ' THR . 8.4 tp60 -48.95 -47.05 44.18 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.848 0.356 . . . . 0.0 111.053 179.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -49.5 -55.65 12.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 0.0 112.21 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 567' ' ' PHE . . . . . 0.914 ' CZ ' HD13 ' A' ' 568' ' ' ILE . 0.6 OUTLIER -96.89 -42.63 7.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.347 0.594 . . . . 0.0 112.46 -178.296 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 568' ' ' ILE . . . . . 0.923 HD11 HD22 ' A' ' 574' ' ' LEU . 1.2 tp -61.2 9.06 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 N-CA-C 113.939 1.088 . . . . 0.0 113.939 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 569' ' ' ILE . . . . . 0.6 HG23 ' O ' ' A' ' 565' ' ' GLN . 0.7 OUTLIER -54.46 -40.25 48.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 N-CA-C 104.005 -2.591 . . . . 0.0 104.005 178.295 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 570' ' ' ASP . . . . . 0.954 ' CG ' HD13 ' A' ' 588' ' ' ILE . 17.2 p30 32.13 56.84 0.36 Allowed 'General case' 0 CA--C 1.509 -0.599 0 CA-C-N 113.738 -1.574 . . . . 0.0 113.527 172.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 571' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 570' ' ' ASP . . . -51.3 -44.79 52.64 Favored Glycine 0 N--CA 1.44 -1.035 0 C-N-CA 116.819 -2.61 . . . . 0.0 108.575 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 572' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -120.29 -15.89 8.55 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 175.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 573' ' ' LEU . . . . . 0.734 HD22 ' HB3' ' A' ' 535' ' ' ARG . 1.1 tp -139.75 139.9 36.6 Favored 'General case' 0 C--N 1.353 0.746 0 N-CA-C 116.913 2.19 . . . . 0.0 116.913 -176.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 574' ' ' LEU . . . . . 0.977 ' HB3' HD11 ' A' ' 588' ' ' ILE . 0.3 OUTLIER -135.07 133.6 39.49 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 172.642 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 575' ' ' ILE . . . . . 0.895 ' N ' HD12 ' A' ' 574' ' ' LEU . 0.0 OUTLIER -134.12 137.24 52.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 118.623 0.647 . . . . 0.0 111.596 178.812 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 576' ' ' LEU . . . . . 0.594 HD22 ' HB3' ' A' ' 509' ' ' LEU . 0.0 OUTLIER -133.15 135.41 45.14 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 177.361 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 577' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -131.45 134.8 46.57 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 119.089 -1.045 . . . . 0.0 110.036 177.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.45 ' CG ' HD11 ' A' ' 576' ' ' LEU . 0.3 OUTLIER -122.46 132.2 54.23 Favored 'General case' 0 C--O 1.243 0.732 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.076 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 579' ' ' GLY . . . . . . . . . . . . . . . -88.18 -2.0 80.96 Favored Glycine 0 N--CA 1.44 -1.047 0 CA-C-N 114.901 -1.045 . . . . 0.0 113.411 -178.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 580' ' ' LYS . . . . . 0.591 ' CD ' ' CE2' ' A' ' 581' ' ' TRP . 0.0 OUTLIER -71.22 -49.65 41.16 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 118.656 -1.217 . . . . 0.0 108.441 179.279 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 581' ' ' TRP . . . . . 0.591 ' CE2' ' CD ' ' A' ' 580' ' ' LYS . 0.7 OUTLIER -140.92 -51.32 0.45 Allowed 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 175.823 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 582' ' ' LYS . . . . . 0.567 ' HE2' ' CD1' ' A' ' 581' ' ' TRP . 0.0 OUTLIER -139.76 165.29 27.69 Favored 'General case' 0 CA--C 1.512 -0.511 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -175.079 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 583' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.13 135.08 51.49 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 175.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 584' ' ' LYS . . . . . 0.661 ' HE2' ' HG ' ' A' ' 514' ' ' LEU . 9.1 tppt? -116.44 133.67 55.75 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 585' ' ' LEU . . . . . 0.882 HD22 ' CD ' ' A' ' 492' ' ' ARG . 7.7 tt -120.88 137.07 54.76 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -179.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 586' ' ' VAL . . . . . 0.985 HG22 ' CG2' ' A' ' 493' ' ' VAL . 55.9 t -131.95 137.01 55.78 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.777 -178.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 587' ' ' SER . . . . . . . . . . . . . 1.4 m -107.31 134.63 50.1 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 177.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.977 HD11 ' HB3' ' A' ' 574' ' ' LEU . 0.0 OUTLIER -135.98 136.4 49.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -177.754 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 6.1 m -133.58 136.81 53.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.943 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 590' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -82.62 162.52 21.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.565 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 591' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -50.58 -49.36 56.56 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.233 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -51.95 -49.57 62.9 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 120.987 0.423 . . . . 0.0 111.343 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 10.2 mmtm -56.65 -49.39 75.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.541 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 594' ' ' PHE . . . . . 0.702 ' O ' ' HG ' ' A' ' 597' ' ' LEU . 1.2 t80 -50.51 -48.55 56.94 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.518 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 595' ' ' LYS . . . . . 0.532 ' O ' ' HB3' ' A' ' 599' ' ' LEU . 6.3 mtpt -51.18 -50.5 58.87 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.328 0.585 . . . . 0.0 110.027 179.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 596' ' ' GLU . . . . . 0.414 ' O ' ' HG ' ' A' ' 599' ' ' LEU . 0.7 OUTLIER -50.43 -48.44 56.3 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.103 -0.953 . . . . 0.0 112.965 -179.647 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 597' ' ' LEU . . . . . 0.783 HD12 ' N ' ' A' ' 598' ' ' GLY . 3.2 pp -72.09 -57.67 4.07 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -177.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 598' ' ' GLY . . . . . 0.786 ' O ' ' CD1' ' A' ' 604' ' ' TRP . . . -86.34 11.68 62.69 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.761 -0.654 . . . . 0.0 113.33 -178.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 599' ' ' LEU . . . . . 0.894 HD12 HG23 ' A' ' 600' ' ' THR . 2.2 pp -48.82 -12.59 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -176.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 600' ' ' THR . . . . . 0.894 HG23 HD12 ' A' ' 599' ' ' LEU . 47.8 p -106.55 64.39 0.66 Allowed 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.027 177.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 601' ' ' ALA . . . . . 0.952 ' HB3' ' CD1' ' A' ' 604' ' ' TRP . . . -133.41 -173.54 0.35 Allowed Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.297 178.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 602' ' ' PRO . . . . . 0.816 ' CD ' ' HB1' ' A' ' 601' ' ' ALA . 3.5 Cg_exo -76.28 -33.07 3.6 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.579 2.186 . . . . 0.0 111.624 178.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 603' ' ' GLY . . . . . . . . . . . . . . . -71.44 -49.33 25.84 Favored Glycine 0 C--N 1.334 0.425 0 C-N-CA 121.079 -0.581 . . . . 0.0 113.072 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 604' ' ' TRP . . . . . 0.952 ' CD1' ' HB3' ' A' ' 601' ' ' ALA . 1.3 m95 -70.94 -47.18 60.43 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 120.846 0.355 . . . . 0.0 111.176 -179.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 605' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -50.79 -56.74 10.67 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.24 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 606' ' ' GLU . . . . . 0.411 ' O ' ' CB ' ' A' ' 610' ' ' LYS . 1.3 tt0 -57.23 -62.15 1.97 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.754 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 607' ' ' VAL . . . . . . . . . . . . . 40.1 t -64.31 -71.68 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 114.379 1.252 . . . . 0.0 114.379 -177.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 608' ' ' VAL . . . . . . . . . . . . . 62.1 t -56.17 -56.94 10.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.796 -178.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 609' ' ' GLY . . . . . . . . . . . . . . . -64.98 -63.51 4.14 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 121.151 -0.547 . . . . 0.0 113.402 -178.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 610' ' ' LYS . . . . . 0.411 ' CB ' ' O ' ' A' ' 606' ' ' GLU . 3.2 tttm -61.56 -49.94 74.64 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.81 0.338 . . . . 0.0 110.921 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 75.24 56.53 4.69 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.592 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.0 -29.68 68.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.748 0.309 . . . . 0.0 110.865 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 613' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -67.91 176.95 2.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.908 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . 0.404 ' CB ' ' CD ' ' A' ' 615' ' ' PRO . 13.4 mt-10 -73.01 -60.94 1.66 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.018 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 615' ' ' PRO . . . . . 0.404 ' CD ' ' CB ' ' A' ' 614' ' ' GLU . 59.1 Cg_endo -72.08 94.95 0.73 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.519 2.146 . . . . 0.0 112.323 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 616' ' ' SER . . . . . . . . . . . . . 3.2 m -75.37 156.89 85.22 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.856 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo . . . . . 0 C--O 1.248 0.992 0 C-N-CA 122.584 2.189 . . . . 0.0 112.293 -179.989 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.718 0.294 . . . . 0.0 111.208 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 455' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.23 118.41 4.56 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.542 2.162 . . . . 0.0 112.337 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 456' ' ' ARG . . . . . . . . . . . . . 1.4 ttm180 -66.66 -26.5 67.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.03 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 20.0 p -70.52 -51.05 31.53 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.858 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -59.95 115.92 3.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.117 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 1.4 m -90.26 149.67 41.68 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.925 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.01 -169.59 0.35 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.606 2.204 . . . . 0.0 112.313 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . 90.33 56.55 1.78 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.557 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -152.17 156.63 33.94 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 120.743 0.306 . . . . 0.0 110.887 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -68.47 119.05 6.07 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.673 2.249 . . . . 0.0 112.273 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 27.9 mttt -99.67 126.24 45.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.9 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.03 -73.99 0.58 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.82 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 27.8 m -111.72 33.75 4.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.846 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -136.5 81.8 1.9 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.903 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.78 43.49 1.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.753 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 129.07 -34.76 2.75 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.053 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -112.82 117.8 33.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.822 0.344 . . . . 0.0 110.393 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 471' ' ' VAL . . . . . 0.572 HG13 ' O ' ' A' ' 471' ' ' VAL . 9.9 p -113.08 107.97 24.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.034 0.445 . . . . 0.0 111.255 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 23.3 t30 -177.89 85.63 0.24 Allowed Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.841 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -63.75 157.24 53.03 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.627 2.218 . . . . 0.0 112.213 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -85.23 -50.99 6.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.79 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 1.5 m -138.05 -46.35 0.52 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.835 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 476' ' ' GLY . . . . . . . . . . . . . . . 127.36 -41.71 1.56 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.527 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 477' ' ' ASN . . . . . 0.55 ' N ' ' HD3' ' A' ' 478' ' ' PRO . 27.9 t-20 47.78 53.37 13.99 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 120.511 0.196 . . . . 0.0 111.473 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 478' ' ' PRO . . . . . 0.55 ' HD3' ' N ' ' A' ' 477' ' ' ASN . 37.6 Cg_exo -55.77 -69.25 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.241 1.961 . . . . 0.0 112.314 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -124.68 85.06 2.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.05 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 480' ' ' ALA . . . . . 0.418 ' CB ' ' HB2' ' A' ' 485' ' ' PHE . . . -140.48 131.64 13.98 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.213 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 481' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 480' ' ' ALA . 39.0 Cg_exo -59.08 -69.5 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.211 1.941 . . . . 0.0 111.931 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 482' ' ' GLN . . . . . . . . . . . . . 17.5 mp0 -135.33 -73.46 0.46 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.661 179.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 483' ' ' THR . . . . . . . . . . . . . 1.9 t -137.61 65.26 1.49 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.072 0.463 . . . . 0.0 110.858 178.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 484' ' ' ASN . . . . . 0.444 ' O ' ' HD3' ' A' ' 489' ' ' PRO . 34.1 t30 -130.94 -69.22 0.65 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.481 0.658 . . . . 0.0 109.653 178.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 485' ' ' PHE . . . . . 0.54 ' HA ' ' HG2' ' A' ' 489' ' ' PRO . 3.6 m-85 -70.71 -46.73 62.56 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.871 179.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 486' ' ' ALA . . . . . 0.4 ' CB ' ' ND2' ' A' ' 477' ' ' ASN . . . -72.39 -47.42 49.44 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -177.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -68.06 -74.6 0.12 Allowed 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 -176.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 488' ' ' MET . . . . . 0.526 ' CB ' ' HD3' ' A' ' 489' ' ' PRO . 0.4 OUTLIER -52.86 -52.63 63.11 Favored Pre-proline 0 N--CA 1.469 0.522 0 CA-C-O 121.176 0.513 . . . . 0.0 111.335 -178.961 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 489' ' ' PRO . . . . . 0.54 ' HG2' ' HA ' ' A' ' 485' ' ' PHE . 2.5 Cg_endo -86.19 43.88 1.18 Allowed 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 124.646 3.564 . . . . 0.0 112.257 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 14.3 p -36.43 -37.16 0.12 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.631 -178.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 491' ' ' ALA . . . . . 0.422 ' CB ' ' NZ ' ' A' ' 584' ' ' LYS . . . -133.41 135.0 44.36 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.63 177.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 492' ' ' ARG . . . . . 0.46 ' HD3' ' HG ' ' A' ' 585' ' ' LEU . 0.0 OUTLIER -136.39 134.93 38.32 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 179.434 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 493' ' ' VAL . . . . . 0.585 ' HB ' ' CA ' ' A' ' 513' ' ' GLY . 75.2 t -135.2 163.48 35.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.68 177.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . 0.579 ' N ' HG12 ' A' ' 493' ' ' VAL . 18.5 m -123.85 135.3 53.66 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.153 0.502 . . . . 0.0 111.201 178.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 495' ' ' LEU . . . . . 0.804 ' O ' HG22 ' A' ' 588' ' ' ILE . 0.0 OUTLIER -134.46 163.7 49.31 Favored Pre-proline 0 CA--C 1.531 0.239 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.298 179.546 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 496' ' ' PRO . . . . . 0.569 ' HB2' HD12 ' A' ' 499' ' ' LEU . 32.5 Cg_exo -57.45 120.06 7.72 Favored 'Trans proline' 0 CA--C 1.532 0.393 0 C-N-CA 122.225 1.95 . . . . 0.0 112.358 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 497' ' ' LYS . . . . . 0.54 ' CA ' ' HB ' ' A' ' 588' ' ' ILE . 0.9 OUTLIER -56.9 -30.31 63.81 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.663 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 498' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.79 -48.34 66.94 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 499' ' ' LEU . . . . . 0.612 ' O ' ' HE3' ' A' ' 507' ' ' LYS . 0.3 OUTLIER -73.45 -8.85 57.61 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.605 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . 0.833 HG22 ' CG2' ' A' ' 568' ' ' ILE . 0.3 OUTLIER -60.06 -24.98 31.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.362 0.601 . . . . 0.0 111.113 -179.836 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 501' ' ' TYR . . . . . 0.56 ' O ' ' CG2' ' A' ' 564' ' ' THR . 0.1 OUTLIER -71.24 -29.9 65.68 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 115.027 1.492 . . . . 0.0 115.027 -177.598 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 502' ' ' ASP . . . . . 0.402 ' OD1' ' CZ ' ' A' ' 501' ' ' TYR . 11.3 m-20 -75.2 -51.22 13.88 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 116.057 1.873 . . . . 0.0 116.057 -174.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 503' ' ' LYS . . . . . 0.627 ' O ' ' CG ' ' A' ' 507' ' ' LYS . 7.4 mttt -120.73 134.48 55.28 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-N 119.346 0.976 . . . . 0.0 111.576 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . 0.689 HG23 HD13 ' A' ' 568' ' ' ILE . 4.2 m -72.91 -76.25 0.12 Allowed 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . 0.54 ' CD1' HG13 ' A' ' 525' ' ' ILE . 12.6 p90 -75.26 -59.12 2.88 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 506' ' ' SER . . . . . 0.783 ' O ' ' CD1' ' A' ' 510' ' ' TRP . 5.2 t -49.39 -72.28 0.05 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 -175.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 507' ' ' LYS . . . . . 0.732 ' HD3' ' N ' ' A' ' 508' ' ' VAL . 0.0 OUTLIER -48.96 -49.12 42.06 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -176.231 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 508' ' ' VAL . . . . . 0.931 ' CG2' HD21 ' A' ' 574' ' ' LEU . 51.5 t -53.33 -60.02 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -179.085 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 509' ' ' LEU . . . . . 0.776 HD12 ' N ' ' A' ' 510' ' ' TRP . 2.6 pp -60.59 -62.69 1.68 Allowed 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 -177.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 510' ' ' TRP . . . . . 0.783 ' CD1' ' O ' ' A' ' 506' ' ' SER . 63.9 p-90 -72.86 -53.63 10.92 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 114.66 1.355 . . . . 0.0 114.66 -176.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 511' ' ' SER . . . . . 0.517 ' N ' ' CE3' ' A' ' 510' ' ' TRP . 1.7 t -65.48 -47.92 74.4 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.89 -177.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 512' ' ' ALA . . . . . 0.916 ' HB3' ' O ' ' A' ' 508' ' ' VAL . . . -71.64 -72.46 0.22 Allowed 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 117.184 2.291 . . . . 0.0 117.184 -174.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 513' ' ' GLY . . . . . 0.631 ' HA3' ' HE3' ' A' ' 584' ' ' LYS . . . -114.57 -34.88 1.49 Allowed Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 121.369 3.308 . . . . 0.0 121.369 -172.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 514' ' ' LEU . . . . . 0.585 ' HG ' ' HE2' ' A' ' 584' ' ' LYS . 1.7 mt -107.12 -46.49 3.89 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 119.579 3.178 . . . . 0.0 119.579 -170.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 515' ' ' VAL . . . . . 1.089 HG13 ' HB2' ' A' ' 517' ' ' SER . 4.7 p -154.28 173.16 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 117.617 2.451 . . . . 0.0 117.617 -171.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 516' ' ' ALA . . . . . 0.59 ' N ' HG22 ' A' ' 515' ' ' VAL . . . -67.84 3.83 1.36 Allowed 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 126.515 1.926 . . . . 0.0 110.078 177.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . 1.089 ' HB2' HG13 ' A' ' 515' ' ' VAL . 0.4 OUTLIER -57.8 9.11 0.01 OUTLIER 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 115.979 1.844 . . . . 0.0 115.979 -172.213 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 518' ' ' LYS . . . . . 0.781 ' HA ' ' CD1' ' A' ' 510' ' ' TRP . 0.0 OUTLIER -45.56 -49.78 13.63 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 104.248 -2.501 . . . . 0.0 104.248 175.304 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 519' ' ' SER . . . . . . . . . . . . . 11.3 p -75.15 -56.93 4.23 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.2 173.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 520' ' ' GLU . . . . . 0.851 ' HB2' ' HA ' ' A' ' 517' ' ' SER . 0.8 OUTLIER -58.1 -47.41 83.31 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.023 -178.892 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 521' ' ' GLY . . . . . 0.805 ' N ' ' O ' ' A' ' 517' ' ' SER . . . -49.18 -55.99 11.3 Favored Glycine 0 CA--C 1.492 -1.39 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.273 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -47.74 -47.42 30.31 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 178.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 523' ' ' ARG . . . . . 0.449 ' O ' ' HB3' ' A' ' 526' ' ' ASN . 0.1 OUTLIER -50.36 -48.9 55.49 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.786 178.534 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 524' ' ' ILE . . . . . 0.722 HD13 ' HE3' ' A' ' 580' ' ' LYS . 1.7 mt -57.33 -55.77 18.95 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 CA-C-O 121.571 0.7 . . . . 0.0 109.613 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 525' ' ' ILE . . . . . 0.595 HG12 ' O ' ' A' ' 521' ' ' GLY . 0.8 OUTLIER -50.15 -47.4 24.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.163 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 526' ' ' ASN . . . . . 0.449 ' HB3' ' O ' ' A' ' 523' ' ' ARG . 1.1 t30 -56.84 -48.02 79.0 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-N 114.36 -1.291 . . . . 0.0 108.314 177.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 527' ' ' ASN . . . . . 0.453 ' ND2' ' O ' ' A' ' 524' ' ' ILE . 0.0 OUTLIER -48.04 -40.09 21.86 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.087 -1.415 . . . . 0.0 107.49 176.658 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 528' ' ' ASN . . . . . 1.036 ' HA ' HG21 ' A' ' 556' ' ' ILE . 1.8 t30 73.61 39.92 0.53 Allowed 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 114.638 -1.164 . . . . 0.0 111.529 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 529' ' ' GLY . . . . . . . . . . . . . . . -113.78 21.97 15.42 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 114.507 -1.224 . . . . 0.0 111.69 178.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 530' ' ' ALA . . . . . 0.795 ' O ' ' HB ' ' A' ' 556' ' ' ILE . . . -133.67 163.07 30.26 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.252 0.548 . . . . 0.0 112.231 -179.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 531' ' ' TYR . . . . . 0.558 ' HA ' ' O ' ' A' ' 554' ' ' THR . 0.0 OUTLIER -133.92 162.69 31.35 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 177.49 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 532' ' ' VAL . . . . . 0.553 HG12 ' OG1' ' A' ' 554' ' ' THR . 0.9 OUTLIER -131.37 135.48 59.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 CA-C-O 122.148 0.975 . . . . 0.0 111.862 179.772 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 533' ' ' GLY . . . . . 0.654 ' HA2' ' HB ' ' A' ' 552' ' ' THR . . . -133.66 153.88 21.05 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 114.189 -1.369 . . . . 0.0 113.966 -179.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 534' ' ' SER . . . . . 0.573 ' HB2' ' OG1' ' A' ' 552' ' ' THR . 19.1 m -134.31 136.39 43.45 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.389 -0.405 . . . . 0.0 111.437 178.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 535' ' ' ARG . . . . . 0.705 ' CG ' HD11 ' A' ' 575' ' ' ILE . 0.0 OUTLIER -160.63 90.92 1.65 Allowed Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 178.306 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 536' ' ' PRO . . . . . 0.443 ' O ' HG23 ' A' ' 538' ' ' VAL . 5.9 Cg_exo -78.22 52.03 3.93 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.903 2.402 . . . . 0.0 112.131 178.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 66.61 11.49 57.15 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.667 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 538' ' ' VAL . . . . . 0.604 ' O ' HG12 ' A' ' 538' ' ' VAL . 16.3 t -116.48 18.83 7.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.656 0.265 . . . . 0.0 111.357 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 539' ' ' LYS . . . . . 0.408 ' HA ' ' HB2' ' A' ' 550' ' ' ASP . 0.1 OUTLIER -45.92 119.74 2.38 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.276 0.56 . . . . 0.0 111.609 -178.931 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.18 31.25 5.09 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.91 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 541' ' ' ASN . . . . . 0.861 ' HB3' HD22 ' A' ' 551' ' ' LEU . 5.9 p30 -35.9 98.1 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.173 0 CA-C-O 121.684 0.754 . . . . 0.0 111.131 -179.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 542' ' ' GLU . . . . . 0.822 ' O ' ' N ' ' A' ' 544' ' ' GLY . 5.7 pt-20 -132.56 161.5 62.93 Favored Pre-proline 0 C--N 1.318 -0.761 0 CA-C-N 114.561 -1.2 . . . . 0.0 111.043 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 543' ' ' PRO . . . . . 0.527 ' HD2' ' HB2' ' A' ' 542' ' ' GLU . 30.6 Cg_exo -25.26 56.03 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.779 1 C-N-CA 125.345 4.03 . . . . 0.0 115.463 179.363 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . 0.822 ' N ' ' O ' ' A' ' 542' ' ' GLU . . . 52.26 53.69 30.09 Favored Glycine 0 C--O 1.229 -0.185 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.749 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 545' ' ' GLY . . . . . 0.5 ' C ' ' HD3' ' A' ' 548' ' ' PRO . . . -51.0 55.55 0.01 OUTLIER Glycine 0 CA--C 1.526 0.733 0 N-CA-C 114.931 0.732 . . . . 0.0 114.931 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . 0.634 ' N ' ' O ' ' A' ' 544' ' ' GLY . . . 53.68 55.83 23.31 Favored Glycine 0 CA--C 1.522 0.528 0 C-N-CA 120.444 -0.884 . . . . 0.0 113.806 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 547' ' ' MET . . . . . . . . . . . . . 1.2 mtt 53.44 55.77 13.41 Favored Pre-proline 0 N--CA 1.466 0.338 0 CA-C-O 121.026 0.441 . . . . 0.0 112.018 179.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 548' ' ' PRO . . . . . 0.5 ' HD3' ' C ' ' A' ' 545' ' ' GLY . 9.5 Cg_endo -50.4 167.67 0.23 Allowed 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 123.31 2.673 . . . . 0.0 112.419 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -110.51 -22.42 11.67 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 550' ' ' ASP . . . . . 0.614 ' O ' ' HA ' ' A' ' 535' ' ' ARG . 0.7 OUTLIER -56.04 -41.3 74.79 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.548 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 551' ' ' LEU . . . . . 0.861 HD22 ' HB3' ' A' ' 541' ' ' ASN . 7.6 tp -131.47 140.09 49.49 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.72 177.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 552' ' ' THR . . . . . 0.962 HG21 ' CG ' ' A' ' 567' ' ' PHE . 0.3 OUTLIER -133.71 149.46 51.5 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 122.118 0.961 . . . . 0.0 112.73 179.078 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 553' ' ' PHE . . . . . 0.532 ' HA ' ' CE2' ' A' ' 531' ' ' TYR . 3.4 m-85 -134.12 137.37 44.5 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 106.29 -1.745 . . . . 0.0 106.29 176.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 554' ' ' THR . . . . . 0.558 ' O ' ' HA ' ' A' ' 531' ' ' TYR . 1.8 m -132.53 138.38 31.96 Favored Pre-proline 0 C--N 1.304 -1.388 0 C-N-CA 119.197 -1.001 . . . . 0.0 110.582 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 555' ' ' PRO . . . . . 0.817 ' O ' HG22 ' A' ' 556' ' ' ILE . 65.3 Cg_endo -84.28 14.27 2.48 Favored 'Trans proline' 0 N--CA 1.439 -1.717 0 C-N-CA 121.647 1.564 . . . . 0.0 111.14 179.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 556' ' ' ILE . . . . . 1.036 HG21 ' HA ' ' A' ' 528' ' ' ASN . 1.2 tp 69.73 33.63 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 N-CA-C 115.065 1.506 . . . . 0.0 115.065 176.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . 0.61 ' O ' ' CE2' ' A' ' 559' ' ' TRP . 0.0 OUTLIER -103.87 148.46 26.12 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -179.289 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 558' ' ' THR . . . . . 0.492 ' HA ' ' CE2' ' A' ' 505' ' ' PHE . 3.7 t -69.96 115.9 9.71 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 -172.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 559' ' ' TRP . . . . . 0.61 ' CE2' ' O ' ' A' ' 557' ' ' LYS . 0.0 OUTLIER -141.24 123.07 15.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 112.642 -2.072 . . . . 0.0 105.599 174.184 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 560' ' ' ASN . . . . . 0.565 ' O ' HG22 ' A' ' 564' ' ' THR . 60.3 m-20 -90.54 -77.01 0.42 Allowed 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 117.627 -1.629 . . . . 0.0 113.129 -177.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 561' ' ' ALA . . . . . 0.524 ' HA ' HG22 ' A' ' 564' ' ' THR . . . -76.22 -50.44 14.45 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 115.502 1.667 . . . . 0.0 115.502 -179.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 562' ' ' SER . . . . . . . . . . . . . 5.1 t -49.37 -56.68 8.78 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -176.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 563' ' ' LYS . . . . . 0.5 ' HG3' ' CZ ' ' A' ' 567' ' ' PHE . 0.0 OUTLIER -69.17 -48.51 62.02 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -178.307 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 564' ' ' THR . . . . . 0.719 HG23 ' H ' ' A' ' 565' ' ' GLN . 10.6 t -50.22 -68.32 0.18 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.801 0.334 . . . . 0.0 111.842 -179.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 565' ' ' GLN . . . . . 0.984 ' O ' HG23 ' A' ' 569' ' ' ILE . 3.8 tp60 -50.02 -47.17 53.27 Favored 'General case' 0 C--N 1.319 -0.721 0 O-C-N 122.173 -0.33 . . . . 0.0 111.635 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . 0.405 ' HG2' ' CD1' ' A' ' 567' ' ' PHE . 27.9 tt0 -49.54 -62.64 1.44 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -178.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 567' ' ' PHE . . . . . 0.962 ' CG ' HG21 ' A' ' 552' ' ' THR . 0.0 OUTLIER -97.27 -50.64 4.48 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.449 0.642 . . . . 0.0 112.132 -178.53 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 568' ' ' ILE . . . . . 0.833 ' CG2' HG22 ' A' ' 500' ' ' VAL . 1.7 mp -58.1 10.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 114.805 -1.089 . . . . 0.0 113.266 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 569' ' ' ILE . . . . . 0.984 HG23 ' O ' ' A' ' 565' ' ' GLN . 1.2 pt -52.8 -38.32 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 N-CA-C 104.253 -2.499 . . . . 0.0 104.253 178.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 570' ' ' ASP . . . . . 0.951 ' CB ' HD11 ' A' ' 588' ' ' ILE . 30.2 m-20 34.55 52.62 0.56 Allowed 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 113.701 -1.59 . . . . 0.0 112.149 173.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -51.48 -44.56 53.43 Favored Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 118.226 -1.94 . . . . 0.0 109.084 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 572' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -118.97 -17.33 9.07 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 176.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 573' ' ' LEU . . . . . 0.608 ' HB3' ' O ' ' A' ' 535' ' ' ARG . 1.1 tp -140.12 137.08 34.19 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -178.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 574' ' ' LEU . . . . . 0.931 HD21 ' CG2' ' A' ' 508' ' ' VAL . 0.3 OUTLIER -134.46 132.92 39.86 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 174.244 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 575' ' ' ILE . . . . . 1.094 HG23 HD13 ' A' ' 585' ' ' LEU . 0.0 OUTLIER -134.05 137.17 52.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 118.914 0.779 . . . . 0.0 112.074 179.125 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 576' ' ' LEU . . . . . 0.585 HD22 ' HB3' ' A' ' 509' ' ' LEU . 0.0 OUTLIER -133.58 135.59 44.37 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 176.948 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 577' ' ' LYS . . . . . 0.42 ' HD2' ' CE1' ' A' ' 531' ' ' TYR . 0.0 OUTLIER -132.8 135.34 45.62 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 118.906 -1.117 . . . . 0.0 110.548 177.99 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.604 HD12 ' O ' ' A' ' 582' ' ' LYS . 0.3 OUTLIER -123.63 131.72 53.68 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 177.834 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 579' ' ' GLY . . . . . . . . . . . . . . . -91.21 -2.38 71.07 Favored Glycine 0 CA--C 1.5 -0.857 0 CA-C-N 115.404 -0.816 . . . . 0.0 114.447 -177.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 580' ' ' LYS . . . . . 0.722 ' HE3' HD13 ' A' ' 524' ' ' ILE . 0.4 OUTLIER -75.32 -46.47 33.13 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 118.777 -1.169 . . . . 0.0 109.153 179.111 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 581' ' ' TRP . . . . . 0.444 ' H ' ' HG3' ' A' ' 580' ' ' LYS . 0.1 OUTLIER -138.74 -51.65 0.56 Allowed 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 177.911 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 582' ' ' LYS . . . . . 0.604 ' O ' HD12 ' A' ' 578' ' ' LEU . 1.1 ptpm? -139.56 165.0 28.4 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -175.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 583' ' ' MET . . . . . . . . . . . . . 2.3 ttt -118.85 134.81 54.91 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 174.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 584' ' ' LYS . . . . . 0.631 ' HE3' ' HA3' ' A' ' 513' ' ' GLY . 0.0 OUTLIER -121.71 133.05 54.94 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.023 -0.989 . . . . 0.0 108.335 179.53 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 585' ' ' LEU . . . . . 1.094 HD13 HG23 ' A' ' 575' ' ' ILE . 2.9 tp -119.46 136.68 54.21 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 179.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 586' ' ' VAL . . . . . 0.589 HG23 ' HD2' ' A' ' 584' ' ' LYS . 11.5 t -131.95 137.08 55.63 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.696 -178.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 587' ' ' SER . . . . . 0.564 ' O ' HG23 ' A' ' 494' ' ' THR . 7.6 m -110.24 135.79 50.44 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 177.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.951 HD11 ' CB ' ' A' ' 570' ' ' ASP . 0.2 OUTLIER -133.81 144.64 35.15 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.607 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -178.606 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 5.3 m -132.87 137.26 54.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 114.204 -1.362 . . . . 0.0 110.742 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 590' ' ' SER . . . . . . . . . . . . . 2.5 t -70.65 135.52 48.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.624 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 591' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -50.6 -50.5 53.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.044 0.45 . . . . 0.0 110.737 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 592' ' ' GLU . . . . . 0.4 ' HA ' ' HG3' ' A' ' 595' ' ' LYS . 18.6 mt-10 -51.55 -50.46 60.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.037 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -50.44 -48.65 56.34 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.708 0.766 . . . . 0.0 109.237 179.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 594' ' ' PHE . . . . . 0.75 ' CD1' HD11 ' A' ' 597' ' ' LEU . 0.9 OUTLIER -50.23 -48.53 54.42 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.687 178.47 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 595' ' ' LYS . . . . . 0.517 ' HA ' ' CE2' ' A' ' 604' ' ' TRP . 5.7 mmpt? -49.37 -47.65 47.45 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 596' ' ' GLU . . . . . 0.503 ' O ' HD23 ' A' ' 599' ' ' LEU . 0.7 OUTLIER -51.98 -60.28 3.37 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.434 179.846 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 597' ' ' LEU . . . . . 0.75 HD11 ' CD1' ' A' ' 594' ' ' PHE . 0.7 OUTLIER -61.66 -62.17 2.0 Allowed 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.417 0.627 . . . . 0.0 112.117 -178.699 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 598' ' ' GLY . . . . . 0.481 ' N ' HD12 ' A' ' 597' ' ' LEU . . . -77.13 14.03 8.72 Favored Glycine 0 C--N 1.32 -0.352 0 CA-C-N 115.043 -0.98 . . . . 0.0 113.401 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 599' ' ' LEU . . . . . 0.69 HD12 ' N ' ' A' ' 600' ' ' THR . 2.8 pp -47.45 -15.95 0.05 Allowed 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -175.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 600' ' ' THR . . . . . 0.69 ' N ' HD12 ' A' ' 599' ' ' LEU . 11.6 t -129.83 65.91 1.48 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 119.939 -0.704 . . . . 0.0 110.413 176.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 601' ' ' ALA . . . . . . . . . . . . . . . -131.99 155.64 81.1 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.442 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 602' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.3 -19.86 44.84 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 121.942 1.761 . . . . 0.0 111.129 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 603' ' ' GLY . . . . . 0.645 ' O ' HG23 ' A' ' 607' ' ' VAL . . . -61.33 -49.1 81.14 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.628 -0.714 . . . . 0.0 113.071 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 604' ' ' TRP . . . . . 0.517 ' CE2' ' HA ' ' A' ' 595' ' ' LYS . 1.2 m95 -66.91 -46.72 73.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.775 0.321 . . . . 0.0 111.427 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 605' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -52.17 -55.45 20.92 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.626 -179.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -59.85 -63.34 1.34 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.739 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 607' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 603' ' ' GLY . 46.3 t -50.79 -69.85 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 -178.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 608' ' ' VAL . . . . . . . . . . . . . 97.4 t -70.59 -60.72 2.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -177.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 609' ' ' GLY . . . . . . . . . . . . . . . -57.65 -62.43 6.34 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.085 -0.579 . . . . 0.0 113.222 -178.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 610' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.93 -70.17 0.29 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.824 0.345 . . . . 0.0 110.877 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 93.49 54.0 1.75 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.499 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 31.5 mtpt -60.0 -31.62 70.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.928 0.394 . . . . 0.0 111.0 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 613' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -92.11 171.15 9.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.924 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . 0.402 ' CB ' ' CD ' ' A' ' 615' ' ' PRO . 21.6 mm-40 -61.29 -61.09 8.61 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.956 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 615' ' ' PRO . . . . . 0.402 ' CD ' ' CB ' ' A' ' 614' ' ' GLU . 57.4 Cg_endo -71.23 117.49 5.18 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.541 2.16 . . . . 0.0 112.312 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 616' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -106.27 87.44 2.58 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.932 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo . . . . . 0 C--O 1.25 1.091 0 C-N-CA 122.585 2.19 . . . . 0.0 112.242 -179.953 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.625 0.25 . . . . 0.0 111.156 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 455' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.23 -28.06 23.46 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.505 2.137 . . . . 0.0 112.381 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 456' ' ' ARG . . . . . . . . . . . . . 5.6 ttt180 -83.69 -26.45 29.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.071 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 55.4 m -84.39 -31.31 24.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.939 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -67.99 121.85 16.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.141 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -114.94 96.91 46.32 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.871 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -56.02 174.34 0.33 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.57 2.18 . . . . 0.0 112.27 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . 115.22 56.55 0.36 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.595 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -158.68 143.2 11.54 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.713 0.292 . . . . 0.0 110.916 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.0 119.93 6.33 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.536 2.157 . . . . 0.0 112.274 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 4.7 mmtp -120.22 -173.55 2.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.126 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 465' ' ' SER . . . . . 0.592 ' O ' HD23 ' A' ' 467' ' ' LEU . 14.5 m -94.96 22.8 6.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.068 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 5.0 m -75.77 43.86 0.27 Allowed 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . 0.615 HD13 ' HB ' ' A' ' 471' ' ' VAL . 0.5 OUTLIER -36.64 152.04 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.723 0.296 . . . . 0.0 111.613 179.774 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 58.3 p -97.16 27.07 4.31 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.693 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 128.93 -25.85 4.58 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.259 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -116.56 116.8 28.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.863 0.363 . . . . 0.0 110.947 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 471' ' ' VAL . . . . . 0.615 ' HB ' HD13 ' A' ' 467' ' ' LEU . 12.0 p -114.23 108.36 25.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.069 179.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -177.25 144.97 0.58 Allowed Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.139 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -57.4 174.64 0.48 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.408 2.072 . . . . 0.0 112.267 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 4.4 pm0 -111.5 36.89 3.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.986 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 12.8 p -49.9 -58.05 6.2 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.298 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 476' ' ' GLY . . . . . . . . . . . . . . . 96.33 -20.81 48.67 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.909 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 477' ' ' ASN . . . . . 0.442 ' N ' ' HD3' ' A' ' 478' ' ' PRO . 6.5 m-20 51.23 53.38 13.53 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-O 120.775 0.321 . . . . 0.0 111.196 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 478' ' ' PRO . . . . . 0.442 ' HD3' ' N ' ' A' ' 477' ' ' ASN . 93.3 Cg_endo -82.53 34.36 0.55 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.803 2.335 . . . . 0.0 113.31 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -53.13 137.92 32.62 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.75 0.31 . . . . 0.0 110.806 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 480' ' ' ALA . . . . . 0.651 ' HB1' ' CD ' ' A' ' 481' ' ' PRO . . . -140.39 176.22 2.65 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.552 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 481' ' ' PRO . . . . . 0.651 ' CD ' ' HB1' ' A' ' 480' ' ' ALA . 3.0 Cg_endo -81.35 40.71 1.02 Allowed 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.627 2.884 . . . . 0.0 112.675 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 482' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -34.9 -31.2 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 483' ' ' THR . . . . . 0.424 ' N ' ' O ' ' A' ' 481' ' ' PRO . 0.2 OUTLIER -46.27 171.71 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.713 0.292 . . . . 0.0 111.444 179.912 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 484' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -33.94 -35.24 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 485' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -57.07 -60.63 3.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.884 0.373 . . . . 0.0 110.208 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 486' ' ' ALA . . . . . 0.418 ' CB ' ' O ' ' A' ' 481' ' ' PRO . . . -71.59 -47.37 55.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.912 178.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 487' ' ' ASN . . . . . 0.449 ' HB3' ' HD3' ' A' ' 489' ' ' PRO . 9.2 t-20 -50.04 -48.52 52.81 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.779 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 488' ' ' MET . . . . . 0.42 ' N ' ' CD ' ' A' ' 489' ' ' PRO . 3.4 mtt 52.27 52.04 10.55 Favored Pre-proline 0 C--N 1.332 -0.155 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.014 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 489' ' ' PRO . . . . . 0.449 ' HD3' ' HB3' ' A' ' 487' ' ' ASN . 67.8 Cg_exo -23.51 -58.9 0.05 OUTLIER 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 124.223 3.282 . . . . 0.0 113.437 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 58.7 m -138.9 -68.16 0.45 Allowed 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.214 178.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 491' ' ' ALA . . . . . . . . . . . . . . . -135.45 135.6 40.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.673 -0.24 . . . . 0.0 111.606 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 492' ' ' ARG . . . . . 0.655 ' HD3' HD22 ' A' ' 585' ' ' LEU . 0.0 OUTLIER -136.05 132.02 35.65 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.583 0.23 . . . . 0.0 110.807 177.49 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 493' ' ' VAL . . . . . 0.764 HG21 ' CA ' ' A' ' 513' ' ' GLY . 39.5 t -138.0 163.11 30.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.492 177.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . 0.5 ' N ' ' CG1' ' A' ' 493' ' ' VAL . 41.9 p -127.19 133.87 50.22 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 120.399 -0.521 . . . . 0.0 110.344 176.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 495' ' ' LEU . . . . . 1.045 ' O ' HG22 ' A' ' 588' ' ' ILE . 0.3 OUTLIER -135.89 164.57 42.26 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.558 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 496' ' ' PRO . . . . . 0.684 ' HD2' HD21 ' A' ' 499' ' ' LEU . 24.3 Cg_exo -61.72 119.31 6.37 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 121.676 1.584 . . . . 0.0 111.185 178.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 497' ' ' LYS . . . . . 0.494 ' CA ' ' HB ' ' A' ' 588' ' ' ILE . 15.0 ttmt -52.33 -30.23 27.45 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -178.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 498' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.3 -48.11 81.55 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -177.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 499' ' ' LEU . . . . . 0.872 HD11 HD13 ' A' ' 495' ' ' LEU . 2.2 pp -73.53 -8.16 54.79 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -178.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . 0.654 HG21 HG21 ' A' ' 588' ' ' ILE . 36.3 t -74.57 -25.45 19.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.435 0.636 . . . . 0.0 111.498 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 501' ' ' TYR . . . . . 0.665 ' O ' ' CG2' ' A' ' 564' ' ' THR . 3.7 m-30 -53.45 -29.13 34.02 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -178.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -76.15 -50.28 15.03 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 116.45 2.019 . . . . 0.0 116.45 -175.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 503' ' ' LYS . . . . . 0.575 ' O ' ' CG ' ' A' ' 507' ' ' LYS . 0.2 OUTLIER -120.27 136.44 54.66 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 119.59 1.086 . . . . 0.0 112.676 -178.51 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . 0.921 HG23 ' CE1' ' A' ' 567' ' ' PHE . 23.7 m -73.61 -77.2 0.11 Allowed 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 179.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . 0.765 ' CZ ' ' HB1' ' A' ' 530' ' ' ALA . 0.2 OUTLIER -75.74 -60.33 2.36 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -179.18 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 506' ' ' SER . . . . . 0.703 ' O ' ' CD1' ' A' ' 510' ' ' TRP . 6.1 t -48.7 -72.04 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 -175.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 507' ' ' LYS . . . . . 0.679 ' HD3' ' N ' ' A' ' 508' ' ' VAL . 0.0 OUTLIER -48.9 -48.58 42.27 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -176.479 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 508' ' ' VAL . . . . . 0.824 HG13 HD21 ' A' ' 574' ' ' LEU . 55.3 t -52.63 -58.02 3.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 C-N-CA 120.668 -0.413 . . . . 0.0 112.081 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 509' ' ' LEU . . . . . 0.679 HD12 ' N ' ' A' ' 510' ' ' TRP . 2.6 pp -59.66 -66.0 0.58 Allowed 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 -177.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 510' ' ' TRP . . . . . 0.71 ' CD1' ' HA ' ' A' ' 518' ' ' LYS . 68.3 p-90 -73.18 -50.74 20.89 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 -176.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 511' ' ' SER . . . . . 0.504 ' N ' ' CD2' ' A' ' 510' ' ' TRP . 0.3 OUTLIER -62.27 -46.23 89.72 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 114.437 -1.256 . . . . 0.0 113.022 -177.024 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 512' ' ' ALA . . . . . 0.755 ' HB3' ' O ' ' A' ' 508' ' ' VAL . . . -71.13 -74.87 0.14 Allowed 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 116.305 1.965 . . . . 0.0 116.305 -174.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 513' ' ' GLY . . . . . 0.764 ' CA ' HG21 ' A' ' 493' ' ' VAL . . . -116.88 -39.56 0.82 Allowed Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 121.837 3.495 . . . . 0.0 121.837 -173.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 514' ' ' LEU . . . . . 0.761 HD21 ' HB2' ' A' ' 584' ' ' LYS . 4.1 pp -112.83 -36.65 5.09 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 121.11 3.744 . . . . 0.0 121.11 -171.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 515' ' ' VAL . . . . . 0.771 ' CG1' ' HB2' ' A' ' 517' ' ' SER . 9.9 p -125.76 165.86 22.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 117.99 2.589 . . . . 0.0 117.99 -171.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 516' ' ' ALA . . . . . 0.533 ' N ' HG22 ' A' ' 515' ' ' VAL . . . -90.44 1.01 57.07 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 112.46 -2.154 . . . . 0.0 109.078 178.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . 0.925 ' O ' ' N ' ' A' ' 521' ' ' GLY . 0.1 OUTLIER -60.15 10.19 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 126.072 1.749 . . . . 0.0 115.224 -172.957 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 518' ' ' LYS . . . . . 0.71 ' HA ' ' CD1' ' A' ' 510' ' ' TRP . 0.0 OUTLIER -43.54 -46.76 7.17 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 177.232 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 519' ' ' SER . . . . . . . . . . . . . 85.2 p -74.63 -56.15 5.13 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.462 173.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 520' ' ' GLU . . . . . 0.821 ' HB2' ' HA ' ' A' ' 517' ' ' SER . 4.8 mm-40 -62.03 -47.25 85.57 Favored 'General case' 0 C--N 1.349 0.573 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.848 -179.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 521' ' ' GLY . . . . . 0.925 ' N ' ' O ' ' A' ' 517' ' ' SER . . . -49.16 -53.09 20.51 Favored Glycine 0 CA--C 1.493 -1.292 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . 0.413 ' HA ' HG12 ' A' ' 525' ' ' ILE . 3.7 mt-30 -48.09 -47.52 34.19 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 177.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 523' ' ' ARG . . . . . 0.467 ' HB3' ' O ' ' A' ' 520' ' ' GLU . 2.4 tpt85 -50.25 -48.92 54.45 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.848 178.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 524' ' ' ILE . . . . . 0.507 HG13 ' HZ2' ' A' ' 580' ' ' LYS . 30.1 mm -57.44 -54.06 35.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.441 0.639 . . . . 0.0 109.592 179.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 525' ' ' ILE . . . . . 0.893 HG23 ' CD1' ' A' ' 556' ' ' ILE . 1.1 mm -50.27 -47.56 25.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 177.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 526' ' ' ASN . . . . . 0.456 ' HB2' ' O ' ' A' ' 523' ' ' ARG . 34.8 m-80 -57.82 -47.33 82.92 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-N 114.225 -1.352 . . . . 0.0 108.575 177.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 527' ' ' ASN . . . . . 0.454 ' ND2' ' O ' ' A' ' 524' ' ' ILE . 0.0 OUTLIER -47.3 -39.32 14.42 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 113.988 -1.46 . . . . 0.0 107.741 177.239 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 528' ' ' ASN . . . . . 0.696 ' HA ' ' CG2' ' A' ' 556' ' ' ILE . 7.9 t-20 74.25 40.42 0.43 Allowed 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.491 -179.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 529' ' ' GLY . . . . . . . . . . . . . . . -117.61 31.55 5.71 Favored Glycine 0 CA--C 1.523 0.593 0 CA-C-N 114.922 -1.035 . . . . 0.0 112.497 178.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 530' ' ' ALA . . . . . 0.886 ' O ' ' HB ' ' A' ' 556' ' ' ILE . . . -133.43 163.93 28.26 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 121.161 0.505 . . . . 0.0 112.263 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 531' ' ' TYR . . . . . 0.592 ' HA ' ' O ' ' A' ' 554' ' ' THR . 0.0 OUTLIER -134.61 152.93 52.13 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.667 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 532' ' ' VAL . . . . . 0.72 HG23 ' CE1' ' A' ' 505' ' ' PHE . 0.5 OUTLIER -127.09 135.64 63.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 CA-C-O 121.981 0.896 . . . . 0.0 112.093 179.635 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 533' ' ' GLY . . . . . 0.702 ' O ' HG13 ' A' ' 575' ' ' ILE . . . -133.68 151.73 20.26 Favored Glycine 0 N--CA 1.441 -0.98 0 CA-C-N 114.251 -1.34 . . . . 0.0 113.4 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 534' ' ' SER . . . . . 0.484 ' N ' ' HB ' ' A' ' 552' ' ' THR . 0.6 OUTLIER -134.57 137.55 43.86 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.447 -0.376 . . . . 0.0 111.016 179.109 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 535' ' ' ARG . . . . . 0.639 ' O ' ' HB3' ' A' ' 573' ' ' LEU . 12.4 tpt180 -159.26 90.98 1.94 Allowed Pre-proline 0 C--N 1.331 -0.202 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 536' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 535' ' ' ARG . 38.1 Cg_endo -65.86 -51.46 1.26 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.464 2.109 . . . . 0.0 112.009 178.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 112.54 -18.52 22.63 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 120.71 -0.757 . . . . 0.0 113.273 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 538' ' ' VAL . . . . . 0.651 ' O ' HG12 ' A' ' 538' ' ' VAL . 17.6 t -116.29 18.52 7.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.951 0.376 . . . . 0.0 111.98 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 539' ' ' LYS . . . . . . . . . . . . . 46.7 mttp -107.38 111.02 23.15 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.463 0.649 . . . . 0.0 112.129 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 4.4 mtpt -99.96 30.75 3.57 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.619 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 541' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -48.34 99.0 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.495 0.664 . . . . 0.0 111.06 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 542' ' ' GLU . . . . . 0.459 ' CB ' ' HD2' ' A' ' 543' ' ' PRO . 0.7 OUTLIER -49.04 177.26 0.04 OUTLIER Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.722 179.469 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 543' ' ' PRO . . . . . 0.459 ' HD2' ' CB ' ' A' ' 542' ' ' GLU . 49.6 Cg_exo -37.19 -52.27 1.43 Allowed 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.578 2.185 . . . . 0.0 112.741 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . 0.448 ' C ' ' O ' ' A' ' 543' ' ' PRO . . . 27.47 55.02 0.1 Allowed Glycine 0 C--N 1.335 0.485 0 C-N-CA 121.468 -0.396 . . . . 0.0 114.015 178.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 545' ' ' GLY . . . . . 0.568 ' O ' ' N ' ' A' ' 547' ' ' MET . . . 52.95 54.64 27.68 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.055 -1.069 . . . . 0.0 111.617 -178.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . 0.549 ' C ' ' HD3' ' A' ' 548' ' ' PRO . . . 53.62 -54.12 0.01 OUTLIER Glycine 0 CA--C 1.522 0.515 0 CA-C-O 119.107 -0.829 . . . . 0.0 114.585 -178.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 547' ' ' MET . . . . . 0.568 ' N ' ' O ' ' A' ' 545' ' ' GLY . 0.0 OUTLIER 19.22 55.74 0.17 Allowed Pre-proline 0 N--CA 1.473 0.71 0 CA-C-N 118.333 1.066 . . . . 0.0 111.796 178.704 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 548' ' ' PRO . . . . . 0.549 ' HD3' ' C ' ' A' ' 546' ' ' GLY . 83.4 Cg_exo -46.2 119.93 3.35 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.012 1.808 . . . . 0.0 113.479 -177.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.8 -36.48 2.4 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.124 -0.943 . . . . 0.0 108.645 178.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 550' ' ' ASP . . . . . 0.557 ' O ' ' HA ' ' A' ' 535' ' ' ARG . 0.6 OUTLIER -72.54 -42.17 65.01 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.263 179.739 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 551' ' ' LEU . . . . . 0.479 HD21 ' HE2' ' A' ' 553' ' ' PHE . 8.8 tp -131.37 140.57 49.71 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.335 178.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 552' ' ' THR . . . . . 0.674 ' O ' ' HA2' ' A' ' 533' ' ' GLY . 27.1 m -133.04 147.93 52.22 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.618 0.723 . . . . 0.0 111.912 179.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 553' ' ' PHE . . . . . 0.528 ' CD1' ' CE1' ' A' ' 531' ' ' TYR . 14.3 m-85 -133.86 136.77 44.59 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 177.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 554' ' ' THR . . . . . 0.633 ' CG2' ' H ' ' A' ' 556' ' ' ILE . 0.8 OUTLIER -134.0 138.96 31.83 Favored Pre-proline 0 C--N 1.308 -1.214 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.327 179.544 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 555' ' ' PRO . . . . . 0.805 ' O ' HG22 ' A' ' 556' ' ' ILE . 79.8 Cg_endo -86.22 20.33 1.25 Allowed 'Trans proline' 0 N--CA 1.445 -1.33 0 C-N-CA 121.972 1.782 . . . . 0.0 111.043 178.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 556' ' ' ILE . . . . . 0.893 ' CD1' HG23 ' A' ' 525' ' ' ILE . 4.2 tp 63.27 35.17 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 177.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 2.2 mtmp? -102.86 122.11 43.86 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 558' ' ' THR . . . . . . . . . . . . . 12.0 m -56.91 118.57 5.08 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 115.61 1.707 . . . . 0.0 115.61 -171.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 559' ' ' TRP . . . . . 0.601 ' CZ2' ' HD2' ' A' ' 555' ' ' PRO . 0.0 OUTLIER -138.24 111.96 8.29 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 112.441 -2.163 . . . . 0.0 105.715 175.486 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 560' ' ' ASN . . . . . 0.559 ' O ' ' HB ' ' A' ' 564' ' ' THR . 51.2 m-20 -80.44 -74.82 0.29 Allowed 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 -175.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 561' ' ' ALA . . . . . 0.431 ' O ' HG22 ' A' ' 564' ' ' THR . . . -73.94 -65.33 0.85 Allowed 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 -176.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 562' ' ' SER . . . . . . . . . . . . . 1.4 p -49.06 -52.19 26.97 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -175.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 563' ' ' LYS . . . . . 0.538 ' HG2' ' CE2' ' A' ' 559' ' ' TRP . 9.3 tppt? -70.93 -49.13 48.97 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 564' ' ' THR . . . . . 0.665 ' CG2' ' O ' ' A' ' 501' ' ' TYR . 1.7 t -50.03 -62.4 1.59 Allowed 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.563 -178.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 565' ' ' GLN . . . . . 0.59 ' O ' HG23 ' A' ' 569' ' ' ILE . 0.0 OUTLIER -49.13 -47.6 45.4 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 122.282 -0.261 . . . . 0.0 111.355 178.495 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . 0.433 ' O ' HD13 ' A' ' 569' ' ' ILE . 1.8 tt0 -49.66 -56.27 10.71 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -178.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 567' ' ' PHE . . . . . 0.921 ' CE1' HG23 ' A' ' 504' ' ' THR . 1.4 p90 -96.83 -46.0 6.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.433 0.635 . . . . 0.0 111.944 -178.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 568' ' ' ILE . . . . . 0.966 HD11 HD13 ' A' ' 574' ' ' LEU . 1.3 tp -58.11 9.44 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.504 -0.822 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 569' ' ' ILE . . . . . 0.59 HG23 ' O ' ' A' ' 565' ' ' GLN . 0.0 OUTLIER -55.0 -38.94 47.51 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 N-CA-C 104.967 -2.234 . . . . 0.0 104.967 179.184 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 570' ' ' ASP . . . . . 0.609 ' CG ' HD11 ' A' ' 588' ' ' ILE . 13.4 p30 31.61 58.12 0.3 Allowed 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 114.289 -1.323 . . . . 0.0 112.307 173.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -51.62 -45.1 54.55 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 117.288 -2.387 . . . . 0.0 108.79 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 572' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -119.57 -16.81 8.82 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 112.411 0.522 . . . . 0.0 112.411 175.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 573' ' ' LEU . . . . . 0.639 ' HB3' ' O ' ' A' ' 535' ' ' ARG . 1.2 tp -140.14 136.9 33.98 Favored 'General case' 0 C--N 1.351 0.659 0 N-CA-C 115.756 1.761 . . . . 0.0 115.756 -177.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 574' ' ' LEU . . . . . 0.966 HD13 HD11 ' A' ' 568' ' ' ILE . 0.1 OUTLIER -134.77 133.83 40.29 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 105.847 -1.908 . . . . 0.0 105.847 173.707 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 575' ' ' ILE . . . . . 0.931 ' N ' HD12 ' A' ' 574' ' ' LEU . 0.0 OUTLIER -133.55 136.08 54.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.401 178.65 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 576' ' ' LEU . . . . . 0.566 ' CD2' ' HB3' ' A' ' 509' ' ' LEU . 0.0 OUTLIER -133.99 135.63 43.56 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 177.1 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 577' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.32 135.26 46.08 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 118.88 -1.128 . . . . 0.0 110.513 177.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.613 HD12 ' O ' ' A' ' 582' ' ' LYS . 0.3 OUTLIER -123.01 132.12 54.0 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 177.892 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 579' ' ' GLY . . . . . . . . . . . . . . . -89.8 -2.15 75.85 Favored Glycine 0 CA--C 1.499 -0.92 0 CA-C-N 115.244 -0.889 . . . . 0.0 113.431 -178.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 580' ' ' LYS . . . . . 0.507 ' HZ2' HG13 ' A' ' 524' ' ' ILE . 0.0 OUTLIER -72.67 -48.15 41.49 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 118.998 -1.081 . . . . 0.0 108.964 179.426 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 581' ' ' TRP . . . . . 0.48 ' CD1' ' O ' ' A' ' 580' ' ' LYS . 28.4 m0 -139.03 -52.82 0.56 Allowed 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 177.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 582' ' ' LYS . . . . . 0.613 ' O ' HD12 ' A' ' 578' ' ' LEU . 0.3 OUTLIER -139.84 165.22 27.88 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 -174.878 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 583' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.2 135.06 53.33 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 174.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 584' ' ' LYS . . . . . 0.761 ' HB2' HD21 ' A' ' 514' ' ' LEU . 2.3 tppt? -117.25 134.27 54.99 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 585' ' ' LEU . . . . . 0.757 ' HG ' HG23 ' A' ' 575' ' ' ILE . 4.2 tt -121.68 135.9 54.95 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 178.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 586' ' ' VAL . . . . . 0.668 HG23 ' HD2' ' A' ' 584' ' ' LYS . 16.9 t -133.31 137.07 53.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.204 -178.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 587' ' ' SER . . . . . . . . . . . . . 70.8 m -109.98 135.02 51.49 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 176.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 1.045 HG22 ' O ' ' A' ' 495' ' ' LEU . 0.0 OUTLIER -134.53 141.85 42.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -177.868 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 5.2 m -133.28 137.02 54.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 114.166 -1.379 . . . . 0.0 110.422 177.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 590' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.12 125.2 30.58 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.445 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 591' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -50.32 -49.34 54.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.16 0.505 . . . . 0.0 110.237 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -51.91 -49.58 62.78 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.176 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.01 -48.57 61.38 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.756 0.789 . . . . 0.0 109.156 179.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 594' ' ' PHE . . . . . 0.768 ' CD1' HD11 ' A' ' 597' ' ' LEU . 0.9 OUTLIER -50.2 -48.39 54.23 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.572 178.281 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 595' ' ' LYS . . . . . 0.582 ' HZ2' HG21 ' A' ' 608' ' ' VAL . 0.0 OUTLIER -49.42 -48.18 47.5 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.911 0.386 . . . . 0.0 110.067 179.215 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 596' ' ' GLU . . . . . 0.491 ' O ' HD23 ' A' ' 599' ' ' LEU . 1.5 mt-10 -53.07 -55.06 26.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.618 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 597' ' ' LEU . . . . . 0.768 HD11 ' CD1' ' A' ' 594' ' ' PHE . 0.8 OUTLIER -65.9 -60.92 2.37 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.283 0.563 . . . . 0.0 112.051 -178.64 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 598' ' ' GLY . . . . . 0.507 ' N ' HD12 ' A' ' 597' ' ' LEU . . . -78.88 13.08 20.43 Favored Glycine 0 C--N 1.32 -0.315 0 CA-C-N 115.279 -0.873 . . . . 0.0 113.459 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 599' ' ' LEU . . . . . 0.616 HD12 ' N ' ' A' ' 600' ' ' THR . 2.8 pp -48.03 -11.49 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -175.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 600' ' ' THR . . . . . 0.616 ' N ' HD12 ' A' ' 599' ' ' LEU . 30.0 m -141.38 66.27 1.36 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.854 0.835 . . . . 0.0 110.962 177.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 601' ' ' ALA . . . . . 0.912 ' HB1' ' HD2' ' A' ' 602' ' ' PRO . . . -132.15 177.91 2.01 Favored Pre-proline 0 N--CA 1.447 -0.592 0 CA-C-N 114.094 -1.412 . . . . 0.0 109.593 178.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 602' ' ' PRO . . . . . 0.912 ' HD2' ' HB1' ' A' ' 601' ' ' ALA . 97.6 Cg_endo -76.63 -8.29 18.1 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 121.908 1.739 . . . . 0.0 111.215 178.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 603' ' ' GLY . . . . . 0.708 ' O ' HG23 ' A' ' 607' ' ' VAL . . . -71.19 -49.7 25.59 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 115.697 -0.683 . . . . 0.0 113.593 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 604' ' ' TRP . . . . . 0.547 ' CD1' ' HA ' ' A' ' 599' ' ' LEU . 2.1 m95 -69.51 -46.08 67.38 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 117.16 0.48 . . . . 0.0 111.67 -179.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 605' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -49.51 -53.69 22.0 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.68 -0.236 . . . . 0.0 110.836 -178.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -64.79 -56.37 13.96 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 607' ' ' VAL . . . . . 0.708 HG23 ' O ' ' A' ' 603' ' ' GLY . 51.9 t -54.67 -72.15 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -178.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 608' ' ' VAL . . . . . 0.582 HG21 ' HZ2' ' A' ' 595' ' ' LYS . 70.7 t -68.62 -55.16 16.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -177.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 609' ' ' GLY . . . . . . . . . . . . . . . -63.72 -62.97 4.79 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.975 -0.631 . . . . 0.0 113.385 -178.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 610' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.77 -68.07 0.41 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.807 0.337 . . . . 0.0 110.964 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 104.59 56.39 0.72 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.483 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.74 38.24 1.23 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.795 0.331 . . . . 0.0 110.954 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 613' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -119.95 -177.48 3.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.899 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -58.81 -60.78 9.33 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.948 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 615' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.35 -168.32 0.38 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.562 2.175 . . . . 0.0 112.313 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 616' ' ' SER . . . . . . . . . . . . . 1.3 m -156.62 86.19 2.95 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.92 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo . . . . . 0 C--O 1.25 1.084 0 C-N-CA 122.571 2.181 . . . . 0.0 112.221 -179.923 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 120.509 0.195 . . . . 0.0 111.424 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 455' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.13 -173.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.445 2.097 . . . . 0.0 112.314 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 456' ' ' ARG . . . . . . . . . . . . . 5.0 mtp180 -58.09 -26.46 62.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.08 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.65 -31.16 66.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.98 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -81.43 108.58 15.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.008 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 10.6 t -88.99 149.32 43.1 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.943 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -52.91 -174.59 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.562 2.175 . . . . 0.0 112.295 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . 129.74 -28.56 3.93 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.521 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -132.16 88.05 41.77 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.761 0.315 . . . . 0.0 110.932 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -69.29 90.58 0.47 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.523 2.149 . . . . 0.0 112.271 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 6.2 mtmp? -117.92 119.36 34.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.877 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -105.05 -75.1 0.63 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.896 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 1.4 m -120.5 30.53 6.89 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.965 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 4.7 tp -136.49 71.23 1.41 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.868 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 73.8 m -138.19 35.85 2.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.95 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 128.83 -36.87 2.33 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.357 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -120.83 117.86 28.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.841 0.353 . . . . 0.0 110.727 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 471' ' ' VAL . . . . . 0.573 HG13 ' O ' ' A' ' 471' ' ' VAL . 9.4 p -112.98 108.11 24.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.097 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 22.0 m-80 -162.6 161.88 19.42 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.866 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -64.56 76.42 0.19 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.535 2.157 . . . . 0.0 112.139 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -97.56 36.72 1.46 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.951 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 15.9 m -54.25 -58.05 8.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.902 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 476' ' ' GLY . . . . . . . . . . . . . . . 57.41 70.07 1.09 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.678 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 477' ' ' ASN . . . . . 0.431 ' N ' ' CD ' ' A' ' 478' ' ' PRO . 0.2 OUTLIER -48.47 -51.41 51.75 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-O 120.698 0.285 . . . . 0.0 111.066 179.923 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 478' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 477' ' ' ASN . 85.4 Cg_endo -86.91 34.41 0.44 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.905 2.403 . . . . 0.0 112.638 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 12.7 p80 -47.26 170.54 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.853 0.358 . . . . 0.0 111.424 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 480' ' ' ALA . . . . . 0.886 ' HB1' ' HD2' ' A' ' 481' ' ' PRO . . . -90.5 176.46 2.94 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.192 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 481' ' ' PRO . . . . . 0.886 ' HD2' ' HB1' ' A' ' 480' ' ' ALA . 65.7 Cg_exo -42.0 -70.45 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.919 2.412 . . . . 0.0 112.884 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 482' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -135.12 -49.59 0.74 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.236 0.541 . . . . 0.0 109.844 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 483' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.66 141.6 43.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.088 179.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 484' ' ' ASN . . . . . 0.587 ' O ' ' CD ' ' A' ' 489' ' ' PRO . 1.3 m120 -86.7 -11.47 51.1 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.081 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 485' ' ' PHE . . . . . 0.682 ' HA ' ' HG2' ' A' ' 489' ' ' PRO . 55.2 m-85 -49.35 -47.33 47.52 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.576 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -72.2 -47.69 48.66 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -178.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -70.91 -74.33 0.15 Allowed 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 -176.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 488' ' ' MET . . . . . 0.519 ' HB2' ' HD3' ' A' ' 489' ' ' PRO . 0.0 OUTLIER -52.88 -52.24 66.81 Favored Pre-proline 0 N--CA 1.473 0.682 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.688 -178.454 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 489' ' ' PRO . . . . . 0.682 ' HG2' ' HA ' ' A' ' 485' ' ' PHE . 6.5 Cg_exo -79.6 41.64 1.15 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 124.18 3.253 . . . . 0.0 112.532 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -42.72 -36.77 1.53 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.904 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 491' ' ' ALA . . . . . . . . . . . . . . . -132.92 136.8 46.35 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.879 0.371 . . . . 0.0 111.934 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 492' ' ' ARG . . . . . 0.522 ' CD ' ' HG ' ' A' ' 585' ' ' LEU . 0.0 OUTLIER -134.37 134.86 42.2 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.855 179.101 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 493' ' ' VAL . . . . . 0.673 HG21 ' CA ' ' A' ' 513' ' ' GLY . 85.9 t -135.28 163.73 35.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.242 178.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . 0.553 ' N ' HG12 ' A' ' 493' ' ' VAL . 1.3 m -125.72 135.89 52.58 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.323 0.582 . . . . 0.0 111.231 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 495' ' ' LEU . . . . . 0.955 ' O ' HG22 ' A' ' 588' ' ' ILE . 2.1 pp -133.93 163.3 52.12 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 115.239 -0.892 . . . . 0.0 110.122 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 496' ' ' PRO . . . . . 0.819 ' HD2' HD21 ' A' ' 499' ' ' LEU . 20.4 Cg_exo -63.36 118.67 5.58 Favored 'Trans proline' 0 CA--C 1.534 0.477 0 C-N-CA 121.712 1.608 . . . . 0.0 111.327 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 497' ' ' LYS . . . . . 0.815 ' O ' HG12 ' A' ' 500' ' ' VAL . 8.6 tttm -50.19 -29.87 10.22 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -179.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 498' ' ' SER . . . . . 0.44 ' HA ' ' CE2' ' A' ' 501' ' ' TYR . 1.0 OUTLIER -56.3 -48.45 76.64 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 113.758 1.022 . . . . 0.0 113.758 -177.345 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 499' ' ' LEU . . . . . 0.819 HD21 ' HD2' ' A' ' 496' ' ' PRO . 0.7 OUTLIER -73.71 -8.43 55.95 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -178.542 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . 0.815 HG12 ' O ' ' A' ' 497' ' ' LYS . 1.7 p -74.73 -25.58 19.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.275 0.56 . . . . 0.0 111.613 -179.016 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 501' ' ' TYR . . . . . 0.635 ' O ' ' CG2' ' A' ' 564' ' ' THR . 6.7 m-30 -53.96 -30.61 47.61 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 114.217 1.192 . . . . 0.0 114.217 -178.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -77.38 -51.16 11.28 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 116.059 1.874 . . . . 0.0 116.059 -175.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 503' ' ' LYS . . . . . 0.558 ' O ' ' CG ' ' A' ' 507' ' ' LYS . 0.0 OUTLIER -121.2 136.12 55.03 Favored 'General case' 0 C--N 1.339 0.132 0 CA-C-N 118.885 0.766 . . . . 0.0 112.375 -179.109 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . 0.769 HG23 ' CD1' ' A' ' 568' ' ' ILE . 90.5 m -73.29 -75.68 0.14 Allowed 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 179.047 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . 0.74 ' HE2' HG21 ' A' ' 554' ' ' THR . 0.0 OUTLIER -74.87 -62.48 1.53 Allowed 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -178.888 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 506' ' ' SER . . . . . 0.802 ' O ' ' CD1' ' A' ' 510' ' ' TRP . 66.5 m -49.59 -73.23 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -175.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 507' ' ' LYS . . . . . 0.723 ' HD3' ' N ' ' A' ' 508' ' ' VAL . 0.0 OUTLIER -49.05 -48.89 43.59 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -176.425 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 508' ' ' VAL . . . . . 0.755 HG21 HD21 ' A' ' 574' ' ' LEU . 47.7 t -55.83 -62.33 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.722 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 509' ' ' LEU . . . . . 0.791 HD12 ' N ' ' A' ' 510' ' ' TRP . 1.9 pp -49.9 -63.01 1.24 Allowed 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -177.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 510' ' ' TRP . . . . . 0.867 ' CD1' ' HA ' ' A' ' 518' ' ' LYS . 67.4 p-90 -72.89 -49.74 27.98 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 -176.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 511' ' ' SER . . . . . 0.507 ' N ' ' CE3' ' A' ' 510' ' ' TRP . 0.3 OUTLIER -62.87 -47.07 84.94 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.289 -0.869 . . . . 0.0 113.178 -176.81 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 512' ' ' ALA . . . . . 0.881 ' HB2' HD23 ' A' ' 495' ' ' LEU . . . -70.97 -73.5 0.17 Allowed 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 118.242 2.682 . . . . 0.0 118.242 -173.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 513' ' ' GLY . . . . . 0.673 ' CA ' HG21 ' A' ' 493' ' ' VAL . . . -114.67 -36.05 1.33 Allowed Glycine 0 CA--C 1.502 -0.743 0 N-CA-C 121.295 3.278 . . . . 0.0 121.295 -172.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 514' ' ' LEU . . . . . 0.809 HD12 ' HB2' ' A' ' 584' ' ' LYS . 1.6 mt -108.94 -43.21 4.26 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 120.053 3.353 . . . . 0.0 120.053 -170.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 515' ' ' VAL . . . . . 0.97 HG13 ' HB2' ' A' ' 517' ' ' SER . 3.8 p -154.0 172.12 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 117.721 2.489 . . . . 0.0 117.721 -171.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 516' ' ' ALA . . . . . 0.581 ' N ' HG22 ' A' ' 515' ' ' VAL . . . -68.42 3.97 1.54 Allowed 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 127.054 2.142 . . . . 0.0 110.238 177.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . 0.97 ' HB2' HG13 ' A' ' 515' ' ' VAL . 0.4 OUTLIER -57.32 8.81 0.01 OUTLIER 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 115.575 1.695 . . . . 0.0 115.575 -171.853 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 518' ' ' LYS . . . . . 0.867 ' HA ' ' CD1' ' A' ' 510' ' ' TRP . 2.3 ttpt -46.37 -51.4 14.96 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 104.462 -2.422 . . . . 0.0 104.462 174.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 519' ' ' SER . . . . . . . . . . . . . 35.2 t -75.0 -57.01 4.17 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.101 173.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 520' ' ' GLU . . . . . 0.735 ' HB2' ' HA ' ' A' ' 517' ' ' SER . 0.3 OUTLIER -57.47 -48.0 80.35 Favored 'General case' 0 C--N 1.348 0.536 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.926 -178.97 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 521' ' ' GLY . . . . . 0.813 ' N ' ' O ' ' A' ' 517' ' ' SER . . . -49.46 -56.81 10.22 Favored Glycine 0 CA--C 1.493 -1.296 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.525 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -47.82 -47.32 31.24 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 523' ' ' ARG . . . . . 0.432 ' O ' ' HB3' ' A' ' 526' ' ' ASN . 0.5 OUTLIER -50.12 -48.79 53.32 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.785 178.557 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 524' ' ' ILE . . . . . 0.526 HD12 ' HD3' ' A' ' 580' ' ' LYS . 29.8 mm -59.36 -54.05 39.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.325 0.583 . . . . 0.0 110.043 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 525' ' ' ILE . . . . . 0.596 ' N ' HD13 ' A' ' 525' ' ' ILE . 1.3 mm -50.27 -47.3 25.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 177.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 526' ' ' ASN . . . . . 0.432 ' HB3' ' O ' ' A' ' 523' ' ' ARG . 1.0 OUTLIER -57.93 -47.85 81.63 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 114.607 -1.179 . . . . 0.0 108.325 177.142 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 527' ' ' ASN . . . . . 0.493 ' HB3' ' HA ' ' A' ' 524' ' ' ILE . 0.0 OUTLIER -47.73 -39.13 16.88 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 113.965 -1.471 . . . . 0.0 107.931 176.807 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 528' ' ' ASN . . . . . 1.03 ' HA ' HG21 ' A' ' 556' ' ' ILE . 14.1 t-20 75.17 40.61 0.33 Allowed 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 114.854 -1.066 . . . . 0.0 112.088 -179.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 529' ' ' GLY . . . . . . . . . . . . . . . -112.46 20.25 21.02 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 114.524 -1.217 . . . . 0.0 111.661 177.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 530' ' ' ALA . . . . . 0.804 ' O ' ' HB ' ' A' ' 556' ' ' ILE . . . -133.76 163.68 28.92 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -179.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 531' ' ' TYR . . . . . 0.533 ' CE2' ' HA ' ' A' ' 553' ' ' PHE . 0.0 OUTLIER -133.76 162.59 31.57 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 177.578 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 532' ' ' VAL . . . . . 0.662 HG12 ' OG1' ' A' ' 554' ' ' THR . 0.6 OUTLIER -127.47 135.06 64.32 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 CA-C-O 121.956 0.884 . . . . 0.0 111.819 179.131 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 533' ' ' GLY . . . . . 0.729 ' HA2' ' O ' ' A' ' 552' ' ' THR . . . -133.62 148.44 19.39 Favored Glycine 0 N--CA 1.445 -0.7 0 CA-C-N 114.252 -1.34 . . . . 0.0 113.496 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 534' ' ' SER . . . . . 0.434 ' HB2' ' OG1' ' A' ' 552' ' ' THR . 0.1 OUTLIER -135.14 141.28 45.92 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 179.724 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 535' ' ' ARG . . . . . 0.674 ' O ' ' HB3' ' A' ' 573' ' ' LEU . 26.2 tpt85 -159.51 89.46 1.97 Allowed Pre-proline 0 N--CA 1.464 0.248 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.848 178.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 536' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -92.21 -84.94 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.364 2.71 . . . . 0.0 112.816 179.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 114.12 -10.04 22.71 Favored Glycine 0 C--N 1.334 0.418 0 C-N-CA 120.558 -0.83 . . . . 0.0 113.102 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 538' ' ' VAL . . . . . 0.554 HG13 ' O ' ' A' ' 538' ' ' VAL . 0.4 OUTLIER -116.07 5.3 7.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-O 121.043 0.449 . . . . 0.0 111.569 -179.767 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 539' ' ' LYS . . . . . 0.408 ' HE2' ' HB3' ' A' ' 549' ' ' ASP . 0.0 OUTLIER -46.81 146.54 1.58 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.708 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -127.78 -73.39 0.6 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.406 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 541' ' ' ASN . . . . . 0.524 ' O ' ' HD3' ' A' ' 543' ' ' PRO . 0.2 OUTLIER -59.62 102.27 0.14 Allowed 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.582 179.032 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 542' ' ' GLU . . . . . 0.554 ' O ' ' N ' ' A' ' 544' ' ' GLY . 1.1 mp0 -47.21 97.86 0.16 Allowed Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.768 -178.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 543' ' ' PRO . . . . . 0.524 ' HD3' ' O ' ' A' ' 541' ' ' ASN . 14.3 Cg_endo -52.66 55.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 124.407 3.404 . . . . 0.0 114.398 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . 0.571 ' O ' ' N ' ' A' ' 546' ' ' GLY . . . 52.91 56.07 20.44 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 119.366 -1.397 . . . . 0.0 111.394 -179.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 545' ' ' GLY . . . . . 0.487 ' O ' ' C ' ' A' ' 546' ' ' GLY . . . 55.65 -53.01 0.01 OUTLIER Glycine 0 CA--C 1.523 0.562 0 CA-C-O 119.015 -0.88 . . . . 0.0 113.86 -177.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . 0.583 ' O ' ' N ' ' A' ' 548' ' ' PRO . . . 31.02 55.87 0.27 Allowed Glycine 0 C--N 1.336 0.555 0 CA-C-N 118.742 1.271 . . . . 0.0 113.164 177.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 547' ' ' MET . . . . . 0.489 ' C ' ' O ' ' A' ' 546' ' ' GLY . 0.1 OUTLIER -6.88 -55.35 0.0 OUTLIER Pre-proline 0 N--CA 1.477 0.925 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 -177.437 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 548' ' ' PRO . . . . . 0.583 ' N ' ' O ' ' A' ' 546' ' ' GLY . 5.9 Cg_endo -88.14 119.56 1.23 Allowed 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 121.756 1.637 . . . . 0.0 110.992 178.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 549' ' ' ASP . . . . . 0.408 ' HB3' ' HE2' ' A' ' 539' ' ' LYS . 3.2 m-20 -126.14 -41.02 1.95 Allowed 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 550' ' ' ASP . . . . . 0.501 ' O ' ' HA ' ' A' ' 535' ' ' ARG . 11.4 m-20 -77.78 -39.37 44.22 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.053 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 551' ' ' LEU . . . . . 0.78 HD11 ' CE1' ' A' ' 553' ' ' PHE . 3.0 tp -131.25 140.76 49.89 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.951 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 552' ' ' THR . . . . . 0.729 ' O ' ' HA2' ' A' ' 533' ' ' GLY . 1.9 m -132.87 146.09 51.5 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.491 0.663 . . . . 0.0 110.98 178.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 553' ' ' PHE . . . . . 0.78 ' CE1' HD11 ' A' ' 551' ' ' LEU . 9.8 m-85 -134.39 137.01 43.75 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 177.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 554' ' ' THR . . . . . 0.896 HG22 ' H ' ' A' ' 556' ' ' ILE . 21.7 m -133.94 138.62 31.14 Favored Pre-proline 0 C--N 1.303 -1.423 0 C-N-CA 119.42 -0.912 . . . . 0.0 110.045 178.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 555' ' ' PRO . . . . . 0.811 ' O ' HG22 ' A' ' 556' ' ' ILE . 85.6 Cg_endo -85.48 25.29 0.7 Allowed 'Trans proline' 0 N--CA 1.438 -1.771 0 C-N-CA 121.452 1.434 . . . . 0.0 109.857 178.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 556' ' ' ILE . . . . . 1.03 HG21 ' HA ' ' A' ' 528' ' ' ASN . 1.4 tp 64.59 32.6 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 177.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -103.96 131.19 51.45 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 558' ' ' THR . . . . . 0.514 ' HA ' ' CE1' ' A' ' 505' ' ' PHE . 3.5 t -58.17 116.38 3.52 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 116.071 1.878 . . . . 0.0 116.071 -172.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 559' ' ' TRP . . . . . 0.645 ' CE3' ' HG3' ' A' ' 563' ' ' LYS . 1.3 m0 -139.33 111.49 7.46 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 104.414 -2.439 . . . . 0.0 104.414 173.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 560' ' ' ASN . . . . . 0.51 ' O ' ' HB ' ' A' ' 564' ' ' THR . 51.1 m-80 -90.98 -75.32 0.47 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 115.116 1.524 . . . . 0.0 115.116 -175.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 561' ' ' ALA . . . . . 0.451 ' O ' HG22 ' A' ' 564' ' ' THR . . . -73.76 -63.42 1.21 Allowed 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 115.729 1.751 . . . . 0.0 115.729 -176.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 562' ' ' SER . . . . . . . . . . . . . 69.2 m -48.83 -50.84 32.65 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -176.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 563' ' ' LYS . . . . . 0.645 ' HG3' ' CE3' ' A' ' 559' ' ' TRP . 1.2 mmpt? -71.2 -49.01 48.02 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -178.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 564' ' ' THR . . . . . 0.706 ' O ' ' HB ' ' A' ' 568' ' ' ILE . 3.4 t -51.17 -62.93 1.31 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.794 0.331 . . . . 0.0 110.709 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 565' ' ' GLN . . . . . 1.014 ' O ' HG23 ' A' ' 569' ' ' ILE . 3.6 tp60 -50.23 -47.34 54.99 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.858 0.361 . . . . 0.0 111.28 178.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . 0.423 ' HG2' ' CD1' ' A' ' 567' ' ' PHE . 23.3 tt0 -49.2 -68.54 0.17 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -178.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 567' ' ' PHE . . . . . 0.714 ' CD2' HG21 ' A' ' 552' ' ' THR . 0.2 OUTLIER -91.01 -51.85 5.14 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.397 0.618 . . . . 0.0 111.57 -179.094 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 568' ' ' ILE . . . . . 0.769 ' CD1' HG23 ' A' ' 504' ' ' THR . 1.9 mp -56.17 8.98 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 114.83 -1.077 . . . . 0.0 113.259 -179.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 569' ' ' ILE . . . . . 1.014 HG23 ' O ' ' A' ' 565' ' ' GLN . 1.3 pt -54.13 -36.39 32.13 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.728 0 N-CA-C 104.146 -2.538 . . . . 0.0 104.146 177.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 570' ' ' ASP . . . . . 0.662 ' OD2' HD22 ' A' ' 574' ' ' LEU . 28.4 m-20 35.39 54.84 0.83 Allowed 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 113.453 -1.703 . . . . 0.0 111.661 174.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -51.28 -44.89 52.62 Favored Glycine 0 N--CA 1.438 -1.169 0 C-N-CA 118.045 -2.026 . . . . 0.0 108.455 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 572' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -119.89 -17.12 8.57 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 175.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 573' ' ' LEU . . . . . 0.674 ' HB3' ' O ' ' A' ' 535' ' ' ARG . 0.9 OUTLIER -140.7 136.65 32.83 Favored 'General case' 0 C--N 1.354 0.768 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 -177.937 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 574' ' ' LEU . . . . . 0.977 ' HB2' HD11 ' A' ' 588' ' ' ILE . 0.7 OUTLIER -135.29 133.48 38.92 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 173.865 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 575' ' ' ILE . . . . . 1.012 HG23 HD13 ' A' ' 585' ' ' LEU . 0.0 OUTLIER -133.48 137.19 53.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 119.133 0.879 . . . . 0.0 111.745 178.736 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 576' ' ' LEU . . . . . 0.64 HD11 HD21 ' A' ' 578' ' ' LEU . 0.0 OUTLIER -133.31 135.32 44.75 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 177.255 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 577' ' ' LYS . . . . . 0.451 ' CD ' ' CD1' ' A' ' 531' ' ' TYR . 0.2 OUTLIER -128.22 135.48 49.74 Favored 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.104 178.044 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.64 HD21 HD11 ' A' ' 576' ' ' LEU . 0.4 OUTLIER -125.81 132.7 52.2 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.537 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 579' ' ' GLY . . . . . . . . . . . . . . . -88.51 -2.14 79.86 Favored Glycine 0 N--CA 1.438 -1.169 0 CA-C-N 114.759 -1.11 . . . . 0.0 112.962 -179.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 580' ' ' LYS . . . . . 0.526 ' HD3' HD12 ' A' ' 524' ' ' ILE . 18.9 pttt -66.1 -50.46 63.96 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 118.891 -1.124 . . . . 0.0 108.047 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 581' ' ' TRP . . . . . 0.458 ' CZ2' ' HD2' ' A' ' 580' ' ' LYS . 0.0 OUTLIER -142.35 -52.03 0.4 Allowed 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 175.815 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 582' ' ' LYS . . . . . 0.433 ' HE3' ' CD1' ' A' ' 581' ' ' TRP . 0.4 OUTLIER -139.56 166.06 25.58 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 114.398 1.258 . . . . 0.0 114.398 -174.508 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 583' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -109.2 135.24 50.63 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 174.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 584' ' ' LYS . . . . . 0.809 ' HB2' HD12 ' A' ' 514' ' ' LEU . 1.1 tmmt? -114.8 133.85 55.6 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 178.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 585' ' ' LEU . . . . . 1.012 HD13 HG23 ' A' ' 575' ' ' ILE . 5.0 tp -122.38 136.69 54.94 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 586' ' ' VAL . . . . . 0.54 HG21 ' HZ3' ' A' ' 584' ' ' LYS . 9.5 t -132.91 144.58 36.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -178.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 587' ' ' SER . . . . . 0.484 ' C ' HD13 ' A' ' 588' ' ' ILE . 2.9 m -109.83 136.35 49.28 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 177.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.977 HD11 ' HB2' ' A' ' 574' ' ' LEU . 0.0 OUTLIER -132.7 136.74 55.38 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -177.958 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 5.6 m -133.07 137.06 54.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 114.356 -1.293 . . . . 0.0 110.688 178.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 590' ' ' SER . . . . . . . . . . . . . 2.6 m -82.27 147.58 28.84 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.449 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 591' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -50.67 -50.87 53.76 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.034 0.445 . . . . 0.0 110.776 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -52.2 -50.64 61.49 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.311 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 12.2 mmmt -50.13 -48.49 53.59 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.766 0.794 . . . . 0.0 108.927 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 594' ' ' PHE . . . . . 0.778 ' CD1' HD11 ' A' ' 597' ' ' LEU . 0.9 OUTLIER -50.33 -47.83 55.66 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.465 -1.243 . . . . 0.0 109.694 178.125 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 595' ' ' LYS . . . . . 0.503 ' HE3' ' CE2' ' A' ' 604' ' ' TRP . 0.0 OUTLIER -48.7 -47.72 40.84 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.428 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 596' ' ' GLU . . . . . 0.686 ' O ' HD23 ' A' ' 599' ' ' LEU . 2.5 mm-40 -55.67 -62.5 1.65 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.744 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 597' ' ' LEU . . . . . 0.778 HD11 ' CD1' ' A' ' 594' ' ' PHE . 0.8 OUTLIER -56.87 -60.94 2.83 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 121.445 0.641 . . . . 0.0 112.108 -178.619 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 598' ' ' GLY . . . . . 0.508 ' N ' HD12 ' A' ' 597' ' ' LEU . . . -78.95 14.01 16.11 Favored Glycine 0 C--N 1.32 -0.34 0 CA-C-N 114.956 -1.02 . . . . 0.0 113.162 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 599' ' ' LEU . . . . . 0.686 HD23 ' O ' ' A' ' 596' ' ' GLU . 4.5 pp -47.48 -15.73 0.05 Allowed 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -175.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 600' ' ' THR . . . . . 0.575 HG23 ' O ' ' A' ' 600' ' ' THR . 9.9 t -129.4 66.11 1.46 Allowed 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.247 176.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 601' ' ' ALA . . . . . . . . . . . . . . . -131.9 154.3 81.69 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.489 179.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 602' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.63 -21.19 45.7 Favored 'Trans proline' 0 N--CA 1.464 -0.207 0 C-N-CA 121.976 1.784 . . . . 0.0 111.097 178.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 603' ' ' GLY . . . . . 0.664 ' O ' HG23 ' A' ' 607' ' ' VAL . . . -61.01 -49.14 81.88 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.669 -0.696 . . . . 0.0 113.079 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 604' ' ' TRP . . . . . 0.503 ' CE2' ' HE3' ' A' ' 595' ' ' LYS . 1.1 m95 -65.58 -46.74 78.26 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 120.856 0.36 . . . . 0.0 111.206 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 605' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -50.38 -59.8 3.63 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.271 -178.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 606' ' ' GLU . . . . . 0.408 ' HA ' ' HB2' ' A' ' 610' ' ' LYS . 0.0 OUTLIER -60.85 -58.69 7.39 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -179.569 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 607' ' ' VAL . . . . . 0.664 HG23 ' O ' ' A' ' 603' ' ' GLY . 60.6 t -50.85 -71.86 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -178.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 608' ' ' VAL . . . . . . . . . . . . . 74.8 t -70.44 -60.34 2.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -177.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 609' ' ' GLY . . . . . . . . . . . . . . . -57.17 -62.87 5.87 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 121.146 -0.55 . . . . 0.0 113.291 -178.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 610' ' ' LYS . . . . . 0.408 ' HB2' ' HA ' ' A' ' 606' ' ' GLU . 17.6 tttt -62.72 -49.82 73.56 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.785 0.326 . . . . 0.0 110.98 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 74.32 54.45 6.18 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.552 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 29.2 mttt -59.0 -25.66 63.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.768 0.318 . . . . 0.0 111.036 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 613' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -77.0 172.94 12.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.824 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . 0.442 ' CB ' ' HD3' ' A' ' 615' ' ' PRO . 0.5 OUTLIER -58.44 -53.26 67.98 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.942 -179.95 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 615' ' ' PRO . . . . . 0.442 ' HD3' ' CB ' ' A' ' 614' ' ' GLU . 36.7 Cg_exo -59.92 85.54 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.402 2.068 . . . . 0.0 112.093 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 616' ' ' SER . . . . . . . . . . . . . 1.2 m -73.71 150.53 88.71 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.844 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo . . . . . 0 C--O 1.248 1.019 0 C-N-CA 122.651 2.234 . . . . 0.0 112.267 179.957 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 454' ' ' MET . . . . . 0.405 ' N ' ' HD2' ' A' ' 455' ' ' PRO . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 120.686 0.279 . . . . 0.0 111.523 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 455' ' ' PRO . . . . . 0.663 ' HB2' HG22 ' A' ' 457' ' ' THR . 94.7 Cg_endo -81.56 153.52 17.9 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.527 2.152 . . . . 0.0 112.349 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 456' ' ' ARG . . . . . . . . . . . . . 29.4 mtm180 -71.18 -26.57 63.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.993 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 457' ' ' THR . . . . . 0.663 HG22 ' HB2' ' A' ' 455' ' ' PRO . 6.0 t -62.04 -31.31 71.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.96 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -59.7 126.74 28.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.111 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 25.1 p -89.27 155.46 49.07 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.866 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -52.13 151.65 16.34 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.649 2.233 . . . . 0.0 112.351 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . 102.67 56.6 0.81 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.499 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 41.5 p30 -86.74 148.56 46.31 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 120.657 0.265 . . . . 0.0 110.896 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -52.82 155.7 10.41 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.591 2.194 . . . . 0.0 112.279 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 5.8 tttt -75.75 160.15 30.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.863 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.74 22.15 8.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.104 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 7.0 p -63.43 -24.82 68.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.999 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.43 71.06 0.73 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.885 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -119.84 43.32 2.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.728 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 128.96 -35.83 2.54 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.261 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -119.03 117.78 29.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.88 0.372 . . . . 0.0 110.686 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 471' ' ' VAL . . . . . 0.573 HG13 ' O ' ' A' ' 471' ' ' VAL . 10.7 p -113.11 108.41 25.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.138 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -151.09 85.79 4.99 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.946 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.79 159.77 47.67 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.545 2.164 . . . . 0.0 112.302 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -59.61 -42.92 93.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.873 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.02 -48.14 0.55 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.678 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 476' ' ' GLY . . . . . . . . . . . . . . . 92.21 -41.7 2.77 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.731 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 477' ' ' ASN . . . . . 0.419 ' N ' ' CD ' ' A' ' 478' ' ' PRO . 3.7 m-20 51.0 52.43 12.22 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-O 120.736 0.303 . . . . 0.0 111.151 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 478' ' ' PRO . . . . . 0.419 ' CD ' ' N ' ' A' ' 477' ' ' ASN . 73.6 Cg_endo -76.29 -44.16 0.26 Allowed 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.516 2.144 . . . . 0.0 112.469 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 33.5 t-80 -99.15 119.78 38.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.064 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 480' ' ' ALA . . . . . 0.414 ' HA ' ' HD3' ' A' ' 481' ' ' PRO . . . -65.79 109.24 2.9 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.974 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 481' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 480' ' ' ALA . 5.6 Cg_exo -79.0 39.88 0.87 Allowed 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.956 2.437 . . . . 0.0 112.89 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 482' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.28 -40.03 64.38 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.127 0.489 . . . . 0.0 110.644 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 483' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -136.29 171.89 13.82 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.442 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 484' ' ' ASN . . . . . 0.543 ' O ' ' CD ' ' A' ' 489' ' ' PRO . 28.0 m-20 -105.0 -17.91 14.34 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.014 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 485' ' ' PHE . . . . . 0.679 ' HA ' ' HG2' ' A' ' 489' ' ' PRO . 18.4 m-85 -49.36 -47.44 47.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.514 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -70.81 -47.99 56.49 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -178.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.66 -73.83 0.17 Allowed 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -176.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 488' ' ' MET . . . . . 0.496 ' CB ' ' HD3' ' A' ' 489' ' ' PRO . 0.0 OUTLIER -52.42 -53.5 52.44 Favored Pre-proline 0 N--CA 1.47 0.567 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -177.354 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 489' ' ' PRO . . . . . 0.679 ' HG2' ' HA ' ' A' ' 485' ' ' PHE . 32.3 Cg_exo -65.09 43.28 0.14 Allowed 'Trans proline' 0 N--CA 1.476 0.485 0 C-N-CA 123.964 3.109 . . . . 0.0 113.979 -179.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 3.8 t -37.96 -42.44 0.63 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.672 0.272 . . . . 0.0 111.211 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 491' ' ' ALA . . . . . 0.417 ' CB ' ' NZ ' ' A' ' 584' ' ' LYS . . . -132.8 135.64 45.8 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.574 178.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 492' ' ' ARG . . . . . 0.66 ' CD ' HD22 ' A' ' 585' ' ' LEU . 0.0 OUTLIER -135.85 135.23 39.61 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.981 0.419 . . . . 0.0 111.851 179.883 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 493' ' ' VAL . . . . . 0.569 HG12 ' N ' ' A' ' 494' ' ' THR . 84.8 t -134.93 163.2 37.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.135 177.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . 0.569 ' N ' HG12 ' A' ' 493' ' ' VAL . 5.3 t -122.49 134.86 54.56 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.143 0.497 . . . . 0.0 111.147 178.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 495' ' ' LEU . . . . . 0.919 HD22 ' HB2' ' A' ' 512' ' ' ALA . 0.0 OUTLIER -135.49 164.57 42.62 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.401 179.593 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 496' ' ' PRO . . . . . 0.737 ' HD2' HD21 ' A' ' 499' ' ' LEU . 15.4 Cg_exo -66.69 119.42 6.45 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 121.759 1.639 . . . . 0.0 110.918 178.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 497' ' ' LYS . . . . . 0.455 ' HB2' ' N ' ' A' ' 589' ' ' VAL . 5.6 tmtt? -53.81 -30.02 43.2 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -178.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 498' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.92 -48.36 82.01 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -177.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 499' ' ' LEU . . . . . 0.757 HD11 ' CD1' ' A' ' 495' ' ' LEU . 2.2 pp -73.52 -8.87 57.71 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -178.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . 0.857 HG21 HG21 ' A' ' 588' ' ' ILE . 39.8 t -75.41 -25.4 17.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.21 0.528 . . . . 0.0 111.922 -179.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 501' ' ' TYR . . . . . 0.83 ' O ' HG21 ' A' ' 564' ' ' THR . 0.7 OUTLIER -52.95 -28.7 24.84 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -178.201 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.4 -50.08 17.0 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 115.563 1.69 . . . . 0.0 115.563 -175.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 503' ' ' LYS . . . . . 0.569 ' O ' ' CG ' ' A' ' 507' ' ' LYS . 0.5 OUTLIER -119.44 135.29 54.82 Favored 'General case' 0 C--N 1.338 0.074 0 CA-C-N 119.201 0.909 . . . . 0.0 111.843 -179.41 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . 0.764 HG23 ' CE1' ' A' ' 567' ' ' PHE . 62.5 m -73.18 -76.61 0.12 Allowed 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . 0.653 ' CE2' HG23 ' A' ' 532' ' ' VAL . 0.2 OUTLIER -75.08 -60.87 2.1 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -179.25 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 506' ' ' SER . . . . . 0.466 ' O ' ' HG ' ' A' ' 509' ' ' LEU . 1.4 m -48.82 -72.72 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 -176.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 507' ' ' LYS . . . . . 0.804 ' HZ1' HG22 ' A' ' 500' ' ' VAL . 0.0 OUTLIER -50.41 -48.92 55.96 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -176.878 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 508' ' ' VAL . . . . . 0.831 HG13 HD21 ' A' ' 574' ' ' LEU . 47.9 t -52.66 -58.84 2.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -178.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 509' ' ' LEU . . . . . 0.812 HD12 ' N ' ' A' ' 510' ' ' TRP . 1.5 pp -58.16 -62.84 1.53 Allowed 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 -177.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 510' ' ' TRP . . . . . 0.812 ' N ' HD12 ' A' ' 509' ' ' LEU . 6.0 p-90 -73.06 -52.49 14.15 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 114.706 1.372 . . . . 0.0 114.706 -176.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 511' ' ' SER . . . . . 0.486 ' N ' ' CE3' ' A' ' 510' ' ' TRP . 0.2 OUTLIER -61.87 -48.41 80.62 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.684 -176.893 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 512' ' ' ALA . . . . . 0.919 ' HB2' HD22 ' A' ' 495' ' ' LEU . . . -72.1 -73.77 0.18 Allowed 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 117.162 2.282 . . . . 0.0 117.162 -174.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 513' ' ' GLY . . . . . 0.681 ' HA3' ' HE3' ' A' ' 584' ' ' LYS . . . -115.23 -35.13 1.36 Allowed Glycine 0 N--CA 1.449 -0.477 0 N-CA-C 121.408 3.323 . . . . 0.0 121.408 -172.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 514' ' ' LEU . . . . . 0.606 ' HG ' ' HE2' ' A' ' 584' ' ' LYS . 1.3 mt -107.58 -38.73 5.82 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 120.09 3.367 . . . . 0.0 120.09 -170.013 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 515' ' ' VAL . . . . . 0.592 HG22 ' N ' ' A' ' 516' ' ' ALA . 14.3 p -152.95 172.08 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 N-CA-C 118.108 2.633 . . . . 0.0 118.108 -172.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 516' ' ' ALA . . . . . 0.592 ' N ' HG22 ' A' ' 515' ' ' VAL . . . -85.94 2.69 45.15 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 127.055 2.142 . . . . 0.0 108.956 178.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . 0.882 ' O ' ' N ' ' A' ' 521' ' ' GLY . 10.4 p -59.82 13.0 0.01 OUTLIER 'General case' 0 N--CA 1.424 -1.729 0 C-N-CA 126.326 1.85 . . . . 0.0 115.49 -173.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 518' ' ' LYS . . . . . 0.631 ' HG3' ' CE3' ' A' ' 510' ' ' TRP . 2.1 mppt? -40.61 -44.36 2.1 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 178.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 519' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.37 -52.46 12.07 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.323 173.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 520' ' ' GLU . . . . . 0.809 ' HB2' ' HA ' ' A' ' 517' ' ' SER . 9.0 mm-40 -63.1 -46.81 85.6 Favored 'General case' 0 C--N 1.35 0.591 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.277 -179.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 521' ' ' GLY . . . . . 0.891 ' HA2' HD12 ' A' ' 524' ' ' ILE . . . -49.16 -58.75 7.58 Favored Glycine 0 CA--C 1.495 -1.172 0 N-CA-C 111.344 -0.702 . . . . 0.0 111.344 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . 0.412 ' HA ' HG12 ' A' ' 525' ' ' ILE . 3.8 mt-30 -47.99 -47.89 32.8 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 178.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 523' ' ' ARG . . . . . 0.477 ' HB3' ' O ' ' A' ' 520' ' ' GLU . 0.4 OUTLIER -50.26 -48.75 54.67 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.823 178.945 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 524' ' ' ILE . . . . . 0.891 HD12 ' HA2' ' A' ' 521' ' ' GLY . 6.0 mt -58.31 -54.86 27.06 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 CA-C-O 121.341 0.591 . . . . 0.0 109.745 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 525' ' ' ILE . . . . . 0.565 ' HA ' HG13 ' A' ' 556' ' ' ILE . 1.0 OUTLIER -50.37 -47.6 26.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.091 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 526' ' ' ASN . . . . . . . . . . . . . 36.7 m-20 -58.2 -47.78 82.4 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 114.373 -1.285 . . . . 0.0 108.643 177.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 527' ' ' ASN . . . . . 0.418 ' ND2' ' O ' ' A' ' 524' ' ' ILE . 0.0 OUTLIER -47.69 -39.83 18.45 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 113.971 -1.468 . . . . 0.0 108.028 177.282 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 528' ' ' ASN . . . . . 1.028 ' HA ' HG21 ' A' ' 556' ' ' ILE . 14.6 t-20 73.99 39.85 0.49 Allowed 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.187 -179.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 529' ' ' GLY . . . . . 0.416 ' H ' ' ND2' ' A' ' 527' ' ' ASN . . . -114.83 20.52 14.77 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 114.265 -1.334 . . . . 0.0 111.54 178.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 530' ' ' ALA . . . . . 0.799 ' O ' ' HB ' ' A' ' 556' ' ' ILE . . . -133.71 156.76 47.36 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.86 0.362 . . . . 0.0 111.649 -179.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 531' ' ' TYR . . . . . 0.532 ' HA ' ' O ' ' A' ' 554' ' ' THR . 0.1 OUTLIER -133.28 158.8 42.03 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 178.039 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 532' ' ' VAL . . . . . 0.653 HG23 ' CE2' ' A' ' 505' ' ' PHE . 0.5 OUTLIER -125.52 135.78 62.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-O 122.025 0.917 . . . . 0.0 112.958 -178.301 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 533' ' ' GLY . . . . . 0.635 ' HA2' ' O ' ' A' ' 552' ' ' THR . . . -134.41 161.14 24.4 Favored Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 114.381 -1.281 . . . . 0.0 114.865 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 534' ' ' SER . . . . . 0.601 ' O ' ' HA ' ' A' ' 551' ' ' LEU . 6.7 t -133.8 137.28 45.01 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 114.912 -0.644 . . . . 0.0 110.628 178.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 535' ' ' ARG . . . . . 0.758 ' O ' ' HB3' ' A' ' 573' ' ' LEU . 7.1 tpt85 -159.83 90.46 1.85 Allowed Pre-proline 0 C--N 1.33 -0.276 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 178.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 536' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -71.25 -31.77 13.85 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.526 2.15 . . . . 0.0 112.21 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 69.08 55.99 9.7 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.528 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 538' ' ' VAL . . . . . 0.546 HG13 ' N ' ' A' ' 539' ' ' LYS . 12.9 p -116.22 -45.93 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 CA-C-O 121.021 0.438 . . . . 0.0 111.458 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 539' ' ' LYS . . . . . 0.546 ' N ' HG13 ' A' ' 538' ' ' VAL . 16.3 mttt -107.93 161.76 14.63 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.636 -178.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.81 30.56 4.3 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.93 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 541' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -96.24 99.52 11.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.106 0.479 . . . . 0.0 110.446 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -49.77 152.21 2.71 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.294 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 543' ' ' PRO . . . . . 0.792 ' HG3' HD23 ' A' ' 551' ' ' LEU . 9.2 Cg_endo -50.29 -44.0 40.86 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.953 2.435 . . . . 0.0 112.555 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . 0.556 ' O ' ' N ' ' A' ' 546' ' ' GLY . . . 51.2 27.26 14.93 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.879 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 545' ' ' GLY . . . . . 0.66 ' O ' ' N ' ' A' ' 547' ' ' MET . . . 53.7 -30.67 0.01 OUTLIER Glycine 0 CA--C 1.532 1.135 0 N-CA-C 115.749 1.06 . . . . 0.0 115.749 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 544' ' ' GLY . . . -51.75 54.48 0.01 OUTLIER Glycine 0 CA--C 1.528 0.888 0 CA-C-N 118.136 0.968 . . . . 0.0 115.051 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 547' ' ' MET . . . . . 0.66 ' N ' ' O ' ' A' ' 545' ' ' GLY . 35.5 mmt 51.14 53.3 13.51 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 117.963 0.882 . . . . 0.0 111.04 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 548' ' ' PRO . . . . . 0.418 ' HB3' ' HA ' ' A' ' 543' ' ' PRO . 59.4 Cg_endo -71.55 166.5 29.2 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.853 2.368 . . . . 0.0 112.912 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -124.31 -21.71 4.89 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.187 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 550' ' ' ASP . . . . . 0.692 ' O ' ' HA ' ' A' ' 535' ' ' ARG . 1.3 t70 -58.75 -47.94 82.93 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 551' ' ' LEU . . . . . 0.792 HD23 ' HG3' ' A' ' 543' ' ' PRO . 7.9 tp -120.37 140.06 51.87 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 552' ' ' THR . . . . . 0.635 ' O ' ' HA2' ' A' ' 533' ' ' GLY . 3.2 m -133.39 148.0 51.79 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.861 0.839 . . . . 0.0 112.295 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 553' ' ' PHE . . . . . 0.514 ' CD1' ' CE1' ' A' ' 531' ' ' TYR . 0.3 OUTLIER -134.66 137.46 43.62 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 176.554 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 554' ' ' THR . . . . . 0.619 HG23 ' HZ2' ' A' ' 559' ' ' TRP . 0.9 OUTLIER -132.83 138.11 31.18 Favored Pre-proline 0 C--N 1.31 -1.124 0 C-N-CA 119.474 -0.89 . . . . 0.0 110.338 179.304 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 555' ' ' PRO . . . . . 0.825 ' O ' HG22 ' A' ' 556' ' ' ILE . 61.0 Cg_endo -86.33 25.07 0.7 Allowed 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 122.208 1.938 . . . . 0.0 112.064 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 556' ' ' ILE . . . . . 1.028 HG21 ' HA ' ' A' ' 528' ' ' ASN . 1.5 tp 64.4 33.11 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 115.714 1.746 . . . . 0.0 115.714 176.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . 0.59 ' O ' ' CE2' ' A' ' 559' ' ' TRP . 3.7 mttt -104.24 125.86 50.87 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 -179.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 558' ' ' THR . . . . . . . . . . . . . 2.8 t -58.13 117.64 4.6 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -173.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 559' ' ' TRP . . . . . 0.619 ' HZ2' HG23 ' A' ' 554' ' ' THR . 0.0 OUTLIER -138.72 112.16 8.17 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 175.479 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 560' ' ' ASN . . . . . 0.716 ' O ' HG22 ' A' ' 564' ' ' THR . 26.2 m-80 -76.26 -76.27 0.17 Allowed 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 118.829 -1.149 . . . . 0.0 113.934 -175.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 561' ' ' ALA . . . . . 0.587 ' HA ' ' CG2' ' A' ' 564' ' ' THR . . . -75.16 -55.04 6.13 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 116.241 1.941 . . . . 0.0 116.241 -177.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 562' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -49.31 -53.77 20.39 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -176.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 563' ' ' LYS . . . . . 0.597 ' HG3' ' CE2' ' A' ' 559' ' ' TRP . 2.4 mmtt -70.86 -47.55 58.7 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -178.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 564' ' ' THR . . . . . 0.83 HG21 ' O ' ' A' ' 501' ' ' TYR . 3.3 t -48.53 -67.45 0.27 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.7 0.286 . . . . 0.0 110.879 -178.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 565' ' ' GLN . . . . . 0.823 ' H ' HG23 ' A' ' 564' ' ' THR . 0.0 OUTLIER -48.86 -46.77 42.84 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.757 0.313 . . . . 0.0 111.055 179.16 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -49.66 -67.18 0.28 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -178.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 567' ' ' PHE . . . . . 0.959 ' CZ ' HD13 ' A' ' 568' ' ' ILE . 0.3 OUTLIER -89.13 -41.02 12.52 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -177.932 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 568' ' ' ILE . . . . . 0.969 HD11 HD13 ' A' ' 574' ' ' LEU . 0.6 OUTLIER -61.59 9.84 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 179.63 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 569' ' ' ILE . . . . . 0.717 HD12 ' N ' ' A' ' 570' ' ' ASP . 2.7 pp -55.56 -45.02 78.57 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.317 0 N-CA-C 104.112 -2.551 . . . . 0.0 104.112 177.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 570' ' ' ASP . . . . . 0.717 ' N ' HD12 ' A' ' 569' ' ' ILE . 1.3 p30 31.29 60.17 0.27 Allowed 'General case' 0 CA--C 1.511 -0.554 0 CA-C-N 114.236 -1.347 . . . . 0.0 112.16 173.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -51.49 -45.22 53.77 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 117.423 -2.323 . . . . 0.0 109.08 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 572' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -119.35 -16.94 8.93 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 175.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 573' ' ' LEU . . . . . 0.758 ' HB3' ' O ' ' A' ' 535' ' ' ARG . 0.7 OUTLIER -140.29 137.94 34.57 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 -178.116 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 574' ' ' LEU . . . . . 0.969 HD13 HD11 ' A' ' 568' ' ' ILE . 0.1 OUTLIER -133.55 134.84 43.86 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 174.223 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 575' ' ' ILE . . . . . 0.862 ' N ' HD12 ' A' ' 574' ' ' LEU . 0.0 OUTLIER -133.04 136.98 54.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 C-N-CA 119.799 -0.76 . . . . 0.0 112.469 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 576' ' ' LEU . . . . . 0.494 ' CD1' ' CE1' ' A' ' 505' ' ' PHE . 0.0 OUTLIER -133.16 135.03 44.9 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 176.73 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 577' ' ' LYS . . . . . 0.542 ' HE2' ' HE2' ' A' ' 583' ' ' MET . 2.9 mtpm? -133.4 135.4 44.61 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 118.762 -1.175 . . . . 0.0 111.232 178.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.615 HD12 ' O ' ' A' ' 582' ' ' LYS . 0.3 OUTLIER -125.62 131.66 52.63 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.068 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 579' ' ' GLY . . . . . . . . . . . . . . . -91.3 -2.19 71.09 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.396 -0.82 . . . . 0.0 113.582 -178.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 580' ' ' LYS . . . . . 0.655 ' HG2' HG23 ' A' ' 524' ' ' ILE . 0.0 OUTLIER -72.8 -47.36 47.12 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 119.123 -1.031 . . . . 0.0 108.945 179.387 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 581' ' ' TRP . . . . . 0.561 ' CG ' ' HD2' ' A' ' 580' ' ' LYS . 32.5 m0 -138.49 -52.93 0.6 Allowed 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 177.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 582' ' ' LYS . . . . . 0.615 ' O ' HD12 ' A' ' 578' ' ' LEU . 0.0 OUTLIER -139.68 165.29 27.65 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 -174.894 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 583' ' ' MET . . . . . 0.542 ' HE2' ' HE2' ' A' ' 577' ' ' LYS . 0.3 OUTLIER -117.15 134.29 54.96 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 174.236 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 584' ' ' LYS . . . . . 0.681 ' HE3' ' HA3' ' A' ' 513' ' ' GLY . 0.1 OUTLIER -121.22 133.66 55.17 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.988 -1.005 . . . . 0.0 108.762 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 585' ' ' LEU . . . . . 0.701 ' HG ' HG23 ' A' ' 575' ' ' ILE . 6.2 tt -118.23 135.55 54.2 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 178.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 586' ' ' VAL . . . . . 0.587 HG11 HD23 ' A' ' 495' ' ' LEU . 77.4 t -133.26 138.57 51.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 C-N-CA 120.506 -0.477 . . . . 0.0 111.538 -178.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 587' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.73 135.53 48.11 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 177.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.857 HG21 HG21 ' A' ' 500' ' ' VAL . 0.1 OUTLIER -133.67 137.12 53.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -177.992 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 589' ' ' VAL . . . . . 0.455 ' N ' ' HB2' ' A' ' 497' ' ' LYS . 5.4 m -127.52 137.37 57.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 114.334 -1.303 . . . . 0.0 110.804 178.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 590' ' ' SER . . . . . . . . . . . . . 28.0 t -56.38 152.79 10.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.279 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 591' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -50.68 -48.98 58.37 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.859 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -60.74 -51.76 67.96 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -178.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 2.4 mttt -54.31 -56.54 17.48 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.466 0.65 . . . . 0.0 110.941 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 594' ' ' PHE . . . . . 0.973 ' CD1' HD11 ' A' ' 597' ' ' LEU . 13.0 t80 -50.2 -47.11 54.83 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.569 179.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 595' ' ' LYS . . . . . 0.796 ' HE3' HG21 ' A' ' 608' ' ' VAL . 0.6 OUTLIER -49.41 -48.32 47.3 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.345 179.405 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 596' ' ' GLU . . . . . 0.555 ' O ' HD23 ' A' ' 599' ' ' LEU . 54.1 tt0 -58.97 -59.66 5.1 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -179.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 597' ' ' LEU . . . . . 0.973 HD11 ' CD1' ' A' ' 594' ' ' PHE . 2.9 pp -52.23 -50.38 62.12 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.182 0.515 . . . . 0.0 112.131 -178.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 598' ' ' GLY . . . . . 0.897 ' N ' HD12 ' A' ' 597' ' ' LEU . . . -94.49 11.38 70.24 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.769 -179.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 599' ' ' LEU . . . . . 0.555 HD23 ' O ' ' A' ' 596' ' ' GLU . 4.4 pp -50.04 -2.25 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -177.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 600' ' ' THR . . . . . 0.591 HG22 ' O ' ' A' ' 600' ' ' THR . 23.2 m -131.75 67.23 1.53 Allowed 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.883 0.849 . . . . 0.0 110.948 178.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 601' ' ' ALA . . . . . 1.038 ' HB1' ' HD2' ' A' ' 602' ' ' PRO . . . -131.63 -173.45 0.34 Allowed Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 114.231 -1.35 . . . . 0.0 109.563 179.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 602' ' ' PRO . . . . . 1.038 ' HD2' ' HB1' ' A' ' 601' ' ' ALA . 57.1 Cg_endo -72.23 -31.81 11.34 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 121.609 1.54 . . . . 0.0 112.529 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 603' ' ' GLY . . . . . . . . . . . . . . . -71.57 -48.78 27.64 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.983 -0.627 . . . . 0.0 113.201 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 604' ' ' TRP . . . . . 0.867 ' CD1' ' HB3' ' A' ' 601' ' ' ALA . 2.1 m95 -70.99 -46.43 62.32 Favored 'General case' 0 CA--C 1.511 -0.547 0 C-N-CA 122.916 0.487 . . . . 0.0 111.554 -178.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 605' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -49.87 -60.6 2.76 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.665 -179.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.55 -60.68 3.33 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 607' ' ' VAL . . . . . . . . . . . . . 54.2 t -54.4 -72.27 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -178.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 608' ' ' VAL . . . . . 0.796 HG21 ' HE3' ' A' ' 595' ' ' LYS . 61.9 t -65.58 -58.84 5.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.384 -0.826 . . . . 0.0 113.202 -177.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 609' ' ' GLY . . . . . . . . . . . . . . . -59.14 -63.8 4.85 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 121.084 -0.579 . . . . 0.0 113.175 -178.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 610' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.67 -49.91 75.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.823 0.345 . . . . 0.0 110.837 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 85.8 56.42 2.35 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.569 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 8.4 pttt -97.81 37.01 1.44 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.825 0.345 . . . . 0.0 110.951 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 613' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -119.93 133.41 55.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.897 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . 0.409 ' CB ' ' CD ' ' A' ' 615' ' ' PRO . 2.8 mt-10 -59.62 -60.72 9.66 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.931 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 615' ' ' PRO . . . . . 0.409 ' CD ' ' CB ' ' A' ' 614' ' ' GLU . 62.9 Cg_endo -73.39 85.56 1.25 Allowed 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.484 2.123 . . . . 0.0 112.303 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 616' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.52 112.57 10.61 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.792 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo . . . . . 0 C--O 1.251 1.128 0 C-N-CA 122.421 2.081 . . . . 0.0 112.369 179.906 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 120.737 0.304 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 455' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.04 -30.05 21.58 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.541 2.161 . . . . 0.0 112.27 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 456' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -66.29 -26.58 67.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.004 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 73.4 p -100.03 31.6 3.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.975 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -107.08 130.37 54.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.101 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 59.6 p -104.43 154.05 38.65 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.814 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.1 117.37 5.07 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.495 2.13 . . . . 0.0 112.298 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . 99.8 56.59 0.95 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.544 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -97.61 148.51 34.55 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 120.74 0.305 . . . . 0.0 110.874 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -52.53 144.41 41.55 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.564 2.176 . . . . 0.0 112.293 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 6.7 tttt -107.77 128.71 54.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.928 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.63 22.31 15.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.123 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 38.3 p -54.05 -24.91 18.94 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.111 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . . . . . . . . . 8.1 mp -102.88 83.69 2.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.878 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.17 43.46 2.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.954 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 129.1 -36.97 2.29 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.314 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -107.1 117.53 34.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.948 0.404 . . . . 0.0 110.526 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 471' ' ' VAL . . . . . 0.568 HG13 ' O ' ' A' ' 471' ' ' VAL . 12.3 p -113.32 109.94 30.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.136 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -89.32 154.35 48.93 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.952 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -51.37 136.13 47.22 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.633 2.222 . . . . 0.0 112.429 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -136.08 -45.75 0.64 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.967 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.9 -27.24 51.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.08 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 476' ' ' GLY . . . . . . . . . . . . . . . 104.57 -24.98 27.18 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.62 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 7.3 p-10 43.97 53.16 10.09 Favored Pre-proline 0 CA--C 1.53 0.202 0 CA-C-O 120.796 0.331 . . . . 0.0 111.445 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 478' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -68.43 -18.82 43.78 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.584 2.189 . . . . 0.0 112.585 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -56.47 127.1 29.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.974 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 480' ' ' ALA . . . . . 0.666 ' HB1' ' CD ' ' A' ' 481' ' ' PRO . . . -140.35 177.91 1.8 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.087 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 481' ' ' PRO . . . . . 0.666 ' CD ' ' HB1' ' A' ' 480' ' ' ALA . 5.8 Cg_exo -78.64 40.01 0.86 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 123.167 2.578 . . . . 0.0 112.76 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 482' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -71.36 -61.12 1.89 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.716 0.293 . . . . 0.0 110.69 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 483' ' ' THR . . . . . 0.401 ' HB ' ' HB2' ' A' ' 487' ' ' ASN . 16.2 p -116.01 65.79 0.7 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.174 0.511 . . . . 0.0 111.137 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 484' ' ' ASN . . . . . 0.577 ' O ' ' HD3' ' A' ' 489' ' ' PRO . 2.2 m120 -130.73 -69.5 0.64 Allowed 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 485' ' ' PHE . . . . . 0.52 ' O ' ' HG2' ' A' ' 489' ' ' PRO . 67.6 m-85 -71.67 -46.73 57.99 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.731 177.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -72.13 -47.47 50.86 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.073 -0.967 . . . . 0.0 113.287 -178.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 487' ' ' ASN . . . . . 0.401 ' HB2' ' HB ' ' A' ' 483' ' ' THR . 1.1 t-20 -70.76 -72.65 0.2 Allowed 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -176.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 488' ' ' MET . . . . . 0.477 ' CB ' ' HD3' ' A' ' 489' ' ' PRO . 2.5 ttt -51.29 -52.77 56.1 Favored Pre-proline 0 N--CA 1.47 0.531 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -177.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 489' ' ' PRO . . . . . 0.577 ' HD3' ' O ' ' A' ' 484' ' ' ASN . 11.1 Cg_exo -76.45 42.34 1.02 Allowed 'Trans proline' 0 CA--C 1.528 0.219 0 C-N-CA 123.82 3.013 . . . . 0.0 112.38 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -38.39 -30.66 0.04 OUTLIER 'General case' 0 C--O 1.232 0.134 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -179.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 491' ' ' ALA . . . . . . . . . . . . . . . -132.77 136.51 46.37 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.44 -0.504 . . . . 0.0 112.1 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 492' ' ' ARG . . . . . 0.862 ' CD ' HD22 ' A' ' 585' ' ' LEU . 0.0 OUTLIER -136.12 134.37 38.24 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.957 178.438 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 493' ' ' VAL . . . . . 0.838 HG21 ' HA3' ' A' ' 513' ' ' GLY . 11.2 m -136.2 163.81 33.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.816 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 9.0 t -120.2 133.36 55.51 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 121.043 0.449 . . . . 0.0 110.305 177.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 495' ' ' LEU . . . . . 1.033 HD11 ' CG2' ' A' ' 500' ' ' VAL . 1.6 pp -136.2 163.16 52.07 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.928 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 496' ' ' PRO . . . . . 0.791 ' HD2' HD21 ' A' ' 499' ' ' LEU . 14.7 Cg_exo -67.35 119.3 6.31 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 122.313 2.008 . . . . 0.0 112.152 178.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 497' ' ' LYS . . . . . 0.526 ' HA ' ' HB ' ' A' ' 588' ' ' ILE . 20.1 tttt -51.85 -30.37 23.37 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -179.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 498' ' ' SER . . . . . . . . . . . . . 11.9 t -60.29 -48.35 82.11 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -177.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 499' ' ' LEU . . . . . 0.791 HD21 ' HD2' ' A' ' 496' ' ' PRO . 2.0 pp -74.18 -8.67 57.0 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -178.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . 1.033 ' CG2' HD11 ' A' ' 495' ' ' LEU . 13.8 t -75.45 -26.01 18.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.099 0.476 . . . . 0.0 112.239 -178.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 501' ' ' TYR . . . . . 0.669 ' O ' HG21 ' A' ' 564' ' ' THR . 6.3 m-85 -53.94 -30.61 47.27 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -178.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -75.82 -50.21 15.82 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 115.456 1.651 . . . . 0.0 115.456 -175.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 503' ' ' LYS . . . . . 0.61 ' O ' ' CG ' ' A' ' 507' ' ' LYS . 0.2 OUTLIER -119.2 132.57 55.96 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 118.79 0.723 . . . . 0.0 111.776 -179.323 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . 0.575 HG21 ' HB3' ' A' ' 563' ' ' LYS . 4.6 m -72.96 -75.62 0.14 Allowed 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . 0.641 ' CE1' ' HA ' ' A' ' 558' ' ' THR . 0.0 OUTLIER -74.71 -62.69 1.45 Allowed 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 -179.107 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 506' ' ' SER . . . . . 0.758 ' O ' ' CD1' ' A' ' 510' ' ' TRP . 66.6 m -49.15 -72.81 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -175.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 507' ' ' LYS . . . . . 0.712 ' HD3' ' N ' ' A' ' 508' ' ' VAL . 0.0 OUTLIER -48.7 -48.49 40.24 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -176.153 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 508' ' ' VAL . . . . . 0.947 ' CG1' HD21 ' A' ' 574' ' ' LEU . 61.3 t -54.76 -57.76 5.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -179.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 509' ' ' LEU . . . . . 0.734 HD12 ' N ' ' A' ' 510' ' ' TRP . 2.0 pp -59.64 -63.45 1.3 Allowed 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 -177.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 510' ' ' TRP . . . . . 0.766 ' CD1' ' HA ' ' A' ' 518' ' ' LYS . 63.7 p-90 -72.75 -49.69 29.34 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -176.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 511' ' ' SER . . . . . 0.523 ' N ' ' CD2' ' A' ' 510' ' ' TRP . 0.3 OUTLIER -62.75 -48.24 80.06 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.658 -177.014 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 512' ' ' ALA . . . . . 0.774 ' HB2' ' CD2' ' A' ' 495' ' ' LEU . . . -71.79 -75.18 0.14 Allowed 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 117.011 2.226 . . . . 0.0 117.011 -174.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 513' ' ' GLY . . . . . 0.838 ' HA3' HG21 ' A' ' 493' ' ' VAL . . . -117.63 -35.23 1.09 Allowed Glycine 0 CA--C 1.501 -0.787 0 N-CA-C 120.778 3.071 . . . . 0.0 120.778 -173.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 514' ' ' LEU . . . . . 0.741 ' HB3' HG23 ' A' ' 515' ' ' VAL . 0.0 OUTLIER -96.67 -46.95 6.09 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 119.542 3.164 . . . . 0.0 119.542 -168.746 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 515' ' ' VAL . . . . . 0.741 HG23 ' HB3' ' A' ' 514' ' ' LEU . 22.0 t -151.2 171.25 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 117.196 2.295 . . . . 0.0 117.196 -172.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 516' ' ' ALA . . . . . 0.631 ' N ' HG12 ' A' ' 515' ' ' VAL . . . -73.59 2.88 7.07 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 112.558 -2.11 . . . . 0.0 108.67 175.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . 0.851 ' HA ' ' HB2' ' A' ' 520' ' ' GLU . 0.6 OUTLIER -58.33 9.6 0.01 OUTLIER 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 116.004 1.853 . . . . 0.0 116.004 -172.024 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 518' ' ' LYS . . . . . 0.766 ' HA ' ' CD1' ' A' ' 510' ' ' TRP . 0.0 OUTLIER -45.1 -48.26 12.04 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 175.841 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 519' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -75.21 -56.31 4.85 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.172 173.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 520' ' ' GLU . . . . . 0.851 ' HB2' ' HA ' ' A' ' 517' ' ' SER . 2.0 mm-40 -59.64 -47.58 85.05 Favored 'General case' 0 C--N 1.35 0.588 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.228 -178.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 521' ' ' GLY . . . . . 0.785 ' N ' ' O ' ' A' ' 517' ' ' SER . . . -49.01 -54.2 15.52 Favored Glycine 0 CA--C 1.496 -1.108 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -48.62 -47.3 40.2 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 523' ' ' ARG . . . . . 0.402 ' O ' ' HB2' ' A' ' 526' ' ' ASN . 0.0 OUTLIER -49.9 -48.92 51.27 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.725 178.667 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 524' ' ' ILE . . . . . 0.769 HD12 ' HG2' ' A' ' 580' ' ' LYS . 28.1 mm -57.33 -55.92 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 CA-C-O 121.403 0.62 . . . . 0.0 109.725 179.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 525' ' ' ILE . . . . . 0.589 ' N ' HD13 ' A' ' 525' ' ' ILE . 1.5 mm -50.28 -47.4 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 177.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 526' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 523' ' ' ARG . 36.6 m-20 -57.63 -47.76 81.32 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 114.633 -1.167 . . . . 0.0 108.5 177.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 527' ' ' ASN . . . . . 0.427 ' ND2' ' O ' ' A' ' 524' ' ' ILE . 0.0 OUTLIER -47.94 -39.54 19.52 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 113.971 -1.468 . . . . 0.0 107.715 176.891 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 528' ' ' ASN . . . . . 1.088 ' HA ' HG21 ' A' ' 556' ' ' ILE . 2.5 t30 74.31 39.99 0.45 Allowed 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 114.631 -1.168 . . . . 0.0 111.633 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 529' ' ' GLY . . . . . 0.405 ' H ' ' ND2' ' A' ' 527' ' ' ASN . . . -114.22 25.6 10.46 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 114.324 -1.307 . . . . 0.0 111.192 177.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 530' ' ' ALA . . . . . 0.83 ' O ' ' HB ' ' A' ' 556' ' ' ILE . . . -133.49 159.48 40.27 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.095 0.474 . . . . 0.0 112.046 -179.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 531' ' ' TYR . . . . . 0.52 ' CE2' ' CD2' ' A' ' 553' ' ' PHE . 0.0 OUTLIER -134.04 158.52 43.34 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 177.508 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 532' ' ' VAL . . . . . 0.742 HG12 ' OG1' ' A' ' 554' ' ' THR . 0.4 OUTLIER -126.69 135.59 63.26 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 C-N-CA 119.401 -0.919 . . . . 0.0 112.356 -179.758 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 533' ' ' GLY . . . . . 0.672 ' HA2' ' O ' ' A' ' 552' ' ' THR . . . -133.83 154.07 21.16 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 114.43 -1.259 . . . . 0.0 114.078 -179.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 534' ' ' SER . . . . . 0.501 ' N ' ' HB ' ' A' ' 552' ' ' THR . 44.7 t -134.16 137.08 44.23 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.303 -0.449 . . . . 0.0 111.37 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 535' ' ' ARG . . . . . 0.703 ' O ' ' HB3' ' A' ' 573' ' ' LEU . 0.0 OUTLIER -160.38 90.56 1.72 Allowed Pre-proline 0 C--N 1.329 -0.326 0 C-N-CA 120.305 -0.558 . . . . 0.0 112.452 178.118 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 536' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -72.63 -38.0 3.6 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.521 2.147 . . . . 0.0 112.18 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 537' ' ' GLY . . . . . 0.4 ' N ' ' HD2' ' A' ' 535' ' ' ARG . . . 84.23 52.62 3.54 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.476 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 538' ' ' VAL . . . . . 0.531 HG13 ' N ' ' A' ' 539' ' ' LYS . 11.9 p -116.23 -45.98 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 CA-C-O 121.06 0.457 . . . . 0.0 111.413 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 539' ' ' LYS . . . . . 0.531 ' N ' HG13 ' A' ' 538' ' ' VAL . 0.3 OUTLIER -107.97 162.06 14.37 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.359 -178.66 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.52 30.77 5.12 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.876 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 541' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -95.12 99.72 11.66 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.174 0.512 . . . . 0.0 110.668 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 542' ' ' GLU . . . . . 0.401 ' CB ' ' CD ' ' A' ' 543' ' ' PRO . 0.1 OUTLIER -49.06 176.05 0.04 OUTLIER Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.269 -179.84 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 543' ' ' PRO . . . . . 0.493 ' HA ' ' CB ' ' A' ' 548' ' ' PRO . 86.3 Cg_exo -45.0 -51.59 7.38 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.636 2.224 . . . . 0.0 112.781 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . 0.612 ' O ' ' N ' ' A' ' 546' ' ' GLY . . . 50.97 23.32 7.1 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.782 -0.723 . . . . 0.0 113.212 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 545' ' ' GLY . . . . . 0.66 ' O ' ' N ' ' A' ' 547' ' ' MET . . . 53.15 -46.13 0.01 OUTLIER Glycine 0 CA--C 1.531 1.046 0 N-CA-C 115.594 0.998 . . . . 0.0 115.594 179.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . 0.612 ' N ' ' O ' ' A' ' 544' ' ' GLY . . . -50.51 54.95 0.01 OUTLIER Glycine 0 CA--C 1.529 0.913 0 N-CA-C 115.522 0.969 . . . . 0.0 115.522 -178.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 547' ' ' MET . . . . . 0.66 ' N ' ' O ' ' A' ' 545' ' ' GLY . 11.6 mmt 51.24 53.67 13.94 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 117.804 0.802 . . . . 0.0 111.51 179.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 548' ' ' PRO . . . . . 0.493 ' CB ' ' HA ' ' A' ' 543' ' ' PRO . 9.5 Cg_endo -52.67 166.56 0.79 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.944 2.429 . . . . 0.0 112.754 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 549' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -124.21 -25.57 4.12 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.216 179.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 550' ' ' ASP . . . . . 0.519 ' O ' ' HA ' ' A' ' 535' ' ' ARG . 4.4 m-20 -59.34 -46.95 87.2 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.23 179.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 551' ' ' LEU . . . . . . . . . . . . . 15.9 tp -131.48 139.87 49.43 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.184 -0.917 . . . . 0.0 108.968 178.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 552' ' ' THR . . . . . 0.672 ' O ' ' HA2' ' A' ' 533' ' ' GLY . 23.6 m -133.43 148.15 51.76 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.667 0.746 . . . . 0.0 111.933 179.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 553' ' ' PHE . . . . . 0.52 ' CD2' ' CE2' ' A' ' 531' ' ' TYR . 9.6 m-85 -134.59 137.07 43.42 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 176.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 554' ' ' THR . . . . . 0.894 HG22 ' H ' ' A' ' 556' ' ' ILE . 2.8 m -133.21 139.03 32.95 Favored Pre-proline 0 C--N 1.306 -1.309 0 C-N-CA 119.745 -0.782 . . . . 0.0 109.554 178.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 555' ' ' PRO . . . . . 0.8 ' O ' HG22 ' A' ' 556' ' ' ILE . 81.2 Cg_endo -83.37 21.76 1.0 Allowed 'Trans proline' 0 N--CA 1.445 -1.324 0 C-N-CA 121.493 1.462 . . . . 0.0 111.878 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 556' ' ' ILE . . . . . 1.088 HG21 ' HA ' ' A' ' 528' ' ' ASN . 2.0 tp 63.74 32.65 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 177.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 4.0 tttm -104.07 120.06 40.28 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 558' ' ' THR . . . . . 0.641 ' HA ' ' CE1' ' A' ' 505' ' ' PHE . 8.4 t -57.85 116.66 3.6 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 115.988 1.847 . . . . 0.0 115.988 -172.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 559' ' ' TRP . . . . . 0.52 ' HB2' ' HB2' ' A' ' 563' ' ' LYS . 1.0 OUTLIER -138.4 111.19 7.68 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 103.638 -2.727 . . . . 0.0 103.638 173.796 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 560' ' ' ASN . . . . . 0.673 ' O ' HG22 ' A' ' 564' ' ' THR . 30.2 m120 -68.91 -75.87 0.1 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 -174.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 561' ' ' ALA . . . . . 0.683 ' HA ' ' CG2' ' A' ' 564' ' ' THR . . . -74.24 -48.77 26.59 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 -177.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 562' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.41 -54.72 16.03 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -177.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 563' ' ' LYS . . . . . 0.575 ' HB3' HG21 ' A' ' 504' ' ' THR . 0.0 OUTLIER -69.32 -48.63 60.91 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.087 0.402 . . . . 0.0 112.087 -178.653 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 564' ' ' THR . . . . . 0.833 HG23 ' H ' ' A' ' 565' ' ' GLN . 5.5 t -49.77 -71.32 0.07 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.661 0.267 . . . . 0.0 111.698 -178.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 565' ' ' GLN . . . . . 0.833 ' H ' HG23 ' A' ' 564' ' ' THR . 0.0 OUTLIER -48.73 -46.91 41.59 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.658 0.266 . . . . 0.0 111.66 179.966 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -49.98 -61.75 1.96 Allowed 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -178.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 567' ' ' PHE . . . . . 0.863 ' CE1' HD13 ' A' ' 568' ' ' ILE . 0.1 OUTLIER -96.66 -31.23 12.81 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -177.145 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 568' ' ' ILE . . . . . 0.897 HD11 HD13 ' A' ' 574' ' ' LEU . 1.0 OUTLIER -73.12 8.73 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.06 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -179.24 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 569' ' ' ILE . . . . . 0.705 HD12 ' N ' ' A' ' 570' ' ' ASP . 2.7 pp -53.57 -38.52 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 N-CA-C 104.709 -2.33 . . . . 0.0 104.709 178.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 570' ' ' ASP . . . . . 0.705 ' N ' HD12 ' A' ' 569' ' ' ILE . 9.7 t0 33.14 60.29 0.44 Allowed 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 114.179 -1.373 . . . . 0.0 111.936 172.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 571' ' ' GLY . . . . . 0.483 ' H ' HD12 ' A' ' 569' ' ' ILE . . . -55.06 -46.27 78.56 Favored Glycine 0 N--CA 1.439 -1.152 0 C-N-CA 116.861 -2.59 . . . . 0.0 107.784 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 572' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -120.85 -17.42 7.91 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 174.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 573' ' ' LEU . . . . . 0.703 ' HB3' ' O ' ' A' ' 535' ' ' ARG . 0.7 OUTLIER -140.57 137.49 33.76 Favored 'General case' 0 C--N 1.355 0.83 0 N-CA-C 116.175 1.917 . . . . 0.0 116.175 -177.848 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 574' ' ' LEU . . . . . 0.947 HD21 ' CG1' ' A' ' 508' ' ' VAL . 0.0 OUTLIER -134.92 134.1 40.28 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 173.612 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 575' ' ' ILE . . . . . 0.93 ' N ' HD12 ' A' ' 574' ' ' LEU . 0.0 OUTLIER -133.13 137.07 54.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-O 121.564 0.697 . . . . 0.0 111.818 179.393 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 576' ' ' LEU . . . . . 0.585 HD22 ' HB3' ' A' ' 509' ' ' LEU . 0.0 OUTLIER -133.19 135.8 45.3 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 177.25 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 577' ' ' LYS . . . . . . . . . . . . . 3.9 mtpt -129.98 135.38 48.24 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.656 178.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.475 HD21 HD11 ' A' ' 576' ' ' LEU . 0.2 OUTLIER -124.99 131.79 53.36 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 177.739 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 579' ' ' GLY . . . . . . . . . . . . . . . -90.78 -1.94 72.93 Favored Glycine 0 N--CA 1.442 -0.965 0 CA-C-N 115.169 -0.923 . . . . 0.0 113.494 -178.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 580' ' ' LYS . . . . . 0.769 ' HG2' HD12 ' A' ' 524' ' ' ILE . 3.0 pptp? -72.53 -47.73 46.0 Favored 'General case' 0 N--CA 1.438 -1.046 0 C-N-CA 118.851 -1.14 . . . . 0.0 108.726 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 581' ' ' TRP . . . . . 0.565 ' CG ' ' HD2' ' A' ' 580' ' ' LYS . 33.3 m0 -138.84 -53.21 0.58 Allowed 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 177.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 582' ' ' LYS . . . . . 0.63 ' HD3' HD11 ' A' ' 514' ' ' LEU . 0.0 OUTLIER -140.44 165.53 27.17 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 -174.316 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 583' ' ' MET . . . . . . . . . . . . . 1.1 ttt -109.32 134.89 51.24 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 173.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 584' ' ' LYS . . . . . 0.57 ' HB2' ' HG ' ' A' ' 514' ' ' LEU . 5.5 tppt? -120.08 133.77 55.43 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 178.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 585' ' ' LEU . . . . . 0.862 HD22 ' CD ' ' A' ' 492' ' ' ARG . 5.8 tt -120.0 136.38 54.57 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 -179.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 586' ' ' VAL . . . . . 0.764 HG22 HG23 ' A' ' 493' ' ' VAL . 72.0 t -133.31 137.65 52.82 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.813 -178.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 587' ' ' SER . . . . . . . . . . . . . 1.9 m -109.83 136.5 49.04 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 177.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.742 HG21 HG21 ' A' ' 500' ' ' VAL . 3.3 pt -133.35 136.35 54.95 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 -178.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 3.8 t -133.74 138.15 51.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 114.022 -1.445 . . . . 0.0 110.287 178.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 590' ' ' SER . . . . . . . . . . . . . 6.9 m -68.12 126.77 30.57 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.254 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 591' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -50.24 -50.05 51.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.136 0.493 . . . . 0.0 110.063 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -51.64 -49.52 62.12 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.176 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 25.4 mtpt -51.08 -48.77 61.55 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.781 0.8 . . . . 0.0 109.257 179.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 594' ' ' PHE . . . . . 0.741 ' CD1' HD11 ' A' ' 597' ' ' LEU . 0.8 OUTLIER -50.24 -48.41 54.65 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 114.543 -1.208 . . . . 0.0 109.648 178.153 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 595' ' ' LYS . . . . . 0.521 ' O ' ' HB3' ' A' ' 599' ' ' LEU . 0.0 OUTLIER -49.42 -48.2 47.45 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.263 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 596' ' ' GLU . . . . . 0.473 ' O ' HD23 ' A' ' 599' ' ' LEU . 0.5 OUTLIER -52.56 -56.88 12.2 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.43 -179.672 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 597' ' ' LEU . . . . . 0.741 HD11 ' CD1' ' A' ' 594' ' ' PHE . 0.6 OUTLIER -64.82 -62.46 1.55 Allowed 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.376 0.608 . . . . 0.0 112.015 -178.767 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 598' ' ' GLY . . . . . 0.487 ' O ' ' CD1' ' A' ' 604' ' ' TRP . . . -77.8 13.45 13.08 Favored Glycine 0 C--N 1.32 -0.324 0 CA-C-N 115.119 -0.946 . . . . 0.0 113.573 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 599' ' ' LEU . . . . . 0.673 HD12 ' N ' ' A' ' 600' ' ' THR . 2.6 pp -47.47 -15.18 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -175.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 600' ' ' THR . . . . . 0.673 ' N ' HD12 ' A' ' 599' ' ' LEU . 11.0 t -131.98 66.79 1.54 Allowed 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.827 176.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 601' ' ' ALA . . . . . 0.741 ' HB1' ' HD2' ' A' ' 602' ' ' PRO . . . -131.47 167.56 21.33 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.477 179.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 602' ' ' PRO . . . . . 0.741 ' HD2' ' HB1' ' A' ' 601' ' ' ALA . 58.4 Cg_endo -70.01 -12.15 31.88 Favored 'Trans proline' 0 N--CA 1.465 -0.2 0 C-N-CA 122.225 1.95 . . . . 0.0 111.262 178.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 603' ' ' GLY . . . . . 0.615 ' O ' HG23 ' A' ' 607' ' ' VAL . . . -70.81 -48.95 31.53 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.675 -0.693 . . . . 0.0 113.037 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 604' ' ' TRP . . . . . 0.533 ' HA ' ' HE3' ' A' ' 604' ' ' TRP . 1.0 OUTLIER -64.03 -46.41 84.58 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 120.734 0.302 . . . . 0.0 111.58 -179.344 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 605' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -50.75 -52.29 42.01 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.863 0.364 . . . . 0.0 110.363 -178.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -61.18 -63.06 1.42 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.482 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 607' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 603' ' ' GLY . 41.9 t -50.75 -71.31 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -178.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 608' ' ' VAL . . . . . 0.429 HG21 ' HZ2' ' A' ' 595' ' ' LYS . 96.1 t -69.59 -58.66 4.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -177.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 609' ' ' GLY . . . . . . . . . . . . . . . -59.83 -63.58 4.96 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.007 -0.616 . . . . 0.0 113.381 -178.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 610' ' ' LYS . . . . . . . . . . . . . 11.4 mttt -70.5 -71.77 0.23 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.785 0.326 . . . . 0.0 111.036 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 101.99 46.85 1.54 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.456 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 20.5 tttt -99.34 38.93 1.34 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.839 0.352 . . . . 0.0 110.999 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 613' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -74.88 172.37 12.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.858 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . 0.404 ' CB ' ' CD ' ' A' ' 615' ' ' PRO . 7.3 mt-10 -62.74 -60.81 8.85 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.904 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 615' ' ' PRO . . . . . 0.404 ' CD ' ' CB ' ' A' ' 614' ' ' GLU . 59.1 Cg_endo -72.0 108.4 2.45 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.625 2.217 . . . . 0.0 112.267 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 616' ' ' SER . . . . . . . . . . . . . 43.2 t -67.52 111.1 6.5 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.902 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo . . . . . 0 C--O 1.249 1.046 0 C-N-CA 122.435 2.09 . . . . 0.0 112.306 -179.996 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 4.0 ptt? . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.741 0.305 . . . . 0.0 111.211 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 455' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.89 161.67 45.06 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.629 2.219 . . . . 0.0 112.288 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 456' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -85.1 -26.54 26.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.065 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 20.6 p -97.38 38.69 1.24 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.916 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -75.43 93.07 2.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.084 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 1.2 m -90.62 163.62 29.71 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.966 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -69.49 -174.7 0.9 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.604 2.202 . . . . 0.0 112.25 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . 107.04 40.77 1.77 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.507 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -94.71 162.83 24.26 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.775 0.321 . . . . 0.0 110.897 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -51.74 112.46 0.84 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.63 2.22 . . . . 0.0 112.308 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.21 119.81 39.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.852 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 1.3 m -115.83 -76.42 0.57 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.952 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -75.43 -25.97 57.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.981 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . 0.48 HD23 ' H ' ' A' ' 467' ' ' LEU . 0.7 OUTLIER -106.31 71.13 0.86 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.889 -179.962 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -114.93 42.89 2.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.785 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 128.96 -36.93 2.31 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.251 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -114.63 117.75 31.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.823 0.344 . . . . 0.0 110.603 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 471' ' ' VAL . . . . . 0.569 HG13 ' O ' ' A' ' 471' ' ' VAL . 10.9 p -113.19 108.34 25.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.092 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 22.7 p30 -136.0 148.43 64.83 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.868 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.16 108.69 0.28 Allowed 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.561 2.174 . . . . 0.0 112.283 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -107.16 -34.03 7.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.833 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 11.1 p -103.27 -30.14 10.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.96 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 476' ' ' GLY . . . . . . . . . . . . . . . 130.96 -23.51 4.39 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.649 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 477' ' ' ASN . . . . . 0.422 ' N ' ' CD ' ' A' ' 478' ' ' PRO . 7.2 p-10 43.93 51.87 8.37 Favored Pre-proline 0 N--CA 1.463 0.202 0 CA-C-O 120.776 0.322 . . . . 0.0 111.442 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 478' ' ' PRO . . . . . 0.422 ' CD ' ' N ' ' A' ' 477' ' ' ASN . 72.0 Cg_endo -76.76 -22.67 11.66 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.614 2.209 . . . . 0.0 112.498 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -61.72 84.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.005 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -140.47 131.54 13.95 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.801 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 481' ' ' PRO . . . . . 0.411 ' HB2' ' H ' ' A' ' 482' ' ' GLN . 84.5 Cg_exo -47.03 -79.12 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.315 2.01 . . . . 0.0 112.359 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 482' ' ' GLN . . . . . 0.411 ' H ' ' HB2' ' A' ' 481' ' ' PRO . 0.0 OUTLIER -136.09 -72.01 0.46 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.294 0.569 . . . . 0.0 109.724 179.092 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 483' ' ' THR . . . . . 0.496 HG22 ' H ' ' A' ' 485' ' ' PHE . 88.3 m -137.12 157.49 46.57 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.294 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 484' ' ' ASN . . . . . 0.484 ' O ' ' CD ' ' A' ' 489' ' ' PRO . 7.4 t-20 -94.59 -34.7 12.53 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 485' ' ' PHE . . . . . 0.742 ' HA ' ' HG2' ' A' ' 489' ' ' PRO . 19.5 m-85 -49.87 -46.8 51.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.02 178.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -68.96 -47.7 65.0 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -178.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 487' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -71.15 -74.81 0.14 Allowed 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 114.962 1.467 . . . . 0.0 114.962 -176.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 488' ' ' MET . . . . . 0.535 ' CB ' ' HD3' ' A' ' 489' ' ' PRO . 3.3 tpp -52.95 -53.13 58.49 Favored Pre-proline 0 N--CA 1.47 0.556 0 CA-C-O 121.204 0.526 . . . . 0.0 111.576 -178.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 489' ' ' PRO . . . . . 0.742 ' HG2' ' HA ' ' A' ' 485' ' ' PHE . 12.3 Cg_exo -75.13 44.18 1.14 Allowed 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 124.566 3.511 . . . . 0.0 112.661 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -36.78 -31.15 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -178.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 491' ' ' ALA . . . . . 0.412 ' CB ' HD21 ' A' ' 514' ' ' LEU . . . -132.02 135.7 46.72 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.499 -0.481 . . . . 0.0 110.967 178.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 492' ' ' ARG . . . . . 0.692 ' HD3' HD22 ' A' ' 585' ' ' LEU . 10.6 tpt180 -136.25 134.38 38.01 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 178.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 493' ' ' VAL . . . . . 0.984 ' CG2' HG22 ' A' ' 586' ' ' VAL . 25.3 m -136.98 163.87 31.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 116.212 -0.449 . . . . 0.0 112.026 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 70.0 p -115.89 132.82 56.53 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 176.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 495' ' ' LEU . . . . . 0.994 ' O ' HG22 ' A' ' 588' ' ' ILE . 0.0 OUTLIER -136.62 162.84 53.76 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.637 -179.667 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 496' ' ' PRO . . . . . 0.696 ' HD2' HD12 ' A' ' 495' ' ' LEU . 9.8 Cg_exo -71.84 120.0 6.58 Favored 'Trans proline' 0 CA--C 1.534 0.481 0 C-N-CA 122.376 2.051 . . . . 0.0 111.328 178.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 497' ' ' LYS . . . . . 0.883 ' O ' HG12 ' A' ' 500' ' ' VAL . 0.1 OUTLIER -56.6 -30.25 63.0 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -178.739 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 498' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.56 -48.47 79.35 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -177.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 499' ' ' LEU . . . . . 0.824 HD11 HD11 ' A' ' 495' ' ' LEU . 2.6 pp -73.85 -9.08 58.29 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -178.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . 0.883 HG12 ' O ' ' A' ' 497' ' ' LYS . 3.5 p -75.34 -25.38 17.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.507 0.67 . . . . 0.0 111.595 -179.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 501' ' ' TYR . . . . . 0.676 ' O ' ' CG2' ' A' ' 564' ' ' THR . 2.6 m-30 -53.72 -29.27 38.54 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -178.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -76.67 -50.2 14.29 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 116.176 1.917 . . . . 0.0 116.176 -175.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 503' ' ' LYS . . . . . 0.579 ' O ' ' CG ' ' A' ' 507' ' ' LYS . 8.9 mttt -119.81 136.41 54.48 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 119.178 0.899 . . . . 0.0 112.561 -178.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . 0.799 HG23 ' CE1' ' A' ' 567' ' ' PHE . 51.0 m -74.07 -76.61 0.13 Allowed 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 179.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . 0.617 ' CZ ' HD13 ' A' ' 556' ' ' ILE . 0.2 OUTLIER -75.31 -60.98 2.06 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -178.965 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 506' ' ' SER . . . . . 0.783 ' O ' ' CD1' ' A' ' 510' ' ' TRP . 0.7 OUTLIER -49.6 -73.07 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 114.833 1.419 . . . . 0.0 114.833 -176.264 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 507' ' ' LYS . . . . . 0.698 ' HD3' ' N ' ' A' ' 508' ' ' VAL . 0.0 OUTLIER -49.18 -48.61 45.0 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -176.756 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 508' ' ' VAL . . . . . 0.87 HG13 HD21 ' A' ' 574' ' ' LEU . 98.0 t -53.91 -59.48 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 509' ' ' LEU . . . . . 0.797 HD12 ' N ' ' A' ' 510' ' ' TRP . 2.2 pp -56.52 -61.8 2.17 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 115.477 1.658 . . . . 0.0 115.477 -177.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 510' ' ' TRP . . . . . 0.859 ' CD1' ' HA ' ' A' ' 518' ' ' LYS . 67.1 p-90 -72.79 -51.46 18.9 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -176.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 511' ' ' SER . . . . . 0.497 ' N ' ' CE3' ' A' ' 510' ' ' TRP . 0.6 OUTLIER -64.18 -47.45 79.78 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.363 -0.835 . . . . 0.0 113.174 -176.854 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 512' ' ' ALA . . . . . 0.761 ' HB3' ' O ' ' A' ' 508' ' ' VAL . . . -70.95 -73.04 0.18 Allowed 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 117.796 2.517 . . . . 0.0 117.796 -174.085 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 513' ' ' GLY . . . . . 0.859 ' CA ' HG21 ' A' ' 493' ' ' VAL . . . -114.76 -35.2 1.42 Allowed Glycine 0 CA--C 1.5 -0.897 0 N-CA-C 120.853 3.101 . . . . 0.0 120.853 -172.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 514' ' ' LEU . . . . . 0.606 HD23 ' CG ' ' A' ' 584' ' ' LYS . 0.1 OUTLIER -107.14 -46.84 3.81 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 119.506 3.151 . . . . 0.0 119.506 -170.056 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 515' ' ' VAL . . . . . 1.012 HG13 ' HB2' ' A' ' 517' ' ' SER . 2.5 p -154.71 172.72 0.61 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.589 0 N-CA-C 117.887 2.551 . . . . 0.0 117.887 -172.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 516' ' ' ALA . . . . . 0.554 ' N ' HG22 ' A' ' 515' ' ' VAL . . . -67.89 4.18 1.26 Allowed 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 126.761 2.025 . . . . 0.0 109.696 177.099 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . 1.012 ' HB2' HG13 ' A' ' 515' ' ' VAL . 0.5 OUTLIER -57.55 9.28 0.01 OUTLIER 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 115.775 1.769 . . . . 0.0 115.775 -172.043 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 518' ' ' LYS . . . . . 0.859 ' HA ' ' CD1' ' A' ' 510' ' ' TRP . 0.0 OUTLIER -45.06 -46.82 11.73 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 104.351 -2.463 . . . . 0.0 104.351 175.413 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 519' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.16 -58.29 3.37 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.962 173.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 520' ' ' GLU . . . . . 0.846 ' HB2' ' HA ' ' A' ' 517' ' ' SER . 2.6 mm-40 -59.05 -47.44 85.21 Favored 'General case' 0 C--N 1.351 0.659 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.941 -178.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 521' ' ' GLY . . . . . 0.841 ' N ' ' O ' ' A' ' 517' ' ' SER . . . -49.12 -55.16 12.57 Favored Glycine 0 CA--C 1.493 -1.333 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.25 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -48.02 -47.42 33.45 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 523' ' ' ARG . . . . . 0.475 ' O ' ' HB3' ' A' ' 526' ' ' ASN . 0.1 OUTLIER -50.2 -48.94 54.02 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.988 178.463 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 524' ' ' ILE . . . . . 0.655 HD12 ' HD3' ' A' ' 580' ' ' LYS . 12.8 mm -58.24 -54.82 27.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.424 0.63 . . . . 0.0 109.717 179.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 525' ' ' ILE . . . . . 0.819 HG23 ' CD1' ' A' ' 556' ' ' ILE . 0.7 OUTLIER -50.4 -47.42 26.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 177.683 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 526' ' ' ASN . . . . . 0.475 ' HB3' ' O ' ' A' ' 523' ' ' ARG . 0.9 OUTLIER -55.8 -47.99 76.16 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 114.122 -1.399 . . . . 0.0 108.228 177.393 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 527' ' ' ASN . . . . . 0.483 ' ND2' ' O ' ' A' ' 524' ' ' ILE . 0.0 OUTLIER -48.13 -40.13 22.75 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.076 -1.42 . . . . 0.0 107.189 176.517 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 528' ' ' ASN . . . . . 0.559 ' HA ' ' CG2' ' A' ' 556' ' ' ILE . 13.5 t-20 73.67 40.47 0.49 Allowed 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 114.631 -1.168 . . . . 0.0 111.736 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 529' ' ' GLY . . . . . . . . . . . . . . . -115.69 27.64 8.23 Favored Glycine 0 CA--C 1.523 0.583 0 C-N-CA 120.337 -0.935 . . . . 0.0 112.779 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 530' ' ' ALA . . . . . 0.969 ' O ' ' HB ' ' A' ' 556' ' ' ILE . . . -133.96 164.03 28.21 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 112.524 0.565 . . . . 0.0 112.524 -179.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 531' ' ' TYR . . . . . 0.538 ' CE2' ' CD2' ' A' ' 553' ' ' PHE . 0.0 OUTLIER -133.99 156.02 48.93 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 177.875 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 532' ' ' VAL . . . . . 0.647 HG12 ' OG1' ' A' ' 554' ' ' THR . 0.5 OUTLIER -127.33 135.5 63.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 C-N-CA 119.537 -0.865 . . . . 0.0 112.123 -179.647 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 533' ' ' GLY . . . . . 0.685 ' O ' HG13 ' A' ' 575' ' ' ILE . . . -133.88 155.64 21.91 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 114.367 -1.288 . . . . 0.0 113.841 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 534' ' ' SER . . . . . 0.555 ' HB2' ' OG1' ' A' ' 552' ' ' THR . 0.6 OUTLIER -134.54 141.24 46.63 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.176 -0.512 . . . . 0.0 110.936 178.605 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 535' ' ' ARG . . . . . 0.569 ' O ' ' HB3' ' A' ' 573' ' ' LEU . 9.2 tpp85 -159.47 90.92 1.9 Allowed Pre-proline 0 CA--C 1.531 0.232 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 179.011 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 536' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.17 -46.23 1.56 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.511 2.141 . . . . 0.0 111.961 178.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 94.86 13.81 51.81 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.865 -0.683 . . . . 0.0 113.03 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 538' ' ' VAL . . . . . 0.658 ' O ' HG12 ' A' ' 538' ' ' VAL . 21.8 t -116.35 18.39 7.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.878 0.37 . . . . 0.0 111.679 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 539' ' ' LYS . . . . . . . . . . . . . 28.6 mttm -107.34 111.36 23.67 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.313 0.578 . . . . 0.0 112.181 -179.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 17.9 mmtt -110.38 -3.2 16.26 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.904 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 541' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -96.43 104.33 16.29 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.001 0.429 . . . . 0.0 109.922 179.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -47.62 101.6 0.27 Allowed Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.974 -179.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 543' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -51.28 -10.51 0.42 Allowed 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.353 2.702 . . . . 0.0 114.263 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . 0.528 ' C ' ' H ' ' A' ' 546' ' ' GLY . . . 52.04 54.64 25.01 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 119.806 -1.188 . . . . 0.0 111.639 -179.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 545' ' ' GLY . . . . . 0.621 ' O ' ' N ' ' A' ' 547' ' ' MET . . . 54.58 -7.07 0.01 OUTLIER Glycine 0 CA--C 1.528 0.881 0 CA-C-O 119.614 -0.548 . . . . 0.0 114.364 -178.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . 0.528 ' H ' ' C ' ' A' ' 544' ' ' GLY . . . -53.42 54.79 0.01 OUTLIER Glycine 0 CA--C 1.528 0.847 0 CA-C-N 117.474 0.637 . . . . 0.0 114.231 177.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 547' ' ' MET . . . . . 0.621 ' N ' ' O ' ' A' ' 545' ' ' GLY . 1.3 mpt? 52.06 54.3 13.92 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 118.568 1.184 . . . . 0.0 110.677 -179.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 548' ' ' PRO . . . . . 0.497 ' HD3' ' N ' ' A' ' 547' ' ' MET . 81.7 Cg_exo -46.44 166.46 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 123.171 2.58 . . . . 0.0 113.559 -179.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 549' ' ' ASP . . . . . 0.69 ' HB3' HD11 ' A' ' 569' ' ' ILE . 9.9 m-20 -124.36 -20.28 5.25 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.404 178.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 550' ' ' ASP . . . . . 0.512 ' O ' ' HA ' ' A' ' 535' ' ' ARG . 1.2 p30 -51.85 -41.89 62.19 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.106 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 551' ' ' LEU . . . . . 0.622 HD21 ' HE1' ' A' ' 553' ' ' PHE . 10.7 tp -131.62 139.47 49.14 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.661 -1.154 . . . . 0.0 108.53 177.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 552' ' ' THR . . . . . 0.799 HG21 ' CB ' ' A' ' 567' ' ' PHE . 5.6 m -133.83 148.31 51.29 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.598 0.713 . . . . 0.0 111.756 179.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 553' ' ' PHE . . . . . 0.622 ' HE1' HD21 ' A' ' 551' ' ' LEU . 21.8 m-85 -134.25 137.65 44.48 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.07 -0.968 . . . . 0.0 108.613 177.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 554' ' ' THR . . . . . 0.849 HG22 ' H ' ' A' ' 556' ' ' ILE . 2.8 m -132.5 139.04 33.49 Favored Pre-proline 0 C--N 1.307 -1.253 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 555' ' ' PRO . . . . . 0.937 ' O ' HG22 ' A' ' 556' ' ' ILE . 77.5 Cg_endo -83.78 24.0 0.79 Allowed 'Trans proline' 0 N--CA 1.444 -1.411 0 C-N-CA 121.573 1.516 . . . . 0.0 112.142 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 556' ' ' ILE . . . . . 0.969 ' HB ' ' O ' ' A' ' 530' ' ' ALA . 7.3 tp 61.38 30.9 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 177.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . 0.505 ' HB3' ' CE2' ' A' ' 559' ' ' TRP . 0.3 OUTLIER -105.79 117.85 35.08 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 105.096 -2.187 . . . . 0.0 105.096 179.257 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 558' ' ' THR . . . . . . . . . . . . . 2.3 t -56.89 117.82 4.33 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -172.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 559' ' ' TRP . . . . . 0.512 ' HB2' ' CB ' ' A' ' 563' ' ' LYS . 5.4 m0 -136.58 111.8 9.08 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 104.981 -2.229 . . . . 0.0 104.981 175.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 560' ' ' ASN . . . . . 0.512 ' O ' ' HB ' ' A' ' 564' ' ' THR . 75.9 m-20 -78.25 -74.4 0.27 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -175.018 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 561' ' ' ALA . . . . . . . . . . . . . . . -73.16 -64.01 1.06 Allowed 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 115.752 1.76 . . . . 0.0 115.752 -176.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 562' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.01 -50.65 35.05 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -176.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 563' ' ' LYS . . . . . 0.638 ' CG ' HG21 ' A' ' 504' ' ' THR . 0.0 OUTLIER -70.67 -49.07 51.18 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.392 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 564' ' ' THR . . . . . 0.676 ' CG2' ' O ' ' A' ' 501' ' ' TYR . 2.0 t -53.7 -64.33 0.86 Allowed 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 121.114 -0.235 . . . . 0.0 110.922 -178.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 565' ' ' GLN . . . . . 0.521 ' N ' HG23 ' A' ' 564' ' ' THR . 0.0 OUTLIER -48.51 -47.46 38.89 Favored 'General case' 0 C--N 1.321 -0.643 0 O-C-N 122.135 -0.353 . . . . 0.0 111.195 179.012 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . 0.419 ' O ' ' CD1' ' A' ' 569' ' ' ILE . 1.8 tt0 -49.61 -56.13 11.12 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -178.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 567' ' ' PHE . . . . . 0.799 ' CB ' HG21 ' A' ' 552' ' ' THR . 0.4 OUTLIER -97.22 -45.09 6.65 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.417 0.627 . . . . 0.0 112.156 -178.387 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 568' ' ' ILE . . . . . 0.947 HD11 HD22 ' A' ' 574' ' ' LEU . 1.5 tp -58.0 9.29 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 569' ' ' ILE . . . . . 0.69 HD11 ' HB3' ' A' ' 549' ' ' ASP . 0.0 OUTLIER -55.09 -39.22 49.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 104.525 -2.398 . . . . 0.0 104.525 179.009 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 570' ' ' ASP . . . . . 0.649 ' CG ' HD11 ' A' ' 588' ' ' ILE . 15.1 p30 31.77 55.75 0.3 Allowed 'General case' 0 CA--C 1.51 -0.587 0 CA-C-N 114.04 -1.436 . . . . 0.0 112.643 173.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -51.39 -44.88 53.22 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 117.316 -2.373 . . . . 0.0 108.505 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 572' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -119.6 -16.44 8.85 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 175.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 573' ' ' LEU . . . . . 0.569 ' HB3' ' O ' ' A' ' 535' ' ' ARG . 1.3 tp -139.86 137.29 34.78 Favored 'General case' 0 C--N 1.353 0.746 0 N-CA-C 116.39 1.996 . . . . 0.0 116.39 -177.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 574' ' ' LEU . . . . . 0.947 HD22 HD11 ' A' ' 568' ' ' ILE . 0.2 OUTLIER -134.81 133.39 39.74 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 173.048 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 575' ' ' ILE . . . . . 0.925 ' N ' HD12 ' A' ' 574' ' ' LEU . 0.0 OUTLIER -134.09 138.24 50.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 118.86 0.754 . . . . 0.0 112.007 179.297 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 576' ' ' LEU . . . . . 0.551 HD11 ' HG ' ' A' ' 578' ' ' LEU . 0.1 OUTLIER -132.99 135.53 45.52 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 177.181 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 577' ' ' LYS . . . . . 0.44 ' HE3' ' HE3' ' A' ' 583' ' ' MET . 25.2 mttt -132.2 135.45 46.34 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 119.009 -1.076 . . . . 0.0 110.359 177.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.551 ' HG ' HD11 ' A' ' 576' ' ' LEU . 0.3 OUTLIER -124.45 131.91 53.5 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 177.84 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 579' ' ' GLY . . . . . . . . . . . . . . . -89.1 -2.2 78.04 Favored Glycine 0 CA--C 1.498 -0.976 0 CA-C-N 115.236 -0.893 . . . . 0.0 113.335 -178.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 580' ' ' LYS . . . . . 0.655 ' HD3' HD12 ' A' ' 524' ' ' ILE . 0.0 OUTLIER -72.41 -48.16 43.52 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 119.087 -1.045 . . . . 0.0 108.889 179.233 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 581' ' ' TRP . . . . . 0.449 ' CD1' ' O ' ' A' ' 580' ' ' LYS . 23.6 m0 -139.7 -53.12 0.53 Allowed 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 177.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 582' ' ' LYS . . . . . 0.486 ' O ' HD12 ' A' ' 578' ' ' LEU . 0.0 OUTLIER -140.26 165.37 27.58 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -174.636 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 583' ' ' MET . . . . . 0.44 ' HE3' ' HE3' ' A' ' 577' ' ' LYS . 1.9 ttt -110.76 134.52 52.41 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.468 -1.679 . . . . 0.0 106.468 173.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 584' ' ' LYS . . . . . 0.792 ' NZ ' HG12 ' A' ' 508' ' ' VAL . 0.5 OUTLIER -119.66 134.73 55.11 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 178.787 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 585' ' ' LEU . . . . . 0.721 ' HG ' HG23 ' A' ' 575' ' ' ILE . 5.7 tt -121.4 136.96 54.9 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 586' ' ' VAL . . . . . 0.984 HG22 ' CG2' ' A' ' 493' ' ' VAL . 30.7 t -132.19 137.07 55.4 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.734 -178.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 587' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -112.87 134.32 54.44 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 177.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.994 HG22 ' O ' ' A' ' 495' ' ' LEU . 0.1 OUTLIER -135.17 140.58 44.81 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.568 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -178.257 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 6.2 p -133.14 145.73 33.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 114.369 -1.287 . . . . 0.0 110.473 178.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 590' ' ' SER . . . . . . . . . . . . . 6.0 t -52.95 142.81 18.56 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.672 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 591' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -50.38 -49.16 55.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.094 0.473 . . . . 0.0 110.541 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -52.85 -50.95 62.73 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.194 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.36 -48.3 55.75 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.733 0.778 . . . . 0.0 109.132 179.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 594' ' ' PHE . . . . . 0.777 ' CD1' HD11 ' A' ' 597' ' ' LEU . 0.9 OUTLIER -49.98 -48.07 52.51 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.495 178.326 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 595' ' ' LYS . . . . . 0.502 ' HA ' ' CE2' ' A' ' 604' ' ' TRP . 0.0 OUTLIER -49.09 -47.7 44.96 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.945 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 596' ' ' GLU . . . . . 0.525 ' O ' HD23 ' A' ' 599' ' ' LEU . 3.2 tp10 -53.14 -63.45 1.14 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.497 -179.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 597' ' ' LEU . . . . . 0.777 HD11 ' CD1' ' A' ' 594' ' ' PHE . 0.7 OUTLIER -57.31 -60.6 3.39 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 121.364 0.602 . . . . 0.0 112.12 -178.682 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 598' ' ' GLY . . . . . 0.516 ' N ' HD12 ' A' ' 597' ' ' LEU . . . -79.78 13.56 23.48 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.056 -0.974 . . . . 0.0 113.365 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 599' ' ' LEU . . . . . 0.619 HD12 ' N ' ' A' ' 600' ' ' THR . 3.6 pp -47.46 -14.05 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -175.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 600' ' ' THR . . . . . 0.619 ' N ' HD12 ' A' ' 599' ' ' LEU . 11.8 t -131.73 66.75 1.54 Allowed 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.775 176.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 601' ' ' ALA . . . . . 0.725 ' HB1' ' HD2' ' A' ' 602' ' ' PRO . . . -131.37 166.79 25.3 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.447 179.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 602' ' ' PRO . . . . . 0.725 ' HD2' ' HB1' ' A' ' 601' ' ' ALA . 56.8 Cg_endo -69.39 -12.61 33.99 Favored 'Trans proline' 0 N--CA 1.465 -0.204 0 C-N-CA 122.215 1.943 . . . . 0.0 111.273 178.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 603' ' ' GLY . . . . . 0.645 ' O ' HG23 ' A' ' 607' ' ' VAL . . . -70.83 -49.14 30.38 Favored Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 115.715 -0.675 . . . . 0.0 113.099 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 604' ' ' TRP . . . . . 0.502 ' CE2' ' HA ' ' A' ' 595' ' ' LYS . 1.3 m95 -65.09 -46.78 79.68 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 120.889 0.375 . . . . 0.0 111.186 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 605' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -50.24 -57.82 6.97 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.329 -178.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -61.78 -56.75 16.19 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 607' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 603' ' ' GLY . 40.0 t -54.97 -71.86 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -178.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 608' ' ' VAL . . . . . . . . . . . . . 78.4 t -68.2 -58.69 5.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -177.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 609' ' ' GLY . . . . . . . . . . . . . . . -59.1 -62.51 6.12 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 121.043 -0.599 . . . . 0.0 113.165 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 610' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.29 -49.88 70.05 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.783 0.325 . . . . 0.0 110.807 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 111.05 55.55 0.51 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.456 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -87.52 -31.12 20.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.795 0.331 . . . . 0.0 110.889 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 613' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -72.96 154.41 40.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.905 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . 0.409 ' CB ' ' CD ' ' A' ' 615' ' ' PRO . 0.0 OUTLIER -60.2 -60.7 9.77 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.885 -179.988 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 615' ' ' PRO . . . . . 0.409 ' CD ' ' CB ' ' A' ' 614' ' ' GLU . 60.3 Cg_endo -72.68 85.57 1.12 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.503 2.136 . . . . 0.0 112.372 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 616' ' ' SER . . . . . . . . . . . . . 1.3 m -87.3 149.65 47.49 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.874 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo . . . . . 0 C--O 1.249 1.054 0 C-N-CA 122.592 2.194 . . . . 0.0 112.292 179.963 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 454' ' ' MET . . . . . . . . . . . . . 1.3 tmm? . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.692 0.282 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 455' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.03 121.93 8.55 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.561 2.174 . . . . 0.0 112.303 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 456' ' ' ARG . . . . . . . . . . . . . 32.9 mtt180 -85.24 -26.53 26.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.977 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -82.42 -38.1 24.54 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.882 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -59.92 110.44 1.18 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.063 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 79.0 p -109.79 147.7 36.68 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.844 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 460' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.36 -170.41 0.57 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.532 2.155 . . . . 0.0 112.307 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 461' ' ' GLY . . . . . . . . . . . . . . . 83.27 27.62 39.45 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.574 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 462' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -164.93 145.42 6.09 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.633 0.254 . . . . 0.0 110.92 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 463' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -73.96 -174.11 1.62 Allowed 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.528 2.152 . . . . 0.0 112.324 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 464' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.77 179.35 5.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.885 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 465' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -98.29 22.14 10.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.117 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 466' ' ' SER . . . . . . . . . . . . . 2.4 m -61.45 -26.74 68.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.978 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 467' ' ' LEU . . . . . 0.451 HD21 HG23 ' A' ' 471' ' ' VAL . 3.1 mt -102.33 81.26 2.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.936 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 468' ' ' SER . . . . . . . . . . . . . 2.5 m -137.95 43.29 2.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.808 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . 129.0 -36.85 2.32 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.217 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 470' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -115.92 117.72 30.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.766 0.317 . . . . 0.0 110.674 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 471' ' ' VAL . . . . . 0.586 HG13 ' O ' ' A' ' 471' ' ' VAL . 9.7 p -112.93 108.12 24.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.158 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -113.75 90.18 17.89 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.86 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 473' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -68.72 145.67 64.06 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.499 2.133 . . . . 0.0 112.227 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 474' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -97.82 36.78 1.48 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.989 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 475' ' ' SER . . . . . . . . . . . . . 3.5 m -90.03 -29.87 18.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.882 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 476' ' ' GLY . . . . . . . . . . . . . . . 124.09 44.51 0.3 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.487 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 477' ' ' ASN . . . . . 0.438 ' N ' ' HD2' ' A' ' 478' ' ' PRO . 0.7 OUTLIER -50.18 -51.69 60.39 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 120.635 0.255 . . . . 0.0 111.393 179.937 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 478' ' ' PRO . . . . . 0.438 ' HD2' ' N ' ' A' ' 477' ' ' ASN . 91.2 Cg_endo -79.64 -27.73 3.89 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.453 2.102 . . . . 0.0 112.431 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 479' ' ' HIS . . . . . . . . . . . . . 5.2 m170 -62.81 115.95 4.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.932 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 480' ' ' ALA . . . . . . . . . . . . . . . -73.46 155.63 89.41 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.066 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.49 -71.32 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.478 2.119 . . . . 0.0 112.252 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 482' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -135.33 28.99 3.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.859 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 483' ' ' THR . . . . . 0.549 HG23 ' HB2' ' A' ' 487' ' ' ASN . 55.5 m -70.39 66.77 0.32 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.073 0.463 . . . . 0.0 110.613 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 484' ' ' ASN . . . . . 0.411 ' CB ' ' CE ' ' A' ' 577' ' ' LYS . 51.1 m-20 -130.22 -68.97 0.68 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.91 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 485' ' ' PHE . . . . . 0.918 ' HB2' HD13 ' A' ' 575' ' ' ILE . 51.1 p90 -70.34 -51.37 30.54 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.814 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 486' ' ' ALA . . . . . 0.452 ' N ' ' CD2' ' A' ' 485' ' ' PHE . . . -59.31 -47.61 84.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.179 0.514 . . . . 0.0 110.071 179.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 487' ' ' ASN . . . . . 0.549 ' HB2' HG23 ' A' ' 483' ' ' THR . 53.6 t30 -69.12 -48.44 62.49 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.03 179.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 488' ' ' MET . . . . . 0.499 ' HB3' HD22 ' A' ' 585' ' ' LEU . 2.0 ptt? 51.26 51.28 10.05 Favored Pre-proline 0 N--CA 1.465 0.285 0 CA-C-O 121.229 0.538 . . . . 0.0 110.576 -179.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 489' ' ' PRO . . . . . 0.463 ' CD ' ' N ' ' A' ' 488' ' ' MET . 71.7 Cg_endo -80.0 13.86 2.06 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.087 2.525 . . . . 0.0 114.414 -178.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.71 -69.48 0.83 Allowed 'General case' 0 C--O 1.232 0.136 0 C-N-CA 119.647 -0.821 . . . . 0.0 112.494 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 491' ' ' ALA . . . . . 0.467 ' CB ' HD21 ' A' ' 514' ' ' LEU . . . -136.12 136.49 40.14 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 179.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 492' ' ' ARG . . . . . 0.458 ' HD3' HD23 ' A' ' 585' ' ' LEU . 1.0 OUTLIER -136.49 131.69 34.32 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 175.561 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 493' ' ' VAL . . . . . 1.142 HG23 HG22 ' A' ' 586' ' ' VAL . 2.5 m -139.33 164.02 25.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.688 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 494' ' ' THR . . . . . . . . . . . . . 79.7 p -130.63 132.9 45.72 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.604 176.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 495' ' ' LEU . . . . . 1.002 HD23 ' HB2' ' A' ' 512' ' ' ALA . 2.2 pp -137.04 163.23 50.84 Favored Pre-proline 0 CA--C 1.53 0.18 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.588 178.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 496' ' ' PRO . . . . . 0.685 ' HB2' HD23 ' A' ' 499' ' ' LEU . 19.8 Cg_exo -63.29 119.21 6.19 Favored 'Trans proline' 0 CA--C 1.533 0.428 0 C-N-CA 121.921 1.747 . . . . 0.0 111.658 179.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 497' ' ' LYS . . . . . 0.462 ' CA ' ' HB ' ' A' ' 588' ' ' ILE . 23.7 ttpt -56.62 -30.39 63.23 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -178.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 498' ' ' SER . . . . . . . . . . . . . 12.2 t -55.94 -48.0 76.55 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -177.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 499' ' ' LEU . . . . . 0.757 HD12 ' NZ ' ' A' ' 507' ' ' LYS . 1.1 pp -73.45 -8.36 55.58 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -178.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 500' ' ' VAL . . . . . 0.796 HG22 HD11 ' A' ' 495' ' ' LEU . 12.0 t -74.59 -25.28 19.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.31 0.576 . . . . 0.0 111.793 -179.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 501' ' ' TYR . . . . . 0.627 ' O ' ' CG2' ' A' ' 564' ' ' THR . 3.1 m-85 -53.55 -29.69 38.18 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -178.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 502' ' ' ASP . . . . . 0.421 ' O ' ' HB2' ' A' ' 560' ' ' ASN . 2.1 m-20 -76.36 -50.09 15.12 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 115.807 1.78 . . . . 0.0 115.807 -175.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 503' ' ' LYS . . . . . 0.553 ' O ' ' CG ' ' A' ' 507' ' ' LYS . 0.1 OUTLIER -119.65 135.39 54.83 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-N 119.153 0.888 . . . . 0.0 111.939 -178.896 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . 0.696 HG21 ' CG ' ' A' ' 563' ' ' LYS . 69.7 m -73.21 -76.63 0.12 Allowed 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . 0.612 ' CZ ' ' HB1' ' A' ' 530' ' ' ALA . 0.3 OUTLIER -75.78 -59.12 2.89 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -179.416 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 506' ' ' SER . . . . . 0.817 ' O ' ' CD1' ' A' ' 510' ' ' TRP . 8.0 t -49.0 -71.48 0.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 -175.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 507' ' ' LYS . . . . . 0.757 ' NZ ' HD12 ' A' ' 499' ' ' LEU . 0.0 OUTLIER -48.01 -49.07 32.22 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -174.782 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 508' ' ' VAL . . . . . 0.758 HG21 HD11 ' A' ' 574' ' ' LEU . 0.2 OUTLIER -64.23 -49.57 80.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 C-N-CA 120.299 -0.561 . . . . 0.0 111.964 -178.467 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 509' ' ' LEU . . . . . 0.761 HD12 ' N ' ' A' ' 510' ' ' TRP . 1.1 pp -55.99 -62.07 1.95 Allowed 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 -178.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 510' ' ' TRP . . . . . 0.878 ' CD1' ' HA ' ' A' ' 518' ' ' LYS . 67.4 p-90 -73.08 -49.67 27.26 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 114.722 1.378 . . . . 0.0 114.722 -176.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 511' ' ' SER . . . . . 0.506 ' N ' ' CE3' ' A' ' 510' ' ' TRP . 0.3 OUTLIER -63.5 -47.61 81.0 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -176.606 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 512' ' ' ALA . . . . . 1.002 ' HB2' HD23 ' A' ' 495' ' ' LEU . . . -70.89 -73.62 0.17 Allowed 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 117.841 2.534 . . . . 0.0 117.841 -174.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 513' ' ' GLY . . . . . 0.938 ' HA2' HG11 ' A' ' 493' ' ' VAL . . . -115.05 -35.06 1.39 Allowed Glycine 0 CA--C 1.499 -0.945 0 N-CA-C 120.696 3.038 . . . . 0.0 120.696 -173.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 514' ' ' LEU . . . . . 0.672 HD23 ' CG ' ' A' ' 584' ' ' LYS . 0.1 OUTLIER -103.08 -47.97 4.18 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 119.105 3.002 . . . . 0.0 119.105 -170.171 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 515' ' ' VAL . . . . . 1.03 HG13 ' HB2' ' A' ' 517' ' ' SER . 2.4 p -155.99 172.26 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 117.606 2.447 . . . . 0.0 117.606 -173.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 516' ' ' ALA . . . . . 0.544 ' N ' ' CG2' ' A' ' 515' ' ' VAL . . . -68.06 4.08 1.36 Allowed 'General case' 0 C--O 1.231 0.104 0 C-N-CA 126.57 1.948 . . . . 0.0 109.636 176.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . 1.03 ' HB2' HG13 ' A' ' 515' ' ' VAL . 0.6 OUTLIER -57.63 8.89 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 116.065 1.876 . . . . 0.0 116.065 -171.984 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 518' ' ' LYS . . . . . 0.878 ' HA ' ' CD1' ' A' ' 510' ' ' TRP . 0.0 OUTLIER -45.4 -46.7 13.47 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 104.432 -2.433 . . . . 0.0 104.432 175.41 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 519' ' ' SER . . . . . . . . . . . . . 1.4 p -75.08 -59.11 2.89 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.607 -1.178 . . . . 0.0 109.966 173.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 520' ' ' GLU . . . . . 0.808 ' HB2' ' HA ' ' A' ' 517' ' ' SER . 2.7 mm-40 -58.28 -47.43 83.65 Favored 'General case' 0 C--N 1.35 0.629 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.75 -179.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 521' ' ' GLY . . . . . 0.839 ' N ' ' O ' ' A' ' 517' ' ' SER . . . -49.01 -53.98 16.37 Favored Glycine 0 CA--C 1.493 -1.317 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.072 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 522' ' ' GLN . . . . . 0.434 ' HA ' HG12 ' A' ' 525' ' ' ILE . 2.0 mm100 -47.91 -47.28 32.31 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 523' ' ' ARG . . . . . 0.478 ' O ' ' HB3' ' A' ' 526' ' ' ASN . 0.4 OUTLIER -50.33 -48.82 55.21 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.818 178.266 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 524' ' ' ILE . . . . . 0.591 HG21 HD22 ' A' ' 578' ' ' LEU . 18.2 mt -57.56 -54.86 25.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.518 0.675 . . . . 0.0 109.585 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 525' ' ' ILE . . . . . 0.825 HG23 ' CD1' ' A' ' 556' ' ' ILE . 0.6 OUTLIER -50.39 -47.47 26.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.834 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 526' ' ' ASN . . . . . 0.478 ' HB3' ' O ' ' A' ' 523' ' ' ARG . 0.9 OUTLIER -56.28 -47.44 78.63 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 113.987 -1.461 . . . . 0.0 108.434 177.651 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 527' ' ' ASN . . . . . 0.493 ' ND2' ' O ' ' A' ' 524' ' ' ILE . 0.0 OUTLIER -47.52 -39.85 17.28 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.115 -1.402 . . . . 0.0 107.523 177.056 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 528' ' ' ASN . . . . . 0.646 ' HA ' ' CG2' ' A' ' 556' ' ' ILE . 1.9 t30 73.79 40.21 0.49 Allowed 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.384 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 529' ' ' GLY . . . . . . . . . . . . . . . -118.05 31.22 5.75 Favored Glycine 0 CA--C 1.523 0.585 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.657 178.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 530' ' ' ALA . . . . . 0.921 ' O ' ' HB ' ' A' ' 556' ' ' ILE . . . -133.54 164.38 27.3 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.333 0.587 . . . . 0.0 112.541 -179.027 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 531' ' ' TYR . . . . . 0.581 ' CE1' ' HA ' ' A' ' 553' ' ' PHE . 0.0 OUTLIER -134.36 152.88 52.06 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 177.752 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 532' ' ' VAL . . . . . 0.628 HG12 ' OG1' ' A' ' 554' ' ' THR . 0.4 OUTLIER -126.04 135.82 62.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 CA-C-O 121.871 0.844 . . . . 0.0 111.745 179.75 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 533' ' ' GLY . . . . . 0.724 ' O ' HG13 ' A' ' 575' ' ' ILE . . . -133.31 152.86 20.54 Favored Glycine 0 N--CA 1.443 -0.844 0 CA-C-N 114.472 -1.24 . . . . 0.0 113.783 -179.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 534' ' ' SER . . . . . 0.582 ' HB2' ' OG1' ' A' ' 552' ' ' THR . 0.5 OUTLIER -134.26 141.83 47.12 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.147 -0.527 . . . . 0.0 110.903 179.079 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 535' ' ' ARG . . . . . 0.6 ' HB3' HD22 ' A' ' 573' ' ' LEU . 0.0 OUTLIER -159.26 90.71 1.96 Allowed Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 179.225 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 536' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -59.04 -58.77 0.57 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.608 2.205 . . . . 0.0 111.86 178.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 537' ' ' GLY . . . . . . . . . . . . . . . 114.64 8.36 16.29 Favored Glycine 0 CA--C 1.519 0.344 0 C-N-CA 120.829 -0.701 . . . . 0.0 113.119 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 538' ' ' VAL . . . . . 0.609 ' O ' HG12 ' A' ' 538' ' ' VAL . 14.2 t -116.26 18.03 7.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.862 0.331 . . . . 0.0 111.653 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 539' ' ' LYS . . . . . . . . . . . . . 4.2 ptpp? -57.39 118.28 4.98 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.039 0.447 . . . . 0.0 111.194 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -128.27 -40.0 1.67 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.975 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 541' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -96.16 100.44 12.09 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.15 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -47.71 103.78 0.38 Allowed Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.884 -179.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 543' ' ' PRO . . . . . 0.459 ' HB2' ' HG3' ' A' ' 548' ' ' PRO . 77.1 Cg_exo -51.1 -7.43 0.14 Allowed 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.336 2.691 . . . . 0.0 114.522 -179.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . 0.525 ' C ' ' H ' ' A' ' 546' ' ' GLY . . . 52.09 54.74 24.69 Favored Glycine 0 C--N 1.335 0.513 0 C-N-CA 119.786 -1.197 . . . . 0.0 111.714 -179.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 545' ' ' GLY . . . . . 0.632 ' O ' ' N ' ' A' ' 547' ' ' MET . . . 54.48 -5.43 0.01 OUTLIER Glycine 0 CA--C 1.528 0.863 0 N-CA-C 114.395 0.518 . . . . 0.0 114.395 -178.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . 0.525 ' H ' ' C ' ' A' ' 544' ' ' GLY . . . -53.47 54.95 0.01 OUTLIER Glycine 0 CA--C 1.528 0.849 0 CA-C-N 117.355 0.578 . . . . 0.0 114.229 177.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 547' ' ' MET . . . . . 0.632 ' N ' ' O ' ' A' ' 545' ' ' GLY . 21.2 ttm 52.33 54.19 13.49 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 118.565 1.183 . . . . 0.0 110.502 -178.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 548' ' ' PRO . . . . . 0.501 ' HD3' ' N ' ' A' ' 547' ' ' MET . 74.4 Cg_exo -46.59 166.46 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.317 2.678 . . . . 0.0 113.639 -179.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 549' ' ' ASP . . . . . 0.495 ' HB3' HD11 ' A' ' 569' ' ' ILE . 65.8 m-20 -124.21 -18.11 5.95 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.229 178.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 550' ' ' ASP . . . . . 0.582 ' O ' ' HA ' ' A' ' 535' ' ' ARG . 40.6 m-20 -54.55 -38.62 66.83 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 551' ' ' LEU . . . . . 0.602 HD21 ' HE1' ' A' ' 553' ' ' PHE . 14.7 tp -131.47 139.61 49.39 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.35 177.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 552' ' ' THR . . . . . 0.695 ' O ' ' HA2' ' A' ' 533' ' ' GLY . 28.9 m -133.54 146.67 51.26 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.714 0.769 . . . . 0.0 112.166 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 553' ' ' PHE . . . . . 0.602 ' HE1' HD21 ' A' ' 551' ' ' LEU . 24.8 m-85 -133.99 136.88 44.41 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 176.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 554' ' ' THR . . . . . 0.891 HG22 ' H ' ' A' ' 556' ' ' ILE . 1.9 m -133.55 138.98 32.41 Favored Pre-proline 0 C--N 1.304 -1.377 0 C-N-CA 120.042 -0.663 . . . . 0.0 109.515 178.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 555' ' ' PRO . . . . . 0.851 ' O ' HG22 ' A' ' 556' ' ' ILE . 81.3 Cg_endo -82.47 19.43 1.28 Allowed 'Trans proline' 0 N--CA 1.447 -1.216 0 C-N-CA 121.486 1.457 . . . . 0.0 111.561 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 556' ' ' ILE . . . . . 0.921 ' HB ' ' O ' ' A' ' 530' ' ' ALA . 4.1 tp 61.92 32.36 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 177.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 557' ' ' LYS . . . . . . . . . . . . . 4.3 tttt -104.09 122.0 44.38 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 105.183 -2.155 . . . . 0.0 105.183 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 558' ' ' THR . . . . . . . . . . . . . 6.5 t -56.88 117.55 4.07 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 -171.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 559' ' ' TRP . . . . . 0.474 ' CH2' ' HD2' ' A' ' 555' ' ' PRO . 5.3 m0 -136.89 112.05 9.06 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 104.408 -2.442 . . . . 0.0 104.408 175.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 560' ' ' ASN . . . . . 0.514 ' O ' ' HB ' ' A' ' 564' ' ' THR . 2.5 p30 -80.93 -74.8 0.3 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 115.372 1.619 . . . . 0.0 115.372 -174.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 561' ' ' ALA . . . . . . . . . . . . . . . -72.9 -61.97 1.62 Allowed 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 115.181 1.548 . . . . 0.0 115.181 -176.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 562' ' ' SER . . . . . . . . . . . . . 85.5 p -49.27 -50.37 39.23 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -177.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 563' ' ' LYS . . . . . 0.696 ' CG ' HG21 ' A' ' 504' ' ' THR . 0.0 OUTLIER -70.98 -48.95 50.41 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -178.449 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 564' ' ' THR . . . . . 0.627 ' CG2' ' O ' ' A' ' 501' ' ' TYR . 2.0 t -54.09 -65.03 0.64 Allowed 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 121.218 -0.193 . . . . 0.0 111.35 -178.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 565' ' ' GLN . . . . . 0.709 ' O ' HG23 ' A' ' 569' ' ' ILE . 0.0 OUTLIER -49.0 -47.41 44.36 Favored 'General case' 0 C--N 1.321 -0.649 0 O-C-N 122.067 -0.395 . . . . 0.0 111.367 179.028 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -49.71 -67.0 0.3 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -178.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 567' ' ' PHE . . . . . 0.917 ' CZ ' HD13 ' A' ' 568' ' ' ILE . 0.2 OUTLIER -86.99 -43.25 12.49 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -178.056 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 568' ' ' ILE . . . . . 1.062 HD11 HD13 ' A' ' 574' ' ' LEU . 1.0 OUTLIER -62.05 8.69 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 -179.64 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 569' ' ' ILE . . . . . 0.709 HG23 ' O ' ' A' ' 565' ' ' GLN . 0.9 OUTLIER -54.72 -40.8 53.06 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 N-CA-C 105.048 -2.204 . . . . 0.0 105.048 178.905 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 570' ' ' ASP . . . . . 0.817 ' CB ' HD11 ' A' ' 588' ' ' ILE . 5.6 m-20 33.8 59.93 0.53 Allowed 'General case' 0 CA--C 1.507 -0.68 0 CA-C-N 113.833 -1.53 . . . . 0.0 112.994 173.113 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 571' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 570' ' ' ASP . . . -51.84 -45.06 55.84 Favored Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 116.865 -2.588 . . . . 0.0 108.088 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 572' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -120.41 -16.15 8.44 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 175.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 573' ' ' LEU . . . . . 0.6 HD22 ' HB3' ' A' ' 535' ' ' ARG . 2.0 tp -139.85 137.05 34.61 Favored 'General case' 0 C--N 1.354 0.772 0 N-CA-C 116.627 2.084 . . . . 0.0 116.627 -176.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 574' ' ' LEU . . . . . 1.062 HD13 HD11 ' A' ' 568' ' ' ILE . 0.1 OUTLIER -135.18 132.97 38.62 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 173.605 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 575' ' ' ILE . . . . . 1.057 HG23 HD13 ' A' ' 585' ' ' LEU . 0.0 OUTLIER -134.58 138.12 50.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 119.222 0.919 . . . . 0.0 111.763 178.786 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 576' ' ' LEU . . . . . 0.523 ' CD1' ' CE2' ' A' ' 505' ' ' PHE . 0.0 OUTLIER -132.93 135.35 45.49 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 176.875 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 577' ' ' LYS . . . . . 0.558 ' HE3' ' HE1' ' A' ' 583' ' ' MET . 0.9 OUTLIER -132.8 135.59 45.77 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 119.057 -1.057 . . . . 0.0 110.533 177.808 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.591 HD22 HG21 ' A' ' 524' ' ' ILE . 0.3 OUTLIER -123.86 131.87 53.66 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 177.749 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 579' ' ' GLY . . . . . . . . . . . . . . . -89.1 -2.06 78.29 Favored Glycine 0 N--CA 1.441 -1.007 0 CA-C-N 115.192 -0.913 . . . . 0.0 113.495 -178.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 580' ' ' LYS . . . . . 0.509 ' HD3' HG23 ' A' ' 524' ' ' ILE . 0.1 OUTLIER -74.33 -47.55 33.74 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 118.968 -1.093 . . . . 0.0 109.151 179.373 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 581' ' ' TRP . . . . . 0.462 ' CD1' ' O ' ' A' ' 580' ' ' LYS . 26.6 m0 -139.34 -52.63 0.55 Allowed 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 178.156 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 582' ' ' LYS . . . . . 0.564 ' O ' HD12 ' A' ' 578' ' ' LEU . 0.0 OUTLIER -139.81 165.25 27.79 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 -174.327 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 583' ' ' MET . . . . . 0.558 ' HE1' ' HE3' ' A' ' 577' ' ' LYS . 0.0 OUTLIER -113.75 134.53 54.7 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 174.099 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 584' ' ' LYS . . . . . 0.683 ' HE2' ' H ' ' A' ' 513' ' ' GLY . 0.3 OUTLIER -123.69 134.43 53.72 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.302 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 585' ' ' LEU . . . . . 1.057 HD13 HG23 ' A' ' 575' ' ' ILE . 6.1 tp -121.05 137.05 54.84 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -179.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 586' ' ' VAL . . . . . 1.142 HG22 HG23 ' A' ' 493' ' ' VAL . 6.0 t -131.56 136.75 56.72 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.67 -179.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 587' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.92 134.21 53.62 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 176.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.817 HD11 ' CB ' ' A' ' 570' ' ' ASP . 0.2 OUTLIER -134.96 147.74 29.33 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 -178.503 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 589' ' ' VAL . . . . . . . . . . . . . 8.0 m -132.46 148.05 31.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 113.916 -1.493 . . . . 0.0 110.334 178.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 590' ' ' SER . . . . . . . . . . . . . 4.2 t -45.99 145.99 1.37 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.978 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 591' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -50.49 -50.05 53.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.044 0.45 . . . . 0.0 110.494 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 592' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -51.51 -49.65 61.48 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.876 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 593' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.19 -48.55 54.12 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 594' ' ' PHE . . . . . 0.759 ' CD1' HD11 ' A' ' 597' ' ' LEU . 0.9 OUTLIER -50.04 -48.23 52.95 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 114.583 -1.19 . . . . 0.0 109.541 178.251 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 595' ' ' LYS . . . . . 0.484 ' HD3' ' CD1' ' A' ' 604' ' ' TRP . 0.0 OUTLIER -49.07 -47.71 44.8 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 179.029 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 596' ' ' GLU . . . . . 0.513 ' O ' HD23 ' A' ' 599' ' ' LEU . 3.6 tp10 -52.73 -63.48 1.13 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.395 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 597' ' ' LEU . . . . . 0.759 HD11 ' CD1' ' A' ' 594' ' ' PHE . 0.5 OUTLIER -58.06 -62.09 2.07 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 121.535 0.683 . . . . 0.0 112.103 -178.798 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 598' ' ' GLY . . . . . 0.459 ' O ' ' CD1' ' A' ' 604' ' ' TRP . . . -77.96 13.74 12.98 Favored Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 114.966 -1.015 . . . . 0.0 113.623 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 599' ' ' LEU . . . . . 0.657 HD12 ' N ' ' A' ' 600' ' ' THR . 3.3 pp -47.26 -15.82 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -175.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 600' ' ' THR . . . . . 0.657 ' N ' HD12 ' A' ' 599' ' ' LEU . 10.1 t -128.37 66.15 1.39 Allowed 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 119.994 -0.683 . . . . 0.0 110.324 176.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 601' ' ' ALA . . . . . . . . . . . . . . . -131.83 153.19 81.36 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.548 179.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 602' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -57.05 -21.37 41.71 Favored 'Trans proline' 0 N--CA 1.465 -0.199 0 C-N-CA 122.023 1.816 . . . . 0.0 111.199 178.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 603' ' ' GLY . . . . . 0.656 ' O ' HG23 ' A' ' 607' ' ' VAL . . . -61.3 -49.2 80.13 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.641 -0.708 . . . . 0.0 113.007 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 604' ' ' TRP . . . . . 0.501 ' CD1' ' HA ' ' A' ' 599' ' ' LEU . 1.1 m95 -64.91 -46.91 79.68 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 120.904 0.383 . . . . 0.0 111.123 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 605' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -50.32 -58.32 5.92 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.264 -178.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -60.77 -57.19 13.73 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -179.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 607' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 603' ' ' GLY . 39.0 t -55.43 -71.93 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -178.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 608' ' ' VAL . . . . . . . . . . . . . 78.8 t -67.69 -58.63 5.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -177.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 609' ' ' GLY . . . . . . . . . . . . . . . -59.51 -62.16 6.46 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 121.132 -0.556 . . . . 0.0 113.197 -178.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 610' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.56 -58.32 6.05 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.848 0.356 . . . . 0.0 110.89 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 611' ' ' GLY . . . . . . . . . . . . . . . 121.63 56.41 0.22 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.576 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -97.41 32.0 2.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.793 0.33 . . . . 0.0 110.976 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 613' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -103.22 179.93 4.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.925 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . 0.407 ' CB ' ' CD ' ' A' ' 615' ' ' PRO . 7.4 mt-10 -62.18 -60.6 9.65 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.886 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 615' ' ' PRO . . . . . 0.407 ' CD ' ' CB ' ' A' ' 614' ' ' GLU . 60.9 Cg_endo -72.81 85.54 1.15 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.558 2.172 . . . . 0.0 112.298 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 616' ' ' SER . . . . . . . . . . . . . 49.0 m -75.49 149.4 83.92 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.915 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo . . . . . 0 C--O 1.249 1.041 0 C-N-CA 122.515 2.143 . . . . 0.0 112.307 -179.964 . . . . . . . . 0 0 . 1 stop_ save_